Citrus Sinensis ID: 005669
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 684 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.910 | 0.795 | 0.541 | 0.0 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.929 | 0.748 | 0.469 | 1e-178 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.921 | 0.773 | 0.502 | 1e-173 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.928 | 0.762 | 0.470 | 1e-172 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.938 | 0.749 | 0.451 | 1e-172 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.906 | 0.731 | 0.462 | 1e-165 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.902 | 0.731 | 0.463 | 1e-164 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.921 | 0.745 | 0.457 | 1e-161 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.915 | 0.737 | 0.439 | 1e-157 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.896 | 0.728 | 0.429 | 1e-153 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 726 bits (1874), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/669 (54%), Positives = 466/669 (69%), Gaps = 46/669 (6%)
Query: 23 MEGFNLL-IIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRY 81
ME N+L ++ LF I A+ D + Q++KDG+T+VS SFE+GFFSPG S++RY
Sbjct: 1 MEATNVLHLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRY 60
Query: 82 LGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQ 141
LGIWYKKI+ TV WVANRD+PL D SG L+++ NG L L N N +WSS+SS S+Q
Sbjct: 61 LGIWYKKISLQTVVWVANRDSPLYDLSGTLKVS--ENGSLCLFNDRNHIIWSSSSSPSSQ 118
Query: 142 K-----PVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFL 196
K P+ ++++GNLVV++ D+ + +WQS DYP D LPGMK G+N TGLNRFL
Sbjct: 119 KASLRNPIVQILDTGNLVVRNSGDDQ--DYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFL 176
Query: 197 SSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTF 256
+SW++ DDP+ G++T +DP G+PQ L+KNS++ FR G WNGL +TG+P L+ NP+Y +
Sbjct: 177 TSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRY 236
Query: 257 EYVSNEKEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDS 316
EYV E+E +YTY L N SV +RM +NP G +QRYTW++ ++W + +D CD
Sbjct: 237 EYVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYL---SAMMDSCDQ 293
Query: 317 YALCGAYASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHG-DGFLEH 375
Y LCG+Y SCNIN SP C CL+GFV + + W S GCVRR LDC G DGFL+
Sbjct: 294 YTLCGSYGSCNINE-SPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKI 352
Query: 376 KAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKEL 435
+KLPDTR SW DKN+ L ECK++C +NC+C+AY+ D+R G GC+LWF DLIDI+E
Sbjct: 353 SKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREY 412
Query: 436 PESGQDLFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSNQ 495
E+GQDL++R+A+SE++ ++R + S++
Sbjct: 413 NENGQDLYVRLASSEIETLQRESS-------------------------------RVSSR 441
Query: 496 GNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ 555
E+E++ELP DL ++ AT FS NKLG+GGFGPVYKG L GQE+AVKRLS+ S Q
Sbjct: 442 KQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQ 501
Query: 556 GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDW 615
G+EEFKNE+ LIAKLQHRNLVK+LG C +ERMLIYEY PNKSLD FIFD R + LDW
Sbjct: 502 GVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDW 561
Query: 616 SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
KR II GIARG+LYLH+DSRLRIIHRDLKASNVLLD+ MN KISDFGLAR+ G D+TE
Sbjct: 562 PKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETE 621
Query: 676 ANTKRVVGT 684
ANT RVVGT
Sbjct: 622 ANTTRVVGT 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 625 bits (1611), Expect = e-178, Method: Compositional matrix adjust.
Identities = 319/679 (46%), Positives = 448/679 (65%), Gaps = 43/679 (6%)
Query: 37 YIISAARTLDTISLGQS--IKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTV 94
Y ISA +T+S +S I T+VS FELGFF PG YLGIWYK I++ T
Sbjct: 25 YSISA----NTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTY 80
Query: 95 TWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSN-SSISAQKP-VAALMESGN 152
WVANRD PLS G L+I+ LV+L+ ++ VWS+N + + P VA L+++GN
Sbjct: 81 VWVANRDTPLSSSIGTLKISDSN---LVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGN 137
Query: 153 LVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTY 212
V++D K++ PD +LWQSFD+P DTLLP MKLG + TG NRF+ SWKS DDP+ GDF++
Sbjct: 138 FVLRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSF 197
Query: 213 GLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLS 272
L+ G P++ L +R+G WNG+ ++GVP++Q F + ++++E Y++ ++
Sbjct: 198 KLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRIT 257
Query: 273 NSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNS 332
S V SR+ I+ +G +QR+TW+E + W ++F DQCD Y CG Y C+ N+ S
Sbjct: 258 KSDVYSRLSISSSGLLQRFTWIETAQNW---NQFWYAPKDQCDEYKECGVYGYCDSNT-S 313
Query: 333 PECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNI 392
P C C++GF P + + W ++ S GCVR+T L C GDGF+ K +KLPDT + VD+ I
Sbjct: 314 PVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGI 373
Query: 393 TLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELD 452
+ EC++ C ++C+CTA+AN D+RG GSGC+ W +L DI+ + GQDL++R+AA++L+
Sbjct: 374 GVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLE 433
Query: 453 NVERRRQSK------------------------NKKQVMIIITSI---SLATAVIFIGGL 485
+ +R R +K +K+ ++I T I L + + + +
Sbjct: 434 D-KRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEV 492
Query: 486 MYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIA 545
+ ++H ++ N +++ELP+ + + +A AT+NFS NKLG+GGFG VYKG L++GQE+A
Sbjct: 493 VISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMA 552
Query: 546 VKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF 605
VKRLSK S QG +EFKNEV LIA+LQH NLV+LL CC E+MLIYEYL N SLD +F
Sbjct: 553 VKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLF 612
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
D +R+ L+W R II GIARGLLYLHQDSR RIIHRDLKASN+LLD M PKISDFG+
Sbjct: 613 DKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGM 672
Query: 666 ARSFGLDQTEANTKRVVGT 684
AR FG D+TEANT++VVGT
Sbjct: 673 ARIFGRDETEANTRKVVGT 691
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 608 bits (1567), Expect = e-173, Method: Compositional matrix adjust.
Identities = 331/659 (50%), Positives = 438/659 (66%), Gaps = 29/659 (4%)
Query: 41 AARTLDTISLGQSIKDGETLVSAKESFELGFFS---PGNSKSRYLGIWYKKIAEGTVTWV 97
A + I+ + +KDG+TL S + F+LGFFS + R+LG+WY + V WV
Sbjct: 21 VALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWY--MEPFAVVWV 78
Query: 98 ANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISA-----QKPVAALMESGN 152
ANR+ PL SG L ++ G L L + + +WSS+SS + P+ + SGN
Sbjct: 79 ANRNNPLYGTSGFLNLSSL--GDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGN 136
Query: 153 LVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTY 212
L+ DG++ +LWQSFDYP +T+L GMKLG N T + LSSWK+ DP+ GDFT
Sbjct: 137 LISSDGEEA----VLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTL 192
Query: 213 GLDPRGIPQLVLRKN--SIITFRAGSWNGLHWTGVPQL-QLNPVYTFEYVSNEKEAFYTY 269
LD RG+PQL+LRKN S ++R GSWNGL +TG P + + N ++ +++ S+ +E Y++
Sbjct: 193 SLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSW 252
Query: 270 NLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNIN 329
+ V SR+V+N G + R+ + W L + D+CD Y++CGAYA C IN
Sbjct: 253 TPRHRIV-SRLVLNNTGKLHRFI-QSKQNQWILANT---APEDECDYYSICGAYAVCGIN 307
Query: 330 S-NSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWV 388
S N+P C CLQGF P S R+W++ + GCV P +C+ D F++ +KLPDT +SW
Sbjct: 308 SKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWY 367
Query: 389 D--KNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRM 446
D +TL +CK CS NCSCTAYAN D+R G GCLLWF DL+D++E GQD++IRM
Sbjct: 368 DAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVYIRM 427
Query: 447 AASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYR-RKKHSNQGNEKEEMELP 505
++++ + R ++ I + + F +M R R ++ +G E+E+++LP
Sbjct: 428 GFAKIE-FKGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGIEEEDLDLP 486
Query: 506 IFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVL 565
IFD K I+ ATD+FS N LG GGFGPVYKG L +GQEIAVKRLS SGQG+EEFKNEV
Sbjct: 487 IFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVK 546
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
LIAKLQHRNLV+LLGCC Q +E MLIYEY+PNKSLD+FIFD RS LDW KR +II G+
Sbjct: 547 LIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGV 606
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
ARG+LYLHQDSRLRIIHRDLKA NVLLDN MNPKISDFGLA+SFG DQ+E++T RVVGT
Sbjct: 607 ARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGT 665
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 605 bits (1560), Expect = e-172, Method: Compositional matrix adjust.
Identities = 315/669 (47%), Positives = 428/669 (63%), Gaps = 34/669 (5%)
Query: 44 TLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAP 103
++DTI QS++DGE ++SA + F GFFS G+S+ RY+GIWY +I++ T+ WVANRD P
Sbjct: 18 SVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHP 77
Query: 104 LSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKP--VAALMESGNLVVKDGKDN 161
++D SG+++ + N + ++ + +WS+N S S +P VA L + GNLV+ D
Sbjct: 78 INDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVTG 137
Query: 162 NPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQ 221
W+SFD+P DT LP M+LG GL+R L+SWKS DP GD ++ RG PQ
Sbjct: 138 RS---FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQ 194
Query: 222 LVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMV 281
L+L K +R GSW G W+GVP++ + ++ +V+NE E +TY ++++SV +R +
Sbjct: 195 LILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTM 254
Query: 282 INPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNI-NSNSPECECLQG 340
+N GT+ R+TW+ R K W + F V +QCD+YA CG C+ +S + EC CL G
Sbjct: 255 VNETGTMHRFTWIARDKRW---NDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPG 311
Query: 341 FVPNSQREWDMQYKSGGCVRRTPLD-CKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKE 399
F P R W ++ SGGC ++ C DGF++ K +K+PDT + VD NITL ECK+
Sbjct: 312 FEPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQ 371
Query: 400 LCSKNCSCTAYANA-DVRGRGS-GCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERR 457
C KNCSC AYA+A RG+ GCL W ++D + SGQD +IR+ EL R
Sbjct: 372 RCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARWNRN 431
Query: 458 RQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSN----------------------Q 495
S ++ ++I+I+ I+ + I + R ++ SN +
Sbjct: 432 GLSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRFE 491
Query: 496 GNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ 555
++ ELP+FDL I AT+NFS +NKLG GGFGPVYKG+L EIAVKRLS+ SGQ
Sbjct: 492 QDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQ 551
Query: 556 GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDW 615
GMEEFKNEV LI+KLQHRNLV++LGCC + +E+ML+YEYLPNKSLDYFIF + LDW
Sbjct: 552 GMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDW 611
Query: 616 SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
KR I+ GIARG+LYLHQDSRLRIIHRDLKASN+LLD+ M PKISDFG+AR FG +Q E
Sbjct: 612 PKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQME 671
Query: 676 ANTKRVVGT 684
T RVVGT
Sbjct: 672 GCTSRVVGT 680
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 604 bits (1557), Expect = e-172, Method: Compositional matrix adjust.
Identities = 315/698 (45%), Positives = 450/698 (64%), Gaps = 56/698 (8%)
Query: 26 FNLLIIYSFLFYIISAART-LDTISLGQS--IKDGETLVSAKESFELGFFSPGNSKSR-Y 81
+ L+++ + I A ++T+S +S I +TLVS FE+GFF + SR Y
Sbjct: 13 MSFLLVFVVMILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFF---RTNSRWY 69
Query: 82 LGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQ 141
LG+WYKK+++ T WVANRD PLS+ G L+I+G LVLL+ +N VW +N + +
Sbjct: 70 LGMWYKKVSDRTYVWVANRDNPLSNAIGTLKISGNN---LVLLDHSNKPVWWTNLTRGNE 126
Query: 142 KP--VAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSW 199
+ VA L+ +GN V++D +N+ LWQSFDYP DTLLP MKLG NL TGLNRFL+SW
Sbjct: 127 RSPVVAELLANGNFVMRDSSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSW 186
Query: 200 KSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYV 259
+S+DDP+ G+F+Y L+ + +P+ L + + R+G WNG+ ++G+P+ Q + ++
Sbjct: 187 RSSDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFI 246
Query: 260 SNEKEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYAL 319
N +E YT+ ++N+S SR+ + G QR TW + W F +S QCD+Y +
Sbjct: 247 ENNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRF--WSSPVDPQCDTYIM 304
Query: 320 CGAYASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVK 379
CG YA C++N+ SP C C+QGF P + ++WD + +GGC+RRT L C GDGF K +K
Sbjct: 305 CGPYAYCDVNT-SPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSCS-GDGFTRMKKMK 362
Query: 380 LPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPES- 438
LP+T + VD++I + ECK+ C +C+CTA+ANAD+R GSGC++W L DI+
Sbjct: 363 LPETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDA 422
Query: 439 --GQDLFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKH---- 492
GQDL++R+AA++ + ++R + K II ++ ++ ++ I +++RK+
Sbjct: 423 IDGQDLYVRLAAAD---IAKKRNASGK----IISLTVGVSVLLLLIMFCLWKRKQKRAKA 475
Query: 493 ------SNQGNEK--------------------EEMELPIFDLKIIANATDNFSEKNKLG 526
+ Q N+ EE+ELP+ +++ + AT+NFS NKLG
Sbjct: 476 SAISIANTQRNQNLPMNEMVLSSKREFSGEYKFEELELPLIEMETVVKATENFSSCNKLG 535
Query: 527 EGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD 586
+GGFG VYKG L++G+EIAVKRLSK S QG +EF NEV LIA+LQH NLV++LGCC + D
Sbjct: 536 QGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGD 595
Query: 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646
E+MLIYEYL N SLD ++F TR L+W++R I G+ARGLLYLHQDSR RIIHRDLK
Sbjct: 596 EKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLK 655
Query: 647 ASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
SN+LLD M PKISDFG+AR F D+TEANT +VVGT
Sbjct: 656 VSNILLDKNMIPKISDFGMARIFERDETEANTMKVVGT 693
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 582 bits (1499), Expect = e-165, Method: Compositional matrix adjust.
Identities = 307/664 (46%), Positives = 428/664 (64%), Gaps = 44/664 (6%)
Query: 53 SIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLR 112
+I +T++S + FELGFF+P +S YLGIWYK I T WVANRD PLS +G L+
Sbjct: 37 TISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSNGTLK 96
Query: 113 INGERNGILVLLNSTNDTVWSSN-SSISAQKPVAA-LMESGNLVVKDGKDNNPDNILWQS 170
I+ LV+ + ++ VWS+N + + PVAA L++ GN V++D K+N P LWQS
Sbjct: 97 ISDNN---LVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDSKNNKPSGFLWQS 153
Query: 171 FDYPCDTLLPGMKLGI-NLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSI 229
FD+P DTLL MK+G N G NR L SWK+TDDP+ GDF+ L G P+ +
Sbjct: 154 FDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNKES 213
Query: 230 ITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMVINPAGTVQ 289
IT+R+G W G ++ VP ++ + N ++ Y+Y ++ +++ S + ++ G +Q
Sbjct: 214 ITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGLLQ 273
Query: 290 RYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQGFVPNSQREW 349
R TWME ++W + D CD+Y CG Y C+ N+ SP C C++GF P +++
Sbjct: 274 RLTWMEAAQSW---KQLWYSPKDLCDNYKECGNYGYCDANT-SPICNCIKGFEPMNEQA- 328
Query: 350 DMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTA 409
++ S GCVR+T L C DGF+ K ++LPDT + VDK I L EC+E C K C+CTA
Sbjct: 329 ALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTA 388
Query: 410 YANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERRRQSKNKK----- 464
+AN D+R GSGC++W L DI+ + GQDL++R+AA +L++ ++ K+KK
Sbjct: 389 FANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLED----KRIKSKKIIGSS 444
Query: 465 ---QVMIIIT-------------SISLATAVI--------FIGGLMYRRKKHSNQGNEKE 500
++++++ SI++ T ++ + L+ + ++++ N+ +
Sbjct: 445 IGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTD 504
Query: 501 EMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEF 560
+ELP+ + K +A AT+NFS NKLG+GGFG VYKGML++G+EIAVKRLSK S QG +EF
Sbjct: 505 YLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEF 564
Query: 561 KNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH 620
NEV LIAKLQH NLV+LLGCC + E+MLIYEYL N SLD +FD TRS L+W KR
Sbjct: 565 MNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFD 624
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
II GIARGLLYLHQDSR RIIHRDLKASNVLLD M PKISDFG+AR FG ++TEANT+R
Sbjct: 625 IINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRR 684
Query: 681 VVGT 684
VVGT
Sbjct: 685 VVGT 688
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 578 bits (1489), Expect = e-164, Method: Compositional matrix adjust.
Identities = 307/663 (46%), Positives = 435/663 (65%), Gaps = 46/663 (6%)
Query: 53 SIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLR 112
+I +T++S + FELGFF+P +S YLGIWYK I T WVANRD PLS +G L+
Sbjct: 37 TISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSNGTLK 96
Query: 113 INGERNGILVLLNSTNDTVWSSN-SSISAQKPVAA-LMESGNLVVKDGKDNNPDNILWQS 170
I+G LV+ + ++ VWS+N + + PVAA L+++GN +++D + +LWQS
Sbjct: 97 ISGNN---LVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDSNNR----LLWQS 149
Query: 171 FDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSII 230
FD+P DTLL MKLG + TG NR L SWK+TDDP+ G+F+ L+ P+ + I
Sbjct: 150 FDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESI 209
Query: 231 TFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMVINPAGTVQR 290
+R+G WNG+ ++ VP + + ++++E Y+Y ++ +++ SR+ +N AG +QR
Sbjct: 210 LYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLYSRLYLNSAGLLQR 269
Query: 291 YTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQGFVPNSQREWD 350
TW E T++W + D CD+Y +CG + C+ NS P C C++GF P +++ WD
Sbjct: 270 LTWFETTQSW---KQLWYSPKDLCDNYKVCGNFGYCDSNS-LPNCYCIKGFKPVNEQAWD 325
Query: 351 MQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAY 410
++ S GC+R+T L C DGF K +KLPDT + VD+ I L CKE C ++C+CTA+
Sbjct: 326 LRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAF 385
Query: 411 ANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERRRQSKNKKQV--MI 468
ANAD+R GSGC++W +++D++ + GQDL++R+AA+EL++ ++ KN+K + I
Sbjct: 386 ANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELED----KRIKNEKIIGSSI 441
Query: 469 IITSISLATAVIF---------------------------IGGLMYRRKKHSNQGNEKEE 501
++ + L + VIF I ++ R+ ++++ + E
Sbjct: 442 GVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEY 501
Query: 502 MELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFK 561
+ELP+ +L+ +A AT+NFS NKLG+GGFG VYKG L++G+EIAVKRLSK S QG +EF
Sbjct: 502 LELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFM 561
Query: 562 NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
NEV LIAKLQH NLV+LLGCC + E+MLIYEYL N SLD +FD TRS L+W KR I
Sbjct: 562 NEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDI 621
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
I GIARGLLYLHQDSR RIIHRDLKASNVLLD M PKISDFG+AR FG ++TEANT+RV
Sbjct: 622 INGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRV 681
Query: 682 VGT 684
VGT
Sbjct: 682 VGT 684
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 568 bits (1464), Expect = e-161, Method: Compositional matrix adjust.
Identities = 309/675 (45%), Positives = 420/675 (62%), Gaps = 45/675 (6%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+TI QS+KDG+ + S + F GFFS GNSK RY+GIWY +++E T+ WVANRD P++
Sbjct: 23 NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKP--VAALMESGNLVVKD---GKD 160
D SG+++ + N + + + +WS++ Q+P VA L + GNLV+ D GK
Sbjct: 83 DTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVTGKS 142
Query: 161 NNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIP 220
W+SF++P +TLLP MK G +G++R ++SW+S DP G+ TY ++ RG P
Sbjct: 143 ------FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFP 196
Query: 221 QLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRM 280
Q+++ K + +R GSW G W+GVP++ ++ +V+N E TY + ++SV +RM
Sbjct: 197 QMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRM 256
Query: 281 VINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSP-ECECLQ 339
V+N GT+QR+ W R K W F D+CD Y CG C+ S EC CL
Sbjct: 257 VLNETGTLQRFRWNGRDKKWI---GFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLP 313
Query: 340 GFVPNSQREWDMQYKSGGCVR-RTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNITLWECK 398
G+ P + R+W ++ S GC R + C +GF + K VK+P+T VD NITL EC+
Sbjct: 314 GYEPKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECE 373
Query: 399 ELCSKNCSCTAYANA--DVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVER 456
+ C KNCSC AYA+A + + GCL W +++D + SGQD ++R+ SEL
Sbjct: 374 QRCLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARWNG 433
Query: 457 RRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSNQGNEK----------------- 499
S K+ V+I+I+ I++ ++ R+++ Q N
Sbjct: 434 NGASGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDS 493
Query: 500 ---EEME-------LPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRL 549
EE+E LP+F+L IA AT+NF+ +NKLG GGFGPVYKG+L G EIAVKRL
Sbjct: 494 FILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRL 553
Query: 550 SKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTR 609
SK SGQGMEEFKNEV LI+KLQHRNLV++LGCC + +E+ML+YEYLPNKSLDYFIF +
Sbjct: 554 SKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQ 613
Query: 610 SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
LDW KR II GI RG+LYLHQDSRLRIIHRDLKASNVLLDN M PKI+DFGLAR F
Sbjct: 614 RAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIF 673
Query: 670 GLDQTEANTKRVVGT 684
G +Q E +T RVVGT
Sbjct: 674 GGNQIEGSTNRVVGT 688
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 554 bits (1427), Expect = e-157, Method: Compositional matrix adjust.
Identities = 313/712 (43%), Positives = 430/712 (60%), Gaps = 86/712 (12%)
Query: 29 LIIYSFLFYIISAARTLDTISLGQSIKDG---ETLVSAKESFELGFFSPGNSKSRYLGIW 85
L +Y FL+ AA +TI G+S++DG + LVS +++FELGFFSPG+S R+LGIW
Sbjct: 13 LFLYFFLYESSMAA---NTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIW 69
Query: 86 YKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSN---SSISAQK 142
Y I + V WVANR P+SD+SGVL I+ + N LVLL+ N TVWSSN S+ +
Sbjct: 70 YGNIEDKAVVWVANRATPISDQSGVLMISNDGN--LVLLDGKNITVWSSNIESSTTNNNN 127
Query: 143 PVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKST 202
V ++ ++GN V+ + + P +W+SF++P DT LP M++ +N TG N SW+S
Sbjct: 128 RVVSIHDTGNFVLSETDTDRP---IWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSE 184
Query: 203 DDPARGDFTYGLDPRGIPQLVL-RKNSIITFRAGSWNGLHWTGVPQLQL--NPVYTFEYV 259
DP+ G+++ G+DP G P++VL N +R+G WN +TG+P + L N +Y F+
Sbjct: 185 TDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLS 244
Query: 260 SNEKE---AFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDS 316
S E ++TY S+ SV R + GT + W E K WT +F +CD
Sbjct: 245 SPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWT---KFQSEPDSECDQ 301
Query: 317 YALCGAYASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHG-----DG 371
Y CG + C++ ++ C C+ G+ S W S GC RRTPL C+ D
Sbjct: 302 YNRCGKFGICDMKGSNGICSCIHGYEQVSVGNW-----SRGCRRRTPLKCERNISVGEDE 356
Query: 372 FLEHKAVKLPDTRFSWVDKNITLWE-CKELCSKNCSCTAYANADVRGRGSGCLLWFHDLI 430
FL K+VKLPD F + N+ E C+E C +NCSC AY+ G GC++W DL+
Sbjct: 357 FLTLKSVKLPD--FEIPEHNLVDPEDCRERCLRNCSCNAYSLVG----GIGCMIWNQDLV 410
Query: 431 DIKELPESGQDLFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLM---Y 487
D+++ G L IR+A SE+ +N+K + +I ++ + +I I L+ +
Sbjct: 411 DLQQFEAGGSSLHIRLADSEV--------GENRKTKIAVIVAVLVGVILIGIFALLLWRF 462
Query: 488 RRKKHSN-----------------------------------QGNEKEEMELPIFDLKII 512
+RKK + +G ELP+F L I
Sbjct: 463 KRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAI 522
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
A AT++F ++N+LG GGFGPVYKG+L +G+EIAVKRLS SGQG++EFKNE++LIAKLQH
Sbjct: 523 AIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQH 582
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
RNLV+LLGCC + +E+ML+YEY+PNKSLD+F+FD T+ L+DW R II GIARGLLYL
Sbjct: 583 RNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYL 642
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
H+DSRLRIIHRDLK SNVLLD MNPKISDFG+AR FG +Q EANT RVVGT
Sbjct: 643 HRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGT 694
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 541 bits (1394), Expect = e-153, Method: Compositional matrix adjust.
Identities = 294/685 (42%), Positives = 418/685 (61%), Gaps = 72/685 (10%)
Query: 46 DTISLGQSIKDGE--TLVSAKESFELGFFSPGNSKSR--YLGIWYKKIAEGTVTWVANRD 101
D I+ IKD E TL+ F GFF+P NS +R Y+GIWY+KI TV WVAN+D
Sbjct: 31 DRITFSSPIKDSESETLLCKSGIFRFGFFTPVNSTTRLRYVGIWYEKIPIQTVVWVANKD 90
Query: 102 APLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAA------LMESGNLVV 155
+P++D SGV+ I ++G L + + N VWS+N S+ PVA LM+SGNL++
Sbjct: 91 SPINDTSGVISI--YQDGNLAVTDGRNRLVWSTNVSV----PVAPNATWVQLMDSGNLML 144
Query: 156 KDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLD 215
+D ++N ILW+SF +P D+ +P M LG + TG N L+SW S DDP+ G++T G+
Sbjct: 145 QDNRNNG--EILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAGIA 202
Query: 216 PRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSS 275
P P+L++ KN++ T+R+G WNG + G+P + ++++ + + + +N S
Sbjct: 203 PFTFPELLIWKNNVPTWRSGPWNGQVFIGLPNMDSLLFLDGFNLNSDNQGTISMSYANDS 262
Query: 276 VPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPEC 335
++P G + + W +TW + +F CD+Y CG + SC+ N P C
Sbjct: 263 FMYHFNLDPEGIIYQKDWSTSMRTWRIGVKFP---YTDCDAYGRCGRFGSCHAGENPP-C 318
Query: 336 ECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKH------------GDGFLEHKAVKLPDT 383
+C++GFVP + EW+ S GC+R+ PL C+ DGFL+ + +K+P
Sbjct: 319 KCVKGFVPKNNTEWNGGNWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKMKVP-- 376
Query: 384 RFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLF 443
S + C ++C NCSCTAYA RG GC+LW DL+D++ SG DLF
Sbjct: 377 -ISAERSEASEQVCPKVCLDNCSCTAYA----YDRGIGCMLWSGDLVDMQSFLGSGIDLF 431
Query: 444 IRMAASELDNVERRRQSKNKKQVMI---IITSISLATAVIFIGGLMYRRKKHSNQGNEKE 500
IR+A SEL ++ + VMI +I + +A + + Y+++ + E
Sbjct: 432 IRVAHSEL-------KTHSNLAVMIAAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAE 484
Query: 501 EM---------------------ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI 539
M ELP+F+ +++A +TD+FS +NKLG+GGFGPVYKG L
Sbjct: 485 LMFKRMEALTSDNESASNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLP 544
Query: 540 EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599
EGQEIAVKRLS+ SGQG+EE NEV++I+KLQHRNLVKLLGCC + +ERML+YEY+P KS
Sbjct: 545 EGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKS 604
Query: 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPK 659
LD ++FD + K+LDW R +I+ GI RGLLYLH+DSRL+IIHRDLKASN+LLD +NPK
Sbjct: 605 LDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPK 664
Query: 660 ISDFGLARSFGLDQTEANTKRVVGT 684
ISDFGLAR F ++ EANT+RVVGT
Sbjct: 665 ISDFGLARIFRANEDEANTRRVVGT 689
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 684 | ||||||
| 224122978 | 831 | predicted protein [Populus trichocarpa] | 0.953 | 0.784 | 0.620 | 0.0 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.950 | 0.800 | 0.609 | 0.0 | |
| 359493725 | 1593 | PREDICTED: uncharacterized protein LOC10 | 0.948 | 0.407 | 0.589 | 0.0 | |
| 147799241 | 818 | hypothetical protein VITISV_027305 [Viti | 0.944 | 0.789 | 0.588 | 0.0 | |
| 255569631 | 868 | S-locus-specific glycoprotein S13 precur | 0.948 | 0.747 | 0.581 | 0.0 | |
| 359493727 | 1767 | PREDICTED: uncharacterized protein LOC10 | 0.944 | 0.365 | 0.578 | 0.0 | |
| 359493715 | 1603 | PREDICTED: uncharacterized protein LOC10 | 0.942 | 0.402 | 0.600 | 0.0 | |
| 359493740 | 2422 | PREDICTED: uncharacterized protein LOC10 | 0.954 | 0.269 | 0.567 | 0.0 | |
| 224115102 | 784 | predicted protein [Populus trichocarpa] | 0.916 | 0.799 | 0.605 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.954 | 0.785 | 0.565 | 0.0 |
| >gi|224122978|ref|XP_002330411.1| predicted protein [Populus trichocarpa] gi|222871796|gb|EEF08927.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 840 bits (2171), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/678 (62%), Positives = 515/678 (75%), Gaps = 26/678 (3%)
Query: 23 MEGFNLLIIYSFLFYIISAAR-TLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRY 81
+ GF +L +++FL +ISA R + DT++ GQSI+DG+ LVSA SFELGFFSPG SK RY
Sbjct: 5 ISGFIILFVHTFL--LISAIRASTDTLTPGQSIRDGDLLVSADGSFELGFFSPGISKGRY 62
Query: 82 LGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQ 141
LGIWY+KI+ GTV WVANR+ PL+D SG L + + GIL+LLNS+ D +WSSN+S +AQ
Sbjct: 63 LGIWYQKISAGTVVWVANRETPLNDSSGALIVTDQ--GILILLNSSKDAIWSSNASRTAQ 120
Query: 142 KPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKS 201
PV L++SGNLVVKD DN+ +N LWQSFDYP DTLLPGMK G N+ TGL+R+LSSWKS
Sbjct: 121 NPVMKLLDSGNLVVKDINDNS-ENFLWQSFDYPGDTLLPGMKWGRNMVTGLDRYLSSWKS 179
Query: 202 TDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSN 261
++DPA+G+FT+ +DPRG Q++L + I +R G+WNG WTG PQL+ N +YT+ ++S
Sbjct: 180 SNDPAQGEFTFRIDPRGNTQMLLMRGPKILYRTGTWNGYRWTGTPQLEPNMLYTYGFIST 239
Query: 262 EKEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCG 321
E +Y ++L NSSV SR+V+N +G QR+TW+ RT +W +RFS V LDQCD YALCG
Sbjct: 240 ATEMYYKFDLINSSVASRIVMNSSGAAQRFTWITRTNSW---ARFSAVLLDQCDDYALCG 296
Query: 322 AYASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLP 381
AY SCN+N P C CL+GF+P S ++W +Q S GCVRRT LDC GD FL+H VKLP
Sbjct: 297 AYGSCNVNKQ-PVCACLEGFIPKSPKDWSIQEWSDGCVRRTKLDCDKGDRFLQHGGVKLP 355
Query: 382 DTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQD 441
D SWVD + L ECK+LC KNCSC AYAN+D+RG GSGCLLWF +LID +EL GQD
Sbjct: 356 DMIKSWVDTSKGLKECKDLCLKNCSCVAYANSDIRGGGSGCLLWFDELIDTRELTTGGQD 415
Query: 442 LFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMY-RRKKHSNQGN--- 497
L+IR+AASEL N+E+ R S +KKQ+ II+ +I V+ + ++Y RRKK Q N
Sbjct: 416 LYIRIAASELYNIEKNRSS-DKKQLGIIVGTIITIVGVLVLAFILYARRKKLKKQANMKT 474
Query: 498 -----------EKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAV 546
KE+MELP FDL IANATDNFS +NKLGEGGFG VYKG LIEGQE+AV
Sbjct: 475 SHLQNYEDEDQRKEDMELPTFDLSTIANATDNFSSRNKLGEGGFGSVYKGTLIEGQEVAV 534
Query: 547 KRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD 606
KRLSK SGQG+ EFKNEV+LIAKLQHRNLVKLLGCC + DER+LIYEY+PNKSLDYFIFD
Sbjct: 535 KRLSKNSGQGLTEFKNEVILIAKLQHRNLVKLLGCCIEGDERILIYEYMPNKSLDYFIFD 594
Query: 607 TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
DW +I+ GIARGLLYLHQDSRLRIIHRDLKA+NVLLDN MNPKISDFGLA
Sbjct: 595 KKTRNSSDWRIWINIVGGIARGLLYLHQDSRLRIIHRDLKAANVLLDNGMNPKISDFGLA 654
Query: 667 RSFGLDQTEANTKRVVGT 684
R+FG DQTEANT ++VGT
Sbjct: 655 RTFGGDQTEANTNKIVGT 672
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 832 bits (2149), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/663 (60%), Positives = 496/663 (74%), Gaps = 13/663 (1%)
Query: 27 NLLIIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWY 86
+++ +YS F I+ + LD ++ QS++DGETLVS SFELGFF+P S SRYLG+WY
Sbjct: 5 DVIFVYSLFFSILKISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYLGLWY 64
Query: 87 KKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAA 146
KK + TV WVANR P+S++ G L + + GILVLLN TN+ VWSSN+S + Q PVA
Sbjct: 65 KKSPQ-TVVWVANRGIPISNKFGTLNVTSQ--GILVLLNGTNNIVWSSNTSTTVQNPVAQ 121
Query: 147 LMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPA 206
L++SGNLVV+DG DN DN LWQSFDYPCDTLLPGMKLG NL TGLN FLSSWK ++PA
Sbjct: 122 LLDSGNLVVRDGNDNKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKENPA 181
Query: 207 RGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAF 266
G FT G+D +G PQL+LRK + I +R GSWNG ++TG P+L+ +P+YTFE+V N E +
Sbjct: 182 PGQFTLGIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPDPIYTFEFVFNRNEVY 241
Query: 267 YTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASC 326
+ + L NSSV SR+ + P+G VQ +TW +T W +F+ +D+C++YALCGA A C
Sbjct: 242 FKFELQNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFAT---AVVDRCENYALCGANARC 298
Query: 327 NINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFS 386
+ NS SP C+CL GF+ S EW+ Q +GGC+RRTPLDC DGF + VKLPDT S
Sbjct: 299 DSNS-SPVCDCLDGFIHKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTGVKLPDTSSS 357
Query: 387 WVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRM 446
W D + +L EC+ LC +NCSC AYAN D RGRGSGCL WF DLID + L E GQD++IR+
Sbjct: 358 WYDDSFSLVECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAEGGQDIYIRL 417
Query: 447 AASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLM-YRRKKHSNQGN----EKEE 501
AAS+ V ++ K K +I ++ L ++++ +G + RR+KH GN ++EE
Sbjct: 418 AASQ-SGVTGEKKRKKKTHAGVIGGAVILGSSILILGIVFCIRRRKHRKNGNFEDRKEEE 476
Query: 502 MELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFK 561
MELP+ DL I +ATDNFS KLGEGGFG VYKG LIEGQEIAVKRLSK SGQG+ EFK
Sbjct: 477 MELPMLDLTTIEHATDNFSSSKKLGEGGFGAVYKGELIEGQEIAVKRLSKSSGQGLNEFK 536
Query: 562 NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
NEVLLIAKLQHRNLVKLLGCC DE+MLIYEY+PN+SLD FIFD TR K LDWSKR+HI
Sbjct: 537 NEVLLIAKLQHRNLVKLLGCCIHEDEKMLIYEYMPNRSLDSFIFDPTRRKFLDWSKRTHI 596
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
I GIARGLLYLHQDSRLRIIHRD+KASN+LLDN +NPKISDFGLAR FG DQTEANTKRV
Sbjct: 597 IDGIARGLLYLHQDSRLRIIHRDIKASNILLDNELNPKISDFGLARMFGGDQTEANTKRV 656
Query: 682 VGT 684
VGT
Sbjct: 657 VGT 659
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493725|ref|XP_002280679.2| PREDICTED: uncharacterized protein LOC100260657 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2070), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/672 (58%), Positives = 492/672 (73%), Gaps = 23/672 (3%)
Query: 30 IIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKI 89
+I+S++ ++ + +DTI + Q+I DGET+ SA SFELGFFSPGNSK+RYLGIWYKK+
Sbjct: 9 VIFSYVLSLLRISVAVDTIIVNQNITDGETITSAGGSFELGFFSPGNSKNRYLGIWYKKV 68
Query: 90 AEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALME 149
A GTV WVANR++PL+D SGVL++ GILVL+N TN +W+SNSS A+ P A L+E
Sbjct: 69 ATGTVVWVANRESPLTDSSGVLKVT--EQGILVLVNGTNGILWNSNSSRFAEDPNAQLLE 126
Query: 150 SGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGD 209
SGNLV++ G D++ +N WQSFDYPCDTLLPGMK G N TGL+R+LSSWKS DDP++G+
Sbjct: 127 SGNLVMRSGNDSDSENFFWQSFDYPCDTLLPGMKFGRNRVTGLDRYLSSWKSDDDPSKGN 186
Query: 210 FTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTY 269
FTYG+D G PQL+LR + FRAG WNG+ ++G+PQL N VYTF +VSNEKE ++ Y
Sbjct: 187 FTYGIDLSGFPQLLLRNGLAVEFRAGPWNGVRYSGIPQLTNNSVYTFNFVSNEKEIYFIY 246
Query: 270 NLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNIN 329
+L NSSV R+V+ P G +R+TW ++ WTL+S D CD+YA+CG Y C I+
Sbjct: 247 SLVNSSVIMRLVLTPDGYSRRFTWTDQKNEWTLYST---TQKDDCDNYAICGVYGICKID 303
Query: 330 SNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVD 389
SP+CEC++GF P Q WDM S GCVR TPLDC+ GDGF+++ VKLPDTR SW D
Sbjct: 304 E-SPKCECMKGFRPKFQSNWDMADWSKGCVRSTPLDCQKGDGFVKYSGVKLPDTRNSWFD 362
Query: 390 KNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAAS 449
+++ L EC LC +NCSCTAYAN+D+RG GSGCLLWF DLIDI++ ++GQ+ + RMAAS
Sbjct: 363 ESMNLKECASLCLRNCSCTAYANSDIRGGGSGCLLWFDDLIDIRDFTQNGQEFYARMAAS 422
Query: 450 ELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRK-------------KHSNQG 496
E D + S KK+ I SIS+ V+ L +H+ +G
Sbjct: 423 ESDALSSLNSSSKKKKKQAIAISISITGVVLLSLVLTLCVLKKRKRRLKRRGYMEHNIEG 482
Query: 497 NE----KEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG 552
+E +E +E+P+FDL + NAT+NFS NKLGEGGFGPVYKG+L EGQEIAVK + K
Sbjct: 483 DETNEGQEHLEIPLFDLDTLLNATNNFSSDNKLGEGGFGPVYKGILQEGQEIAVKMMLKT 542
Query: 553 SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL 612
S QG+EE KNE IAKLQHRNLVKLLGCC ERMLIYEYLPNKSLD FIFD RS +
Sbjct: 543 SRQGLEELKNEAESIAKLQHRNLVKLLGCCIHGRERMLIYEYLPNKSLDLFIFDQMRSVV 602
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
LDW KR HII GIARGLLYLHQDSRLRIIHRDLKA N+LLDN M+PKISDFG+ARSFG +
Sbjct: 603 LDWPKRFHIINGIARGLLYLHQDSRLRIIHRDLKAENILLDNEMSPKISDFGIARSFGGN 662
Query: 673 QTEANTKRVVGT 684
+TEANT RV GT
Sbjct: 663 ETEANTTRVAGT 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 798 bits (2060), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/671 (58%), Positives = 503/671 (74%), Gaps = 25/671 (3%)
Query: 28 LLIIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYK 87
L+ ++S++ I+ + +D+I+ Q IKDGET++SA +FELGF G SK++YLGIWYK
Sbjct: 7 LVFLFSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGIWYK 66
Query: 88 KIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAAL 147
K+ TV WVANR+ P++D SG L++ + G LV+LN +N +WSSNSS SA+ P A L
Sbjct: 67 KVTPRTVVWVANRELPVTDSSGXLKVTDQ--GSLVILNGSNGLIWSSNSSRSARNPTAQL 124
Query: 148 MESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPAR 207
++SGNLV+K G D++PDN LWQSFDYP DTLLPGMK G N TGL+R+LSSWKS DDP++
Sbjct: 125 LDSGNLVIKSGNDSDPDNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSNDDPSK 184
Query: 208 GDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFY 267
GDFTYGLDP G PQL LR S + FR+G WNG+ + G P+L+ NPV+ + +V NEKE ++
Sbjct: 185 GDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVFNEKEMYF 244
Query: 268 TYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCN 327
TY L NSSV SR+V+NP G VQR W+ RTK+W ++S D CDSYALCGAY++CN
Sbjct: 245 TYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVYST---AYKDDCDSYALCGAYSTCN 301
Query: 328 INSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSW 387
I+ SP C C++GFVP +WD S GCVR+T LDC+ GDGF ++ VKLPDTR SW
Sbjct: 302 IH-RSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFAKYSGVKLPDTRNSW 360
Query: 388 VDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMA 447
++++ L EC LC +NCSC+AY N+D++G GSGCLLWF DLIDIKE E+GQD +IRMA
Sbjct: 361 FNESMNLKECASLCFRNCSCSAYTNSDIKGGGSGCLLWFGDLIDIKEFTENGQDFYIRMA 420
Query: 448 ASELDNVERRRQSKNKKQVMIIITSISLATAVIF-IGGLMYRRKKH---------SNQGN 497
ASELD + SK K+ +I++++S+A ++ + +Y KK +N+G
Sbjct: 421 ASELDAI-----SKVTKRRWVIVSTVSIAGMILLSLVVTLYLLKKRLKRKGTTELNNEGA 475
Query: 498 E----KEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS 553
E +E++ELP+F L I NAT NFS NKLGEGGFGPVYKGML +G+EIAVKRLSK S
Sbjct: 476 ETNERQEDLELPLFXLDTILNATHNFSRNNKLGEGGFGPVYKGMLQDGKEIAVKRLSKES 535
Query: 554 GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLL 613
QG++EFKNEV+ I+KLQHRNLVKLLGCC +E+MLIYEY+PNKSL++FIFD +S +L
Sbjct: 536 NQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLNFFIFDGIQSMVL 595
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
DW KR II GIARGLLYLHQDSRLRIIHRDLKA NVLLDN MNP+ISDFG+ARSFG ++
Sbjct: 596 DWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFGGNE 655
Query: 674 TEANTKRVVGT 684
T A TKRVVGT
Sbjct: 656 TIARTKRVVGT 666
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255569631|ref|XP_002525781.1| S-locus-specific glycoprotein S13 precursor, putative [Ricinus communis] gi|223534931|gb|EEF36617.1| S-locus-specific glycoprotein S13 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 796 bits (2057), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/686 (58%), Positives = 508/686 (74%), Gaps = 37/686 (5%)
Query: 23 MEGFNLLIIY-SFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRY 81
M+ ++L+I+ S+L I+ + DTI++ QS+ DGETLVSA ESF+LGFFSPGNS++RY
Sbjct: 44 MDDTSILVIFCSYLLLSITTSTAADTINITQSVTDGETLVSAGESFKLGFFSPGNSRTRY 103
Query: 82 LGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQ 141
LGIWY K++ TV WVANR+ PL D SGVL+I R IL LLN +WSSN +++A+
Sbjct: 104 LGIWYNKVSVMTVVWVANRETPLIDSSGVLKITDHR--ILALLNHNGSKIWSSNVTMAAR 161
Query: 142 KPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKS 201
PVA L++SGNL+VKD D+NP+N LWQSFDYPC+TLLPGMKLG N+ TGL+R++SSWK+
Sbjct: 162 NPVAQLLDSGNLIVKDEGDDNPENFLWQSFDYPCNTLLPGMKLGRNIATGLDRYISSWKT 221
Query: 202 TDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSN 261
DP+RG+FTYGLDP G P+++LR+NSI FRAG WNG ++G QL +NP++ +E+V N
Sbjct: 222 PSDPSRGNFTYGLDPAGYPEMILRENSIERFRAGPWNGRSYSGTSQLNVNPIFKYEFVIN 281
Query: 262 EKEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCG 321
E E +Y + L NSSV SRMVIN G +QR+ W ER + W L+ F+ + D CD YALCG
Sbjct: 282 ETEIYYDFQLLNSSVLSRMVINENGILQRFIWAERERKWRLY--FT-IQTDDCDQYALCG 338
Query: 322 AYASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLP 381
A+ASCNI SNS C CL GFVP +EWD SGGCVR+TPL+C DGF ++ A KLP
Sbjct: 339 AFASCNIKSNS-YCSCLNGFVPKFPKEWDQADWSGGCVRKTPLNCS-SDGFQKYLAFKLP 396
Query: 382 DTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQD 441
+TR SW ++++ L +CK +C KNCSCT YAN D+R SGCLLWF D+ID EL GQD
Sbjct: 397 ETRKSWFNRSMNLEDCKNMCVKNCSCTVYANLDIREGESGCLLWFSDVIDTTELDGDGQD 456
Query: 442 LFIRMAASEL-----DNVERRRQSKNKKQVMIIITSI------SLATAVIFIGGLMYRRK 490
++IRM+AS+L D+ + + +S KKQ+ II++S+ SL+ AVI ++R+K
Sbjct: 457 IYIRMSASQLGVAHDDDPKIQSKSNVKKQMRIILSSLLSAGMMSLSLAVIL---YVWRKK 513
Query: 491 KH------------SNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGML 538
+ +N EKEE++LP+FD IA AT NFS+ NKLGEGGFG G L
Sbjct: 514 QKKEGKAIGILEISANDKGEKEELKLPLFDFGTIACATCNFSDANKLGEGGFG---LGNL 570
Query: 539 IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598
+GQEIAV+RLSK S QG++EF NEVL IAKLQHRNLV+LLGCC Q +E++LIYE++PNK
Sbjct: 571 KDGQEIAVRRLSKNSNQGVDEFMNEVLHIAKLQHRNLVRLLGCCIQSEEKLLIYEFMPNK 630
Query: 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658
SLD+FIFD T+SKLLDW KR HII GIARGLLYLHQDSRLRIIHRDLKA N+LLD MNP
Sbjct: 631 SLDFFIFDQTKSKLLDWPKRYHIINGIARGLLYLHQDSRLRIIHRDLKAGNILLDYEMNP 690
Query: 659 KISDFGLARSFGLDQTEANTKRVVGT 684
KISDFG AR F ++TEA+T +VVGT
Sbjct: 691 KISDFGPARCFWGNETEASTDKVVGT 716
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493727|ref|XP_002280656.2| PREDICTED: uncharacterized protein LOC100243545 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2054), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/655 (57%), Positives = 483/655 (73%), Gaps = 9/655 (1%)
Query: 30 IIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKI 89
+I+S++ ++ + +DTI + Q+I DGET+ SA SFELGFFSPGNSK+RYLGIWYKK
Sbjct: 9 VIFSYVLSLLRISVAVDTIIVNQNITDGETITSAGGSFELGFFSPGNSKNRYLGIWYKKA 68
Query: 90 AEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALME 149
++ V WVANR++P++D SGVL++ + GILVL+N TN +W+S SS SAQ P A L+E
Sbjct: 69 SKKPVVWVANRESPITDSSGVLKVT--QPGILVLVNGTNGILWNSTSSRSAQDPNAQLLE 126
Query: 150 SGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGD 209
SGNLV+++G D +P+N LWQSFDYPCDTLLPGMKLG N GL+R+LSSWKS DDP++G+
Sbjct: 127 SGNLVMRNGNDRDPENFLWQSFDYPCDTLLPGMKLGRNRVAGLDRYLSSWKSADDPSKGN 186
Query: 210 FTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTY 269
FTY +DP G PQL+LR + FR G WNG+ ++G+PQL +NPVY++EYVSNEKE +Y Y
Sbjct: 187 FTYWIDPSGFPQLLLRNGLAVAFRPGPWNGIRFSGIPQLTINPVYSYEYVSNEKEIYYIY 246
Query: 270 NLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNIN 329
+L NSSV R+V+ P G QR W ++ WTL+S DQCD+YA+CG C I+
Sbjct: 247 SLVNSSVIMRLVLTPDGAAQRSIWTDKKNEWTLYST---AQRDQCDNYAICGVNGICKID 303
Query: 330 SNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVD 389
SP CEC++GF P Q WDM+ S GCVR TPLDC+ GDGF+++ VKLPDTR SW +
Sbjct: 304 -QSPNCECMKGFRPKFQSNWDMEDWSNGCVRSTPLDCQKGDGFVKYSGVKLPDTRSSWFN 362
Query: 390 KNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAAS 449
+++ L EC LC NCSCTAYAN+D+RG GSGCLLWF DLIDI++ E+GQ+ ++RMAA+
Sbjct: 363 ESMNLKECASLCLSNCSCTAYANSDIRGGGSGCLLWFGDLIDIRDFTENGQEFYVRMAAA 422
Query: 450 ELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSNQGNEKEEMELPIFDL 509
+L+ + +R I + S+ L + ++ M K +E +ELP+FDL
Sbjct: 423 DLETTKEKRLGNRLNS--IFVNSLILHS-ILHFAAYMEHNSKGGENNEGQEHLELPLFDL 479
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK 569
+ NAT+NFS NKLGEGGFGPVYKG+L EGQEIAVK +SK S QG++EFKNEV IAK
Sbjct: 480 DTLLNATNNFSSDNKLGEGGFGPVYKGILQEGQEIAVKMMSKTSRQGLKEFKNEVESIAK 539
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
LQHRNLVKLLGCC ER+LIYE++PNKSLD FIFD R ++LDW KR II GIA+GL
Sbjct: 540 LQHRNLVKLLGCCIHGRERLLIYEHMPNKSLDLFIFDQMRRRVLDWPKRFLIINGIAQGL 599
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
LYLH+DSRLRIIHRDLKA N+LLDN M PKISDFG+ SFG ++ E NT RV T
Sbjct: 600 LYLHRDSRLRIIHRDLKAENILLDNEMIPKISDFGITGSFGGNEIETNTTRVART 654
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493715|ref|XP_002280938.2| PREDICTED: uncharacterized protein LOC100246941 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2052), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/663 (60%), Positives = 493/663 (74%), Gaps = 18/663 (2%)
Query: 34 FLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGT 93
+F I + +DTI+L Q ++DGE L SA SFELGFFSP +S RYLGIWYKK++ T
Sbjct: 9 LVFSIFRISIAVDTIALNQVVRDGEILTSAGGSFELGFFSPDDSNRRYLGIWYKKVSTMT 68
Query: 94 VTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTV-WSSNSSISAQKPVAALMESGN 152
V WVANR+ PL+D SGVL++ + G L +LN +N + WSSNSS SA+ P A L++SGN
Sbjct: 69 VVWVANREIPLNDSSGVLKVTDQ--GTLAILNGSNTNILWSSNSSRSARNPTAQLLDSGN 126
Query: 153 LVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTY 212
LV+KDG D+NP+N LWQSFDYPC+TLLPGMKLG N TGL+R+LS+WKS DDP++G+FTY
Sbjct: 127 LVMKDGNDDNPENFLWQSFDYPCNTLLPGMKLGRNTVTGLDRYLSAWKSVDDPSKGNFTY 186
Query: 213 GLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLS 272
LDP G PQL+LRK S +TFR+G WNGL ++G P+L NPVYT+E+V NEKE ++ Y L
Sbjct: 187 RLDPSGYPQLILRKGSAVTFRSGPWNGLRFSGFPELGSNPVYTYEFVFNEKEMYFRYELV 246
Query: 273 NSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNS 332
NSSV SR+V+NP G+ QR W++RT W L+S +D CDSYALCG Y SCNIN S
Sbjct: 247 NSSVVSRLVLNPDGSKQRVNWIDRTHGWILYS---SAPMDSCDSYALCGVYGSCNIN-RS 302
Query: 333 PECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNI 392
P+CEC++GFVP +WDM S GCVR TPL C++G+GF++ VKLPDTR SW ++++
Sbjct: 303 PKCECMEGFVPKFPNDWDMADWSNGCVRSTPLGCQNGEGFVKFSGVKLPDTRNSWFNRSM 362
Query: 393 TLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELD 452
L EC +C NCSCTAY N D+R GSGCLLWF DLIDI+E E+GQ+L++RMAASEL
Sbjct: 363 DLKECAAVCLSNCSCTAYTNLDIRDGGSGCLLWFGDLIDIREFNENGQELYVRMAASELG 422
Query: 453 NVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKK-----------HSNQGNEKEE 501
R K KK+ +I+ S+S ++ L K ++ +G +KE+
Sbjct: 423 MHRRSGNFKGKKREWVIVGSVSSLGIILLCLLLTLYLLKKKKLRKKGTMGYNLEGGQKED 482
Query: 502 MELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFK 561
+ELP+FD ++ AT++FS NKLGEGGFG VYKG L E QEIAVKRLSK SGQG+ EFK
Sbjct: 483 VELPLFDFATVSKATNHFSIHNKLGEGGFGLVYKGTLQEEQEIAVKRLSKNSGQGLNEFK 542
Query: 562 NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
NEV+ I+KLQHRNLV+LLG C +E+MLIYEY+PNKSLD FIFD TRS LDW+KR I
Sbjct: 543 NEVIYISKLQHRNLVRLLGGCIHDEEKMLIYEYMPNKSLDSFIFDKTRSMELDWNKRFLI 602
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
I GIARGLLYLHQDSRLRIIHRDLKA NVLLD M PKISDFG+ARSFG ++TEANTKRV
Sbjct: 603 INGIARGLLYLHQDSRLRIIHRDLKADNVLLDEEMTPKISDFGIARSFGGNETEANTKRV 662
Query: 682 VGT 684
VGT
Sbjct: 663 VGT 665
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493740|ref|XP_002280379.2| PREDICTED: uncharacterized protein LOC100262430 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2052), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/707 (56%), Positives = 507/707 (71%), Gaps = 54/707 (7%)
Query: 23 MEGFNLLIIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYL 82
MEGF L++ +F I+ + +DT+++ Q I DGET+ SA SFELGFFSP +S++RY+
Sbjct: 1 MEGFATLVL---VFSILRVSIAVDTLTVNQIITDGETITSAGGSFELGFFSPDSSRNRYV 57
Query: 83 GIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQK 142
GIWYKK+A TV WVANR PL+ SG+L++ G LV+LN TN T+WSSNSS AQ
Sbjct: 58 GIWYKKVATRTVVWVANRQIPLTASSGILKVTDR--GTLVILNGTNTTIWSSNSSRPAQN 115
Query: 143 PVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKST 202
P A L++SGNLV+K+G D++ +N LWQSFDYPC+TLLPGMK G N TGL+R+LSSWK+T
Sbjct: 116 PNAQLLDSGNLVMKNGNDSDSENFLWQSFDYPCNTLLPGMKFGRNRVTGLDRYLSSWKTT 175
Query: 203 DDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNE 262
DDP+ G+FTY LDP G PQL++R S +TFR+G WNGL ++G PQL+ N VY++ ++ N+
Sbjct: 176 DDPSIGNFTYRLDPGGSPQLLVRNGSTVTFRSGPWNGLRFSGFPQLRPNSVYSYAFIFND 235
Query: 263 KEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGA 322
KE +YT+ L NSSV +R+V++P G QR+TW++RT W L +S D CDSYALCG
Sbjct: 236 KETYYTFELVNSSVITRLVLSPEGYAQRFTWIDRTSDWIL---YSSAQTDDCDSYALCGV 292
Query: 323 YASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPD 382
Y C IN SP+CEC++GF P Q WDM S GCVR TP+ C+ +GFL++ VKLPD
Sbjct: 293 YGICEIN-RSPKCECMKGFEPKFQSNWDMADWSDGCVRSTPMVCQKSNGFLKYSGVKLPD 351
Query: 383 TRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDL 442
TR SW ++++ L EC LC NCSCTAY N+D+RG GSGCLLWF DLIDI+E E+GQD
Sbjct: 352 TRNSWFNESMNLKECASLCLGNCSCTAYTNSDIRGGGSGCLLWFGDLIDIREYTENGQDF 411
Query: 443 FIRMAASEL------------DNVE---------------RRRQSKNKKQVMIIITSISL 475
+IRMA SEL ++V+ SK K+ +I++++S+
Sbjct: 412 YIRMAKSELGMSLSVPYLRIINSVQVFNDKYCTCVYAFAMTNSGSKGAKRKWVIVSTVSI 471
Query: 476 ATAVIFIGGLM--------YRRK------KHSNQG---NEKEE-MELPIFDLKIIANATD 517
++ L RRK KH+ +G NE+EE +ELP+FDL I NATD
Sbjct: 472 VGIILLSLVLTLYVLRKKRLRRKGNNLYSKHNCKGAEINEREEDLELPLFDLDTILNATD 531
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
NFS NKLGEGGFGPVYKGML +G+EIAVKRLSK S QG++EFKNEV I+KLQHRNLVK
Sbjct: 532 NFSNDNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESRQGLDEFKNEVTHISKLQHRNLVK 591
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
LLGCC +E+MLIYEY+PNKSLD+FIFD +S +LDW KR II GIARGLLYLHQDSR
Sbjct: 592 LLGCCIHGEEKMLIYEYMPNKSLDFFIFDGMQSLVLDWPKRFVIINGIARGLLYLHQDSR 651
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
LRIIHRDLKA NVLLDN MNP+ISDFG+ARSF +++EA TKRVVGT
Sbjct: 652 LRIIHRDLKADNVLLDNEMNPRISDFGMARSFRGNESEARTKRVVGT 698
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115102|ref|XP_002316940.1| predicted protein [Populus trichocarpa] gi|222860005|gb|EEE97552.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 793 bits (2047), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/666 (60%), Positives = 474/666 (71%), Gaps = 39/666 (5%)
Query: 20 MSKMEG-FNLLIIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSK 78
M K EG L +YSFL I + D IS GQ I DG+T+VSA ++FELGFFSPG+S
Sbjct: 5 MRKTEGGIRGLFVYSFLLSTIRVSNAPDIISPGQFIGDGDTIVSAGQNFELGFFSPGSST 64
Query: 79 SRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSI 138
RYLGIWYKK + GTV WVANR+ P+ D SGVL + G L+LLN T D VWSSN +
Sbjct: 65 RRYLGIWYKKFSTGTVVWVANRENPIFDHSGVLYFTNQ--GTLLLLNGTKDVVWSSNRTT 122
Query: 139 SAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSS 198
PVA L+ESGNLVVKDG D+NP++ LWQSFDYP DT LP MKLG NL TGL+ +SS
Sbjct: 123 PKNNPVAQLLESGNLVVKDGNDSNPESFLWQSFDYPGDTNLPDMKLGRNLVTGLDWSISS 182
Query: 199 WKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEY 258
WKS DDPARG+++ G+DPRG QLV +K I FRAGSWNG+ +TG +L+ NPVY +E+
Sbjct: 183 WKSLDDPARGEYSLGIDPRGYQQLVYKKGRAIQFRAGSWNGIRFTGATRLRPNPVYRYEF 242
Query: 259 VSNEKEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYA 318
V N+KE ++ + L NSSV SR V+N +G V+R TW+ + WT R+ V DQCD+Y+
Sbjct: 243 VLNDKEVYFNFELLNSSVASRFVVNASGVVERLTWISQMHRWT---RYFAVGEDQCDAYS 299
Query: 319 LCGAYASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAV 378
CG+ A CNI+ SP C CL GF P S R+W Q SGGCVRRT L C G+GF++H +
Sbjct: 300 FCGSNAKCNID-KSPVCACLDGFEPKSARDWSFQDWSGGCVRRTTLTCNRGEGFVKHTGM 358
Query: 379 KLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPES 438
KLPDT SW + +I+L EC+ELC K CSC AYAN DVRG GSGCLLWF DLID++E +
Sbjct: 359 KLPDTSSSWYNTSISLKECQELCLKKCSCMAYANTDVRGGGSGCLLWFGDLIDMREFVNT 418
Query: 439 GQDLFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSNQGNE 498
GQDL+IRMAAS ++G + + + +
Sbjct: 419 GQDLYIRMAAS-------------------------------YLGKMKNILEMDYDSHSR 447
Query: 499 KEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGME 558
KEE+ELPI DL IA AT NFS KLGEGGFG VYKG L GQ+IAVKRLS SGQG+E
Sbjct: 448 KEELELPIIDLSTIAKATGNFSSNKKLGEGGFGLVYKGTLY-GQDIAVKRLSMYSGQGIE 506
Query: 559 EFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR 618
EFKNEVLLIAKLQHRNLVKLLGCC + DERMLIYEY+PNKSLDYFIFD +RSKLLDW R
Sbjct: 507 EFKNEVLLIAKLQHRNLVKLLGCCIEGDERMLIYEYMPNKSLDYFIFDQSRSKLLDWPTR 566
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
II GIARGLLYLHQDSRLRIIHRDLKASNVLLD MNPKISDFG+AR FG +QTEANT
Sbjct: 567 ISIIDGIARGLLYLHQDSRLRIIHRDLKASNVLLDTDMNPKISDFGMARIFGGNQTEANT 626
Query: 679 KRVVGT 684
KRVVGT
Sbjct: 627 KRVVGT 632
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 792 bits (2045), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/681 (56%), Positives = 504/681 (74%), Gaps = 28/681 (4%)
Query: 23 MEGFNLLIIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYL 82
M G +L + S +F++ + +++I+ QS++DG+TLVS++ FELGFFSPGNS++RY+
Sbjct: 8 MGGQTILFLLSIVFFLSIPSTAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYM 67
Query: 83 GIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQK 142
GIWYKKI+ TV WVANR+ PL+D SG+L+ +G L +NSTN T+WSSN S +A
Sbjct: 68 GIWYKKISSFTVVWVANRNTPLNDSSGMLKF--VDHGNLAFINSTNGTIWSSNISRAAIN 125
Query: 143 PVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKST 202
PVA L+++GNLVV+ DN+P+N LWQSFDYP D+ LPGMK GI+ TGLNR+L+SWKS
Sbjct: 126 PVAQLLDTGNLVVRAENDNDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSP 185
Query: 203 DDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNE 262
DP+ G +T LDP G+PQ L + S+ FR+G WNGL ++G+ L+ NP+YTFE+V N+
Sbjct: 186 SDPSTGKYTNKLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFEFVFNQ 245
Query: 263 KEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGA 322
+E +Y Y ++NSSV SRMV++P G +QR+TW++RT+ WTL+ +D CD +ALCGA
Sbjct: 246 EEIYYKYQIANSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLT---ANMDNCDRFALCGA 302
Query: 323 YASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPD 382
+ CNIN NSP C+CL+ F P S EW S GCVR+ PLDC +G+GF+++ +K+PD
Sbjct: 303 HGVCNIN-NSPACDCLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPD 361
Query: 383 TRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDL 442
TR SW +K I L EC+E+C KNCSCTAYAN DVR GSGC+LWF DLIDI++ E+GQD+
Sbjct: 362 TRKSWYNKTINLEECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQYNENGQDI 421
Query: 443 FIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYR------RKKHSNQG 496
+IR+AAS +D + +S+ KK+V II+ +SL + L R +++ + +G
Sbjct: 422 YIRIAASVID---KPVKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREG 478
Query: 497 N-------------EKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE 543
N E++ELP+FDL + +AT+ FS NKLG+GGFGPVYKG+L +GQE
Sbjct: 479 NVVTNPEQDRTKESRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGILQDGQE 538
Query: 544 IAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF 603
IAVKRLSK S QG+ EF+NEV+ IAKLQHRNLVKLLGCC + +ERMLIYEY+PNKSLD F
Sbjct: 539 IAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPNKSLDSF 598
Query: 604 IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663
IFD R+ LLDW+KR II GIARGLLYLHQDSRLRIIHRDLKASN+LLD MNPKISDF
Sbjct: 599 IFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMNPKISDF 658
Query: 664 GLARSFGLDQTEANTKRVVGT 684
G+ARSFG D+T ANT R+VGT
Sbjct: 659 GMARSFGGDETSANTSRIVGT 679
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 684 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.608 | 0.531 | 0.516 | 9.8e-196 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.631 | 0.508 | 0.426 | 1.1e-168 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.913 | 0.766 | 0.512 | 3.8e-165 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.627 | 0.508 | 0.401 | 2.9e-161 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.627 | 0.506 | 0.405 | 1.8e-157 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.654 | 0.527 | 0.365 | 6.7e-147 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.577 | 0.469 | 0.372 | 3e-142 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.644 | 0.531 | 0.343 | 1.8e-133 | |
| TAIR|locus:2197704 | 831 | AT1G61390 [Arabidopsis thalian | 0.897 | 0.738 | 0.418 | 9.6e-128 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.266 | 0.214 | 0.692 | 1.1e-127 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1220 (434.5 bits), Expect = 9.8e-196, Sum P(2) = 9.8e-196
Identities = 223/432 (51%), Positives = 306/432 (70%)
Query: 42 ARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRD 101
A+ D + Q++KDG+T+VS SFE+GFFSPG S++RYLGIWYKKI+ TV WVANRD
Sbjct: 21 AQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANRD 80
Query: 102 APLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQK-----PVAALMESGNLVVK 156
+PL D SG L+++ NG L L N N +WSS+SS S+QK P+ ++++GNLVV+
Sbjct: 81 SPLYDLSGTLKVS--ENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVR 138
Query: 157 DGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDP 216
+ D+ + +WQS DYP D LPGMK G+N TGLNRFL+SW++ DDP+ G++T +DP
Sbjct: 139 NSGDDQ--DYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDP 196
Query: 217 RGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSV 276
G+PQ L+KNS++ FR G WNGL +TG+P L+ NP+Y +EYV E+E +YTY L N SV
Sbjct: 197 NGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENPSV 256
Query: 277 PSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECE 336
+RM +NP G +QRYTW++ ++W + S + +D CD Y LCG+Y SCNIN SP C
Sbjct: 257 LTRMQLNPNGALQRYTWVDNLQSWNFY--LSAM-MDSCDQYTLCGSYGSCNINE-SPACR 312
Query: 337 CLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHG-DGFLEHKAVKLPDTRFSWVDKNITLW 395
CL+GFV + + W S GCVRR LDC G DGFL+ +KLPDTR SW DKN+ L
Sbjct: 313 CLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLN 372
Query: 396 ECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVE 455
ECK++C +NC+C+AY+ D+R G GC+LWF DLIDI+E E+GQDL++R+A+SE++ ++
Sbjct: 373 ECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEIETLQ 432
Query: 456 RR--RQSKNKKQ 465
R R S K++
Sbjct: 433 RESSRVSSRKQE 444
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 998 (356.4 bits), Expect = 1.1e-168, Sum P(2) = 1.1e-168
Identities = 193/452 (42%), Positives = 294/452 (65%)
Query: 46 DTISLGQS--IKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAP 103
+T+S +S I T+VS FELGFF PG YLGIWYK I++ T WVANRD P
Sbjct: 30 NTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANRDTP 89
Query: 104 LSDRSGVLRINGERNGILVLLNSTNDTVWSSN-SSISAQKP-VAALMESGNLVVKDGKDN 161
LS G L+I+ + N LV+L+ ++ VWS+N + + P VA L+++GN V++D K++
Sbjct: 90 LSSSIGTLKIS-DSN--LVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNS 146
Query: 162 NPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQ 221
PD +LWQSFD+P DTLLP MKLG + TG NRF+ SWKS DDP+ GDF++ L+ G P+
Sbjct: 147 APDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPE 206
Query: 222 LVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMV 281
+ L +R+G WNG+ ++GVP++Q F + ++++E Y++ ++ S V SR+
Sbjct: 207 IFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLS 266
Query: 282 INPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQGF 341
I+ +G +QR+TW+E + W ++F DQCD Y CG Y C+ N+ SP C C++GF
Sbjct: 267 ISSSGLLQRFTWIETAQNW---NQFWYAPKDQCDEYKECGVYGYCDSNT-SPVCNCIKGF 322
Query: 342 VPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELC 401
P + + W ++ S GCVR+T L C GDGF+ K +KLPDT + VD+ I + EC++ C
Sbjct: 323 KPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKC 382
Query: 402 SKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERRRQSK 461
++C+CTA+AN D+RG GSGC+ W +L DI+ + GQDL++R+AA++L++ +R R +K
Sbjct: 383 LRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLED-KRNRSAK 441
Query: 462 NKKQVMIIITSISLATAVI--FIGGLMYRRKK 491
II +SI ++ ++ FI +++RK+
Sbjct: 442 ------IIGSSIGVSVLLLLSFIIFFLWKRKQ 467
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1607 (570.8 bits), Expect = 3.8e-165, P = 3.8e-165
Identities = 335/654 (51%), Positives = 442/654 (67%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKS---RYLGIWYKKIAEGTVTWVANRDA 102
+ I+ + +KDG+TL S + F+LGFFS + R+LG+WY + V WVANR+
Sbjct: 26 NVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWYME--PFAVVWVANRNN 83
Query: 103 PLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSIS-----AQKPVAALMESGNLVVKD 157
PL SG L ++ G L L + + +WSS+SS + A P+ + SGNL+ D
Sbjct: 84 PLYGTSGFLNLSSL--GDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLISSD 141
Query: 158 GKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPR 217
G++ +LWQSFDYP +T+L GMKLG N T + LSSWK+ DP+ GDFT LD R
Sbjct: 142 GEEA----VLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTR 197
Query: 218 GIPQLVLRKN--SIITFRAGSWNGLHWTGVPQL-QLNPVYTFEYVSNEKEAFYTYNLSNS 274
G+PQL+LRKN S ++R GSWNGL +TG P + + N ++ +++ S+ +E Y++ +
Sbjct: 198 GLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTPRHR 257
Query: 275 SVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINS-NSP 333
V SR+V+N G + R+ ++ + W L + D+CD Y++CGAYA C INS N+P
Sbjct: 258 IV-SRLVLNNTGKLHRFIQSKQNQ-WILANT---APEDECDYYSICGAYAVCGINSKNTP 312
Query: 334 ECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVD-KN- 391
C CLQGF P S R+W++ + GCV P +C+ D F++ +KLPDT +SW D KN
Sbjct: 313 SCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNE 372
Query: 392 ITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASEL 451
+TL +CK CS NCSCTAYAN D+R G GCLLWF DL+D++E GQD++IRM +++
Sbjct: 373 MTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVYIRMGFAKI 432
Query: 452 DNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYR-RKKHSNQGNEKEEMELPIFDLK 510
+ R V+ I + + A F +M R R ++ +G E+E+++LPIFD K
Sbjct: 433 EFKGREVVGMVVGSVVAIAVVLVVVFAC-FRKKIMKRYRGENFRKGIEEEDLDLPIFDRK 491
Query: 511 IIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
I+ ATD+FS N LG GGFGPVYKG L +GQEIAVKRLS SGQG+EEFKNEV LIAKL
Sbjct: 492 TISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKL 551
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
QHRNLV+LLGCC Q +E MLIYEY+PNKSLD+FIFD RS LDW KR +II G+ARG+L
Sbjct: 552 QHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGIL 611
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
YLHQDSRLRIIHRDLKA NVLLDN MNPKISDFGLA+SFG DQ+E++T RVVGT
Sbjct: 612 YLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGT 665
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 910 (325.4 bits), Expect = 2.9e-161, Sum P(2) = 2.9e-161
Identities = 181/451 (40%), Positives = 289/451 (64%)
Query: 46 DTISLGQS--IKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAP 103
+T+S +S I +T++S + FELGFF+P +S YLGIWYK I T WVANRD P
Sbjct: 28 NTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNP 87
Query: 104 LSDRSGVLRINGERNGILVLLNSTNDTVWSSN-SSISAQKPVAA-LMESGNLVVKDGKDN 161
LS +G L+I+G LV+ + ++ VWS+N + + PVAA L+++GN +++D N
Sbjct: 88 LSSSNGTLKISGNN---LVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDS--N 142
Query: 162 NPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQ 221
N +LWQSFD+P DTLL MKLG + TG NR L SWK+TDDP+ G+F+ L+ P+
Sbjct: 143 N--RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPE 200
Query: 222 LVLRKNSIITFRAGSWNGLHWTGVP-QLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRM 280
+ I +R+G WNG+ ++ VP +Q++ + + + ++++E Y+Y ++ +++ SR+
Sbjct: 201 FYICSKESILYRSGPWNGMRFSSVPGTIQVDYM-VYNFTASKEEVTYSYRINKTNLYSRL 259
Query: 281 VINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQG 340
+N AG +QR TW E T++W +S D CD+Y +CG + C+ NS P C C++G
Sbjct: 260 YLNSAGLLQRLTWFETTQSWKQLW-YS--PKDLCDNYKVCGNFGYCDSNS-LPNCYCIKG 315
Query: 341 FVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKEL 400
F P +++ WD++ S GC+R+T L C DGF K +KLPDT + VD+ I L CKE
Sbjct: 316 FKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKER 375
Query: 401 CSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERRRQS 460
C ++C+CTA+ANAD+R GSGC++W +++D++ + GQDL++R+AA+EL++ ++
Sbjct: 376 CLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELED----KRI 431
Query: 461 KNKKQVMIIITSISLATAVIFIGGLMYRRKK 491
KN+K + I +S+ + F+ ++RK+
Sbjct: 432 KNEKIIGSSI-GVSILLLLSFVIFHFWKRKQ 461
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 875 (313.1 bits), Expect = 1.8e-157, Sum P(2) = 1.8e-157
Identities = 180/444 (40%), Positives = 270/444 (60%)
Query: 53 SIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLR 112
+I +T++S + FELGFF+P +S YLGIWYK I T WVANRD PLS +G L+
Sbjct: 37 TISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSNGTLK 96
Query: 113 INGERNGILVLLNSTNDTVWSSN-SSISAQKPVAA-LMESGNLVVKDGKDNNPDNILWQS 170
I+ + N LV+ + ++ VWS+N + + PVAA L++ GN V++D K+N P LWQS
Sbjct: 97 IS-DNN--LVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDSKNNKPSGFLWQS 153
Query: 171 FDYPCDTLLPGMKLGI-NLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSI 229
FD+P DTLL MK+G N G NR L SWK+TDDP+ GDF+ L G P+ +
Sbjct: 154 FDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNKES 213
Query: 230 ITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMVINPAGTVQ 289
IT+R+G W G ++ VP ++ + N ++ Y+Y ++ +++ S + ++ G +Q
Sbjct: 214 ITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGLLQ 273
Query: 290 RYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQGFVPNSQREW 349
R TWME ++W +S D CD+Y CG Y C+ N+ SP C C++GF P +++
Sbjct: 274 RLTWMEAAQSWKQLW-YS--PKDLCDNYKECGNYGYCDANT-SPICNCIKGFEPMNEQA- 328
Query: 350 DMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTA 409
++ S GCVR+T L C DGF+ K ++LPDT + VDK I L EC+E C K C+CTA
Sbjct: 329 ALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTA 388
Query: 410 YANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERRRQSKNKKQVMII 469
+AN D+R GSGC++W L DI+ + GQDL++R+AA +L+ ++R +SK I
Sbjct: 389 FANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLE--DKRIKSKKIIGSSIG 446
Query: 470 ITSISLATAVIFIGGLMYRRKKHS 493
++ + L + +IF R++K S
Sbjct: 447 VSILLLLSFIIF--HFWKRKQKRS 468
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 765 (274.4 bits), Expect = 6.7e-147, Sum P(2) = 6.7e-147
Identities = 182/498 (36%), Positives = 276/498 (55%)
Query: 46 DTISLGQSIKDG---ETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDA 102
+TI G+S++DG + LVS +++FELGFFSPG+S R+LGIWY I + V WVANR
Sbjct: 27 NTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDKAVVWVANRAT 86
Query: 103 PLSDRSGVLRINGERNGILVLLNSTNDTVWSSN---SSISAQKPVAALMESGNLVVKDGK 159
P+SD+SGVL I+ + N LVLL+ N TVWSSN S+ + V ++ ++GN V+ +
Sbjct: 87 PISDQSGVLMISNDGN--LVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVLSETD 144
Query: 160 DNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGI 219
+ P +W+SF++P DT LP M++ +N TG N SW+S DP+ G+++ G+DP G
Sbjct: 145 TDRP---IWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDPSGA 201
Query: 220 PQLVLRK-NSIITFRAGSWNGLHWTGVPQLQL--NPVYTFEYVSNEKEA---FYTYNLSN 273
P++VL + N +R+G WN +TG+P + L N +Y F+ S E ++TY S+
Sbjct: 202 PEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYVPSD 261
Query: 274 SSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSP 333
SV R + GT + W E K WT +F +CD Y CG + C++ ++
Sbjct: 262 PSVLLRFKVLYNGTEEELRWNETLKKWT---KFQSEPDSECDQYNRCGKFGICDMKGSNG 318
Query: 334 ECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHG-----DGFLEHKAVKLPDTRFSWV 388
C C+ G+ S W S GC RRTPL C+ D FL K+VKLPD F
Sbjct: 319 ICSCIHGYEQVSVGNW-----SRGCRRRTPLKCERNISVGEDEFLTLKSVKLPD--FEIP 371
Query: 389 DKNITLWE-CKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMA 447
+ N+ E C+E C +NCSC AY+ + G G GC++W DL+D+++ G L IR+A
Sbjct: 372 EHNLVDPEDCRERCLRNCSCNAYS---LVG-GIGCMIWNQDLVDLQQFEAGGSSLHIRLA 427
Query: 448 ASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLM---YRRKKHSNQG--NEKEEM 502
SE+ +N+K + +I ++ + +I I L+ ++RKK + + +
Sbjct: 428 DSEV--------GENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDT 479
Query: 503 ELPIFDLKIIANATDNFS 520
+ + DL T FS
Sbjct: 480 SVVVADLTKSKETTSAFS 497
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 746 (267.7 bits), Expect = 3.0e-142, Sum P(2) = 3.0e-142
Identities = 157/421 (37%), Positives = 239/421 (56%)
Query: 44 TLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAP 103
T ++ + +I++G++L+S ESFELGFF+P NS RY+GIWYK I TV WVANR+ P
Sbjct: 28 TSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVVWVANREKP 87
Query: 104 LSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNP 163
L D G L+I + N LV++N N+T+WS+N + VA L ++G+LV+ D
Sbjct: 88 LLDHKGALKIADDGN--LVIVNGQNETIWSTNVEPESNNTVAVLFKTGDLVLCSDSDRR- 144
Query: 164 DNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLV 223
W+SF+ P DT LPGM++ +N G NR WKS DP+ G ++ G+DP G ++V
Sbjct: 145 -KWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEIV 203
Query: 224 LRKNSIITFRAGSWNGLHWTGVPQLQ--LNPVYTFEYVS---NEKEAFYTYNLSNSSVPS 278
+ + +R+G WN +TG+P + N +Y F+ S + ++TY S+SS
Sbjct: 204 IWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASDSSDFL 263
Query: 279 RMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINS--NSPECE 336
R I P G +++ W + + W L ++ T +C+ Y CG Y+ C+ + +S +C
Sbjct: 264 RFWIRPDGVEEQFRWNKDIRNWNLL-QWKPST--ECEKYNRCGNYSVCDDSKEFDSGKCS 320
Query: 337 CLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHG------DGFLEHKAVKLPDTRFSWVDK 390
C+ GF P Q +W+ + SGGC RR PL+C DGF K +K+PD F V
Sbjct: 321 CIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPD--FGSVVL 378
Query: 391 NITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASE 450
+ CK++C+++CSC AYA G GC++W DLID++ G + IR+A S+
Sbjct: 379 HNNSETCKDVCARDCSCKAYALVV----GIGCMIWTRDLIDMEHFERGGNSINIRLAGSK 434
Query: 451 L 451
L
Sbjct: 435 L 435
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 705 (253.2 bits), Expect = 1.8e-133, Sum P(2) = 1.8e-133
Identities = 162/472 (34%), Positives = 258/472 (54%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
D I+ +D ET+VS +F GFFSP NS RY GIW+ I TV WVAN ++P++
Sbjct: 23 DVITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIWFNNIPVQTVVWVANSNSPIN 82
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNS--SISAQKPVAALMESGNLVVKDGKDNNP 163
D SG++ I+ E N LV+++ WS+N ++A A L+ +GNLV+ G N
Sbjct: 83 DSSGMVSISKEGN--LVVMDGRGQVHWSTNVLVPVAANTFYARLLNTGNLVLL-GTTNTG 139
Query: 164 DNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLV 223
D ILW+SF++P + LP M L + TG + L SWKS DP+ G ++ GL P P+LV
Sbjct: 140 DEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLIPLPFPELV 199
Query: 224 LRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEY-VSNEKEAFYTYNLSNSSVPSRMVI 282
+ K+ ++ +R+G WNG ++ G+P + + FE +S++ + + + +++ ++
Sbjct: 200 VWKDDLLMWRSGPWNGQYFIGLPNMDYR-INLFELTLSSDNRGSVSMSYAGNTLLYHFLL 258
Query: 283 NPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNS-PECECLQGF 341
+ G+V + W + W + + V +CD+YA CG +ASC N S P C C++GF
Sbjct: 259 DSEGSVFQRDWNVAIQEWKTWLK---VPSTKCDTYATCGQFASCRFNPGSTPPCMCIRGF 315
Query: 342 VPNSQREWDMQYKSGGCVRRTPLDC---------KHGDGFLEHKAVKLP-DTRFSWVDKN 391
P S EW+ + GCVR+ PL C + DGF+ + +K+P + + S ++
Sbjct: 316 KPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNPQRSGANEQ 375
Query: 392 ITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASEL 451
+C E C KNCSCTAY+ D RG GCLLW +L+D++E +G +IR+A SE
Sbjct: 376 ----DCPESCLKNCSCTAYS-FD---RGIGCLLWSGNLMDMQEFSGTGVVFYIRLADSEF 427
Query: 452 DNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSNQGNEKEEME 503
+R +S +++ + T V+ + + R+K+ N E ME
Sbjct: 428 K--KRTNRSIVITVTLLVGAFLFAGTVVLALWKIAKHREKNRNTRLLNERME 477
|
|
| TAIR|locus:2197704 AT1G61390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1254 (446.5 bits), Expect = 9.6e-128, P = 9.6e-128
Identities = 278/665 (41%), Positives = 392/665 (58%)
Query: 48 ISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDR 107
I+ + G+TL S +ELGFFSP NS+ +Y+GIW+K IA V WVANRD P++
Sbjct: 44 INTSSPLSIGQTLSSPDGVYELGFFSPNNSRKQYVGIWFKNIAPQVVVWVANRDKPVTKT 103
Query: 108 SGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNIL 167
+ L I+ NG L+LL+ T D +WS+ + ++ K A L+++GNLVV D L
Sbjct: 104 AANLTISS--NGSLILLDGTQDVIWSTGEAFTSNKCHAELLDTGNLVVIDDVSGKT---L 158
Query: 168 WQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKN 227
W+SF+ +T+LP + ++ G NR L+SW+S DP+ G+FT P+ PQ ++R+
Sbjct: 159 WKSFENLGNTMLPQSSVMYDIPRGKNRVLTSWRSNSDPSPGEFTLEFTPQVPPQGLIRRG 218
Query: 228 SIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKE--AFYTYNLSNSSVPSRMVINPA 285
S +R+G W ++G+P + + V F + + + A ++Y++ + S + +
Sbjct: 219 SSPYWRSGPWAKTRFSGIPGIDASYVSPFTVLQDVAKGTASFSYSMLRNYKLSYVTLTSE 278
Query: 286 GTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQGFVPNS 345
G + + W + K+W L F T CD Y CG + C + S +P+C CL+GFVP S
Sbjct: 279 GKM-KILWNDG-KSWKL--HFEAPT-SSCDLYRACGPFGLC-VRSRNPKCICLKGFVPKS 332
Query: 346 QREWDMQYKSGGCVRRTPLDC----------KHGDGFLEHKAVKLPDTRFSWVDKNITLW 395
EW + GCVRRT L C K D F VK PD + +
Sbjct: 333 DDEWKKGNWTSGCVRRTQLSCHTNSSTKTQGKETDSFYHMTRVKTPD--LYQLAGFLNAE 390
Query: 396 ECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVE 455
+C + C NCSCTA+A G GCL+W +L+D + G+ L +R+A+SEL
Sbjct: 391 QCYQDCLGNCSCTAFAYIS----GIGCLVWNRELVDTVQFLSDGESLSLRLASSELAG-- 444
Query: 456 RRRQSKNKKQVMIIITSISLATAVIFIG--GLMYRRKK--------HSNQGNEKEEME-- 503
S K ++ S+S+ ++F YR K+ HS+Q ++ME
Sbjct: 445 ----SNRTKIILGTTVSLSIFVILVFAAYKSWRYRTKQNEPNPMFIHSSQDAWAKDMEPQ 500
Query: 504 ----LPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEE 559
+ +FD+ I AT+NFS NKLG+GGFGPVYKG L++G+EIAVKRLS SGQG +E
Sbjct: 501 DVSGVNLFDMHTIRTATNNFSSSNKLGQGGFGPVYKGKLVDGKEIAVKRLSSSSGQGTDE 560
Query: 560 FKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS 619
F NE+ LI+KLQH+NLV+LLGCC + +E++LIYEYL NKSLD F+FD+T +DW KR
Sbjct: 561 FMNEIRLISKLQHKNLVRLLGCCIKGEEKLLIYEYLVNKSLDVFLFDSTLKFEIDWQKRF 620
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
+II G+ARGLLYLH+DSRLR+IHRDLK SN+LLD M PKISDFGLAR Q + NT+
Sbjct: 621 NIIQGVARGLLYLHRDSRLRVIHRDLKVSNILLDEKMIPKISDFGLARMSQGTQYQDNTR 680
Query: 680 RVVGT 684
RVVGT
Sbjct: 681 RVVGT 685
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 1.1e-127, Sum P(2) = 1.1e-127
Identities = 126/182 (69%), Positives = 150/182 (82%)
Query: 503 ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN 562
EL ++ L I AT NFS+ NKLGEGGFGPVY G L G+E+AVKRL + SGQG+EEFKN
Sbjct: 514 ELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKN 573
Query: 563 EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
EV+LIAKLQHRNLV+LLGCC R+E++L+YEY+PNKSLD F+F+ + +LLDW KR II
Sbjct: 574 EVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDII 633
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
GIARGLLYLH+DSRLR++HRDLKASN+LLD M PKISDFG+AR FG DQ + NT RVV
Sbjct: 634 EGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVV 693
Query: 683 GT 684
GT
Sbjct: 694 GT 695
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81832 | Y4729_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5411 | 0.9108 | 0.7956 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.01340036 | hypothetical protein (831 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 684 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-38 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-37 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 2e-37 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 3e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-37 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-34 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 3e-34 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 3e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-29 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 7e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-23 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 2e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-20 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-09 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 1e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-06 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 1e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.002 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.003 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 65/150 (43%), Positives = 83/150 (55%), Gaps = 10/150 (6%)
Query: 524 KLGEGGFGPVYKGMLI-----EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVK 577
KLGEG FG VYKG L + E+AVK L + S Q +EEF E ++ KL H N+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
LLG CT+ + M++ EY+P L ++ R K L S IARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
IHRDL A N L+ + KISDFGL+R
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 61/152 (40%), Positives = 79/152 (51%), Gaps = 11/152 (7%)
Query: 522 KNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNL 575
KLGEG FG VYKG L + E+AVK L + S Q +EEF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
VKLLG CT+ + ++ EY+ L ++ L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
IHRDL A N L+ + KISDFGL+R
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 56/156 (35%), Positives = 79/156 (50%), Gaps = 14/156 (8%)
Query: 523 NKLGEGGFGPVYKGMLIEGQ----EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVK 577
KLGEG FG VYKG L E+AVK L + S + ++F E ++ KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFI------FDTTRSKLLDWSKRSHIIAGIARGLLY 631
LLG CT+ + L+ EY+ L ++ F + L IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
L + +HRDL A N L+ + KISDFGL+R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 58/165 (35%), Positives = 81/165 (49%), Gaps = 13/165 (7%)
Query: 524 KLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFK---NEVLLIAKLQHRNLVKLL 579
KLG G FG VYK G+ +AVK L K + ++ + E+ ++ +L H N+V+L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
+D L+ EY L ++ +R L + I I RGL YLH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNG 118
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
IIHRDLK N+LLD KI+DFGLA+ + T VGT
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGT 161
|
Length = 260 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 44/114 (38%), Positives = 77/114 (67%), Gaps = 4/114 (3%)
Query: 232 FRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMVINPAGTVQRY 291
+R+G WNG+ ++G+P++Q Y + + N +E +YTY ++N+S+ SR+ ++ G+++R+
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERF 60
Query: 292 TWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQGFVPNS 345
TW+ ++ W LF +S DQCD Y CG Y C++N SP+C C++GFVP +
Sbjct: 61 TWIPNSQDWNLF--WS-APKDQCDVYGRCGPYGYCDVN-TSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 3e-37
Identities = 56/116 (48%), Positives = 69/116 (59%), Gaps = 7/116 (6%)
Query: 91 EGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMES 150
TV WVANR PL+D S L + +G LVL + VWSSN+S VA L +
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQS--DGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDD 58
Query: 151 GNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPA 206
GNLV+ D N +LWQSFD+P DTLLPG K G N+ G +R L+SWKS DP+
Sbjct: 59 GNLVLYD----NSGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 9e-37
Identities = 58/150 (38%), Positives = 80/150 (53%), Gaps = 11/150 (7%)
Query: 524 KLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVK 577
KLGEG FG VYKG L ++AVK L +G+ + EEF E ++ KL H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
LLG CTQ + ++ EY+P L F+ + L + IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+HRDL A N L+ + KISDFGL+R
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 59/163 (36%), Positives = 83/163 (50%), Gaps = 10/163 (6%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
LGEGGFG VY G+++A+K + K S +EE E+ ++ KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
+ L+ EY SL + + L + I+ I GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 643 RDLKASNVLLDN-TMNPKISDFGLARSFGLDQTEANTKRVVGT 684
RDLK N+LLD+ K++DFGL++ D++ T VGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI--VGT 156
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 52/168 (30%), Positives = 76/168 (45%), Gaps = 11/168 (6%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHRNLV 576
+ KLGEG FG VY + G+ +A+K + K + E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+L D+ L+ EY L + + L + + I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS-- 115
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
I+HRDLK N+LLD + K++DFGLAR VGT
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGT 159
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 51/123 (41%), Positives = 64/123 (52%), Gaps = 8/123 (6%)
Query: 52 QSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVL 111
+ G+TLVS+ FELGFF Y I YK TV WVANRD P S S L
Sbjct: 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGS-SRTVVWVANRDNP-SGSSCTL 59
Query: 112 RINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSF 171
+ +G LV+ + + VWSSN++ V L++ GNLV+ D N LWQSF
Sbjct: 60 TLQ--SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD----GNFLWQSF 113
Query: 172 DYP 174
DYP
Sbjct: 114 DYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 52/122 (42%), Positives = 67/122 (54%), Gaps = 9/122 (7%)
Query: 52 QSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVL 111
++ G+TLVS FELGFF+ Y I YK TV WVANRD P+SD S L
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSS-SRTVVWVANRDNPVSD-SCTL 58
Query: 112 RINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSF 171
+ +G LVL + VWSSN++ + V L++ GNLV+ D + N LWQSF
Sbjct: 59 TLQ--SDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD----SDGNFLWQSF 112
Query: 172 DY 173
DY
Sbjct: 113 DY 114
|
Length = 114 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 55/174 (31%), Positives = 83/174 (47%), Gaps = 25/174 (14%)
Query: 523 NKLGEGGFGPVYKGMLIE-GQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
LG G FG VY + + G+ +AVK LS S + +E + E+ +++ LQH N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 580 GCCTQRDERML-IY-EYLPNKSLDYFI--F-----DTTRSKLLDWSKRSHIIAGIARGLL 630
G ++ L I+ EY+ SL + F R I GL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ----------ILEGLA 115
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
YLH I+HRD+K +N+L+D+ K++DFG A+ G +T T V GT
Sbjct: 116 YLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 7e-29
Identities = 38/67 (56%), Positives = 49/67 (73%), Gaps = 1/67 (1%)
Query: 366 CKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLW 425
C GDGFL +KLPDT + VD++I L EC++ C NCSCTAYA AD+RG GSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRG-GSGCLIW 59
Query: 426 FHDLIDI 432
+L+D+
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 56/157 (35%), Positives = 81/157 (51%), Gaps = 21/157 (13%)
Query: 523 NKLGEGGFGPVYKGMLI-----EGQEIAVKRLSK-GSGQGMEEFKNEVLLIAKLQHRNLV 576
+LGEG FG V G+++AVK L+ G Q +F+ E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 577 KLLGCCTQRDER--MLIYEYLPNKSLDYFIFDT----TRSKLLDWSKRSHIIAGIARGLL 630
K G C + R LI EYLP+ SL ++ +LL +S + I +G+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ------ICKGMD 123
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
YL R IHRDL A N+L+++ KISDFGLA+
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 63/169 (37%), Positives = 84/169 (49%), Gaps = 25/169 (14%)
Query: 519 FSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSK-GSGQGMEEFKNEVLLIAKLQ 571
F E+ LGEG FG VYKG L +A+K L + + +EF+ E L++ LQ
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF-------------DTTRSKLLDWSKR 618
H N+V LLG CT+ +++EYL + L F+ D T LD S
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
HI IA G+ YL S +HRDL A N L+ + KISDFGL+R
Sbjct: 127 LHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 54/167 (32%), Positives = 89/167 (53%), Gaps = 9/167 (5%)
Query: 519 FSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
F K+G+GGFG VYK G+E+A+K + S + E+ NE+ ++ K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
G ++DE ++ E+ SL + + ++ L S+ +++ + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS--- 116
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
IIHRD+KA+N+LL + K+ DFGL+ +VGT
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGT 160
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 55/170 (32%), Positives = 88/170 (51%), Gaps = 11/170 (6%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLS--KGSGQGMEEFKNEVLLIAKLQHRN 574
N+ + +G G FG VYKG+ +E G +A+K++S K + ++ E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VK +G D +I EY N SL I + S + + + +GL YLH+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLHE 117
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+IHRD+KA+N+L K++DFG+A L+ + VVGT
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 56/162 (34%), Positives = 91/162 (56%), Gaps = 22/162 (13%)
Query: 525 LGEGGFGPVYKGMLI-EGQ----EIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKL 578
LG G FG VYKG+ I EG+ +A+K L + + + +E +E ++A + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 579 LGCC-TQRDERMLIYEYLPNKSLDYFIF---DTTRSK-LLDWSKRSHIIAGIARGLLYLH 633
LG C + + LI + +P L ++ D S+ LL+W + IA+G+ YL
Sbjct: 75 LGICLSSQ--VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
+ R++HRDL A NVL+ + KI+DFGLA+ +D+ E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 57/195 (29%), Positives = 92/195 (47%), Gaps = 27/195 (13%)
Query: 500 EEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGME 558
EE++ + D+ + + + K+GEG G VYK G+E+A+K++ + Q E
Sbjct: 2 EELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKE 60
Query: 559 EFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR 618
NE+L++ +H N+V DE ++ EY+ SL ++ +
Sbjct: 61 LIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD---------IITQNFV 111
Query: 619 S---HIIAGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
IA + R GL YLH +IHRD+K+ N+LL + K++DFG A
Sbjct: 112 RMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQL-- 166
Query: 672 DQTEANTKR--VVGT 684
T+ +KR VVGT
Sbjct: 167 --TKEKSKRNSVVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 55/160 (34%), Positives = 80/160 (50%), Gaps = 19/160 (11%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGM--EEFKNEVLLIAKLQHRNLVKLLGC 581
KLG G FG V+ G ++AVK L G+ M E F E ++ KL+H LV+L
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 582 CTQRDERMLIYEYLPNKSL-DYFIFDTTRS----KLLDWSKRSHIIAGIARGLLYLHQDS 636
C++ + ++ EY+ SL D+ + +L+D + A IA G+ YL
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA------AQIAEGMAYLE--- 120
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676
IHRDL A N+L+ + KI+DFGLAR D+ A
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-23
Identities = 38/89 (42%), Positives = 50/89 (56%), Gaps = 8/89 (8%)
Query: 362 TPLDCKHG---DGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGR 418
TPL+C DGFL+ VKLPD + I+L EC+E C NCSCTAYA +
Sbjct: 1 TPLNCGGDGSTDGFLKLPDVKLPDN--ASAITAISLEECREACLSNCSCTAYAYNNG--- 55
Query: 419 GSGCLLWFHDLIDIKELPESGQDLFIRMA 447
GCLLW L +++ L G L++R+A
Sbjct: 56 SGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (250), Expect = 3e-23
Identities = 56/174 (32%), Positives = 88/174 (50%), Gaps = 24/174 (13%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN--------EVLLIAK 569
+ + KLGEG +G VYK + EI A+K++ ++ + E+ L+ +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR------LDNEEEGIPSTALREISLLKE 54
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGIARG 628
L+H N+VKLL + L++EY + L ++ D L + K I+ + RG
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPLSPNLIK--SIMYQLLRG 110
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
L Y H RI+HRDLK N+L++ K++DFGLAR+FG+ T VV
Sbjct: 111 LAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 54/161 (33%), Positives = 81/161 (50%), Gaps = 18/161 (11%)
Query: 523 NKLGEGGFGPVYKGMLIE--GQEI--AVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVK 577
+LG G FG V KG+ + G+E+ AVK L + G +EF E ++A+L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFD---TTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
L+G C + + ML+ E P L ++ S L + + + +A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
+HRDL A NVLL N KISDFG++R+ G
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 53/175 (30%), Positives = 82/175 (46%), Gaps = 33/175 (18%)
Query: 517 DNFSEKNKLGEGGFGPVYKG---MLIEGQE---IAVKRLSKGSGQGMEE-FKNEVLLIAK 569
D K +LGEG FG V+ G L + +AVK L + + + F+ E L+
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI-----------------FDTTRSKL 612
QH N+VK G CT+ D ++++EY+ + L+ F+ + T S+L
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
L I IA G++YL + +HRDL N L+ + KI DFG++R
Sbjct: 125 L------QIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 5e-22
Identities = 52/160 (32%), Positives = 84/160 (52%), Gaps = 10/160 (6%)
Query: 525 LGEGGFGPVYKGML-IEGQE---IAVKRLSKGSGQGME-EFKNEVLLIAKLQHRNLVKLL 579
+G G FG V +G L + G++ +A+K L GS +F E ++ + H N+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
G T+ M+I EY+ N SLD F+ + ++ GIA G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SEMN 126
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
+HRDL A N+L+++ + K+SDFGL+R + TK
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 51/167 (30%), Positives = 83/167 (49%), Gaps = 10/167 (5%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
F KLGEG +G VYK + E GQ +A+K + + ++E E+ ++ + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
G + + ++ EY S+ + +K L + + I+ +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS--- 117
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ IHRD+KA N+LL+ K++DFG+ S L T A V+GT
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 52/175 (29%), Positives = 91/175 (52%), Gaps = 23/175 (13%)
Query: 519 FSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN--------EVLLIAK 569
+ + ++GEG +G VYK G+ +A+K++ ME K E+ L+ K
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR------MENEKEGFPITAIREIKLLQK 54
Query: 570 LQHRNLVKLLGCCTQRDER--MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
L+H N+V+L T + + +++EY+ + L + D+ K + S+ + +
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTE-SQIKCYMKQLLE 111
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
GL YLH + I+HRD+K SN+L++N K++DFGLAR + + T RV+
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 7e-21
Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 21/177 (11%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKR--LSKGSGQGMEEFKNEVLLIAKLQHRN 574
+ ++G+G FG VY ++ +K LS S + E+ NEV ++ KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS-------KLLDWSKRSHIIAGIAR 627
++K ++ + ++ EY L I + ++LDW +
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW------FVQLCL 114
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
L YLH SR +I+HRD+K N+ L + K+ DFG+++ L T K VVGT
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 94.8 bits (234), Expect = 9e-21
Identities = 55/172 (31%), Positives = 82/172 (47%), Gaps = 10/172 (5%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH-R 573
++ KLGEG FG VY + +A+K L+K + +E F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+VKL L+ EY+ SL+ + R L S+ I+A I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 634 QDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
IIHRD+K N+LLD + K+ DFGLA+ + ++ + T
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167
|
Length = 384 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 9/153 (5%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN--EVLLIAKLQHRNLVKLLG 580
K+GEG +G VYK + G+ +A+K++ E+ L+ +L H N++KLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
+ + L++E++ D + R + L S + + +GL + H I
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
+HRDLK N+L++ K++DFGLARSFG
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 51/155 (32%), Positives = 76/155 (49%), Gaps = 10/155 (6%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+G+G FG V G GQ++AVK L K + F E ++ L+H NLV+LLG
Sbjct: 11 GATIGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 582 CTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIA-GIARGLLYLHQDSRLR 639
Q + ++ EY+ SL DY +R + + + A + G+ YL +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK---N 122
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
+HRDL A NVL+ + K+SDFGLA+ Q
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 45/149 (30%), Positives = 79/149 (53%), Gaps = 4/149 (2%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
F+ + KLG G FG V++G+ +A+K L ++F+ EV + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
C+ + +I E + SL F+ + ++L + + +A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLAR 667
IHRDL A N+L+ + K++DFGLAR
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLAR 152
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 7/158 (4%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
KLG G FG V++G+ +AVK L G+ ++F E ++ KL+H L++L
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 582 CTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
CT + ++ E + SL +Y R+ L + + A +A G+ YL +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQN---Y 124
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
IHRDL A NVL+ K++DFGLAR D EA
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 58/149 (38%), Positives = 82/149 (55%), Gaps = 16/149 (10%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG G FG V+ G ++A+K L +GS E F E L+ +LQH LV+L T
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 584 QRDERMLIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
Q + +I EY+ N SL F+ T +KL+D + A IA G+ ++ R
Sbjct: 72 Q-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMA------AQIAEGMAFIE---RK 121
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLAR 667
IHRDL+A+N+L+ T+ KI+DFGLAR
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 54/157 (34%), Positives = 79/157 (50%), Gaps = 14/157 (8%)
Query: 525 LGEGGFGPV----YKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
LG+G FG V Y + G+ +AVK+L + + + +F+ E+ ++ LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 580 GCCTQRDER--MLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
G C R L+ EYLP SL DY R LD K + I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL---G 125
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
R +HRDL N+L+++ KI DFGL + D+
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 62/176 (35%), Positives = 89/176 (50%), Gaps = 25/176 (14%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLS-KGSGQGMEEFKNEV 564
I +T F E+ LGE FG VYKG L + Q +A+K L K G EEFK+E
Sbjct: 2 INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 565 LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF-------------DTTRSK 611
++ ++LQH N+V LLG T+ +I+ Y + L F+ D T
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
L+ + HI+ IA G+ +L S ++H+DL NVL+ + +N KISD GL R
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 60/157 (38%), Positives = 82/157 (52%), Gaps = 25/157 (15%)
Query: 525 LGEGGFG--------PVYKGMLIEGQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHRNL 575
LGEG FG P G G+ +AVK L + GQ +K E+ ++ L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 576 VKLLGCCTQRDER--MLIYEYLPNKSL-DYFI-FDTTRSKLLDWSKRSHIIAGIARGLLY 631
VK GCC+++ + LI EY+P SL DY ++LL ++++ I G+ Y
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAY 122
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
LH IHRDL A NVLLDN KI DFGLA++
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 17/167 (10%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRL-SKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
LG+G G VYK G+ A+K++ G + ++ E+ + + +VK G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR----GLLYLHQDSR 637
+ E ++ EY+ SL + K+ + ++A IAR GL YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEP--VLAYIARQILKGLDYLHTK-- 118
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
IIHRD+K SN+L+++ KI+DFG+++ L+ T VGT
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGT 163
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 48/157 (30%), Positives = 86/157 (54%), Gaps = 10/157 (6%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
++G G FG V+ G +E +++A+K + +G+ E+F E ++ KL H LV+L G CT
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS--HIIAGIARGLLYLHQDSRLRII 641
+R L++E++ + L ++ R++ +S+ + + + G+ YL + +I
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 642 HRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
HRDL A N L+ K+SDFG+ R DQ ++T
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 60/163 (36%), Positives = 96/163 (58%), Gaps = 20/163 (12%)
Query: 525 LGEGGFGPVYKGMLI-EGQEI----AVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKL 578
LG G FG VYKG+ + EG+ + A+K L++ +G + EF +E L++A + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIF---DTTRSKLL-DWSKRSHIIAGIARGLLYLHQ 634
LG C + L+ + +P+ L ++ D S+LL +W + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677
R++HRDL A NVL+ + + KI+DFGLAR D+ E N
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 48/147 (32%), Positives = 81/147 (55%), Gaps = 6/147 (4%)
Query: 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
K+KLG G +G VY+G+ + +AVK L K +EEF E ++ +++H NLV+LLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
CT+ +I E++ +L ++ + R ++ ++ I+ + YL + +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 125
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLAR 667
IHRDL A N L+ K++DFGL+R
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 5e-19
Identities = 56/177 (31%), Positives = 78/177 (44%), Gaps = 29/177 (16%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-Q 571
D+F +GEG F V E +E A+K L K + ++ K E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 572 HRNLVKLLGCCTQRDERML--IYEYLPNKSLDYFI-------FDTTRSKLLDWSKRSHII 622
H ++KL T +DE L + EY PN L +I TR
Sbjct: 61 HPGIIKLY--YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTR----------FYA 108
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
A I L YLH IIHRDLK N+LLD M+ KI+DFG A+ + + + K
Sbjct: 109 AEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 54/159 (33%), Positives = 87/159 (54%), Gaps = 11/159 (6%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRL---SKGSGQGMEEFKNEVLLIAKLQHR 573
++++ K+GEG +G VYKG GQ +A+K++ S+ G + E+ L+ +LQH
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHP 59
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGLLYL 632
N+V L Q LI+E+L Y D+ + +D + I +G+L+
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYL--DSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
H R++HRDLK N+L+DN K++DFGLAR+FG+
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 53/162 (32%), Positives = 72/162 (44%), Gaps = 28/162 (17%)
Query: 524 KLGEGGFGPVYKG----MLIEGQEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVKL 578
KLG+G FG V +G + +AVK L M++F E ++ L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTR---------SKLLDWSKRSHIIAGIARGL 629
G M++ E P SL D R S L D++ + IA G+
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSL----LDRLRKDALGHFLISTLCDYAVQ------IANGM 110
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
YL R IHRDL A N+LL + KI DFGL R+
Sbjct: 111 RYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 8e-19
Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 24/170 (14%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG+G FG V + G+ A+K L K + +E E +++++ H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 581 CCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
Q +E++ L+ EY P L + F R++ A I L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--------YAAEIVLALEYLH- 110
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
L II+RDLK N+LLD + K++DFGLA+ + + NT GT
Sbjct: 111 --SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 49/150 (32%), Positives = 90/150 (60%), Gaps = 14/150 (9%)
Query: 525 LGEGGFGPVYKGML-IEGQE---IAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+G G FG V++G+L + G++ +A+K L G + + ++F +E ++ + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS--KRSHIIAGIARGLLYLHQDSR 637
G T+ M+I EY+ N +LD ++ R ++S + ++ GIA G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYL----RDHDGEFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ +HRDL A N+L+++ + K+SDFGL+R
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 56/153 (36%), Positives = 80/153 (52%), Gaps = 5/153 (3%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG G FG V+ G ++AVK L G+ ++ F E L+ LQH LV+L T
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
+ + +I EY+ SL F+ K+L K A IA G+ Y+ R IHR
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIHR 127
Query: 644 DLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676
DL+A+NVL+ ++ KI+DFGLAR ++ A
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 56/160 (35%), Positives = 75/160 (46%), Gaps = 20/160 (12%)
Query: 525 LGEGGFGPVYKGMLI-------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLV 576
LG G FG VY+G +AVK L KG+ Q +EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLLYL 632
KLLG C + + +I E + L ++ D LL + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 633 HQDSRLRIIHRDLKASNVLL-----DNTMNPKISDFGLAR 667
Q + IHRDL A N L+ D KI DFGLAR
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 51/162 (31%), Positives = 86/162 (53%), Gaps = 18/162 (11%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-----EVLLIAKLQ 571
+ + KLGEG + VYK E G+ +A+K++ G + ++ N E+ L+ +L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI---IAGIARG 628
H N++ LL + L++E++ L+ I + K + + + I + RG
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-DLEKVI----KDKSIVLTP-ADIKSYMLMTLRG 114
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
L YLH I+HRDLK +N+L+ + K++DFGLARSFG
Sbjct: 115 LEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 48/148 (32%), Positives = 75/148 (50%), Gaps = 7/148 (4%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ 584
LG G FG V+ G ++A+K + +G+ ++F E ++ KL H NLV+L G CT+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRD 644
+ ++ EY+ N L ++ R L + + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 645 LKASNVLLDNTMNPKISDFGLARSFGLD 672
L A N L+ K+SDFGLAR + LD
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLAR-YVLD 152
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 50/145 (34%), Positives = 73/145 (50%), Gaps = 6/145 (4%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQHRNLVKLLGCC 582
K+G+G FG VYKG+L E+AVK + +F E ++ + H N+VKL+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
Q+ ++ E +P SL F+ + L K + A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 643 RDLKASNVLLDNTMNPKISDFGLAR 667
RDL A N L+ KISDFG++R
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 51/168 (30%), Positives = 78/168 (46%), Gaps = 19/168 (11%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRL-SKGSGQGMEEFKNEVLLI 567
D+ + LG G FG VY+G+ ++AVK L S Q +F E L++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT----TRSKLLDWSKRSHIIA 623
+K H+N+V+L+G +R R ++ E + L F+ + R L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLAR 667
+A+G YL ++ IHRD+ A N LL P KI+DFG+AR
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLL-TCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 9e-18
Identities = 56/168 (33%), Positives = 84/168 (50%), Gaps = 31/168 (18%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKR--LSKGSGQG-------MEEFKNEVLLIAKLQHRN 574
+G G FG VY GM G+ +AVK+ L S ++ E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSL-----DYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
+V+ LG D + EY+P S+ +Y F+ T + + + I +GL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--------NFVRQILKGL 119
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677
YLH IIHRD+K +N+L+DN KISDFG+++ + EAN
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK-----KLEAN 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 50/164 (30%), Positives = 85/164 (51%), Gaps = 21/164 (12%)
Query: 522 KNKLGEGGFGPVYKG---MLIEGQE---IAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
K +LGEG FG V+ L+ Q+ +AVK L + S ++F+ E L+ LQH+++
Sbjct: 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFI-FDTTRSKLLDWSKRS-----------HIIA 623
V+ G CT+ ++++EY+ + L+ F+ +K+L + I +
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
IA G++YL + L +HRDL N L+ + KI DFG++R
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 50/163 (30%), Positives = 87/163 (53%), Gaps = 16/163 (9%)
Query: 519 FSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS-KGSGQGMEEFK-NEVLLIAKLQ---H 572
+ E ++GEG +G VYK L G+ +A+K++ S +G+ E+ L+ +L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 573 RNLVKLLGCC-TQRDER----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
N+V+LL C R +R L++E++ ++ L ++ L ++ + R
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLR 118
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
G+ +LH RI+HRDLK N+L+ + KI+DFGLAR +
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 53/178 (29%), Positives = 83/178 (46%), Gaps = 41/178 (23%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVL 565
++ KLGEG FG VYK I+ G+ +A+K++ M K+ E+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL------MHNEKDGFPITALREIK 59
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD----YFIF---DTTRSKLLDWSK- 617
++ KL+H N+V L+ + E Y + D S LL+
Sbjct: 60 ILKKLKHPNVVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV 110
Query: 618 ---RSHI---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
S I + + G+ YLH++ I+HRD+KA+N+L+DN KI+DFGLAR +
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPY 165
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 53/149 (35%), Positives = 75/149 (50%), Gaps = 10/149 (6%)
Query: 524 KLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN--EVLLIAKLQ-HRNLVKLL 579
+LG+G FG VY E E+ A+K++ K EE N EV + KL H N+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
+ DE ++EY+ +L Y + + K S II I +GL ++H +
Sbjct: 65 EVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHG 119
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARS 668
HRDLK N+L+ KI+DFGLAR
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLARE 148
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 47/169 (27%), Positives = 84/169 (49%), Gaps = 13/169 (7%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKR--LSKGSGQGMEEFKNEVLLIAKLQHRNL 575
F+ +G+G FG VYK + Q +A+K L + + +E+ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
K G + + +I EY S D + LD + + I+ + GL YLH++
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
IHRD+KA+N+LL + K++DFG++ ++ NT VGT
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGT 161
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 58/164 (35%), Positives = 79/164 (48%), Gaps = 23/164 (14%)
Query: 524 KLGEGGFGPVYKGMLI-----EGQEIAVKRLSK-GSGQGMEEFKNEVLLIAKLQHRNLVK 577
+LGE FG +YKG L Q +A+K L + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIF--------------DTTRSKLLDWSKRSHIIA 623
LLG TQ +++EYL L F+ D T LD HI
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
IA G+ YL S +H+DL A N+L+ ++ KISD GL+R
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 54/156 (34%), Positives = 87/156 (55%), Gaps = 26/156 (16%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLS-----KGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG G FG VY+G+ L +G AVK +S + + +++ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 579 LGCCTQRDERML-IY-EYLPNKSL-----DYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
LG T+R+E L I+ E +P SL Y F +L ++++ I GL Y
Sbjct: 68 LG--TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL--YTRQ------ILLGLEY 117
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
LH +HRD+K +N+L+D K++DFG+A+
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 16/163 (9%)
Query: 518 NFSEKNKLGEGGFGPVY----KGMLIEGQE--IAVKRLSKGSGQGME-EFKNEVLLIAKL 570
N E LG G FG V+ KG+ EG E + VK L K + ++ EF+ E+ + KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI------FDTTRSKLLDWSKRSHIIAG 624
H+N+V+LLG C + + +I EY L F+ + + L ++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
IA G+ +L S R +HRDL A N L+ + K+S L++
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 48/157 (30%), Positives = 84/157 (53%), Gaps = 20/157 (12%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN--------EVLLIAKLQHRN 574
K+GEG +G VYK + G+ +A+K++ +E E+ L+ +L H N
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIR------LETEDEGVPSTAIREISLLKELNHPN 59
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+V+LL ++ L++E+L + L ++ D++ LD + + +G+ Y H
Sbjct: 60 IVRLLDVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
R++HRDLK N+L+D K++DFGLAR+FG+
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLARAFGV 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 50/156 (32%), Positives = 86/156 (55%), Gaps = 6/156 (3%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFK-NEVLLIAKLQHRNL 575
NF + KLGEG + VYKG EI A+K + + +G E+ L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
V+L ++ ML++EY+ +K L ++ LD + + +G+ + H++
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
R++HRDLK N+L++ K++DFGLAR+FG+
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGI 152
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 51/173 (29%), Positives = 85/173 (49%), Gaps = 28/173 (16%)
Query: 522 KNKLGEGGFGPVY----KGML---------IEGQE--IAVKRL-SKGSGQGMEEFKNEVL 565
K KLGEG FG V+ +G+ +GQ +AVK L + + +F E+
Sbjct: 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD-TTRSKL--------LDWS 616
++++L++ N+++LLG C D +I EY+ N L+ F+ S + +
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
++ IA G+ YL + L +HRDL N L+ N KI+DFG++R+
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 53/162 (32%), Positives = 79/162 (48%), Gaps = 21/162 (12%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQ-EIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
D E+ LG+G +G VY + Q IA+K + + + ++ E+ L + L+HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDW----SKRSHII---AGIAR 627
+V+ LG ++ + E +P SL RSK W II I
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLS----ALLRSK---WGPLKDNEQTIIFYTKQILE 119
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNP--KISDFGLAR 667
GL YLH +I+HRD+K NVL+ NT + KISDFG ++
Sbjct: 120 GLKYLHD---NQIVHRDIKGDNVLV-NTYSGVVKISDFGTSK 157
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 53/172 (30%), Positives = 83/172 (48%), Gaps = 31/172 (18%)
Query: 518 NFSEKNKLGEGGFGPVYKGM---LIEGQE---IAVKRLSKGSGQGMEEFKNEVLLIAKLQ 571
N K +LGEG FG V+ L Q+ +AVK L S ++F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI----------------FDTTRSKLLDW 615
H ++VK G C + D ++++EY+ + L+ F+ + T+S++L
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML-- 123
Query: 616 SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
HI IA G++YL + +HRDL N L+ + KI DFG++R
Sbjct: 124 ----HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 525 LGEGGFGPVYKGMLIEG----QEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LGEG FG V +G L + ++AVK +L + +EEF +E + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 579 LGCCTQRDER------MLIYEYLPNKSLDYFIFDT---TRSKLLDWSKRSHIIAGIARGL 629
+G C + M+I ++ + L F+ + + L + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
YL S IHRDL A N +L M ++DFGL++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 6/144 (4%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGME-EFKNEVLLIAKLQHRNLVKLLGCCT 583
LG+G FG V+KG L + +AVK + Q ++ +F +E ++ + H N+VKL+G CT
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
QR ++ E +P D+ F + L + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 644 DLKASNVLLDNTMNPKISDFGLAR 667
DL A N L+ KISDFG++R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 57/167 (34%), Positives = 89/167 (53%), Gaps = 20/167 (11%)
Query: 519 FSEKNKLGEGGFGPVYKGMLI-EGQEI----AVKRLSKG-SGQGMEEFKNEVLLIAKLQH 572
F + LG G FG VYKG+ I EG+++ A+K L + S + +E +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTR---SKLLDWSKRSHIIAGIARG 628
++ +LLG C + LI + +P L DY LL+W + IA+G
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
+ YL + R++HRDL A NVL+ + KI+DFGLA+ G D+ E
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 53/173 (30%), Positives = 85/173 (49%), Gaps = 16/173 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
+++ ++G G +G VYK I E+ A+K + G E + E+ ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR----GLLY 631
V G +RD+ ++ EY SL I+ TR L IA + R GL Y
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPL-----SELQIAYVCRETLKGLAY 116
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
LH+ IHRD+K +N+LL + K++DFG++ L T A K +GT
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ--LTATIAKRKSFIGT 164
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 49/144 (34%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG G FG V+ G ++AVK L G+ E F E ++ KL+H LV+L +
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
+ ++ EY+ SL F+ D + L + A +A G+ Y+ R+ IHR
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 644 DLKASNVLLDNTMNPKISDFGLAR 667
DL+++N+L+ + + KI+DFGLAR
Sbjct: 127 DLRSANILVGDGLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 51/157 (32%), Positives = 88/157 (56%), Gaps = 8/157 (5%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRN 574
NF + K+GEG +G VYK + G+ +A+K RL + E+ L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VKLL ++ L++E+L ++ L F+ + S + +S++ + +GL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQ-LLQGLAFCHS 118
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
R++HRDLK N+L++ K++DFGLAR+FG+
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-16
Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 29/177 (16%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM---LIEGQE---IAVKRLSKGSGQGME-EFKNEVLLIAK 569
+N +G+G FG V++ L+ + +AVK L + + M+ +F+ E L+A+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH--------- 620
H N+VKLLG C L++EY+ L+ F+ + S +
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 621 ----------IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
I +A G+ YL S + +HRDL N L+ M KI+DFGL+R
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 23/184 (12%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QH 572
+ T F +GEG +G VYK + ++ ++ EE K E ++ K H
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH 62
Query: 573 RNLVKLLGCCTQR------DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR------SH 620
N+ G ++ D+ L+ E S + D + L KR ++
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVK-GLRKKGKRLKEEWIAY 117
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
I+ RGL YLH++ ++IHRD+K N+LL K+ DFG++ LD T
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ--LDSTLGRRNT 172
Query: 681 VVGT 684
+GT
Sbjct: 173 FIGT 176
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 55/177 (31%), Positives = 78/177 (44%), Gaps = 31/177 (17%)
Query: 518 NFSEKNKLGEGGFGPVY-----------------KGMLIEGQEIAVKRLSKG-SGQGMEE 559
NF EK LGEG FG V+ +AVK L S E+
Sbjct: 8 NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 560 FKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI--------FDTTRSK 611
F EV ++++L N+ +LLG CT +I EY+ N L+ F+ SK
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
L +S ++ IA G+ YL L +HRDL N L+ KI+DFG++R+
Sbjct: 126 SLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRN 179
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 54/164 (32%), Positives = 88/164 (53%), Gaps = 19/164 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS-KGSGQGMEEFK-NEVLLIAKLQHR 573
D + + K+GEG +G VYK + + IA+K++ + +G+ E+ L+ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF-DTTRSKLLDWSKRSHIIAG----IARG 628
N+V+L L++EYL LD D++ D++K +I I RG
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSP----DFAKNPRLIKTYLYQILRG 114
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNP-KISDFGLARSFGL 671
+ Y H R++HRDLK N+L+D N K++DFGLAR+FG+
Sbjct: 115 IAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 47/151 (31%), Positives = 82/151 (54%), Gaps = 9/151 (5%)
Query: 524 KLGEGGFGPVYKGMLIEGQEI-AVKRLS-KGSGQGMEEFK-NEVLLIAKLQHRNLVKLLG 580
K+GEG +G V+K E EI A+KR+ +G+ E+ L+ +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
+ L++EY ++ L + FD+ + D + + +GL + H +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
+HRDLK N+L++ K++DFGLAR+FG+
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGI 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 15/173 (8%)
Query: 518 NFSEKNKLGEGGFGPVYKGML-IEGQEIAVKR--LSKGSGQGMEEFKNEVLLIAKLQHRN 574
+F NK+G+G FG V+K + + + A+K+ LSK + + EE +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLD---WSKRSHIIAGIARGLLY 631
+++ + + ++ EY N L + L + W I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
LH +I+HRD+K+ N+ LD N KI D G+A+ + ANT +VGT
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 12/149 (8%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKR-----LSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG VY ++ G+E+AVK+ S + + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
GC + + EY+P S+ + L + R + I G+ YLH +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYT-RQILEGVEYLHSN--- 123
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLAR 667
I+HRD+K +N+L D+ N K+ DFG ++
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 51/151 (33%), Positives = 84/151 (55%), Gaps = 15/151 (9%)
Query: 525 LGEGGFGPVYKGMLI--EGQEI--AVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLL 579
+G+G FG VY G LI +GQ+I AVK L++ + + +E+F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 580 GCCTQRD-ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAG--IARGLLYLHQDS 636
G C + +++ Y+ + L FI T + + + I G +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV----KDLIGFGLQVAKGMEYLASK- 117
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ +HRDL A N +LD + K++DFGLAR
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 9/162 (5%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKR--LSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
++GEG G V+K E G+ +A+K+ L + G + E+ + QH +VKLL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
+L+ EY+P+ L + D R L + +S + + +G+ Y+H I
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERP-LPEAQVKS-YMRMLLKGVAYMHA---NGI 120
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
+HRDLK +N+L+ KI+DFGLAR F ++ + +V
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 49/152 (32%), Positives = 84/152 (55%), Gaps = 18/152 (11%)
Query: 525 LGEGGFGPVYKGML-IEGQE---IAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+G G FG V +G L + G+ +A+K L G + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDT----TRSKLLDWSKRSHIIAGIARGLLYLHQD 635
G T+ M+I E++ N +LD F+ T +L+ ++ GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVG------MLRGIAAGMKYL--- 122
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
S + +HRDL A N+L+++ + K+SDFGL+R
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 48/144 (33%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG+G FG V+ G +A+K L G+ E F E ++ KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
+ + ++ EY+ SL F+ K L + + A IA G+ Y+ R+ +HR
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 644 DLKASNVLLDNTMNPKISDFGLAR 667
DL+A+N+L+ + K++DFGLAR
Sbjct: 127 DLRAANILVGENLVCKVADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 50/148 (33%), Positives = 78/148 (52%), Gaps = 14/148 (9%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
+LG G FG V G ++A+K + +GS +EF E ++ KL H LV+L G CT
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTR----SKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
++ ++ EY+ N L ++ + + S+LL+ K + G+ YL +
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK------DVCEGMAYLESK---Q 120
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLAR 667
IHRDL A N L+D+ K+SDFGL+R
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 31/171 (18%)
Query: 525 LGEGGFGPVYKGMLIEGQ------EIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVK 577
LGEG FG V K + +AVK L + + + + +E L+ ++ H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAG 624
L G C+Q +LI EY SL F+ ++ + S LD + G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 625 --------IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
I+RG+ YL + ++++HRDL A NVL+ KISDFGL+R
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 56/174 (32%), Positives = 74/174 (42%), Gaps = 44/174 (25%)
Query: 525 LGEGGFGPVYKGMLI------EGQEIAVKRLSKGSG---------QGMEEFKNEVLLIAK 569
LGEG FG V K + E +AVK L K ME K +I K
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVSEMEMMK----MIGK 74
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAG----- 624
H+N++ LLG CTQ ++ EY + +L F+ R S
Sbjct: 75 --HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLTQ 131
Query: 625 ---------IARGLLYLHQDSRLRIIHRDLKASNVLL--DNTMNPKISDFGLAR 667
+ARG+ +L + IHRDL A NVL+ D+ M KI+DFGLAR
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVM--KIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 6e-15
Identities = 54/172 (31%), Positives = 85/172 (49%), Gaps = 32/172 (18%)
Query: 525 LGEGGFGPVYKGML-IEGQE---IAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+G G FG V G L + G+ +A+K L G + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH-----------IIAGIARG 628
G T+ M++ EY+ N SLD F+ R H ++ GIA G
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL-------------RKHDGQFTVIQLVGMLRGIASG 118
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
+ YL S + +HRDL A N+L+++ + K+SDFGL+R D A T R
Sbjct: 119 MKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 56/161 (34%), Positives = 87/161 (54%), Gaps = 20/161 (12%)
Query: 525 LGEGGFGPVYKGMLIEGQE-----IAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG G FG VYKG+ I E +A+K L + S + +E +E ++A + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 579 LGCCTQRDERMLIYEYLPNKSL-DYFIFDTTR---SKLLDWSKRSHIIAGIARGLLYLHQ 634
LG C + L+ + +P L DY + R LL+W + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
+R++HRDL A NVL+ + + KI+DFGLAR +D+TE
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLS---------KGSGQGM-EEFKNEVLLIAKLQHR 573
+G+G +G VY + + G+ +AVK++ + M + ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+V+ LG T + + EY+P S+ + R + + GL YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYLH 125
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
I+HRDLKA N+L+D KISDFG+++
Sbjct: 126 SKG---ILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 22/165 (13%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
K +LGEG FG V+ + +AVK L + ++F+ E L+ LQH ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-------------LDWSKRSHII 622
VK G C D ++++EY+ + L+ F+ + L S+ HI
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ IA G++YL + +HRDL N L+ + KI DFG++R
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 8e-15
Identities = 48/146 (32%), Positives = 78/146 (53%), Gaps = 10/146 (6%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
+LG G FG V+ G ++A+K +++G+ E+F E ++ KL H LV+L G CT
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS--HIIAGIARGLLYLHQDSRLRII 641
Q+ ++ E++ N L ++ R + SK + + G+ YL ++S I
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL----RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FI 122
Query: 642 HRDLKASNVLLDNTMNPKISDFGLAR 667
HRDL A N L+ +T K+SDFG+ R
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 54/149 (36%), Positives = 81/149 (54%), Gaps = 16/149 (10%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG G FG V+ + ++AVK + GS +E F E ++ LQH LVKL T
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 584 QRDERMLIYEYLPNKSL-DYFIFDTTRS----KLLDWSKRSHIIAGIARGLLYLHQDSRL 638
++ +I E++ SL D+ D KL+D+S A IA G+ ++ Q +
Sbjct: 72 -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS------AQIAEGMAFIEQRN-- 122
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLAR 667
IHRDL+A+N+L+ ++ KI+DFGLAR
Sbjct: 123 -YIHRDLRAANILVSASLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 6/154 (3%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
N D + +LG+G FG VYK E G A K + S + +E+F E+ ++++ +H
Sbjct: 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
N+V L ++ ++ E+ +LD + + R L + ++ + L +L
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFL 119
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
H ++IHRDLKA N+LL + K++DFG++
Sbjct: 120 HSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 53/164 (32%), Positives = 81/164 (49%), Gaps = 21/164 (12%)
Query: 522 KNKLGEGGFGPVYKGMLIEG---QEIAVKRLSK-GSGQGMEEFKNEVLLIAKL-QHRNLV 576
++ +GEG FG V K + + + A+KR+ + S +F E+ ++ KL H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 577 KLLGCCTQRDERMLIYEYLPNKSL-DY------------FIFDTTRSKLLDWSKRSHIIA 623
LLG C R L EY P+ +L D+ F + + L + H A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ARG+ YL Q + IHRDL A N+L+ KI+DFGL+R
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 54/184 (29%), Positives = 95/184 (51%), Gaps = 29/184 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFK----NEVLLIAKLQ 571
D F ++GEG +G VYK G+ +A+K++ + + E F E+ ++ +L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLN 64
Query: 572 HRNLVKLLGCCTQRDERM----------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
HRN+V L T + + + L++EY+ D+ + S L+ +S+ HI
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSE-DHI 118
Query: 622 ---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
+ + GL Y H+ + L HRD+K SN+LL+N K++DFGLAR + +++ T
Sbjct: 119 KSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 679 KRVV 682
+V+
Sbjct: 176 NKVI 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 48/174 (27%), Positives = 83/174 (47%), Gaps = 10/174 (5%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQ 571
NF + K+G+G F VYK + L++G+ +A+K++ + ++ E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK-LLDWSKRSHIIAGIARGLL 630
H N++K L + +E ++ E L I + K L+ + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
++H RI+HRD+K +NV + T K+ D GL R F T A++ VGT
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 47/147 (31%), Positives = 75/147 (51%), Gaps = 9/147 (6%)
Query: 523 NKLGEGGFGPVYKGM-LIEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
NK+G G FG VY + L G+ +AVK R+ + ++E +E+ ++ L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
G R++ + EY +L+ + ++LD + GL YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH---G 119
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLA 666
I+HRD+K +N+ LD+ K+ DFG A
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCA 146
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 60/176 (34%), Positives = 87/176 (49%), Gaps = 30/176 (17%)
Query: 517 DNFSEKNKLGEGGFGPVYK----GMLIEGQE----IAVKRLS-KGSGQGMEEFKNEVLLI 567
D LGEG FG V + G+ + +AVK L + + + + +E+ L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 568 AKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI-----------FDTTRS--KLL 613
+ +H+N++ LLG CTQ +I EY +L F+ FD T+ + L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNTMNPKISDFGLAR 667
+ +ARG+ YL +SR R IHRDL A NVL+ DN M KI+DFGLAR
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVM--KIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 56/183 (30%), Positives = 87/183 (47%), Gaps = 38/183 (20%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN--------EVLLIA 568
F + N++GEG +G VY+ G+ +A+K++ M+ ++ E+ L+
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR------MDNERDGIPISSLREITLLL 61
Query: 569 KLQHRNLVKLLGCCT--QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
L+H N+V+L D L+ EY + + LLD + +
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYC----------EQDLASLLDNMPTPFSESQVK 111
Query: 627 -------RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
RGL YLH++ IIHRDLK SN+LL + KI+DFGLAR++GL T
Sbjct: 112 CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-TP 167
Query: 680 RVV 682
+VV
Sbjct: 168 KVV 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 16/177 (9%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAV-KRLSKGSGQGMEEFK-----NEVLLIAKLQH 572
+ +G+G FG V K +I V K + G+ M E + +EV ++ +L+H
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSEVNILRELKH 58
Query: 573 RNLVKLLGCCTQRD-ERMLIY-EYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGIARGL 629
N+V+ R + + I EY L I + + ++ I+ + L
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 630 LYLH--QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
H D ++HRDLK +N+ LD N K+ DFGLA+ G D + A T VGT
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 56/176 (31%), Positives = 95/176 (53%), Gaps = 22/176 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRL---SKGSGQGMEEFKNEVLLIAKLQH 572
D + + N++ EG +G VY+ + EI A+K+L + G + + E+ ++ KLQH
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63
Query: 573 RNLVKL----LGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
N+V + +G + D+ ++ EY+ + KSL +T + L S+ ++ +
Sbjct: 64 PNIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSL----METMKQPFLQ-SEVKCLMLQLL 116
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
G+ +LH + I+HRDLK SN+LL+N KI DFGLAR +G + T+ VV
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVV 168
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 49/174 (28%), Positives = 91/174 (52%), Gaps = 10/174 (5%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
I + ++ K+G+G G V+ + + GQE+A+K+++ E NE+L++ +L
Sbjct: 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL 73
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
++ N+V L DE ++ EYL SL D +D ++ + + + L
Sbjct: 74 KNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALE 129
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+LH + ++IHRD+K+ NVLL + K++DFG +Q++ +T +VGT
Sbjct: 130 FLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 54/172 (31%), Positives = 84/172 (48%), Gaps = 16/172 (9%)
Query: 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLS------KGSGQGMEEFKNEVLLIAKLQHRNLV 576
LG+G +G VY G+ +GQ IAVK++ + + E+ + EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ LG C + + E++P S+ + R L I G+ YLH +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSF---GLDQTEANT-KRVVGT 684
++HRD+K +NV+L K+ DFG AR GL T +N K + GT
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT 171
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 53/168 (31%), Positives = 85/168 (50%), Gaps = 15/168 (8%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCT 583
+G G +G VYKG ++ ++A ++ +G EE K E+ ++ K HRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 584 QR------DERMLIYEYLPNKSLDYFIFDTTRSKLL-DWSKRSHIIAGIARGLLYLHQDS 636
++ D+ L+ E+ S+ I +T + L +W ++I I RGL +LHQ
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILRGLSHLHQH- 130
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
++IHRD+K NVLL K+ DFG+ S LD+T +GT
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGT 174
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 50/178 (28%), Positives = 90/178 (50%), Gaps = 18/178 (10%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ + ++ K+G+G G VY + + GQE+A+K+++ E NE+L++ +
Sbjct: 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN 73
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+H N+V L DE ++ EYL SL + +T + IA + R L
Sbjct: 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE--------GQIAAVCRECL 125
Query: 631 ----YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+LH + ++IHRD+K+ N+LL + K++DFG +Q++ +T +VGT
Sbjct: 126 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 17/157 (10%)
Query: 525 LGEGGFGPVYKGMLIEGQEI---AVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
LGEG FG V +G L + I AVK +++ + ME+F +E + + + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 580 GCCTQRDER------MLIYEYLPNKSLDYFIFDT---TRSKLLDWSKRSHIIAGIARGLL 630
G C Q E ++I ++ + L F+ + + L + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
YL S IHRDL A N +L+ MN ++DFGL++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 9/167 (5%)
Query: 523 NKLGEGGFGPVYKGMLIEGQE-IAVKR--LSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+G G VY + + E +A+KR L K ++E + EV +++ H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
DE L+ YL SL + + LD + + ++ + +GL YLH + +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSF--GLDQTEANTKRVVGT 684
IHRD+KA N+LL + KI+DFG++ S G D+T K VGT
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 57/159 (35%), Positives = 84/159 (52%), Gaps = 17/159 (10%)
Query: 525 LGEGGFGPVY------KGMLIEGQEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVK 577
LGEG FG V +G G+++AVK L SG + + K E+ ++ L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 578 LLGCCTQRDER--MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIA-GIARGLLYLHQ 634
G CT+ LI E+LP+ SL ++ R+K K+ A I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYL-- 125
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
SR + +HRDL A NVL+++ KI DFGL ++ D+
Sbjct: 126 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 52/152 (34%), Positives = 79/152 (51%), Gaps = 20/152 (13%)
Query: 525 LGEGGFGPVYKGMLI-EGQEI----AVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKL 578
LG G FG V+KG+ I EG I A+K + SG Q +E + +L + L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS----KLLDWSKRSHIIAGIARGLLYLHQ 634
LG C L+ + P SL + S +LL+W + IA+G+ YL +
Sbjct: 75 LGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
R++HR+L A N+LL + +I+DFG+A
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 36/182 (19%)
Query: 523 NKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN--------EVLLIAKLQHR 573
K+G+G FG V+K + ++I A+K++ ME K E+ ++ L+H
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVL------MENEKEGFPITALREIKILQLLKHE 71
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL----------LDWSKRSHIIA 623
N+V L+ C R Y K Y +F+ L S+ ++
Sbjct: 72 NVVNLIEIC-----RTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMK 126
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN---TKR 680
+ GL Y+H R +I+HRD+KA+N+L+ K++DFGLAR+F L + T R
Sbjct: 127 MLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 681 VV 682
VV
Sbjct: 184 VV 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 48/152 (31%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---EVLLIAKLQHRN 574
FS+ ++G G FG VY + E+ A+K++S Q E++++ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
++ GC + L+ EY + D K L + + + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
+ +IHRD+KA N+LL K+ DFG A
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 46/152 (30%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---EVLLIAKLQHRN 574
F++ ++G G FG VY + E+ A+K++S Q E++++ EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
++ GC + L+ EY + D K L + + I G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
+ +IHRD+KA N+LL K++DFG A
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA 172
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 52/185 (28%), Positives = 82/185 (44%), Gaps = 43/185 (23%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQE-----------------IAVKRL-SKGSGQGMEEFKNE 563
K KLGEG FG V+ ++ Q+ +AVK L + +F E
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKE 69
Query: 564 VLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS---- 619
V ++++L+ N+++LLG C D +I EY+ N L+ F+ + L D +
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAV 126
Query: 620 ---------------HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664
H+ IA G+ YL S L +HRDL N L+ + KI+DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 665 LARSF 669
++R+
Sbjct: 184 MSRNL 188
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 48/144 (33%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
+LG+G FG VYK E G A K + S + +E++ E+ ++A H +VKLLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
+ ++ E+ P ++D + + R L + I + L YLH ++IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLHS---MKIIH 133
Query: 643 RDLKASNVLLDNTMNPKISDFGLA 666
RDLKA NVLL + K++DFG++
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 49/144 (34%), Positives = 79/144 (54%), Gaps = 6/144 (4%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG+G FG V+ G ++A+K L G+ E F E ++ KL+H LV L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
+ + ++ E++ SL F+ + K L + + A IA G+ Y+ R+ IHR
Sbjct: 72 E-EPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 644 DLKASNVLLDNTMNPKISDFGLAR 667
DL+A+N+L+ + + KI+DFGLAR
Sbjct: 127 DLRAANILVGDNLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 51/168 (30%), Positives = 89/168 (52%), Gaps = 11/168 (6%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLV 576
F++ ++G+G FG VYKG+ +E+ A+K + + +E+ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ G + + +I EYL S D + L+ + + I+ I +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
R IHRD+KA+NVLL + K++DFG+A Q + NT VGT
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 48/172 (27%), Positives = 87/172 (50%), Gaps = 9/172 (5%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
N ++F ++G G +G VYK + G+ A+K + G+ + E++++ +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
N+V G +RD+ + E+ SL I+ T L S+ +++ +GL YL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYL 122
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
H + +HRD+K +N+LL + + K++DFG+ S + T A K +GT
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGV--SAQITATIAKRKSFIGT 169
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 24/165 (14%)
Query: 525 LGEGGFGPVYK------GMLIEGQEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVK 577
LG G F Y+ G L+ +++ R + + +E + E+ L+A+L H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 578 LLGCCTQRDERMLIYEYLPNKSL-----DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
+LG + L E++ S+ Y F + + RGL YL
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI--------INYTEQLLRGLSYL 119
Query: 633 HQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGLARSFGLDQTEA 676
H++ +IIHRD+K +N+L+D+T +I+DFG A T A
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA 161
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 6e-13
Identities = 48/174 (27%), Positives = 89/174 (51%), Gaps = 10/174 (5%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ + ++ K+G+G G VY + I GQE+A+K+++ E NE+L++ +
Sbjct: 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN 73
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
++ N+V L DE ++ EYL SL D +D + + + + L
Sbjct: 74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALD 129
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+LH + ++IHRD+K+ N+LL + K++DFG +Q++ +T +VGT
Sbjct: 130 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 519 FSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---EVLLIAKLQHRN 574
F++ ++G G FG VY + + +A+K++S Q E++++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
++ GC + L+ EY + D I + + K L + + I G +GL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHK-KPLQEVEIAAICHGALQGLAYLHS 133
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
R IHRD+KA N+LL K++DFG A
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 50/168 (29%), Positives = 89/168 (52%), Gaps = 11/168 (6%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLV 576
F++ ++G+G FG V+KG+ Q++ A+K + + +E+ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
K G + + +I EYL S D R+ D + + ++ I +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ IHRD+KA+NVLL + K++DFG+A Q + NT VGT
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 50/155 (32%), Positives = 78/155 (50%), Gaps = 10/155 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHR 573
D++ + KLGEG + VYKG + G+ +A+K RL + G + E L+ L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+V L ++ L++EY+ Y L + + RGL Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
Q I+HRDLK N+L+ +T K++DFGLAR+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 29/179 (16%)
Query: 517 DNFSEKNKLGEGGFGPVY----KGMLIEGQE-------------IAVKRL-SKGSGQGME 558
+ K KLGEG FG V+ +GM + +AVK L +
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 559 EFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI--------FDTTRS 610
+F E+ ++++L+ N+++LL C D +I EY+ N L+ F+ +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 611 KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
+ +S + IA G+ YL S L +HRDL N L+ KI+DFG++R+
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 51/168 (30%), Positives = 87/168 (51%), Gaps = 11/168 (6%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLV 576
F++ K+G+G FG V+KG+ Q++ A+K + + +E+ + E+ ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
K G + + +I EYL S D LD ++ + I+ I +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ IHRD+KA+NVLL K++DFG+A L T+ VGT
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNTFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 13/150 (8%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN----EVLLIAKLQHRNLVKL 578
+GEG +G V K G+ +A+K+ K S + E+ K EV ++ +L+H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF-KES-EDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
++ L++EY+ L+ L I + + + Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARS 668
IIHRD+K N+L+ + K+ DFG AR+
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARA 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 53/166 (31%), Positives = 77/166 (46%), Gaps = 15/166 (9%)
Query: 525 LGEGGFGPVY------KGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+GGFG V G + +++ KRL K G+ M NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
+D+ L+ + L Y I++ ++ A I GL +LHQ
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQ---R 114
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
RI++RDLK NVLLD+ N +ISD GLA + K GT
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGT 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 50/148 (33%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFK--NEVLLIAKLQHRNLVKLLG 580
KLGEG + VYKG+ I GQ +A+K +S + +G+ F E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHD 70
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
++ ++EY+ Y I L ++ R + + RGL Y+H I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMI--QHPGGLHPYNVRLFMFQ-LLRGLAYIH---GQHI 124
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARS 668
+HRDLK N+L+ K++DFGLAR+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 40/163 (24%), Positives = 71/163 (43%), Gaps = 29/163 (17%)
Query: 525 LGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGME-EFKNEVLLIAKLQHRNLVK 577
LG+G FG VY+G+ +A+K +++ + EF NE ++ + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 578 LLGCCTQRDERMLIYEYL-------------PNKSLDYFIFDTTRSKLLDWSKRSHIIAG 624
LLG + +++ E + P + + T K + + A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA------AE 127
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
IA G+ YL + +HRDL A N ++ + KI DFG+ R
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 57/165 (34%), Positives = 78/165 (47%), Gaps = 10/165 (6%)
Query: 525 LGEGGFGPVYK-GMLIEGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG+GGFG V M G+ A K+L+K +G E E ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGIARGLLYLHQDSRLR 639
+ + L+ + L Y I++ + A I GL +LHQ R
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
II+RDLK NVLLDN N +ISD GLA Q++ TK GT
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGT 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 46/174 (26%), Positives = 88/174 (50%), Gaps = 10/174 (5%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ + ++ K+G+G G VY M + GQE+A+++++ E NE+L++ +
Sbjct: 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN 74
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
++ N+V L DE ++ EYL SL D +D + + + + L
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALE 130
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+LH + ++IHRD+K+ N+LL + K++DFG +Q++ + +VGT
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 52/159 (32%), Positives = 72/159 (45%), Gaps = 12/159 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM---LIEGQ---EIAVKRL-SKGSGQGMEEFKNEVLLIAK 569
+N S LG G FG V + L + ++AVK L E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 570 L-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARG 628
L H N+V LLG CT ++I EY L F+ R L +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ +L + IHRDL A NVLL + KI DFGLAR
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 53/163 (32%), Positives = 82/163 (50%), Gaps = 20/163 (12%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
+GEG FG V +G GQ++AVK + + F E ++ KL H+NLV+LLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRS-----KLLDWSKRSHIIAGIARGLLYLHQDSRL 638
++ E + +L F+ R+ +LL +S +A G+ YL
Sbjct: 70 HNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFS------LDVAEGMEYLESK--- 119
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLAR--SFGLDQTEANTK 679
+++HRDL A N+L+ K+SDFGLAR S G+D ++ K
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK 162
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 2e-12
Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 41/180 (22%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVLLIAKLQHRN 574
+G G +G V + G+++A+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD----------TTRSKLLDWSKRSHIIAG 624
++ LL +L + + Y + + + L D + +
Sbjct: 61 IIGLL--------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTD-DHIQYFLYQ 111
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN--TKRVV 682
I RGL YLH +IHRDLK SN+L+++ + KI DFGLAR D+ E T+ VV
Sbjct: 112 ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 50/152 (32%), Positives = 76/152 (50%), Gaps = 16/152 (10%)
Query: 523 NKLGEGGFGPVYKGM------LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+KLGEG + VYKG L+ +EI RL G + EV L+ L+H N+V
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIR-EVSLLKDLKHANIV 67
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
L L++EYL +K L ++ D ++ + + RGL Y H
Sbjct: 68 TLHDIIHTEKSLTLVFEYL-DKDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCH--- 121
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
R +++HRDLK N+L++ K++DFGLAR+
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARA 153
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 45/149 (30%), Positives = 77/149 (51%), Gaps = 11/149 (7%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE--FKNEVLLIAKLQHRNLVKLLG 580
+GEG +G V K E GQ +A+K+ + M + E+ ++ +L+H NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGIARGLLYLHQDSRLR 639
++ L++E++ + LD D + LD S+ + I RG+ + H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARS 668
IIHRD+K N+L+ + K+ DFG AR+
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFART 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 16/152 (10%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRL-----SKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG VY ++ G+E+A K++ S + + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 579 LGCCTQRDERML--IYEYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGLLYLHQD 635
GC R E+ L EY+P S+ D ++ L S I G+ YLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
I+HRD+K +N+L D+ N K+ DFG ++
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 46/155 (29%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 524 KLGEGGFGPVYKG---MLIEGQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQHRNLVKLL 579
+LG G FG V KG M + ++A+K L + + + +E E ++ +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
G C + + ML+ E L+ F+ + + + S ++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
+HRDL A NVLL N KISDFGL+++ G D +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 15/185 (8%)
Query: 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLI 567
DL + + F +G G +G VYKG ++ ++A ++ + EE K E+ ++
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 568 AKL-QHRNLVKLLGCCTQR------DERMLIYEYLPNKSLDYFIFDTTRSKLL-DWSKRS 619
K HRN+ G ++ D+ L+ E+ S+ + +T + L DW +
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--A 124
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
+I I RGL +LH ++IHRD+K NVLL K+ DFG+ S LD+T
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRN 179
Query: 680 RVVGT 684
+GT
Sbjct: 180 TFIGT 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 10/152 (6%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---EVLLIAKLQHRN 574
F +++G G FG VY E+ AVK++S Q E++++ EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
++ GC + L+ EY + D K L + + I G +GL YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
+ +IHRD+KA N+LL K++DFG A
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSA 168
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 47/165 (28%), Positives = 84/165 (50%), Gaps = 14/165 (8%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQH---RNLVKLL 579
+G G +G VY+G + G+ +A+K ++ + + + + EV L+++L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
G + +I EY S+ + ++ + S II + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG--- 121
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+IHRD+KA+N+L+ NT N K+ DFG+A L+Q + VGT
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 53/164 (32%), Positives = 82/164 (50%), Gaps = 27/164 (16%)
Query: 525 LGEGGFGPVYKGMLI-EGQEI--AVKRLSK-GSGQGMEEFKNEVLLIAKL-QHRNLVKLL 579
+GEG FG V + M+ +G ++ A+K L + S +F E+ ++ KL H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS---KRSHIIAG------------ 624
G C R + EY P +L F+ +S++L+ + H A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 625 -IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+A G+ YL S + IHRDL A NVL+ + KI+DFGL+R
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 6e-12
Identities = 53/169 (31%), Positives = 87/169 (51%), Gaps = 44/169 (26%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---------EVLLIAKL- 570
KLG+G +G V+K + +E+ A+K++ + F+N E++ + +L
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELG 64
Query: 571 QHRNLVKLLGCCTQRDERM----LIYEYLPNKSLDYFIFDT-----TRSKLL-DWSKRSH 620
H N+VKLL + E L++EY+ +T R+ +L D KR +
Sbjct: 65 DHPNIVKLLN--VIKAENDKDIYLVFEYM----------ETDLHAVIRANILEDVHKR-Y 111
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
I+ + + L Y+H S +IHRDLK SN+LL++ K++DFGLARS
Sbjct: 112 IMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 45/161 (27%), Positives = 80/161 (49%), Gaps = 13/161 (8%)
Query: 509 LKIIANATD---NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEV 564
L+++ + D K+GEG G V G+++AVK++ Q E NEV
Sbjct: 8 LQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEV 67
Query: 565 LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIA 623
+++ QH N+V++ DE ++ E+L +L D I TR ++ + + +
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD--IVTHTR---MNEEQIATVCL 122
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664
+ + L +LH +IHRD+K+ ++LL + K+SDFG
Sbjct: 123 AVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 49/153 (32%), Positives = 78/153 (50%), Gaps = 18/153 (11%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRL-----SKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG VY + G+E+AVK++ S + + + + E+ L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 579 LGCCTQRDERML--IYEYLPNKSLDYFIFDTTRS--KLLDWSKRSHIIAGIARGLLYLHQ 634
GC ER L E++P S I D +S L + R + I G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYT-RQILEGVSYLHS 124
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ I+HRD+K +N+L D+ N K+ DFG ++
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 45/168 (26%), Positives = 83/168 (49%), Gaps = 15/168 (8%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLIEG-----QEIAVKRLSKGSGQ-GMEEFKNEVL 565
IA + D + + L EG FG ++ G+LI+ +E+ VK + + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 566 LIAKLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYF-----IFDTTRSKLLDWSKRS 619
L+ L H+N++ +L C + E ++Y Y+ +L F + + + L +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
H+ IA G+ YLH + +IH+D+ A N ++D + KI+D L+R
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 522 KNKLGEGGFGPVYKGMLI--EGQEI--AVKRLSKGSGQGM-EEFKNEVLLIAKLQHRNLV 576
+GEG FG VY+G+ + E ++I AVK + + E+F E ++ + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
KL+G T+ + ++ E P L ++ LD + ++ L YL
Sbjct: 71 KLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES-- 125
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
R +HRD+ A NVL+ + K+ DFGL+R
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 525 LGEGGFGPV------YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+GGFG V G + +++ KRL K SG+ M + E+L K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
+ L+ + L Y I++ + L+ + H A I G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLA 666
I++RD+K NVLLD+ N ++SD GLA
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 45/166 (27%), Positives = 72/166 (43%), Gaps = 30/166 (18%)
Query: 524 KLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSGQGMEEFK----NEVLLIAKLQHRNLV 576
+G G +G VYK G+E A+K+ KG + E+ L+ +L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFD---------TTRSKLLDWSKRSHIIAGIAR 627
L+ + ++ + YL DY D + + S ++ I
Sbjct: 66 SLVEVFLEHADKSV---YL---LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSF 669
G+ YLH + ++HRDLK +N+L+ KI D GLAR F
Sbjct: 120 GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 47/173 (27%), Positives = 84/173 (48%), Gaps = 11/173 (6%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
N ++ ++G G +G VYK + G+ AVK + G + E+ ++ + +H
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH 65
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
N+V G R++ + EY SL D + S+L + +++ +GL Y
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL----QIAYVCRETLQGLAY 121
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
LH ++ HRD+K +N+LL + + K++DFG+A + T A K +GT
Sbjct: 122 LHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKSFIGT 169
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 55/182 (30%), Positives = 83/182 (45%), Gaps = 33/182 (18%)
Query: 518 NFSEKNKLGEGGFGPVYK-GMLIEGQEIAVKR--LSKGSGQGMEEFKNEVLLIAKLQHRN 574
+F KLG+G +G VYK L + Q A+K L S + E+ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 575 LVK-----LLGC--CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLL-----DWSKRSHII 622
++ L G C + EY P L I + + L W I
Sbjct: 61 IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IF 109
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
+ RGL LH+ +I+HRDLK++N+LL KI D G+++ L + A T +
Sbjct: 110 IQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKT--QI 162
Query: 683 GT 684
GT
Sbjct: 163 GT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 16/158 (10%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM------LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ + + KLGEG + V+KG L+ +EI RL G + EV L+ L
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIR-EVSLLKDL 61
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+H N+V L L++EYL +K L ++ D ++ + I RGL
Sbjct: 62 KHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDC--GNIMSMHNVKIFLYQILRGLA 118
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
Y H R +++HRDLK N+L++ K++DFGLAR+
Sbjct: 119 YCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA 153
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 21/169 (12%)
Query: 525 LGEGGFGPVY--------KGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+G G FG V+ K ++I ++I V++++K + NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVII--KQIPVEQMTKDERLAAQ---NECQVLKLLSHPNII 62
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ + M++ EY P +L +I S LLD H I L ++H
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS-LLDEDTILHFFVQILLALHHVHTKL 121
Query: 637 RLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
I+HRDLK N+LLD + M KI DFG+++ +++ VVGT
Sbjct: 122 ---ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 51/155 (32%), Positives = 73/155 (47%), Gaps = 24/155 (15%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
KLGEG + VYKG + GQ +A+K RL G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH-------IIAGIARGLLYLH 633
+ L++EYL DT + +D + + RGL Y H
Sbjct: 71 IIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
Q R++HRDLK N+L+ K++DFGLAR+
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 525 LGEGGFGPVYKGMLIEG---QEIAVKRLSK-GSGQGMEEFKNEVLLIAKL-QHRNLVKLL 579
+GEG FG V K + + + A+KR+ + S +F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS---KRSHIIAGI--ARGLLYLHQ 634
G C R L EY P+ +L F+ +S++L+ ++ A ++ LL+
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 635 D--------SRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
D S+ + IHRDL A N+L+ KI+DFGL+R
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 43/144 (29%), Positives = 74/144 (51%), Gaps = 6/144 (4%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAV-KRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
+LG+G FG VYK E +A K + S + +E++ E+ ++A H N+VKLL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
+ ++ E+ ++D + + R L + + L YLH++ +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 643 RDLKASNVLLDNTMNPKISDFGLA 666
RDLKA N+L + K++DFG++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQ-----GMEEFKNEVLLI 567
+ + + +GEG +G V G ++A+K++S Q + E K ++
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF--------IFDTTRSKLLDWSKRS 619
+ +H N++ I + + S + F + +T KL+ S
Sbjct: 58 RRFKHENIIG-------------ILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLS 104
Query: 620 --HI---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
HI + I RGL Y+H + ++HRDLK SN+LL+ + KI DFGLAR
Sbjct: 105 NDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 21/215 (9%)
Query: 457 RRQSKNKKQVMIIITSISLATAVIFIG-GLMYRRKKHSNQ----GNEKEEMELPIFDLKI 511
+R K I ++ + + G ++ R +++ + NE EL FD K+
Sbjct: 620 KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKV 679
Query: 512 IANATDN-----FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVL 565
+ T N E+N + G G YKG I+ G + VK ++ + E +
Sbjct: 680 SKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD--- 736
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+ KLQH N+VKL+G C LI+EY+ K+L + + L W +R I GI
Sbjct: 737 -MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGI 789
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660
A+ L +LH ++ +L +++D P +
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 12/172 (6%)
Query: 518 NFSEKNKLGEGGFGPVY--KGMLIEGQEIAVKR--LSKGSGQGMEEFKNEVLLIAKLQHR 573
+ K+GEG FG +Y K + + +K L+K + E K EV+L+AK++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+V + ++ EY L I + R L + I+ GL ++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 634 QDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+I+HRD+K+ N+ L N M K+ DFG+AR L+ + VGT
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 42/176 (23%), Positives = 83/176 (47%), Gaps = 23/176 (13%)
Query: 513 ANATDNFSEKNK-LGEGGFGPVYKGM-LIEGQEIAVKR--LSKGSGQGMEEFKN------ 562
+ ++ + +K LGEG +G V K + G+ +A+K+ + + S ++ +
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63
Query: 563 ------EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS 616
E+ ++ +++H N++ L+ + D L+ + + L + R L S
Sbjct: 64 HFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIR---LTES 119
Query: 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
+ I+ I GL LH+ +HRDL +N+ +++ KI+DFGLAR +G
Sbjct: 120 QVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYP 172
|
Length = 335 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 49/160 (30%), Positives = 83/160 (51%), Gaps = 18/160 (11%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRL-----SKGSGQGMEEFKNEVLLIAKLQ 571
N+ LG G FG VY + G+E+AVK++ S+ + + + + E+ L+ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 572 HRNLVKLLGCCTQRDERML--IYEYLPNKSLDYFIFDTTRS--KLLDWSKRSHIIAGIAR 627
H +V+ GC +E+ L EY+P S I D ++ L + R + I +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYT-RQILQ 117
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
G+ YLH + I+HRD+K +N+L D+ N K+ DFG ++
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 44/149 (29%), Positives = 70/149 (46%), Gaps = 9/149 (6%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN---EVLLIAKLQHRNLVKLLG 580
+G G +G V + G+++A+K+LS+ Q K E+ L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSR-PFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 581 CCTQRDERMLIYE-YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
T + YL + + + + + L ++ I RGL Y+H
Sbjct: 82 VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS---AG 138
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARS 668
IIHRDLK SN+ ++ KI DFGLAR
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLARH 167
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 51/177 (28%), Positives = 78/177 (44%), Gaps = 36/177 (20%)
Query: 528 GGFGPVY---KGMLIEGQEIAVKRLSKGSGQG---MEEFKNEVLLIAKLQHRNLVKLLGC 581
G +G V+ K G A+K + K +++ E ++++ Q +VKL
Sbjct: 4 GAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-Y 60
Query: 582 CTQRDERM-LIYEYLPN-------KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
Q + + L+ EYLP +++ D R IA I L YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR----------IYIAEIVLALEYLH 110
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA------RSFGLDQTEANTKRVVGT 684
IIHRDLK N+L+D+ + K++DFGL+ R L+ E KR+VGT
Sbjct: 111 S---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 525 LGEGGFGP--VYK----GMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG +Y+ L+ +E+ + RLS+ + + NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQHPNIIAY 64
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
+ ++ EY +L Y + +L + + I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
I+HRD+K N+ L K+ DFG+++ G + + A T VVGT
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 53/172 (30%), Positives = 80/172 (46%), Gaps = 15/172 (8%)
Query: 519 FSEKNKLGEGGFGPV------YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
F + LG+GGFG V G + +++ KR+ K G+ M NE ++ K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
R +V L +D L+ + L + I+ + + + A I GL L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF-EEGRAVFYAAEICCGLEDL 118
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
HQ+ RI++RDLK N+LLD+ + +ISD GLA QT K VGT
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 525 LGEGGFGPVYK-------GMLIEGQEIAVKRLSKGSG-----QGMEEFKNEVLLIAK-LQ 571
LG G FG VYK L+ +EI V + G + + + +EV +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
H N+V+ + D ++ + + L ++F + + + +I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
YLH++ R I+HRDL +N++L I+DFGLA+ Q E+ VVGT
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQ---KQPESKLTSVVGT 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 53/168 (31%), Positives = 82/168 (48%), Gaps = 30/168 (17%)
Query: 525 LGEGGFGPVYKGMLI--------EGQEIAVKRLSK-GSGQGMEEFKNEVLLIAKL-QHRN 574
LGEG FG V I + +AVK L + + + + +E+ ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFI-----------FDTTR--SKLLDWSKRSHI 621
++ LLG CTQ ++ EY +L ++ FDT + + L +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNTMNPKISDFGLAR 667
+ARG+ YL + + IHRDL A NVL+ DN M KI+DFGLAR
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVM--KIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 48/178 (26%), Positives = 74/178 (41%), Gaps = 27/178 (15%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---EVLLIAKLQHR 573
+F +G+G FG V + +++ A+K ++K +N E ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 574 NLVKLLGCCT-QRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIA 626
LV L + Q +E M L+ + L L Y + F + K I I
Sbjct: 61 FLVNL--WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF--------WICEIV 110
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
L YLH IIHRD+K N+LLD + I+DF +A + T GT
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGT 162
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 8e-11
Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 11/153 (7%)
Query: 522 KNKLGEGGFGPVY---KGMLIEGQEIAV-KRLSKGSGQGMEEFKN--EVLLIAKLQHRNL 575
+ +LG+G FG VY + + + V K + G E + E L++KL H +
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGLLYLHQ 634
VK +RD +I EY + LD + + + K L ++ + G+ Y+HQ
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
RI+HRDLKA N+ L N + KI DFG++R
Sbjct: 125 R---RILHRDLKAKNIFLKNNL-LKIGDFGVSR 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 42/154 (27%), Positives = 66/154 (42%), Gaps = 10/154 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQG-MEEFKNEVLLIAKLQHRN 574
+ E ++LGEG G V K L I A+K ++ ++ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 575 LVKLLGCCTQRDERML--IYEYLPNKSLDYFIFDTTRSKLLDWSKR--SHIIAGIARGLL 630
+VK G + EY SLD I+ + + ++ I + +GL
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664
YLH +IIHRD+K SN+LL K+ DFG
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 8e-11
Identities = 47/154 (30%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 525 LGEGGFGPVYKGML-IEGQEIAVKRLSKGS--GQGMEE-FKNEVLLIAKLQHRNLVKLLG 580
LG GGFG V + + + A+K + K G +E +E ++ + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 581 CCTQRDER---MLIYEYLPNKSLDYFIFDTTRSK-LLDWSKRSHIIAGIARGLLYLHQDS 636
T +D++ ML+ EY L + R + L D IA + YLH
Sbjct: 60 -RTFKDKKYIYMLM-EYCLGGEL----WTILRDRGLFDEYTARFYIACVVLAFEYLH--- 110
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
II+RDLK N+LLD+ K+ DFG A+
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK 144
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 44/146 (30%), Positives = 72/146 (49%), Gaps = 7/146 (4%)
Query: 524 KLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGME-EFKNEVLLIAKLQHRNLVKLLGC 581
++G G FG V+ G L + +AVK + ++ +F E ++ + H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRII 641
CTQ+ ++ E + + D+ F T L + ++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 642 HRDLKASNVLLDNTMNPKISDFGLAR 667
HRDL A N L+ KISDFG++R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 46/157 (29%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRL-SKGSGQGMEEFKNEVLLIAKLQH- 572
++ + ++G G FG V K ML + G +AVKR+ S + + ++ ++ +
Sbjct: 4 EDLKDLGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYF---IFDTTRSKLLDWSKRSHIIAGIARGL 629
+VK G R+ I L + SLD F +++ +S + I + L
Sbjct: 63 PYIVKFYGA-LFREGDCWICMELMDISLDKFYKYVYEVLKSVI-PEEILGKIAVATVKAL 120
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
YL ++ L+IIHRD+K SN+LLD N K+ DFG++
Sbjct: 121 NYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 26/174 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLS-KGSGQGMEEFKNEVLLI 567
D + LGEG FG V + E +AVK L + + + + +E+ ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 568 AKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI-----------FDTTR--SKLL 613
+ +H+N++ LLG CTQ +I EY +L ++ +D R + +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ +ARG+ YL + + IHRDL A NVL+ KI+DFGLAR
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 8/144 (5%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ 584
+G+G FG V G G ++AVK + + + F E ++ +L+H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 585 RDERMLIY-EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
+ I EY+ SL ++ RS +L + + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 644 DLKASNVLLDNTMNPKISDFGLAR 667
DL A NVL+ K+SDFGL +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 48/149 (32%), Positives = 75/149 (50%), Gaps = 9/149 (6%)
Query: 524 KLGEGGFGPVYKGMLIEG---QEIAVKRL-SKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
++G G FG V G + G ++ VK L S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLL--DWSKRSHIIAGIARGLLYLHQDSR 637
G CT+ +L+ E+ P L ++ +++L+ D + + IA GLL+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLA 666
IH DL N LL + KI D+GL+
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 47/149 (31%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 523 NKLGEGGFGPVYKGML-IEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+KLGEG + V+KG + +A+K RL G + EV L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
L++EYL + Y L+ + + RGL Y H + +
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARS 668
I+HRDLK N+L++ K++DFGLAR+
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 46/162 (28%), Positives = 73/162 (45%), Gaps = 24/162 (14%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVL--------- 565
T+ + + +G G FG V + GQ +A+K++ M+ F VL
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYRELK 61
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
L+ L+H N++ L E + L L + S+ L+ + + I
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFIQYFLYQI 117
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
RGL Y+H ++HRDLK SN+L++ + KI DFGLAR
Sbjct: 118 LRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 40/150 (26%), Positives = 66/150 (44%), Gaps = 12/150 (8%)
Query: 523 NKLGEGGFGPVYKGMLI--EGQEIAVKRLSKGSGQGMEEFKN---EVLLIAKLQHRNLVK 577
+LG G G V K +L G+ +AVK + K E+ ++ K +V
Sbjct: 7 GELGAGNSGVVSK-VLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVG 63
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
G + + EY+ SLD + + I + +GL YLH +
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLH--EK 119
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+IIHRD+K SN+L+++ K+ DFG++
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 30/105 (28%), Positives = 51/105 (48%), Gaps = 6/105 (5%)
Query: 563 EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
E +L+ + H +++++ ++ LP+ S D + + T RS+ L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
I GL YLH RIIHRD+K N+ +++ I D G A+
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 43/149 (28%), Positives = 74/149 (49%), Gaps = 18/149 (12%)
Query: 525 LGEGGFGPVYKGML-IEGQE---IAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLL 579
LG G FG + +G L + + +A+ L G S + F E L + + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIF----DTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
G T+ + M++ EY+ N +LD F+ +L+ ++ G+A G+ YL
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG------MLPGLASGMKYL--- 123
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFG 664
S + +H+ L A VL+++ + KIS F
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 30/164 (18%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG V + L Q++AVK L S +EEF E + + H N++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 579 LGCCTQRDER------MLIYEYLPNKSLDYFI---------FDTTRSKLLDWSKRSHIIA 623
+G + + M+I ++ + L F+ F L+ + +
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF------MI 120
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
IA G+ YL S IHRDL A N +L+ M ++DFGL++
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 47/158 (29%), Positives = 83/158 (52%), Gaps = 17/158 (10%)
Query: 524 KLGEGGFGPVYKGMLIE--GQEIAVKRLS-KGSGQGME-EFKNEVLLIAKLQ---HRNLV 576
++GEG +G V+K ++ G+ +A+KR+ + +GM EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 577 KLLGCCT-QRDER----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
+L CT R +R L++E++ Y D + ++ + RGL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
LH R++HRDLK N+L+ ++ K++DFGLAR +
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 16/157 (10%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN--EVLLIAKLQ---HRNLVK 577
++G G +G VYK G +A+K + + + EV L+ +L+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 578 LLG-CCTQRDER----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
L+ C T R +R L++E++ Y D L ++ RGL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYL--DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
H + I+HRDLK N+L+ + K++DFGLAR +
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 47/176 (26%), Positives = 82/176 (46%), Gaps = 18/176 (10%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQHR 573
NF + K+G G F VY+ L++ + +A+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLD-----WSKRSHIIAGIARG 628
N++K L + +E ++ E L I + K L W + + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
H SR R++HRD+K +NV + T K+ D GL R F T A++ +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 17/162 (10%)
Query: 528 GGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN----EVLLIAKLQHRNLVKLLGCC 582
G FG VY G A+K L K + N +++ + + + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
+D L+ EYL I T DW+K+ IA + G+ LHQ IIH
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQ--YIAEVVLGVEDLHQRG---IIH 120
Query: 643 RDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
RD+K N+L+D T + K++DFGL+R+ GL+ K+ VGT
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRN-GLEN-----KKFVGT 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 51/178 (28%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 515 ATDNFSE---KNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN----EVLL 566
A + SE N++G G G VYK + G+ A+K + G + + E+ +
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIY---GNHEDTVRRQICREIEI 125
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
+ + H N+VK E ++ E++ SL+ + + D + + I
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-------GTHIADEQFLADVARQIL 178
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
G+ YLH R I+HRD+K SN+L+++ N KI+DFG++R L QT VGT
Sbjct: 179 SGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGT 231
|
Length = 353 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 36/171 (21%)
Query: 525 LGEGGFGPVYKGMLIEG-----------QEIAVKRL-SKGSGQGMEEFKNEVLLIAKL-Q 571
LGEG FG V ++ E ++AVK L S + + + + +E+ ++ + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF-------------DTTRSKLLDWSKR 618
H+N++ LLG CTQ +I EY +L ++ + L +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNTMNPKISDFGLAR 667
+ARG+ YL + + IHRDL A NVL+ DN M KI+DFGLAR
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM--KIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 26/163 (15%)
Query: 519 FSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
+ + +G G G V + G +AVK+LS+ F+N+ AK +R LV
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-------PFQNQTH--AKRAYRELV- 72
Query: 578 LLGCCTQRDERMLIYEYLPNKSLD-----YFIFDTTRSKL-------LDWSKRSHIIAGI 625
LL C ++ L+ + P KSL+ Y + + + L LD + S+++ +
Sbjct: 73 LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 132
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
G+ +LH IIHRDLK SN+++ + KI DFGLAR+
Sbjct: 133 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 172
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 42/150 (28%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 524 KLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFK---NEVLLIAKLQHRNLVKLL 579
++G+GG+G V+ + EI A+KR+ K + E + E ++ + LVKLL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
+ L EY+P D+ L + R ++ + LH L
Sbjct: 68 YAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFE-AVDALH---ELG 121
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSF 669
IHRDLK N L+D + + K++DFGL++
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGI 151
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 9/152 (5%)
Query: 523 NKLGEGGFGPVYKG---MLIEGQEIAVKRL-SKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
+++G G FG V G + + VK L + + F EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS--HIIAGIARGLLYLHQDS 636
LG C + +L+ E+ P L ++ K + +A GLL+LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
IH DL N L ++ KI D+GLA
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALE 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 16/157 (10%)
Query: 524 KLGEGGFGPVYKG---MLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK----LQHRNLV 576
+LG G FG V KG M + +AVK L + K+E+L A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+++G C + + ML+ E L+ F+ ++K + + ++ ++ G+ YL + +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
+HRDL A NVLL KISDFGL+++ G D+
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 50/155 (32%), Positives = 67/155 (43%), Gaps = 28/155 (18%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVKRLSKG---SGQGMEEFKNE--VLLIA-KLQHRN 574
LG G FG V +L E G+ A+K L KG + +E E + A +H
Sbjct: 7 LGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLL 630
LV L C D + EY L I F R+ A + GL
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY--------AACVVLGLQ 115
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
YLH++ +I++RDLK N+LLD KI+DFGL
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-09
Identities = 25/81 (30%), Positives = 33/81 (40%), Gaps = 6/81 (7%)
Query: 367 KHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSK-NCSCTAYANADVRGRGSGCLLW 425
K D F+ KLP + +L EC C NCSC ++ GCLLW
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTY---NNGTKGCLLW 56
Query: 426 -FHDLIDIKELPESGQDLFIR 445
L D + P G DL+ +
Sbjct: 57 SESSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 21/153 (13%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVKRLSKG---SGQGMEEFKNE--VLLIAKLQHRNL 575
LG+G FG V +L E + AVK L K +E E VL +A +H L
Sbjct: 3 LGKGSFGKV---LLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFL 58
Query: 576 VKLLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+L C Q +R+ + EY+ L + I RS D + A I GL +LH+
Sbjct: 59 TQLH-SCFQTKDRLFFVMEYVNGGDLMFHI---QRSGRFDEPRARFYAAEIVLGLQFLHE 114
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
II+RDLK NVLLD+ + KI+DFG+ +
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 10/162 (6%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
K+GEG G V G+++AVK++ Q E NEV+++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
DE ++ E+L +L D ++ + + + + R L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 643 RDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
RD+K+ ++LL + K+SDFG + + K +VGT
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKSLVGT 181
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
DNF K+GEG G V + G+ +AVK++ Q E NEV+++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
V++ DE ++ E+L +L D ++ + + + + + L LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+IHRD+K+ ++LL + K+SDFG + + K +VGT
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 30/172 (17%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVK--RLSKGSGQGMEE------FKNEVLLI 567
D + + K+GEG +G VYK G+ +A+K RL M+E E+ L+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE------MDEEGIPPTALREISLL 54
Query: 568 AKLQHRN-LVKLLGCCTQRDERM------LIYEYLPNKSLDYFIFDTTR--SKLLDWSKR 618
L +V+LL +E+ L++EYL + L F+ R + L
Sbjct: 55 QMLSESIYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTI 112
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP-KISDFGLARSF 669
+ + +G+ + H + ++HRDLK N+L+D KI+D GL R+F
Sbjct: 113 KSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 46/163 (28%), Positives = 75/163 (46%), Gaps = 23/163 (14%)
Query: 525 LGEGGFGPVYKGMLIE---------GQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQHRN 574
LG+G F +YKG+L GQE++V GS F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
LVKL G C RDE +++ EY+ LD F+ + L W + + +A L YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 635 DSRLRIIHRDLKASNVLL----DNTMNP---KISDFGLARSFG 670
+++H ++ N+L+ N K+SD G+ +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 20/191 (10%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE-IAVKR 548
+ H+N E E+ E I D I + ++ N +G G FG VY+ + I+ E +A+K+
Sbjct: 40 RSHNNNAGEDEDEEKMI-DNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKK 98
Query: 549 LSKGSGQGMEEFKNEVLLIAK-LQHRNLVKLLGC----CTQRDERML----IYEYLPNKS 599
+ + ++KN LLI K L H N++ L C +++E+ + + E++P
Sbjct: 99 VLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTV 153
Query: 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNP 658
Y + L + R L Y+H I HRDLK N+L+D NT
Sbjct: 154 HKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTL 210
Query: 659 KISDFGLARSF 669
K+ DFG A++
Sbjct: 211 KLCDFGSAKNL 221
|
Length = 440 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 519 FSEKNKLGEGGFGPV------YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
F LG+GGFG V G + +++ KR+ K G+ M NE ++ K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNS 59
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
R +V L +D L+ + L + I++ D + A + GL L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-DEQRAIFYAAELCCGLEDL 118
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
++ RI++RDLK N+LLD+ + +ISD GLA
Sbjct: 119 QRE---RIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 6e-09
Identities = 50/163 (30%), Positives = 73/163 (44%), Gaps = 26/163 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKG----SGQGMEEFKNEVLLIAKLQ 571
D+F LG G FG V + A+K LSK Q +E NE ++ ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 572 HRNLVKLLGCCTQRDERML--IYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAG 624
H LV L G + +D+ L + EY+P L + F ++ A
Sbjct: 60 HPFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY--------AAQ 109
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ L YLH L I++RDLK N+LLD+ KI+DFG A+
Sbjct: 110 VVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 43/154 (27%)
Query: 538 LIEGQEIAVKRLSKGSGQGMEEFKN---------EVLLIAKLQHRNLVKLLGCCTQRDER 588
+ GQ +A+K+LS+ F+N E++L+ + H+N++ LL T
Sbjct: 38 TVTGQNVAIKKLSR-------PFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFT----- 85
Query: 589 MLIYEYLPNKSLD-----YFIFDTTRSKL-------LDWSKRSHIIAGIARGLLYLHQDS 636
P KSL+ Y + + + L LD + S+++ + G+ +LH
Sbjct: 86 -------PQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG 138
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
IIHRDLK SN+++ + KI DFGLAR+ G
Sbjct: 139 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 8e-09
Identities = 50/150 (33%), Positives = 76/150 (50%), Gaps = 15/150 (10%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNE--VLLIAKLQHRNLVKL 578
LG+G FG V L E G+ AVK L K +E E +L +A+ H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 579 LGCCTQRDERML-IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
CC Q +R+ + E++ L +F +S+ D ++ A I L++LH
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG- 116
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
II+RDLK NVLLD+ + K++DFG+ +
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 44/141 (31%), Positives = 73/141 (51%), Gaps = 25/141 (17%)
Query: 542 QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601
+ +A+K+LS+ F+N+ AK +R LV L+ C ++ L+ + P KSL+
Sbjct: 50 RNVAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 602 -----YFIFDTTRSKL-------LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASN 649
Y + + + L LD + S+++ + G+ +LH IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 650 VLLDNTMNPKISDFGLARSFG 670
+++ + KI DFGLAR+ G
Sbjct: 157 IVVKSDCTLKILDFGLARTAG 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 30/161 (18%)
Query: 525 LGEGGFGPV---YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+G G G V Y +L + +A+K+LS+ F+N+ AK +R LV L+ C
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSR-------PFQNQTH--AKRAYRELV-LMKC 72
Query: 582 CTQRDERMLIYEYLPNKSLD-----YFIFDTTRSKL-------LDWSKRSHIIAGIARGL 629
++ L+ + P KSL+ Y + + + L LD + S+++ + G+
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
+LH IIHRDLK SN+++ + KI DFGLAR+ G
Sbjct: 133 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 10/162 (6%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
K+GEG G V G+++AVK + Q E NEV+++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
+E ++ E+L +L D L+ + + + + + L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 643 RDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
RD+K+ ++LL K+SDFG D + K +VGT
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGT 180
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 48/172 (27%), Positives = 81/172 (47%), Gaps = 10/172 (5%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQHR 573
NF + K+G G F VY+ L++G +A+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS-HIIAGIARGLLYL 632
N++K + +E ++ E L I + K L K + L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
H SR R++HRD+K +NV + T K+ D GL R F T A++ +VGT
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 41/160 (25%), Positives = 76/160 (47%), Gaps = 21/160 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-------EVLLIA 568
+ + + +K+GEG +G V+K E GQ +A+K+ + E+ E+ ++
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLK 55
Query: 569 KLQHRNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
+L+H NLV L+ +R ++ L++EY + L+ + + II +
Sbjct: 56 QLKHPNLVNLIEV-FRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQ 111
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ + H+ IHRD+K N+L+ K+ DFG AR
Sbjct: 112 AVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 519 FSEKNKLGEGGFGPV------YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
F + LG+GGFG V G + + + KR+ K G+ M NE ++ K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
+ +V L +D L+ + L + I++ + + A I GL L
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-EEERALFYAAEILCGLEDL 118
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
H+++ ++RDLK N+LLD+ + +ISD GLA
Sbjct: 119 HREN---TVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 56/184 (30%), Positives = 87/184 (47%), Gaps = 14/184 (7%)
Query: 509 LKIIANATDNFSEKNKLGEGGFGPVYK-GMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLI 567
L+ + + TD + +G+G +G VYK +G AVK L S EE + E ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 568 AKL-QHRNLVKLLGCCTQRDERM-----LIYEYLPNKSLDYFIFDTTR-SKLLDWSKRSH 620
L H N+VK G + D+ + L+ E S+ + + LD + S+
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
I+ G GL +LH + RIIHRD+K +N+LL K+ DFG++ + NT
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188
Query: 681 VVGT 684
VGT
Sbjct: 189 -VGT 191
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 26/58 (44%), Positives = 36/58 (62%), Gaps = 3/58 (5%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
I RGL YLH I+HRD+K N+L+++ KI DFGLAR D+++ T+ VV
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 19/159 (11%)
Query: 524 KLGEGGFGPVY----KGMLIEGQE--IAVKRLSK-GSGQGMEEFKNEVLLIAKLQHRNLV 576
+LG+G FG VY KG++ + E +A+K +++ S + EF NE ++ + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK--------LLDWSKRSHIIAGIARG 628
+LLG +Q ++I E + L ++ + R + K + IA G
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ YL+ + + +HRDL A N ++ KI DFG+ R
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 47/148 (31%), Positives = 71/148 (47%), Gaps = 12/148 (8%)
Query: 525 LGEGGFGPV------YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+GGFG V G + +++ KR+ K G+ M NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
+D L+ + L + I++ D + A I GL LH R
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF-DEERAVFYAAEITCGLEDLH---RE 121
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLA 666
RI++RDLK N+LLD+ + +ISD GLA
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 44/161 (27%), Positives = 73/161 (45%), Gaps = 28/161 (17%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL---LG 580
LG G G V+ + + + +AVK++ Q ++ E+ +I +L H N+VK+ LG
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 581 CCTQRDERMLIYEYLPNKSLDYF--------IFDTTRSKLLDWSKRS--HI---IAGIAR 627
+ SL +T + +L+ S H + + R
Sbjct: 73 PSGSDLTEDV-------GSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLAR 667
GL Y+H + ++HRDLK +NV ++ + KI DFGLAR
Sbjct: 126 GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 14/157 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGM---EEFKNEVLLIAKLQH 572
D+ +G G FG V+ I A+K ++ + + NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 573 RNLVKLLGCCTQRDERML--IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+++L T+ D+R L + EY+P L F + + + + + + I L
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYA-SEIVCALE 115
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
YLH I++RDLK N+LLD + K++DFG A+
Sbjct: 116 YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 47/178 (26%), Positives = 85/178 (47%), Gaps = 27/178 (15%)
Query: 519 FSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRL--SKGSGQGMEEFKNEVLLIAKLQH 572
+ + K+GEG FG K +L+ +G++ +K + SK S + EE + EV +++ ++H
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS------KLLDWSKRSHIIAGIA 626
N+V+ + ++ +Y L Y + R ++LDW I
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLFPEDQILDW------FVQIC 111
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
L ++H +I+HRD+K+ N+ L K+ DFG+AR L+ T + +GT
Sbjct: 112 LALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 48/183 (26%), Positives = 74/183 (40%), Gaps = 48/183 (26%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
+ +G G +G V + G+++A+K++ +V +AK R L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---------DVPTLAKRTLREL 55
Query: 576 VKLLGCCTQR----DERMLIYEYL-PNKSLD---YFIFDTTRSKLLDWSKRSHIIAG--- 624
K+L R D + I + L P + Y + D S L HII
Sbjct: 56 -KIL-----RHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDL------HHIIHSDQP 103
Query: 625 ------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
+ RGL Y+H + +IHRDLK SN+L++ +I DFG+AR
Sbjct: 104 LTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160
Query: 673 QTE 675
TE
Sbjct: 161 PTE 163
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 45/163 (27%), Positives = 84/163 (51%), Gaps = 10/163 (6%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRL--SKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+GEG +G V K E +EI A+K+ S+ + + E E+ ++ L+ N+V+L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRII 641
+R + L++EY+ L+ + + + + RS+I I + + + H++ I+
Sbjct: 69 FRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLI-KAIHWCHKND---IV 122
Query: 642 HRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
HRD+K N+L+ + K+ DFG AR+ + + AN V T
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVAT 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 11/148 (7%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG+G FG V L E+ A+K L K ++ E ++A + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 581 CCTQRDERML-IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
CC Q +R+ + EY+ L +F RS+ D + A + L++LH+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--- 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLAR 667
+I+RDLK N+LLD + K++DFG+ +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 48/172 (27%), Positives = 70/172 (40%), Gaps = 43/172 (25%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
D+ +LG G +G V K M G +AVKR+ + + E Q R
Sbjct: 1 DDLEVIEELGRGAYGVVDK-MRHVPTGTIMAVKRI-RATVNSQE------------QKRL 46
Query: 575 LVKL-----LGCCTQ---------RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR-- 618
L+ L C R+ + I + + SLD F K+ D
Sbjct: 47 LMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFY-----KKVYDKGLTIP 101
Query: 619 ----SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
I I + L YLH S+L +IHRD+K SNVL++ K+ DFG++
Sbjct: 102 EDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 9e-08
Identities = 39/160 (24%), Positives = 71/160 (44%), Gaps = 30/160 (18%)
Query: 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--EVLLIAKLQ-HRNLVKL 578
K+GEG F V K + G+ A+K + K + +E+ N E+ + +L H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 579 L--------GCCTQRDE--RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARG 628
+ G E M +YE + R + L + + + +
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKG-----------RKRPLPEKRVKSYMYQLLKS 112
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
L ++H++ I HRD+K N+L+ + K++DFG R
Sbjct: 113 LDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRG 148
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 42/158 (26%), Positives = 78/158 (49%), Gaps = 17/158 (10%)
Query: 524 KLGEGGFGPVYKGM---LIEGQ---EIAVKRLSK-GSGQGMEEFKNEVLLIAKLQHRNLV 576
+LG+G FG VY+G +I+G+ +AVK +++ S + EF NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIF-------DTTRSKLLDWSKRSHIIAGIARGL 629
+LLG ++ +++ E + + L ++ + + + A IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
YL+ + +HRDL A N ++ + KI DFG+ R
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 21/158 (13%)
Query: 525 LGEGGFGPVYKGMLIE----GQ----EIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
LG+G F ++KG+ E G+ E+ +K L K E F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
G C DE +++ EY+ SLD ++ L++ S + + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 637 RLRIIHRDLKASNVLL-----DNTMNP---KISDFGLA 666
+ H ++ A NVLL T NP K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 53/176 (30%), Positives = 78/176 (44%), Gaps = 35/176 (19%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN---EVL 565
K I + + + +G G +G V + G +AVK+LS+ Q + K E+
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 68
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF--IFDTTR------------SK 611
L+ ++H N++ LL T P +SL+ F ++ T K
Sbjct: 69 LLKHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQK 116
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
L D +I I RGL Y+H IIHRDLK SN+ ++ KI DFGLAR
Sbjct: 117 LTD-DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 35/161 (21%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN---------EVLLIAKLQHRN 574
+G G +G V E +++A+K+++ F N E+ L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 575 LVKLLGCC--TQRDERMLIYEYLPNKSLDYFIFDT------TRSKLLDWSKRSHIIAGIA 626
++ + R+ +Y + Y + DT S+ L + + +
Sbjct: 66 VIAIKDIMPPPHREAFNDVY-------IVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLL 118
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
RGL Y+H + ++HRDLK SN+LL+ + KI DFGLAR
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 12/150 (8%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK--GSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+G G +G V + G+++A+K+LS+ S + E+ L+ +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 582 CTQR---DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
T DE Y +P D L K +++ + GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARS 668
IIHRDLK N+ ++ KI DFGLAR
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLARH 166
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 14/149 (9%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
+GEG FG + +L++ Q+ A+K RL K S +E+ + E +L+AK++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
++ EY L I R KL + G+ ++H+
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEK--- 119
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLAR 667
R++HRD+K+ N+ L K+ DFG AR
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 31/174 (17%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--GSGQGMEEFKNEVLL 566
K I D + + ++G G +G V + G ++A+K+L + S + E+ L
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF--------IFDTTRSKLLDWSKR 618
+ ++H N++ LL T P+ SLD F T KL+ K
Sbjct: 68 LKHMKHENVIGLLDVFT------------PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL 115
Query: 619 S-----HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
S ++ + +GL Y+H IIHRDLK N+ ++ KI DFGLAR
Sbjct: 116 SEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 52/165 (31%), Positives = 77/165 (46%), Gaps = 23/165 (13%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEEFKNEVLLIAK------LQHRN 574
LG+G FG V ML E + A+K L K +E+ E ++ + +H
Sbjct: 3 LGKGSFGKV---MLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPF 57
Query: 575 LVKLLGCCTQRDERML-IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
L L C Q E + + EYL L + I + R D ++ A I GL +LH
Sbjct: 58 LTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGR---FDEARARFYAAEIICGLQFLH 113
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
+ II+RDLK NVLLD + KI+DFG+ + + +A+T
Sbjct: 114 KKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 11/148 (7%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEV----LLIAKLQHRNLVKLL 579
+G+G FG V +G+ AVK L K + +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
D+ + +Y+ L F R + + A IA L YLH L
Sbjct: 63 YSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---LN 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLAR 667
II+RDLK N+LLD+ + ++DFGL +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 24/161 (14%)
Query: 518 NFSEKNKLGEGGFGPV----YKGMLIEGQEIAVKRLSKGSGQGMEEFKN---EVLLIAKL 570
+F LG G FG V +KG G+ A+K L K M++ ++ E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 571 QHRNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLL---DWSKRSHIIAGIA 626
H +V ++ C Q + R+ + E++ L F R D +K H A +
Sbjct: 76 SHPFIVNMM-CSFQDENRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYH--AELV 128
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
YLH II+RDLK N+LLDN + K++DFG A+
Sbjct: 129 LAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 8e-07
Identities = 40/156 (25%), Positives = 68/156 (43%), Gaps = 24/156 (15%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEE---FKNEVLLIAKLQHRNLVKLLG 580
+G G FG V+ + ++ A+K L K + + E ++A +VKL
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67
Query: 581 CCTQRDERML--IYEYLPNKSL-----DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
+ +DE L + EY+P L +F ++ IA + L +H
Sbjct: 68 -YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY--------IAELVLALDSVH 118
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
+ L IHRD+K N+L+D + K++DFGL +
Sbjct: 119 K---LGFIHRDIKPDNILIDADGHIKLADFGLCKKM 151
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 50/162 (30%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 525 LGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEE------FKNEVLLIAKLQHRNLVK 577
LG+G FG V+ L Q A+K L K M++ + VL +A +H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLA-WEHPFLTH 60
Query: 578 LLGCCTQRDERML-IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
L C Q E + + EYL L + I + D + + A I GL +LH
Sbjct: 61 LY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG 116
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
I++RDLK N+LLD + KI+DFG+ + L + T
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 44/147 (29%), Positives = 69/147 (46%), Gaps = 7/147 (4%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--EVLLIAKLQHRNLVKLLGC 581
+G G +G V Q++AVK+LS+ + + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 582 CTQRDERMLIYE-YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
T E YL + + + + + L +I + RGL Y+H I
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---I 139
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLAR 667
IHRDLK SNV ++ +I DFGLAR
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 50/154 (32%), Positives = 70/154 (45%), Gaps = 23/154 (14%)
Query: 525 LGEGGFGPVYKGMLIE--GQE--IAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVK 577
LG+G FG V ML E G + A+K L K +E E ++A +
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 578 LLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII---AGIARGLLYLH 633
L C Q +R+ + EY+ L Y I + K H + A IA GL +LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFK------EPHAVFYAAEIAIGLFFLH 118
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
II+RDLK NV+LD + KI+DFG+ +
Sbjct: 119 SKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 49/151 (32%), Positives = 78/151 (51%), Gaps = 16/151 (10%)
Query: 525 LGEGGFGPVYKGMLI----EGQEIAVKRLSKGSGQGMEEF--KNEVLLIAKLQHRNLVKL 578
LG+G FG V+ I GQ A+K L K + + + K E ++A++ H +VKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR--SHIIAGIARGLLYLHQDS 636
+ LI ++L + D F T SK + +++ +A +A L +LH
Sbjct: 64 HYAFQTEGKLYLILDFL--RGGDLF---TRLSKEVMFTEEDVKFYLAELALALDHLH--- 115
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
L II+RDLK N+LLD + K++DFGL++
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 35/137 (25%), Positives = 60/137 (43%), Gaps = 23/137 (16%)
Query: 541 GQEIAVKRLSKGSGQGMEE---FKNEVLLIAKLQHRNLVKLLGCCTQRDERML-IYEYLP 596
G E+A+K L + + + F+ E L A+L H N+V LL + ++EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 597 NKSLDYFIFDTTRSKL-----LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651
++L R L L + ++ + L H I+HRDLK N++
Sbjct: 63 GRTL--------REVLAADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIM 111
Query: 652 L---DNTMNPKISDFGL 665
+ + K+ DFG+
Sbjct: 112 VSQTGVRPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 49/159 (30%), Positives = 71/159 (44%), Gaps = 11/159 (6%)
Query: 525 LGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG+G FG V L +G+ AVK L K +E E ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 581 CCTQ-RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
C Q ++ + E+L L + I D R D + + A I GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG--- 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
II+RDLK NV+LD + KI+DFG+ + A+T
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 22/155 (14%)
Query: 523 NKLGEGGFGPVYK------GMLIEGQEIAVKRLSKGSGQGMEEFK-NEVLLIAKLQHR-- 573
++LG+G +G VYK G+ + +EI RL ++E K N++++ + H+
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE------LDESKFNQIIMELDILHKAV 57
Query: 574 --NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
+V G + EY+ SLD ++ + I + +GL +
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
L ++ IIHRD+K +NVL++ K+ DFG++
Sbjct: 118 LKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 39/113 (34%), Positives = 51/113 (45%), Gaps = 14/113 (12%)
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII---AGIARGLLY 631
L +L C D + EY+ L Y I R K H + A IA GL +
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFK------EPHAVFYAAEIAIGLFF 116
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
LH II+RDLK NV+LD+ + KI+DFG+ + D TK GT
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 19/163 (11%)
Query: 521 EKNKLGEGGFGPVYKGMLIEGQ---EIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
E K+G G +G VYK +G+ E A+K++ +G+G M + E+ L+ +L+H N++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI-EGTGISMSACR-EIALLRELKHPNVIA 62
Query: 578 LLGCCTQRDERM--LIYEYLPNKSLDYFIFD-----TTRSKLLDWSKRSHIIAGIARGLL 630
L +R L+++Y + F + L S ++ I G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 631 YLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLARSF 669
YLH + ++HRDLK +N+L+ KI+D G AR F
Sbjct: 123 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 15/167 (8%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQE----IAVKRLSKGS----GQGMEEFKNEVLLIAK 569
NF LG G +G V+ + G + A+K L K + + E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 570 LQHRNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARG 628
++ + L Q D ++ LI +Y+ L F + R + + + + I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYS-GEIVLA 117
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
L +LH +L II+RD+K N+LLD+ + ++DFGL++ F D+ E
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 525 LGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEV----LLIAKLQHRNLVKLL 579
+G+G FG V ++G+ AVK L K +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
++ + +++ L F R + + A IA L YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---IN 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
I++RDLK N+LLD+ + ++DFGL + G+ Q++ T
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTT 154
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 32/150 (21%), Positives = 54/150 (36%), Gaps = 15/150 (10%)
Query: 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV--K 577
S L G VY + + +K S + + + EV ++ L + L K
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDE-DYVLKI--NPSREKGADREREVAILQLLARKGLPVPK 57
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
+L L+ E++ ++LD + +A L LHQ
Sbjct: 58 VLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ----------LAELLAKLHQLPL 107
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
L + H DL N+L+D+ I D+ A
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVK 577
LG+G FG V ML E + A+K L K +E E ++A +
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 578 LLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
L C Q +R+ + EY+ L Y I + K + A I+ GL +LH+
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFK---EPQAVFYAAEISVGLFFLHRRG 121
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
II+RDLK NV+LD+ + KI+DFG+ + +D T
Sbjct: 122 ---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 28/158 (17%)
Query: 525 LGEGGFGPVYKGMLIEGQE----IAVKRLSKG----SGQGMEEFKNEVLLIAKLQHRNLV 576
LG+GG+G V++ + G + A+K L K + + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 577 KLLGCCTQRDERMLIYEYLPNKSL-------DYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
L+ + LI EYL L F+ DT ++ I+ L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA----------CFYLSEISLAL 113
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+LHQ II+RDLK N+LLD + K++DFGL +
Sbjct: 114 EHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 42/157 (26%), Positives = 65/157 (41%), Gaps = 30/157 (19%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLL--------------IAKL 570
LG+G FG V I V+ + G M+ K EV++ +
Sbjct: 3 LGKGTFGKV----------ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+H L L +D + EY+ L F +R ++ + A I L
Sbjct: 53 RHPFLTSLKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALD 109
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
YLH +I++RDLK N++LD + KI+DFGL +
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-05
Identities = 23/84 (27%), Positives = 34/84 (40%), Gaps = 13/84 (15%)
Query: 366 CKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKN---CSCTAYANADVRGRGSGC 422
CK L A+K+ T+ T EC C KN SC A+ A R C
Sbjct: 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKARK---QC 55
Query: 423 LLW-FHDLIDIKELPESGQDLFIR 445
L + F+ + +++ G DL+
Sbjct: 56 LWFPFNSMSGVRKEFSHGFDLYEN 79
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 22/51 (43%), Positives = 30/51 (58%), Gaps = 3/51 (5%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
I GL Y+H + ++HRDLK N+L++ KI DFGLAR F + E
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE 161
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 21/46 (45%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
I+ +A L YLH+ IIHRDLK N+L+ N + K++DFGL++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 47/164 (28%), Positives = 67/164 (40%), Gaps = 46/164 (28%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
+G G G VYK + G +AVK++ + + EE K R L+ L
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENK-----------RILMDLDVVLK 69
Query: 584 QRDERMLIYEYLPNKSLDYFIFD-----------TTRSKLLDWSKRS----------HII 622
D ++ K YFI D T KLL KR +
Sbjct: 70 SHDCPYIV------KCYGYFITDSDVFICMELMSTCLDKLL---KRIQGPIPEDILGKMT 120
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
I + L YL + +IHRD+K SN+LLD + N K+ DFG++
Sbjct: 121 VAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 42/149 (28%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 525 LGEGGFGPVYKGMLI----EGQEIAVKRLS--KGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
+G+G +G V L+ +G++ +K+L+ S + + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
D + I Y + KLL ++ IA L YLH+
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK--- 121
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLAR 667
I+HRDLK NV L T K+ D G+AR
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIAR 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 30/159 (18%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGS----GQGMEEFKNEVLLIAKLQHRNLVKLL 579
+G G FG V + I A+K+L K Q + + E ++A+ + +VKL
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVVKLY 67
Query: 580 GCCTQRDER--MLIYEYLPNKSL-------DYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+ +DE LI EYLP + D F + TR IA +L
Sbjct: 68 --YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY-------------IAETIL 112
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
+ +L IHRD+K N+LLD + K+SDFGL
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 23/54 (42%), Positives = 35/54 (64%), Gaps = 3/54 (5%)
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
IA I L +LHQ L II+RD+K N+LLD+ + ++DFGL++ F ++ E
Sbjct: 111 IAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 49/175 (28%), Positives = 69/175 (39%), Gaps = 34/175 (19%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK------------LQ- 571
LG+G FG V I V+ + G M+ + EV+ IAK LQ
Sbjct: 3 LGKGTFGKV----------ILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQN 51
Query: 572 --HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H L L D + EY L F +R ++ + A I L
Sbjct: 52 TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSAL 108
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
YLH +++RD+K N++LD + KI+DFGL + D A K GT
Sbjct: 109 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 158
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 25/65 (38%), Positives = 38/65 (58%), Gaps = 6/65 (9%)
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
I + GL YL+ + RI+HRD+K SN+L+++ K+ DFG+ S L + A+T
Sbjct: 107 KIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGV--SGELINSIADT- 161
Query: 680 RVVGT 684
VGT
Sbjct: 162 -FVGT 165
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 45/163 (27%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 521 EKNKLGEGGFGPVYKGMLIEGQE---IAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
E K+G G +G VYK +G++ A+K++ +G+G M + E+ L+ +L+H N++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSACR-EIALLRELKHPNVIS 62
Query: 578 LLGCCTQRDERM--LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY---- 631
L +R L+++Y + + I R+ + K + G+ + LLY
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDL--WHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILD 119
Query: 632 -LHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLARSF 669
+H ++HRDLK +N+L+ KI+D G AR F
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 49/172 (28%), Positives = 70/172 (40%), Gaps = 40/172 (23%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
++F +G+G FG V L++ G+ A+K L K E FK + L K +
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKS-----EMFKKDQLAHVKAER 52
Query: 573 RNL--------VKLLGCCTQRDERMLIYEYLPNKSL-------DYFIFDTTRSKLLDWSK 617
L V L LI E+LP L D F D TR
Sbjct: 53 DVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY------ 106
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
+A +L + +L IHRD+K N+L+D + K+SDFGL+ F
Sbjct: 107 -------MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 42/157 (26%), Positives = 63/157 (40%), Gaps = 29/157 (18%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLL--------------IAKL 570
LG+G FG V I VK + G M+ K EV++ +
Sbjct: 3 LGKGTFGKV----------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+H L L D + EY L F +R ++ + A I L
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALD 109
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
YLH + +++RDLK N++LD + KI+DFGL +
Sbjct: 110 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 41/171 (23%), Positives = 72/171 (42%), Gaps = 21/171 (12%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIA---VKRL-SKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
++G G FG V + +A VK L + S + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS-------HIIAGIARGLLYL 632
G C + +L++EY L ++ W +R+ + IA G+ ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEANTKRVV 682
H + +H DL N L + + K+ D+G+ S + D E + V
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV 163
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 38/152 (25%), Positives = 70/152 (46%), Gaps = 20/152 (13%)
Query: 522 KNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+ LG G G VYK L+ + +AVK + + + ++ +E+ ++ K ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA----RGLLYLHQD 635
G + + E++ SLD + H++ IA +GL YL
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS- 113
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
L+I+HRD+K SN+L++ K+ DFG++
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 11/148 (7%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKNEV----LLIAKLQHRNLVKLL 579
+G+G FG V ++ AVK L K + +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
D+ + +Y+ L Y + R + + A IA L YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYLHS---LN 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLAR 667
I++RDLK N+LLD+ + ++DFGL +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 23/43 (53%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ARG+ +L SR + IHRDL A N+LL KI DFGLAR
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 9e-05
Identities = 32/129 (24%), Positives = 59/129 (45%), Gaps = 15/129 (11%)
Query: 547 KRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD 606
KR+ GS + + +NE+L + +L H N++K+ + R Y+ + D+ ++
Sbjct: 198 KRVKAGS-RAAIQLENEILALGRLNHENILKI-----EEILRSEANTYMITQKYDFDLYS 251
Query: 607 TTRSKLLDWSKR------SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660
+ DW R I+ + + Y+H ++IHRD+K N+ L+ +
Sbjct: 252 FMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVL 308
Query: 661 SDFGLARSF 669
DFG A F
Sbjct: 309 GDFGTAMPF 317
|
Length = 501 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 13/165 (7%)
Query: 525 LGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEV----LLIAKLQHRNLVKLL 579
+G+G FG V +G AVK L K + +E + + +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
++ + +Y+ L F R + + A +A + YLH L
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLHS---LN 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
II+RDLK N+LLD+ + ++DFGL + G++ E T GT
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEP-EETTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 14/174 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE---GQEIAVKRLSK---GSGQGMEEFKNEVLLIAKL 570
+F K+ +G G FG V ++ E G A+K + K + + + F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+ +L +D L+ EY P L + ++ D +A +L
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL-----NRYEDQFDEDMAQFYLAELVL 113
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+H ++ +HRD+K NVL+D T + K++DFG A ++ N+K VGT
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGT 166
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 31/96 (32%), Positives = 45/96 (46%), Gaps = 6/96 (6%)
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H LV L C + EY+ L +F R + L A I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
LH+ II+RDLK NVLLD+ + K++D+G+ +
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 16/187 (8%)
Query: 506 IFDLKIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEV 564
IFD + +D + +G+G +G V+K + G + AVK L EE + E
Sbjct: 9 IFD--SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEY 65
Query: 565 LLIAKLQ-HRNLVKLLGCCTQRDER-----MLIYEYLPNKSL-DYFIFDTTRSKLLDWSK 617
++ L H N+VK G ++D + L+ E S+ D R + ++
Sbjct: 66 NILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI 125
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677
++I+ GL +LH + + IHRD+K +N+LL K+ DFG++ + N
Sbjct: 126 IAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182
Query: 678 TKRVVGT 684
T VGT
Sbjct: 183 TS--VGT 187
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 32/184 (17%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQE----IAVKRLSKGS----GQGMEEFKNEVLLIAK 569
NF LG G +G V+ + G + A+K L K + + +E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 570 LQHRNLVKLLGCCTQRDERM-LIYEYLPNKSL-------DYFIFDTTRSKLLDWSKRSHI 621
++ + L Q + ++ LI +Y+ + D F D R
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVR-----------F 109
Query: 622 IAG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
+G I L +LH +L I++RD+K N+LLD+ + ++DFGL++ F L + + T
Sbjct: 110 YSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYS 165
Query: 681 VVGT 684
GT
Sbjct: 166 FCGT 169
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 7/104 (6%)
Query: 563 EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
E ++ + H ++++L G T LI LP D + + + + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILA-IE 188
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
+ R + YLH++ RIIHRD+KA N+ +++ + + DFG A
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 52/178 (29%), Positives = 70/178 (39%), Gaps = 40/178 (22%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK------------LQ- 571
LG+G FG V I V+ + G M+ K EV+ IAK LQ
Sbjct: 3 LGKGTFGKV----------ILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQN 51
Query: 572 --HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H L L D + EY L F +R ++ + A I L
Sbjct: 52 TRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSAL 108
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR---SFGLDQTEANTKRVVGT 684
YLH +++RDLK N++LD + KI+DFGL + S G A K GT
Sbjct: 109 GYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-----ATMKTFCGT 158
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 19/41 (46%), Positives = 24/41 (58%), Gaps = 3/41 (7%)
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
R L Y+H + + HRDLK N+L + KI DFGLAR
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 29/129 (22%), Positives = 55/129 (42%), Gaps = 8/129 (6%)
Query: 544 IAVKRLSKGSGQGMEEFK---NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600
+AVK+++ S E+ K E++ +LQH N++ + E ++ + S
Sbjct: 28 VAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86
Query: 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660
+ + T + L + I+ + L Y+H IHR +KAS++LL +
Sbjct: 87 EDLL-KTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVL 142
Query: 661 SDFGLARSF 669
S + S
Sbjct: 143 SGLRYSVSM 151
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 33/121 (27%), Positives = 52/121 (42%), Gaps = 12/121 (9%)
Query: 546 VKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF 605
VK ++ G G E+ ++ + HR ++ L+ + ++ +P D F +
Sbjct: 124 VKAVTGGKTPG-----REIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTY 175
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
RS L + I + L YLH IIHRD+K N+ LD N + DFG
Sbjct: 176 -VDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA 231
Query: 666 A 666
A
Sbjct: 232 A 232
|
Length = 392 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 24/60 (40%), Positives = 38/60 (63%), Gaps = 6/60 (10%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ RGL YL + + +I+HRD+K SN+L+++ K+ DFG+ S L + AN+ VGT
Sbjct: 108 VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANS--FVGT 161
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 25/62 (40%), Positives = 33/62 (53%), Gaps = 3/62 (4%)
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
DT S LD + +A+G+ +L + IHRD+ A NVLL + KI DFGL
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGL 258
Query: 666 AR 667
AR
Sbjct: 259 AR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 30/93 (32%), Positives = 43/93 (46%), Gaps = 6/93 (6%)
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
LV L C L+ EY+ L +F R + L A I L +LH+
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
II+RDLK NVLLD + K++D+G+ +
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 23/43 (53%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ARG+ +L SR + IHRDL A N+LL KI DFGLAR
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 9e-04
Identities = 29/101 (28%), Positives = 46/101 (45%), Gaps = 9/101 (8%)
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK-LLDWSKRSHIIAGIARGLL 630
+ N +KL T +LI +Y+ + L FD + + L ++ II + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNP-KISDFGLARSFG 670
LH + IIH D+K NVL D + + D+GL + G
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161
|
Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 9e-04
Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 7/90 (7%)
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
L C Q + R+ + E++ L +F R + L A I+ L +LH+
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLHERG- 116
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
II+RDLK NVLLD + K++D+G+ +
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 44/179 (24%), Positives = 73/179 (40%), Gaps = 36/179 (20%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSGQGMEEFKNEVLL----- 566
D+F KLGEG FG VYK L+ + +K+ + G +E + NE +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNERVRRACPN 189
Query: 567 -IAKLQHRNLVKLLGCCTQRDERMLIYEY---------LPNKSLDY----FIFDTTRSKL 612
A + L + + DE L++ Y + +K Y ++ +
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 613 LDWSKRSHIIAGIARGLLY----LHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLA 666
+ + II I R +L+ LH I+HRD+K N++ + + KI D G A
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 43/156 (27%), Positives = 66/156 (42%), Gaps = 16/156 (10%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEE---FKNEVLLIAK 569
D+F +G G FG V L++ G A+K L K E+ + E ++ +
Sbjct: 1 DDFESLKVIGRGAFGEV---RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE 57
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
+VK+ + LI E+LP + + + L IA +
Sbjct: 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAI 114
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
+HQ L IHRD+K N+LLD + K+SDFGL
Sbjct: 115 DAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 42/156 (26%), Positives = 68/156 (43%), Gaps = 16/156 (10%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEE---FKNEVLLIAK 569
++F +G G FG V L++ G A+K L K E+ + E ++ +
Sbjct: 1 EDFESLKVIGRGAFGEV---RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE 57
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
+VK+ + LI E+LP + + + L + IA +
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAI 114
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
+HQ L IHRD+K N+LLD+ + K+SDFGL
Sbjct: 115 DSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 22/43 (51%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+A+G+ +L SR + IHRDL A N+LL KI DFGLAR
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 19/168 (11%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLG 580
+G GGFG VY + G+ A+K L K QG NE ++++ L +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS-LVSTGDCPFIV 60
Query: 581 CCT----QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
C T D+ I + + L Y + ++ + + I GL ++H +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMH--N 115
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
R +++RDLK +N+LLD + +ISD GLA F + A+ VGT
Sbjct: 116 RF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 22/74 (29%), Positives = 33/74 (44%), Gaps = 11/74 (14%)
Query: 605 FDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664
FD +R++ A L L + +I+RDLK N+LLD + + DFG
Sbjct: 90 FDLSRARFY-----------TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFG 138
Query: 665 LARSFGLDQTEANT 678
L + D + NT
Sbjct: 139 LCKLNMKDDDKTNT 152
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 24/76 (31%), Positives = 38/76 (50%), Gaps = 11/76 (14%)
Query: 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL----YLHQDSRLRIIHRDLKASNV 650
LP D + + R + L ++ + +AR LL Y+H + IIHRD+K NV
Sbjct: 239 LPKYRSDLYTYLGARLRPLGLAQ----VTAVARQLLSAIDYIHGEG---IIHRDIKTENV 291
Query: 651 LLDNTMNPKISDFGLA 666
L++ + + DFG A
Sbjct: 292 LVNGPEDICLGDFGAA 307
|
Length = 461 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 21/48 (43%), Positives = 28/48 (58%), Gaps = 3/48 (6%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
+A+G+ +L + IHRDL A N+LL + KI DFGLAR D
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 684 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.96 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.95 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.95 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.95 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.95 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.94 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.94 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.94 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.94 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.94 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.93 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.93 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.93 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.93 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.93 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.92 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.92 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.92 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.92 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.91 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.91 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.91 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.9 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.9 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.9 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.9 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.9 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.9 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.9 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.9 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.9 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.9 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.9 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.9 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.9 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.9 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.9 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.9 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.9 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.9 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.9 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.9 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.89 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.89 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.89 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.89 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.89 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.89 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.89 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.89 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.89 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.89 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.89 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.89 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.89 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.89 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.89 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.89 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.88 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.88 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.88 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.88 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.88 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.88 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.88 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.88 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.88 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.88 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.88 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.88 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.88 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.88 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.88 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.88 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.88 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.88 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.88 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.88 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.88 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.88 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.88 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.88 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.87 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.87 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.87 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.87 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.87 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.87 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.87 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.87 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.87 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.87 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.87 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.87 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.87 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.87 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.87 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.87 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.87 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.87 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.87 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.87 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.87 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.87 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.87 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.87 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.86 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.86 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.86 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.86 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.86 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.86 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.86 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.86 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.86 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.86 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.86 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.86 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.86 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.86 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.86 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.86 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.86 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.86 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.86 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.86 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.86 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.86 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.86 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.86 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.86 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.86 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.86 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.86 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.86 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.86 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.86 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.86 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.86 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.86 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.86 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.86 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.85 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.85 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.85 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.85 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.85 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.85 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.85 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.85 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.85 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.85 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.85 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.85 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.85 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.85 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.85 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.85 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.85 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.85 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.85 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.85 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.85 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.85 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.85 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.85 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.85 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.85 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.85 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.85 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.85 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.84 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.84 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.84 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.84 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.84 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.84 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.84 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.84 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.84 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.84 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.84 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.84 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.84 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.84 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.84 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.84 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.84 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.84 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.84 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.84 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.84 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.84 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.84 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.83 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.83 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.83 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.83 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.83 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.83 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.83 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.83 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.83 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.83 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.83 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.83 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.83 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.83 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.82 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.82 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.82 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.82 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.82 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.82 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.82 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.82 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.82 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.82 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.82 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.82 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.82 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.82 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.82 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.82 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.82 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.82 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.82 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.82 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.82 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.82 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.82 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.82 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.82 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.82 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.82 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.82 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.82 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.81 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.81 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.81 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.81 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.81 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.81 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.81 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.81 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.81 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.8 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.8 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.8 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.8 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.8 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.8 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.8 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.8 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.8 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.8 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.79 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.79 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.79 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.79 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.79 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.79 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.79 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.79 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.79 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.79 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.79 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.78 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.78 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.77 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.77 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.77 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.77 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.77 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.76 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.76 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.76 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.76 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.75 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.75 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.74 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.74 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.74 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.73 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.7 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.68 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.68 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.66 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.61 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.61 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.56 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.55 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.36 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.21 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.06 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.01 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 98.97 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 98.9 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.9 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.71 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.65 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.61 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.59 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.57 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.54 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.49 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.47 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.45 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.32 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.28 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.25 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.24 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.24 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.21 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.18 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.17 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.11 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.1 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.01 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.99 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.98 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.89 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.84 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.83 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.72 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.67 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.67 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.61 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.46 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.22 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.1 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.09 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.97 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.95 | |
| PLN02236 | 344 | choline kinase | 96.89 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.89 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.78 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.64 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.62 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 96.31 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.29 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.12 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.82 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.74 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.67 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.47 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.42 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.34 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=299.06 Aligned_cols=167 Identities=52% Similarity=0.854 Sum_probs=153.2
Q ss_pred CcCcccHHHHHhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEE
Q 005669 503 ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582 (684)
Q Consensus 503 ~~~~~~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~ 582 (684)
....|++.++..+|++|+..+.||+|+||.||+|...++..||||++.....+...+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56679999999999999999999999999999999999999999988865433156699999999999999999999999
Q ss_pred EeCC-eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEE
Q 005669 583 TQRD-ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (684)
Q Consensus 583 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~ 661 (684)
.+.+ +.+||||||++|+|+++|+..... .++|.+|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999765443 88999999999999999999999988899999999999999999999999
Q ss_pred eeccccccC
Q 005669 662 DFGLARSFG 670 (684)
Q Consensus 662 DFGla~~~~ 670 (684)
|||+|+...
T Consensus 220 DFGLa~~~~ 228 (361)
T KOG1187|consen 220 DFGLAKLGP 228 (361)
T ss_pred CccCcccCC
Confidence 999997654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=268.92 Aligned_cols=161 Identities=32% Similarity=0.542 Sum_probs=140.5
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
...+|...++||+|+|++||+|+++. +.+||||.+.+. .....+.+..|+.+|+.++|||||++++++..++..++|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 34678888999999999999999865 889999999875 445567788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC------CcEEEEeecc
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT------MNPKISDFGL 665 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~------~~vkI~DFGl 665 (684)
||||.||+|..++.. .+.+++..+..++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999943 457999999999999999999999999 9999999999999754 4689999999
Q ss_pred ccccCCCCCccCCcccccC
Q 005669 666 ARSFGLDQTEANTKRVVGT 684 (684)
Q Consensus 666 a~~~~~~~~~~~~~~~~GT 684 (684)
||.+.... ...+++||
T Consensus 162 AR~L~~~~---~a~tlcGS 177 (429)
T KOG0595|consen 162 ARFLQPGS---MAETLCGS 177 (429)
T ss_pred hhhCCchh---HHHHhhCC
Confidence 99986433 23345554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=256.64 Aligned_cols=161 Identities=30% Similarity=0.460 Sum_probs=138.6
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcc-------cHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ-------GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD 586 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 586 (684)
..+.|.+.+.||+|+||.|-+|..+ +++.||||++.+.... .....++|+++|++++|||||+++++++..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4467888899999999999999875 4999999999864211 2234679999999999999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CcEEEEee
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDF 663 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~---~~vkI~DF 663 (684)
..|+||||++||.|.+.+. ..+.+.+..-..+++|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999884 3556788888999999999999999999 9999999999999755 77999999
Q ss_pred ccccccCCCCCccCCcccccC
Q 005669 664 GLARSFGLDQTEANTKRVVGT 684 (684)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~GT 684 (684)
|+|+..+.. ..+++++||
T Consensus 324 GlAK~~g~~---sfm~TlCGT 341 (475)
T KOG0615|consen 324 GLAKVSGEG---SFMKTLCGT 341 (475)
T ss_pred chhhccccc---eehhhhcCC
Confidence 999998632 356678887
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=264.54 Aligned_cols=160 Identities=33% Similarity=0.478 Sum_probs=145.5
Q ss_pred CCCCccceecccCcEeEEEEEe-eCCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
..|...+.||+|+|+.||+++. ..|+.||+|++.+. .....+.+.+||++.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999998 56999999999864 3455678899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|+|++++|..++. +.+.+++.++..+++||+.||.|||+++ |||||||..|++|+++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999984 4677999999999999999999999998 999999999999999999999999999999766
Q ss_pred CCccCCcccccC
Q 005669 673 QTEANTKRVVGT 684 (684)
Q Consensus 673 ~~~~~~~~~~GT 684 (684)
+.+. .+++||
T Consensus 172 ~Erk--~TlCGT 181 (592)
T KOG0575|consen 172 GERK--KTLCGT 181 (592)
T ss_pred cccc--ceecCC
Confidence 5443 357887
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=227.81 Aligned_cols=110 Identities=48% Similarity=0.782 Sum_probs=81.9
Q ss_pred CCcEEEEecCCCCCCCC--CceEEEeeccCceEEEecCCCCeEEEe-cccCCC-CCceEEEecCccEEEecCCCCCCCCe
Q 005669 91 EGTVTWVANRDAPLSDR--SGVLRINGERNGILVLLNSTNDTVWSS-NSSISA-QKPVAALMESGNLVVKDGKDNNPDNI 166 (684)
Q Consensus 91 ~~t~vW~anr~~pv~~~--~~~l~~~~~~~g~l~l~~~~~~~~w~s-~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~~~~ 166 (684)
++||||+|||+.|+... .++|.|+. ||+|+|++..++++|++ ++.+.. ....|.|+|+|||||++. .+.+
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~--dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~----~~~~ 74 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQS--DGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS----SGNV 74 (114)
T ss_dssp ---------TTEEEEECETTEEEEEET--TSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET----TSEE
T ss_pred CcccccccccccccccccccccceECC--CCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee----cceE
Confidence 36999999999999542 47899988 99999999999999999 555433 578899999999999996 5789
Q ss_pred eEeeccCCCCCcCCCCeecccccCccceeEEEccCCCCCC
Q 005669 167 LWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPA 206 (684)
Q Consensus 167 ~WQSFd~PTDTlLpgq~l~~~~~tg~~~~L~Sw~s~~dps 206 (684)
|||||||||||+||||+|+.+..++.+..++||++.+|||
T Consensus 75 lW~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 75 LWQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EEESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EEeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 9999999999999999999988888888899999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=248.36 Aligned_cols=157 Identities=28% Similarity=0.372 Sum_probs=137.2
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-eeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-ERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey 594 (684)
+.+..+.||+|..|+|||+.++. ++.+|+|.+... ++...+++.+|++++++.+||+||++||.|.... ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 34556789999999999999864 788999999544 3445678999999999999999999999999998 59999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
|++|+|+.++.. .+.+++.....|+.+|++||.|||+ ++ ||||||||+||||+..|.+||+|||.++.+...
T Consensus 160 MDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999843 3669999999999999999999996 55 999999999999999999999999999988543
Q ss_pred CccCCcccccC
Q 005669 674 TEANTKRVVGT 684 (684)
Q Consensus 674 ~~~~~~~~~GT 684 (684)
...+++||
T Consensus 233 ---~a~tfvGT 240 (364)
T KOG0581|consen 233 ---IANTFVGT 240 (364)
T ss_pred ---hccccccc
Confidence 33457776
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=255.42 Aligned_cols=160 Identities=31% Similarity=0.499 Sum_probs=137.4
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC--CeeEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERML 590 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 590 (684)
.+.|+.+++||+|.||.||+++... |+.||+|++.... .....-..+||.+|++|+||||++|.+...+. ..+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3567888999999999999999754 8999999987653 34455678999999999999999999999877 67999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|+|||++ +|.-++. ...-.+++.++..++.|++.||+|+|.++ |+|||||.+|||||.+|.+||+|||||+.+.
T Consensus 196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999986 5666652 23446999999999999999999999999 9999999999999999999999999999998
Q ss_pred CCCCccCCccc
Q 005669 671 LDQTEANTKRV 681 (684)
Q Consensus 671 ~~~~~~~~~~~ 681 (684)
......-|.++
T Consensus 270 ~~~~~~~T~rV 280 (560)
T KOG0600|consen 270 PSGSAPYTSRV 280 (560)
T ss_pred CCCCcccccce
Confidence 77665555554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=248.00 Aligned_cols=162 Identities=31% Similarity=0.464 Sum_probs=144.0
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
..++|++++.||+|+||+||.++..+ ++.+|+|.+++. .....+..++|..+|.+++||.||+++-.|++.+..|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 35789999999999999999999766 889999999865 23345678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|+||+.||.|...| .++..+++..+..++.+|+.||.|||+++ ||||||||+|||||.+|+++|+|||+++.--
T Consensus 103 Vld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999999 44567999999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCccCCcccccC
Q 005669 671 LDQTEANTKRVVGT 684 (684)
Q Consensus 671 ~~~~~~~~~~~~GT 684 (684)
.+. ..+.+++||
T Consensus 177 ~~~--~~t~tfcGT 188 (357)
T KOG0598|consen 177 KDG--DATRTFCGT 188 (357)
T ss_pred cCC--CccccccCC
Confidence 333 245568888
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=251.43 Aligned_cols=149 Identities=38% Similarity=0.617 Sum_probs=131.6
Q ss_pred CccceecccCcEeEEEEEeeCCcEEEEEEccCCCccc--HHHHHHHHHHHhccCCCceeeEEEEEEeCC-eeEEEEEccC
Q 005669 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG--MEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-ERMLIYEYLP 596 (684)
Q Consensus 520 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey~~ 596 (684)
...+.||+|+||+||+|.+.....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ...+||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3445699999999999998655559999998653222 568999999999999999999999999888 7999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-cEEEEeeccccccCC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFGL 671 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~-~vkI~DFGla~~~~~ 671 (684)
+|+|..+++.. ....+++..++.++.|||+||.|||++++ ||||||||+|||++.++ ++||+|||+++....
T Consensus 124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999654 45679999999999999999999999873 99999999999999997 999999999998754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=238.27 Aligned_cols=149 Identities=24% Similarity=0.435 Sum_probs=132.7
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
++|+.+.++|+|+||.||+++.++ |+.||||++..... .-.+-.++|+++|++++|+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468888899999999999999876 99999999876432 234456899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|++..-|+++- .....++.+.+..++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+||.+..
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99987776654 23456899999999999999999999999 99999999999999999999999999999974
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=210.49 Aligned_cols=110 Identities=45% Similarity=1.038 Sum_probs=104.9
Q ss_pred EecCCCCCcccccccccccCCeeEEEEEecCCeeEEEEecCCCCcceeEEECcCCcEEEEEEecCCceEEEeeeccCCCc
Q 005669 232 FRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTL 311 (684)
Q Consensus 232 w~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~w~~~~~~W~~~~~~~~~~~ 311 (684)
||+|+|+|..|+++|++.....+.+.|+.+++|.+++|.+.+.+.++|++||++|++++|.|++..++|..+|. +|.
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~---~p~ 77 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWS---APK 77 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEE---ecc
Confidence 89999999999999999988889999999999999999999989999999999999999999999999999999 999
Q ss_pred cCCCccCCCCCCcccccCCCCCcccccCCCccCC
Q 005669 312 DQCDSYALCGAYASCNINSNSPECECLQGFVPNS 345 (684)
Q Consensus 312 ~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~~ 345 (684)
|+||+|+.||+||+|+.+..+ .|.||+||+|++
T Consensus 78 d~Cd~y~~CG~~g~C~~~~~~-~C~Cl~GF~P~n 110 (110)
T PF00954_consen 78 DQCDVYGFCGPNGICNSNNSP-KCSCLPGFEPKN 110 (110)
T ss_pred cCCCCccccCCccEeCCCCCC-ceECCCCcCCCc
Confidence 999999999999999887666 899999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=249.72 Aligned_cols=154 Identities=32% Similarity=0.427 Sum_probs=136.7
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCee
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 588 (684)
....+|...+.||+|+|++|++|+..+ ++++|||++.+. .+...+-...|-.+|.+| .||.|++|+-.|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345678889999999999999999765 899999998764 223334566788899999 899999999999999999
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
|+|+||+++|+|.++|.+ .+.+++.....++.+|+.||+|||++| ||||||||+|||||+++++||+|||.|+.
T Consensus 150 YFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999944 467999999999999999999999999 99999999999999999999999999999
Q ss_pred cCCCC
Q 005669 669 FGLDQ 673 (684)
Q Consensus 669 ~~~~~ 673 (684)
+++.+
T Consensus 224 l~~~~ 228 (604)
T KOG0592|consen 224 LSPSQ 228 (604)
T ss_pred CChhh
Confidence 96543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=228.59 Aligned_cols=151 Identities=33% Similarity=0.593 Sum_probs=134.4
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcc--cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ--GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
++|...++||+|.||.||+|++.. |+.||||+++..... ......+|++.|+.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467788999999999999999754 899999999865322 23457899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
||+ .+|+..+.+ +...++..++..++.++++||+|+|++. |+||||||.|+|++++|.+||+|||+|+.++...
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 997 689888854 3567899999999999999999999998 9999999999999999999999999999997554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=248.52 Aligned_cols=151 Identities=38% Similarity=0.616 Sum_probs=136.6
Q ss_pred CCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005669 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 598 (684)
+...+.||+|.||.|+.|.+.....||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|..++.++||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3445789999999999999987789999999875 344578999999999999999999999999989999999999999
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCCC
Q 005669 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (684)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~~ 674 (684)
+|.++|.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||||.++.++.
T Consensus 287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 99999965 34567899999999999999999999998 99999999999999999999999999997665544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=228.12 Aligned_cols=158 Identities=32% Similarity=0.422 Sum_probs=140.3
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.++|+..+.||.|+||.|.+++.+. |.-+|+|++++.. -...+...+|..+|+.+.||.++++++.+.+.+..++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 3578888999999999999999765 7889999998653 23345677899999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||++||.|..+++ +.+++++..+..++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+....
T Consensus 123 meyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999994 4567999999999999999999999998 99999999999999999999999999998742
Q ss_pred CCCccCCcccccC
Q 005669 672 DQTEANTKRVVGT 684 (684)
Q Consensus 672 ~~~~~~~~~~~GT 684 (684)
+|-+++||
T Consensus 197 -----rT~TlCGT 204 (355)
T KOG0616|consen 197 -----RTWTLCGT 204 (355)
T ss_pred -----cEEEecCC
Confidence 35567776
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-28 Score=235.66 Aligned_cols=166 Identities=26% Similarity=0.444 Sum_probs=140.3
Q ss_pred CCCCccceecccCcEeEEEEEe-eCCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEE-EEEeCCe-eEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLG-CCTQRDE-RMLI 591 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g-~~~~~~~-~~lV 591 (684)
.+|++.++||+|.||+||++.. .+|..+|.|.+.-. +......+..|+.+|++|+|||||++++ .+.++++ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4588889999999999999985 56999999998743 3445567889999999999999999998 5555555 7999
Q ss_pred EEccCCCChhHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 592 YEYLPNKSLDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQDS-RLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~-~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
|||+.+|+|...+.+..+ .+.+++..+++++.|++.||.++|.+- +..|+||||||.||+|+.+|.+||+|||++|.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999876443 457899999999999999999999842 123999999999999999999999999999999
Q ss_pred CCCCCccCCcccccC
Q 005669 670 GLDQTEANTKRVVGT 684 (684)
Q Consensus 670 ~~~~~~~~~~~~~GT 684 (684)
....+. ++..+||
T Consensus 179 ~s~~tf--A~S~VGT 191 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGT 191 (375)
T ss_pred cchhHH--HHhhcCC
Confidence 765543 4457787
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-27 Score=237.28 Aligned_cols=149 Identities=27% Similarity=0.508 Sum_probs=136.7
Q ss_pred CCCCccceecccCcEeEEEEEe-eCCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
-+|++.+.||+|.||+|-++.. ..|+.||||.+++. +.+.+..+++|+++|..|+||||++++.+|+..+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4577888999999999999986 56999999999865 4566778999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
||..+|.|.+++. ..+.|++.++..+++||..|+.|+|.+. ++|||||.+|||+|.++++||+|||++..+..
T Consensus 133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999993 4567999999999999999999999988 99999999999999999999999999998854
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=201.40 Aligned_cols=115 Identities=43% Similarity=0.710 Sum_probs=100.9
Q ss_pred CcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEEecCCCCeE
Q 005669 52 QSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTV 131 (684)
Q Consensus 52 ~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l~~~~~~~~ 131 (684)
+.|.+|++|+|+++.|++|||.+......+.+|||...+ +++||.|||+.|. ...+.|.|+. ||+|+|+|.+|.++
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~-~~~~~l~l~~--dGnLvl~~~~g~~v 77 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPS-GSSCTLTLQS--DGNLVIYDGSGTVV 77 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCC-CCCEEEEEec--CCCeEEEcCCCcEE
Confidence 568889999999999999999987544489999998876 7899999999984 4568899988 99999999999999
Q ss_pred EEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCC
Q 005669 132 WSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYP 174 (684)
Q Consensus 132 w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~P 174 (684)
|+|++.+.....+|+|+|+|||||++. .+.++|||||||
T Consensus 78 W~S~~~~~~~~~~~~L~ddGnlvl~~~----~~~~~W~Sf~~P 116 (116)
T cd00028 78 WSSNTTRVNGNYVLVLLDDGNLVLYDS----DGNFLWQSFDYP 116 (116)
T ss_pred EEecccCCCCceEEEEeCCCCEEEECC----CCCEEEcCCCCC
Confidence 999987533567899999999999987 468999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-27 Score=243.70 Aligned_cols=150 Identities=33% Similarity=0.505 Sum_probs=132.7
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHH--HHHHHHHhccC-CCceeeEEEEEEeCC-eeE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEF--KNEVLLIAKLQ-HRNLVKLLGCCTQRD-ERM 589 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~--~~Ei~~l~~l~-H~nIv~l~g~~~~~~-~~~ 589 (684)
..++|...++||.|.||.||+|+..+ +..||||++++.-. ..++. .+|+..|+++. ||||+++.+++.+.+ ..+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34678889999999999999999755 88999999987532 23443 57999999998 999999999999888 899
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+|||||+ .+|.+++.+. +..+++.++..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||.+
T Consensus 87 fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 9999997 5888888543 678999999999999999999999999 999999999999998889999999999988
Q ss_pred CC
Q 005669 670 GL 671 (684)
Q Consensus 670 ~~ 671 (684)
..
T Consensus 161 ~S 162 (538)
T KOG0661|consen 161 RS 162 (538)
T ss_pred cc
Confidence 54
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=229.53 Aligned_cols=151 Identities=32% Similarity=0.524 Sum_probs=133.0
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC--eeEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD--ERMLIY 592 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~ 592 (684)
..+|...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|.....+ .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3457778999999999999999865 8999999987653333677899999999999999999999855544 589999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~-~~~vkI~DFGla~~~~~ 671 (684)
||+++|+|.+++.+.. . .+++..+..+..||++||+|||+++ ||||||||+|||++. ++.+||+|||+|+....
T Consensus 96 Ey~~~GsL~~~~~~~g-~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYG-G-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcC-C-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999995432 2 6999999999999999999999998 999999999999999 79999999999998864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=237.92 Aligned_cols=163 Identities=26% Similarity=0.426 Sum_probs=140.2
Q ss_pred hhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC----Cc-ccHHHHHHHHHHHhccC-CCceeeEEEEEEeCC
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG----SG-QGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRD 586 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~----~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~ 586 (684)
...++|...+.||+|+||+|+.|... .++.||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 44578999999999999999999865 4899999977653 12 23456778999999998 999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CcEEEEeecc
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGL 665 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~-~~vkI~DFGl 665 (684)
..++||||+.+|.|.+++.+ ..++.+.++..++.|++.|++|+|+++ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999944 456888999999999999999999998 9999999999999999 9999999999
Q ss_pred ccccCCCCCccCCcccccC
Q 005669 666 ARSFGLDQTEANTKRVVGT 684 (684)
Q Consensus 666 a~~~~~~~~~~~~~~~~GT 684 (684)
+.... ......++.+||
T Consensus 168 s~~~~--~~~~~l~t~cGs 184 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGS 184 (370)
T ss_pred ccccC--CCCCcccCCCCC
Confidence 99874 112234456665
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=236.17 Aligned_cols=150 Identities=29% Similarity=0.415 Sum_probs=137.2
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
..++|+.++.||+|+||.||+++.++ |+.+|+|++++.. ....+..+.|-.+|...+++.||+|+..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999999765 8999999998763 3445678889999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||++||++..+| .+...|++..+..++.+++.|+.-||+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999 44667999999999999999999999999 9999999999999999999999999997653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=224.46 Aligned_cols=153 Identities=29% Similarity=0.432 Sum_probs=131.3
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEe--CCeeE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDERM 589 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~ 589 (684)
..+.|+.+++|++|+||.||+|++.. ++.||+|+++.... ...-...+||.+|.+++|||||.+-.+..- -+.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 34678889999999999999999865 78999999986431 223346789999999999999999988764 35689
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+||||++. +|..++... ..++...++..++.|+++|++|||.+. |+||||||+|+|++..|.+||+|||+||.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 99999985 788888432 357899999999999999999999998 999999999999999999999999999999
Q ss_pred CCCC
Q 005669 670 GLDQ 673 (684)
Q Consensus 670 ~~~~ 673 (684)
+.+.
T Consensus 228 gsp~ 231 (419)
T KOG0663|consen 228 GSPL 231 (419)
T ss_pred cCCc
Confidence 7653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-26 Score=239.30 Aligned_cols=159 Identities=29% Similarity=0.478 Sum_probs=139.8
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
++|.+.+.||+|+||.||||+.+. .+.||+|.+.+.. ....+.+++|+++++.++||||+.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578888999999999999999765 7899999998653 3446678999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
|+.| +|..+|. ....++++.+..|+.+++.||.|||++. |+|||+||+|||++..+.+|++|||+||.+..+.
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 9999993 4567999999999999999999999988 9999999999999999999999999999986432
Q ss_pred CccCCcccccC
Q 005669 674 TEANTKRVVGT 684 (684)
Q Consensus 674 ~~~~~~~~~GT 684 (684)
...+++.||
T Consensus 155 --~vltsikGt 163 (808)
T KOG0597|consen 155 --SVLTSIKGT 163 (808)
T ss_pred --eeeeeccCc
Confidence 233456665
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-25 Score=222.27 Aligned_cols=153 Identities=29% Similarity=0.499 Sum_probs=131.6
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhccCCCc-eeeEEEEEEeCC-----
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRN-LVKLLGCCTQRD----- 586 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~----- 586 (684)
...|+..++||+|+||+||+|+.. +|+.||+|++..... .......+|+.++++++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345777789999999999999975 488999999986533 23456689999999999999 999999998877
Q ss_pred -eeEEEEEccCCCChhHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 587 -ERMLIYEYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 587 -~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
..++|+||++ -+|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 7899999996 5888888554322 45788899999999999999999998 9999999999999999999999999
Q ss_pred cccccCCC
Q 005669 665 LARSFGLD 672 (684)
Q Consensus 665 la~~~~~~ 672 (684)
+|+.+.-+
T Consensus 166 lAra~~ip 173 (323)
T KOG0594|consen 166 LARAFSIP 173 (323)
T ss_pred hHHHhcCC
Confidence 99987643
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=228.06 Aligned_cols=148 Identities=31% Similarity=0.502 Sum_probs=128.5
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--------------cccHHHHHHHHHHHhccCCCceeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--------------GQGMEEFKNEVLLIAKLQHRNLVKLL 579 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--------------~~~~~~~~~Ei~~l~~l~H~nIv~l~ 579 (684)
..++|++.+.||+|.||.|-+|+.. +++.||||++.+.. ....+..++|+.+|++++|+|||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4578999999999999999999975 48999999997541 11235788999999999999999999
Q ss_pred EEEEeC--CeeEEEEEccCCCChhHHHhccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 005669 580 GCCTQR--DERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (684)
Q Consensus 580 g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~ 656 (684)
.+..+. +.+|||+|||..|.+... ..... +.+.++..++.+++.||+|||.++ ||||||||+|+||+++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 998764 568999999999888533 22334 899999999999999999999999 99999999999999999
Q ss_pred cEEEEeecccccc
Q 005669 657 NPKISDFGLARSF 669 (684)
Q Consensus 657 ~vkI~DFGla~~~ 669 (684)
++||+|||.+..+
T Consensus 248 ~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 248 TVKISDFGVSNEF 260 (576)
T ss_pred cEEeeccceeeec
Confidence 9999999999877
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=230.18 Aligned_cols=161 Identities=32% Similarity=0.527 Sum_probs=137.5
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhc--cCCCceeeEEEEEEeCC----eeE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK--LQHRNLVKLLGCCTQRD----ERM 589 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~~~----~~~ 589 (684)
....+..+.||+|.||.||||.+. ++.||||++.. +....|++|-.+.+. ++|+||+++++.-.... +++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 445666789999999999999984 59999999974 345667777666554 68999999999987666 789
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCceEecCCCCCcEEEcCCCcEEEEee
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS------RLRIIHRDLKASNVLLDNTMNPKISDF 663 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~------~~~IvHrDLkp~NILl~~~~~vkI~DF 663 (684)
||+||.+.|+|.++|. ...++|....+|+..+++||+|||+.- +++|+|||||.+||||.+|++..|+||
T Consensus 285 LVt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999993 456899999999999999999999753 458999999999999999999999999
Q ss_pred ccccccCCCCCccCCcccccC
Q 005669 664 GLARSFGLDQTEANTKRVVGT 684 (684)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~GT 684 (684)
|+|.++........+..-+||
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT 381 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGT 381 (534)
T ss_pred ceeEEecCCCCCcchhhhhhh
Confidence 999999877766666666776
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=233.34 Aligned_cols=160 Identities=31% Similarity=0.507 Sum_probs=143.2
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
...|...++||+|+.|.||.+... .++.||||++........+-+.+|+.+|+..+|+|||.++..+..+++.++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 356777789999999999999865 4889999999887666667789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~~ 674 (684)
|++|+|.+.+. ...+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+...+.
T Consensus 352 m~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999988873 345899999999999999999999999 99999999999999999999999999999987765
Q ss_pred ccCCcccccC
Q 005669 675 EANTKRVVGT 684 (684)
Q Consensus 675 ~~~~~~~~GT 684 (684)
.+ .+++||
T Consensus 425 KR--~TmVGT 432 (550)
T KOG0578|consen 425 KR--STMVGT 432 (550)
T ss_pred cc--ccccCC
Confidence 43 357887
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-25 Score=213.25 Aligned_cols=162 Identities=31% Similarity=0.455 Sum_probs=139.6
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
..++|++.+.||+|.||.||.|+.+. +..||+|++.+. ..+...++++|+++-..|+||||+++++++.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 34678999999999999999999765 678999998764 23345689999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++||...|.+...|... +...+++.....++.|+|.||.|+|..+ +|||||||+|+|++.++.+||+|||-+-.-.
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999998542 3556899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCCccCCcccccC
Q 005669 671 LDQTEANTKRVVGT 684 (684)
Q Consensus 671 ~~~~~~~~~~~~GT 684 (684)
.. ..++++||
T Consensus 176 --~~--kR~tlcgt 185 (281)
T KOG0580|consen 176 --SN--KRKTLCGT 185 (281)
T ss_pred --CC--Cceeeecc
Confidence 22 23346666
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=191.29 Aligned_cols=113 Identities=46% Similarity=0.752 Sum_probs=99.0
Q ss_pred CcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEEecCCCCeE
Q 005669 52 QSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTV 131 (684)
Q Consensus 52 ~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l~~~~~~~~ 131 (684)
+.|..|+.|+|+++.|++|||.+... ..+.+|||...+ +++||+|||+.|+.+ ++.|.|+. ||+|+|++.+|.++
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~-~~~l~l~~--dGnLvl~~~~g~~v 76 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSD-SCTLTLQS--DGNLVLYDGDGRVV 76 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCC-CEEEEEeC--CCCEEEEeCCCCEE
Confidence 56788999999999999999998743 578999999876 789999999999875 48899988 99999999999999
Q ss_pred EEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccC
Q 005669 132 WSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDY 173 (684)
Q Consensus 132 w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~ 173 (684)
|+|++.......+|+|+|+|||||++. .+.++||||||
T Consensus 77 W~S~t~~~~~~~~~~L~ddGnlvl~~~----~~~~~W~Sf~~ 114 (114)
T smart00108 77 WSSNTTGANGNYVLVLLDDGNLVIYDS----DGNFLWQSFDY 114 (114)
T ss_pred EEecccCCCCceEEEEeCCCCEEEECC----CCCEEeCCCCC
Confidence 999986334567899999999999987 46799999997
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=233.33 Aligned_cols=148 Identities=35% Similarity=0.512 Sum_probs=130.8
Q ss_pred CCCCccceecccCcEeEEEEEeeCC----cE-EEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCee
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEG----QE-IAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g----~~-vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 588 (684)
++....++||+|+||.||+|.+... .. ||||..+.. ......++.+|+++|++++|||||+++|++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 3444558999999999999997542 23 899998752 355678899999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
+||||+|.||+|+++|.+.. ..++..++..++.+.|.||+|||+++ +|||||..+|+|++.++.+||+|||+++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 99999999999999995432 36999999999999999999999998 99999999999999999999999999876
Q ss_pred c
Q 005669 669 F 669 (684)
Q Consensus 669 ~ 669 (684)
-
T Consensus 312 ~ 312 (474)
T KOG0194|consen 312 G 312 (474)
T ss_pred C
Confidence 4
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=219.50 Aligned_cols=166 Identities=24% Similarity=0.360 Sum_probs=142.7
Q ss_pred hcCCCCccceecccCcEeEEEEEe-eCCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
..+.|+..+.||.|..++||+|+. +.++.||||++..+. ....+.+++|+..|+.++||||++++..|..++..|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 346799999999999999999986 458999999998553 334689999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
.||.+|++.++++... ...+++..+..|++++++||.|||++| .||||||+.||||+++|.|||+|||.+..+-..
T Consensus 104 pfMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999996543 345899999999999999999999999 999999999999999999999999987776444
Q ss_pred CCccCC--cccccC
Q 005669 673 QTEANT--KRVVGT 684 (684)
Q Consensus 673 ~~~~~~--~~~~GT 684 (684)
..+... ++++||
T Consensus 180 G~R~~~rf~tfvgt 193 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGT 193 (516)
T ss_pred CceeeEeeccccCc
Confidence 333211 345665
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-24 Score=227.11 Aligned_cols=152 Identities=32% Similarity=0.488 Sum_probs=129.1
Q ss_pred cCCCCccceecccCcEeEEEEEee------CCcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCC-
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD- 586 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~- 586 (684)
.++|++.++||+|+||.||+|... .++.||||++.... ......+.+|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 467889999999999999999742 24689999987542 23345788999999999 8999999999987654
Q ss_pred eeEEEEEccCCCChhHHHhccCC---------------------------------------------------------
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTR--------------------------------------------------------- 609 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 609 (684)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999998864211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 610 --SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 610 --~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
...+++.++..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~ 225 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY 225 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccc
Confidence 134788899999999999999999988 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=221.27 Aligned_cols=151 Identities=32% Similarity=0.541 Sum_probs=130.4
Q ss_pred CCCCccceecccCcEeEEEEEeeC-----------------CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-----------------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKL 578 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l 578 (684)
++|...++||+|+||.||++...+ +..||+|.+.... .....++.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568888999999999999997532 3369999987642 3345678999999999999999999
Q ss_pred EEEEEeCCeeEEEEEccCCCChhHHHhccC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 005669 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTT----------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642 (684)
Q Consensus 579 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvH 642 (684)
++++.+.+..++||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885421 1134688899999999999999999998 999
Q ss_pred cCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 643 RDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 643 rDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|||||+|||+++++.+||+|||+++.+.
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~ 189 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLY 189 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecc
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-24 Score=228.99 Aligned_cols=148 Identities=26% Similarity=0.395 Sum_probs=132.4
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|+..+.||+|+||+||++.... ++.+|+|++++.. ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 468889999999999999998754 8899999987531 233456788999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||+++++|.+++.. ...+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999843 356899999999999999999999998 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=228.65 Aligned_cols=154 Identities=23% Similarity=0.265 Sum_probs=135.1
Q ss_pred HHHhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 005669 511 IIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD 586 (684)
Q Consensus 511 ~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 586 (684)
.+....++|+..+.||+|+||.||++.... ++.+|+|.+.+. .......+.+|+.+++.++||||+++++.+..++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 344456789999999999999999999865 789999998642 2223456788999999999999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
..++||||+++++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 99999999999999998842 34788999999999999999999998 999999999999999999999999999
Q ss_pred cccCC
Q 005669 667 RSFGL 671 (684)
Q Consensus 667 ~~~~~ 671 (684)
+.+..
T Consensus 190 ~~~~~ 194 (370)
T cd05621 190 MKMDE 194 (370)
T ss_pred eeccc
Confidence 88743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=227.54 Aligned_cols=153 Identities=32% Similarity=0.523 Sum_probs=134.8
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
+...+.++||+|.||.|.++....+..||||+++..... ...+|.+|+++|.+++||||++++|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 445677899999999999999877899999999976443 4588999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
++|+|.+++.+.... .+..+...+|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||++|-+-..+
T Consensus 618 EnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred hcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999654322 2456667789999999999999987 9999999999999999999999999999664433
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=229.01 Aligned_cols=147 Identities=27% Similarity=0.371 Sum_probs=131.1
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|++.++||+|+||.||++... +++.||||++.+. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999875 4889999998643 2234567888999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999998843 356889999999999999999999998 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-24 Score=229.27 Aligned_cols=163 Identities=29% Similarity=0.434 Sum_probs=141.9
Q ss_pred HhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCe
Q 005669 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 513 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 587 (684)
....++|...++||+|.||+|+++..+. ++.+|||.+++. .....+..+.|.+++... +||.++.++..+++.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3455789999999999999999999865 788999999876 345667788899888887 59999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.|+||||+.||++..+ .....+++..+..++..|+.||+|||+++ |||||||.+|||||.+|.+||+|||++|
T Consensus 444 l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999995333 34467999999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCccCCcccccC
Q 005669 668 SFGLDQTEANTKRVVGT 684 (684)
Q Consensus 668 ~~~~~~~~~~~~~~~GT 684 (684)
.-.... ..|.+++||
T Consensus 517 e~m~~g--~~TsTfCGT 531 (694)
T KOG0694|consen 517 EGMGQG--DRTSTFCGT 531 (694)
T ss_pred ccCCCC--CccccccCC
Confidence 754333 357789998
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=224.38 Aligned_cols=148 Identities=26% Similarity=0.418 Sum_probs=132.6
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|++.+.||+|+||.||+|.... ++.||+|+++... ......+.+|+.++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 468889999999999999999865 8899999987531 233456888999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 99999999999843 346889999999999999999999998 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-24 Score=220.70 Aligned_cols=155 Identities=32% Similarity=0.492 Sum_probs=132.1
Q ss_pred cceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005669 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 598 (684)
.+.||+|.||+||-|+++. |+.||||.+.+. ......++++|+.+|++++||.||.+...|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 3789999999999999764 999999999865 2344578999999999999999999999999999999999999876
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCcEEEEeeccccccCCCCCc
Q 005669 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGLARSFGLDQTE 675 (684)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~---~~~vkI~DFGla~~~~~~~~~ 675 (684)
-|+-+| . ....+|++.....++.||+.||.|||.++ |+|+||||+|||+.+ --.+||+|||+||++++..-
T Consensus 649 MLEMIL-S-sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 649 MLEMIL-S-SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred HHHHHH-H-hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 665555 3 33467899999999999999999999999 999999999999964 34699999999999975543
Q ss_pred cCCcccccC
Q 005669 676 ANTKRVVGT 684 (684)
Q Consensus 676 ~~~~~~~GT 684 (684)
.+.++||
T Consensus 723 --RrsVVGT 729 (888)
T KOG4236|consen 723 --RRSVVGT 729 (888)
T ss_pred --hhhhcCC
Confidence 3356776
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.9e-24 Score=228.24 Aligned_cols=148 Identities=28% Similarity=0.406 Sum_probs=132.7
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|+..+.||+|+||.||++.... ++.||||++... .......+.+|+.++..++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 468889999999999999999764 889999998753 1233456788999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999843 346899999999999999999999998 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=228.06 Aligned_cols=146 Identities=25% Similarity=0.406 Sum_probs=130.6
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.|+..+.||+|+||+||++.... ++.+|+|++.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57888999999999999998754 7899999987532 2345678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
|+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 9999999999843 345889999999999999999999988 999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-24 Score=233.09 Aligned_cols=160 Identities=31% Similarity=0.460 Sum_probs=137.2
Q ss_pred CCccceecccCcEeEEEEEeeC-CcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC------eeEE
Q 005669 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ERML 590 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~l 590 (684)
|...+.||+|+||.||+++.+. |+.||||.++.. .....+...+|+++|++++|+|||++++.-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4556789999999999999654 999999999864 3445677889999999999999999999876544 4689
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc--CCC--cEEEEeeccc
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NTM--NPKISDFGLA 666 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~--~~~--~vkI~DFGla 666 (684)
|||||.+|+|...|.+......|++.+.+.+..++..||.|||+++ |+||||||.||++- .+| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999987777778999999999999999999999998 99999999999993 334 4799999999
Q ss_pred cccCCCCCccCCcccccC
Q 005669 667 RSFGLDQTEANTKRVVGT 684 (684)
Q Consensus 667 ~~~~~~~~~~~~~~~~GT 684 (684)
|.++++. ....++||
T Consensus 172 rel~d~s---~~~S~vGT 186 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGT 186 (732)
T ss_pred ccCCCCC---eeeeecCc
Confidence 9987554 34567887
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=223.88 Aligned_cols=149 Identities=26% Similarity=0.372 Sum_probs=133.2
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|++.+.||+|+||.||++.... ++.||+|.+... .....+.+.+|+.++++++||||+++++.+..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 578889999999999999999864 789999998743 1233567889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999998843 346889999999999999999999998 99999999999999999999999999987643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=238.88 Aligned_cols=152 Identities=36% Similarity=0.580 Sum_probs=134.8
Q ss_pred cCCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 588 (684)
..+.+..++||+|+||+||+|+... ...||||.++..... ...+|++|++++..++|||||+++|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 3455667899999999999998643 357999999976554 778999999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTR-----------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN 657 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~ 657 (684)
++|+|||..|+|.++|..... ...|+..+.+.|+.|||.||.||-++. +|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 999999999999999964221 223889999999999999999999987 999999999999999999
Q ss_pred EEEEeeccccccC
Q 005669 658 PKISDFGLARSFG 670 (684)
Q Consensus 658 vkI~DFGla~~~~ 670 (684)
|||+|||++|.+-
T Consensus 642 VKIsDfGLsRdiY 654 (774)
T KOG1026|consen 642 VKISDFGLSRDIY 654 (774)
T ss_pred EEecccccchhhh
Confidence 9999999999764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=229.32 Aligned_cols=147 Identities=33% Similarity=0.569 Sum_probs=131.0
Q ss_pred hcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
..+.+.+.+.||+|.||+||+|.+. -.||||.++.. .....+.|++|+.++++.+|.||+-+.|+|..+.. .||+
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred CHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 3445567789999999999999984 37999999865 34567889999999999999999999999998777 9999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
.+|+|.+|..+|+.. ...++..+.+.|+.||++||.|||.++ |||||||..||++.+++.|||+|||+|..-
T Consensus 467 qwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred hhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeee
Confidence 999999999998543 356899999999999999999999999 999999999999999999999999999764
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=226.68 Aligned_cols=147 Identities=24% Similarity=0.407 Sum_probs=130.8
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
.+|++.++||+|+||.||++.... ++.||||.+.... ......+.+|++++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 368899999999999999999754 8899999986431 223456889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|..+
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999999843 346889999999999999999999998 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=221.11 Aligned_cols=141 Identities=27% Similarity=0.346 Sum_probs=125.7
Q ss_pred ceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005669 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 598 (684)
+.||+|+||.||++... +++.||+|+++.. .......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 4889999998753 2233456788999999999999999999999999999999999999
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 99888843 356899999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=223.17 Aligned_cols=149 Identities=26% Similarity=0.348 Sum_probs=132.3
Q ss_pred cCCCCccceecccCcEeEEEEEeeC--CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
.++|+..+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4578899999999999999998654 368999998643 22345678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999843 346899999999999999999999998 9999999999999999999999999998764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-24 Score=234.29 Aligned_cols=151 Identities=32% Similarity=0.536 Sum_probs=135.7
Q ss_pred CCCccceecccCcEeEEEEEeeC----CcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
...+.+.||.|.||.|++|+++- ...||||.++.. .+....+|+.|+.+|.+++||||++|.|+.......+||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34567899999999999999754 347999999876 3455678999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|||++|+|+.+|+.. ...+.+.+...++++|+.||+||-+.+ .|||||.++|||++.+..+|++|||++|.+.++
T Consensus 710 EyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 999999999999654 345899999999999999999999998 999999999999999999999999999988655
Q ss_pred C
Q 005669 673 Q 673 (684)
Q Consensus 673 ~ 673 (684)
.
T Consensus 785 ~ 785 (996)
T KOG0196|consen 785 P 785 (996)
T ss_pred C
Confidence 5
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=220.19 Aligned_cols=148 Identities=25% Similarity=0.356 Sum_probs=132.1
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888899999999999999976 48899999986432 233456889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 99999999999843 346899999999999999999999998 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=217.93 Aligned_cols=150 Identities=31% Similarity=0.477 Sum_probs=123.9
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe-----eEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE-----RMLI 591 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~-----~~lV 591 (684)
.|...+++|.|+||.||+|...+ +++||||++-.+.+ .-.+|+++|++++|||||++.-+|..... ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46667899999999999999866 68999999875432 22469999999999999999998865332 3489
Q ss_pred EEccCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CcEEEEeecccccc
Q 005669 592 YEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGLARSF 669 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~-~~vkI~DFGla~~~ 669 (684)
||||+ .+|.+.+... ..+..++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99998 4787777532 22456888889999999999999999988 9999999999999965 89999999999999
Q ss_pred CCCCCc
Q 005669 670 GLDQTE 675 (684)
Q Consensus 670 ~~~~~~ 675 (684)
..++..
T Consensus 177 ~~~epn 182 (364)
T KOG0658|consen 177 VKGEPN 182 (364)
T ss_pred ccCCCc
Confidence 765543
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=227.13 Aligned_cols=146 Identities=25% Similarity=0.409 Sum_probs=130.1
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.|+..++||+|+||.||++.... ++.+|+|++.... ......+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 57888999999999999999754 7899999987532 2334578899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
|+++|+|.+++.+ ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 9999999998843 346889999999999999999999998 999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=225.49 Aligned_cols=151 Identities=25% Similarity=0.280 Sum_probs=133.0
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
...++|+..++||+|+||.||++.... ++.+|+|.+.+. .......+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 345689999999999999999999764 789999998642 2233455788999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+||||+++|+|..++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999998843 34788899999999999999999998 999999999999999999999999999876
Q ss_pred CC
Q 005669 670 GL 671 (684)
Q Consensus 670 ~~ 671 (684)
..
T Consensus 193 ~~ 194 (370)
T cd05596 193 DA 194 (370)
T ss_pred cC
Confidence 53
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-23 Score=219.69 Aligned_cols=141 Identities=28% Similarity=0.370 Sum_probs=126.0
Q ss_pred ceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005669 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 598 (684)
+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999975 4889999998753 2234567788999999999999999999999999999999999999
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 99888743 346899999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-23 Score=230.01 Aligned_cols=152 Identities=19% Similarity=0.230 Sum_probs=133.4
Q ss_pred CCCccceecccCcEeEEEEEeeC--CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
.|...+.||+|++|.||++.... ++.||+|.+..........+++|+.+++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 48888999999999999998643 5778889876554455567888999999999999999999999999999999999
Q ss_pred CCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 596 PNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 596 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
++++|.+++... .....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999999887542 22446889999999999999999999988 999999999999999999999999999987543
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=224.09 Aligned_cols=156 Identities=22% Similarity=0.264 Sum_probs=136.2
Q ss_pred HHHHHhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 005669 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ 584 (684)
Q Consensus 509 ~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 584 (684)
..++....++|++.+.||+|+||.||++.... ++.+|+|.+.+. .......+.+|+.+++.++||||+++++.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 34455566899999999999999999999864 789999998642 22234557889999999999999999999999
Q ss_pred CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
++..++||||+++++|..++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999998843 34788899999999999999999998 9999999999999999999999999
Q ss_pred cccccCC
Q 005669 665 LARSFGL 671 (684)
Q Consensus 665 la~~~~~ 671 (684)
+|+.+..
T Consensus 188 ~a~~~~~ 194 (371)
T cd05622 188 TCMKMNK 194 (371)
T ss_pred ceeEcCc
Confidence 9988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=213.76 Aligned_cols=148 Identities=30% Similarity=0.429 Sum_probs=130.2
Q ss_pred CCccceecccCcEeEEEEEee-CCcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 677889999999999999875 58999999986432 22334678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++++|...+... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIP 153 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence 9999998887532 2346899999999999999999999998 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-23 Score=221.82 Aligned_cols=148 Identities=27% Similarity=0.403 Sum_probs=132.1
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|+..+.||+|+||.||++.... ++.||+|++... .......+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468888999999999999999764 889999998643 2234567888999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999843 346899999999999999999999998 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=219.55 Aligned_cols=150 Identities=24% Similarity=0.304 Sum_probs=132.6
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|++.+.||+|+||.||++.... ++.||+|.+.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468889999999999999999764 889999998642 2233456888999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
||+++++|.+++.+. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999998432 346899999999999999999999998 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-23 Score=217.56 Aligned_cols=139 Identities=24% Similarity=0.311 Sum_probs=124.9
Q ss_pred ecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCCh
Q 005669 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (684)
Q Consensus 525 LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (684)
||+|+||.||++...+ ++.||+|.+... .......+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999864 789999998643 233456778899999999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~ 143 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLN 143 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccC
Confidence 998843 346899999999999999999999998 999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-23 Score=219.15 Aligned_cols=151 Identities=23% Similarity=0.283 Sum_probs=132.7
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|++.+.||+|+||.||++.... ++.||+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 478889999999999999999764 788999998642 1223455788999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998542 346889999999999999999999988 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=220.08 Aligned_cols=151 Identities=25% Similarity=0.340 Sum_probs=133.8
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|++.+.||+|+||.||++... +++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999975 48899999987532 234556888999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998543 246899999999999999999999998 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=219.26 Aligned_cols=141 Identities=26% Similarity=0.353 Sum_probs=125.5
Q ss_pred ceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005669 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 598 (684)
+.||+|+||.||++... +++.||+|.+... .......+.+|++++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999975 4889999998753 2233456778999999999999999999999999999999999999
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 99888743 346899999999999999999999998 999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=212.24 Aligned_cols=151 Identities=28% Similarity=0.456 Sum_probs=131.1
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccC--CCcccHHHHHHHHHHHhccCCCceeeEEEEEEe-----CC
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--GSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-----RD 586 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-----~~ 586 (684)
....|...+.||+|+||.|..+.... |+.||||++.. ......++..+|+++|+.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34566667899999999999999754 89999999873 345566788999999999999999999999865 34
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
..|+|+|+| ..+|...+. .+..++..++..++.||++||.|+|+.+ |+||||||+|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 579999999 478888883 3445999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCC
Q 005669 667 RSFGLD 672 (684)
Q Consensus 667 ~~~~~~ 672 (684)
|.....
T Consensus 173 R~~~~~ 178 (359)
T KOG0660|consen 173 RYLDKF 178 (359)
T ss_pred eecccc
Confidence 998643
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-23 Score=221.93 Aligned_cols=150 Identities=27% Similarity=0.409 Sum_probs=134.5
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|++.+.||+|+||.||++... +++.||+|++... .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999986 4889999998753 1234567889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 56899999999999999999999988 999999999999999999999999999887544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-23 Score=220.06 Aligned_cols=162 Identities=30% Similarity=0.428 Sum_probs=141.3
Q ss_pred HhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcc---cHHHHHHHHHHHhccC-CCceeeEEEEEEeCCe
Q 005669 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ---GMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDE 587 (684)
Q Consensus 513 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~ 587 (684)
......|+..+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||++++.+++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 3455778888999999999999999876 999999999865432 3468999999999998 9999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC----CCcEEEEee
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN----TMNPKISDF 663 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~----~~~vkI~DF 663 (684)
.++|||++.||.|.+.+... .+++.++..++.||+.+++|||+.+ |+||||||+|+|+.. ++.+|++||
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 99999999999999998654 3999999999999999999999988 999999999999953 357999999
Q ss_pred ccccccCCCCCccCCcccccC
Q 005669 664 GLARSFGLDQTEANTKRVVGT 684 (684)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~GT 684 (684)
|+|..+.. ......++||
T Consensus 184 Gla~~~~~---~~~~~~~~Gt 201 (382)
T KOG0032|consen 184 GLAKFIKP---GERLHTIVGT 201 (382)
T ss_pred CCceEccC---CceEeeecCC
Confidence 99999876 2234556776
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=222.97 Aligned_cols=162 Identities=25% Similarity=0.400 Sum_probs=141.7
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe-eEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE-RMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~lV~ 592 (684)
++|...+++|+|+||.++..+.+. ++.+++|++... .....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 578889999999999999998754 778999998754 33344567899999999999999999999999888 89999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+|++||+|.+.+.+.+ +..++++.+..++.|++.|+.|||++. |+|||||+.||+++.+..|||.|||+||.++.+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999996644 567899999999999999999999877 999999999999999999999999999999876
Q ss_pred CCccCCcccccC
Q 005669 673 QTEANTKRVVGT 684 (684)
Q Consensus 673 ~~~~~~~~~~GT 684 (684)
... ..+++||
T Consensus 160 ~~~--a~tvvGT 169 (426)
T KOG0589|consen 160 DSL--ASTVVGT 169 (426)
T ss_pred hhh--hheecCC
Confidence 533 3346776
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9e-23 Score=213.41 Aligned_cols=148 Identities=30% Similarity=0.486 Sum_probs=129.7
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
++|+..++||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999875 47899999987542 23345678999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++ +|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 985 88887743 2345789999999999999999999998 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=216.07 Aligned_cols=141 Identities=27% Similarity=0.352 Sum_probs=124.6
Q ss_pred ceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005669 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 598 (684)
+.||+|+||.||++... +++.||+|.+... .......+.+|+++++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 4889999998753 2233456788999999999999999999999999999999999999
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 99888743 3468999999999999999999997 56 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.6e-23 Score=217.69 Aligned_cols=148 Identities=26% Similarity=0.361 Sum_probs=129.6
Q ss_pred CCCccceecccCcEeEEEEEee----CCcEEEEEEccCC----CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCee
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG----SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 588 (684)
+|++.++||+|+||.||+++.. .++.||+|++.+. .....+.+.+|+.++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999998863 4789999998642 122345678899999999 599999999999999999
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++||||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999998843 345899999999999999999999998 99999999999999999999999999987
Q ss_pred cCC
Q 005669 669 FGL 671 (684)
Q Consensus 669 ~~~ 671 (684)
+..
T Consensus 155 ~~~ 157 (332)
T cd05614 155 FLS 157 (332)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.89 E-value=9e-23 Score=221.70 Aligned_cols=153 Identities=32% Similarity=0.446 Sum_probs=131.4
Q ss_pred cCCCCccceecccCcEeEEEEEee------CCcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCe
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 587 (684)
.++|+..++||+|+||.||++... .+..||||+++... ....+.+.+|+.++..+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 356888899999999999999742 25689999987542 33456788999999999 89999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCC----------------------------------------------------------
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTR---------------------------------------------------------- 609 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 609 (684)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999988854211
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 610 --------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 610 --------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
...+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 124788999999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=191.81 Aligned_cols=150 Identities=29% Similarity=0.505 Sum_probs=130.5
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.+|...++||+|.||+||+++..+ ++.||+|+++.. ++.-.....+|+-+++.++|.|||++++....+...-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 356777899999999999999766 788999988754 23335667899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
||. .+|..+... -++.++.+....++.|+++||.|.|+++ +.||||||.|.||+.+|.+|++|||+||.++-+
T Consensus 82 ~cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 82 FCD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred Hhh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 996 467666532 2456899999999999999999999998 999999999999999999999999999988754
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=211.81 Aligned_cols=149 Identities=25% Similarity=0.423 Sum_probs=130.8
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
++|++.+.||+|+||.||+++... ++.+|+|++.... ....+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 468889999999999999999864 7899999987542 2335678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|++++.+..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 999987765542 2346899999999999999999999988 99999999999999999999999999988643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=216.19 Aligned_cols=149 Identities=21% Similarity=0.277 Sum_probs=131.2
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|++.++||+|+||.||++.... ++.+|+|.+.+. .......+.+|+.++..++|++|+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468889999999999999999765 778999998642 1223345788999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||+++|+|.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 999999999998542 345899999999999999999999988 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=203.90 Aligned_cols=164 Identities=28% Similarity=0.452 Sum_probs=139.3
Q ss_pred HHhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC----cc----cHHHHHHHHHHHhcc-CCCceeeEEEE
Q 005669 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS----GQ----GMEEFKNEVLLIAKL-QHRNLVKLLGC 581 (684)
Q Consensus 512 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~----~~----~~~~~~~Ei~~l~~l-~H~nIv~l~g~ 581 (684)
....-++|...+.||.|..+.|-++.... +++.|+|++.... .. ..++-++|+.+|+++ -||+|+++.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 34455778889999999999999988754 8899999886431 11 134456799999998 59999999999
Q ss_pred EEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEE
Q 005669 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (684)
Q Consensus 582 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~ 661 (684)
++.+...++|+|.|+.|.|.++|. ..-.+++++..+|++|+..|+.|||.++ ||||||||+|||+|++.++||+
T Consensus 92 yes~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEe
Confidence 999999999999999999999993 3446899999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCCCccCCcccccC
Q 005669 662 DFGLARSFGLDQTEANTKRVVGT 684 (684)
Q Consensus 662 DFGla~~~~~~~~~~~~~~~~GT 684 (684)
|||+|..+.+.+. ...++||
T Consensus 166 DFGFa~~l~~Gek---LrelCGT 185 (411)
T KOG0599|consen 166 DFGFACQLEPGEK---LRELCGT 185 (411)
T ss_pred ccceeeccCCchh---HHHhcCC
Confidence 9999999976654 3345565
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=215.52 Aligned_cols=141 Identities=30% Similarity=0.435 Sum_probs=124.4
Q ss_pred ceecccCcEeEEEEEee----CCcEEEEEEccCC----CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 523 NKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG----SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+.||+|+||.||++... .++.||+|.++.. .......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999863 4789999998743 122345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+++++|.+++.. ...+.+..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 999999988843 345788899999999999999999998 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=223.01 Aligned_cols=147 Identities=31% Similarity=0.452 Sum_probs=133.0
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
.-|+..+.||.|+.|.|-.|++.. |+.+|||++.+.. ......+.+|+.+|+.+.|||+++++++++...++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 457888999999999999999754 9999999998652 223456789999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
||+++|.|.+++. +.+.+++.++.+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||||.+-
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE 162 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc
Confidence 9999999999983 4567999999999999999999999998 999999999999999999999999999864
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=212.73 Aligned_cols=149 Identities=32% Similarity=0.483 Sum_probs=129.5
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.++|++.++||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999986 488999999875432 233467889999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|++ ++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 996 567666643 2345889999999999999999999998 9999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=214.24 Aligned_cols=143 Identities=31% Similarity=0.352 Sum_probs=125.9
Q ss_pred ceecccCcEeEEEEEee----CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 523 NKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
+.||+|+||.||++... .++.+|+|++.... ......+.+|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999998752 47899999987532 2234557789999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++|.+++.+ ...+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 9999988843 346899999999999999999999998 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=220.16 Aligned_cols=153 Identities=34% Similarity=0.489 Sum_probs=131.1
Q ss_pred cCCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCe
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 587 (684)
.++|+..+.||+|+||.||++.... ++.||+|+++... ....+.+.+|+.+++.+ +|+||+++++++...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 3578889999999999999988532 3579999997542 23345688999999999 89999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccC-----------------------------------------------------------
Q 005669 588 RMLIYEYLPNKSLDYFIFDTT----------------------------------------------------------- 608 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 608 (684)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 609 --------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 609 --------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
....+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 0124788899999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=214.51 Aligned_cols=146 Identities=31% Similarity=0.396 Sum_probs=127.5
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCC-CceeeEEEEEEeCCeeEEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH-RNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~ 592 (684)
+|++.+.||+|+||.||+|...+ ++.||+|++... .....+.+..|.+++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788999999999999999765 679999998753 23345667889999999976 56888999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 99999999988843 345889999999999999999999998 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.6e-23 Score=209.86 Aligned_cols=149 Identities=27% Similarity=0.325 Sum_probs=134.0
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
+.|+.++.||.|.-|+||++++.+ +..+|+|++.+.. .....+...|-+||+.++||.++.||+.++.++..+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456777899999999999999876 5889999998752 334556778999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
|||+||+|..+.++ +..+.+++..+..++.+|+-||+|||-.| ||.|||||+||||.++|++-|+||.++...
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999887754 44678999999999999999999999998 999999999999999999999999999876
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=219.39 Aligned_cols=153 Identities=32% Similarity=0.445 Sum_probs=131.3
Q ss_pred cCCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCC-cccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCe
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDE 587 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~ 587 (684)
.++|.+.++||+|+||.||+|.... +..||||++.... ....+.+.+|+.+++++. ||||+++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4678889999999999999998532 3479999997543 233467899999999996 9999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCC----------------------------------------------------------
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTR---------------------------------------------------------- 609 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 609 (684)
.++||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999988854210
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC
Q 005669 610 -----------------------------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 654 (684)
Q Consensus 610 -----------------------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~ 654 (684)
...+++.++..++.||++||+|||+.+ |+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124788889999999999999999988 999999999999999
Q ss_pred CCcEEEEeeccccccCC
Q 005669 655 TMNPKISDFGLARSFGL 671 (684)
Q Consensus 655 ~~~vkI~DFGla~~~~~ 671 (684)
++.+||+|||+++.+..
T Consensus 273 ~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 273 GKIVKICDFGLARDIMH 289 (400)
T ss_pred CCEEEEEeCCcceeccc
Confidence 99999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=219.59 Aligned_cols=141 Identities=21% Similarity=0.323 Sum_probs=125.6
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.++|++.++||+|+||.||++.... ++.||+|.... ..+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 4679999999999999999999754 78999997542 3567899999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+. ++|..++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 96 677777733 345899999999999999999999998 999999999999999999999999999764
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=214.18 Aligned_cols=141 Identities=26% Similarity=0.392 Sum_probs=124.3
Q ss_pred ceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.||+|+||.||++.... ++.+|+|.+++. .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999764 789999998753 223345677888888776 899999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 999888743 346899999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-23 Score=229.04 Aligned_cols=154 Identities=29% Similarity=0.400 Sum_probs=134.1
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeCC-cEEEEEEccCCCcccHHHHHHHHHHHhccC-CCceeeEEEEE-Ee------
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIEG-QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCC-TQ------ 584 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~-~~------ 584 (684)
...-++++.+.|.+|||+.||.+....+ .++|+|++-..++...+.+++|+++|++|+ |+|||.+++.. ..
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3445677889999999999999998775 999999988778888899999999999997 99999999932 21
Q ss_pred CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
.-+++|.||||++|.|-+++.... ...|++.++++|+.++++|+++||... ++|||||||.+||||+.++..||+|||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rl-q~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRL-QTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHH-hccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 125789999999999999996533 344999999999999999999999985 789999999999999999999999999
Q ss_pred ccccc
Q 005669 665 LARSF 669 (684)
Q Consensus 665 la~~~ 669 (684)
-|.-.
T Consensus 192 Satt~ 196 (738)
T KOG1989|consen 192 SATTK 196 (738)
T ss_pred ccccc
Confidence 88654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=213.28 Aligned_cols=150 Identities=25% Similarity=0.338 Sum_probs=133.0
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.++|+..+.||+|+||.||++.... +..+|+|.+.... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4689999999999999999999764 7889999987542 2345678999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 9999999999843 345889999999999999999999853 39999999999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=218.07 Aligned_cols=145 Identities=28% Similarity=0.450 Sum_probs=126.6
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
++|+..++||+|+||.||++... +++.||||++.... ....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 44666789999999999999975 48999999986542 23356788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++++|... ...++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 154 ~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 154 MDGGSLEGT-------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 999998542 23567788899999999999999998 99999999999999999999999999987643
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=213.62 Aligned_cols=141 Identities=29% Similarity=0.452 Sum_probs=124.0
Q ss_pred ceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.||+|+||.||+|+... ++.||+|++... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999765 789999998753 223345677888888866 799999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
++|...+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceec
Confidence 999888843 346899999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=213.11 Aligned_cols=142 Identities=32% Similarity=0.439 Sum_probs=122.2
Q ss_pred ceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhc-cCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAK-LQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~-l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.||+|+||.||++...+ ++.||+|.++.. .....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999755 788999998753 12334455667777765 4899999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 999988843 346899999999999999999999988 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=213.09 Aligned_cols=147 Identities=31% Similarity=0.382 Sum_probs=127.4
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
+|+..+.||+|+||.||++.... ++.||+|.+.+.. ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47788999999999999998764 7799999987532 22334567788888777 5899999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||+++++|...+.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999988843 345899999999999999999999998 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=214.28 Aligned_cols=144 Identities=32% Similarity=0.471 Sum_probs=124.8
Q ss_pred CCccceecccCcEeEEEEEee-CCcEEEEEEccCCC---cccHHHHHHHHHHH---hccCCCceeeEEEEEEeCCeeEEE
Q 005669 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLI---AKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l---~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
|++.+.||+|+||.||++... +++.||||.++... ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999875 48899999987531 23345566676655 566899999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
|||+++++|...+. ...+++..+..++.||+.||+|||+++ |+||||||+||++++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 99999999988773 246899999999999999999999998 999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=214.06 Aligned_cols=140 Identities=25% Similarity=0.392 Sum_probs=124.5
Q ss_pred ceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.||+|+||.||++.... ++.||+|++++. .....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 469999999999999754 789999999753 223345678899999988 799999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccc
Confidence 999888743 356899999999999999999999998 99999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=207.37 Aligned_cols=144 Identities=35% Similarity=0.460 Sum_probs=126.0
Q ss_pred ecccCcEeEEEEEee-CCcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCCh
Q 005669 525 LGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (684)
Q Consensus 525 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (684)
||+|+||+||++... +++.+|+|.+.... ....+.+..|++++++++|+||+++++++..++..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 48899999986532 22345678899999999999999999999999999999999999999
Q ss_pred hHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 601 DYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 601 ~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
...+.... ....+++..+..++.||+.||.|||+++ |+||||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 88875432 3456899999999999999999999998 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=224.94 Aligned_cols=159 Identities=20% Similarity=0.292 Sum_probs=134.6
Q ss_pred HHHhhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-
Q 005669 511 IIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD- 586 (684)
Q Consensus 511 ~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~- 586 (684)
+.....++|.+.+.||+|+||+||++... +++.||||.+... .......+.+|+.++..++|+|+++++..+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34445679999999999999999999865 5899999998654 2334567889999999999999999988775432
Q ss_pred -------eeEEEEEccCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcE
Q 005669 587 -------ERMLIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (684)
Q Consensus 587 -------~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~v 658 (684)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 3679999999999999885432 2356899999999999999999999988 9999999999999999999
Q ss_pred EEEeeccccccCCC
Q 005669 659 KISDFGLARSFGLD 672 (684)
Q Consensus 659 kI~DFGla~~~~~~ 672 (684)
||+|||+++.+...
T Consensus 183 kL~DFGls~~~~~~ 196 (496)
T PTZ00283 183 KLGDFGFSKMYAAT 196 (496)
T ss_pred EEEecccCeecccc
Confidence 99999999887543
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-24 Score=209.92 Aligned_cols=159 Identities=30% Similarity=0.492 Sum_probs=140.5
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
+-|.++.+||+|+||.||++.+++ |+.+|||.+.. .....++.+|+.+|++++.+++|++||.+......++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 447778899999999999999876 99999999985 356788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCCCc
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~~~ 675 (684)
..|+..++++. +++.|.+.++..+++..++||+|||... -||||||+.|||++-+|.+||+|||.|-.+...-..
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 99999999843 4678999999999999999999999876 799999999999999999999999999887643332
Q ss_pred cCCcccccC
Q 005669 676 ANTKRVVGT 684 (684)
Q Consensus 676 ~~~~~~~GT 684 (684)
..+++||
T Consensus 186 --RNTVIGT 192 (502)
T KOG0574|consen 186 --RNTVIGT 192 (502)
T ss_pred --hCccccC
Confidence 3346776
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=212.55 Aligned_cols=141 Identities=28% Similarity=0.399 Sum_probs=121.4
Q ss_pred ceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHH-HHhccCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVL-LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.||+|+||.||++... +++.+|+|++... ......++..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 4889999998653 1223344555554 56779999999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 99988874 3456899999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=211.99 Aligned_cols=141 Identities=29% Similarity=0.398 Sum_probs=121.3
Q ss_pred ceecccCcEeEEEEEee-CCcEEEEEEccCCC---cccHHHHHHHHH-HHhccCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVL-LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.||+|+||+||++... +++.||+|++.... .....++.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999985 48899999987431 122334445544 56789999999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 999988843 446899999999999999999999998 999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=206.94 Aligned_cols=149 Identities=28% Similarity=0.464 Sum_probs=131.1
Q ss_pred cCCCCccceecccCcEeEEEEEee----CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ......+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888899999999999999864 25689999988642 2334578899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
||||+++++|.+++... ...+++.+++.++.||+.||+|||+++ ++||||||+||+++.++.+|++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998542 346899999999999999999999988 999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=213.65 Aligned_cols=146 Identities=24% Similarity=0.425 Sum_probs=125.7
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-----eeE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-----ERM 589 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~ 589 (684)
+|++.++||+|+||.||++... +++.||||++... ......++.+|+.++++++||||+++++++...+ ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999975 4889999998743 2233456889999999999999999999886432 479
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+||||++ ++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 688888733 345899999999999999999999998 999999999999999999999999999865
Q ss_pred C
Q 005669 670 G 670 (684)
Q Consensus 670 ~ 670 (684)
.
T Consensus 154 ~ 154 (338)
T cd07859 154 F 154 (338)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=213.10 Aligned_cols=150 Identities=23% Similarity=0.343 Sum_probs=132.2
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.++|+..++||+|+||.||++.... ++.+|+|.+... .....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4689999999999999999999764 788999988754 22334678999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+|+||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999999843 345889999999999999999999752 39999999999999999999999999998663
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=212.29 Aligned_cols=141 Identities=33% Similarity=0.486 Sum_probs=124.0
Q ss_pred ceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.||+|+||.||++.... ++.||+|++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999764 789999998753 223445677888888876 699999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 999988843 346899999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=233.27 Aligned_cols=151 Identities=35% Similarity=0.607 Sum_probs=134.6
Q ss_pred cCCCCccceecccCcEeEEEEEeeC--Cc----EEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE--GQ----EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~--g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 588 (684)
.++.+..+.||+|+||.||+|...+ +. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3455667899999999999999765 33 4899999876 456678899999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 589 MLIYEYLPNKSLDYFIFDTTR----SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
+|++|||++|+|..+|.+.+. ...+...+.+.++.|||+|+.||++++ +|||||..+|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999976422 356899999999999999999999998 9999999999999999999999999
Q ss_pred ccccc
Q 005669 665 LARSF 669 (684)
Q Consensus 665 la~~~ 669 (684)
|||.+
T Consensus 848 lArDi 852 (1025)
T KOG1095|consen 848 LARDI 852 (1025)
T ss_pred hhHhh
Confidence 99955
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=211.87 Aligned_cols=141 Identities=28% Similarity=0.378 Sum_probs=120.8
Q ss_pred ceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHH-HHhccCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVL-LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.||+|+||.||+++... ++.||+|.+.+.. .....++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999854 7899999986431 122334555544 67889999999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
++|...+.. ...+++.++..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 999888743 346888999999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-22 Score=203.71 Aligned_cols=150 Identities=31% Similarity=0.517 Sum_probs=135.1
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
.++|+..+.||+|++|.||++...+++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999998778899999987543 34577899999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999985432 346899999999999999999999988 9999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=212.18 Aligned_cols=147 Identities=30% Similarity=0.397 Sum_probs=127.2
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~ 592 (684)
+|+..+.||+|+||.||++.... ++.||+|++.+. .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 36677899999999999998754 889999998753 2233456778888888885 577888999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999988843 346899999999999999999999998 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=211.38 Aligned_cols=150 Identities=32% Similarity=0.571 Sum_probs=129.3
Q ss_pred CCCCccceecccCcEeEEEEEeeC-Cc----EEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
.+|+..+.||+|+||.||+|.+.. ++ .||+|.++... ....+++.+|+.+++.++|+||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468889999999999999998643 33 48999987542 33456788999999999999999999999764 5779
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999998542 345889999999999999999999998 9999999999999999999999999999875
Q ss_pred CC
Q 005669 671 LD 672 (684)
Q Consensus 671 ~~ 672 (684)
..
T Consensus 161 ~~ 162 (316)
T cd05108 161 AD 162 (316)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-22 Score=205.97 Aligned_cols=151 Identities=36% Similarity=0.558 Sum_probs=130.8
Q ss_pred CCCCccceecccCcEeEEEEEee-----CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
+.|+..+.||+|+||.||+|... .++.+++|.+.... ......+.+|+.++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 45777899999999999999852 35789999997532 3344678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 005669 591 IYEYLPNKSLDYFIFDTTR--------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~ 656 (684)
+|||+++++|.+++..... ...+++.++..++.|++.||.|||+++ |+|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999998853211 235788999999999999999999988 99999999999999999
Q ss_pred cEEEEeeccccccC
Q 005669 657 NPKISDFGLARSFG 670 (684)
Q Consensus 657 ~vkI~DFGla~~~~ 670 (684)
.+||+|||+++.+.
T Consensus 162 ~~kl~dfg~~~~~~ 175 (283)
T cd05090 162 HVKISDLGLSREIY 175 (283)
T ss_pred cEEecccccccccc
Confidence 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-22 Score=206.95 Aligned_cols=149 Identities=31% Similarity=0.441 Sum_probs=130.6
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
+|+..++||+|+||.||++... +++.||+|++.... ......+.+|+.++++++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999975 48899999987532 1223457789999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++.+.
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999887542 2346899999999999999999999998 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-22 Score=203.19 Aligned_cols=148 Identities=31% Similarity=0.499 Sum_probs=132.3
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
++|+..+.||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457778899999999999999888889999988643 3345678999999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+||++++++.+||+|||+++...
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 99999988532 235889999999999999999999998 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.4e-22 Score=203.25 Aligned_cols=149 Identities=26% Similarity=0.465 Sum_probs=134.0
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++|+||+++++.+..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357899999999999999999974 5789999998765445556788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 999999998843 346899999999999999999999988 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-22 Score=211.02 Aligned_cols=141 Identities=26% Similarity=0.373 Sum_probs=124.7
Q ss_pred ceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.||+|+||.||++.... ++.+|+|+++... ....+.+.+|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999755 7899999997542 23345678899999888 699999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 999888743 346899999999999999999999998 999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=205.48 Aligned_cols=152 Identities=30% Similarity=0.535 Sum_probs=138.0
Q ss_pred hcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
...+|+..++||+|+||.||+|...+++.+++|.+..........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568888999999999999999888899999999876555567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++++|.+++.+. ....+++.++..++.||+.||.|||+++ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcC
Confidence 9999999999553 3456899999999999999999999988 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-22 Score=210.95 Aligned_cols=141 Identities=28% Similarity=0.386 Sum_probs=120.0
Q ss_pred ceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHH-HHHhccCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEV-LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei-~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.||+|+||.||++.... ++.+|+|++.... ......+..|. .+++.++|+||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999764 6789999987531 12223344444 456788999999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
++|.+++.. ...+.+..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 999998843 345788888999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=214.68 Aligned_cols=153 Identities=29% Similarity=0.447 Sum_probs=136.3
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
.....|.+.+.||+|.|++|.++++.. +.+||||.+++... .....+.+|+++|..++|||||+++.+.+.....|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 455789999999999999999999754 89999999987532 233458899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+.+|.+.+++.+ .....+..+..++.|+.+|++|+|+++ |+|||||++||||+.+.++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999954 344666888999999999999999998 9999999999999999999999999999986
Q ss_pred CC
Q 005669 671 LD 672 (684)
Q Consensus 671 ~~ 672 (684)
..
T Consensus 207 ~~ 208 (596)
T KOG0586|consen 207 YG 208 (596)
T ss_pred cc
Confidence 43
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.88 E-value=8e-22 Score=202.43 Aligned_cols=149 Identities=32% Similarity=0.513 Sum_probs=132.7
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
++|...+.||+|+||.||++...++..+|+|.+... ....+++.+|+.++++++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 457788999999999999998877778999998753 3345678999999999999999999999999889999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 99999988542 236899999999999999999999998 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=203.31 Aligned_cols=151 Identities=34% Similarity=0.527 Sum_probs=135.1
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
.++|+..++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3578889999999999999999878889999998753 234578899999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999998543 2456888999999999999999999988 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.2e-22 Score=203.64 Aligned_cols=144 Identities=28% Similarity=0.454 Sum_probs=123.2
Q ss_pred ceecccCcEeEEEEEeeC---CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005669 523 NKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 598 (684)
++||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++|+||+++++.+......++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997644 3478888876432 233456889999999999999999999999999999999999999
Q ss_pred ChhHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 599 SLDYFIFDTTR--SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 599 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+|.+++..... ....++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 99999865432 233567888999999999999999998 999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.6e-22 Score=205.18 Aligned_cols=150 Identities=31% Similarity=0.533 Sum_probs=131.7
Q ss_pred CCCCccceecccCcEeEEEEEee-----CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeC--CeeE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERM 589 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 589 (684)
++|++.+.||+|+||.||++... .++.||+|.+........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 56888899999999999999742 4789999999876556667889999999999999999999987543 4578
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+|+||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998432 345899999999999999999999998 999999999999999999999999999976
Q ss_pred CC
Q 005669 670 GL 671 (684)
Q Consensus 670 ~~ 671 (684)
..
T Consensus 159 ~~ 160 (284)
T cd05081 159 PQ 160 (284)
T ss_pred cC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-22 Score=228.31 Aligned_cols=150 Identities=23% Similarity=0.337 Sum_probs=131.7
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|++.++||+|+||.||+|.... ++.||+|++.... ....+++.+|++++++++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 578999999999999999999764 8899999987532 223457889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 593 EYLPNKSLDYFIFDTTR--------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
||+++++|.+++..... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998854211 234567788999999999999999998 9999999999999999999999999
Q ss_pred ccccc
Q 005669 665 LARSF 669 (684)
Q Consensus 665 la~~~ 669 (684)
+|+..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99877
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-22 Score=210.17 Aligned_cols=141 Identities=32% Similarity=0.448 Sum_probs=123.0
Q ss_pred ceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.||+|+||.||++.... ++.||+|.++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999864 7899999987531 23345567788887754 899999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
++|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 999988843 346889999999999999999999998 999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.9e-22 Score=209.26 Aligned_cols=141 Identities=30% Similarity=0.460 Sum_probs=122.9
Q ss_pred ceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhc-cCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAK-LQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~-l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.||+|+||.||++...+ ++.||+|.++... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999765 7899999987531 2334556677788876 4899999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
++|..++.. ...+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 999998843 346889999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.3e-22 Score=207.86 Aligned_cols=148 Identities=30% Similarity=0.494 Sum_probs=129.0
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
++|...++||+|+||.||++.... ++.||+|.++... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 568889999999999999998754 7889999987542 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++ +|..++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence 985 777776432 345789999999999999999999998 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=204.77 Aligned_cols=151 Identities=34% Similarity=0.589 Sum_probs=133.1
Q ss_pred CCCCccceecccCcEeEEEEEee------CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888899999999999999852 245689999876655566789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEE
Q 005669 591 IYEYLPNKSLDYFIFDTT----------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI 660 (684)
+|||+++++|.+++.... ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999985432 1235899999999999999999999988 999999999999999999999
Q ss_pred EeeccccccC
Q 005669 661 SDFGLARSFG 670 (684)
Q Consensus 661 ~DFGla~~~~ 670 (684)
+|||+++.+.
T Consensus 162 ~dfg~~~~~~ 171 (288)
T cd05093 162 GDFGMSRDVY 171 (288)
T ss_pred ccCCcccccc
Confidence 9999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=201.53 Aligned_cols=149 Identities=32% Similarity=0.562 Sum_probs=132.1
Q ss_pred CCCCccceecccCcEeEEEEEeeC----CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
++|+..+.||+|+||.||+|.... ...||+|.++... .....++.+|+.++++++|+||+++++.+...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999998743 3579999987543 33346788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|||+++++|.+++... ...+++.++..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999998542 236899999999999999999999988 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=217.55 Aligned_cols=144 Identities=23% Similarity=0.283 Sum_probs=126.9
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
..+|.+.+.||+|+||.||++.... ++.||||.... ..+.+|++++++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999999865 78899996432 3457899999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+. ++|..++.. ....+++.++..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 96 677777743 2346899999999999999999999998 99999999999999999999999999987643
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=204.65 Aligned_cols=153 Identities=25% Similarity=0.465 Sum_probs=130.9
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 587 (684)
..++|++.++||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999997542 4589999887543 2234567889999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEE
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTR-------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI 660 (684)
.++||||+++++|.+++..... ...+++..+..++.|++.||.|||+++ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999864221 234567888999999999999999988 999999999999999999999
Q ss_pred EeeccccccC
Q 005669 661 SDFGLARSFG 670 (684)
Q Consensus 661 ~DFGla~~~~ 670 (684)
+|||+++.+.
T Consensus 161 ~Dfg~~~~~~ 170 (288)
T cd05061 161 GDFGMTRDIY 170 (288)
T ss_pred CcCCcccccc
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.9e-22 Score=213.70 Aligned_cols=147 Identities=27% Similarity=0.417 Sum_probs=127.6
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-----eeE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-----ERM 589 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~ 589 (684)
+|+..++||+|+||.||++... +++.||+|++... .....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999975 5899999998653 2233467889999999999999999999998776 789
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+|+||+. ++|.+.+. ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 56777663 3456899999999999999999999998 999999999999999999999999999876
Q ss_pred CC
Q 005669 670 GL 671 (684)
Q Consensus 670 ~~ 671 (684)
..
T Consensus 154 ~~ 155 (372)
T cd07853 154 EP 155 (372)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=203.59 Aligned_cols=150 Identities=27% Similarity=0.496 Sum_probs=123.7
Q ss_pred CCCCccceecccCcEeEEEEEee--CCcEEEEEEccCCC--cccHHHHHHHHHHHhcc---CCCceeeEEEEEEe-----
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI--EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKL---QHRNLVKLLGCCTQ----- 584 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~----- 584 (684)
++|++.+.||+|+||.||++... +++.||+|.++... ......+.+|+.+++++ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999873 36789999886532 22234566777777665 69999999999863
Q ss_pred CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
....++||||++ ++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345899999997 5888887442 2345899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCC
Q 005669 665 LARSFGL 671 (684)
Q Consensus 665 la~~~~~ 671 (684)
+++.+..
T Consensus 156 ~~~~~~~ 162 (290)
T cd07862 156 LARIYSF 162 (290)
T ss_pred ceEeccC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=203.56 Aligned_cols=153 Identities=27% Similarity=0.494 Sum_probs=131.3
Q ss_pred hcCCCCccceecccCcEeEEEEEee------CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 587 (684)
..++|+..+.||+|+||.||+|... .+..||+|.+.... .....++.+|+.+++.++|+||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998753 24679999986432 2334568899999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEE
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTR-------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI 660 (684)
.++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854321 234678889999999999999999988 999999999999999999999
Q ss_pred EeeccccccC
Q 005669 661 SDFGLARSFG 670 (684)
Q Consensus 661 ~DFGla~~~~ 670 (684)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05062 161 GDFGMTRDIY 170 (277)
T ss_pred CCCCCccccC
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=200.69 Aligned_cols=148 Identities=30% Similarity=0.490 Sum_probs=131.7
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
.+|+..+.||+|+||.||++....+..+|+|.+... ....+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 357788999999999999999877778999998653 2334678899999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVL 151 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecc
Confidence 99999998542 236899999999999999999999998 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=201.18 Aligned_cols=145 Identities=41% Similarity=0.651 Sum_probs=126.2
Q ss_pred ccceecccCcEeEEEEEee-----CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 521 EKNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 521 ~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
..+.||.|.||.||+|.+. .+..|+||.++... ....+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999987 25689999996532 33468899999999999999999999999988889999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+++|+|.++|... ....+++.++..|+.||++||.|||+++ ++|+||+|+||++++++.+||+|||+++..
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999999654 2456899999999999999999999988 999999999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=213.22 Aligned_cols=152 Identities=31% Similarity=0.455 Sum_probs=129.9
Q ss_pred cCCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCCc-ccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCe
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDE 587 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~ 587 (684)
.++|.+.++||+|+||.||++.+.+ ++.||+|+++.... ...+.+.+|+.++.++. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 3467778999999999999998532 46899999976432 22457889999999997 9999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCC----------------------------------------------------------
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTR---------------------------------------------------------- 609 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 609 (684)
.++|+||+++|+|.+++.....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999864311
Q ss_pred -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 005669 610 -------------------------------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (684)
Q Consensus 610 -------------------------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl 652 (684)
...+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 124677888999999999999999987 9999999999999
Q ss_pred cCCCcEEEEeeccccccC
Q 005669 653 DNTMNPKISDFGLARSFG 670 (684)
Q Consensus 653 ~~~~~vkI~DFGla~~~~ 670 (684)
++++.+||+|||+++.+.
T Consensus 273 ~~~~~~kL~DfGla~~~~ 290 (401)
T cd05107 273 CEGKLVKICDFGLARDIM 290 (401)
T ss_pred eCCCEEEEEecCcceecc
Confidence 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=207.92 Aligned_cols=141 Identities=34% Similarity=0.470 Sum_probs=124.4
Q ss_pred ceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.||+|+||.||++.... ++.||+|.+++. .......+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999765 789999998753 223445677888888887 799999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
++|...+.. ...+++.++..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 999888843 346899999999999999999999998 999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=202.87 Aligned_cols=142 Identities=19% Similarity=0.294 Sum_probs=124.8
Q ss_pred ceecccCcEeEEEEEeeCCcEEEEEEccCCCccc---HHHHHHHHHHHhccCCCceeeEEEEEEe----CCeeEEEEEcc
Q 005669 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG---MEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDERMLIYEYL 595 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~ 595 (684)
..|++|+++.||+|.. +++.||||.++...... .+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 68999999997643332 4678899999999999999999999877 34678999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
++|+|.+++.. ...+++..+..++.|++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+..
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 99999999843 34688999999999999999999984 5 88999999999999999999999999987543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=226.52 Aligned_cols=149 Identities=28% Similarity=0.374 Sum_probs=133.0
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.++|.+.++||+|+||.||+|... .++.||||+++... ......+.+|+.+++.++|+||+++++.+...+..++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367889999999999999999986 48899999987532 22346788899999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|||+++++|..++.. ...+++..++.++.||+.||.|||.++ |+||||||+||||+.++.+||+|||+++...
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~ 155 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence 999999999999843 345889999999999999999999988 9999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=213.62 Aligned_cols=147 Identities=32% Similarity=0.484 Sum_probs=127.6
Q ss_pred ccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCCh
Q 005669 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (684)
Q Consensus 521 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (684)
.++-||.|+.|.||+|++ .++.||||+++... ..+|+-|++|+|+||+.+.|+|....-++||||||..|.|
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 346899999999999998 56899999986432 3478889999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCCCccCCcc
Q 005669 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680 (684)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~~~~~~~~ 680 (684)
..+|. .+..+.......+..+||.||.|||.+. |||||||.-||||..+..+||+|||.++..... .....
T Consensus 200 ~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS 270 (904)
T KOG4721|consen 200 YEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS 270 (904)
T ss_pred HHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence 99994 4566888999999999999999999998 999999999999999999999999999987533 12234
Q ss_pred cccC
Q 005669 681 VVGT 684 (684)
Q Consensus 681 ~~GT 684 (684)
|.||
T Consensus 271 FaGT 274 (904)
T KOG4721|consen 271 FAGT 274 (904)
T ss_pred hhhh
Confidence 6665
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=208.59 Aligned_cols=139 Identities=26% Similarity=0.359 Sum_probs=119.4
Q ss_pred ecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhcc---CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL---QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 525 LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
||+|+||.||++.... ++.||+|++.... .........|..++.+. +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999754 8899999986431 12233445566666655 699999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
++|..++.+ ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 999888843 456899999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=202.24 Aligned_cols=151 Identities=38% Similarity=0.632 Sum_probs=131.2
Q ss_pred CCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
++|+..+.||+|+||.||+|.... ...||+|.+.... .....++.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998644 2579999987543 233567899999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 005669 590 LIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~ 656 (684)
++|||+++++|.+++..... ...+++.++..++.|++.||.|||+++ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999864321 145889999999999999999999998 99999999999999999
Q ss_pred cEEEEeeccccccC
Q 005669 657 NPKISDFGLARSFG 670 (684)
Q Consensus 657 ~vkI~DFGla~~~~ 670 (684)
.+||+|||+++...
T Consensus 162 ~~~L~dfg~~~~~~ 175 (283)
T cd05048 162 TVKISDFGLSRDIY 175 (283)
T ss_pred cEEECCCcceeecc
Confidence 99999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=201.55 Aligned_cols=148 Identities=26% Similarity=0.495 Sum_probs=133.3
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
++|+..++||+|+||.||++.... ++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 578888999999999999998754 8899999987655455567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++++|.+++.. ...+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+.
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 99999998843 346899999999999999999999998 9999999999999999999999999997664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-23 Score=212.03 Aligned_cols=160 Identities=27% Similarity=0.460 Sum_probs=141.2
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
..|...+.||+|+||.||+|.+.. ++.||+|++... .....+.+++|+.++.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 356677899999999999999755 789999999865 344567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~~ 674 (684)
+.+|++.+.+ .....+++.++..|+++++.||.|||.++ .+|||||+.|||+..+|.+|++|||.+-.+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999988 33445688889999999999999999998 99999999999999999999999999998876554
Q ss_pred ccCCcccccC
Q 005669 675 EANTKRVVGT 684 (684)
Q Consensus 675 ~~~~~~~~GT 684 (684)
.. .+++||
T Consensus 167 rr--~tfvGT 174 (467)
T KOG0201|consen 167 RR--KTFVGT 174 (467)
T ss_pred cc--cccccc
Confidence 43 568887
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=202.69 Aligned_cols=152 Identities=33% Similarity=0.585 Sum_probs=133.1
Q ss_pred cCCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 588 (684)
.++|.+.+.||+|+||.||+|...+ ++.||+|.++..... ..+.+.+|++++++++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3467888999999999999998643 478999998765433 457899999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 005669 589 MLIYEYLPNKSLDYFIFDTT-----------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN 657 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~ 657 (684)
+++|||+++++|.+++.... ....+++.++..++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999986432 1245789999999999999999999998 999999999999999999
Q ss_pred EEEEeeccccccC
Q 005669 658 PKISDFGLARSFG 670 (684)
Q Consensus 658 vkI~DFGla~~~~ 670 (684)
+||+|||+++.+.
T Consensus 161 ~kl~d~g~~~~~~ 173 (280)
T cd05049 161 VKIGDFGMSRDVY 173 (280)
T ss_pred EEECCcccceecc
Confidence 9999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=200.33 Aligned_cols=145 Identities=31% Similarity=0.462 Sum_probs=124.3
Q ss_pred ceecccCcEeEEEEEeeC---CcEEEEEEccCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005669 523 NKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 598 (684)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998643 45799999875432 33457888999999999999999999999999999999999999
Q ss_pred ChhHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 599 SLDYFIFDTTR--SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 599 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+|.+++..... ....++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999864322 234677788899999999999999988 9999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=204.83 Aligned_cols=151 Identities=30% Similarity=0.488 Sum_probs=129.8
Q ss_pred CCCCccceecccCcEeEEEEEeeC---------------CcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE---------------GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLG 580 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~---------------g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g 580 (684)
++|++.++||+|+||.||++...+ ...||+|.+... .......+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987632 235899998754 2334567899999999999999999999
Q ss_pred EEEeCCeeEEEEEccCCCChhHHHhccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 005669 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTR---------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (684)
Q Consensus 581 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NIL 651 (684)
++...+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+++ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999998854211 124688999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEeeccccccC
Q 005669 652 LDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 652 l~~~~~vkI~DFGla~~~~ 670 (684)
+++++.+||+|||+++.+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~ 180 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLY 180 (295)
T ss_pred EcCCCcEEecccccccccc
Confidence 9999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=199.20 Aligned_cols=143 Identities=29% Similarity=0.501 Sum_probs=126.7
Q ss_pred ceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCCh
Q 005669 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (684)
+.||+|+||.||++... +++.+|+|.+.... ......+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999975 58899999876432 33456789999999999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
.+++.. ....+++.++..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 999843 2345889999999999999999999988 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-21 Score=204.42 Aligned_cols=148 Identities=25% Similarity=0.336 Sum_probs=130.7
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
++|++.+.||+|+||.||++.... +..+|+|.+.... .....++.+|++++++++||||+++++.+..++..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 468889999999999999998754 7889999886542 23345688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++++|.+++.. ...+++..+..++.|+++||.|||+. + ++|+||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 999999999843 35689999999999999999999974 5 9999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=213.79 Aligned_cols=145 Identities=23% Similarity=0.370 Sum_probs=126.9
Q ss_pred cCCCCccceecccCcEeEEEEEeeC---CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
..+|.+.++||+|+||.||++...+ ++.||+|.+... ....+|++++++++|+||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 3579999999999999999997543 578999988643 24568999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|++. ++|.+++ .....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 5777777 23456899999999999999999999998 999999999999999999999999999877543
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-21 Score=199.23 Aligned_cols=155 Identities=28% Similarity=0.425 Sum_probs=133.8
Q ss_pred HhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 513 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
+.+++++.....||+|+||.||++...+ +..|++|.+........+.+.+|+.++++++|+||+++++++..++..+++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 4456667667899999999999999654 778999998876556677899999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCcEEEEeeccccccC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSFG 670 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~-~~~vkI~DFGla~~~~ 670 (684)
+||+++++|..++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++..+.
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999854322212378888899999999999999988 999999999999976 6789999999998763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-21 Score=201.00 Aligned_cols=149 Identities=34% Similarity=0.563 Sum_probs=131.0
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+|+..+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999975 48899999986432 22346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++ ++|.+++........+++..+..++.||++||.|||+++ |+|+||||+||++++++.+||+|||+++..+
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 98 588888755444467899999999999999999999988 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=201.02 Aligned_cols=145 Identities=34% Similarity=0.554 Sum_probs=128.9
Q ss_pred CCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHH--HHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGME--EFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~--~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
|+..+.||+|+||+||++.... ++.+|+|.+......... ...+|+.++++++|+||+++++++...+..+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677899999999999999876 668999999876433222 3456999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
++++|.+++. ....+++.++..++.||++||.+||+++ |+|+||||+||++++++.++|+|||.+..+
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999985 3456899999999999999999999998 999999999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=200.15 Aligned_cols=150 Identities=31% Similarity=0.513 Sum_probs=133.4
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
.+|+..++||+|+||.||++...+ ++.||+|.+... ....+++.+|++++++++|+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 457778899999999999999765 789999998753 344567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
++++|.+++... ....+++..+..++.|+++||+|||+++ ++||||||+||++++++.+||+|||+++....
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999998543 2346899999999999999999999988 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=200.53 Aligned_cols=150 Identities=31% Similarity=0.513 Sum_probs=131.4
Q ss_pred CCCCccceecccCcEeEEEEEeeC----CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.+|++.+.||+|+||.||+|.... +..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 467888999999999999998642 3479999987542 23356789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++++|.+++... ...+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998542 345899999999999999999999988 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-21 Score=202.69 Aligned_cols=152 Identities=33% Similarity=0.498 Sum_probs=132.5
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-----------------CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-----------------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVK 577 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~ 577 (684)
.++|++.++||+|+||.||++...+ +..||+|.+.... ....+.+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999988643 2468999987543 334567889999999999999999
Q ss_pred EEEEEEeCCeeEEEEEccCCCChhHHHhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 005669 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTT--------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASN 649 (684)
Q Consensus 578 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~N 649 (684)
+++++..++..++++||+++++|.+++.... ....+++..+..++.|++.||+|||+++ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985432 1236899999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEeeccccccC
Q 005669 650 VLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 650 ILl~~~~~vkI~DFGla~~~~ 670 (684)
|++++++.+||+|||+++.+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred eeecCCCceEEccccceeecc
Confidence 999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-23 Score=200.93 Aligned_cols=150 Identities=31% Similarity=0.477 Sum_probs=130.9
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.++.|++.+.||+|.|+.||++... .|+.+|+|++... .....+++.+|+++.+.++||||++++....+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4577888899999999999999864 4889999887643 344678899999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCcEEEEeeccccc
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGLARS 668 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~---~~~vkI~DFGla~~ 668 (684)
+|+|.|+.|..-+.. ...+++..+...+.||+++|.|.|.++ |||||+||+|+|+.+ ..-+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999665532 245788999999999999999999999 999999999999953 34599999999999
Q ss_pred cC
Q 005669 669 FG 670 (684)
Q Consensus 669 ~~ 670 (684)
++
T Consensus 163 l~ 164 (355)
T KOG0033|consen 163 VN 164 (355)
T ss_pred eC
Confidence 87
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=202.35 Aligned_cols=149 Identities=32% Similarity=0.405 Sum_probs=133.0
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|+..+.||+|++|.||++.... ++.+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 468888999999999999999764 8899999986432 233567889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999843 356899999999999999999999988 99999999999999999999999999988643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.6e-23 Score=216.04 Aligned_cols=151 Identities=30% Similarity=0.482 Sum_probs=130.3
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
+-|+.++.||.|+||.||.+++.. .+.||||++.-... .....+..|+..|++++|||++.+.|++..+...+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 346777899999999999999754 67899999875433 33567899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|||- |+-.+++. ...+++.+.++..|..+.+.||+|||+++ .||||||+.|||+++.|.|||+|||.|.+..+.
T Consensus 106 EYCl-GSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 106 EYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHh-ccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 9996 45666652 22467889999999999999999999998 999999999999999999999999999988654
Q ss_pred C
Q 005669 673 Q 673 (684)
Q Consensus 673 ~ 673 (684)
.
T Consensus 180 n 180 (948)
T KOG0577|consen 180 N 180 (948)
T ss_pred h
Confidence 4
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=203.02 Aligned_cols=151 Identities=28% Similarity=0.478 Sum_probs=135.5
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
..++|+..+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 4468999999999999999999974 589999999976555556778899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|+++++|.+++.+ ..+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999998832 35789999999999999999999988 999999999999999999999999999876443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=209.26 Aligned_cols=152 Identities=31% Similarity=0.480 Sum_probs=128.0
Q ss_pred cCCCCccceecccCcEeEEEEEe------eCCcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC-C
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGML------IEGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR-D 586 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~-~ 586 (684)
.++|++.+.||+|+||.||+|.. ..++.||||+++... ......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999974 236789999997543 23345688999999999 689999999988654 4
Q ss_pred eeEEEEEccCCCChhHHHhccCC---------------------------------------------------------
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTR--------------------------------------------------------- 609 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 609 (684)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999998854210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 610 -------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 610 -------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
...+++.++..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 123678888999999999999999998 9999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=198.16 Aligned_cols=149 Identities=31% Similarity=0.527 Sum_probs=133.7
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
.++|+..+.||+|+||.||++... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888899999999999999864 78999999976533 5678999999999999999999999999989999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 9999999985432 236899999999999999999999998 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=201.78 Aligned_cols=150 Identities=33% Similarity=0.524 Sum_probs=129.2
Q ss_pred CCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
+|++.+.||+|+||.||+|.... ...+++|.+.... .....++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778999999999999998632 3578899887543 2335678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 005669 591 IYEYLPNKSLDYFIFDTT---------------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASN 649 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~N 649 (684)
++||+++++|.+++.... ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999885321 1235789999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEeeccccccC
Q 005669 650 VLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 650 ILl~~~~~vkI~DFGla~~~~ 670 (684)
||+++++.+||+|||+++.+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~ 178 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVY 178 (290)
T ss_pred EEEcCCCcEEecccccccccc
Confidence 999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=199.46 Aligned_cols=149 Identities=31% Similarity=0.558 Sum_probs=125.2
Q ss_pred CccceecccCcEeEEEEEeeCC-c--EEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC------Cee
Q 005669 520 SEKNKLGEGGFGPVYKGMLIEG-Q--EIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------DER 588 (684)
Q Consensus 520 ~~~~~LG~G~fG~Vy~~~~~~g-~--~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~ 588 (684)
.+.++||+|+||.||+|...+. + .+|+|.++.. .....+.+.+|+.++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4568899999999999997653 2 6899988753 234456788999999999999999999988542 246
Q ss_pred EEEEEccCCCChhHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecc
Q 005669 589 MLIYEYLPNKSLDYFIFDTT---RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGl 665 (684)
+++|||+++++|..++.... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874322 2345899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCC
Q 005669 666 ARSFGL 671 (684)
Q Consensus 666 a~~~~~ 671 (684)
++.+..
T Consensus 159 ~~~~~~ 164 (272)
T cd05075 159 SKKIYN 164 (272)
T ss_pred ccccCc
Confidence 987643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=202.58 Aligned_cols=152 Identities=32% Similarity=0.548 Sum_probs=132.6
Q ss_pred CCCCccceecccCcEeEEEEEee------CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
.+|...+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999853 245689999876555556779999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 005669 591 IYEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN 657 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~ 657 (684)
||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985432 1235899999999999999999999998 999999999999999999
Q ss_pred EEEEeeccccccCC
Q 005669 658 PKISDFGLARSFGL 671 (684)
Q Consensus 658 vkI~DFGla~~~~~ 671 (684)
+||+|||+++....
T Consensus 162 ~~l~dfg~a~~~~~ 175 (291)
T cd05094 162 VKIGDFGMSRDVYS 175 (291)
T ss_pred EEECCCCcccccCC
Confidence 99999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=200.63 Aligned_cols=153 Identities=25% Similarity=0.460 Sum_probs=132.4
Q ss_pred cCCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 588 (684)
.++|++.+.||+|+||.||++.... +..||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578888999999999999998753 3689999987543 23345788999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEE
Q 005669 589 MLIYEYLPNKSLDYFIFDTTR-------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~ 661 (684)
++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999854321 234788999999999999999999988 9999999999999999999999
Q ss_pred eeccccccCC
Q 005669 662 DFGLARSFGL 671 (684)
Q Consensus 662 DFGla~~~~~ 671 (684)
|||+++.+..
T Consensus 162 dfg~~~~~~~ 171 (277)
T cd05032 162 DFGMTRDIYE 171 (277)
T ss_pred Ccccchhhcc
Confidence 9999987643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=202.93 Aligned_cols=155 Identities=31% Similarity=0.505 Sum_probs=133.6
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCC-CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR 585 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 585 (684)
...++|+..+.||+|+||.||++...+ ...+|+|.+... ......++.+|+.++.++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 344678888999999999999998643 357999998754 223345688999999999 799999999999999
Q ss_pred CeeEEEEEccCCCChhHHHhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 005669 586 DERMLIYEYLPNKSLDYFIFDT-------------TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl 652 (684)
+..+++|||+++++|..++... .....+++..+..++.|++.||.|||+++ |+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999998542 12346899999999999999999999988 9999999999999
Q ss_pred cCCCcEEEEeeccccccCC
Q 005669 653 DNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 653 ~~~~~vkI~DFGla~~~~~ 671 (684)
++++.+||+|||+++.+..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 166 TEDHVMKIADFGLARDIHH 184 (293)
T ss_pred cCCCeEEeCcccccccccc
Confidence 9999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=202.67 Aligned_cols=151 Identities=30% Similarity=0.500 Sum_probs=130.4
Q ss_pred CCCCccceecccCcEeEEEEEee-----------------CCcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-----------------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKL 578 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-----------------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l 578 (684)
++|++.++||+|+||.||++... +...+|+|.+... .......+.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56889999999999999998532 1346899998754 23345678999999999999999999
Q ss_pred EEEEEeCCeeEEEEEccCCCChhHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcE
Q 005669 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTR--------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNV 650 (684)
Q Consensus 579 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NI 650 (684)
++++...+..+++|||+++++|.+++..... ...+++.++..++.|++.||+|||+.+ |+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999864321 134778899999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEeeccccccC
Q 005669 651 LLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 651 Ll~~~~~vkI~DFGla~~~~ 670 (684)
|+++++.+||+|||+++.+.
T Consensus 162 li~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred EEcCCCCEEeccCccccccc
Confidence 99999999999999998763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=203.84 Aligned_cols=154 Identities=31% Similarity=0.518 Sum_probs=132.3
Q ss_pred hcCCCCccceecccCcEeEEEEEee--------CCcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEe
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ 584 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~ 584 (684)
..++|.+.+.||+|+||.||++... ++..||+|.+.... ......+.+|+.+++.+ +|+||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3467888899999999999999742 23579999987532 33456788999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 005669 585 RDERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (684)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NIL 651 (684)
....+++|||+++++|.+++..... ...+++.++..++.||++||.|||+++ |+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999865321 235788999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEeeccccccCC
Q 005669 652 LDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 652 l~~~~~vkI~DFGla~~~~~ 671 (684)
+++++.+||+|||+++.+..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 170 VTENNVMKIADFGLARDVNN 189 (304)
T ss_pred EcCCCcEEECCCccceeccc
Confidence 99999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=208.61 Aligned_cols=152 Identities=32% Similarity=0.491 Sum_probs=128.3
Q ss_pred CCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC-Ce
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR-DE 587 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~ 587 (684)
++|++.+.||+|+||.||+|...+ ++.||+|+++... ....+.+.+|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 478889999999999999997432 4789999987532 22345678899999999 899999999988654 56
Q ss_pred eEEEEEccCCCChhHHHhccCC----------------------------------------------------------
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTR---------------------------------------------------------- 609 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 609 (684)
.++++||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999998853211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 610 SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 610 ~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 126789999999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=197.45 Aligned_cols=151 Identities=34% Similarity=0.559 Sum_probs=135.6
Q ss_pred hcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
..++|.+.++||+|+||.||++...+++.+|||.+... ....+++.+|+.++++++|+||+++++++......+++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 34678889999999999999999877889999998754 34457899999999999999999999999988899999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++++|.+++... ....+++.++..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||+++.+.
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceecc
Confidence 9999999998542 2346899999999999999999999998 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-21 Score=198.27 Aligned_cols=149 Identities=30% Similarity=0.516 Sum_probs=128.0
Q ss_pred CCccceecccCcEeEEEEEeeC----CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe-----
Q 005669 519 FSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE----- 587 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~----- 587 (684)
|++.+.||+|+||.||+|.... +..||+|+++... ....+.+.+|+..++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4667899999999999998753 3679999987532 2345678999999999999999999999876554
Q ss_pred -eEEEEEccCCCChhHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEee
Q 005669 588 -RMLIYEYLPNKSLDYFIFDTT---RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (684)
Q Consensus 588 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DF 663 (684)
.++++||+++++|..++.... ....+++..+..++.|++.||.|||+++ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999998885432 2346899999999999999999999988 999999999999999999999999
Q ss_pred ccccccC
Q 005669 664 GLARSFG 670 (684)
Q Consensus 664 Gla~~~~ 670 (684)
|+++.+.
T Consensus 158 g~~~~~~ 164 (273)
T cd05035 158 GLSKKIY 164 (273)
T ss_pred cceeecc
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=200.84 Aligned_cols=149 Identities=31% Similarity=0.495 Sum_probs=126.2
Q ss_pred CCCCccceecccCcEeEEEEEeeC-Cc----EEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
++|+..+.||+|+||.||+|.... ++ .+++|.+.... .....++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 467788999999999999998743 43 47888876432 233467788888999999999999999875 455788
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++||+++++|.+++... ...+++..+..++.||+.||.|||+++ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998542 346899999999999999999999988 9999999999999999999999999998764
Q ss_pred C
Q 005669 671 L 671 (684)
Q Consensus 671 ~ 671 (684)
.
T Consensus 161 ~ 161 (279)
T cd05111 161 P 161 (279)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=199.36 Aligned_cols=143 Identities=31% Similarity=0.439 Sum_probs=124.1
Q ss_pred ecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCCh
Q 005669 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (684)
Q Consensus 525 LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (684)
||+|+||.||++.... ++.+|+|.+.... ......+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999998754 8999999986421 12234556799999999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
..++... ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 8887543 2345889999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=201.05 Aligned_cols=149 Identities=32% Similarity=0.481 Sum_probs=134.5
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.++|++.++||+|+||.||++.... ++.+++|.+........+.+.+|+.++++++|+||+++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 3678899999999999999999765 789999999876666677889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+++++|..++.+. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence 9999998877432 345899999999999999999999988 999999999999999999999999998764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=200.78 Aligned_cols=154 Identities=27% Similarity=0.498 Sum_probs=133.4
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-----CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEe-CCe
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDE 587 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~ 587 (684)
..++|+..+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678889999999999999999866 6789999887542 3345678899999999999999999999876 467
Q ss_pred eEEEEEccCCCChhHHHhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEe
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRS-----KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISD 662 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~D 662 (684)
.++++||+++++|.+++...... ..+++.++..++.|++.||+|||+++ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998553322 46899999999999999999999988 99999999999999999999999
Q ss_pred eccccccCC
Q 005669 663 FGLARSFGL 671 (684)
Q Consensus 663 FGla~~~~~ 671 (684)
||+++.+..
T Consensus 161 ~g~~~~~~~ 169 (280)
T cd05043 161 NALSRDLFP 169 (280)
T ss_pred CCCcccccC
Confidence 999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=198.75 Aligned_cols=150 Identities=31% Similarity=0.514 Sum_probs=131.0
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
.++|.+.++||+|+||.||+|...+...||+|+++.. ....+++.+|+.++++++|+||+++++.+. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 3568889999999999999998877778999999753 234567899999999999999999999874 45679999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||.++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999999998542 2345789999999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=201.81 Aligned_cols=150 Identities=27% Similarity=0.433 Sum_probs=135.4
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.++|++.+.||+|+||.||++... +++.+|+|.+........+.+.+|++++++++|+||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467889999999999999999975 4789999998766555667889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++++|..++.+. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999988432 346899999999999999999999998 9999999999999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=199.57 Aligned_cols=150 Identities=26% Similarity=0.414 Sum_probs=132.1
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
++|+..+.||+|++|.||++.... ++.||+|++.... ....+.+.+|+.++++++|+|++++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468888999999999999999864 8899999886432 2234567899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|++++.|..++. ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999999888763 2345899999999999999999999988 999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-21 Score=200.39 Aligned_cols=148 Identities=30% Similarity=0.425 Sum_probs=129.4
Q ss_pred CCccceecccCcEeEEEEEee-CCcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
|+..+.||+|+||+||++... +++.+|+|.+.... ......+.+|++++++++|+|++++++.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999875 48899999986532 22234578899999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 9999999887542 2346899999999999999999999988 9999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=200.47 Aligned_cols=150 Identities=33% Similarity=0.546 Sum_probs=130.3
Q ss_pred CCCCccceecccCcEeEEEEEee-----CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeC--Cee
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DER 588 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 588 (684)
+.|++.++||+|+||.||++... .++.||+|.++... ......+.+|+.++++++|+|++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 45788899999999999999742 36789999987542 33456789999999999999999999999875 568
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++||||+++++|.+++.+. ...+++.++..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998432 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCC
Q 005669 669 FGL 671 (684)
Q Consensus 669 ~~~ 671 (684)
+..
T Consensus 159 ~~~ 161 (284)
T cd05079 159 IET 161 (284)
T ss_pred ccc
Confidence 743
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=201.71 Aligned_cols=150 Identities=27% Similarity=0.478 Sum_probs=134.6
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
...+|+..+.||+|++|.||++... +++.+++|.+........+.+.+|+.+++.++|+||+++++.+..+.+.++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 3467888999999999999999864 488999999886655556788999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|+++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++....
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999998832 34789999999999999999999998 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=199.16 Aligned_cols=152 Identities=33% Similarity=0.527 Sum_probs=132.2
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC------
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR------ 585 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~------ 585 (684)
.+++.|+..+.||+|+||.||+|...+ ++.+|+|.+... ......+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 456778888999999999999998754 788999998754 34456788999999998 799999999998753
Q ss_pred CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecc
Q 005669 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGl 665 (684)
...+++|||+++++|.+++... ....+++..+..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4579999999999999988542 3456899999999999999999999988 99999999999999999999999999
Q ss_pred ccccC
Q 005669 666 ARSFG 670 (684)
Q Consensus 666 a~~~~ 670 (684)
++.+.
T Consensus 158 ~~~~~ 162 (272)
T cd06637 158 SAQLD 162 (272)
T ss_pred ceecc
Confidence 98764
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=202.05 Aligned_cols=150 Identities=35% Similarity=0.549 Sum_probs=129.5
Q ss_pred CCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
+|++.++||+|+||.||+|...+ ++.||+|+++..... ..+.+.+|+.++.+++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46677899999999999998643 478999999754322 34568899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 005669 591 IYEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN 657 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~ 657 (684)
++||+++++|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999984221 1235788999999999999999999998 999999999999999999
Q ss_pred EEEEeeccccccC
Q 005669 658 PKISDFGLARSFG 670 (684)
Q Consensus 658 vkI~DFGla~~~~ 670 (684)
+||+|||+++.+.
T Consensus 163 ~kl~Dfg~~~~~~ 175 (283)
T cd05091 163 VKISDLGLFREVY 175 (283)
T ss_pred eEecccccccccc
Confidence 9999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=200.94 Aligned_cols=141 Identities=22% Similarity=0.343 Sum_probs=120.8
Q ss_pred eecccCcEeEEEEEeeC-------------------------CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeE
Q 005669 524 KLGEGGFGPVYKGMLIE-------------------------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578 (684)
Q Consensus 524 ~LG~G~fG~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l 578 (684)
.||+|+||.||+|.... ...|++|.+.........++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589999876544445678889999999999999999
Q ss_pred EEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC--
Q 005669 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-- 656 (684)
Q Consensus 579 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~-- 656 (684)
++++.+....++||||+++++|+.++... ...+++..+..++.||++||+|||+++ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999888432 346889999999999999999999988 99999999999997643
Q ss_pred -----cEEEEeecccccc
Q 005669 657 -----NPKISDFGLARSF 669 (684)
Q Consensus 657 -----~vkI~DFGla~~~ 669 (684)
.+|++|||+++..
T Consensus 157 ~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred cCccceeeecCCcccccc
Confidence 3899999988654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=197.04 Aligned_cols=148 Identities=30% Similarity=0.531 Sum_probs=131.1
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-----cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-----GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
++|+..+.||+|++|.||++... +++++|+|.+.... ......+.+|+.++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999875 48899999886432 1223568889999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998843 345889999999999999999999998 9999999999999999999999999998664
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-21 Score=199.89 Aligned_cols=148 Identities=31% Similarity=0.441 Sum_probs=129.5
Q ss_pred CCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
|+..+.||+|+||.||++.... ++.+|+|.+.... ......+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 6677899999999999999764 8899999986532 12234577899999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++++|.+++... ....+++.++..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++....
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 9999999888542 2345899999999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=197.72 Aligned_cols=152 Identities=24% Similarity=0.409 Sum_probs=132.7
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|++.+.||+|+||.||++... +++.||||.+... .......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999975 5889999987642 2233456889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
||+++++|.+++.... ....+++..+..++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875432 2345789999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=213.42 Aligned_cols=149 Identities=25% Similarity=0.441 Sum_probs=122.9
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeC--------
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-------- 585 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-------- 585 (684)
..++|+..+.||+|+||.||+|...+ ++.||||++.... ....+|+.++++++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 45679999999999999999999754 7899999886432 2345799999999999999999887432
Q ss_pred CeeEEEEEccCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-cEEEEee
Q 005669 586 DERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDF 663 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~-~vkI~DF 663 (684)
...++||||+++ +|.+++... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 236789999985 565655332 23456899999999999999999999998 99999999999998654 7999999
Q ss_pred ccccccCC
Q 005669 664 GLARSFGL 671 (684)
Q Consensus 664 Gla~~~~~ 671 (684)
|+|+.+..
T Consensus 216 Gla~~~~~ 223 (440)
T PTZ00036 216 GSAKNLLA 223 (440)
T ss_pred ccchhccC
Confidence 99997743
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=198.74 Aligned_cols=150 Identities=31% Similarity=0.528 Sum_probs=131.5
Q ss_pred CCCCccceecccCcEeEEEEEeeC-C---cEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-G---QEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
..|+..+.||+|+||.||+|.... + ..||+|.+... ......++..|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 347778999999999999999754 3 36999998754 233456899999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++++|.+++... ...+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999988532 345899999999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=201.52 Aligned_cols=151 Identities=25% Similarity=0.412 Sum_probs=132.6
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
++|++.+.||+|+||.||++... .++.+|+|.+... .......+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999986 5899999988653 233346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++++|..++........+++..+..++.|++.||.|||+. + |+|+||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999999885433334689999999999999999999974 5 9999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=197.13 Aligned_cols=149 Identities=36% Similarity=0.557 Sum_probs=132.3
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
.+.|++.++||+|+||.||++...+++.+|+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 45788889999999999999998888999999987543 34568899999999999999999999864 56789999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++++|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++.+.
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 999999988543 2456899999999999999999999988 9999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=211.41 Aligned_cols=147 Identities=27% Similarity=0.407 Sum_probs=128.8
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccC-C-----CceeeEEEEEEeCCeeEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-H-----RNLVKLLGCCTQRDERML 590 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H-----~nIv~l~g~~~~~~~~~l 590 (684)
+|.+.+.||+|+||.|.+|.+.. ++.||||+++.. .....+-..|+.+|..++ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78899999999999999999765 899999999864 445567788999999996 4 489999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC--CcEEEEeeccccc
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT--MNPKISDFGLARS 668 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~--~~vkI~DFGla~~ 668 (684)
|+|.++ .+|.++|... +...++...+..++.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.|..
T Consensus 266 VfELL~-~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999996 6899999554 4456999999999999999999999988 9999999999999643 3699999999987
Q ss_pred cC
Q 005669 669 FG 670 (684)
Q Consensus 669 ~~ 670 (684)
..
T Consensus 341 ~~ 342 (586)
T KOG0667|consen 341 ES 342 (586)
T ss_pred cC
Confidence 54
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.1e-21 Score=198.01 Aligned_cols=144 Identities=24% Similarity=0.382 Sum_probs=127.6
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
++|+..+.||+|+||.||++... +++.+|+|.+... ......++.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35778899999999999999864 4789999998654 233346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+.
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV 146 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence 9999996542 3678889999999999999999998 9999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.2e-21 Score=195.49 Aligned_cols=151 Identities=26% Similarity=0.454 Sum_probs=134.1
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|+..+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|++++++++|+|++++++.+...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999986 5899999988642 2233567899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 593 EYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||+++++|..++.... ....+++.++..++.++++||.|||+.+ |+|+||||+||+++.++.++|+|||+++.+.
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 9999999999885432 2345899999999999999999999988 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=199.32 Aligned_cols=148 Identities=29% Similarity=0.456 Sum_probs=132.2
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
.|++.+.||+|+||.||++.... +..+++|.+........+.+.+|+++++.++|+|++++++++..++..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 36777899999999999999765 77889999876555566788999999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++|..++.. ....+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||+++...
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 9999888743 2346899999999999999999999998 9999999999999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-21 Score=199.83 Aligned_cols=151 Identities=30% Similarity=0.534 Sum_probs=132.6
Q ss_pred CCCCccceecccCcEeEEEEEee------CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
++|+..++||+|+||.||++... ++..+|+|.+........+.+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999742 256799999887666667789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcE
Q 005669 591 IYEYLPNKSLDYFIFDTTR------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~v 658 (684)
+|||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 135889999999999999999999988 9999999999999999999
Q ss_pred EEEeeccccccC
Q 005669 659 KISDFGLARSFG 670 (684)
Q Consensus 659 kI~DFGla~~~~ 670 (684)
||+|||+++.+.
T Consensus 162 kL~dfg~~~~~~ 173 (280)
T cd05092 162 KIGDFGMSRDIY 173 (280)
T ss_pred EECCCCceeEcC
Confidence 999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=199.79 Aligned_cols=150 Identities=26% Similarity=0.418 Sum_probs=127.9
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhc--cCCCceeeEEEEEEeCC----eeE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK--LQHRNLVKLLGCCTQRD----ERM 589 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~~~----~~~ 589 (684)
.+.....+.||+|.||.||+|.+ .|+.||||++... +...+.+|.++.+. |+|+||+.+++.-..++ +.+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 35667889999999999999998 5789999999753 33556677776654 69999999998865543 479
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-----DSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-----~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
||.+|.+.|+|.++|. ...++.+..++++..+|.||+|||. ++++.|.|||||..|||+.+++.+-|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999993 3568999999999999999999995 467889999999999999999999999999
Q ss_pred cccccCCCC
Q 005669 665 LARSFGLDQ 673 (684)
Q Consensus 665 la~~~~~~~ 673 (684)
+|-....+.
T Consensus 362 LAv~h~~~t 370 (513)
T KOG2052|consen 362 LAVRHDSDT 370 (513)
T ss_pred eeEEecccC
Confidence 998876553
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-21 Score=196.66 Aligned_cols=149 Identities=32% Similarity=0.541 Sum_probs=131.5
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
++|++.++||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 5688889999999999999998888889999987643 34567899999999999999999999875 456899999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++|.+++... ....+++.++..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 99999998542 2345899999999999999999999998 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=203.07 Aligned_cols=150 Identities=35% Similarity=0.604 Sum_probs=129.1
Q ss_pred CCCCccceecccCcEeEEEEEeeC-Cc--EEEEEEccCC-CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ--EIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 591 (684)
++|++.+.||+|+||.||+|.... +. .+++|.+... .......+.+|++++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 578888999999999999999754 43 4678877643 233456788999999999 899999999999999999999
Q ss_pred EEccCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcE
Q 005669 592 YEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~v 658 (684)
|||+++++|.+++.... ....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 1235889999999999999999999988 9999999999999999999
Q ss_pred EEEeecccccc
Q 005669 659 KISDFGLARSF 669 (684)
Q Consensus 659 kI~DFGla~~~ 669 (684)
||+|||+++..
T Consensus 164 kl~dfg~~~~~ 174 (303)
T cd05088 164 KIADFGLSRGQ 174 (303)
T ss_pred EeCccccCccc
Confidence 99999999643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.4e-22 Score=195.74 Aligned_cols=142 Identities=30% Similarity=0.433 Sum_probs=127.8
Q ss_pred ceecccCcEeEEEEEe-eCCcEEEEEEccCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEEEEccCCCCh
Q 005669 523 NKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (684)
+.||+|+|+.|.-+.. ..+.++|||++.+.......+..+|++++.+.+ |+||++++.+|+++...|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 6799999999999885 569999999999876677888999999999996 99999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---EEEEeeccccccC
Q 005669 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN---PKISDFGLARSFG 670 (684)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~---vkI~DFGla~~~~ 670 (684)
...|.+ ...+++.++.++.++|+.||.|||.++ |.||||||+|||-.+... +||+||.++.-+.
T Consensus 164 LshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 164 LSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred HHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccc
Confidence 988843 456999999999999999999999999 999999999999965443 8999999887553
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.6e-21 Score=194.57 Aligned_cols=147 Identities=37% Similarity=0.603 Sum_probs=130.9
Q ss_pred ceecccCcEeEEEEEeeC----CcEEEEEEccCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.||+|+||.||++.... +..+++|.+...... ..+.+.+|++.+..++|+|++++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999764 778999999865333 367889999999999999999999999999999999999999
Q ss_pred CChhHHHhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 598 KSLDYFIFDTTR------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 598 gsL~~~l~~~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
++|.+++..... ...+++.++..++.|++.||+|||+++ ++|+||||+||++++++.+||+|||.++.+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865321 366899999999999999999999988 99999999999999999999999999998764
Q ss_pred C
Q 005669 672 D 672 (684)
Q Consensus 672 ~ 672 (684)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-21 Score=202.01 Aligned_cols=152 Identities=32% Similarity=0.510 Sum_probs=131.6
Q ss_pred cCCCCccceecccCcEeEEEEEeeC--------CcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR 585 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 585 (684)
.++|.+.+.||+|+||.||++.... ...+|+|.+.... .....++.+|+.+++++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3578999999999999999998532 2469999987542 33456788899999999 799999999999999
Q ss_pred CeeEEEEEccCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 005669 586 DERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl 652 (684)
+..++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+++ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999965321 235889999999999999999999988 9999999999999
Q ss_pred cCCCcEEEEeeccccccC
Q 005669 653 DNTMNPKISDFGLARSFG 670 (684)
Q Consensus 653 ~~~~~vkI~DFGla~~~~ 670 (684)
++++.+||+|||+++.+.
T Consensus 174 ~~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 174 TEDNVMKIADFGLARDIH 191 (307)
T ss_pred cCCCcEEECCCccccccc
Confidence 999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-21 Score=200.92 Aligned_cols=148 Identities=30% Similarity=0.496 Sum_probs=129.7
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
++|...++||+|+||.||++.... ++.||+|.++... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 568889999999999999998754 7899999987542 23345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++ ++|..++... ...+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 98 5888877432 345889999999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=196.57 Aligned_cols=142 Identities=27% Similarity=0.463 Sum_probs=123.2
Q ss_pred ceecccCcEeEEEEEeeCCc-----------EEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 523 NKLGEGGFGPVYKGMLIEGQ-----------EIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999986532 5788877654333 6788999999999999999999999988 778999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-------cEEEEeec
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-------NPKISDFG 664 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~-------~vkI~DFG 664 (684)
|||+++++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999985432 26899999999999999999999988 99999999999999887 79999999
Q ss_pred cccccCC
Q 005669 665 LARSFGL 671 (684)
Q Consensus 665 la~~~~~ 671 (684)
+++.+..
T Consensus 154 ~a~~~~~ 160 (259)
T cd05037 154 IPITVLS 160 (259)
T ss_pred ccccccc
Confidence 9987643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.7e-21 Score=198.44 Aligned_cols=146 Identities=38% Similarity=0.575 Sum_probs=126.5
Q ss_pred CCccceecccCcEeEEEEEe-----eCCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeC--CeeEE
Q 005669 519 FSEKNKLGEGGFGPVYKGML-----IEGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERML 590 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 590 (684)
|+..+.||+|+||+||++.. .+++.||+|.+.... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988653 246789999987543 23456788999999999999999999998754 35789
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+|||+++++|.+++.. ..+++.++..++.|+++||.|||+++ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999843 34899999999999999999999998 9999999999999999999999999998764
Q ss_pred C
Q 005669 671 L 671 (684)
Q Consensus 671 ~ 671 (684)
.
T Consensus 159 ~ 159 (283)
T cd05080 159 E 159 (283)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.2e-21 Score=195.35 Aligned_cols=151 Identities=28% Similarity=0.491 Sum_probs=135.7
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.++|+..+.||+|+||.||++.... ++.+++|.+........+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 3678889999999999999999754 788999998866555677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++++|.+++... ...+++.++..++.|++.||.|||+++ |+|+||||+||++++++.+||+|||++..+..
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999999988442 246899999999999999999999988 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.8e-21 Score=193.92 Aligned_cols=143 Identities=33% Similarity=0.520 Sum_probs=127.0
Q ss_pred ceecccCcEeEEEEEeeCCcEEEEEEccCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCChh
Q 005669 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 601 (684)
+.||+|+||.||++...+++.+|+|.+..... .....+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999987889999999876432 23456889999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 602 YFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 602 ~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++... ...+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence 988432 345789999999999999999999988 9999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.2e-21 Score=198.22 Aligned_cols=150 Identities=30% Similarity=0.463 Sum_probs=131.6
Q ss_pred CCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
++|+..+.||+|+||.||++.... .+.+++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578888999999999999998642 467999988754333 4567999999999999999999999999989999
Q ss_pred EEEEccCCCChhHHHhccCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEee
Q 005669 590 LIYEYLPNKSLDYFIFDTTRS------KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DF 663 (684)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998644321 25899999999999999999999998 999999999999999999999999
Q ss_pred cccccc
Q 005669 664 GLARSF 669 (684)
Q Consensus 664 Gla~~~ 669 (684)
|+++..
T Consensus 162 ~~~~~~ 167 (275)
T cd05046 162 SLSKDV 167 (275)
T ss_pred cccccc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.7e-21 Score=194.41 Aligned_cols=151 Identities=28% Similarity=0.419 Sum_probs=133.7
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+|+..+.||+|++|.||++... +++.|++|.+... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999975 4889999988643 234566788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999998643 2456899999999999999999999988 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=206.80 Aligned_cols=147 Identities=30% Similarity=0.455 Sum_probs=125.3
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-----
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD----- 586 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----- 586 (684)
..++|+..+.||+|+||.||++.... ++.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 45789999999999999999998754 889999998653 2334567889999999999999999999986543
Q ss_pred -eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecc
Q 005669 587 -ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (684)
Q Consensus 587 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGl 665 (684)
..++||||+++ +|...+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 47999999986 4555542 24788999999999999999999998 99999999999999999999999999
Q ss_pred ccccC
Q 005669 666 ARSFG 670 (684)
Q Consensus 666 a~~~~ 670 (684)
++...
T Consensus 170 a~~~~ 174 (359)
T cd07876 170 ARTAC 174 (359)
T ss_pred ccccc
Confidence 98653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.2e-21 Score=195.11 Aligned_cols=142 Identities=31% Similarity=0.551 Sum_probs=123.0
Q ss_pred eecccCcEeEEEEEee---CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005669 524 KLGEGGFGPVYKGMLI---EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (684)
Q Consensus 524 ~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 599 (684)
.||+|+||.||+|... .+..||+|.+.... ....+++.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 24579999987653 233467899999999999999999999885 457899999999999
Q ss_pred hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 600 L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|.+++.. ....+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccC
Confidence 9998843 2346899999999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.4e-21 Score=196.74 Aligned_cols=147 Identities=29% Similarity=0.486 Sum_probs=128.7
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc----------ccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG----------QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD 586 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~----------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 586 (684)
+|...+.||+|+||.||+|... +++.+|+|.++.... ...+.+.+|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677789999999999999865 488999998753211 11346788999999999999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||+|+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999843 256899999999999999999999988 999999999999999999999999999
Q ss_pred cccC
Q 005669 667 RSFG 670 (684)
Q Consensus 667 ~~~~ 670 (684)
+...
T Consensus 156 ~~~~ 159 (272)
T cd06629 156 KKSD 159 (272)
T ss_pred cccc
Confidence 8754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-22 Score=211.66 Aligned_cols=152 Identities=31% Similarity=0.496 Sum_probs=136.6
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
+....++||-|.||.||.|.++. .-.||||.++.+ ....++|+.|+.+|+.++|||+|+|+|+|..+..+|||+|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 44556899999999999999876 668999999864 4567899999999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCCC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~~ 674 (684)
+|+|.++|.+.. ...++.-..++++.||..||.||..++ +|||||..+|.|+.++..+||+|||++|++..+..
T Consensus 347 yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 347 YGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred CccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 999999996644 345777888899999999999999998 99999999999999999999999999999976543
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-21 Score=198.07 Aligned_cols=150 Identities=31% Similarity=0.543 Sum_probs=128.5
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCc----EEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQ----EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
.++|+..++||+|+||.||+|... +++ .||+|.++.. ......++.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 356888899999999999999854 344 4899998754 23345678899999999999999999999975 4578
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+++||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999988532 346899999999999999999999998 999999999999999999999999999877
Q ss_pred CC
Q 005669 670 GL 671 (684)
Q Consensus 670 ~~ 671 (684)
..
T Consensus 160 ~~ 161 (279)
T cd05109 160 DI 161 (279)
T ss_pred cc
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-22 Score=197.25 Aligned_cols=153 Identities=29% Similarity=0.429 Sum_probs=127.0
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-----CcEEEEEEccCCCcc--cHHHHHHHHHHHhccCCCceeeEEEEEEe-CCe
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSGQ--GMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDE 587 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~ 587 (684)
...|+...+||+|.||.||++...+ .+++|+|+++..+.. ......+|+.+++.++|+|++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4568888999999999999997543 237899999864221 13456789999999999999999999877 778
Q ss_pred eEEEEEccCCCChhHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC----CcEEEE
Q 005669 588 RMLIYEYLPNKSLDYFIFDT--TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT----MNPKIS 661 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~----~~vkI~ 661 (684)
.++++||.+. +|..+++.. .+.+.++...+..|+.||+.|+.|||++- |+||||||.||||..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999986 555665432 23457899999999999999999999998 9999999999999766 899999
Q ss_pred eeccccccCCC
Q 005669 662 DFGLARSFGLD 672 (684)
Q Consensus 662 DFGla~~~~~~ 672 (684)
|||+||++..+
T Consensus 179 DlGlaR~~~~p 189 (438)
T KOG0666|consen 179 DLGLARLFNNP 189 (438)
T ss_pred cccHHHHhhcc
Confidence 99999998644
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-20 Score=193.73 Aligned_cols=151 Identities=23% Similarity=0.363 Sum_probs=133.3
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+|+..+.||+|+||.||.+.... ++.+++|.+... ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47888999999999999998654 789999987643 234456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+++++|.+++.... ...+++.++..++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999985432 356899999999999999999999988 999999999999999999999999999877443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.1e-21 Score=201.20 Aligned_cols=146 Identities=23% Similarity=0.363 Sum_probs=130.3
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|+..+.||+|+||.||++.... ++.|++|.+.... ......+.+|+.+++.++|+||+++++.+..+++.++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468888999999999999999765 7899999987542 233457789999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 99999999999843 345899999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.7e-21 Score=195.18 Aligned_cols=147 Identities=33% Similarity=0.580 Sum_probs=129.7
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcc---------cHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ---------GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 587 (684)
+|...+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999875 4789999988654221 23568889999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.++++||+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999843 345889999999999999999999988 9999999999999999999999999998
Q ss_pred ccC
Q 005669 668 SFG 670 (684)
Q Consensus 668 ~~~ 670 (684)
.+.
T Consensus 155 ~~~ 157 (267)
T cd06628 155 KLE 157 (267)
T ss_pred ccc
Confidence 875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-21 Score=196.51 Aligned_cols=146 Identities=32% Similarity=0.537 Sum_probs=130.0
Q ss_pred CCCccceecccCcEeEEEEEeeCCcEEEEEEccCCC------cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS------GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
+|...+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477789999999999999998788999999886432 12235688899999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999999843 345789999999999999999999988 999999999999999999999999999865
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-22 Score=198.27 Aligned_cols=161 Identities=29% Similarity=0.363 Sum_probs=138.8
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.++|+.+++||+|.||+|.+++-+. ++.+|+|++++.. ......-..|-++|+..+||.+..+.-.++..++.++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4678888999999999999998654 8899999998753 23334456789999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||..||.|..+| .+...+++.....+-..|+.||.|||+++ ||.||||.+|.|+|++|++||+|||+++.--.
T Consensus 247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999998777 44567899999999999999999999998 99999999999999999999999999986332
Q ss_pred CCCccCCcccccC
Q 005669 672 DQTEANTKRVVGT 684 (684)
Q Consensus 672 ~~~~~~~~~~~GT 684 (684)
....+++++||
T Consensus 321 --~g~t~kTFCGT 331 (516)
T KOG0690|consen 321 --YGDTTKTFCGT 331 (516)
T ss_pred --ccceeccccCC
Confidence 22456778887
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.1e-21 Score=194.77 Aligned_cols=148 Identities=31% Similarity=0.528 Sum_probs=131.3
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-----cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-----GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.+++.++|+||+++++++..++..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999986 58899999886532 22456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+||+++++|.+++.+ ...+++..+..++.||+.||+|||+.+ |+|+||+|+||+++.++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 345889999999999999999999998 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.4e-21 Score=198.24 Aligned_cols=158 Identities=27% Similarity=0.391 Sum_probs=134.6
Q ss_pred HHHHHhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEE---
Q 005669 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCT--- 583 (684)
Q Consensus 509 ~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~--- 583 (684)
+..+....++|++.+.||+|+||.||++.... ++.+|+|.+... .....++.+|+.+++++ +|+||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 44556678899999999999999999998754 789999988643 22346688899999999 6999999999884
Q ss_pred --eCCeeEEEEEccCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEE
Q 005669 584 --QRDERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (684)
Q Consensus 584 --~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI 660 (684)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+++ |+||||||+||++++++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 345689999999999999887532 22356889999999999999999999988 999999999999999999999
Q ss_pred EeeccccccC
Q 005669 661 SDFGLARSFG 670 (684)
Q Consensus 661 ~DFGla~~~~ 670 (684)
+|||+++.+.
T Consensus 166 ~dfg~~~~~~ 175 (286)
T cd06638 166 VDFGVSAQLT 175 (286)
T ss_pred ccCCceeecc
Confidence 9999998764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.8e-21 Score=194.67 Aligned_cols=149 Identities=32% Similarity=0.518 Sum_probs=130.0
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
++|.+.++||+|++|.||++....+..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4578889999999999999998777789999887542 34567889999999999999999999875 456889999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 99999998542 2345789999999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=193.25 Aligned_cols=150 Identities=25% Similarity=0.391 Sum_probs=132.2
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
+|+..++||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999875 4889999988643 2334567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
++++|.+++... ....+++..+..++.|++.||.|||+++ |+|+||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999998887432 3455789999999999999999999998 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.3e-21 Score=197.20 Aligned_cols=142 Identities=24% Similarity=0.419 Sum_probs=121.1
Q ss_pred eecccCcEeEEEEEeeCC---cEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005669 524 KLGEGGFGPVYKGMLIEG---QEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (684)
Q Consensus 524 ~LG~G~fG~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 599 (684)
+||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999986543 346677766432 2345688999999999999999999999999999999999999999
Q ss_pred hhHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 600 LDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 600 L~~~l~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
|.+++.+... ....++..+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 9999865322 234677778899999999999999988 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.3e-21 Score=195.30 Aligned_cols=148 Identities=28% Similarity=0.487 Sum_probs=128.1
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-----cccHHHHHHHHHHHhccCCCceeeEEEEEEeC--Cee
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-----GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DER 588 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 588 (684)
.+|+..+.||+|+||.||++...+ ++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 468888999999999999999754 8899999875321 12345788899999999999999999988764 457
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
+++|||+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999998843 245788999999999999999999998 99999999999999999999999999986
Q ss_pred cC
Q 005669 669 FG 670 (684)
Q Consensus 669 ~~ 670 (684)
+.
T Consensus 156 ~~ 157 (265)
T cd06652 156 LQ 157 (265)
T ss_pred cc
Confidence 53
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8e-21 Score=195.83 Aligned_cols=143 Identities=23% Similarity=0.396 Sum_probs=123.0
Q ss_pred ceecccCcEeEEEEEeeC-------------CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 523 NKLGEGGFGPVYKGMLIE-------------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
+.||+|+||.||+|.... ...|++|.+..........+.+|+.++++++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358999887655555567889999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc-------EEEEe
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN-------PKISD 662 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~-------vkI~D 662 (684)
++|||+++++|+.++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999888743 2345899999999999999999999988 999999999999986654 89999
Q ss_pred eccccccC
Q 005669 663 FGLARSFG 670 (684)
Q Consensus 663 FGla~~~~ 670 (684)
||++..+.
T Consensus 156 ~g~~~~~~ 163 (262)
T cd05077 156 PGIPITVL 163 (262)
T ss_pred CCCCcccc
Confidence 99997654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.6e-21 Score=200.78 Aligned_cols=151 Identities=33% Similarity=0.472 Sum_probs=131.3
Q ss_pred CCCCccceecccCcEeEEEEEee------CCcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCee
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 588 (684)
++|...+.||+|+||.||++... .+..||+|.++... ....+.+.+|+.+++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 56888899999999999999742 24579999987542 23346788999999999 799999999999999999
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
+++|||+++++|.+++.... ...+++.++..++.|++.||+|||+++ |+|+||||+|||++.++.+||+|||+++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 99999999999999985422 334899999999999999999999988 99999999999999999999999999987
Q ss_pred cCC
Q 005669 669 FGL 671 (684)
Q Consensus 669 ~~~ 671 (684)
+..
T Consensus 191 ~~~ 193 (302)
T cd05055 191 IMN 193 (302)
T ss_pred ccC
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.4e-21 Score=205.32 Aligned_cols=143 Identities=23% Similarity=0.329 Sum_probs=125.3
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
...+|++.+.||+|+||.||+|.... ++.||+|..... ....|+.++++++|+||+++++++...+..++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 44679999999999999999999765 678999975432 23569999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
|+. ++|..++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 996 577777643 2456899999999999999999999998 999999999999999999999999999854
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.6e-21 Score=199.32 Aligned_cols=149 Identities=28% Similarity=0.501 Sum_probs=134.4
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
..+|+..+.||.|++|.||++... +++.|++|.+........+.+.+|+.+++.++|+|++++++.+...+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 456899999999999999999864 5889999998765555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++++|..++.. ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 98 LAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred cCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 999999998832 35899999999999999999999998 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.8e-21 Score=200.55 Aligned_cols=151 Identities=33% Similarity=0.524 Sum_probs=130.4
Q ss_pred CCCCccceecccCcEeEEEEEee--------CCcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCC
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD 586 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 586 (684)
++|.+.++||+|+||.||++... ....+|+|.++... ......+.+|+.+++++ +|+||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56788899999999999999742 24578999987542 33456788999999999 6999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~ 653 (684)
..+++|||+++++|.+++.... ....+++.++..++.||+.||.|||+++ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999986532 1245889999999999999999999988 99999999999999
Q ss_pred CCCcEEEEeeccccccC
Q 005669 654 NTMNPKISDFGLARSFG 670 (684)
Q Consensus 654 ~~~~vkI~DFGla~~~~ 670 (684)
+++.+||+|||+++.+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~ 185 (314)
T cd05099 169 EDNVMKIADFGLARGVH 185 (314)
T ss_pred CCCcEEEcccccccccc
Confidence 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=197.96 Aligned_cols=150 Identities=31% Similarity=0.477 Sum_probs=128.8
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++++|...+.||+|+||.||+|... +++.+|+|.+..... .....+.+|+.+++.++|+||+++++++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999875 488999999875432 22346788999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||++ ++|...+... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9996 5666665332 245788889999999999999999988 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.1e-21 Score=196.01 Aligned_cols=150 Identities=31% Similarity=0.603 Sum_probs=131.7
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-C---cEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-G---QEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
.++|+..+.||+|+||.||++.... + ..+|+|.++... ....+.+.+|++++++++|+|++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3467788999999999999999753 3 379999987542 3345678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++++|..++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999998542 346899999999999999999999988 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.4e-21 Score=199.57 Aligned_cols=148 Identities=33% Similarity=0.535 Sum_probs=130.4
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcc-----cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ-----GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
+|+..+.||+|++|.||+|... ++++||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999975 4889999998754322 234567899999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999984322 36899999999999999999999998 99999999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=7e-21 Score=198.83 Aligned_cols=152 Identities=31% Similarity=0.539 Sum_probs=132.3
Q ss_pred cCCCCccceecccCcEeEEEEEee------CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 588 (684)
.++|+..+.||+|+||.||++... ++..+|+|.+.... .....++.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999864 35789999987542 23356788999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 005669 589 MLIYEYLPNKSLDYFIFDTT-------------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASN 649 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~N 649 (684)
++++||+++++|.+++.... ....+++.+++.++.|++.||.|||+++ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986321 1134788999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEeeccccccC
Q 005669 650 VLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 650 ILl~~~~~vkI~DFGla~~~~ 670 (684)
|++++++.+||+|||+++.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred eEecCCCceEECccccceecc
Confidence 999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.4e-21 Score=199.79 Aligned_cols=150 Identities=33% Similarity=0.576 Sum_probs=129.0
Q ss_pred CCCCccceecccCcEeEEEEEeeC-C--cEEEEEEccCC-CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-G--QEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g--~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 591 (684)
++|++.+.||+|+||.||++...+ + ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578888999999999999998754 3 35788888743 233456788999999999 799999999999999999999
Q ss_pred EEccCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcE
Q 005669 592 YEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~v 658 (684)
+||+++++|.+++.... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 1135889999999999999999999988 9999999999999999999
Q ss_pred EEEeecccccc
Q 005669 659 KISDFGLARSF 669 (684)
Q Consensus 659 kI~DFGla~~~ 669 (684)
||+|||+++..
T Consensus 159 kl~dfg~~~~~ 169 (297)
T cd05089 159 KIADFGLSRGE 169 (297)
T ss_pred EECCcCCCccc
Confidence 99999998643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.5e-21 Score=205.72 Aligned_cols=150 Identities=29% Similarity=0.448 Sum_probs=127.7
Q ss_pred hhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC-----
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR----- 585 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~----- 585 (684)
...++|+..+.||+|+||.||++... .++.||||++.... ......+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999875 47899999987532 22345677899999999999999999987543
Q ss_pred -CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 586 -DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 586 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
...++++|++ +++|..++. ...+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999987 678887762 345899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCC
Q 005669 665 LARSFGL 671 (684)
Q Consensus 665 la~~~~~ 671 (684)
+++....
T Consensus 164 ~~~~~~~ 170 (343)
T cd07878 164 LARQADD 170 (343)
T ss_pred cceecCC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=196.47 Aligned_cols=153 Identities=31% Similarity=0.534 Sum_probs=131.5
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 587 (684)
..++|++.+.||+|++|.||+|...+ +..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678899999999999999999754 4678999887543 3334568899999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---cEEE
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTR----SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM---NPKI 660 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~---~vkI 660 (684)
.++||||+++++|.+++..... ...+++..+..++.||+.||+|||+++ ++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999854321 235899999999999999999999998 99999999999998654 5999
Q ss_pred EeeccccccC
Q 005669 661 SDFGLARSFG 670 (684)
Q Consensus 661 ~DFGla~~~~ 670 (684)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05036 161 ADFGMARDIY 170 (277)
T ss_pred ccCccccccC
Confidence 9999998763
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=195.80 Aligned_cols=149 Identities=32% Similarity=0.559 Sum_probs=129.8
Q ss_pred CCCCccceecccCcEeEEEEEeeC-C----cEEEEEEccCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-G----QEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g----~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
.+|+..+.||+|+||.||+|.... + ..+|+|.+..... ....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467888999999999999998653 3 2689998876532 345678899999999999999999999987 78899
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998543 335899999999999999999999988 9999999999999999999999999998775
Q ss_pred C
Q 005669 671 L 671 (684)
Q Consensus 671 ~ 671 (684)
.
T Consensus 161 ~ 161 (279)
T cd05057 161 V 161 (279)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.8e-21 Score=196.84 Aligned_cols=151 Identities=25% Similarity=0.426 Sum_probs=132.6
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|+..+.||+|+||.||++... +++.+|||.+... ......++.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46788899999999999999964 6899999987643 2233457889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 593 EYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||+++++|.+++.... ....+++..+..++.||++||.|||+++ ++|+||||+||+++.++.+||+|||+++.+.
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 9999999999885422 2456899999999999999999999998 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.1e-22 Score=212.01 Aligned_cols=156 Identities=31% Similarity=0.474 Sum_probs=130.1
Q ss_pred ccceecccCcEeEEEEEeeC-CcEEEEEEcc---C-CCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe--eEEEEE
Q 005669 521 EKNKLGEGGFGPVYKGMLIE-GQEIAVKRLS---K-GSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE--RMLIYE 593 (684)
Q Consensus 521 ~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~---~-~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~lV~E 593 (684)
...+||+|+|-+||+|.+.. |.+||--.++ . .++...++|..|+.+|+.|+|+||++++.++.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 34689999999999999854 7777632222 1 134556899999999999999999999999987766 678999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCcEEEEeeccccccCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~-~~~~vkI~DFGla~~~~~~ 672 (684)
.+..|+|..++.+ .+.++...+..+++||++||.|||++. ++|||||||.+||+|+ ..|.|||+|+|+|.++...
T Consensus 124 L~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999854 345788999999999999999999996 7899999999999997 5689999999999998543
Q ss_pred CCccCCcccccC
Q 005669 673 QTEANTKRVVGT 684 (684)
Q Consensus 673 ~~~~~~~~~~GT 684 (684)
. .+.++||
T Consensus 200 ~----aksvIGT 207 (632)
T KOG0584|consen 200 H----AKSVIGT 207 (632)
T ss_pred c----cceeccC
Confidence 2 3347887
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-22 Score=215.73 Aligned_cols=162 Identities=27% Similarity=0.444 Sum_probs=141.1
Q ss_pred cCCCCccceecccCcEeEEEEEeeCC-cEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEG-QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.+.|.++..||.|+||.||++..++. -..|.|.+...+....+.|.-|+++|+.++||+||++++.|...+..+++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 35577778899999999999998763 34567888877788889999999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~~ 674 (684)
|.||..+.++... ...|.+.++..+++|++.||.|||++. |||||||+.|||++-+|.++|+|||.+........
T Consensus 111 C~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 111 CGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred cCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 9999999988553 457999999999999999999999998 99999999999999999999999999877543322
Q ss_pred ccCCcccccC
Q 005669 675 EANTKRVVGT 684 (684)
Q Consensus 675 ~~~~~~~~GT 684 (684)
....|+||
T Consensus 186 --kRDsFIGT 193 (1187)
T KOG0579|consen 186 --KRDSFIGT 193 (1187)
T ss_pred --hhccccCC
Confidence 23357776
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=197.63 Aligned_cols=147 Identities=32% Similarity=0.511 Sum_probs=129.2
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
++|+..+.||+|++|.||++... +++.||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67888999999999999999976 478999999875422 2234567899999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+++ +|.+++.+. ...+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||+++..
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 985 898887543 236889999999999999999999988 999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.2e-20 Score=192.16 Aligned_cols=153 Identities=29% Similarity=0.461 Sum_probs=135.6
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
++|++.+.||+|+||.||++... ++..+++|++.... ......+.+|+++++.++|+|++++++.+..++..++++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999965 47899999987542 23567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+++++|.+++........+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999865433356899999999999999999999988 999999999999999999999999999877543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=200.04 Aligned_cols=144 Identities=27% Similarity=0.418 Sum_probs=119.1
Q ss_pred cceecccCcEeEEEEEee---CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe--CCeeEEEEEccC
Q 005669 522 KNKLGEGGFGPVYKGMLI---EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDERMLIYEYLP 596 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~ 596 (684)
.++||+|+||.||+|... .++.+|+|.+... .....+.+|+.++++++||||+++++.+.. +...+++|||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999865 3578999998753 223567889999999999999999998854 456789999987
Q ss_pred CCChhHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCcEEEEeeccc
Q 005669 597 NKSLDYFIFDTT------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLA 666 (684)
Q Consensus 597 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl----~~~~~vkI~DFGla 666 (684)
+ +|..++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||+|
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 7766664221 1235899999999999999999999998 9999999999999 45678999999999
Q ss_pred cccCC
Q 005669 667 RSFGL 671 (684)
Q Consensus 667 ~~~~~ 671 (684)
+.+..
T Consensus 160 ~~~~~ 164 (317)
T cd07868 160 RLFNS 164 (317)
T ss_pred eccCC
Confidence 88754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=202.26 Aligned_cols=151 Identities=31% Similarity=0.506 Sum_probs=130.3
Q ss_pred CCCCccceecccCcEeEEEEEeeC--------CcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCC
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD 586 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 586 (684)
.+|.+.+.||+|+||.||++.... ...||+|.++... ....+++.+|+.+++++ +|+||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468888999999999999997532 2368999887532 33456789999999999 7999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~ 653 (684)
..++++||+++++|.+++.... ....+++.++..++.|++.||.|||+++ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986432 1235788999999999999999999988 99999999999999
Q ss_pred CCCcEEEEeeccccccC
Q 005669 654 NTMNPKISDFGLARSFG 670 (684)
Q Consensus 654 ~~~~vkI~DFGla~~~~ 670 (684)
+++.+||+|||+++.+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~ 185 (334)
T cd05100 169 EDNVMKIADFGLARDVH 185 (334)
T ss_pred CCCcEEECCcccceecc
Confidence 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=194.09 Aligned_cols=142 Identities=32% Similarity=0.559 Sum_probs=123.5
Q ss_pred eecccCcEeEEEEEee---CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005669 524 KLGEGGFGPVYKGMLI---EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (684)
Q Consensus 524 ~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 598 (684)
+||+|+||.||+|... +++.+|+|+++... ....+++.+|+.+++.++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 46889999986542 234567899999999999999999999885 45678999999999
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 99999843 346899999999999999999999988 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-22 Score=224.66 Aligned_cols=169 Identities=25% Similarity=0.281 Sum_probs=147.5
Q ss_pred HHHHHhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 005669 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ 584 (684)
Q Consensus 509 ~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 584 (684)
..++....++|.+++.||+|+||.|..++.+. ++.+|+|++.+. .......|+.|-.+|..-+.+-|++++-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 45566667899999999999999999999865 788999999862 34445678999999999999999999999999
Q ss_pred CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
.++.|+|||||+||+|-.++.+ ...+++.-+..++..|+.||.-||+-| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999999843 337999999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCCccCCcccccC
Q 005669 665 LARSFGLDQTEANTKRVVGT 684 (684)
Q Consensus 665 la~~~~~~~~~~~~~~~~GT 684 (684)
.+-.++.+..-. ....+||
T Consensus 221 sClkm~~dG~V~-s~~aVGT 239 (1317)
T KOG0612|consen 221 SCLKMDADGTVR-SSVAVGT 239 (1317)
T ss_pred hHHhcCCCCcEE-eccccCC
Confidence 999998766533 3346776
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=195.19 Aligned_cols=149 Identities=31% Similarity=0.557 Sum_probs=131.1
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
+|+..++||+|++|.||+|+... ++.||+|.++.... .....+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 47888999999999999999864 88999999876432 23466788999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++ +|.+++........+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 85 78787754443456899999999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=207.79 Aligned_cols=154 Identities=30% Similarity=0.484 Sum_probs=134.9
Q ss_pred eecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCChhH
Q 005669 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDY 602 (684)
Q Consensus 524 ~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 602 (684)
+||+|.||+||-|++.+ ...+|||.+.....+...-+.+|+.+.+.++|.|||+++|.+.++++.-|.||-++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999866 55899999988777777889999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCcEEEEeeccccccCCCCCccCCc
Q 005669 603 FIFDTTRSKLL--DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTK 679 (684)
Q Consensus 603 ~l~~~~~~~~l--~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~-~~~~vkI~DFGla~~~~~~~~~~~~~ 679 (684)
+|... -+++ .+.+.-.+.+||++||.|||++. |||||||-+||||+ -.|.+||+|||.++.+..- ...|.
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE 734 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE 734 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence 99542 3445 78888899999999999999998 99999999999996 6889999999999988432 23455
Q ss_pred ccccC
Q 005669 680 RVVGT 684 (684)
Q Consensus 680 ~~~GT 684 (684)
++.||
T Consensus 735 TFTGT 739 (1226)
T KOG4279|consen 735 TFTGT 739 (1226)
T ss_pred ccccc
Confidence 67776
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=193.87 Aligned_cols=144 Identities=34% Similarity=0.477 Sum_probs=127.8
Q ss_pred ceecccCcEeEEEEEeeC--C--cEEEEEEccCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE--G--QEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~--g--~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.||+|++|.||++.+.. + ..||+|.+..... ...+.+.+|+.++++++|+||+++++.+.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998744 2 3699999987655 556789999999999999999999999988 889999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
++|.+++.+... ..+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999865332 56899999999999999999999998 99999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=195.47 Aligned_cols=149 Identities=29% Similarity=0.466 Sum_probs=132.7
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999975 48899999987543 33356789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+ +++|.+++... ...+++.++..++.||++||+|||+++ ++|+||||+||++++++.++|+|||+++.+...
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 99999988543 256899999999999999999999998 999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=193.36 Aligned_cols=150 Identities=33% Similarity=0.503 Sum_probs=132.4
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
.++|+..++||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++|+||+++++.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678889999999999999999777788999988753 3345678899999999999999999999887 7789999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999998543 2446788999999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-20 Score=191.16 Aligned_cols=143 Identities=35% Similarity=0.539 Sum_probs=128.3
Q ss_pred ceecccCcEeEEEEEeeCCcEEEEEEccCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCChh
Q 005669 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 601 (684)
++||+|+||.||++...+++.||+|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765333 4567899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 602 YFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 602 ~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++... ...+++..+..++.+++.||+|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 998542 335789999999999999999999988 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-21 Score=205.75 Aligned_cols=148 Identities=29% Similarity=0.441 Sum_probs=125.7
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC------
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------ 585 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------ 585 (684)
..++|+..+.||+|+||.||++.... ++.||||++.... ......+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45789999999999999999998754 7899999987532 23346778899999999999999999988643
Q ss_pred CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecc
Q 005669 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGl 665 (684)
...++||||+++ +|...+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 346999999976 5555552 24788999999999999999999998 99999999999999999999999999
Q ss_pred ccccCC
Q 005669 666 ARSFGL 671 (684)
Q Consensus 666 a~~~~~ 671 (684)
++..+.
T Consensus 166 ~~~~~~ 171 (355)
T cd07874 166 ARTAGT 171 (355)
T ss_pred cccCCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-20 Score=198.31 Aligned_cols=150 Identities=27% Similarity=0.348 Sum_probs=133.5
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|+..+.||+|++|.||++...+ ++.+|+|.+..... ...+.+.+|++++++++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468888999999999999999865 89999999876432 24567889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999988532 3456899999999999999999999988 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=201.49 Aligned_cols=153 Identities=26% Similarity=0.351 Sum_probs=134.6
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.-|...+.||+|.|+.|-++++. .|..||||++.+..- .....+.+|++.|+.++|||||++|.+.......|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45777789999999999998863 699999999987532 334578899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCcEEEEeeccccccCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~-~~~~vkI~DFGla~~~~~~ 672 (684)
.-++|+|.++|.+. ...+.+..+.+++.||+.|+.|+|+.. +|||||||+||++- +-|-+||+|||++..+.+.
T Consensus 98 LGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999998654 345899999999999999999999988 99999999999874 6788999999999999766
Q ss_pred CC
Q 005669 673 QT 674 (684)
Q Consensus 673 ~~ 674 (684)
+.
T Consensus 173 ~k 174 (864)
T KOG4717|consen 173 KK 174 (864)
T ss_pred ch
Confidence 53
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-20 Score=191.99 Aligned_cols=147 Identities=28% Similarity=0.480 Sum_probs=128.3
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEE-eCCeeEEEEEcc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT-QRDERMLIYEYL 595 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~lV~Ey~ 595 (684)
++|+..+.||+|+||.||++.. .++.+|+|.++.. ...+.+.+|+.++++++|+|++++++++. .++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4688889999999999999976 4788999998643 33567899999999999999999999765 456789999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++++|.+++... ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++...
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecc
Confidence 999999998543 2345889999999999999999999988 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=195.37 Aligned_cols=149 Identities=33% Similarity=0.529 Sum_probs=131.1
Q ss_pred CCCCccceecccCcEeEEEEEee-----CCcEEEEEEccCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEe--CCee
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDER 588 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~ 588 (684)
+.|+..+.||+|+||.||++... .++.+|||.+...... ..+.+.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777789999999999999853 2678999999865432 46789999999999999999999999887 5578
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998543 235899999999999999999999988 99999999999999999999999999998
Q ss_pred cC
Q 005669 669 FG 670 (684)
Q Consensus 669 ~~ 670 (684)
+.
T Consensus 159 ~~ 160 (284)
T cd05038 159 LP 160 (284)
T ss_pred cc
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.7e-21 Score=198.48 Aligned_cols=149 Identities=29% Similarity=0.484 Sum_probs=131.3
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
++|+..++||+|+||.||++...+ ++.+|+|++..... ...+.+.+|+++++.++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 468888999999999999999864 88999998865322 234578899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|+++++|..+... ...+++.++..++.||++||+|||+.+ |+|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999887632 335899999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=195.09 Aligned_cols=148 Identities=28% Similarity=0.501 Sum_probs=130.0
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC------cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS------GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
+|+..+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778899999999999999864 48899999987432 1134678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-cEEEEeecccccc
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSF 669 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~-~vkI~DFGla~~~ 669 (684)
|+||+++++|.+++.+ ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++ .+||+|||+++.+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999843 346889999999999999999999998 99999999999998765 5999999999877
Q ss_pred CC
Q 005669 670 GL 671 (684)
Q Consensus 670 ~~ 671 (684)
..
T Consensus 155 ~~ 156 (268)
T cd06630 155 AA 156 (268)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=201.08 Aligned_cols=142 Identities=23% Similarity=0.270 Sum_probs=114.9
Q ss_pred hhcCCCCccceecccCcEeEEEEEee--CCcEEEEEEccCC-----CcccHHHHHHHHHHHhccCCCceee-EEEEEEeC
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLI--EGQEIAVKRLSKG-----SGQGMEEFKNEVLLIAKLQHRNLVK-LLGCCTQR 585 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~-l~g~~~~~ 585 (684)
...++|...+.||+|+||+||+|... +++.+|||++... .....+.+.+|+++|++++|+|+++ ++. .
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence 44578999999999999999999875 4677899987532 1223456899999999999999985 443 2
Q ss_pred CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC-CCCcEEEcCCCcEEEEeec
Q 005669 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDL-KASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDL-kp~NILl~~~~~vkI~DFG 664 (684)
+..++||||+++++|.. + . .. . ...++.|++++|.|||+++ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~-~--~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-A-R--PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHH-h-C--cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 46799999999999962 2 1 11 1 1467889999999999998 999999 9999999999999999999
Q ss_pred cccccCCC
Q 005669 665 LARSFGLD 672 (684)
Q Consensus 665 la~~~~~~ 672 (684)
+|+.+...
T Consensus 158 lA~~~~~~ 165 (365)
T PRK09188 158 LASVFRRR 165 (365)
T ss_pred cceecccC
Confidence 99987543
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-20 Score=198.04 Aligned_cols=150 Identities=28% Similarity=0.432 Sum_probs=127.9
Q ss_pred CCCccceecccCcEeEEEEEeeC---CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeC--CeeE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERM 589 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 589 (684)
+|+..++||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788899999999999999754 7899999988632 33456778899999999999999999999988 7899
Q ss_pred EEEEccCCCChhHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC----CCcEEEEee
Q 005669 590 LIYEYLPNKSLDYFIFDTTR--SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN----TMNPKISDF 663 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~----~~~vkI~DF 663 (684)
+||||+++ +|..++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 56555533222 236899999999999999999999998 999999999999999 999999999
Q ss_pred ccccccCC
Q 005669 664 GLARSFGL 671 (684)
Q Consensus 664 Gla~~~~~ 671 (684)
|+++.+..
T Consensus 157 g~~~~~~~ 164 (316)
T cd07842 157 GLARLFNA 164 (316)
T ss_pred ccccccCC
Confidence 99987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=204.30 Aligned_cols=148 Identities=28% Similarity=0.440 Sum_probs=125.9
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC------
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------ 585 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------ 585 (684)
..++|+..+.||+|+||.||++.... ++.||||++... .......+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 35789999999999999999999754 789999998753 223346788899999999999999999987543
Q ss_pred CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecc
Q 005669 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGl 665 (684)
...++||||+++ +|...+. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999975 5666652 24788999999999999999999998 99999999999999999999999999
Q ss_pred ccccCC
Q 005669 666 ARSFGL 671 (684)
Q Consensus 666 a~~~~~ 671 (684)
++..+.
T Consensus 173 a~~~~~ 178 (364)
T cd07875 173 ARTAGT 178 (364)
T ss_pred ccccCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=195.21 Aligned_cols=160 Identities=30% Similarity=0.418 Sum_probs=136.7
Q ss_pred ccHHHHHhhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEe
Q 005669 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ 584 (684)
Q Consensus 507 ~~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~ 584 (684)
+.+..+..++++|+..+.||+|+||.||++... +++.+|+|.+... ......+.+|+.+++++ +|+|++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344566677899999999999999999999975 4889999998653 22346678899999998 79999999999875
Q ss_pred C-----CeeEEEEEccCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcE
Q 005669 585 R-----DERMLIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (684)
Q Consensus 585 ~-----~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~v 658 (684)
. +..++|+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 35799999999999998875322 2456899999999999999999999988 9999999999999999999
Q ss_pred EEEeeccccccC
Q 005669 659 KISDFGLARSFG 670 (684)
Q Consensus 659 kI~DFGla~~~~ 670 (684)
||+|||+++.+.
T Consensus 168 kl~dfg~~~~~~ 179 (291)
T cd06639 168 KLVDFGVSAQLT 179 (291)
T ss_pred EEeecccchhcc
Confidence 999999998764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=191.32 Aligned_cols=148 Identities=29% Similarity=0.551 Sum_probs=131.8
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
.+|+..+.||+|+||.||++...+++.+|+|.+... .....++.+|++++++++|||++++++++......++++||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 457778999999999999999877889999998753 3345678999999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++|.+++... ...++++.+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVL 151 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecc
Confidence 99999988432 245789999999999999999999988 9999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=194.65 Aligned_cols=150 Identities=27% Similarity=0.406 Sum_probs=126.2
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHH-HhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLL-IAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
++|++.+.||+|+||.||++... +++.||+|+++... .....++..|+.. ++.++|+||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999976 48999999987542 2233455556664 566789999999999999999999999
Q ss_pred ccCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 594 YLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 594 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|++ ++|.+++... .....+++..+..++.||+.||+|||++ + ++||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 997 6787777542 2335689999999999999999999986 6 9999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=195.28 Aligned_cols=148 Identities=28% Similarity=0.494 Sum_probs=122.7
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhcc---CCCceeeEEEEEEe-----CC
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKL---QHRNLVKLLGCCTQ-----RD 586 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~-----~~ 586 (684)
+|++.+.||+|+||.||++...+ ++.||+|.++... ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47888999999999999999764 8899999987532 22233556677776665 69999999998864 24
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
..+++|||+++ +|..++... ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 787777432 2345899999999999999999999998 999999999999999999999999999
Q ss_pred cccC
Q 005669 667 RSFG 670 (684)
Q Consensus 667 ~~~~ 670 (684)
+.+.
T Consensus 156 ~~~~ 159 (288)
T cd07863 156 RIYS 159 (288)
T ss_pred cccc
Confidence 8764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=195.75 Aligned_cols=148 Identities=27% Similarity=0.357 Sum_probs=129.8
Q ss_pred CCCccceecccCcEeEEEEEee----CCcEEEEEEccCCC----cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCee
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGS----GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 588 (684)
+|+..+.||+|+||.||++... +++.||+|.+.... ....+++.+|+.+++++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4778899999999999999863 57899999987532 22346778899999999 599999999999999999
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++|+||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998843 345889999999999999999999988 99999999999999999999999999987
Q ss_pred cCC
Q 005669 669 FGL 671 (684)
Q Consensus 669 ~~~ 671 (684)
+..
T Consensus 155 ~~~ 157 (290)
T cd05613 155 FHE 157 (290)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=192.39 Aligned_cols=148 Identities=30% Similarity=0.527 Sum_probs=132.8
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+|+..+.||+|+||.||++... +++.+++|.+..... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 588999999876543 2567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++++|.+++.. ...+++..+..++.|+++||.|||+.+ |+|+||+|+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 999999999843 345788999999999999999999988 99999999999999999999999999987743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-21 Score=187.19 Aligned_cols=154 Identities=27% Similarity=0.323 Sum_probs=136.1
Q ss_pred hcCCCCccceecccCcEeEEEEEe-eCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeC-----Cee
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-----DER 588 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~ 588 (684)
..++|.+.+.||+|+|+-||.++. .+++.+|+|++...+.+..+..++|++..++++|||+++++++...+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 457899999999999999999984 45889999999877777888999999999999999999999887543 348
Q ss_pred EEEEEccCCCChhHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
||+++|...|+|.+.+..... +..+++.+.+.|+.+|++||++||+.. ++.+||||||.|||+.+++.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999988865433 457999999999999999999999986 579999999999999999999999999987
Q ss_pred cc
Q 005669 668 SF 669 (684)
Q Consensus 668 ~~ 669 (684)
..
T Consensus 178 ~a 179 (302)
T KOG2345|consen 178 QA 179 (302)
T ss_pred cc
Confidence 65
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=192.06 Aligned_cols=148 Identities=30% Similarity=0.536 Sum_probs=128.4
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-----cccHHHHHHHHHHHhccCCCceeeEEEEEEeC--Cee
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-----GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DER 588 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 588 (684)
.+|+..+.||+|+||.||++.... ++.+++|++.... ......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 468889999999999999998754 8899999886432 12345688899999999999999999988753 567
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++++||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999998843 345889999999999999999999988 99999999999999999999999999986
Q ss_pred cC
Q 005669 669 FG 670 (684)
Q Consensus 669 ~~ 670 (684)
+.
T Consensus 156 ~~ 157 (266)
T cd06651 156 LQ 157 (266)
T ss_pred cc
Confidence 53
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=194.52 Aligned_cols=150 Identities=25% Similarity=0.422 Sum_probs=131.9
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
++|+..++||+|++|.||++...+ ++.||+|.++.. .....+.+.+|++++++++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368889999999999999999864 789999988753 23345678999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|++++.+..+.. ....+++.++..++.||+.||.|||+++ ++|+||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877776652 2345899999999999999999999998 999999999999999999999999999887544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.7e-21 Score=194.62 Aligned_cols=148 Identities=27% Similarity=0.387 Sum_probs=132.8
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
+|+..+.||+|+||.||++.... ++.+|+|.+.... ....+.+.+|++++++++||||+++++.+..++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 47888999999999999999864 8899999987542 2346788999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|+++++|.+++.. ...+++..+..++.||++||.|||+++ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 9999999999843 246899999999999999999999988 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=198.68 Aligned_cols=145 Identities=18% Similarity=0.248 Sum_probs=125.4
Q ss_pred ccceeccc--CcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 521 EKNKLGEG--GFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 521 ~~~~LG~G--~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
+.++||+| +|++||++... +++.||+|+++... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 78999999875 48899999987542 233456778999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
++++|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++++||+.+..+
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 9999999985422 345899999999999999999999988 999999999999999999999999865443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=193.47 Aligned_cols=148 Identities=28% Similarity=0.467 Sum_probs=128.5
Q ss_pred CCCCccceecccCcEeEEEEEeeC----CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
++|...++||+|+||.||+|...+ ...|++|...... ....+.+.+|+.++++++|+||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457888999999999999998654 2468999887654 3445678999999999999999999998875 557899
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+.
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999998542 335899999999999999999999988 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=195.50 Aligned_cols=149 Identities=28% Similarity=0.489 Sum_probs=133.3
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.++|...+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++|||++++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 367888999999999999999864 4789999998755445567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++++|.+++.+ ..+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++..+..
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 999999998832 34789999999999999999999998 99999999999999999999999999876643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=190.23 Aligned_cols=149 Identities=30% Similarity=0.485 Sum_probs=134.7
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.++|+..+.||+|+||.||++...+ ++.+++|.+..... .+++.+|++++++++|+||+++++.+......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678889999999999999999865 78999999875422 67899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+..
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 999999999843 2356899999999999999999999988 99999999999999999999999999988754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-20 Score=189.92 Aligned_cols=149 Identities=42% Similarity=0.644 Sum_probs=131.0
Q ss_pred CccceecccCcEeEEEEEeeC-----CcEEEEEEccCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 520 SEKNKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 520 ~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
++.+.||+|+||.||++...+ +..||+|.+...... ..+.+.+|+..++.++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456899999999999999764 378999999765433 56789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|+++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 82 YMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred ccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999985422 122899999999999999999999998 999999999999999999999999999877543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=9e-21 Score=198.79 Aligned_cols=145 Identities=28% Similarity=0.450 Sum_probs=129.0
Q ss_pred CCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
|.....||+|+||.||++... +++.||||.+........+.+.+|+.++++++|+||+++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 344467999999999999875 4889999998765555567788999999999999999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++|.+++.. ..+++.++..++.||+.||.|||+++ |+||||||+||++++++.+||+|||+++.+.
T Consensus 104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 999988732 35889999999999999999999998 9999999999999999999999999998664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-20 Score=195.75 Aligned_cols=143 Identities=29% Similarity=0.432 Sum_probs=118.4
Q ss_pred ceecccCcEeEEEEEeeC---CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe--CCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~ 597 (684)
.+||+|+||.||+|...+ +..+|+|.+.... ....+.+|+.++++++||||+++++++.. +...++++||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 689999999999999653 5789999987532 23567889999999999999999999854 4567999999875
Q ss_pred CChhHHHhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCcEEEEeecccc
Q 005669 598 KSLDYFIFDT------TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLAR 667 (684)
Q Consensus 598 gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl----~~~~~vkI~DFGla~ 667 (684)
+|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+|||+ ++++.+||+|||+|+
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 666665321 11235889999999999999999999998 9999999999999 566789999999999
Q ss_pred ccCC
Q 005669 668 SFGL 671 (684)
Q Consensus 668 ~~~~ 671 (684)
.+..
T Consensus 161 ~~~~ 164 (317)
T cd07867 161 LFNS 164 (317)
T ss_pred ccCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=191.91 Aligned_cols=143 Identities=37% Similarity=0.633 Sum_probs=123.5
Q ss_pred ceecccCcEeEEEEEeeC-Cc--EEEEEEccCC-CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE-GQ--EIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.||+|+||.||++...+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999755 33 5788888743 234456788999999999 799999999999999999999999999
Q ss_pred CChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 598 KSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 598 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
++|.+++.... ....+++.++..++.|++.||+|||+++ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985432 1235789999999999999999999988 9999999999999999999999999
Q ss_pred cccc
Q 005669 665 LARS 668 (684)
Q Consensus 665 la~~ 668 (684)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=218.29 Aligned_cols=158 Identities=23% Similarity=0.351 Sum_probs=131.1
Q ss_pred HhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEe--CCe
Q 005669 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDE 587 (684)
Q Consensus 513 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~ 587 (684)
....++|.+.++||+|+||.||++.... ++.+|+|.+... .......+..|+.++++++||||+++++++.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 4456789999999999999999999765 678899988643 23345678899999999999999999998854 356
Q ss_pred eEEEEEccCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CceEecCCCCCcEEEcC--------
Q 005669 588 RMLIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSR----LRIIHRDLKASNVLLDN-------- 654 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~----~~IvHrDLkp~NILl~~-------- 654 (684)
.+|||||+++++|..+|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999885432 23568999999999999999999998531 24999999999999964
Q ss_pred ---------CCcEEEEeeccccccC
Q 005669 655 ---------TMNPKISDFGLARSFG 670 (684)
Q Consensus 655 ---------~~~vkI~DFGla~~~~ 670 (684)
...+||+|||+++.+.
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~ 193 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIG 193 (1021)
T ss_pred cccccccCCCCceEEccCCcccccc
Confidence 3348999999998764
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=196.62 Aligned_cols=149 Identities=34% Similarity=0.612 Sum_probs=126.5
Q ss_pred CCCCccceecccCcEeEEEEEeeC-Cc----EEEEEEccCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
++|+..+.||+|+||.||++.... ++ .+|+|.+..... ....++.+|+.++++++|+||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 467778899999999999998643 43 578998875432 2234688999999999999999999998754 4678
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999988432 335889999999999999999999988 9999999999999999999999999998765
Q ss_pred C
Q 005669 671 L 671 (684)
Q Consensus 671 ~ 671 (684)
.
T Consensus 161 ~ 161 (303)
T cd05110 161 G 161 (303)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-20 Score=189.70 Aligned_cols=143 Identities=36% Similarity=0.604 Sum_probs=124.3
Q ss_pred ceecccCcEeEEEEEeeC----CcEEEEEEccCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
++||+|+||.||+|.... +..+|+|.+..... ...+++.+|+.++++++|+||+++++++. .+..+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998643 26899999886533 24567899999999999999999999876 5568999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+...
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 9999998542 36899999999999999999999988 999999999999999999999999999877433
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=184.83 Aligned_cols=142 Identities=15% Similarity=0.137 Sum_probs=109.9
Q ss_pred cceecccCcEeEEEEEeeCCcEEEEEEccCCCcc--c-------HHH-----------------HHHHHHHHhccCCCce
Q 005669 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ--G-------MEE-----------------FKNEVLLIAKLQHRNL 575 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--~-------~~~-----------------~~~Ei~~l~~l~H~nI 575 (684)
...||+|+||.||+|...+|+.||||+++..... . ... ..+|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999888999999998754211 1 112 2349999999987776
Q ss_pred eeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCCCCCcEEEcC
Q 005669 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL-HQDSRLRIIHRDLKASNVLLDN 654 (684)
Q Consensus 576 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~~~~IvHrDLkp~NILl~~ 654 (684)
.....+.. ...++||||++++++..... ....+++.+...++.|++.+|.|+ |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 22489999999987765432 234688999999999999999999 6777 99999999999998
Q ss_pred CCcEEEEeeccccccCCC
Q 005669 655 TMNPKISDFGLARSFGLD 672 (684)
Q Consensus 655 ~~~vkI~DFGla~~~~~~ 672 (684)
++.++|+|||+|...+.+
T Consensus 153 ~~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 153 DGKLYIIDVSQSVEHDHP 170 (190)
T ss_pred CCcEEEEEccccccCCCc
Confidence 478999999999876443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-20 Score=191.84 Aligned_cols=148 Identities=28% Similarity=0.486 Sum_probs=131.2
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCC-CcccHHHHHHHHHHHhccC---CCceeeEEEEEEeCCeeEEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~ 592 (684)
.|+..+.||+|+||.||+|... +++.+|+|.+... ......++.+|+.++++++ |+|++++++++..+...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777889999999999999974 5889999998754 2344567889999999986 999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988732 36899999999999999999999998 999999999999999999999999999877543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-20 Score=192.27 Aligned_cols=149 Identities=27% Similarity=0.440 Sum_probs=133.3
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
++|+..+.||.|++|.||++.... ++.+|+|.+.... ......+.+|+.++++++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 367888999999999999999764 8899999987543 33456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999998843 26899999999999999999999988 999999999999999999999999999887543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.3e-20 Score=189.15 Aligned_cols=150 Identities=25% Similarity=0.406 Sum_probs=132.0
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+|+..+.||+|+||.||++... +++.+|+|.+... .....+++.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999875 4789999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++++|.+.+... ....+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999999888432 2345789999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=197.35 Aligned_cols=146 Identities=27% Similarity=0.426 Sum_probs=129.4
Q ss_pred CCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
|+...+||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++.+..++..++++||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334457999999999999875 4889999998765555567788999999999999999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
++|..++. ...+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+..
T Consensus 103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 99988773 245899999999999999999999998 99999999999999999999999999986643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=195.52 Aligned_cols=147 Identities=29% Similarity=0.479 Sum_probs=129.9
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
.|+..+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++|+||+++++.+..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 46667889999999999998754 7889999987442 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
++++|.+++. ...+++..+..++.|+++||.|||+++ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999998873 245889999999999999999999988 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-20 Score=193.57 Aligned_cols=150 Identities=29% Similarity=0.454 Sum_probs=127.7
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCe-----
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDE----- 587 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~----- 587 (684)
++|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999975 48899999876542 223457888999999995 6999999999987665
Q ss_pred eEEEEEccCCCChhHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCcEEEEeec
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTR--SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFG 664 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~-~~~vkI~DFG 664 (684)
.+++|||+++ +|..++..... ...+++..+..++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78777754322 346899999999999999999999988 999999999999998 8899999999
Q ss_pred cccccC
Q 005669 665 LARSFG 670 (684)
Q Consensus 665 la~~~~ 670 (684)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-20 Score=189.84 Aligned_cols=150 Identities=27% Similarity=0.393 Sum_probs=135.3
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
++|+..+.||+|++|.||++.... ++.+++|++..... .....+.+|+..+.+++|+|++++++++...+..++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367888999999999999999875 89999999876543 4467899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+++++|.+++... ..+++..+..++.|+++||.|||+ .+ ++|+||+|+||+++.++.++|+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999998542 568999999999999999999999 88 999999999999999999999999999887543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=194.54 Aligned_cols=147 Identities=24% Similarity=0.383 Sum_probs=130.5
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
++|++.++||+|+||+||++.... ++.+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 567888999999999999999754 7899999876542 33457889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+++++|..++.. ...+++..+..++.+++.||.|||+ ++ ++|+||||+||++++++.++|+|||+++.+
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 999999988743 3468999999999999999999997 45 999999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.1e-20 Score=191.30 Aligned_cols=147 Identities=30% Similarity=0.482 Sum_probs=129.9
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
-|+..++||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.+++|+||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667789999999999999864 47899999886432 233467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
++++|..++. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 9999998883 235889999999999999999999988 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=190.52 Aligned_cols=146 Identities=32% Similarity=0.521 Sum_probs=127.7
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
++|++.+.||+|+||.||++.. .++.+|+|.++.. ...+.+.+|+.++++++|+|++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588889999999999999875 6788999998653 2346789999999999999999999998654 4799999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 99999998543 2345889999999999999999999988 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.2e-20 Score=191.92 Aligned_cols=148 Identities=28% Similarity=0.472 Sum_probs=131.5
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
..|+..++||+|+||.||+|.... ++.||+|.+.... ......+.+|+.+++++.|+||+++++.+.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 357777899999999999999754 7899999987542 34456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+..
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 999999998832 35788999999999999999999988 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=195.84 Aligned_cols=148 Identities=28% Similarity=0.513 Sum_probs=128.3
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+|+..+.||+|+||.||++... +|+.+|+|.++... ......+.+|+.++++++|+||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999986 48899999986532 22335678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++ +|.+++... ...+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.++.
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 985 676666432 345899999999999999999999998 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.7e-22 Score=215.87 Aligned_cols=151 Identities=34% Similarity=0.540 Sum_probs=131.7
Q ss_pred CccceecccCcEeEEEEEe-eCC----cEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 520 SEKNKLGEGGFGPVYKGML-IEG----QEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 520 ~~~~~LG~G~fG~Vy~~~~-~~g----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
...++||+|+||+||+|.+ +++ -+||+|++... ..+..+++.+|+.+|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 4457899999999999986 344 37899988754 3445688999999999999999999999998765 889999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
||+.|.|.++++.. +..+-....+.+..|||+||.|||++. +|||||..+||||.+-..+||.|||+|+.+..+.
T Consensus 778 ~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999653 345788899999999999999999887 9999999999999999999999999999998776
Q ss_pred Ccc
Q 005669 674 TEA 676 (684)
Q Consensus 674 ~~~ 676 (684)
.+-
T Consensus 853 ~ey 855 (1177)
T KOG1025|consen 853 KEY 855 (1177)
T ss_pred ccc
Confidence 653
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.6e-20 Score=194.00 Aligned_cols=150 Identities=31% Similarity=0.466 Sum_probs=129.8
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC--CeeEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERMLI 591 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV 591 (684)
++|+..+.||+|+||.||+|.... ++.+++|.++... ......+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 578888999999999999999864 7899999987542 22234567899999999999999999999877 789999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++ +|.+++... ...+++..+..++.||+.||+|||+++ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999985 888887432 236899999999999999999999998 99999999999999999999999999987754
Q ss_pred C
Q 005669 672 D 672 (684)
Q Consensus 672 ~ 672 (684)
.
T Consensus 159 ~ 159 (293)
T cd07843 159 P 159 (293)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=6e-20 Score=188.06 Aligned_cols=149 Identities=26% Similarity=0.372 Sum_probs=129.5
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe-CCeeEEEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDERMLIYE 593 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E 593 (684)
+|++.+.||+|++|.||++.... ++.+|+|++.... ....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47888999999999999999754 7889999986532 2345678899999999999999999998764 446789999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|+++++|.+++... ....+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~ 153 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEec
Confidence 99999999988543 2346899999999999999999999998 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-20 Score=190.50 Aligned_cols=148 Identities=29% Similarity=0.511 Sum_probs=128.6
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC-----CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC--Cee
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-----SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DER 588 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 588 (684)
.+|++.+.||+|+||.||++.... ++.+|+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 478889999999999999999754 889999987532 123345788999999999999999999998764 457
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998843 345789999999999999999999998 99999999999999999999999999987
Q ss_pred cC
Q 005669 669 FG 670 (684)
Q Consensus 669 ~~ 670 (684)
+.
T Consensus 156 ~~ 157 (264)
T cd06653 156 IQ 157 (264)
T ss_pred cc
Confidence 63
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.5e-20 Score=190.19 Aligned_cols=149 Identities=31% Similarity=0.509 Sum_probs=125.4
Q ss_pred CCccceecccCcEeEEEEEee----CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC------
Q 005669 519 FSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ 586 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 586 (684)
|.+.+.||+|+||.||+|... .++.||||.+... .....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456789999999999999864 2678999998754 2334567889999999999999999999886543
Q ss_pred eeEEEEEccCCCChhHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEee
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTT---RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DF 663 (684)
..++++||+++++|..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988875322 1235789999999999999999999988 999999999999999999999999
Q ss_pred ccccccC
Q 005669 664 GLARSFG 670 (684)
Q Consensus 664 Gla~~~~ 670 (684)
|+++.+.
T Consensus 158 g~~~~~~ 164 (273)
T cd05074 158 GLSKKIY 164 (273)
T ss_pred ccccccc
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.9e-20 Score=186.85 Aligned_cols=149 Identities=32% Similarity=0.514 Sum_probs=133.5
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+|+..+.||+|++|.||++... .++.+++|.+..... ...+.+.+|++++++++|+|++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999876 478999999876543 4567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999998843 256899999999999999999999988 999999999999999999999999999987543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=211.76 Aligned_cols=153 Identities=22% Similarity=0.380 Sum_probs=119.9
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC--CcEEEEE------------------EccCCCcccHHHHHHHHHHHhccCCCc
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE--GQEIAVK------------------RLSKGSGQGMEEFKNEVLLIAKLQHRN 574 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~--g~~vavK------------------~l~~~~~~~~~~~~~Ei~~l~~l~H~n 574 (684)
..++|++.++||+|+||+||++.... +...++| .+.. .......+.+|+.++++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987543 1112222 1111 1223456889999999999999
Q ss_pred eeeEEEEEEeCCeeEEEEEccCCCChhHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 005669 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTR--SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (684)
Q Consensus 575 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl 652 (684)
|+++++++...+..++++|++.+ +|..++..... .......++..++.||+.||.|||+++ ||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999999999999999999864 55555533211 122345677889999999999999998 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCC
Q 005669 653 DNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 653 ~~~~~vkI~DFGla~~~~~~ 672 (684)
+.++.+||+|||+++.+...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~ 320 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKE 320 (501)
T ss_pred CCCCCEEEEeCCCceecCcc
Confidence 99999999999999987543
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=193.43 Aligned_cols=143 Identities=29% Similarity=0.460 Sum_probs=123.5
Q ss_pred ceecccCcEeEEEEEeeC--------CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 523 NKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+.||+|+||.||+|.... ..++++|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998643 235888888765445567788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc--------EEEEeeccc
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN--------PKISDFGLA 666 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~--------vkI~DFGla 666 (684)
+++++|..++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998543 235899999999999999999999988 999999999999987665 699999998
Q ss_pred cccC
Q 005669 667 RSFG 670 (684)
Q Consensus 667 ~~~~ 670 (684)
....
T Consensus 156 ~~~~ 159 (258)
T cd05078 156 ITVL 159 (258)
T ss_pred cccC
Confidence 7654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-20 Score=192.54 Aligned_cols=148 Identities=31% Similarity=0.539 Sum_probs=129.6
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+|+..+.||+|++|.||+++.. +++.||||++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999875 48899999887532 22345788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+. ++|..++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 96 5788887443 2456899999999999999999999988 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-20 Score=191.10 Aligned_cols=158 Identities=31% Similarity=0.494 Sum_probs=134.5
Q ss_pred cHHHHHhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEe-
Q 005669 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ- 584 (684)
Q Consensus 508 ~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~- 584 (684)
++.++....+.|+..+.||+|+||.||++.... ++.+|+|.+... .....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 445555667889999999999999999999754 789999988653 23446788899999998 69999999999853
Q ss_pred -----CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEE
Q 005669 585 -----RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPK 659 (684)
Q Consensus 585 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vk 659 (684)
.+..+++|||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 45789999999999999988543 2345788889999999999999999998 99999999999999999999
Q ss_pred EEeeccccccC
Q 005669 660 ISDFGLARSFG 670 (684)
Q Consensus 660 I~DFGla~~~~ 670 (684)
|+|||+++...
T Consensus 162 l~dfg~~~~~~ 172 (282)
T cd06636 162 LVDFGVSAQLD 172 (282)
T ss_pred EeeCcchhhhh
Confidence 99999988653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-20 Score=189.20 Aligned_cols=143 Identities=31% Similarity=0.546 Sum_probs=121.4
Q ss_pred ceecccCcEeEEEEEeeC----CcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEe-CCeeEEEEEccC
Q 005669 523 NKLGEGGFGPVYKGMLIE----GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDERMLIYEYLP 596 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~~ 596 (684)
+.||+|+||.||+|...+ ...+|+|.+... .....+.+.+|+.+++.++||||+++++++.. ++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 357999998643 23345678899999999999999999998764 455789999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999998532 234677888899999999999999988 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-19 Score=183.42 Aligned_cols=150 Identities=35% Similarity=0.557 Sum_probs=135.1
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
.|+..+.||+|++|.||++... +++.+++|++..........+.+|++++++++|+|++++++.+...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999986 588999999987654566789999999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+...
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999988442 246899999999999999999999988 999999999999999999999999999887654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=7e-20 Score=179.51 Aligned_cols=142 Identities=17% Similarity=0.186 Sum_probs=112.8
Q ss_pred cceecccCcEeEEEEEeeCCcEEEEEEccCCCccc--------------------------HHHHHHHHHHHhccCCCce
Q 005669 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG--------------------------MEEFKNEVLLIAKLQHRNL 575 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~--------------------------~~~~~~Ei~~l~~l~H~nI 575 (684)
...||+|++|.||+|...+|+.||||+++...... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999998789999999987642110 1123578999999999987
Q ss_pred eeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcC
Q 005669 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDN 654 (684)
Q Consensus 576 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~IvHrDLkp~NILl~~ 654 (684)
.....+... ..++||||++++++..... ....++..+...++.|++.+|.++|+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554444332 2489999999886543321 12357888999999999999999999 88 99999999999999
Q ss_pred CCcEEEEeeccccccCCC
Q 005669 655 TMNPKISDFGLARSFGLD 672 (684)
Q Consensus 655 ~~~vkI~DFGla~~~~~~ 672 (684)
++.++|+|||+|+.+..+
T Consensus 153 ~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 153 DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred CCCEEEEEcccceecCCC
Confidence 789999999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.83 E-value=8e-20 Score=186.88 Aligned_cols=150 Identities=27% Similarity=0.416 Sum_probs=130.8
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+|+..+.||+|++|.||++... .++.+|+|.+... .......+.+|++++++++|+|++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999875 4789999998754 233456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CcEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~-~~vkI~DFGla~~~~~ 671 (684)
+++++|.+++... ....+++..+..++.|+++||+|||+++ ++|+||||+||+++++ +.+||+|||+++.+..
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999998542 2345899999999999999999999988 9999999999999854 4689999999987753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=7e-20 Score=190.25 Aligned_cols=142 Identities=34% Similarity=0.466 Sum_probs=124.7
Q ss_pred ecccCcEeEEEEEee-CCcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCCh
Q 005669 525 LGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (684)
Q Consensus 525 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (684)
||+|+||+||++... +++.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 48899999986432 22344567899999999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
.+++.... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 99885432 246899999999999999999999998 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.2e-20 Score=192.40 Aligned_cols=149 Identities=30% Similarity=0.482 Sum_probs=128.6
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.+.|+..+.||+|+||.||++... +++.||+|.+..... ....++.+|+++++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 456888899999999999999975 488999998864322 2345688999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+||++ +++.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++...
T Consensus 94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99997 466665532 2345899999999999999999999988 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.8e-20 Score=189.72 Aligned_cols=153 Identities=29% Similarity=0.474 Sum_probs=133.3
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCC-----
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD----- 586 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~----- 586 (684)
..+++|+..+.||+|++|.||++.... ++.+++|.+.... ...+++.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 456889999999999999999999854 7899999987643 3456789999999999 6999999999997654
Q ss_pred -eeEEEEEccCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 587 -ERMLIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 587 -~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999885432 2456899999999999999999999988 9999999999999999999999999
Q ss_pred cccccC
Q 005669 665 LARSFG 670 (684)
Q Consensus 665 la~~~~ 670 (684)
++....
T Consensus 159 ~~~~~~ 164 (275)
T cd06608 159 VSAQLD 164 (275)
T ss_pred cceecc
Confidence 987653
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.7e-21 Score=195.70 Aligned_cols=154 Identities=31% Similarity=0.419 Sum_probs=128.5
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-------cccHHHHHHHHHHHhccCCCceeeEEEEEEe-CCe
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-------GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDE 587 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~ 587 (684)
++|-.++.||+|+|+.||++.+.. .+-||||+-.... ....+...+|.++.+.|+||.||++|+++.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 567778899999999999998654 6788998754321 1122345679999999999999999999965 456
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc---CCCcEEEEeec
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFG 664 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~---~~~~vkI~DFG 664 (684)
++-|+|||+|.+|+-+|. ..+.+++.++..|+.||+.||.||.+.. ++|||-||||.|||+. .-|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 789999999999999993 4567899999999999999999999885 7899999999999994 45789999999
Q ss_pred cccccCCCCC
Q 005669 665 LARSFGLDQT 674 (684)
Q Consensus 665 la~~~~~~~~ 674 (684)
++++++.+..
T Consensus 619 LSKIMdddSy 628 (775)
T KOG1151|consen 619 LSKIMDDDSY 628 (775)
T ss_pred hhhhccCCcc
Confidence 9999965543
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=200.84 Aligned_cols=149 Identities=29% Similarity=0.528 Sum_probs=130.0
Q ss_pred CCCccceecccCcEeEEEEEeeC---Cc--EEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE---GQ--EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~---g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.....++||+|.||.||+|...+ |+ .||||.-+.+ .....+.|..|..+|++++||||++++|+|.+ ...+||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 34456789999999999999643 33 5889988764 45567889999999999999999999999975 678999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
||.++-|.|..+|.. +...++......++.||+.||+|||+.. +|||||..+|||+.....+||+|||++|-+..
T Consensus 469 mEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999954 3456889999999999999999999987 99999999999999999999999999998854
Q ss_pred C
Q 005669 672 D 672 (684)
Q Consensus 672 ~ 672 (684)
+
T Consensus 544 ~ 544 (974)
T KOG4257|consen 544 D 544 (974)
T ss_pred c
Confidence 4
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.5e-20 Score=189.88 Aligned_cols=149 Identities=26% Similarity=0.391 Sum_probs=132.3
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
++|+..+.||+|++|.||++... +++.+|+|.+.... ....+++.+|++++++++|+||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999986 48899999987653 33456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||.+..+.
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 99999999985432 568999999999999999999999 77 9999999999999999999999999987663
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.4e-20 Score=190.72 Aligned_cols=151 Identities=28% Similarity=0.392 Sum_probs=130.1
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeC--CeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 592 (684)
++|+..++||.|++|.||++.... ++.+|+|.+..... ....++.+|++++++++|+||+++++++... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 367788999999999999999854 78999999875422 3456789999999999999999999998654 4689999
Q ss_pred EccCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 593 EYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999988875322 2456889999999999999999999988 9999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-20 Score=215.73 Aligned_cols=150 Identities=33% Similarity=0.485 Sum_probs=123.3
Q ss_pred hhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEE--------
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT-------- 583 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~-------- 583 (684)
+...+|+..+.||+|+||.||+++.+ ||+.+|||++... +......+.+|+.++++|+|||||+++..+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567888999999999999999974 7999999999864 2334556889999999999999998874110
Q ss_pred ----------------------------------------------------------------------e---------
Q 005669 584 ----------------------------------------------------------------------Q--------- 584 (684)
Q Consensus 584 ----------------------------------------------------------------------~--------- 584 (684)
+
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ------------------------C--------CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 005669 585 ------------------------R--------DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632 (684)
Q Consensus 585 ------------------------~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yL 632 (684)
+ ...||-||||+..++.+++.++.... .....++++.+|+.||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 0 12478899999988888884432211 4677889999999999999
Q ss_pred HhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 633 H~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
|+++ ||||||||.||++|++..|||+|||+|+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 9999 99999999999999999999999999987
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=189.06 Aligned_cols=141 Identities=28% Similarity=0.394 Sum_probs=118.1
Q ss_pred eecccCcEeEEEEEeeC-CcEEEEEEccCCCc---ccHHHHHHHHHHHh---ccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLIA---KLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 524 ~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~~l~---~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
.||+|+||.||++...+ ++.+|+|.+..... .....+.+|..+++ ..+|+|++.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999754 78999998865321 11223444544333 3479999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.+||+|||++..+.
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 9999988843 346899999999999999999999998 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.82 E-value=7e-20 Score=192.44 Aligned_cols=152 Identities=29% Similarity=0.480 Sum_probs=129.7
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC----
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD---- 586 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~---- 586 (684)
...++|++.+.||+|+||.||+|.... ++.||+|.++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 456789999999999999999999864 7899999987542 223456788999999999999999999987655
Q ss_pred ------eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEE
Q 005669 587 ------ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (684)
Q Consensus 587 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI 660 (684)
..++++||+++ ++...+.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 66666532 2346899999999999999999999998 999999999999999999999
Q ss_pred EeeccccccCC
Q 005669 661 SDFGLARSFGL 671 (684)
Q Consensus 661 ~DFGla~~~~~ 671 (684)
+|||+++.+..
T Consensus 158 ~dfg~~~~~~~ 168 (302)
T cd07864 158 ADFGLARLYNS 168 (302)
T ss_pred CcccccccccC
Confidence 99999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=187.37 Aligned_cols=152 Identities=24% Similarity=0.424 Sum_probs=128.5
Q ss_pred CCCccceecccCcEeEEEEEeeC--CcEEEEEEccCC----------CcccHHHHHHHHHHHhc-cCCCceeeEEEEEEe
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRLSKG----------SGQGMEEFKNEVLLIAK-LQHRNLVKLLGCCTQ 584 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~----------~~~~~~~~~~Ei~~l~~-l~H~nIv~l~g~~~~ 584 (684)
+|++.+.||+|+||.||++.... ++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999865 678999987532 12233457778888865 799999999999999
Q ss_pred CCeeEEEEEccCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCcEEEEe
Q 005669 585 RDERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISD 662 (684)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~IvHrDLkp~NILl~~~~~vkI~D 662 (684)
++..+++|||+++++|.+++... .....+++..+..++.|++.||.|||+ .+ ++|+||||+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999998887432 224568999999999999999999996 45 99999999999999999999999
Q ss_pred eccccccCCC
Q 005669 663 FGLARSFGLD 672 (684)
Q Consensus 663 FGla~~~~~~ 672 (684)
||++......
T Consensus 158 fg~~~~~~~~ 167 (269)
T cd08528 158 FGLAKQKQPE 167 (269)
T ss_pred ccceeecccc
Confidence 9999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.8e-20 Score=189.98 Aligned_cols=152 Identities=29% Similarity=0.491 Sum_probs=136.3
Q ss_pred HhhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 513 ANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 513 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
...++.|+..+.||+|++|.||++... +++.+++|.+..... ..+.+.+|++++++++|+|++++++.+...+..+++
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 346678888999999999999999986 488999999976543 567788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 99999999999985432 36899999999999999999999988 9999999999999999999999999887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=186.89 Aligned_cols=141 Identities=30% Similarity=0.382 Sum_probs=126.2
Q ss_pred ecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCCh
Q 005669 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (684)
Q Consensus 525 LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (684)
||.|++|.||++.... ++.+|+|.+.... ....+.+.+|+.++++++|+||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999864 8899999987532 23446789999999999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
.+++.+ ...+++..+..++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 999843 345899999999999999999999988 99999999999999999999999999988754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=183.98 Aligned_cols=150 Identities=29% Similarity=0.502 Sum_probs=134.0
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeC--CeeEEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERMLIY 592 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 592 (684)
+|+..+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|+.++++++|+||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999986 588999999876432 4567889999999999999999999999988 8899999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
||+++++|.+++... ..+++.++..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998542 37899999999999999999999988 999999999999999999999999999987654
Q ss_pred C
Q 005669 673 Q 673 (684)
Q Consensus 673 ~ 673 (684)
.
T Consensus 155 ~ 155 (260)
T cd06606 155 E 155 (260)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.3e-20 Score=195.67 Aligned_cols=152 Identities=26% Similarity=0.451 Sum_probs=129.7
Q ss_pred HHhhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC--
Q 005669 512 IANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-- 586 (684)
Q Consensus 512 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-- 586 (684)
+....++|+..+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++|+||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445678999999999999999999865 48899999986432 223456889999999999999999999987654
Q ss_pred ----eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEe
Q 005669 587 ----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISD 662 (684)
Q Consensus 587 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~D 662 (684)
..++||||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 358999998 678888773 245899999999999999999999988 99999999999999999999999
Q ss_pred eccccccCC
Q 005669 663 FGLARSFGL 671 (684)
Q Consensus 663 FGla~~~~~ 671 (684)
||+++....
T Consensus 162 fg~~~~~~~ 170 (343)
T cd07880 162 FGLARQTDS 170 (343)
T ss_pred ccccccccc
Confidence 999987643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.9e-20 Score=186.77 Aligned_cols=152 Identities=26% Similarity=0.456 Sum_probs=130.0
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEe--CCeeEEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDERMLIY 592 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~ 592 (684)
+|+..+.||.|+||.||++... +++.+|+|.+... .....+++.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999875 4789999988643 23345678899999999999999999998764 44579999
Q ss_pred EccCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 593 EYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLH-----QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH-----~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
||+++++|.+++.... ....+++..+..++.||+.||.||| +.+ ++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999985432 2456899999999999999999999 665 999999999999999999999999999
Q ss_pred cccCCC
Q 005669 667 RSFGLD 672 (684)
Q Consensus 667 ~~~~~~ 672 (684)
+.+...
T Consensus 158 ~~~~~~ 163 (265)
T cd08217 158 KILGHD 163 (265)
T ss_pred ccccCC
Confidence 987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=188.65 Aligned_cols=149 Identities=32% Similarity=0.505 Sum_probs=126.6
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
++|+..+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56888999999999999999976 48899999986532 2234678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCcEEEEeeccccccC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSFG 670 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~-~~~vkI~DFGla~~~~ 670 (684)
|+++ +|.+++... ....+++..+..++.||+.||+|||+++ ++|+||||+||++++ ++.+||+|||+++.+.
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 9974 676666332 2334678888899999999999999988 999999999999985 5679999999998764
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.8e-20 Score=189.08 Aligned_cols=145 Identities=39% Similarity=0.599 Sum_probs=125.0
Q ss_pred ceecccCcEeEEEEEeeC-------CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 523 NKLGEGGFGPVYKGMLIE-------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+.||+|+||.||++...+ ++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2578999886542 23456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-----cEEEEeecc
Q 005669 595 LPNKSLDYFIFDTT----RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-----NPKISDFGL 665 (684)
Q Consensus 595 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~-----~vkI~DFGl 665 (684)
+++++|.+++.... ....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986432 2234789999999999999999999988 99999999999999877 899999999
Q ss_pred ccccC
Q 005669 666 ARSFG 670 (684)
Q Consensus 666 a~~~~ 670 (684)
++.+.
T Consensus 158 ~~~~~ 162 (269)
T cd05044 158 ARDIY 162 (269)
T ss_pred ccccc
Confidence 98663
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.4e-20 Score=188.75 Aligned_cols=140 Identities=30% Similarity=0.444 Sum_probs=125.9
Q ss_pred ecccCcEeEEEEEeeC-CcEEEEEEccCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCCh
Q 005669 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (684)
Q Consensus 525 LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (684)
||+|+||.||++.... ++.+++|.+..... ...+.+.+|++++++++|+||+++++.+..++..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999875 89999999875432 3456788999999999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
.+++.+. ..+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~ 144 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGL 144 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence 9998542 36899999999999999999999988 9999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.1e-20 Score=204.39 Aligned_cols=150 Identities=23% Similarity=0.301 Sum_probs=120.5
Q ss_pred HHhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCC------CceeeEEEEEEe
Q 005669 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH------RNLVKLLGCCTQ 584 (684)
Q Consensus 512 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H------~nIv~l~g~~~~ 584 (684)
+....++|++.++||+|+||+||++.... ++.||||+++.. .........|+.+++.++| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 34456889999999999999999999754 788999998643 2233456667777777654 458899998876
Q ss_pred C-CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCC------
Q 005669 585 R-DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTM------ 656 (684)
Q Consensus 585 ~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~IvHrDLkp~NILl~~~~------ 656 (684)
. .+.++|||++ +++|.+++.+ ...+++.++..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 4 4688999988 5677777743 34689999999999999999999974 6 99999999999998665
Q ss_pred ----------cEEEEeecccccc
Q 005669 657 ----------NPKISDFGLARSF 669 (684)
Q Consensus 657 ----------~vkI~DFGla~~~ 669 (684)
.+||+|||.+...
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred cccccCCCCceEEECCCCccccC
Confidence 4999999988653
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=188.63 Aligned_cols=146 Identities=27% Similarity=0.438 Sum_probs=130.0
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
.|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3455579999999999999864 578999999875544556678899999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++|.+++.. ..+++.++..++.|++.||+|||+++ |+||||+|+||+++.++.+||+|||+++...
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence 9999998843 45889999999999999999999998 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=200.71 Aligned_cols=170 Identities=29% Similarity=0.474 Sum_probs=145.2
Q ss_pred cHHHHHhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEe-
Q 005669 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ- 584 (684)
Q Consensus 508 ~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~- 584 (684)
.+..+...++.|++.+.||.|.+|.||+++... ++.+|+|++... ....+++..|.++++.. +|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 345556677889999999999999999999654 888999998764 44557788899999887 69999999999864
Q ss_pred ----CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEE
Q 005669 585 ----RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (684)
Q Consensus 585 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI 660 (684)
++.++||||||.+|+.-+++.... ...+.|+.+..|++.++.||.|||.+. ++|||||-.|||++.++.+|+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 567999999999999999986655 778999999999999999999999987 999999999999999999999
Q ss_pred EeeccccccCCCCCccCCcccccC
Q 005669 661 SDFGLARSFGLDQTEANTKRVVGT 684 (684)
Q Consensus 661 ~DFGla~~~~~~~~~~~~~~~~GT 684 (684)
.|||++..++... .+..+.+||
T Consensus 165 vDFGvSaQldsT~--grRnT~iGt 186 (953)
T KOG0587|consen 165 VDFGVSAQLDSTV--GRRNTFIGT 186 (953)
T ss_pred eeeeeeeeeeccc--ccccCcCCC
Confidence 9999999886443 334456776
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=221.57 Aligned_cols=144 Identities=29% Similarity=0.522 Sum_probs=122.8
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
....+...+.||+|+||.||+|... +++.||||+++..... ..+|++.+++++|||||+++++|.+++..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3456777889999999999999974 5899999998754321 2356889999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
|+++++|.+++. .++|.++..++.||++||+|||.++..+|+||||||+||+++.++.+++. ||.+...
T Consensus 764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 999999999983 27899999999999999999996655569999999999999999888875 6666543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-20 Score=198.04 Aligned_cols=150 Identities=28% Similarity=0.389 Sum_probs=127.7
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc--------ccHHHHHHHHHHHhccC---CCceeeEEEEEEe
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--------QGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQ 584 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~ 584 (684)
..|...+.+|+|+||.|+.+.++. ..+|+||.+.+..- ...-..--|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 358888999999999999999876 57899998876411 11122445999999997 9999999999999
Q ss_pred CCeeEEEEEcc-CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEee
Q 005669 585 RDERMLIYEYL-PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (684)
Q Consensus 585 ~~~~~lV~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DF 663 (684)
++.+||+||-. ++-+|.+++ .....+++.++..|++||+.|+++||+++ |||||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999975 456788888 34556999999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCC
Q 005669 664 GLARSFGLD 672 (684)
Q Consensus 664 Gla~~~~~~ 672 (684)
|.|......
T Consensus 715 gsaa~~ksg 723 (772)
T KOG1152|consen 715 GSAAYTKSG 723 (772)
T ss_pred cchhhhcCC
Confidence 999876543
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=191.06 Aligned_cols=150 Identities=28% Similarity=0.517 Sum_probs=126.6
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC------
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ 586 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 586 (684)
.++|+..++||+|+||.||++... +++.||||.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457899999999999999999975 48899999886432 222345678999999999999999999987654
Q ss_pred --eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 587 --ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 587 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
..++||||+++ +|...+.. ....+++.++..++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 34999999975 77776632 2336899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCC
Q 005669 665 LARSFGL 671 (684)
Q Consensus 665 la~~~~~ 671 (684)
++..+..
T Consensus 165 ~~~~~~~ 171 (310)
T cd07865 165 LARAFSL 171 (310)
T ss_pred CcccccC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.3e-20 Score=190.72 Aligned_cols=149 Identities=34% Similarity=0.464 Sum_probs=132.8
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV 591 (684)
++|...+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++ |+||+++++.+..++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999976 4899999998753 2233467888999999998 99999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999843 346999999999999999999999988 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-20 Score=193.45 Aligned_cols=156 Identities=29% Similarity=0.403 Sum_probs=137.3
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.+.|..-+.||+|+||.||-+.... |+-+|.|++.+. ..++.....+|-.+|.+++.+.||.+-..+++.+..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 4567777899999999999998765 889999988653 344555678899999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+..|.||+|..+|... ....+++..+..++.+|+.||++||... ||.|||||+|||+|+.|+++|+|.|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999888553 3467999999999999999999999987 99999999999999999999999999999876
Q ss_pred CCCc
Q 005669 672 DQTE 675 (684)
Q Consensus 672 ~~~~ 675 (684)
.+..
T Consensus 340 g~~~ 343 (591)
T KOG0986|consen 340 GKPI 343 (591)
T ss_pred CCcc
Confidence 6543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=191.43 Aligned_cols=151 Identities=34% Similarity=0.547 Sum_probs=128.9
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC--CeeE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERM 589 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 589 (684)
..++|+..+.||+|+||.||++.... ++.||+|.++... ......+.+|+.++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 34679999999999999999999754 8899999987432 22234567899999999999999999998765 4689
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+||||+++ +|.+++... ...+++.++..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||+++.+
T Consensus 85 lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999975 787777432 256899999999999999999999998 999999999999999999999999999887
Q ss_pred CC
Q 005669 670 GL 671 (684)
Q Consensus 670 ~~ 671 (684)
..
T Consensus 159 ~~ 160 (309)
T cd07845 159 GL 160 (309)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=188.12 Aligned_cols=148 Identities=30% Similarity=0.505 Sum_probs=129.6
Q ss_pred CCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC--CeeEEEEE
Q 005669 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERMLIYE 593 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E 593 (684)
|++.++||+|++|.||++...+ ++.+|+|++.... ......+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5677899999999999999765 7899999998652 33345688999999999999999999999988 78999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|+++ +|..++... ...+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9985 888877432 246899999999999999999999988 999999999999999999999999999887544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-20 Score=202.87 Aligned_cols=151 Identities=34% Similarity=0.512 Sum_probs=133.8
Q ss_pred CccceecccCcEeEEEEEeeC--Cc--EEEEEEccCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 520 SEKNKLGEGGFGPVYKGMLIE--GQ--EIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 520 ~~~~~LG~G~fG~Vy~~~~~~--g~--~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
...++||+|.||.|++|.+.. |+ .||||.++..... .+..|++|+.+|.+|+|+|+++|||+..+ ....+|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 345789999999999999754 43 6899999876443 68899999999999999999999999987 778899999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~~ 674 (684)
++.|+|.+.|.+ .....|.......++.|||.||.||..+. +|||||..+|+||-....+||+|||+.|.++.++.
T Consensus 192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999976 44566888899999999999999999987 99999999999999998999999999999987665
Q ss_pred c
Q 005669 675 E 675 (684)
Q Consensus 675 ~ 675 (684)
.
T Consensus 268 ~ 268 (1039)
T KOG0199|consen 268 M 268 (1039)
T ss_pred c
Confidence 3
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=190.30 Aligned_cols=143 Identities=27% Similarity=0.424 Sum_probs=127.7
Q ss_pred cceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCCh
Q 005669 522 KNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (684)
..+||+|+||.||++... +++.||+|++........+.+.+|+.++++++|+|++++++.+...+..+++|||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 367999999999999875 5889999998755445566789999999999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
.+++. ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++..+..
T Consensus 105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 98773 235789999999999999999999988 99999999999999999999999999876643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.7e-20 Score=194.88 Aligned_cols=149 Identities=27% Similarity=0.445 Sum_probs=127.3
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-----e
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-----E 587 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~ 587 (684)
..++|++.++||+|+||.||++... +++.||+|.+... .......+.+|+.++++++|+||+++++++.... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999865 4889999998643 2334566888999999999999999999876543 5
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.++++||+++ +|...+. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 83 VYIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 7999999975 7766662 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCC
Q 005669 668 SFGL 671 (684)
Q Consensus 668 ~~~~ 671 (684)
....
T Consensus 155 ~~~~ 158 (336)
T cd07849 155 IADP 158 (336)
T ss_pred eccc
Confidence 7643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-20 Score=198.30 Aligned_cols=148 Identities=24% Similarity=0.420 Sum_probs=130.9
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
..-|..++.||-|+||+|.++...+ ...+|+|.+++.+ .......+.|-.||+..+.+-||+|+-.|++++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3457788999999999999998655 5678999998653 33445678899999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
|||++||++-.+|. +-+.++++.+..++.++..|+++.|..| +|||||||+|||||.+|++||+||||+.-+
T Consensus 708 MdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 99999999998884 3466899999999999999999999988 999999999999999999999999999755
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=194.47 Aligned_cols=149 Identities=30% Similarity=0.545 Sum_probs=127.5
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC--Cee
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR--DER 588 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~--~~~ 588 (684)
..++|+..+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888999999999999999976 4789999988542 223345677899999999 999999999998654 367
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999998 588887732 26789999999999999999999988 99999999999999999999999999987
Q ss_pred cCC
Q 005669 669 FGL 671 (684)
Q Consensus 669 ~~~ 671 (684)
+..
T Consensus 157 ~~~ 159 (337)
T cd07852 157 LSE 159 (337)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.2e-20 Score=195.26 Aligned_cols=149 Identities=22% Similarity=0.442 Sum_probs=128.4
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe----CCee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~ 588 (684)
.++|+..+.||+|++|.||++.... ++.||+|++.... ......+.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3688889999999999999999754 8899999987542 2345677889999999999999999998753 3467
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++||||+. ++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 58888873 3345899999999999999999999988 99999999999999999999999999987
Q ss_pred cCC
Q 005669 669 FGL 671 (684)
Q Consensus 669 ~~~ 671 (684)
+..
T Consensus 157 ~~~ 159 (334)
T cd07855 157 LSS 159 (334)
T ss_pred ecc
Confidence 643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.2e-21 Score=219.05 Aligned_cols=154 Identities=29% Similarity=0.458 Sum_probs=135.4
Q ss_pred HhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 513 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
...+-+|+...+||.|.||.||.+...+ |...|+|.++.. .........+|..++..++|||+|+.+|+-.+.+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3455678888999999999999999765 888999987643 3445667889999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
|.||||++|+|.+.+.. ....++.....+..|++.|+.|||+++ ||||||||+||+|+.+|.+|++|||.|..+
T Consensus 1311 IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 99999999999999833 344677777888999999999999999 999999999999999999999999999998
Q ss_pred CCC
Q 005669 670 GLD 672 (684)
Q Consensus 670 ~~~ 672 (684)
...
T Consensus 1385 ~~~ 1387 (1509)
T KOG4645|consen 1385 KNN 1387 (1509)
T ss_pred cCc
Confidence 654
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-19 Score=187.18 Aligned_cols=147 Identities=31% Similarity=0.532 Sum_probs=128.7
Q ss_pred CCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
|+..++||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++|+|++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999875 58999999987542 223457889999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+ ++|.+++.... ...+++..+..++.|+++||.|||+++ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 68988874432 246899999999999999999999988 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=193.99 Aligned_cols=148 Identities=30% Similarity=0.458 Sum_probs=126.4
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC------
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------ 585 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------ 585 (684)
..++|+..+.||+|+||.||++... +++.||+|.+... .......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3478999999999999999999975 4889999998643 223345677899999999999999999988643
Q ss_pred CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecc
Q 005669 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGl 665 (684)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 346999999975 77776622 2888999999999999999999998 99999999999999999999999999
Q ss_pred ccccCC
Q 005669 666 ARSFGL 671 (684)
Q Consensus 666 a~~~~~ 671 (684)
++..+.
T Consensus 165 ~~~~~~ 170 (353)
T cd07850 165 ARTAGT 170 (353)
T ss_pred ceeCCC
Confidence 987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-19 Score=185.71 Aligned_cols=141 Identities=30% Similarity=0.401 Sum_probs=118.3
Q ss_pred eecccCcEeEEEEEeeC-CcEEEEEEccCCCc---ccHHHHHHHHH---HHhccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVL---LIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 524 ~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~---~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
.||+|+||.||++.... ++.||+|.+..... .....+..|.. .++...|++|+++++.+...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999998754 78999999875321 11222344443 3444579999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++|..++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 9999988843 356899999999999999999999988 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-19 Score=188.80 Aligned_cols=148 Identities=29% Similarity=0.492 Sum_probs=127.4
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.|+..+.||+|+||.||++... +++.+|+|.+..... .....+.+|++++++++|+|++++++++..++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4777889999999999999975 478999999874322 234568889999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|+++ +|.+.+.. ....+++.++..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9975 66666532 2345899999999999999999999998 99999999999999999999999999876643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=184.99 Aligned_cols=150 Identities=27% Similarity=0.450 Sum_probs=130.9
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+|+..+.||+|+||.||++.... +..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47788999999999999999865 7899999986531 23456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-cEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~-~vkI~DFGla~~~~~ 671 (684)
+++++|.+++.+. ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++ .+||+|||.+..+..
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999988543 2345799999999999999999999988 99999999999998875 579999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-19 Score=181.73 Aligned_cols=152 Identities=24% Similarity=0.406 Sum_probs=134.6
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+|+..+.||+|+||.||++... +++.+++|++..... .....+.+|++++++++|+|++++++.+..++..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999986 488999999876432 4566788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+++++|.+++.... ....+++.++..++.+++.||.|||+++ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999885432 1367899999999999999999999998 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=200.43 Aligned_cols=153 Identities=24% Similarity=0.407 Sum_probs=120.3
Q ss_pred hcCCCCccceecccCcEeEEEEEe-----------------eCCcEEEEEEccCCCcccHHH--------------HHHH
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGML-----------------IEGQEIAVKRLSKGSGQGMEE--------------FKNE 563 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~--------------~~~E 563 (684)
..++|++.++||+|+||.||+|.. ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 235679999987543222222 3346
Q ss_pred HHHHhccCCCce-----eeEEEEEEe--------CCeeEEEEEccCCCChhHHHhccCC---------------------
Q 005669 564 VLLIAKLQHRNL-----VKLLGCCTQ--------RDERMLIYEYLPNKSLDYFIFDTTR--------------------- 609 (684)
Q Consensus 564 i~~l~~l~H~nI-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~--------------------- 609 (684)
+..+.+++|.++ ++++++|.. .+..++||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 677777753 3568999999999999998853211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 610 SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 610 ~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~ 360 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence 123567788899999999999999988 9999999999999999999999999997654
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=187.97 Aligned_cols=148 Identities=29% Similarity=0.378 Sum_probs=128.5
Q ss_pred CCCccceecccCcEeEEEEEee----CCcEEEEEEccCCC----cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCee
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGS----GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 588 (684)
+|+..+.||+|++|.||++... +++.+|||.++... ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677889999999999999853 46789999986431 22345678899999999 599999999999999999
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++||||+++++|..++.. ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999988843 345889999999999999999999988 99999999999999999999999999987
Q ss_pred cCC
Q 005669 669 FGL 671 (684)
Q Consensus 669 ~~~ 671 (684)
+..
T Consensus 155 ~~~ 157 (288)
T cd05583 155 FLA 157 (288)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.4e-19 Score=182.23 Aligned_cols=149 Identities=24% Similarity=0.312 Sum_probs=122.4
Q ss_pred HHhhcCCCCcccee--cccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCe
Q 005669 512 IANATDNFSEKNKL--GEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 512 l~~~t~~y~~~~~L--G~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 587 (684)
.....++|++.+.+ |+|+||.||++.... ++.+|+|.+........ |+.....+ +|+||+++++.+...+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34445677776666 999999999999754 78899998865321111 22222222 79999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-cEEEEeeccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLA 666 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~-~vkI~DFGla 666 (684)
.++||||+++++|.+++.. ...+++.++..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999843 237899999999999999999999998 99999999999999888 9999999999
Q ss_pred cccCC
Q 005669 667 RSFGL 671 (684)
Q Consensus 667 ~~~~~ 671 (684)
+....
T Consensus 158 ~~~~~ 162 (267)
T PHA03390 158 KIIGT 162 (267)
T ss_pred eecCC
Confidence 87654
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-19 Score=191.45 Aligned_cols=154 Identities=30% Similarity=0.458 Sum_probs=129.9
Q ss_pred HHHHHhhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 005669 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR 585 (684)
Q Consensus 509 ~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~ 585 (684)
..++....++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3445667799999999999999999999864 58899999987532 22345678899999999999999999988643
Q ss_pred ------CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEE
Q 005669 586 ------DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPK 659 (684)
Q Consensus 586 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vk 659 (684)
...++++|++ +++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3367888876 678887773 235899999999999999999999998 99999999999999999999
Q ss_pred EEeeccccccC
Q 005669 660 ISDFGLARSFG 670 (684)
Q Consensus 660 I~DFGla~~~~ 670 (684)
|+|||+++...
T Consensus 161 l~dfg~~~~~~ 171 (345)
T cd07877 161 ILDFGLARHTD 171 (345)
T ss_pred Eeccccccccc
Confidence 99999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=183.39 Aligned_cols=142 Identities=30% Similarity=0.385 Sum_probs=119.9
Q ss_pred ceecccCcEeEEEEEeeC-CcEEEEEEccCCCc---ccHHHHHHHHHHH-hccCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLI-AKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~~l-~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.||+|+||.||+|.... ++.||+|.+..... .....+..|..++ ...+|+|++++++.+..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999998754 78999999875321 1223344454444 455899999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 999999843 345899999999999999999999988 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=191.63 Aligned_cols=148 Identities=26% Similarity=0.402 Sum_probs=126.8
Q ss_pred cCCCCc-cceecccCcEeEEEEEee-CCcEEEEEEccCCCccc--------------HHHHHHHHHHHhccCCCceeeEE
Q 005669 516 TDNFSE-KNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQG--------------MEEFKNEVLLIAKLQHRNLVKLL 579 (684)
Q Consensus 516 t~~y~~-~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~Ei~~l~~l~H~nIv~l~ 579 (684)
.++|.. .+.||+|+||.||++... .++.||||.+....... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345653 467999999999999975 48899999886532211 12477899999999999999999
Q ss_pred EEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEE
Q 005669 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPK 659 (684)
Q Consensus 580 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vk 659 (684)
+++..++..+++|||++ ++|.+++.. ...+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 588888732 345899999999999999999999988 99999999999999999999
Q ss_pred EEeeccccccC
Q 005669 660 ISDFGLARSFG 670 (684)
Q Consensus 660 I~DFGla~~~~ 670 (684)
|+|||+++.+.
T Consensus 160 l~dfg~~~~~~ 170 (335)
T PTZ00024 160 IADFGLARRYG 170 (335)
T ss_pred ECCccceeecc
Confidence 99999998765
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-19 Score=192.12 Aligned_cols=149 Identities=26% Similarity=0.472 Sum_probs=127.8
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC-----Ce
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-----DE 587 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 587 (684)
.++|...+.||+|+||.||++... +++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999975 4889999998753 233345677899999999999999999988654 34
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.++++||+. ++|.+++. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 67877773 2356899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCC
Q 005669 668 SFGL 671 (684)
Q Consensus 668 ~~~~ 671 (684)
....
T Consensus 157 ~~~~ 160 (337)
T cd07858 157 TTSE 160 (337)
T ss_pred ccCC
Confidence 7643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-19 Score=184.83 Aligned_cols=145 Identities=25% Similarity=0.376 Sum_probs=122.6
Q ss_pred CCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccC-CCceeeEEEEEEeC--CeeEEEEE
Q 005669 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQR--DERMLIYE 593 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~E 593 (684)
|+..++||+|+||.||++... +++.+|+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566789999999999999975 48899999987542 222234457888898885 99999999999987 88999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|+++ +|.+.+... ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++ +.+||+|||+++.+.
T Consensus 81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 9975 776766432 246899999999999999999999998 999999999999999 999999999998764
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-19 Score=190.03 Aligned_cols=150 Identities=29% Similarity=0.456 Sum_probs=128.9
Q ss_pred HhhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEe-CCee
Q 005669 513 ANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDER 588 (684)
Q Consensus 513 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~ 588 (684)
...+++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999865 5889999988643 22345678899999999999999999999876 5578
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++++||+. ++|..++. ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.
T Consensus 86 ~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELLG-TDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehhc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 99999984 68887773 235788888999999999999999998 99999999999999999999999999986
Q ss_pred cC
Q 005669 669 FG 670 (684)
Q Consensus 669 ~~ 670 (684)
..
T Consensus 158 ~~ 159 (328)
T cd07856 158 QD 159 (328)
T ss_pred cC
Confidence 54
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-19 Score=181.98 Aligned_cols=152 Identities=30% Similarity=0.475 Sum_probs=132.4
Q ss_pred CCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+|++.++||+|++|.||++... +++.+++|.+.... ......+.+|++++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999865 47899999987532 23345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+++++|..++.+.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999885422 2356899999999999999999999998 999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.4e-19 Score=188.20 Aligned_cols=146 Identities=28% Similarity=0.410 Sum_probs=123.0
Q ss_pred CCCccceecccCcEeEEEEEeeC---CcEEEEEEccCCC--cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC----Ce
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR----DE 587 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~----~~ 587 (684)
+|+..+.||+|+||.||++.... +..+|+|++.... ....+.+.+|+.+++++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47778899999999999999753 6789999987432 22345678899999999 599999999976433 45
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.++++||++ ++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788899886 58888873 3456899999999999999999999998 9999999999999999999999999998
Q ss_pred ccC
Q 005669 668 SFG 670 (684)
Q Consensus 668 ~~~ 670 (684)
.+.
T Consensus 154 ~~~ 156 (332)
T cd07857 154 GFS 156 (332)
T ss_pred ecc
Confidence 764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-21 Score=185.79 Aligned_cols=151 Identities=29% Similarity=0.555 Sum_probs=124.1
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEe--------C
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--------R 585 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--------~ 585 (684)
..|+...+||+|.||.||+++..+ ++.||+|++-.. .........+|+++|..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 457777899999999999999765 778898875432 22334556789999999999999999888753 2
Q ss_pred CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecc
Q 005669 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGl 665 (684)
...|+|+.+|+. +|.-+|. .....++..++..++.+++.||.|+|... |+|||+||+|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347999999985 6766662 23356899999999999999999999887 99999999999999999999999999
Q ss_pred ccccCCCC
Q 005669 666 ARSFGLDQ 673 (684)
Q Consensus 666 a~~~~~~~ 673 (684)
||.+....
T Consensus 171 ar~fs~~~ 178 (376)
T KOG0669|consen 171 ARAFSTSK 178 (376)
T ss_pred ccceeccc
Confidence 99885443
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.9e-19 Score=183.91 Aligned_cols=148 Identities=32% Similarity=0.516 Sum_probs=129.2
Q ss_pred CCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
|+..+.||+|++|.||++... +++.+++|.+..... .....+.+|+.++++++|+||+++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999975 488999999875432 24567888999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
++ +|.+++... ...+++.++..++.|++.||.|||+++ |+|+||||+||++++++.+||+|||.+..+...
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 85 777777432 246899999999999999999999998 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-19 Score=190.62 Aligned_cols=148 Identities=30% Similarity=0.481 Sum_probs=130.0
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-----eeE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-----ERM 589 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~ 589 (684)
+|++.+.||+|++|.||++.... ++.+|+|++.... ....+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47788999999999999999765 8899999987643 344567899999999999999999999998775 789
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
++|||++ ++|..++.. ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 478887733 337899999999999999999999998 999999999999999999999999999987
Q ss_pred CCC
Q 005669 670 GLD 672 (684)
Q Consensus 670 ~~~ 672 (684)
...
T Consensus 154 ~~~ 156 (330)
T cd07834 154 DPD 156 (330)
T ss_pred ccc
Confidence 544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=184.57 Aligned_cols=148 Identities=34% Similarity=0.467 Sum_probs=127.4
Q ss_pred CCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc-ccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEEEEcc
Q 005669 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
|++.+.||+|++|.||+|...+ ++.|++|++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5677899999999999999865 78899999875422 22234567999999999 999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++|.+.+.... ...+++.++..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||+++....
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 788888774432 346899999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-18 Score=183.74 Aligned_cols=145 Identities=31% Similarity=0.501 Sum_probs=124.8
Q ss_pred CCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
|...++||+|+||.||+|... .++.|++|++..... .....+.+|++++++++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566678999999999999875 478999999874322 2345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+.+ ++.+++.. ....+++.++..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++...
T Consensus 103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 974 66666632 2346899999999999999999999998 999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.6e-19 Score=188.96 Aligned_cols=146 Identities=29% Similarity=0.496 Sum_probs=124.7
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC------
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ 586 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 586 (684)
.++|...+.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999975 4899999998753 2223456889999999999999999999987543
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999974 666554 235889999999999999999999988 999999999999999999999999999
Q ss_pred cccC
Q 005669 667 RSFG 670 (684)
Q Consensus 667 ~~~~ 670 (684)
+...
T Consensus 165 ~~~~ 168 (342)
T cd07879 165 RHAD 168 (342)
T ss_pred cCCC
Confidence 8753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.80 E-value=6e-19 Score=188.10 Aligned_cols=142 Identities=23% Similarity=0.324 Sum_probs=123.0
Q ss_pred ceeccc--CcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEG--GFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G--~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
..||+| +||+||++.+. .++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 99999999975 58999999987532 22346788999999999999999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+..
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 99999885432 345889999999999999999999988 99999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.6e-19 Score=186.85 Aligned_cols=144 Identities=19% Similarity=0.221 Sum_probs=122.9
Q ss_pred cceecccCcEeEEEEEeeCCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005669 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 599 (684)
.+.+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++|+||+++++++...+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34555666666666654 5899999998754 33455789999999999999999999999999999999999999999
Q ss_pred hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 600 L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|.+++.... ...+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||.+..+.
T Consensus 86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence 999985432 345889999999999999999999998 9999999999999999999999999987653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.2e-19 Score=187.17 Aligned_cols=150 Identities=33% Similarity=0.505 Sum_probs=126.2
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCC------
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ 586 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 586 (684)
.++|++.++||+|+||.||++... +++.+|+|++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999975 478999998864322 22346788999999999999999999875433
Q ss_pred --eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 587 --ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 587 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
..++|+||+++ +|...+.. ....+++..+..++.|+++||.|||+++ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999975 56565532 2346899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCC
Q 005669 665 LARSFGL 671 (684)
Q Consensus 665 la~~~~~ 671 (684)
+++....
T Consensus 161 ~~~~~~~ 167 (311)
T cd07866 161 LARPYDG 167 (311)
T ss_pred cchhccC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.7e-19 Score=189.34 Aligned_cols=163 Identities=23% Similarity=0.314 Sum_probs=136.1
Q ss_pred hcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCC--CcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV 591 (684)
....|+++++||+||.+.||++...+.+.+|+|++... +.+....|++|+..|.+|+ |.+||++++|-..++..|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 34568999999999999999999888888998877533 5566788999999999995 99999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||-+ .+|..+|.... ...+.-.+..+..|++.|+.++|+++ |||.||||.|+|+-+ |.+||+|||+|..+..
T Consensus 439 mE~Gd-~DL~kiL~k~~--~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKK--SIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eeccc-ccHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 99864 68989885432 22332377889999999999999998 999999999999974 5999999999999987
Q ss_pred CCCccCCcccccC
Q 005669 672 DQTEANTKRVVGT 684 (684)
Q Consensus 672 ~~~~~~~~~~~GT 684 (684)
+.+......-+||
T Consensus 512 DTTsI~kdsQvGT 524 (677)
T KOG0596|consen 512 DTTSIVKDSQVGT 524 (677)
T ss_pred cccceeeccccCc
Confidence 7665544445665
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.4e-19 Score=184.03 Aligned_cols=149 Identities=24% Similarity=0.413 Sum_probs=125.9
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-cccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~ 592 (684)
.++|+..+.||+|++|.||++.... ++.||||.++... .....++.+|+.++.+.. |+||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3678888999999999999999865 8899999987542 223455667777777775 999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||+++ ++..++... ...+++..+..++.||+.||+|||+ .+ |+||||+|+||++++++.+||+|||+++.+.
T Consensus 94 e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99864 676666332 3468999999999999999999997 46 9999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-20 Score=188.68 Aligned_cols=160 Identities=31% Similarity=0.392 Sum_probs=134.7
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 591 (684)
.+|..+.+||+|+||+|.++..+. .+.+|||++++.- ....+--+.|-++|+.. +-|.+++++.+++.-+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 457788999999999999998765 5679999998752 23344456677788776 578999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+.||+|-..+. +-..+.+..+..++.+|+-||-+||+++ ||.||||..|||+|.+|++||+|||+++.---
T Consensus 429 MEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999988883 3456888899999999999999999999 99999999999999999999999999986432
Q ss_pred CCCccCCcccccC
Q 005669 672 DQTEANTKRVVGT 684 (684)
Q Consensus 672 ~~~~~~~~~~~GT 684 (684)
....|++++||
T Consensus 503 --~~~TTkTFCGT 513 (683)
T KOG0696|consen 503 --DGVTTKTFCGT 513 (683)
T ss_pred --CCcceeeecCC
Confidence 23456778887
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-18 Score=180.32 Aligned_cols=148 Identities=30% Similarity=0.519 Sum_probs=124.4
Q ss_pred CCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc--ccHHHHHHHHHHHhcc---CCCceeeEEEEEEeCCe-----
Q 005669 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKL---QHRNLVKLLGCCTQRDE----- 587 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~~~~----- 587 (684)
|++.+.||+|+||.||++.... ++.+|+|+++.... .....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999865 89999999874322 2234566787776665 59999999999988776
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.+++|||+.+ +|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 7888774422 235899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCC
Q 005669 668 SFGL 671 (684)
Q Consensus 668 ~~~~ 671 (684)
.+..
T Consensus 156 ~~~~ 159 (287)
T cd07838 156 IYSF 159 (287)
T ss_pred eccC
Confidence 8753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.1e-19 Score=183.16 Aligned_cols=149 Identities=26% Similarity=0.407 Sum_probs=124.2
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-cccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+|+..++||+|+||.||++.... ++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 45566889999999999999754 7899999987542 234567889999999996 99999999999999999999999
Q ss_pred cCCCChhHHHhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFD--TTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+.. ++..+... ......+++..+..++.|++.||+|||+. + |+||||||+||++++++.+||+|||+++.+.
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 874 55443211 11235689999999999999999999975 5 9999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=177.79 Aligned_cols=141 Identities=31% Similarity=0.412 Sum_probs=125.9
Q ss_pred ecccCcEeEEEEEeeC-CcEEEEEEccCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCCh
Q 005669 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (684)
Q Consensus 525 LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (684)
||+|+||.||++...+ ++.+|+|.+..... .....+..|+.++++++|+||+++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999764 88999999875422 2456788999999999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 999843 335899999999999999999999988 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=184.67 Aligned_cols=149 Identities=31% Similarity=0.497 Sum_probs=127.3
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
+.|+..+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 447777899999999999999754 788999988642 2233456788999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
||+. +++...+... ...+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+..
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9997 5776666332 345889999999999999999999988 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.79 E-value=6e-19 Score=189.32 Aligned_cols=147 Identities=27% Similarity=0.466 Sum_probs=126.6
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeC---------
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--------- 585 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--------- 585 (684)
..+|...+.||+|+||.||+|.... ++.||+|.+........+.+.+|++++++++|+||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 3678999999999999999999754 889999998766556667889999999999999999999776543
Q ss_pred -----CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCcEE
Q 005669 586 -----DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPK 659 (684)
Q Consensus 586 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~-~~~~vk 659 (684)
...++|+||++ ++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 58877773 235889999999999999999999988 99999999999997 456799
Q ss_pred EEeeccccccC
Q 005669 660 ISDFGLARSFG 670 (684)
Q Consensus 660 I~DFGla~~~~ 670 (684)
|+|||+++.+.
T Consensus 156 l~dfg~~~~~~ 166 (342)
T cd07854 156 IGDFGLARIVD 166 (342)
T ss_pred ECCcccceecC
Confidence 99999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.8e-19 Score=182.72 Aligned_cols=147 Identities=33% Similarity=0.541 Sum_probs=129.6
Q ss_pred CCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
|+..+.||+|.+|.||++.... ++.+|+|.+.... ....+.+.+|+.++++++|+|++++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5566889999999999999865 8999999988652 334567888999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+ ++|.+++.... ..+++..+..++.|++.||+|||+++ |+|+||+|+||++++++.+||+|||+++....
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 8 58999885432 46899999999999999999999998 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=180.98 Aligned_cols=150 Identities=22% Similarity=0.326 Sum_probs=111.7
Q ss_pred hcCCCCccceecccCcEeEEEEEeeCC----cEEEEEEccCCCcccH-H----------HHHHHHHHHhccCCCceeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIEG----QEIAVKRLSKGSGQGM-E----------EFKNEVLLIAKLQHRNLVKLL 579 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~g----~~vavK~l~~~~~~~~-~----------~~~~Ei~~l~~l~H~nIv~l~ 579 (684)
..++|++.++||+|+||.||+|...+. ..+|+|.......... + ....+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999997553 4566665432221111 1 112233455667899999999
Q ss_pred EEEEeCC----eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC
Q 005669 580 GCCTQRD----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT 655 (684)
Q Consensus 580 g~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~ 655 (684)
+.+.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 9776543 34678887653 55555522 223578888999999999999999988 9999999999999999
Q ss_pred CcEEEEeeccccccCC
Q 005669 656 MNPKISDFGLARSFGL 671 (684)
Q Consensus 656 ~~vkI~DFGla~~~~~ 671 (684)
+.+||+|||+|+.+..
T Consensus 163 ~~~~l~DFGla~~~~~ 178 (294)
T PHA02882 163 NRGYIIDYGIASHFII 178 (294)
T ss_pred CcEEEEEcCCceeecc
Confidence 9999999999988743
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.5e-19 Score=167.19 Aligned_cols=152 Identities=26% Similarity=0.389 Sum_probs=127.2
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC-CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
.+.......||+|++|.|-+-++. +|..+|+|++... ..+..++...|+.+..+. ..|.+|+++|........++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 344555678999999999888864 5899999999754 345567788899877665 7999999999999999999999
Q ss_pred EccCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 593 EYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|.|. .+|+.+-.+. ..+..+++...-+|+..+.+||.|||++- .+||||+||+||||+.+|++||+|||++-.+.
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 9996 5787665332 24567899999999999999999999964 69999999999999999999999999987663
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.6e-19 Score=188.58 Aligned_cols=149 Identities=30% Similarity=0.483 Sum_probs=128.5
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe----
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE---- 587 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~---- 587 (684)
..++|+..+.||+|++|.||++.... ++.||+|++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 45789999999999999999999864 789999998653 22234567789999999999999999988766554
Q ss_pred --eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecc
Q 005669 588 --RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (684)
Q Consensus 588 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGl 665 (684)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5689888732 46899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCC
Q 005669 666 ARSFGL 671 (684)
Q Consensus 666 a~~~~~ 671 (684)
+.....
T Consensus 165 ~~~~~~ 170 (343)
T cd07851 165 ARHTDD 170 (343)
T ss_pred cccccc
Confidence 987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-19 Score=171.68 Aligned_cols=147 Identities=26% Similarity=0.456 Sum_probs=127.0
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCe--eEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDE--RML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~--~~l 590 (684)
..++|++.+++|+|.++.||.|... +.++++||++++. ..+.+.+|+.+|+.+. ||||+++++...+... ..|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 4578999999999999999999854 5788999999753 4577899999999997 9999999999877544 579
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCcEEEEeecccccc
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSF 669 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~-~~~vkI~DFGla~~~ 669 (684)
|+||+.+.+...+- ..++..++..++.++++||.|+|+.| |+|||+||.|++||. ...++|+|+|+|..+
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998886654 34778889999999999999999999 999999999999985 556999999999998
Q ss_pred CCCC
Q 005669 670 GLDQ 673 (684)
Q Consensus 670 ~~~~ 673 (684)
.+..
T Consensus 184 Hp~~ 187 (338)
T KOG0668|consen 184 HPGK 187 (338)
T ss_pred CCCc
Confidence 6554
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-20 Score=181.31 Aligned_cols=154 Identities=27% Similarity=0.430 Sum_probs=126.5
Q ss_pred CCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-----eeEE
Q 005669 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-----ERML 590 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~l 590 (684)
.+..+.||-|+||.||.+.++ +|+.||+|++...- -...+++.+|+.+|..++|.|++..++..+-.. +.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 344578999999999999975 49999999886431 223467888999999999999999988776443 3578
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++|.|. .+|..++ .....++...+.-+.+||++||+|||+.+ |.||||||.|.|++++..+||+|||+||.-+
T Consensus 135 ~TELmQ-SDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQ-SDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHH-hhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 888886 5777776 34567888999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCccCCc
Q 005669 671 LDQTEANTK 679 (684)
Q Consensus 671 ~~~~~~~~~ 679 (684)
.++....|.
T Consensus 208 ~d~~~hMTq 216 (449)
T KOG0664|consen 208 QRDRLNMTH 216 (449)
T ss_pred hhhhhhhHH
Confidence 665544443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=179.30 Aligned_cols=150 Identities=31% Similarity=0.421 Sum_probs=124.5
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC-----CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-----SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
+|.+.++||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998754 444555554431 122334567899999999999999999999999999999
Q ss_pred EEccCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 592 YEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+||+++++|..++... .....+++.++..++.|++.||.|||+.+ ++|+||||+||++++ +.+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888542 23456899999999999999999999988 999999999999975 469999999998764
Q ss_pred C
Q 005669 671 L 671 (684)
Q Consensus 671 ~ 671 (684)
.
T Consensus 157 ~ 157 (260)
T cd08222 157 G 157 (260)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.9e-18 Score=168.58 Aligned_cols=138 Identities=21% Similarity=0.308 Sum_probs=107.3
Q ss_pred CccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhcc-----CCCceeeEEEEEEeCC---eeE-E
Q 005669 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-----QHRNLVKLLGCCTQRD---ERM-L 590 (684)
Q Consensus 520 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-----~H~nIv~l~g~~~~~~---~~~-l 590 (684)
...+.||+|+||.||. +++....+||++........+.+.+|+.+++.+ +||||++++|+++++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4457899999999996 444333479988765445567899999999999 5799999999998874 333 7
Q ss_pred EEEc--cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceEecCCCCCcEEEcC----CCcEEEEe-
Q 005669 591 IYEY--LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL-LYLHQDSRLRIIHRDLKASNVLLDN----TMNPKISD- 662 (684)
Q Consensus 591 V~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL-~yLH~~~~~~IvHrDLkp~NILl~~----~~~vkI~D- 662 (684)
|+|| +.+++|.+++.+ ..+++. ..++.|++.++ +|||+++ |+||||||+|||++. +..++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 558999999943 235555 35678888887 9999998 999999999999974 34799999
Q ss_pred eccccc
Q 005669 663 FGLARS 668 (684)
Q Consensus 663 FGla~~ 668 (684)
||.+..
T Consensus 154 ~G~~~~ 159 (210)
T PRK10345 154 IGESTF 159 (210)
T ss_pred CCCcce
Confidence 554444
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-19 Score=175.88 Aligned_cols=147 Identities=27% Similarity=0.352 Sum_probs=123.1
Q ss_pred hcCCCCcc-ceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEe----CCe
Q 005669 515 ATDNFSEK-NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ----RDE 587 (684)
Q Consensus 515 ~t~~y~~~-~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~ 587 (684)
.+++|++. ++||-|-.|+|..+..+. ++.+|+|++... ...++|+++.-+. .|+|||.++++++. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45566543 689999999999998764 889999998753 4567888877666 59999999999864 334
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc---CCCcEEEEeec
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFG 664 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~---~~~~vkI~DFG 664 (684)
..+|||.|+||.|...+.+ +....+++.++..|+.||+.|+.|||+.+ |.||||||+|+|.. .+..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 6899999999999988854 34567999999999999999999999998 99999999999995 45679999999
Q ss_pred cccccC
Q 005669 665 LARSFG 670 (684)
Q Consensus 665 la~~~~ 670 (684)
+|+.-.
T Consensus 210 FAK~t~ 215 (400)
T KOG0604|consen 210 FAKETQ 215 (400)
T ss_pred cccccC
Confidence 999764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.1e-19 Score=175.73 Aligned_cols=162 Identities=25% Similarity=0.355 Sum_probs=137.8
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 589 (684)
..++|..+++||+|+|++|..+++.. .+.+|+|++++. .....+-.+.|-.+..+. +||.+|-++.+++.+...+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 34678899999999999999999765 678999998864 334455567787777776 6999999999999999999
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+|.||++||+|--.+ .++..++++.+..+...|..||.|||+++ ||.||||..|+|+|.+|++||+|+|+++.-
T Consensus 328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999996555 45667999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCccCCcccccC
Q 005669 670 GLDQTEANTKRVVGT 684 (684)
Q Consensus 670 ~~~~~~~~~~~~~GT 684 (684)
-.+. ..|.+++||
T Consensus 402 l~~g--d~tstfcgt 414 (593)
T KOG0695|consen 402 LGPG--DTTSTFCGT 414 (593)
T ss_pred CCCC--cccccccCC
Confidence 3333 245668887
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.76 E-value=3e-18 Score=173.90 Aligned_cols=132 Identities=24% Similarity=0.206 Sum_probs=115.0
Q ss_pred cCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCChhHHHhc
Q 005669 528 GGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD 606 (684)
Q Consensus 528 G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 606 (684)
|.+|.||++.... ++.+|+|++.... .+.+|...+....||||+++++++...+..+++|||+++++|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8899999999754 7899999997642 234455566666799999999999999999999999999999998843
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 607 TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 607 ~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++|||.++.+.
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~ 136 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVE 136 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence 235899999999999999999999988 9999999999999999999999999887654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.6e-20 Score=177.61 Aligned_cols=149 Identities=28% Similarity=0.428 Sum_probs=123.4
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+.+.+..||.|+||+|+|-.++. |+.+|||+++... .....+++.|.++..+- +.||||+++|.+..++..++-||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 44555789999999999998754 9999999998653 35567888888866555 689999999999999999999999
Q ss_pred cCCCChhHHHhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 595 LPNKSLDYFIFD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 595 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
|+ .+|+.+-.. ..+...+++...-.|.....+||.||.+.- .|||||+||+|||++..|.+||+|||++-.+
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence 96 577655321 123456888888899999999999998754 6999999999999999999999999998765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-17 Score=166.55 Aligned_cols=149 Identities=36% Similarity=0.503 Sum_probs=132.6
Q ss_pred CCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
|+..+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999876 889999999865444 56788999999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+..+...
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9999999854221 1789999999999999999999987 999999999999999999999999999987544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-19 Score=189.77 Aligned_cols=159 Identities=26% Similarity=0.327 Sum_probs=137.7
Q ss_pred CCCCccceecccCcEeEEEEEeeCCc-EEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQ-EIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~-~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
.+++.+..||-|+||.|-++.....+ .+|+|++++. +....+.+..|-.+|...+.+.||++|..|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45566678999999999998875533 4788888754 3344567888999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|-|-||.|...|. ..+.++...+..++..+++|++|||.++ ||.|||||+|.+++.+|-+||.|||+|+.++..
T Consensus 500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999994 4566899999999999999999999998 999999999999999999999999999999755
Q ss_pred CCccCCcccccC
Q 005669 673 QTEANTKRVVGT 684 (684)
Q Consensus 673 ~~~~~~~~~~GT 684 (684)
. .|-+++||
T Consensus 574 ~---KTwTFcGT 582 (732)
T KOG0614|consen 574 R---KTWTFCGT 582 (732)
T ss_pred C---ceeeecCC
Confidence 4 45678887
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.3e-19 Score=193.33 Aligned_cols=163 Identities=28% Similarity=0.460 Sum_probs=142.5
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
+..++|+....+|.|.||.|||+++.. ++..|+|.++........-+++|+-+++..+|+|||.++|.+...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 345678889999999999999999754 8899999998776667778889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|||.+|+|.+.-+ .-..+++.++...++..++||+|||+.+ -+|||||-.|||+++.|.+|++|||.+..++..
T Consensus 92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 9999999987652 2457899999999999999999999998 899999999999999999999999999888643
Q ss_pred CCccCCcccccC
Q 005669 673 QTEANTKRVVGT 684 (684)
Q Consensus 673 ~~~~~~~~~~GT 684 (684)
- +..+.++||
T Consensus 166 i--~KrksfiGt 175 (829)
T KOG0576|consen 166 I--AKRKSFIGT 175 (829)
T ss_pred h--hhhhcccCC
Confidence 2 234456776
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-18 Score=168.69 Aligned_cols=148 Identities=23% Similarity=0.365 Sum_probs=123.0
Q ss_pred CccceecccCcEeEEEEEeeC-CcEEEEEEccCC-CcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEEEEccC
Q 005669 520 SEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 520 ~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
+.+..||.|..|.|++++... |..+|||.+.+. .....++++..+.++.+-+ .|.||+.+|+|..+...++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 345679999999999999865 889999999865 3445667788888877765 8999999999999999999999985
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
.-++.++.+ -.+++++..+-++...+.+||.||.+++ +|+|||+||+|||+|+.|++|++|||++-.+-..
T Consensus 175 -~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 175 -TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred -HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 334455532 2456888888899999999999998865 6999999999999999999999999999877543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.9e-18 Score=191.55 Aligned_cols=149 Identities=26% Similarity=0.365 Sum_probs=106.4
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-----CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEE------EE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC------CT 583 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~------~~ 583 (684)
..++|+..++||+|+||.||+|.+.+ +..||+|++..... .+...+| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999999754 58999998864321 1111111 1122222222222111 24
Q ss_pred eCCeeEEEEEccCCCChhHHHhccCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 005669 584 QRDERMLIYEYLPNKSLDYFIFDTTRS-----------------KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646 (684)
Q Consensus 584 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLk 646 (684)
.+...++|+||+++++|.+++...... .......+..++.||+.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999888532110 01123445679999999999999988 9999999
Q ss_pred CCcEEEcC-CCcEEEEeeccccccC
Q 005669 647 ASNVLLDN-TMNPKISDFGLARSFG 670 (684)
Q Consensus 647 p~NILl~~-~~~vkI~DFGla~~~~ 670 (684)
|+|||+++ ++.+||+|||+|+.+.
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~ 307 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLR 307 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccc
Confidence 99999985 6799999999998764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.9e-18 Score=188.46 Aligned_cols=149 Identities=32% Similarity=0.473 Sum_probs=120.5
Q ss_pred CCccceecccCcEe-EEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 519 FSEKNKLGEGGFGP-VYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 519 y~~~~~LG~G~fG~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
|...+.+|.|+.|+ ||+|.. ++++||||++-.. ......+|+..|+.- +|||||++++.-.+....||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44556789999876 789987 7799999998643 334668899999988 59999999999999999999999996
Q ss_pred CCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---C--CcEEEEeeccccccC
Q 005669 597 NKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---T--MNPKISDFGLARSFG 670 (684)
Q Consensus 597 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~---~--~~vkI~DFGla~~~~ 670 (684)
.+|++++... .......-.....+..|++.||+|||+-+ ||||||||.||||+. + .+++|+|||+++++.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 6999998543 11111121445678999999999999987 999999999999965 3 469999999999998
Q ss_pred CCCCc
Q 005669 671 LDQTE 675 (684)
Q Consensus 671 ~~~~~ 675 (684)
.+.+.
T Consensus 663 ~~~sS 667 (903)
T KOG1027|consen 663 GGKSS 667 (903)
T ss_pred CCcch
Confidence 76654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=191.59 Aligned_cols=155 Identities=34% Similarity=0.470 Sum_probs=132.5
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeC--------CcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEE
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCT 583 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~ 583 (684)
...++..+.+.||+|.||.|++|.... ...||||.++... ....+.+..|+++|+.+ +|+||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 334445566699999999999998532 3479999998652 34567899999999998 6999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHHhccC---------C--C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcE
Q 005669 584 QRDERMLIYEYLPNKSLDYFIFDTT---------R--S--KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNV 650 (684)
Q Consensus 584 ~~~~~~lV~Ey~~~gsL~~~l~~~~---------~--~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NI 650 (684)
..+..++|+||++.|+|.+++...+ . . ..+...+.+.++.|||.|++||++.. +|||||.++||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhE
Confidence 9999999999999999999997654 0 0 23889999999999999999999987 99999999999
Q ss_pred EEcCCCcEEEEeeccccccCC
Q 005669 651 LLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 651 Ll~~~~~vkI~DFGla~~~~~ 671 (684)
|+.++..+||+|||+||....
T Consensus 450 Li~~~~~~kIaDFGlar~~~~ 470 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYN 470 (609)
T ss_pred EecCCCEEEEccccceeccCC
Confidence 999999999999999997544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.4e-17 Score=158.15 Aligned_cols=143 Identities=38% Similarity=0.604 Sum_probs=127.0
Q ss_pred ecccCcEeEEEEEeeC-CcEEEEEEccCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCChhH
Q 005669 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDY 602 (684)
Q Consensus 525 LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 602 (684)
||+|.+|.||++...+ ++++++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 899999999865332 35678999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCcEEEEeeccccccCCC
Q 005669 603 FIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSFGLD 672 (684)
Q Consensus 603 ~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~-~~~vkI~DFGla~~~~~~ 672 (684)
++.... ..+++..+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 984321 45899999999999999999999998 999999999999998 899999999999877543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=159.67 Aligned_cols=152 Identities=25% Similarity=0.369 Sum_probs=126.3
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCC-CceeeEEEEEEeCCeeEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH-RNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~ 592 (684)
...+|..+++||.|+||.+|.|... +|++||||.-+... ...++..|..+.+.++| ..|..+..+..+...-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 3468999999999999999999864 59999999876432 23567788899998875 67888888888889999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCcEEEEeecccccc
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGLARSF 669 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~---~~~vkI~DFGla~~~ 669 (684)
|.+ |.+|+++..- -...++..+++-++-|++.-++|+|.++ +|||||||+|+|+.- ...+.++|||+|+.+
T Consensus 91 dLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 988 6788887632 2345889999999999999999999998 999999999999953 345899999999998
Q ss_pred CCCCC
Q 005669 670 GLDQT 674 (684)
Q Consensus 670 ~~~~~ 674 (684)
-...+
T Consensus 165 ~d~~t 169 (341)
T KOG1163|consen 165 RDIRT 169 (341)
T ss_pred ccccc
Confidence 54443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.8e-18 Score=164.99 Aligned_cols=147 Identities=23% Similarity=0.431 Sum_probs=123.4
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEE-EEeCCeeEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGC-CTQRDERMLIY 592 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~-~~~~~~~~lV~ 592 (684)
.+.|.+.+.||+|.||.+-++.++. ...+++|.+... .....+|.+|..---.| .|.||+.-++. |+..+.+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3568888999999999999999866 678999988763 34567899998765555 58999987765 56677788999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc--CCCcEEEEeeccccccC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NTMNPKISDFGLARSFG 670 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~--~~~~vkI~DFGla~~~~ 670 (684)
||++.|+|..-+ ....+-+.....++.|++.|+.|||+++ +||||||.+||||- +..++||+|||..+..+
T Consensus 102 E~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999997766 3355788889999999999999999999 99999999999993 45589999999998765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.1e-17 Score=165.93 Aligned_cols=147 Identities=16% Similarity=0.144 Sum_probs=113.7
Q ss_pred CCCCccceecccCcEeEEEEE--eeCCcEEEEEEccCCCcc------------------------cHHHHHHHHHHHhcc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGM--LIEGQEIAVKRLSKGSGQ------------------------GMEEFKNEVLLIAKL 570 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~Ei~~l~~l 570 (684)
..|++.+.||+|++|.||+|. ..+|+.||+|+++..... ....+..|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357888999999999999998 457999999998753210 012356899999999
Q ss_pred CCC--ceeeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCC
Q 005669 571 QHR--NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKAS 648 (684)
Q Consensus 571 ~H~--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~ 648 (684)
.+. .++++++. ...++||||+++.+|..... ....+...+...++.||+.+|.+||+++ .|+||||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence 753 34455543 23589999999988865542 1234566667899999999999999876 4999999999
Q ss_pred cEEEcCCCcEEEEeeccccccCCCC
Q 005669 649 NVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 649 NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
||+++ ++.++|+|||.|...+.+.
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccCCcc
Confidence 99999 7899999999999776543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.9e-17 Score=162.98 Aligned_cols=140 Identities=14% Similarity=0.120 Sum_probs=115.5
Q ss_pred hcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHH---------HHHHHHHHhccCCCceeeEEEEEEeC
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEE---------FKNEVLLIAKLQHRNLVKLLGCCTQR 585 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~---------~~~Ei~~l~~l~H~nIv~l~g~~~~~ 585 (684)
..++|...+.+|+|+||.||.... ++..+|+|.+.......... +.+|+..+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468899999999999999999655 67789999997653322222 67899999999999999999886643
Q ss_pred --------CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 005669 586 --------DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN 657 (684)
Q Consensus 586 --------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~ 657 (684)
...+++|||++|.+|.++. .+++ ....+++.+|..+|+.+ ++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 3578999999999997763 1222 24569999999999998 99999999999999888
Q ss_pred EEEEeeccccccC
Q 005669 658 PKISDFGLARSFG 670 (684)
Q Consensus 658 vkI~DFGla~~~~ 670 (684)
++|+|||..+...
T Consensus 173 i~liDfg~~~~~~ 185 (232)
T PRK10359 173 LRIIDLSGKRCTA 185 (232)
T ss_pred EEEEECCCccccc
Confidence 9999999988764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.9e-17 Score=160.83 Aligned_cols=136 Identities=21% Similarity=0.265 Sum_probs=114.1
Q ss_pred ceecccCcEeEEEEEeeCCcEEEEEEccCCCcc--------cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ--------GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
+.||+|++|.||+|.. .+..+++|+....... ....+.+|+.++..++|++++....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999976533211 124577899999999999988887777778888999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++|++|.+++... .. ++..++.+++.+|.+||+.+ ++|+|++|+|||++ ++.++|+|||.++...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999988321 12 78899999999999999998 99999999999999 7889999999998643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5e-17 Score=162.72 Aligned_cols=151 Identities=20% Similarity=0.337 Sum_probs=127.8
Q ss_pred CCCCccceecccCcEeEEEEEe-eCCcEEEEEEccCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
-+|.+.++||+|+||.++.|+. .++++||||.-... ....+++.|.+..+.|. .++|...+-+..++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 4688999999999999999984 56899999986643 23457888888888884 78999999998999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-----CcEEEEeecccccc
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-----MNPKISDFGLARSF 669 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~-----~~vkI~DFGla~~~ 669 (684)
+ |-+|+++.. -.+..++..++..++.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 678888762 23567999999999999999999999998 9999999999999643 35899999999999
Q ss_pred CCCCCc
Q 005669 670 GLDQTE 675 (684)
Q Consensus 670 ~~~~~~ 675 (684)
..+.+.
T Consensus 180 rDp~Tk 185 (449)
T KOG1165|consen 180 RDPKTK 185 (449)
T ss_pred cCcccc
Confidence 766554
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.7e-17 Score=159.49 Aligned_cols=146 Identities=19% Similarity=0.212 Sum_probs=113.5
Q ss_pred HHHhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcc----------------------cHHHHHHHHHHHh
Q 005669 511 IIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ----------------------GMEEFKNEVLLIA 568 (684)
Q Consensus 511 ~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~----------------------~~~~~~~Ei~~l~ 568 (684)
++......|...+.||+|+||.||++...+++.||||++...... .......|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444457888999999999999999888999999987643210 0123567888999
Q ss_pred ccCCC--ceeeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 005669 569 KLQHR--NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646 (684)
Q Consensus 569 ~l~H~--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLk 646 (684)
++.|+ .+++.++ ....+++|||+++++|..... ......++.+++.++.++|+.+ |+|+|||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 98877 4455544 244589999999999876531 1345678899999999999988 9999999
Q ss_pred CCcEEEcCCCcEEEEeeccccccCCC
Q 005669 647 ASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 647 p~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|+||++++++.++|+|||+|.....+
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~~ 178 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDHP 178 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCCc
Confidence 99999999999999999999877543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=154.80 Aligned_cols=132 Identities=23% Similarity=0.194 Sum_probs=105.8
Q ss_pred ccceecccCcEeEEEEEeeCCcEEEEEEccCCCcc----cHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEEEEcc
Q 005669 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ----GMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 521 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~----~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++++ |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997765 6788888877654221 1125789999999995 5889999886 4469999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC-CCCcEEEcCCCcEEEEeeccccccC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDL-KASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDL-kp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+|.+|...+. . ....++.|++++|.++|+++ |+|||| ||+|||++.++.++|+|||+|....
T Consensus 81 ~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 81 AGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred cCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 9999864431 0 11357789999999999998 999999 7999999999999999999998654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=161.41 Aligned_cols=138 Identities=33% Similarity=0.476 Sum_probs=123.9
Q ss_pred CcEeEEEEEeeC-CcEEEEEEccCCCccc-HHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCChhHHHhc
Q 005669 529 GFGPVYKGMLIE-GQEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD 606 (684)
Q Consensus 529 ~fG~Vy~~~~~~-g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 606 (684)
+||.||++...+ ++.+++|++....... .+.+.+|++.+++++|+|++++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999865 8999999998654444 68899999999999999999999999999999999999999999998844
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 607 TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 607 ~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
. ..+++..+..++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG 140 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence 2 22889999999999999999999988 999999999999999999999999999987543
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=180.71 Aligned_cols=143 Identities=20% Similarity=0.316 Sum_probs=115.2
Q ss_pred HhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEE-ccCCC-------cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 005669 513 ANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKR-LSKGS-------GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ 584 (684)
Q Consensus 513 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~-l~~~~-------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 584 (684)
......|...+.||+|+||.||++...+.. +++|+ +.+.. ....+++.+|++++++++|++++....++..
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 334455667789999999999999875543 33333 22211 1123568899999999999999988888888
Q ss_pred CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
.+..++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCc
Confidence 778899999999999998873 35678999999999999998 9999999999999 57799999999
Q ss_pred cccccCC
Q 005669 665 LARSFGL 671 (684)
Q Consensus 665 la~~~~~ 671 (684)
+|+....
T Consensus 473 la~~~~~ 479 (535)
T PRK09605 473 LGKYSDL 479 (535)
T ss_pred ccccCCc
Confidence 9987643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=156.39 Aligned_cols=132 Identities=23% Similarity=0.342 Sum_probs=107.6
Q ss_pred eecccCcEeEEEEEeeCCcEEEEEEccCCCcc--------cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ--------GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 524 ~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
.||+|+||.||++.. ++..+++|........ ...++.+|++++..++|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 5788999986532111 1356778999999999887666555666677789999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+|++|.+.+.... ..++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||+++...
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999988773211 078999999999999998 99999999999999 7899999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.9e-17 Score=175.51 Aligned_cols=147 Identities=28% Similarity=0.360 Sum_probs=123.5
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
.++.|.....+|.|+|+.|-++... +++..++|++.+.. .+..+|+.++... +|+||+++++.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4677888888999999999998865 47899999998652 2345577666655 7999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE-cCCCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL-DNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl-~~~~~vkI~DFGla~~~~~ 671 (684)
|++.++-+.+.+... .....++..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++...+
T Consensus 396 e~l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 999999887766332 2233778889999999999999998 9999999999999 5899999999999998765
Q ss_pred C
Q 005669 672 D 672 (684)
Q Consensus 672 ~ 672 (684)
.
T Consensus 469 ~ 469 (612)
T KOG0603|consen 469 S 469 (612)
T ss_pred h
Confidence 4
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.5e-16 Score=166.29 Aligned_cols=145 Identities=28% Similarity=0.368 Sum_probs=121.9
Q ss_pred CCCccceecccCcEeEEEEEeeCC--cEEEEEEccCCCcccHHHHHHHHHHHhccCC----CceeeEEEEE-EeCCeeEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIEG--QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH----RNLVKLLGCC-TQRDERML 590 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H----~nIv~l~g~~-~~~~~~~l 590 (684)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997663 4788888765433333378889999988873 5889999888 47778899
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-----CcEEEEeecc
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-----MNPKISDFGL 665 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~-----~~vkI~DFGl 665 (684)
||+.+ |.+|.++..... .+.++..+...|+.|++.+|++||+.+ ++||||||+|+++... ..++|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 689988764433 577999999999999999999999999 9999999999999754 4699999999
Q ss_pred cc
Q 005669 666 AR 667 (684)
Q Consensus 666 a~ 667 (684)
|+
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 99
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.8e-16 Score=160.36 Aligned_cols=155 Identities=22% Similarity=0.263 Sum_probs=127.6
Q ss_pred HhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCC--C----ceeeEEEEEEeC
Q 005669 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH--R----NLVKLLGCCTQR 585 (684)
Q Consensus 513 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~----nIv~l~g~~~~~ 585 (684)
...+++|.+...+|+|.||.|..+.+.. +..||||+++.. ....+..+-|+++++++.+ | -+|++.+++...
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 3447889999999999999999998765 689999999753 3445667789999999942 2 378888999999
Q ss_pred CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-----------
Q 005669 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN----------- 654 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~----------- 654 (684)
++.+||+|.+ |-++.++|.. ....+++..++..++.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred CceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCC
Confidence 9999999998 4588888844 33467899999999999999999999988 999999999999821
Q ss_pred ---------CCcEEEEeeccccccCCCC
Q 005669 655 ---------TMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 655 ---------~~~vkI~DFGla~~~~~~~ 673 (684)
+..+||+|||-|+.-.+..
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h 266 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH 266 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc
Confidence 2348999999998765433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.8e-16 Score=163.94 Aligned_cols=148 Identities=28% Similarity=0.507 Sum_probs=129.0
Q ss_pred HHhhcCCCCccceecccCcEeEEEEEeeC----CcEEEEEEccCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCC
Q 005669 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRD 586 (684)
Q Consensus 512 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~ 586 (684)
+....+.|..+++||+|.|++||++.+.. .+.||+|.+... ....++.+|++.|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 44556788999999999999999998643 578999998764 33467899999999995 899999999999999
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCcEEEEeecc
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGL 665 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~-~~~vkI~DFGl 665 (684)
...+|+||++.....++.. .++..++..++..+++||.++|.+| ||||||||+|+|.+. -+.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999999988873 2678899999999999999999999 999999999999974 56678999999
Q ss_pred ccccC
Q 005669 666 ARSFG 670 (684)
Q Consensus 666 a~~~~ 670 (684)
|...+
T Consensus 180 A~~~d 184 (418)
T KOG1167|consen 180 AQRYD 184 (418)
T ss_pred HHHHH
Confidence 98543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.5e-15 Score=138.27 Aligned_cols=137 Identities=22% Similarity=0.200 Sum_probs=116.0
Q ss_pred ccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCC--CceeeEEEEEEeCCeeEEEEEccCCC
Q 005669 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH--RNLVKLLGCCTQRDERMLIYEYLPNK 598 (684)
Q Consensus 521 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~g 598 (684)
+.+.||+|.++.||++...+ +.+++|....... ...+.+|+.+++.++| .++++++++....+..++++||+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999754 7899999875433 5678899999999976 58999999888888899999999987
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||.++...
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 77432 556777889999999999998654569999999999999998999999999998643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.3e-16 Score=123.62 Aligned_cols=66 Identities=50% Similarity=1.052 Sum_probs=57.8
Q ss_pred CCCCCceEEeeeeeCCCCcccccccccCHHHHHHHHhccCceeeeeeecccCCCcceEEeecccccc
Q 005669 366 CKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDI 432 (684)
Q Consensus 366 C~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~~~~~~~~~~gC~~w~~~L~~l 432 (684)
|+.+|+|+++++|++|+++...++.+.++++|+++||+||||+||+|.++. ++.+|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 545799999999999999877666679999999999999999999998655 567899999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.8e-15 Score=146.28 Aligned_cols=139 Identities=19% Similarity=0.246 Sum_probs=100.3
Q ss_pred cceecccCcEeEEEEEeeCCcEEEEEEccCCCcc--cHHH----------------------HHHHHHHHhccCCC--ce
Q 005669 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ--GMEE----------------------FKNEVLLIAKLQHR--NL 575 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--~~~~----------------------~~~Ei~~l~~l~H~--nI 575 (684)
.+.||+|+||.||++...++++||||++...... .... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999988753211 1111 13456666666443 34
Q ss_pred eeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcC
Q 005669 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDN 654 (684)
Q Consensus 576 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~IvHrDLkp~NILl~~ 654 (684)
.+.++. ...+++|||++++.+......... .. .++..++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 555543 245899999999544221111000 11 5678899999999999999 77 99999999999999
Q ss_pred CCcEEEEeeccccccCCC
Q 005669 655 TMNPKISDFGLARSFGLD 672 (684)
Q Consensus 655 ~~~vkI~DFGla~~~~~~ 672 (684)
++.++|+|||.|.....+
T Consensus 150 ~~~~~liDfg~a~~~~~~ 167 (187)
T cd05119 150 DGKVYIIDVPQAVEIDHP 167 (187)
T ss_pred CCcEEEEECcccccccCc
Confidence 889999999999877553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.8e-16 Score=162.25 Aligned_cols=162 Identities=20% Similarity=0.268 Sum_probs=137.0
Q ss_pred ccHHHHHhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccC------CCceeeEE
Q 005669 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ------HRNLVKLL 579 (684)
Q Consensus 507 ~~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~------H~nIv~l~ 579 (684)
+.+...+..-..|.+....|+|-|++|.+|.+.. |++||||++..+ ....+.=+.|+++|++|+ .-|.++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 4455555666789988999999999999999755 889999999864 333445578999999995 34899999
Q ss_pred EEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CcE
Q 005669 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNP 658 (684)
Q Consensus 580 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~-~~v 658 (684)
..|...++++||+|-+. .+|.++|......-.|....+..++.|+..||..|...+ |+|.||||.|||+++. ..+
T Consensus 501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence 99999999999999884 789999977666777899999999999999999999888 9999999999999864 568
Q ss_pred EEEeeccccccCCCC
Q 005669 659 KISDFGLARSFGLDQ 673 (684)
Q Consensus 659 kI~DFGla~~~~~~~ 673 (684)
||+|||.|...+.++
T Consensus 577 KLCDfGSA~~~~ene 591 (752)
T KOG0670|consen 577 KLCDFGSASFASENE 591 (752)
T ss_pred eeccCcccccccccc
Confidence 999999998876544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.4e-16 Score=154.41 Aligned_cols=147 Identities=31% Similarity=0.452 Sum_probs=120.9
Q ss_pred cCCCCccceecccCcEeEEEEEe-eCCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC------
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ 586 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 586 (684)
..+|..++.+|.|.- .|..+.+ ..+++||+|++... .....++..+|..++..++|+||++++.++.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777788998887 5555543 24889999987643 2344567788999999999999999999986443
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
+.|+|||||. .+|.+.+. ..++-++...|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 4699999996 57877773 34788899999999999999999998 999999999999999999999999999
Q ss_pred cccCCC
Q 005669 667 RSFGLD 672 (684)
Q Consensus 667 ~~~~~~ 672 (684)
+.-+.+
T Consensus 166 r~e~~~ 171 (369)
T KOG0665|consen 166 RTEDTD 171 (369)
T ss_pred cccCcc
Confidence 976544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3e-15 Score=156.83 Aligned_cols=134 Identities=28% Similarity=0.374 Sum_probs=111.1
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccC-----C---CceeeEEEEEEe---
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-----H---RNLVKLLGCCTQ--- 584 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----H---~nIv~l~g~~~~--- 584 (684)
.+|.+.++||-|.|++||++.+.. .+-||+|+.+.. ....+....||++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 678899999999999999999765 678999998753 444566788999999984 3 479999999975
Q ss_pred -CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC
Q 005669 585 -RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT 655 (684)
Q Consensus 585 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~ 655 (684)
+.++++|+|++. .+|..+|... ..+.++...+..|++||+.||.|||.++ +|||-||||+|||+...
T Consensus 157 NG~HVCMVfEvLG-dnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 157 NGQHVCMVFEVLG-DNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCcEEEEEehhhh-hHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 457899999994 5666666442 3456899999999999999999999987 79999999999999543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-14 Score=145.24 Aligned_cols=136 Identities=20% Similarity=0.239 Sum_probs=105.7
Q ss_pred ceec-ccCcEeEEEEEeeCCcEEEEEEccCCC-------------cccHHHHHHHHHHHhccCCCce--eeEEEEEEeCC
Q 005669 523 NKLG-EGGFGPVYKGMLIEGQEIAVKRLSKGS-------------GQGMEEFKNEVLLIAKLQHRNL--VKLLGCCTQRD 586 (684)
Q Consensus 523 ~~LG-~G~fG~Vy~~~~~~g~~vavK~l~~~~-------------~~~~~~~~~Ei~~l~~l~H~nI--v~l~g~~~~~~ 586 (684)
..|| .|+.|+||++... +..++||++.... ......+.+|++++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8899999998874 6788998875321 1223567889999999998775 67777654432
Q ss_pred e----eEEEEEccCC-CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEE
Q 005669 587 E----RMLIYEYLPN-KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (684)
Q Consensus 587 ~----~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~ 661 (684)
. .++|+|++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+|+||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 3599999997 689888732 234443 3678999999999998 9999999999999988899999
Q ss_pred eeccccccC
Q 005669 662 DFGLARSFG 670 (684)
Q Consensus 662 DFGla~~~~ 670 (684)
|||.++...
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999998754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.56 E-value=8.8e-14 Score=145.34 Aligned_cols=150 Identities=36% Similarity=0.499 Sum_probs=127.8
Q ss_pred CCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcc---cHHHHHHHHHHHhccCCC-ceeeEEEEEEeCCeeEEEEEc
Q 005669 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ---GMEEFKNEVLLIAKLQHR-NLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~lV~Ey 594 (684)
|...+.||.|+|+.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566789999999999999986 78899998765332 367889999999999988 799999999777778999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-cEEEEeeccccccCCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFGLDQ 673 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~-~vkI~DFGla~~~~~~~ 673 (684)
+.++++.+++........+.......++.|++.++.|+|+.+ ++|||+||+||+++... .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966633211126889999999999999999999998 99999999999999888 79999999998765443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.2e-15 Score=150.97 Aligned_cols=160 Identities=23% Similarity=0.360 Sum_probs=134.8
Q ss_pred HHHHhhcCCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEE
Q 005669 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582 (684)
Q Consensus 510 ~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~ 582 (684)
+++.....+++....+.+|.||.||+|.+.+ .+.|.+|.++.. ++-....+..|...+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 4455556778888899999999999997654 356778888765 344566788999999999999999999998
Q ss_pred EeC-CeeEEEEEccCCCChhHHHh-----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 005669 583 TQR-DERMLIYEYLPNKSLDYFIF-----DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (684)
Q Consensus 583 ~~~-~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~ 656 (684)
.+. ...+++|.++.-|+|..+|. +....+.++..+...++.|++.|++|||.++ +||.||..+|.+||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 754 55789999999999999997 3344456788889999999999999999998 99999999999999999
Q ss_pred cEEEEeeccccccCCC
Q 005669 657 NPKISDFGLARSFGLD 672 (684)
Q Consensus 657 ~vkI~DFGla~~~~~~ 672 (684)
++||+|=.++|.+-+.
T Consensus 434 qVkltDsaLSRDLFP~ 449 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPG 449 (563)
T ss_pred eEEeccchhccccCcc
Confidence 9999999999987443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=7e-14 Score=161.85 Aligned_cols=150 Identities=23% Similarity=0.329 Sum_probs=117.5
Q ss_pred HHhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccC---CCceeeEEEEEEeCCee
Q 005669 512 IANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQRDER 588 (684)
Q Consensus 512 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~ 588 (684)
.+...+.|.+.+.||+|+||+||+|...+|+.||+|.-+....-. |.-=.+++.+|+ -+.|..+...+...+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 344556788999999999999999999889999999887643321 111122333333 23455555566667788
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-------CCCcEEEE
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-------NTMNPKIS 661 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~-------~~~~vkI~ 661 (684)
+||+||.+.|+|.+++. ..+.+++.....++.|+++-+++||..+ |||+||||+|.||. +...++|+
T Consensus 770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 99999999999999994 5667899999999999999999999998 99999999999993 23459999
Q ss_pred eeccccccC
Q 005669 662 DFGLARSFG 670 (684)
Q Consensus 662 DFGla~~~~ 670 (684)
|||-+-.+.
T Consensus 844 DfG~siDm~ 852 (974)
T KOG1166|consen 844 DFGRSIDMK 852 (974)
T ss_pred ecccceeee
Confidence 999886653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=3e-13 Score=148.83 Aligned_cols=141 Identities=22% Similarity=0.302 Sum_probs=100.2
Q ss_pred ceecccCcEeEEEEEeeCCcEEEEEEccCCCcccH----------------------------------------HHHHH
Q 005669 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGM----------------------------------------EEFKN 562 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~----------------------------------------~~~~~ 562 (684)
+.||.|++|.||+|++.+|+.||||+.++...... -.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 68999999999999999999999999875421110 01344
Q ss_pred HHHHHhcc----CCCceeeEEEEE-EeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 005669 563 EVLLIAKL----QHRNLVKLLGCC-TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR-GLLYLHQDS 636 (684)
Q Consensus 563 Ei~~l~~l----~H~nIv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~-gL~yLH~~~ 636 (684)
|++.+.++ +|.+-+.+-..+ ......+|||||++|++|.++...... .. .+..++.++++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 55555554 232223322222 224457999999999999877632111 12 23456666666 468889888
Q ss_pred CCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 637 ~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
++|+|+||.||++++++.++++|||++..+++
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999998864
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.36 E-value=9.3e-13 Score=108.36 Aligned_cols=71 Identities=28% Similarity=0.430 Sum_probs=61.0
Q ss_pred CCCCCceEEeeeeeCCCCcccccccccCHHHHHHHHhc---cCceeeeeeecccCCCcceEEeeccc-ccccccCCCCCc
Q 005669 366 CKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSK---NCSCTAYANADVRGRGSGCLLWFHDL-IDIKELPESGQD 441 (684)
Q Consensus 366 C~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~A~~~~~~~~~~~gC~~w~~~L-~~l~~~~~~~~~ 441 (684)
|..++.|+++.++++|++.. .+.+||+++|++ ||||+||+|.+ .+.||++|.++| ++++++...+.+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~---~~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAK---ARKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccC---CCCCeEEecCcchhhHHhccCCCce
Confidence 33467899999999999765 578999999999 99999999975 246899999999 999888777899
Q ss_pred eeee
Q 005669 442 LFIR 445 (684)
Q Consensus 442 lylr 445 (684)
+|+|
T Consensus 76 Ly~r 79 (80)
T cd00129 76 LYEN 79 (80)
T ss_pred eEeE
Confidence 9987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.3e-12 Score=107.44 Aligned_cols=80 Identities=46% Similarity=0.897 Sum_probs=64.5
Q ss_pred CCCCCCC---CceEEeeeeeCCCCcccccccccCHHHHHHHHhccCceeeeeeecccCCCcceEEeecccccccccCCCC
Q 005669 363 PLDCKHG---DGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESG 439 (684)
Q Consensus 363 ~l~C~~~---~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~~~~~~~~~~gC~~w~~~L~~l~~~~~~~ 439 (684)
+++|..+ +.|..++++++|+..+.. ...++++|++.||+||+|.||+|.+ ++.+|++|...+.+.......+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 4567543 689999999999876653 6778999999999999999999974 3567999999998877654455
Q ss_pred Cceeeeec
Q 005669 440 QDLFIRMA 447 (684)
Q Consensus 440 ~~lylrva 447 (684)
..+|+|++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 78999874
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1e-11 Score=118.91 Aligned_cols=132 Identities=21% Similarity=0.154 Sum_probs=98.5
Q ss_pred cceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCce-eeEEEEEEeCCeeEEEEEccCCCCh
Q 005669 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL-VKLLGCCTQRDERMLIYEYLPNKSL 600 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gsL 600 (684)
.+.|+.|.++.||++... ++.+++|....... ....+.+|+.+++.+.+.++ .+++... ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 357899999999999864 77899998765422 23356789999998865544 4455443 3345899999999887
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
... . .....++.+++++|+.||+.+ +..++|+|++|.||+++ ++.++++|||.|..-
T Consensus 79 ~~~-------~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 79 LTE-------D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred ccc-------c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 532 0 111345678999999999886 23469999999999999 668999999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.4e-11 Score=137.48 Aligned_cols=145 Identities=17% Similarity=0.230 Sum_probs=95.6
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCccc----------------------------------HH---
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG----------------------------------ME--- 558 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~----------------------------------~~--- 558 (684)
..|+. +.||+|++|+||+|++.+ |++||||++++..... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999987 9999999997542110 01
Q ss_pred ---HHHHHHHHHhccC----CCceeeEEEEEEe-CCeeEEEEEccCCCChhHHHhccCCC---CCCCHHHHHHHHHHHHH
Q 005669 559 ---EFKNEVLLIAKLQ----HRNLVKLLGCCTQ-RDERMLIYEYLPNKSLDYFIFDTTRS---KLLDWSKRSHIIAGIAR 627 (684)
Q Consensus 559 ---~~~~Ei~~l~~l~----H~nIv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~qi~~ 627 (684)
++.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++..-...+ ..+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 1334444444442 4443444333332 45678999999999997642111111 112222233333333
Q ss_pred HHHHHHhCCCCceEecCCCCCcEEEcCCC----cEEEEeeccccccCCC
Q 005669 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTM----NPKISDFGLARSFGLD 672 (684)
Q Consensus 628 gL~yLH~~~~~~IvHrDLkp~NILl~~~~----~vkI~DFGla~~~~~~ 672 (684)
+..+ ++|+|+||.||+++.++ .+++.|||++..+++.
T Consensus 277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 4456 99999999999999888 9999999999988643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.7e-10 Score=112.35 Aligned_cols=139 Identities=12% Similarity=0.086 Sum_probs=101.2
Q ss_pred ceecccCcEeEEEEEeeC-------CcEEEEEEccCCC------------c----------ccHHHHH----HHHHHHhc
Q 005669 523 NKLGEGGFGPVYKGMLIE-------GQEIAVKRLSKGS------------G----------QGMEEFK----NEVLLIAK 569 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-------g~~vavK~l~~~~------------~----------~~~~~~~----~Ei~~l~~ 569 (684)
..||.|.-+.||.|...+ +..+|||+.+... . .....+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 4799999765321 0 0112233 79999999
Q ss_pred cC--CCceeeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCCC
Q 005669 570 LQ--HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL-HQDSRLRIIHRDLK 646 (684)
Q Consensus 570 l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~~~~IvHrDLk 646 (684)
+. ..++++++++ ...+|||||+.+..+..... +...++..+...+..+++.+|..| |+.+ |||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 85 3567777764 45789999998754422111 112345566778889999999999 7777 9999999
Q ss_pred CCcEEEcCCCcEEEEeeccccccCCC
Q 005669 647 ASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 647 p~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+.|||+++ +.++|+|||-|-..+.+
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~~hp 177 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEPTHP 177 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeCCCC
Confidence 99999974 68999999998776543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.8e-12 Score=142.59 Aligned_cols=148 Identities=25% Similarity=0.318 Sum_probs=113.0
Q ss_pred CccceecccCcEeEEEEEeeC-CcEEEEEEcc----CC-Cc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 520 SEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLS----KG-SG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 520 ~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~----~~-~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
...+.+|.|++|.|+...... .+..+.|... .. .. .....+..|+.+-..++|+|++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 345789999999777776533 3333333322 11 11 11122556777778889999988877777766666669
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
||+++ +|..++.. ...+...++..++.|++.|++|||+.+ |.||||||+|+++..++.+||+|||.+..+.-+
T Consensus 401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 99888833 346888999999999999999999999 999999999999999999999999999887544
Q ss_pred CC
Q 005669 673 QT 674 (684)
Q Consensus 673 ~~ 674 (684)
..
T Consensus 474 ~e 475 (601)
T KOG0590|consen 474 WE 475 (601)
T ss_pred cc
Confidence 43
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.2e-11 Score=145.18 Aligned_cols=92 Identities=16% Similarity=0.192 Sum_probs=69.2
Q ss_pred ccCC-CceeeEEEEE-------EeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 005669 569 KLQH-RNLVKLLGCC-------TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640 (684)
Q Consensus 569 ~l~H-~nIv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~I 640 (684)
.++| +||++++++| ...+..++++||+ +++|.++|... ...+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3445 5777777776 2334567788987 56999998532 345899999999999999999999998 9
Q ss_pred EecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 641 IHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 641 vHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
+||||||+||||+..+.+|++|||++
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~ 127 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASC 127 (793)
T ss_pred eeccCCchhEEEcccCcEEEeecccc
Confidence 99999999999965444444444333
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.7e-10 Score=112.84 Aligned_cols=143 Identities=20% Similarity=0.251 Sum_probs=111.8
Q ss_pred ceecccCcEeEEEEEeeCCcEEEEEEccCCCc-ccHHHHHHHHHHHhccCC--CceeeEEEEEEeCC---eeEEEEEccC
Q 005669 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQH--RNLVKLLGCCTQRD---ERMLIYEYLP 596 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~---~~~lV~Ey~~ 596 (684)
+.|+.|..+.||++...+|+.+++|....... .....+.+|+++++.+.+ ..+.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999886678999999765422 235678899999999975 44677887776543 5689999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS---------------------------------------- 636 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~---------------------------------------- 636 (684)
+.++...+. ...++..+...++.+++++|.+||+..
T Consensus 84 G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 988866541 134677788888888999998888531
Q ss_pred -------------CCceEecCCCCCcEEEcC--CCcEEEEeecccccc
Q 005669 637 -------------RLRIIHRDLKASNVLLDN--TMNPKISDFGLARSF 669 (684)
Q Consensus 637 -------------~~~IvHrDLkp~NILl~~--~~~vkI~DFGla~~~ 669 (684)
+..++|+|++|.||+++. ++.+.|+||+.+..-
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245799999999999998 667899999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.5e-10 Score=106.43 Aligned_cols=134 Identities=22% Similarity=0.314 Sum_probs=102.3
Q ss_pred ceecccCcEeEEEEEeeCCcEEEEEE-ccCCC--c-----ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 523 NKLGEGGFGPVYKGMLIEGQEIAVKR-LSKGS--G-----QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~g~~vavK~-l~~~~--~-----~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
..+.+|+-+.+|.+.+. |.++++|. +++.- + -..++.++|++++.+++-..|...+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999663 34466664 33221 1 1134567899999999766666555566778888999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
++|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++|||++..-+.
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~ 143 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE 143 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccccc
Confidence 9999999888332 2567788888889999999 99999999999998774 99999999986443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.1e-09 Score=100.72 Aligned_cols=148 Identities=23% Similarity=0.295 Sum_probs=107.7
Q ss_pred ccceecccCcEeEEEEEeeCCcEEEEEE-ccCC-------CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKR-LSKG-------SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 521 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~-l~~~-------~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
....|-+|+-+.|+++.. .|+...||. ..+. ..-...+.++|++++.+++--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999987 456666664 3322 1122456788999999987656655555666777778999
Q ss_pred EccCC-CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---cEEEEeeccccc
Q 005669 593 EYLPN-KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM---NPKISDFGLARS 668 (684)
Q Consensus 593 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~---~vkI~DFGla~~ 668 (684)
||+++ .++.+++....... ...+....++..|-+.+.-||.++ |+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 47777775443322 223333678899999999999998 99999999999996554 368999999976
Q ss_pred cCCCC
Q 005669 669 FGLDQ 673 (684)
Q Consensus 669 ~~~~~ 673 (684)
-..++
T Consensus 166 s~~~E 170 (229)
T KOG3087|consen 166 SRLPE 170 (229)
T ss_pred ccCcc
Confidence 54333
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.3e-11 Score=129.73 Aligned_cols=143 Identities=28% Similarity=0.321 Sum_probs=117.6
Q ss_pred eecccCcEeEEEEEee----CCcEEEEEEccCCCc--ccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEEEEccC
Q 005669 524 KLGEGGFGPVYKGMLI----EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 524 ~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
.+|+|.||.|+.+... .++-+|+|.+++... ........|..++..++ ||.+++++..++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3799999999986532 366788887765421 11125566888888887 9999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+|.|...+ .....+.+.....+...++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++.+-..
T Consensus 81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 99997666 34455777788888889999999999998 999999999999999999999999999987433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.4e-09 Score=108.76 Aligned_cols=149 Identities=24% Similarity=0.339 Sum_probs=97.6
Q ss_pred CCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCC----------CceeeEEEEEE-
Q 005669 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH----------RNLVKLLGCCT- 583 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H----------~nIv~l~g~~~- 583 (684)
+...+.||.|+++.||.+++.+ ++++|||..... .....+++++|...+..+.+ -.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4456789999999999999876 899999987533 23346777877766655433 12222222221
Q ss_pred --------eCC--------eeEEEEEccCCCChhHHHh---ccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEec
Q 005669 584 --------QRD--------ERMLIYEYLPNKSLDYFIF---DTTRS-KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643 (684)
Q Consensus 584 --------~~~--------~~~lV~Ey~~~gsL~~~l~---~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHr 643 (684)
... ..+++|+-+. ++|.+++. ..... ..+....+..+..|+++.+++||+++ ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 111 1256777774 67777643 22211 22444556677899999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 644 DLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 644 DLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
||||+|++++.+|.++|+||+.....+.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~ 197 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT 197 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc
Confidence 9999999999999999999998877653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.5e-10 Score=132.32 Aligned_cols=143 Identities=19% Similarity=0.234 Sum_probs=115.4
Q ss_pred CCCccceecccCcEeEEEEEeeCCcEEEEEEccCCC-cccHHHHHHHHHH--HhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS-GQGMEEFKNEVLL--IAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~Ei~~--l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
++...+.||++.|=+|.++++++|. |+||++-+.. ....+.|.++++- ...++|||.+++.-+-......|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666789999999999999998887 8888876543 3345555554443 4456899999988777777777888888
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
..+ +|.+.+ ..+.-+...+..-|+.|++.||..+|..+ |.|+|||.+||||+.-.-+.|+||.--|.
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKP 169 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCC
Confidence 864 666665 34556788889999999999999999998 99999999999999998999999986654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.2e-10 Score=111.20 Aligned_cols=137 Identities=26% Similarity=0.451 Sum_probs=113.3
Q ss_pred cceecccCcEeEEEEEeeCCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005669 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 599 (684)
..+|.+...|..|+|++. |..+++|++... .......|.+|.-.|+-+.||||..++|.|....+..++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 457888889999999984 556667776543 33445678999999999999999999999999999999999999999
Q ss_pred hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEE
Q 005669 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (684)
Q Consensus 600 L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~ 661 (684)
|...|+.. ..-..+..++.+++.+|++|++|||+..+ -|..--|....++||++.+++|+
T Consensus 274 lynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 274 LYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred HHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee
Confidence 99999653 34457888999999999999999999863 24445688999999999988774
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=7.2e-09 Score=100.52 Aligned_cols=127 Identities=25% Similarity=0.317 Sum_probs=84.7
Q ss_pred eEEEEEeeCCcEEEEEEccCCC-------------cc-------------cHHHHHHHHHHHhccCCC--ceeeEEEEEE
Q 005669 532 PVYKGMLIEGQEIAVKRLSKGS-------------GQ-------------GMEEFKNEVLLIAKLQHR--NLVKLLGCCT 583 (684)
Q Consensus 532 ~Vy~~~~~~g~~vavK~l~~~~-------------~~-------------~~~~~~~Ei~~l~~l~H~--nIv~l~g~~~ 583 (684)
.||.|...++..+|||..+... .. .....++|.+.|.++... ++++++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999899999999875421 00 012356799999999765 567776542
Q ss_pred eCCeeEEEEEccC--CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCceEecCCCCCcEEEcCCCcEEE
Q 005669 584 QRDERMLIYEYLP--NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY-LHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (684)
Q Consensus 584 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~y-LH~~~~~~IvHrDLkp~NILl~~~~~vkI 660 (684)
...|||||++ |..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 3579999999 66665443111 1134456777888886666 46777 9999999999999988 9999
Q ss_pred EeeccccccCC
Q 005669 661 SDFGLARSFGL 671 (684)
Q Consensus 661 ~DFGla~~~~~ 671 (684)
+|||-|.....
T Consensus 148 IDf~qav~~~~ 158 (188)
T PF01163_consen 148 IDFGQAVDSSH 158 (188)
T ss_dssp --GTTEEETTS
T ss_pred EecCcceecCC
Confidence 99999877653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.9e-08 Score=100.30 Aligned_cols=141 Identities=18% Similarity=0.114 Sum_probs=100.8
Q ss_pred ceecccCcEeEEEEEeeCCcEEEEEEccCCCc-----------ccHHHHHHHHHHHhccCC--CceeeEEEEEEe-----
Q 005669 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG-----------QGMEEFKNEVLLIAKLQH--RNLVKLLGCCTQ----- 584 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~-----------~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~----- 584 (684)
+.+-+-....|++... +|+.+.||+...... .....+.+|...+.++.. -..++++++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445667654 678899997643221 111247789999888853 334455666543
Q ss_pred CCeeEEEEEccCCC-ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-------CC
Q 005669 585 RDERMLIYEYLPNK-SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-------TM 656 (684)
Q Consensus 585 ~~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~-------~~ 656 (684)
....+||+|++++. +|.+++.+.. ....+...+..++.+++..+.-||..+ |+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23468999999986 8988874321 234566777899999999999999999 999999999999975 46
Q ss_pred cEEEEeeccccc
Q 005669 657 NPKISDFGLARS 668 (684)
Q Consensus 657 ~vkI~DFGla~~ 668 (684)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 799999999865
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.6e-09 Score=107.20 Aligned_cols=74 Identities=24% Similarity=0.462 Sum_probs=59.3
Q ss_pred CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE--cCCC--cEEEE
Q 005669 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNTM--NPKIS 661 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl--~~~~--~vkI~ 661 (684)
...|+||.-++ .+|.+++.. ...+.....-|+.|+++|+.|||.++ |.|||+|.+|||| |+|+ .+.|+
T Consensus 316 ~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 316 KTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred ceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEc
Confidence 34688888775 478888732 33566777889999999999999999 9999999999999 4444 37899
Q ss_pred eecccc
Q 005669 662 DFGLAR 667 (684)
Q Consensus 662 DFGla~ 667 (684)
|||.+-
T Consensus 388 DFGCcL 393 (598)
T KOG4158|consen 388 DFGCCL 393 (598)
T ss_pred ccceee
Confidence 999774
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=9.9e-08 Score=95.28 Aligned_cols=137 Identities=20% Similarity=0.240 Sum_probs=100.2
Q ss_pred CCccceecccCcEeEEEEEeeCCcEEEEEEccCCC----------------------cccHHHHHHHHHHHhccCCC--c
Q 005669 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS----------------------GQGMEEFKNEVLLIAKLQHR--N 574 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~----------------------~~~~~~~~~Ei~~l~~l~H~--n 574 (684)
..+.++||-|.-+.||.|..++|.++|||.=+... .......++|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45568999999999999999999999999543210 00122356799999999754 6
Q ss_pred eeeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC
Q 005669 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 654 (684)
Q Consensus 575 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~ 654 (684)
+.+.+++ +...+||||++|-.|... +++.+....++..|+.-+..+...| |||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~--------r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRL--------RLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecc--------cCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7777653 556899999998766322 1233444455556666666555666 999999999999999
Q ss_pred CCcEEEEeeccccccC
Q 005669 655 TMNPKISDFGLARSFG 670 (684)
Q Consensus 655 ~~~vkI~DFGla~~~~ 670 (684)
+|.+.++||==+-..+
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999997665544
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.70 E-value=7.9e-08 Score=85.79 Aligned_cols=87 Identities=23% Similarity=0.359 Sum_probs=63.5
Q ss_pred EEEeeccCceEEEecCC-CCeEEEecccCC-CCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCCCeecccc
Q 005669 111 LRINGERNGILVLLNST-NDTVWSSNSSIS-AQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINL 188 (684)
Q Consensus 111 l~~~~~~~g~l~l~~~~-~~~~w~s~~~~~-~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~~~ 188 (684)
+.++. ||+||+++.. +.++|++++... .....+.|+++|||||++. .+.++|+|= |.
T Consensus 24 ~~~q~--dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~----~g~~vW~S~---t~------------ 82 (114)
T smart00108 24 LIMQN--DYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDG----DGRVVWSSN---TT------------ 82 (114)
T ss_pred cCCCC--CEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeC----CCCEEEEec---cc------------
Confidence 34444 9999999875 579999998642 2236789999999999987 457899981 10
Q ss_pred cCccceeEEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecC
Q 005669 189 GTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAG 235 (684)
Q Consensus 189 ~tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g 235 (684)
...|.|.+.|+++|+..++- ..+.+.|.+.
T Consensus 83 ----------------~~~~~~~~~L~ddGnlvl~~-~~~~~~W~Sf 112 (114)
T smart00108 83 ----------------GANGNYVLVLLDDGNLVIYD-SDGNFLWQSF 112 (114)
T ss_pred ----------------CCCCceEEEEeCCCCEEEEC-CCCCEEeCCC
Confidence 13467889999999987763 3346778653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.7e-09 Score=121.56 Aligned_cols=164 Identities=27% Similarity=0.357 Sum_probs=126.1
Q ss_pred cCCCCccceecccCcEeEEEEEeeCC--cEEEEEEccCCC--cccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEG--QEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g--~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~l 590 (684)
...|...+.||+|+|+.|-....... ..+|+|.+.... ....+....|..+-..+. |+|++++++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 34577778899999999988876443 456666665432 233445556777777776 9999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEecCCCCCcEEEcCCC-cEEEEeeccccc
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH-QDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARS 668 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~~~~IvHrDLkp~NILl~~~~-~vkI~DFGla~~ 668 (684)
+.||..++++...+.. ......+......++.|+..++.|+| +.+ +.|+||||+|.+++..+ ..|++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999777631 11124566777889999999999999 777 99999999999999999 999999999998
Q ss_pred cCC-CCCccCCccccc
Q 005669 669 FGL-DQTEANTKRVVG 683 (684)
Q Consensus 669 ~~~-~~~~~~~~~~~G 683 (684)
+.. +.........+|
T Consensus 175 ~~~~~g~~~~~~~~~g 190 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCG 190 (601)
T ss_pred ccccCCcceeeecccC
Confidence 866 444333333333
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=4e-08 Score=107.36 Aligned_cols=100 Identities=33% Similarity=0.487 Sum_probs=90.2
Q ss_pred HhccCCCceeeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 005669 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646 (684)
Q Consensus 567 l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLk 646 (684)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ....+++.-...++++|++||.|||+.. -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3578999999999999999999999999999999999954 3456899999999999999999999865 12999999
Q ss_pred CCcEEEcCCCcEEEEeeccccccC
Q 005669 647 ASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 647 p~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+.|.++|....+||+|||+.....
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred cccceeeeeEEEEechhhhccccc
Confidence 999999999999999999998874
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.7e-07 Score=82.61 Aligned_cols=83 Identities=22% Similarity=0.355 Sum_probs=62.6
Q ss_pred CceEEEecCC-CCeEEEecccCC-CCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCCCeecccccCcccee
Q 005669 118 NGILVLLNST-NDTVWSSNSSIS-AQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRF 195 (684)
Q Consensus 118 ~g~l~l~~~~-~~~~w~s~~~~~-~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~~~~tg~~~~ 195 (684)
||+||+++.. +.++|++++... .....+.|+++|||||++. ++.++|||=-
T Consensus 30 dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~----~g~~vW~S~~----------------------- 82 (116)
T cd00028 30 DYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDG----SGTVVWSSNT----------------------- 82 (116)
T ss_pred eEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcC----CCcEEEEecc-----------------------
Confidence 8999999875 579999998652 3456789999999999987 4578999721
Q ss_pred EEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCC
Q 005669 196 LSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGS 236 (684)
Q Consensus 196 L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~ 236 (684)
. ...+.+.+.|+++|+..++-. .+.+.|.+..
T Consensus 83 -------~-~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~ 114 (116)
T cd00028 83 -------T-RVNGNYVLVLLDDGNLVLYDS-DGNFLWQSFD 114 (116)
T ss_pred -------c-CCCCceEEEEeCCCCEEEECC-CCCEEEcCCC
Confidence 0 024678999999999877643 3567787654
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.9e-07 Score=89.70 Aligned_cols=108 Identities=26% Similarity=0.269 Sum_probs=86.1
Q ss_pred HHHHHHHHHHHhccC--CCceeeEEEEEEeCC----eeEEEEEccCCC-ChhHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 005669 557 MEEFKNEVLLIAKLQ--HRNLVKLLGCCTQRD----ERMLIYEYLPNK-SLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629 (684)
Q Consensus 557 ~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL 629 (684)
.....+|...+..+. .-..++.+++.+... ..++|+|++++. +|.+++.... ..+......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 456788888888875 445566777766532 358999999984 7988884322 256677889999999999
Q ss_pred HHHHhCCCCceEecCCCCCcEEEcCCC---cEEEEeeccccccC
Q 005669 630 LYLHQDSRLRIIHRDLKASNVLLDNTM---NPKISDFGLARSFG 670 (684)
Q Consensus 630 ~yLH~~~~~~IvHrDLkp~NILl~~~~---~vkI~DFGla~~~~ 670 (684)
.-||+.+ |+|+|++|.|||++.+. .+.++||+-++...
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999999 99999999999998876 89999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.1e-07 Score=103.47 Aligned_cols=142 Identities=17% Similarity=0.267 Sum_probs=94.1
Q ss_pred ceecccCcEeEEEEEeeCCcEEEEEEccCCCcccH--------------------------H--------------HHHH
Q 005669 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGM--------------------------E--------------EFKN 562 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~--------------------------~--------------~~~~ 562 (684)
+.|+.++-|+||+|++.+|++||||+.+++-.... . .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 68999999999999999999999998876421100 0 1333
Q ss_pred HHHHHhccC-----CCceeeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 005669 563 EVLLIAKLQ-----HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARG-LLYLHQDS 636 (684)
Q Consensus 563 Ei~~l~~l~-----H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~g-L~yLH~~~ 636 (684)
|..-+.+++ .+++.-..=+.+......|+|||++|..+.+...-.. ...+... ++..++++ +..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 444444442 2333222222334567889999999999987742221 2344333 33333332 22233345
Q ss_pred CCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 637 ~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
++|.|.+|.||+++.++.+.+.|||+...+++.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999999888644
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.54 E-value=6e-07 Score=96.34 Aligned_cols=140 Identities=21% Similarity=0.287 Sum_probs=110.8
Q ss_pred EeEEEEEe-eCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe----CCeeEEEEEccCC-CChhHHH
Q 005669 531 GPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDERMLIYEYLPN-KSLDYFI 604 (684)
Q Consensus 531 G~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~~l 604 (684)
.+.||+.. .+|..+++|++.....+.......-++.++++.|.|+|++..++.. +...++||+|.++ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 56788875 4699999999954333333334456788999999999999998863 3457899999986 4665554
Q ss_pred hcc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 605 FDT------------TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 605 ~~~------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+.. ..+...+++..+.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+..|+...+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 432 12345788999999999999999999999 888999999999999999999999999888665
Q ss_pred C
Q 005669 673 Q 673 (684)
Q Consensus 673 ~ 673 (684)
.
T Consensus 447 ~ 447 (655)
T KOG3741|consen 447 P 447 (655)
T ss_pred C
Confidence 5
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.6e-07 Score=100.26 Aligned_cols=122 Identities=18% Similarity=0.274 Sum_probs=101.0
Q ss_pred eCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHH
Q 005669 539 IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR 618 (684)
Q Consensus 539 ~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~ 618 (684)
.++.+|.|...+.......+...+-++.|+.++||||++++...+..+..|||+|-+. .|..++.+ +.....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence 3578888888876554334556778889999999999999999999999999999884 66666632 235666
Q ss_pred HHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 619 ~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
...+.||+.||.|||+.+ .++|++|.-.-|++++.|..||++|-++....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~ 156 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS 156 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence 778899999999999766 49999999999999999999999999886653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=4.3e-06 Score=81.81 Aligned_cols=141 Identities=15% Similarity=0.133 Sum_probs=103.7
Q ss_pred eecccCcEeEEEEEeeCCcEEEEEEccCC------CcccHHHHHHHHHHHhccCC--CceeeEEEEEEeCC----eeEEE
Q 005669 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKG------SGQGMEEFKNEVLLIAKLQH--RNLVKLLGCCTQRD----ERMLI 591 (684)
Q Consensus 524 ~LG~G~fG~Vy~~~~~~g~~vavK~l~~~------~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~----~~~lV 591 (684)
--|+|+-+.|++... +|+.+-+|+-... .+.....|.+|+..|.++.. ..+.++........ ..+||
T Consensus 25 N~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 25 NYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred CcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 346688888998766 4456888876521 14456789999999999853 33555552222211 25799
Q ss_pred EEccCC-CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc--EEEEeeccccc
Q 005669 592 YEYLPN-KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN--PKISDFGLARS 668 (684)
Q Consensus 592 ~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~--vkI~DFGla~~ 668 (684)
+|-+++ .+|.+++.+. .....+...+..++.++++.+.-||+.+ +.|+|+-+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997654 6888887332 2235677888899999999999999998 999999999999986666 99999987775
Q ss_pred c
Q 005669 669 F 669 (684)
Q Consensus 669 ~ 669 (684)
.
T Consensus 180 ~ 180 (216)
T PRK09902 180 R 180 (216)
T ss_pred h
Confidence 4
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.1e-06 Score=85.13 Aligned_cols=140 Identities=18% Similarity=0.210 Sum_probs=87.1
Q ss_pred ceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCc--eeeEEEEEEeCCeeEEEEEccCCCC-
Q 005669 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN--LVKLLGCCTQRDERMLIYEYLPNKS- 599 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gs- 599 (684)
..||+|..+.||+. .+..+++|...... ......+|.++++.+.... +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 35567888876532 3456789999999986433 5777888877788889999999863
Q ss_pred hhHHHh--------------------ccCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHh-CCCCceEecCCC
Q 005669 600 LDYFIF--------------------DTTRSKLLDWSKRS-HIIA----------GIAR-GLLYLHQ-DSRLRIIHRDLK 646 (684)
Q Consensus 600 L~~~l~--------------------~~~~~~~l~~~~~~-~i~~----------qi~~-gL~yLH~-~~~~~IvHrDLk 646 (684)
+...+. +............. .+.. .+.. ...+|.. ..+..++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211110 00000011111100 0100 0111 1112221 123357899999
Q ss_pred CCcEEEcCCCcEEEEeeccccc
Q 005669 647 ASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 647 p~NILl~~~~~vkI~DFGla~~ 668 (684)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999887 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.8e-07 Score=104.96 Aligned_cols=111 Identities=26% Similarity=0.395 Sum_probs=76.4
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
..+|..++.|..|++|.||..+++. .+++|+|+ .+.. ..+++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~----lilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN----LILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccc----hhhhc---cccccCCccee------------------
Confidence 4678888999999999999998865 56788843 3211 01111 22222233332
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
|+....+ ...+.++.. ++.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+.++.
T Consensus 136 ---gDc~tll---k~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ---GDCATLL---KNIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ---chhhhhc---ccCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 3444444 112233322 278999999988 999999999999999999999999999865
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.32 E-value=3e-07 Score=100.73 Aligned_cols=148 Identities=26% Similarity=0.298 Sum_probs=117.9
Q ss_pred hcCCCCccceecccCcEeEEEEEee--CCcEEEEEEccCCCcccHHH--HHHHHHHHhcc-CCCceeeEEEEEEeCCeeE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI--EGQEIAVKRLSKGSGQGMEE--FKNEVLLIAKL-QHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~~~~~~~~--~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 589 (684)
.+.+|..+..||.|.|+.|++...+ ++..+++|.+.+.......+ -..|+.+...+ .|.++++....+...++.|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4467888899999999999998754 36789999887653332222 23566666666 4888888888888888888
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CcEEEEeeccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGLARS 668 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~-~~vkI~DFGla~~ 668 (684)
+--||++++++...+ .-...+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+..
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999999887655 22345788889999999999999999887 9999999999999875 7889999999864
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.9e-06 Score=70.88 Aligned_cols=73 Identities=33% Similarity=0.621 Sum_probs=54.3
Q ss_pred CCceEEeeeeeCCCCcccccccccCHHHHHHHHhc-cCceeeeeeecccCCCcceEEee-cccccccccCCCCCceeee
Q 005669 369 GDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSK-NCSCTAYANADVRGRGSGCLLWF-HDLIDIKELPESGQDLFIR 445 (684)
Q Consensus 369 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~A~~~~~~~~~~~gC~~w~-~~L~~l~~~~~~~~~lylr 445 (684)
...|..++++.+++..... ....++++|++.|++ +|+|.||.|.+ .+.+|.+|. ..+.+....+..+.++|.+
T Consensus 3 ~~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred CceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence 3568999999998654432 346789999999999 99999999964 345799999 6777766444445555544
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.25 E-value=9.2e-06 Score=80.65 Aligned_cols=154 Identities=15% Similarity=0.170 Sum_probs=102.1
Q ss_pred HHHHHhhcCCCCccc---eecccCcEeEEEEEeeCCcEEEEEEccCCCccc-------------------HH-----HHH
Q 005669 509 LKIIANATDNFSEKN---KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG-------------------ME-----EFK 561 (684)
Q Consensus 509 ~~~l~~~t~~y~~~~---~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~-------------------~~-----~~~ 561 (684)
+..+........+.. .|.+|.-+.||+|...++..+|||+.+...... .. -..
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 344444444443333 566788889999998889999999886432111 11 123
Q ss_pred HHHHHHhccC--CCceeeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 005669 562 NEVLLIAKLQ--HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639 (684)
Q Consensus 562 ~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ 639 (684)
+|+.-|.++. +-.+.+.+++. +..|||||+.......-. -..-.+..++...+..++++.+.-|.... +
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~a--~ 187 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKEA--G 187 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHhc--C
Confidence 5777777763 45556666554 347999999754221100 01122334467788889999999888733 3
Q ss_pred eEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 640 IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+||+||..-|||+. ++.+.|+|||=|-....+
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 99999999999999 779999999988776543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.1e-05 Score=82.10 Aligned_cols=141 Identities=15% Similarity=0.125 Sum_probs=87.4
Q ss_pred eecccCc-EeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEEEEccCCCChh
Q 005669 524 KLGEGGF-GPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601 (684)
Q Consensus 524 ~LG~G~f-G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 601 (684)
.|-.|.. ..||+.... +..+.||+..... ...+.+|+++++.+. +.-+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555665 788998764 4788888876432 345678999888884 455667888777666789999999998876
Q ss_pred HHHh-------------------ccCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----C
Q 005669 602 YFIF-------------------DTTR-SKLLDW--SKRSHIIA--------------------GIARGLLYLHQ----D 635 (684)
Q Consensus 602 ~~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------qi~~gL~yLH~----~ 635 (684)
.... .... ...+.. ........ .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4320 0000 001110 00000000 01111122211 1
Q ss_pred CCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 636 ~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
..+.++|+|+.|.|||++++..+.|+||+.|..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234589999999999999987789999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.24 E-value=7.6e-07 Score=97.59 Aligned_cols=150 Identities=23% Similarity=0.274 Sum_probs=118.9
Q ss_pred CCCccceecc--cCcEeEEEEEe--e-CCcEEEEEEccC--CCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeE
Q 005669 518 NFSEKNKLGE--GGFGPVYKGML--I-EGQEIAVKRLSK--GSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 518 ~y~~~~~LG~--G~fG~Vy~~~~--~-~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~ 589 (684)
.+...+.+|. |.+|.||.+.. . +++.+|+|+-+. ..+.....=.+|+...++++ |+|.++.+..++..+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4555678999 99999999986 3 478899998432 22233334456777777774 999999999999999999
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceEecCCCCCcEEEcCC-CcEEEEeec
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFG 664 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~----gL~yLH~~~~~~IvHrDLkp~NILl~~~-~~vkI~DFG 664 (684)
+-+|++. .+|..+.. .....++....+.+..+... ||.++|... |+|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~~-~sl~~~~~--~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCH--TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhh--cccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999986 56666653 22344777888888888888 999999998 9999999999999988 889999999
Q ss_pred cccccCCCC
Q 005669 665 LARSFGLDQ 673 (684)
Q Consensus 665 la~~~~~~~ 673 (684)
+...+....
T Consensus 269 ~v~~i~~~~ 277 (524)
T KOG0601|consen 269 LVSKISDGN 277 (524)
T ss_pred eeEEccCCc
Confidence 999986554
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.4e-05 Score=78.65 Aligned_cols=139 Identities=15% Similarity=0.161 Sum_probs=91.6
Q ss_pred hcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHH---------HHHHHHHHhccCC---CceeeEEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEE---------FKNEVLLIAKLQH---RNLVKLLGCC 582 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~---------~~~Ei~~l~~l~H---~nIv~l~g~~ 582 (684)
..++|...+.+-......|.+-.. +++.+++|..+.......+. ..+++..+.+++. ...+.++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 456788777887777777776655 67889999877543322222 2233333444432 2223323222
Q ss_pred E-----eCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 005669 583 T-----QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN 657 (684)
Q Consensus 583 ~-----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~ 657 (684)
+ .....+++|||++|..|.+.. .+++ .+...+.+++.-||+.| ++|+|.+|.|++++++ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence 2 223456899999998885543 1222 35566778899999999 9999999999999966 4
Q ss_pred EEEEeecccccc
Q 005669 658 PKISDFGLARSF 669 (684)
Q Consensus 658 vkI~DFGla~~~ 669 (684)
++++||+..+..
T Consensus 173 i~iID~~~k~~~ 184 (229)
T PF06176_consen 173 IRIIDTQGKRMS 184 (229)
T ss_pred EEEEECcccccc
Confidence 999999977653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=5.5e-06 Score=91.95 Aligned_cols=140 Identities=15% Similarity=0.198 Sum_probs=90.9
Q ss_pred ceecccCcEeEEEEEeeCCcEEEEEEccCCCcccH-------------------------------H------HHHHHHH
Q 005669 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGM-------------------------------E------EFKNEVL 565 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~-------------------------------~------~~~~Ei~ 565 (684)
+.|+.-+.|.||+|++++|+.||||+-++.-.... + .|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 68999999999999999999999998765421110 0 1333444
Q ss_pred HHhc----cCCCc------eeeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 005669 566 LIAK----LQHRN------LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635 (684)
Q Consensus 566 ~l~~----l~H~n------Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~ 635 (684)
-..+ +.|-+ |.+++- .......|+||||+|..+.+...- ....++...+..-+.+...-+ |-..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~q--If~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQ--IFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHH--HHhc
Confidence 3333 33544 333332 223567899999999888665321 223355554433333332222 2233
Q ss_pred CCCceEecCCCCCcEEEcC----CCcEEEEeeccccccCC
Q 005669 636 SRLRIIHRDLKASNVLLDN----TMNPKISDFGLARSFGL 671 (684)
Q Consensus 636 ~~~~IvHrDLkp~NILl~~----~~~vkI~DFGla~~~~~ 671 (684)
| ++|+|-+|.||++.. ++.+.+-|||+.+.+..
T Consensus 321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 4 999999999999983 67899999999988753
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.8e-05 Score=79.33 Aligned_cols=145 Identities=20% Similarity=0.190 Sum_probs=86.6
Q ss_pred cceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCC--ceeeEEEEEEe---CCeeEEEEEccC
Q 005669 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR--NLVKLLGCCTQ---RDERMLIYEYLP 596 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--nIv~l~g~~~~---~~~~~lV~Ey~~ 596 (684)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++..... ....+++||+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3679999999999999866 69999997643 4556788899998888533 35677765533 334689999999
Q ss_pred CCChhH----------------HHh---cc-CCCCCCCHHHH--H-------HH------------HHHHHH-HHHHHHh
Q 005669 597 NKSLDY----------------FIF---DT-TRSKLLDWSKR--S-------HI------------IAGIAR-GLLYLHQ 634 (684)
Q Consensus 597 ~gsL~~----------------~l~---~~-~~~~~l~~~~~--~-------~i------------~~qi~~-gL~yLH~ 634 (684)
+..+.. .+. .. ........... . .. ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988876 111 11 01111111100 0 00 011222 2333332
Q ss_pred ----CCCCceEecCCCCCcEEEc-CCCcEEEEeecccccc
Q 005669 635 ----DSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSF 669 (684)
Q Consensus 635 ----~~~~~IvHrDLkp~NILl~-~~~~vkI~DFGla~~~ 669 (684)
..+..++|+|+.|.|||++ +++.+.|+||+.+..-
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2345699999999999999 6666789999988653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.6e-06 Score=80.75 Aligned_cols=61 Identities=23% Similarity=0.107 Sum_probs=53.0
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|+|.+++.. ....+++.++..++.||++||.|||+++ ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecc
Confidence 678888843 2446999999999999999999999875 999999999999999 999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.1e-05 Score=78.52 Aligned_cols=105 Identities=24% Similarity=0.235 Sum_probs=82.9
Q ss_pred HHHHHHHhccCC-CceeeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 005669 561 KNEVLLIAKLQH-RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639 (684)
Q Consensus 561 ~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ 639 (684)
.+|..+++.+++ +++++++|+|- .+++.||.+.+++...-.....-...+|..+.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888876 69999999994 3778999987755321000011123689999999999999999999865556
Q ss_pred eEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 640 IIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 640 IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+.-+|++|+|+-+++++++|++|...+-..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999877654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.10 E-value=6.4e-07 Score=96.50 Aligned_cols=81 Identities=27% Similarity=0.369 Sum_probs=72.1
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
..||.|++++..+|.++|.+.......++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999766666678889999999999999999 55 899999999999999989999999999
Q ss_pred cccCCCC
Q 005669 667 RSFGLDQ 673 (684)
Q Consensus 667 ~~~~~~~ 673 (684)
.......
T Consensus 404 ts~~~~~ 410 (516)
T KOG1033|consen 404 TSQDKDE 410 (516)
T ss_pred eecccCC
Confidence 8775544
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=4e-06 Score=85.19 Aligned_cols=96 Identities=28% Similarity=0.345 Sum_probs=80.8
Q ss_pred HHHhccCCCceeeEEEEEEeC-----CeeEEEEEccCCCChhHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 005669 565 LLIAKLQHRNLVKLLGCCTQR-----DERMLIYEYLPNKSLDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQDSRL 638 (684)
Q Consensus 565 ~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ 638 (684)
.-|-++.|.|||+++.|+.+. .+..++.|||..|++..+|.+..+ ...+......+++.||+.||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 345566799999999998653 346889999999999999976443 356778888899999999999999986 7
Q ss_pred ceEecCCCCCcEEEcCCCcEEEE
Q 005669 639 RIIHRDLKASNVLLDNTMNPKIS 661 (684)
Q Consensus 639 ~IvHrDLkp~NILl~~~~~vkI~ 661 (684)
+|+|+++..+-|++..++-+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred ccccCCcchhheeecCCceEEec
Confidence 89999999999999999888874
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.99 E-value=6.7e-05 Score=66.78 Aligned_cols=99 Identities=25% Similarity=0.428 Sum_probs=65.5
Q ss_pred CEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEe-cCCCCCCCCCceEEEeeccCceEEEecCCCCeEEEecc
Q 005669 58 ETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVA-NRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNS 136 (684)
Q Consensus 58 ~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~a-nr~~pv~~~~~~l~~~~~~~g~l~l~~~~~~~~w~s~~ 136 (684)
+.+.+.+|.+.|-|-..|+ |-| |.. ..+++|.. +...+.. ..+.+.|+. ||||||+|..+.++|+|..
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl-~~~--~~~~iWss~~t~~~~~-~~~~~~L~~--~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVL-YDS--NGSVIWSSNNTSGRGN-SGCYLVLQD--DGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEE-EET--TTEEEEE--S-TTSS--SSEEEEEET--TSEEEEEETTSEEEEESTT
T ss_pred cccccccccccceECCCCe-----EEE-EcC--CCCEEEEecccCCccc-cCeEEEEeC--CCCEEEEeecceEEEeecC
Confidence 3455545778888876663 323 332 35779999 4444432 468899988 9999999999999999942
Q ss_pred cCCCCCceEEEec--CccEEEecCCCCCCCCeeEeeccCC
Q 005669 137 SISAQKPVAALME--SGNLVVKDGKDNNPDNILWQSFDYP 174 (684)
Q Consensus 137 ~~~~~~~~~~l~d--~GNlvl~~~~~~~~~~~~WQSFd~P 174 (684)
. ...+.+..++ .||++ +.. ...+.|.|=+.|
T Consensus 81 ~--ptdt~L~~q~l~~~~~~-~~~----~~~~sw~s~~dp 113 (114)
T PF01453_consen 81 Y--PTDTLLPGQKLGDGNVT-GKN----DSLTSWSSNTDP 113 (114)
T ss_dssp S--SS-EEEEEET--TSEEE-EES----TSSEEEESS---
T ss_pred C--CccEEEeccCcccCCCc-ccc----ceEEeECCCCCC
Confidence 2 3456778888 99999 654 246889886665
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.98 E-value=8.5e-05 Score=88.97 Aligned_cols=79 Identities=20% Similarity=0.377 Sum_probs=58.6
Q ss_pred cceecccCcEeEEEEEeeCC---cEEEEEEccCCC-cccHHHHHHHHHHHhccC-CCce--eeEEEEEEeC---CeeEEE
Q 005669 522 KNKLGEGGFGPVYKGMLIEG---QEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQ-HRNL--VKLLGCCTQR---DERMLI 591 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~nI--v~l~g~~~~~---~~~~lV 591 (684)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876553 467888765432 123457889999999995 6654 8888888764 457899
Q ss_pred EEccCCCCh
Q 005669 592 YEYLPNKSL 600 (684)
Q Consensus 592 ~Ey~~~gsL 600 (684)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00016 Score=70.86 Aligned_cols=135 Identities=16% Similarity=0.250 Sum_probs=92.6
Q ss_pred ccceecccCcEeEEEEEeeCCcEEEEEEccCCC----------------cccHHHHHHHHHHHhccC------CCceeeE
Q 005669 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS----------------GQGMEEFKNEVLLIAKLQ------HRNLVKL 578 (684)
Q Consensus 521 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~Ei~~l~~l~------H~nIv~l 578 (684)
....||+|+.-.||. +++....+||+..... ....++.++|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346899999999995 5566778888887654 122456667776555554 8899999
Q ss_pred EEEEEeCCeeEEEEEccCC------CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 005669 579 LGCCTQRDERMLIYEYLPN------KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (684)
Q Consensus 579 ~g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl 652 (684)
+|+.+++...-+|+|.+.+ .+|.+++. ...++. .....+. +-..||-+++ |+.+|++|.||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999997643 35677762 233554 3333333 3445666666 9999999999999
Q ss_pred cC--C-C-cEEEEe-eccccc
Q 005669 653 DN--T-M-NPKISD-FGLARS 668 (684)
Q Consensus 653 ~~--~-~-~vkI~D-FGla~~ 668 (684)
.. + . .+.|+| ||-...
T Consensus 152 ~~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred EecCCCceEEEEEeCCCCccc
Confidence 52 2 2 477777 454443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00013 Score=73.85 Aligned_cols=73 Identities=15% Similarity=0.274 Sum_probs=47.0
Q ss_pred ceecccCcE-eEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCC---ceeeEEEEEEeCC---eeEEEEEcc
Q 005669 523 NKLGEGGFG-PVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR---NLVKLLGCCTQRD---ERMLIYEYL 595 (684)
Q Consensus 523 ~~LG~G~fG-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~g~~~~~~---~~~lV~Ey~ 595 (684)
+.|+.|+.. .||+. +..+++|..+. ......+.+|.+++..+... -+.++++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567776666 58875 24577776553 22345788999999887532 3455555443322 347899999
Q ss_pred CCCChh
Q 005669 596 PNKSLD 601 (684)
Q Consensus 596 ~~gsL~ 601 (684)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00027 Score=74.24 Aligned_cols=79 Identities=14% Similarity=0.120 Sum_probs=58.3
Q ss_pred CCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCC---CceeeEEEEEEeC---CeeEEEE
Q 005669 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH---RNLVKLLGCCTQR---DERMLIY 592 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H---~nIv~l~g~~~~~---~~~~lV~ 592 (684)
....+.||.|..+.||+....++ .+.+|..+. ......+..|.+.|+.+.. ..+.++++.+..+ +..++||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 34456899999999999876555 466676432 1234578899999988853 4688899888643 5689999
Q ss_pred EccCCCCh
Q 005669 593 EYLPNKSL 600 (684)
Q Consensus 593 Ey~~~gsL 600 (684)
|++++.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998764
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00025 Score=66.92 Aligned_cols=130 Identities=19% Similarity=0.207 Sum_probs=87.9
Q ss_pred CccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCcee-eEEEEEEeCCeeEEEEEccCCC
Q 005669 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV-KLLGCCTQRDERMLIYEYLPNK 598 (684)
Q Consensus 520 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~g 598 (684)
...+.|++|.+|.||++.+. +.++|+|.-..+ .....+..|+++|..++-.++. +++.+-. ..+.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 34568999999999999874 458899887654 3457789999999999866654 4444432 34559999998
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC-CCcEEEcCCCcEEEEeecccccc
Q 005669 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK-ASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLk-p~NILl~~~~~vkI~DFGla~~~ 669 (684)
.|.+.-.. .+..+.. .+++.---|...+ |-|..|. |..++|-.+..+.|+||.-|+.-
T Consensus 98 ~L~~~~~~------~~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 98 PLGKLEIG------GDRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred chhhhhhc------ccHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 88765411 1233333 3333333344444 8888876 55555555559999999999854
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00047 Score=67.15 Aligned_cols=125 Identities=26% Similarity=0.390 Sum_probs=90.0
Q ss_pred CCCCccceecccCc-EeEEEEEeeCCcEEEEEEccC---CC--------c----------ccHHHHHHHHHHHhccC---
Q 005669 517 DNFSEKNKLGEGGF-GPVYKGMLIEGQEIAVKRLSK---GS--------G----------QGMEEFKNEVLLIAKLQ--- 571 (684)
Q Consensus 517 ~~y~~~~~LG~G~f-G~Vy~~~~~~g~~vavK~l~~---~~--------~----------~~~~~~~~Ei~~l~~l~--- 571 (684)
.+++.++.||.|.. |.||++.. +|+.+|+|.... .. . .....|..|.++..+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888899999999 99999987 678999999321 00 0 11235788999888875
Q ss_pred CCce--eeEEEEEEeCC------------------eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 005669 572 HRNL--VKLLGCCTQRD------------------ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631 (684)
Q Consensus 572 H~nI--v~l~g~~~~~~------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~y 631 (684)
+.++ |+.+|+..-.. ...||.||++... .+. ..-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 4456 99999974321 1356777765432 122 2335677788889
Q ss_pred HHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 632 LH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99988 999999999985 3489999865
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00044 Score=69.88 Aligned_cols=142 Identities=18% Similarity=0.214 Sum_probs=83.0
Q ss_pred ceecccCcEeEEEEEeeC--CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCc-eeeEEEEEEeCCeeEEEEEccCCCC
Q 005669 523 NKLGEGGFGPVYKGMLIE--GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN-LVKLLGCCTQRDERMLIYEYLPNKS 599 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey~~~gs 599 (684)
+.|..|-...+|+....+ ++.+++|+....... .....+|+.+++.+...+ .+++++... ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567888888999998764 678999977643221 223357888888885333 445544332 247999999877
Q ss_pred hhHH-------H----------hccCCC--------CCCC-HHHHHHHHH----------------------HHH---HH
Q 005669 600 LDYF-------I----------FDTTRS--------KLLD-WSKRSHIIA----------------------GIA---RG 628 (684)
Q Consensus 600 L~~~-------l----------~~~~~~--------~~l~-~~~~~~i~~----------------------qi~---~g 628 (684)
+... + +..... .... +..+..+.. .+. ..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 0 110100 0111 122111111 111 11
Q ss_pred HH-HHHhC-CCCceEecCCCCCcEEEcC-CCcEEEEeecccccc
Q 005669 629 LL-YLHQD-SRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSF 669 (684)
Q Consensus 629 L~-yLH~~-~~~~IvHrDLkp~NILl~~-~~~vkI~DFGla~~~ 669 (684)
|. .+... .+..++|+|+.|.|||+++ ++.+.|+||..|..-
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~ 202 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN 202 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence 11 11111 2346999999999999997 578999999988653
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00085 Score=72.79 Aligned_cols=75 Identities=15% Similarity=0.203 Sum_probs=55.5
Q ss_pred ceecccCcEeEEEEEeeCC-cEEEEEEccCC-----C--cccHHHHHHHHHHHhccC---CCceeeEEEEEEeCCeeEEE
Q 005669 523 NKLGEGGFGPVYKGMLIEG-QEIAVKRLSKG-----S--GQGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~g-~~vavK~l~~~-----~--~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV 591 (684)
+.||.|.+..||++...+| +.++||.-... . +...++...|.+.|..+. ..++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998776 58999985421 1 234567788888888763 3467778776 34557899
Q ss_pred EEccCCCC
Q 005669 592 YEYLPNKS 599 (684)
Q Consensus 592 ~Ey~~~gs 599 (684)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00068 Score=69.56 Aligned_cols=139 Identities=17% Similarity=0.111 Sum_probs=80.0
Q ss_pred eecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCce-eeEEEEEEeCCeeEEEEEccCCCChhH
Q 005669 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL-VKLLGCCTQRDERMLIYEYLPNKSLDY 602 (684)
Q Consensus 524 ~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gsL~~ 602 (684)
.+..|-...+|+.. .+++.+++|..............+|.++++.+....+ .+++.... .++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 35667788899887 3567888887654322211235778888888864333 44444432 368999999876532
Q ss_pred H-----------------HhccC-CCCCCCHHH-HHHHHHHH---------HHHHHHHHhC-----CCCceEecCCCCCc
Q 005669 603 F-----------------IFDTT-RSKLLDWSK-RSHIIAGI---------ARGLLYLHQD-----SRLRIIHRDLKASN 649 (684)
Q Consensus 603 ~-----------------l~~~~-~~~~l~~~~-~~~i~~qi---------~~gL~yLH~~-----~~~~IvHrDLkp~N 649 (684)
. ++... ....++... ...+..++ .+.+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 011122211 11111111 1112222211 12358999999999
Q ss_pred EEEcCCCcEEEEeeccccc
Q 005669 650 VLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 650 ILl~~~~~vkI~DFGla~~ 668 (684)
|++++++ ++|+||..|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00062 Score=71.37 Aligned_cols=143 Identities=20% Similarity=0.191 Sum_probs=86.6
Q ss_pred cceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCC--ceeeEEEE------EEeCCeeEEEEE
Q 005669 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR--NLVKLLGC------CTQRDERMLIYE 593 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--nIv~l~g~------~~~~~~~~lV~E 593 (684)
.+.|..|....+|+.... +..+++|+... ...+++..|++++..+.+. .+++++.. ....+..++++|
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 467888888899998754 45788898764 2345677788888887533 24454432 223455689999
Q ss_pred ccCCCChhH----H----------HhccCC----C----CCCCHHHHH----------HHHHHHHHHHHHHHh----CCC
Q 005669 594 YLPNKSLDY----F----------IFDTTR----S----KLLDWSKRS----------HIIAGIARGLLYLHQ----DSR 637 (684)
Q Consensus 594 y~~~gsL~~----~----------l~~~~~----~----~~l~~~~~~----------~i~~qi~~gL~yLH~----~~~ 637 (684)
|++|..+.. . ++.... . ....|.... .....+..++.++.+ .-+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 0 010000 0 011111110 111223344455543 122
Q ss_pred CceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 638 ~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
..++|+|+.|.||+++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3599999999999999987789999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0025 Score=67.02 Aligned_cols=142 Identities=24% Similarity=0.333 Sum_probs=84.6
Q ss_pred ceecccCcEeEEEEEeeC-------CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCc-eeeEEEEEEeCCeeEEEEEc
Q 005669 523 NKLGEGGFGPVYKGMLIE-------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN-LVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey 594 (684)
+.+..|-...+|+....+ ++.+++|+..... .......+|.+++..+.... ..++++.+.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777899888654 4789999876542 23345677888888875333 3455555532 358999
Q ss_pred cCCCChhHH-----------------HhccCCCC------CCC--HHHHHH--------------------------HHH
Q 005669 595 LPNKSLDYF-----------------IFDTTRSK------LLD--WSKRSH--------------------------IIA 623 (684)
Q Consensus 595 ~~~gsL~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~ 623 (684)
++|..+... +++..... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776431 01111000 111 111100 111
Q ss_pred HHHHHHHHHHh------CCCCceEecCCCCCcEEEcCC----CcEEEEeecccccc
Q 005669 624 GIARGLLYLHQ------DSRLRIIHRDLKASNVLLDNT----MNPKISDFGLARSF 669 (684)
Q Consensus 624 qi~~gL~yLH~------~~~~~IvHrDLkp~NILl~~~----~~vkI~DFGla~~~ 669 (684)
.+..-+..|.. ..+..++|+|+.|.|||++++ +.++++||..|..-
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 22223334432 234568999999999999874 78999999988753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.01 Score=62.70 Aligned_cols=143 Identities=24% Similarity=0.239 Sum_probs=82.8
Q ss_pred cceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCC--ceeeEEEEE------EeCCeeEEEEE
Q 005669 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR--NLVKLLGCC------TQRDERMLIYE 593 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--nIv~l~g~~------~~~~~~~lV~E 593 (684)
.+.++.|....+|+....++ .+++|+.... ...+.+..|++++..|... .+++++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677787789999875444 6778876542 1234556677777777422 244444421 22456789999
Q ss_pred ccCCCChhH-----------H---HhccCCC------C---CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 005669 594 YLPNKSLDY-----------F---IFDTTRS------K---LLDWSKRS------------HIIAGIARGLLYLHQ---- 634 (684)
Q Consensus 594 y~~~gsL~~-----------~---l~~~~~~------~---~l~~~~~~------------~i~~qi~~gL~yLH~---- 634 (684)
|++|..+.. . ++..... . .-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999865420 0 1110000 0 01111100 011123344555532
Q ss_pred CCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 635 ~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
..+..++|+|+++.||++++++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223469999999999999988777899999884
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.012 Score=62.39 Aligned_cols=142 Identities=18% Similarity=0.202 Sum_probs=77.7
Q ss_pred cceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCC--CceeeEEE------EEEeCCeeEEEEE
Q 005669 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH--RNLVKLLG------CCTQRDERMLIYE 593 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g------~~~~~~~~~lV~E 593 (684)
.+.|..|....+|+....+| .+++|+... ...+.+..|+.++..+.. -.+.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35677777789999876554 688888752 122344455565555532 12334332 1223556789999
Q ss_pred ccCCCChhH-----------HH---hccCCC--------CCCCH-HHHHH------------HHHH-HHHHHHHHHhC--
Q 005669 594 YLPNKSLDY-----------FI---FDTTRS--------KLLDW-SKRSH------------IIAG-IARGLLYLHQD-- 635 (684)
Q Consensus 594 y~~~gsL~~-----------~l---~~~~~~--------~~l~~-~~~~~------------i~~q-i~~gL~yLH~~-- 635 (684)
|++|..+.. .+ +..... ..+.+ ..... .+.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999875421 11 110000 01111 11111 1111 11122233211
Q ss_pred --CCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 636 --SRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 636 --~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
-+.+++|+|+.|.||+++.+...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999977666899999885
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0051 Score=63.87 Aligned_cols=32 Identities=22% Similarity=0.389 Sum_probs=26.7
Q ss_pred CceEecCCCCCcEEEcCCCc-EEEEeecccccc
Q 005669 638 LRIIHRDLKASNVLLDNTMN-PKISDFGLARSF 669 (684)
Q Consensus 638 ~~IvHrDLkp~NILl~~~~~-vkI~DFGla~~~ 669 (684)
..++|+|++|.|||+++++. .-|+||+.|..=
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999997555 579999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0011 Score=68.19 Aligned_cols=140 Identities=17% Similarity=0.186 Sum_probs=94.9
Q ss_pred HHHHhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCC---------Cc-----------cc--HHHHHHHHHHH
Q 005669 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG---------SG-----------QG--MEEFKNEVLLI 567 (684)
Q Consensus 510 ~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~---------~~-----------~~--~~~~~~Ei~~l 567 (684)
+.+....--++..+.||-|.-+.||.+...+|++.++|.-+.. .. .. .-...+|...|
T Consensus 85 ktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafm 164 (465)
T KOG2268|consen 85 KTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFM 164 (465)
T ss_pred HHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHH
Confidence 3333333457788999999999999999988999998843211 00 00 11245688888
Q ss_pred hccCC--CceeeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC
Q 005669 568 AKLQH--RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDL 645 (684)
Q Consensus 568 ~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDL 645 (684)
+.+.. --+++.+++ +..++|||++.+-.|...- ...+..+ +...+..-+.-|..+| +||+|.
T Consensus 165 kaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~---ly~~lm~~Iv~la~~G---lIHgDF 228 (465)
T KOG2268|consen 165 KALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPT---LYDDLMGLIVRLANHG---LIHGDF 228 (465)
T ss_pred HHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHH---HHHHHHHHHHHHHHcC---ceeccc
Confidence 88753 234444443 4568999999988885432 1223333 3334444455666777 999999
Q ss_pred CCCcEEEcCCCcEEEEeecc
Q 005669 646 KASNVLLDNTMNPKISDFGL 665 (684)
Q Consensus 646 kp~NILl~~~~~vkI~DFGl 665 (684)
.--||++++++.++++||==
T Consensus 229 NEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 229 NEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred chheeEEecCCCEEEeechH
Confidence 99999999999999999953
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.01 Score=63.69 Aligned_cols=142 Identities=18% Similarity=0.258 Sum_probs=82.6
Q ss_pred ceecccCcEeEEEEEeeC-----CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCce-eeEEEEEEeCCeeEEEEEccC
Q 005669 523 NKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL-VKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~ 596 (684)
+.|-.|-.-.+|+....+ ++.+++|+.........+ -.+|..+++.+...++ .++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 456567778899887532 367899988665433333 3678888888864444 3555655322 5799998
Q ss_pred CCChhHH-----------------HhccC-CC-C-CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 005669 597 NKSLDYF-----------------IFDTT-RS-K-LLDWSKRSHIIAGI-----------------ARGLLYL----HQ- 634 (684)
Q Consensus 597 ~gsL~~~-----------------l~~~~-~~-~-~l~~~~~~~i~~qi-----------------~~gL~yL----H~- 634 (684)
+.++... ++... .. . ...+.+...+..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 11111 00 1 11122222222111 1111122 21
Q ss_pred CCCCceEecCCCCCcEEEcC-CCcEEEEeecccccc
Q 005669 635 DSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSF 669 (684)
Q Consensus 635 ~~~~~IvHrDLkp~NILl~~-~~~vkI~DFGla~~~ 669 (684)
..+..++|+|+++.|||+++ ++.++++||..|..-
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 22346899999999999986 468999999988753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0084 Score=62.92 Aligned_cols=144 Identities=15% Similarity=0.252 Sum_probs=80.8
Q ss_pred ceecccCcEeEEEEEeeCCcEEEEEEccC--CCcccHHHHHHHHHHHhccCC--CceeeEEEEEEeCC--eeEEEEEccC
Q 005669 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSK--GSGQGMEEFKNEVLLIAKLQH--RNLVKLLGCCTQRD--ERMLIYEYLP 596 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~--~~~lV~Ey~~ 596 (684)
+.+..|.--.+|..... ++++++. ... ..........+|.++|+.+.- .-+.+.++.|.++. ..+.||+|++
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 34433433344444433 6778887 331 122334566778888888753 34556677777666 5689999998
Q ss_pred CCChhHHH----------h--------ccC----------------CCCC-CCHHHHHHHH--------HHHHHHHHHHH
Q 005669 597 NKSLDYFI----------F--------DTT----------------RSKL-LDWSKRSHII--------AGIARGLLYLH 633 (684)
Q Consensus 597 ~gsL~~~l----------~--------~~~----------------~~~~-l~~~~~~~i~--------~qi~~gL~yLH 633 (684)
|..+...+ . .-. .... -.+....+.+ -....-..+|+
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 84332111 0 000 0000 0111111000 01122233444
Q ss_pred hC-----CCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 634 QD-----SRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 634 ~~-----~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++ ++..++|+|+++.||+++.+.-+-|.||+++..
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 33 235799999999999999888899999999975
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0013 Score=53.38 Aligned_cols=50 Identities=18% Similarity=0.360 Sum_probs=35.9
Q ss_pred EeeeeeCCCCcccccccccCHHHHHHHHhccCceeeeeeecccCCCcceEEeec
Q 005669 374 EHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFH 427 (684)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~~~~~~~~~~gC~~w~~ 427 (684)
.++++.++..+.... ...+.++|++.|+.+|+|.||.|.. ....|+++..
T Consensus 8 ~~~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~ 57 (73)
T cd01100 8 QGSNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSS 57 (73)
T ss_pred ccCCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccC
Confidence 335666666555433 3568899999999999999999973 2345988654
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.017 Score=60.21 Aligned_cols=76 Identities=20% Similarity=0.273 Sum_probs=49.3
Q ss_pred CCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccC---CCceeeEEEEEEeCCeeEEEEEcc
Q 005669 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
.+..+.++.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. -..+++++++....+..+|++||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445688989999999987 567889999876 233456788888777773 456889999988888889999999
Q ss_pred CCC
Q 005669 596 PNK 598 (684)
Q Consensus 596 ~~g 598 (684)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.031 Score=60.65 Aligned_cols=73 Identities=12% Similarity=0.104 Sum_probs=51.9
Q ss_pred cceecccCcEeEEEEEeeCCcEEEEEEccCC-----C--cccHHHHHHHHHHHhccC---CCceeeEEEEEEeCCeeEEE
Q 005669 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG-----S--GQGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~-----~--~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV 591 (684)
.+.||.|....||+... +++.++||+-... . +....+-..|...|+.+. ...+++++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46899999999999886 4567999976521 1 123455556677776653 357888988887 446788
Q ss_pred EEccCC
Q 005669 592 YEYLPN 597 (684)
Q Consensus 592 ~Ey~~~ 597 (684)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.012 Score=61.97 Aligned_cols=141 Identities=19% Similarity=0.187 Sum_probs=95.7
Q ss_pred cceecccCcEeEEEEEeeCCcEEEEEEccCCC------------------------cccHH--HHHHHHHHHhccCCCce
Q 005669 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS------------------------GQGME--EFKNEVLLIAKLQHRNL 575 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~------------------------~~~~~--~~~~Ei~~l~~l~H~nI 575 (684)
.-.|..|.-+-||.+.-.+|..+|||+.+... +..+. -...|++-|.+++...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 35788999999999999899999999876321 00011 12347777777765544
Q ss_pred eeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC
Q 005669 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT 655 (684)
Q Consensus 576 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~ 655 (684)
.-.--... ....|||+|+.......-. .+.-.++...+..+-.|++.-+.-|.+.+ ++||.||.--|+|+.+
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPk---LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd- 300 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPK---LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD- 300 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCcc---cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-
Confidence 32211111 1246899999643221111 12334677788888899999999998877 5999999999999964
Q ss_pred CcEEEEeeccccccC
Q 005669 656 MNPKISDFGLARSFG 670 (684)
Q Consensus 656 ~~vkI~DFGla~~~~ 670 (684)
|.+.|+|-+=+-..+
T Consensus 301 G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEHD 315 (520)
T ss_pred CEEEEEEccccccCC
Confidence 589999987665443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.00053 Score=79.89 Aligned_cols=150 Identities=18% Similarity=0.216 Sum_probs=102.8
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
..+.+.+.+.+.+|.++.++.+.-.. +...++|..... .....+..+.+-.++-..+||-+++...-+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 44667777788899999998876433 433343333221 11122223333333333445666655544555677899
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
+++|+.+++|...|+.. ...+.+-....+..+..+++|||... ++|+|++|.|+++..++..+++|||..+..+
T Consensus 882 ~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 99999999998888432 24555556667778899999999876 8999999999999999999999999666553
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.038 Score=58.93 Aligned_cols=72 Identities=14% Similarity=0.191 Sum_probs=48.8
Q ss_pred eecccCcEeEEEEEeeCC-cEEEEEEccC-------CCcccHHHHHHHHHHHhccC--CC-ceeeEEEEEEeCCeeEEEE
Q 005669 524 KLGEGGFGPVYKGMLIEG-QEIAVKRLSK-------GSGQGMEEFKNEVLLIAKLQ--HR-NLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 524 ~LG~G~fG~Vy~~~~~~g-~~vavK~l~~-------~~~~~~~~~~~Ei~~l~~l~--H~-nIv~l~g~~~~~~~~~lV~ 592 (684)
.||.|....||++..+++ +.|+||.-.. .-+-..++..-|.+.|+... -| .+++++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999998654 6899997431 11344566677888776653 23 45555543 445567999
Q ss_pred EccCC
Q 005669 593 EYLPN 597 (684)
Q Consensus 593 Ey~~~ 597 (684)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99964
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.00083 Score=74.56 Aligned_cols=146 Identities=17% Similarity=0.119 Sum_probs=100.9
Q ss_pred HHhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCc-eeeEEEEEEeCCeeEE
Q 005669 512 IANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN-LVKLLGCCTQRDERML 590 (684)
Q Consensus 512 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~l 590 (684)
++..++.+...+.++++++++++|.+....+....+.+... ....-++++|.+++||| .+..++-++.++..++
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 34445556666788999999999987544444555555432 44566889999999999 6666776777778899
Q ss_pred EEEccCCC-ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 591 IYEYLPNK-SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 591 V~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+++++..+ +-.... ......+..-+...+...-++++++||+.. =+|+| ||+..+ +..|..||+.+..+
T Consensus 312 ~~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 312 PMRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred hhhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCccc
Confidence 99999876 221111 011122334444556667788999999864 48998 777766 57899999999887
Q ss_pred CCC
Q 005669 670 GLD 672 (684)
Q Consensus 670 ~~~ 672 (684)
.+.
T Consensus 382 ~~~ 384 (829)
T KOG0576|consen 382 TRT 384 (829)
T ss_pred Ccc
Confidence 654
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.041 Score=59.42 Aligned_cols=74 Identities=12% Similarity=0.105 Sum_probs=50.9
Q ss_pred cceecccCcEeEEEEEeeC-CcEEEEEEccC------CCcccHHHHHHHHHHHhccC--CC-ceeeEEEEEEeCCeeEEE
Q 005669 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK------GSGQGMEEFKNEVLLIAKLQ--HR-NLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~------~~~~~~~~~~~Ei~~l~~l~--H~-nIv~l~g~~~~~~~~~lV 591 (684)
.+.||.|.-.-||++.... ++.|+||.-.. .-+-..++..-|.++|+... -| .+++++.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4689999999999999753 56899996432 12344667777888887763 23 45556544 44556788
Q ss_pred EEccCC
Q 005669 592 YEYLPN 597 (684)
Q Consensus 592 ~Ey~~~ 597 (684)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.091 Score=56.07 Aligned_cols=142 Identities=16% Similarity=0.211 Sum_probs=80.0
Q ss_pred ceecccCcEeEEEEEeeC----CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCce-eeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL-VKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
+.|..|=.-.+|+....+ +..+++|+....... .-.-.+|..+++.+...++ +++++++. .+ +|.||+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 455556677788886543 237888887654332 2233678888888865555 45666553 22 58999987
Q ss_pred CChhHH-------H----------hccC-C-CC-CCCHHHHHHHHHHH----------------------HHHH---HHH
Q 005669 598 KSLDYF-------I----------FDTT-R-SK-LLDWSKRSHIIAGI----------------------ARGL---LYL 632 (684)
Q Consensus 598 gsL~~~-------l----------~~~~-~-~~-~l~~~~~~~i~~qi----------------------~~gL---~yL 632 (684)
..|..- + +... . .. .-.+..+..+..++ .+-+ ..+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 765321 1 1111 0 01 11122222222111 1111 111
Q ss_pred H-h-CCCCceEecCCCCCcEEEcC-CCcEEEEeecccccc
Q 005669 633 H-Q-DSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSF 669 (684)
Q Consensus 633 H-~-~~~~~IvHrDLkp~NILl~~-~~~vkI~DFGla~~~ 669 (684)
. . ..+..+.|.|+.+.|||+++ ++.++++||..|-.-
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 1 1 11234789999999999974 578999999988653
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.22 Score=52.39 Aligned_cols=29 Identities=24% Similarity=0.368 Sum_probs=25.3
Q ss_pred CceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 638 LRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 638 ~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45999999999999987 578999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.27 Score=52.33 Aligned_cols=72 Identities=14% Similarity=0.093 Sum_probs=45.9
Q ss_pred cCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCC--ceeeEE---E--EEEeCCeeEEEEEccCCCCh
Q 005669 528 GGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR--NLVKLL---G--CCTQRDERMLIYEYLPNKSL 600 (684)
Q Consensus 528 G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--nIv~l~---g--~~~~~~~~~lV~Ey~~~gsL 600 (684)
+.-..||+....+++.+++|..+.. .....++..|++.+..+... .++... | ....++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 3446799988877888999987643 23456777888887766321 122211 1 12335567889999987653
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.14 Score=54.46 Aligned_cols=140 Identities=24% Similarity=0.302 Sum_probs=82.1
Q ss_pred eecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCC---Cc---eeeEEEE----EEeCCeeEEEEE
Q 005669 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH---RN---LVKLLGC----CTQRDERMLIYE 593 (684)
Q Consensus 524 ~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H---~n---Iv~l~g~----~~~~~~~~lV~E 593 (684)
.|.+ .-..+|+....+|+. ++|+.+.. ....++..|...+..+.- +- +..+-|- ...+...+-++|
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 456789888877666 88888764 445667777777777632 11 2222121 111236788999
Q ss_pred ccCCCChhH-H----H----------hc----cC--C---CCCCCHHH-------------HHHHHHHHHHHHHHHHhCC
Q 005669 594 YLPNKSLDY-F----I----------FD----TT--R---SKLLDWSK-------------RSHIIAGIARGLLYLHQDS 636 (684)
Q Consensus 594 y~~~gsL~~-~----l----------~~----~~--~---~~~l~~~~-------------~~~i~~qi~~gL~yLH~~~ 636 (684)
|++|..+.. . + +. .. . .....|.. ......++...+..+.+.-
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988872 1 0 10 00 0 01223320 0112334444444444331
Q ss_pred ----C---CceEecCCCCCcEEEcCCCc-EEEEeecccc
Q 005669 637 ----R---LRIIHRDLKASNVLLDNTMN-PKISDFGLAR 667 (684)
Q Consensus 637 ----~---~~IvHrDLkp~NILl~~~~~-vkI~DFGla~ 667 (684)
+ ..+||+|+.|.||+++.+.. +.++||+-|.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 22999999999999998874 8999999775
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.031 Score=55.48 Aligned_cols=30 Identities=30% Similarity=0.460 Sum_probs=21.2
Q ss_pred ceEecCCCCCcEEE-cCCCcEEEEeeccccc
Q 005669 639 RIIHRDLKASNVLL-DNTMNPKISDFGLARS 668 (684)
Q Consensus 639 ~IvHrDLkp~NILl-~~~~~vkI~DFGla~~ 668 (684)
.+.|+|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47899999999999 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 684 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-34 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-28 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-27 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-19 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 5e-96
Identities = 76/201 (37%), Positives = 110/201 (54%), Gaps = 14/201 (6%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEK------NKLGEGGFGPVYKGMLIEGQEIAVK 547
N+ E + F + N T+NF E+ NK+GEGGFG VYKG + +AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVK 60
Query: 548 RLSKG----SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF 603
+L+ + + ++F E+ ++AK QH NLV+LLG + D+ L+Y Y+PN SL
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 604 IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663
+ + L W R I G A G+ +LH++ IHRD+K++N+LLD KISDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177
Query: 664 GLARSFGLDQTEANTKRVVGT 684
GLAR+ T R+VGT
Sbjct: 178 GLARASEKFAQTVMTSRIVGT 198
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 3e-93
Identities = 83/181 (45%), Positives = 108/181 (59%), Gaps = 3/181 (1%)
Query: 506 IFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGME-EFKNEV 564
F L+ + A+DNFS KN LG GGFG VYKG L +G +AVKRL + QG E +F+ EV
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 565 LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIA 623
+I+ HRNL++L G C ER+L+Y Y+ N S+ + + S+ LDW KR I
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
G ARGL YLH +IIHRD+KA+N+LLD + DFGLA+ T T V G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRG 197
Query: 684 T 684
T
Sbjct: 198 T 198
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 265 bits (681), Expect = 1e-83
Identities = 75/180 (41%), Positives = 113/180 (62%), Gaps = 6/180 (3%)
Query: 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLL 566
L + AT+NF K +G G FG VYKG+L +G ++A+KR + S QG+EEF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGI 625
++ +H +LV L+G C +R+E +LIY+Y+ N +L ++ + + + W +R I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF-GLDQTEANTKRVVGT 684
ARGL YLH + IIHRD+K+ N+LLD PKI+DFG+++ LDQT +T V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGT 204
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-63
Identities = 51/189 (26%), Positives = 87/189 (46%), Gaps = 17/189 (8%)
Query: 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLL 566
+ + + G FG V+K + + +AVK Q + + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQ-NEYEVYS 71
Query: 567 IAKLQHRNLVKLLGCCTQRD----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
+ ++H N+++ +G + + LI + SL F+ ++ ++ W++ HI
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 623 AGIARGLLYLHQD-------SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
+ARGL YLH+D + I HRD+K+ NVLL N + I+DFGLA F ++
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 676 ANTKRVVGT 684
+T VGT
Sbjct: 188 GDTHGQVGT 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-53
Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 26/200 (13%)
Query: 502 MELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFK 561
ME + + DN +G G +G VYKG L + + +AVK S + Q K
Sbjct: 1 MEAAASEPSL---DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK 56
Query: 562 NEVLLIAKLQHRNLVKLLGCCT-----QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS 616
+ + ++H N+ + + R E +L+ EY PN SL ++ T DW
Sbjct: 57 -NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWV 111
Query: 617 KRSHIIAGIARGLLYLHQD------SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF- 669
+ + RGL YLH + + I HRDL + NVL+ N ISDFGL+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 670 -----GLDQTEANTKRVVGT 684
+ + VGT
Sbjct: 172 GNRLVRPGEEDNAAISEVGT 191
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-48
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 491 KHSNQGNEKEEMELPIFDLKIIANATD------NFSE---KNKLGEGGFGPVYKGMLIEG 541
KH + + + ++P + A D + + K K+G G FG V++ G
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HG 60
Query: 542 QEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599
++AVK L + + + EF EV ++ +L+H N+V +G TQ ++ EYL S
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPK 659
L + + + LD +R + +A+G+ YLH I+HR+LK+ N+L+D K
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVK 179
Query: 660 ISDFGLARSFGLDQTEANTKRVVGT 684
+ DFGL+R T ++K GT
Sbjct: 180 VCDFGLSRL--KASTFLSSKSAAGT 202
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-44
Identities = 51/179 (28%), Positives = 76/179 (42%), Gaps = 16/179 (8%)
Query: 503 ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFK 561
DL LG+G FG K E G+ + +K L + + F
Sbjct: 6 IFRPSDLIH----------GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFL 55
Query: 562 NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
EV ++ L+H N++K +G + I EY+ +L I WS+R
Sbjct: 56 KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSF 113
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
IA G+ YLH + IIHRDL + N L+ N ++DFGLAR ++T+ R
Sbjct: 114 AKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 55/182 (30%), Positives = 83/182 (45%), Gaps = 24/182 (13%)
Query: 518 NFSE---KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG----SGQGMEEFKNEVLLIAKL 570
+F+E + +G GGFG VY+ G E+AVK Q +E + E L A L
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+H N++ L G C + L+ E+ L+ + K + + IARG+
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMN 119
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNP--------KISDFGLARSFGLDQTEANTKRVV 682
YLH ++ + IIHRDLK+SN+L+ + KI+DFGLAR +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAA 175
Query: 683 GT 684
G
Sbjct: 176 GA 177
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 9e-44
Identities = 53/195 (27%), Positives = 100/195 (51%), Gaps = 25/195 (12%)
Query: 503 ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG----- 556
E P L +A+ + + ++G+GGFG V+KG L++ +A+K L G +G
Sbjct: 7 EFPKSRLPTLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 557 --MEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLD 614
+EF+ EV +++ L H N+VKL G ++ E++P L + + D ++ +
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLD--KAHPIK 120
Query: 615 WSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----TMNPKISDFGLARSF 669
WS + ++ IA G+ Y+ I+HRDL++ N+ L + + K++DFGL++
Sbjct: 121 WSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-- 177
Query: 670 GLDQTEANTKRVVGT 684
Q+ + ++G
Sbjct: 178 ---QSVHSVSGLLGN 189
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 518 NFSE---KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQH 572
+F + KL E G ++KG +G +I VK L S + +F E + H
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 573 RNLVKLLGCCTQRDER--MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
N++ +LG C LI ++P SL + + T + D S+ +ARG+
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMA 125
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
+LH L I L + +V++D M +IS + SF
Sbjct: 126 FLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-43
Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 6/152 (3%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+ +G G FG V K +++A+K++ S + F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
KL G C L+ EY SL + + ++G+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 637 RLRIIHRDLKASNVLLDNTMN-PKISDFGLAR 667
+IHRDLK N+LL KI DFG A
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 20/198 (10%)
Query: 489 RKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKR 548
H + ++ E+P + + ++G G FG VYKG ++AVK
Sbjct: 6 HHHHHGSRDAADDWEIPDGQITV----------GQRIGSGSFGTVYKGKW--HGDVAVKM 53
Query: 549 LSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD 606
L+ + Q ++ FKNEV ++ K +H N++ +G T + ++ ++ SL + +
Sbjct: 54 LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHA 112
Query: 607 TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
+ K I ARG+ YLH IIHRDLK++N+ L KI DFGLA
Sbjct: 113 --SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167
Query: 667 RSFGLDQTEANTKRVVGT 684
+++ G+
Sbjct: 168 TEKSRWSGSHQFEQLSGS 185
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 23/202 (11%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVK 547
+K S +E ++P L+I +G+G FG VY G E+A++
Sbjct: 14 FPRKASQTSIFLQEWDIPFEQLEI----------GELIGKGRFGQVYHGRW--HGEVAIR 61
Query: 548 RLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF 605
+ + ++ FK EV+ + +H N+V +G C +I ++L +
Sbjct: 62 LIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR 121
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
D +LD +K I I +G+ YLH I+H+DLK+ NV DN I+DFGL
Sbjct: 122 D--AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDN-GKVVITDFGL 175
Query: 666 ARSFGLDQTEANTKR---VVGT 684
G+ Q + G
Sbjct: 176 FSISGVLQAGRREDKLRIQNGW 197
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 46/194 (23%), Positives = 79/194 (40%), Gaps = 24/194 (12%)
Query: 504 LPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNE 563
LP+ + IA ++G+G +G V+ G G+++AVK + E
Sbjct: 27 LPLLVQRTIA---KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRE 79
Query: 564 --VLLIAKLQHRNLVKLLGCCTQ----RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSK 617
+ ++H N++ + + + LI +Y N SL ++ +S LD
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKS 135
Query: 618 RSHIIAGIARGLLYLHQDSRLR-----IIHRDLKASNVLLDNTMNPKISDFGLARSF--G 670
+ GL +LH + I HRDLK+ N+L+ I+D GLA F
Sbjct: 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195
Query: 671 LDQTEANTKRVVGT 684
++ + VGT
Sbjct: 196 TNEVDIPPNTRVGT 209
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-38
Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 21/175 (12%)
Query: 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNE--VLLIAKLQHRNLVKLLG 580
+G+G +G V++G +G+ +AVK S + + + E + L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 581 CCT----QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ LI Y SL ++ + LD I+ IA GL +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 637 RLR-----IIHRDLKASNVLLDNTMNPKISDFGLAR--SFGLDQTEANTKRVVGT 684
I HRDLK+ N+L+ I+D GLA S +Q + VGT
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 30/199 (15%)
Query: 486 MYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-----E 540
+Y + + +++ + LK + +LG+G FG V
Sbjct: 20 LYFQGAMGSAFEDRDPTQFEERHLKFL----------QQLGKGNFGSVEMCRYDPLQDNT 69
Query: 541 GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER--MLIYEYLPNK 598
G+ +AVK+L + + + +F+ E+ ++ LQH N+VK G C R LI EYLP
Sbjct: 70 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 599 SLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 654
SL ++ KLL ++ + I +G+ YL R IHRDL N+L++N
Sbjct: 130 SLRDYLQKHKERIDHIKLLQYT------SQICKGMEYL---GTKRYIHRDLATRNILVEN 180
Query: 655 TMNPKISDFGLARSFGLDQ 673
KI DFGL + D+
Sbjct: 181 ENRVKIGDFGLTKVLPQDK 199
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 53/163 (32%), Positives = 79/163 (48%), Gaps = 20/163 (12%)
Query: 522 KNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+LG+G FG V G+ +AVK+L + + + +F+ E+ ++ LQH N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 577 KLLGCCTQRDER--MLIYEYLPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLL 630
K G C R LI EYLP SL ++ KLL ++ + I +G+
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT------SQICKGME 128
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
YL R IHRDL N+L++N KI DFGL + D+
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 48/194 (24%), Positives = 80/194 (41%), Gaps = 24/194 (12%)
Query: 504 LPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNE 563
LP+ + IA + +G+G FG V++G G+E+AVK S + + E
Sbjct: 32 LPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFRE 84
Query: 564 --VLLIAKLQHRNLVKLLGCCTQRD----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSK 617
+ L+H N++ + + + + L+ +Y + SL FD +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEG 140
Query: 618 RSHIIAGIARGLLYLHQD-----SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF--G 670
+ A GL +LH + + I HRDLK+ N+L+ I+D GLA
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200
Query: 671 LDQTEANTKRVVGT 684
D + VGT
Sbjct: 201 TDTIDIAPNHRVGT 214
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 35/203 (17%)
Query: 483 GGLMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI--- 539
G ++ +K + E + LK I LGEG FG V
Sbjct: 1 GDIVSEKKPAT----EVDPTHFEKRFLKRI----------RDLGEGHFGKVELCRYDPEG 46
Query: 540 --EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER--MLIYEY 594
G+++AVK L SG + + K E+ ++ L H N+VK G CT+ LI E+
Sbjct: 47 DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 106
Query: 595 LPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNV 650
LP+ SL ++ + L ++ I +G+ YL + +HRDL A NV
Sbjct: 107 LPSGSLKEYLPKNKNKINLKQQLKYA------VQICKGMDYL---GSRQYVHRDLAARNV 157
Query: 651 LLDNTMNPKISDFGLARSFGLDQ 673
L+++ KI DFGL ++ D+
Sbjct: 158 LVESEHQVKIGDFGLTKAIETDK 180
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 30/195 (15%)
Query: 492 HSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-----EGQEIAV 546
H+ ++ LK I ++LG+G FG V G +AV
Sbjct: 8 HAQLYACQDPTIFEERHLKYI----------SQLGKGNFGSVELCRYDPLGDNTGALVAV 57
Query: 547 KRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER--MLIYEYLPNKSLDYFI 604
K+L +F+ E+ ++ L +VK G + L+ EYLP+ L F+
Sbjct: 58 KQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL 117
Query: 605 FD----TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660
S+LL +S + I +G+ YL R +HRDL A N+L+++ + KI
Sbjct: 118 QRHRARLDASRLLLYS------SQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKI 168
Query: 661 SDFGLARSFGLDQTE 675
+DFGLA+ LD+
Sbjct: 169 ADFGLAKLLPLDKDY 183
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 52/160 (32%), Positives = 72/160 (45%), Gaps = 15/160 (9%)
Query: 522 KNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNL 575
LGEG FG V G+ +AVK L +G Q +K E+ ++ L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 576 VKLLGCCTQRDER--MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
+K GCC L+ EY+P SL ++ + ++ I G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
IHRDL A NVLLDN KI DFGLA++
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 51/166 (30%), Positives = 82/166 (49%), Gaps = 20/166 (12%)
Query: 523 NKLGEGGFGPVYKGMLIEGQE-----IAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLV 576
LG G FG VYKG+ I E +A+K L + + +E +E ++A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLLYL 632
+LLG C LI + +P L ++ + LL+W IA+G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAKGMNYL 133
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
R++HRDL A NVL+ + KI+DFGLA+ G ++ E +
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 48/187 (25%), Positives = 78/187 (41%), Gaps = 17/187 (9%)
Query: 483 GGLMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGML-IEG 541
L + ++ K++ L DL + ++G G FG V+ G L +
Sbjct: 90 QPLTKKSGVVLHRAVPKDKWVLNHEDLVLG----------EQIGRGNFGEVFSGRLRADN 139
Query: 542 QEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600
+AVK + +F E ++ + H N+V+L+G CTQ+ ++ E +
Sbjct: 140 TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 199
Query: 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660
F+ T L ++ A G+ YL IHRDL A N L+ KI
Sbjct: 200 LTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKI 254
Query: 661 SDFGLAR 667
SDFG++R
Sbjct: 255 SDFGMSR 261
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 45/192 (23%), Positives = 84/192 (43%), Gaps = 31/192 (16%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVK 547
++ + D+ + +LGEG FG V+ + +AVK
Sbjct: 28 QYFSDACVHHIKRRDIVLK----------WELGEGAFGKVFLAECHNLLPEQDKMLVAVK 77
Query: 548 RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF---- 603
L + S ++F+ E L+ LQH+++V+ G CT+ ++++EY+ + L+ F
Sbjct: 78 ALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH 137
Query: 604 --------IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT 655
+ L + + + +A G++YL + L +HRDL N L+
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQG 194
Query: 656 MNPKISDFGLAR 667
+ KI DFG++R
Sbjct: 195 LVVKIGDFGMSR 206
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 20/167 (11%)
Query: 522 KNKLGEGGFGPVYKGMLI---EGQEI--AVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNL 575
LG G FG V+KG+ I E +I +K + SG Q + + +L I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLLY 631
V+LLG C L+ +YLP SL + LL+W IA+G+ Y
Sbjct: 78 VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG------VQIAKGMYY 130
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
L ++HR+L A NVLL + +++DFG+A D +
Sbjct: 131 L---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 48/193 (24%), Positives = 80/193 (41%), Gaps = 32/193 (16%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVK 547
+ + D+ + +LGEG FG V+ + +AVK
Sbjct: 2 AMHSGIHVQHIKRRDIVLK----------RELGEGAFGKVFLAECYNLSPTKDKMLVAVK 51
Query: 548 RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF---- 603
L + ++F+ E L+ LQH ++VK G C D ++++EY+ + L+ F
Sbjct: 52 ALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH 111
Query: 604 ---------IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 654
L S+ HI + IA G++YL + +HRDL N L+
Sbjct: 112 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGA 168
Query: 655 TMNPKISDFGLAR 667
+ KI DFG++R
Sbjct: 169 NLLVKIGDFGMSR 181
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 59/166 (35%), Positives = 82/166 (49%), Gaps = 23/166 (13%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRN 574
+LGE FG VYKG L + Q +A+K L G EEF++E +L A+LQH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYF-------------IFDTTRSKLLDWSKRSHI 621
+V LLG T+ +I+ Y + L F D T L+ H+
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+A IA G+ YL S ++H+DL NVL+ + +N KISD GL R
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 20/172 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQE-----IAVKRLSKGSGQG-MEEFKNEVLLIAKL 570
F + LG G FG VYKG+ I E +A+K L + + +E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIA 626
+ ++ +LLG C LI + +P L ++ + LL+W IA
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
+G+ YL R++HRDL A NVL+ + KI+DFGLA+ G ++ E +
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 14/161 (8%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
++G G FG V+ G + ++A+K + +G+ E+F E ++ KL H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDT----TRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
C ++ L+ E++ + L ++ LL + G+ YL
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMC------LDVCEGMAYL---EE 122
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
+IHRDL A N L+ K+SDFG+ R DQ ++T
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 18/171 (10%)
Query: 498 EKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGM 557
+ L + +LK++ +G+G FG V G G ++AVK + +
Sbjct: 12 YRSGWALNMKELKLL----------QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-- 58
Query: 558 EEFKNEVLLIAKLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIFDTTRSKLLDWS 616
+ F E ++ +L+H NLV+LLG + ++ EY+ SL ++ + +L
Sbjct: 59 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGD 117
Query: 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ + YL +HRDL A NVL+ K+SDFGL +
Sbjct: 118 CLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-32
Identities = 45/182 (24%), Positives = 76/182 (41%), Gaps = 18/182 (9%)
Query: 487 YRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAV 546
+ + L + +LK++ +G+G FG V G G ++AV
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLL----------QTIGKGEFGDVMLGDY-RGNKVAV 221
Query: 547 KRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIF 605
K + + + F E ++ +L+H NLV+LLG + ++ EY+ SL ++
Sbjct: 222 KCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR 279
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
R +L + + YL +HRDL A NVL+ K+SDFGL
Sbjct: 280 SRGR-SVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335
Query: 666 AR 667
+
Sbjct: 336 TK 337
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 39/166 (23%), Positives = 70/166 (42%), Gaps = 29/166 (17%)
Query: 522 KNKLGEGGFGPVYKGML--------IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR 573
LG+G F ++KG+ + E+ +K L K E F +++KL H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT----TRSKLLDWSKRSHIIAGIARGL 629
+LV G C DE +L+ E++ SLD ++ L+ + +A +
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA------KQLAAAM 126
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNP--------KISDFGLAR 667
+L +IH ++ A N+LL + K+SD G++
Sbjct: 127 HFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 50/180 (27%), Positives = 87/180 (48%), Gaps = 19/180 (10%)
Query: 500 EEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE---IAVKRLSKGSG-Q 555
+++ L +L I +LG G FG V +G+ ++ +A+K L +G+
Sbjct: 2 KKLFLKRDNLLIA---------DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA 52
Query: 556 GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDW 615
EE E ++ +L + +V+L+G C + ML+ E L F+ + + +
Sbjct: 53 DTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPV 109
Query: 616 SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
S + ++ ++ G+ YL +HRDL A NVLL N KISDFGL+++ G D +
Sbjct: 110 SNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 16/189 (8%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVK 547
+ S G E+ DL + +LG G FG V G ++A+K
Sbjct: 5 SKNAPSTAGLGYGSWEIDPKDLTFL----------KELGTGQFGVVKYGKWRGQYDVAIK 54
Query: 548 RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT 607
+ +GS +EF E ++ L H LV+L G CT++ +I EY+ N L ++
Sbjct: 55 MIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--R 111
Query: 608 TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ + + + YL + +HRDL A N L+++ K+SDFGL+R
Sbjct: 112 EMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168
Query: 668 SFGLDQTEA 676
D+ +
Sbjct: 169 YVLDDEYTS 177
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 42/160 (26%), Positives = 73/160 (45%), Gaps = 17/160 (10%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRN 574
+LG+G FG VY+G+ +A+K +++ S + EF NE ++ + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYF-------IFDTTRSKLLDWSKRSHIIAGIAR 627
+V+LLG +Q ++I E + L + + + SK + IA
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
G+ YL + + +HRDL A N ++ KI DFG+ R
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-32
Identities = 47/146 (32%), Positives = 73/146 (50%), Gaps = 6/146 (4%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+LG G FG V G ++AVK + +GS +EF E + KL H LVK G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRII 641
C++ ++ EY+ N L ++ + K L+ S+ + + G+ +L + I
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 642 HRDLKASNVLLDNTMNPKISDFGLAR 667
HRDL A N L+D + K+SDFG+ R
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTR 152
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 52/195 (26%), Positives = 78/195 (40%), Gaps = 31/195 (15%)
Query: 497 NEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGML--IEGQEI--AVKRLSKG 552
+ + DL+++ KLG+G FG V +G G+ + AVK L
Sbjct: 8 LQSLTCLIGEKDLRLL----------EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD 57
Query: 553 ---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI----F 605
+ M++F EV + L HRNL++L G ++ E P SL +
Sbjct: 58 VLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG 116
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
L ++ +A G+ YL R IHRDL A N+LL KI DFGL
Sbjct: 117 HFLLGTLSRYA------VQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGL 167
Query: 666 ARSFGLDQTEANTKR 680
R+ + +
Sbjct: 168 MRALPQNDDHYVMQE 182
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 52/165 (31%), Positives = 79/165 (47%), Gaps = 21/165 (12%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQE---IAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLV 576
++ +GEG FG V K + + A+KR+ + S +F E+ ++ KL H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYF-------------IFDTTRSKLLDWSKRSHIIA 623
LLG C R L EY P+ +L F + + L + H A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
+ARG+ YL S+ + IHRDL A N+L+ KI+DFGL+R
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG 191
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 27/181 (14%)
Query: 497 NEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE----IAVKRLSKG 552
E +++ +P + +G+G FG VY G I+ + A+K LS+
Sbjct: 9 AEVKDVLIPHERVVT--------HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI 60
Query: 553 SGQG-MEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIFDT--- 607
+ +E F E LL+ L H N++ L+G + ++ Y+ + L FI
Sbjct: 61 TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN 120
Query: 608 -TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
T L+ + +ARG+ YL + + +HRDL A N +LD + K++DFGLA
Sbjct: 121 PTVKDLISFG------LQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
Query: 667 R 667
R
Sbjct: 172 R 172
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 28/196 (14%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRL 549
+ E+ + I + +G G G V G L +A+K L
Sbjct: 36 GRAGRSFTREIEASRIHI----------EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL 85
Query: 550 SKGSGQGM-EEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT- 607
G + +F +E ++ + H N+++L G T+ M++ EY+ N SLD F+
Sbjct: 86 KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD 145
Query: 608 ---TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664
T +L+ G+ G+ YL S L +HRDL A NVL+D+ + K+SDFG
Sbjct: 146 GQFTIMQLVGML------RGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 665 LARSFGLDQTEANTKR 680
L+R D A T
Sbjct: 197 LSRVLEDDPDAAYTTT 212
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 6/159 (3%)
Query: 522 KNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
K+KLG G +G VY+G+ +AVK L + + + +EEF E ++ +++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
CT+ +I E++ +L ++ + + ++ I+ + YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
IHRDL A N L+ K++DFGL+R D A+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 55/195 (28%), Positives = 88/195 (45%), Gaps = 20/195 (10%)
Query: 491 KHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE----IAV 546
+ Q + EL ++ I +G G FG V G L + +A+
Sbjct: 29 EDPTQTVHEFAKELDATNISID----------KVVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 547 KRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF 605
K L G + +F E ++ + H N+++L G T+ M++ EY+ N SLD F+
Sbjct: 79 KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL- 137
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
+ ++ GIA G+ YL S + +HRDL A N+L+++ + K+SDFGL
Sbjct: 138 -RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 666 ARSFGLDQTEANTKR 680
R D A T R
Sbjct: 194 GRVLEDDPEAAYTTR 208
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 29/197 (14%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE-----IAVKR 548
NQ K E+ + +G G FG VYKGML +A+K
Sbjct: 31 NQAVLKFTTEIHPSCVTRQ----------KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT 80
Query: 549 LSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI--- 604
L G + + +F E ++ + H N+++L G ++ M+I EY+ N +LD F+
Sbjct: 81 LKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK 140
Query: 605 -FDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663
+ + +L+ GIA G+ YL + + +HRDL A N+L+++ + K+SDF
Sbjct: 141 DGEFSVLQLVGML------RGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDF 191
Query: 664 GLARSFGLDQTEANTKR 680
GL+R D T
Sbjct: 192 GLSRVLEDDPEATYTTS 208
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 46/190 (24%), Positives = 78/190 (41%), Gaps = 27/190 (14%)
Query: 499 KEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGML-IEGQEI--AVKRLSKG--S 553
+E+ L L + E +LG G FG V KG ++ AVK L
Sbjct: 8 PKEVYLDRKLLTL---------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND 58
Query: 554 GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD---TTRS 610
+E E ++ +L + +V+++G C + ML+ E L+ ++
Sbjct: 59 PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDK 117
Query: 611 KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
+++ ++ G+ YL +HRDL A NVLL KISDFGL+++
Sbjct: 118 NIIELV------HQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168
Query: 671 LDQTEANTKR 680
D+ +
Sbjct: 169 ADENYYKAQT 178
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 50/162 (30%), Positives = 71/162 (43%), Gaps = 21/162 (12%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRN 574
LG G FG VY+G + ++AVK L + S Q +F E L+I+K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLL 630
+V+ +G Q R ++ E + L F+ ++ L H+ IA G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 631 YLHQDSRLRIIHRDLKASNVLL-----DNTMNPKISDFGLAR 667
YL IHRD+ A N LL KI DFG+AR
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVA--KIGDFGMAR 191
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 29/182 (15%)
Query: 495 QGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI--EGQEI--AVKRLS 550
G+ + E+ +++ +GEG FG V++G+ + E + A+K
Sbjct: 3 MGSSTRDYEIQRERIELG----------RCIGEGQFGDVHQGIYMSPENPALAVAIKTCK 52
Query: 551 KG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI----F 605
S E+F E L + + H ++VKL+G T+ + +I E L F+ +
Sbjct: 53 NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKY 111
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
+ L+ ++ ++ L YL R +HRD+ A NVL+ + K+ DFGL
Sbjct: 112 SLDLASLILYA------YQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGL 162
Query: 666 AR 667
+R
Sbjct: 163 SR 164
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 60/170 (35%), Positives = 92/170 (54%), Gaps = 16/170 (9%)
Query: 498 EKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGM 557
++E E+P LK++ +LG G FG V+ G ++AVK L +GS
Sbjct: 4 WEDEWEVPRETLKLV----------ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-P 52
Query: 558 EEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSK 617
+ F E L+ +LQH+ LV+L TQ + +I EY+ N SL F+ T L +K
Sbjct: 53 DAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINK 110
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ A IA G+ ++ IHRDL+A+N+L+ +T++ KI+DFGLAR
Sbjct: 111 LLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLAR 157
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 17/160 (10%)
Query: 522 KNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNL 575
LGEG FG V +G L ++AVK + S + +EEF +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 576 VKLLGCCTQRD-----ERMLIYEYLPNKSLDYFI---FDTTRSKLLDWSKRSHIIAGIAR 627
++LLG C + + M+I ++ L ++ T K + + IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
G+ YL S +HRDL A N +L + M ++DFGL++
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 48/188 (25%), Positives = 88/188 (46%), Gaps = 16/188 (8%)
Query: 493 SNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSK 551
++ E+ D+ + +KLG G +G VY+G+ +AVK L +
Sbjct: 206 YGVSPNYDKWEMERTDITMK----------HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE 255
Query: 552 GSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK 611
+ + +EEF E ++ +++H NLV+LLG CT+ +I E++ +L ++ +
Sbjct: 256 DTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQ 313
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
+ ++ I+ + YL + IHR+L A N L+ K++DFGL+R
Sbjct: 314 EVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370
Query: 672 DQTEANTK 679
D A+
Sbjct: 371 DTYTAHAG 378
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 19/155 (12%)
Query: 523 NKLGEGGFGPVYKGMLIEG----QEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVK 577
+G G FG VY G L++ AVK L++ + +F E +++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 578 LLGCCTQRDE-RMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
LLG C + + +++ Y+ + L FI + T L+ + +A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG------LQVAKGMKYL 144
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ + +HRDL A N +LD K++DFGLAR
Sbjct: 145 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-31
Identities = 58/183 (31%), Positives = 89/183 (48%), Gaps = 26/183 (14%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRL 549
+ EK+ E+P LK+ KLG G FG V+ + ++AVK +
Sbjct: 171 SSKPQKPWEKDAWEIPRESLKLE----------KKLGAGQFGEVWMATYNKHTKVAVKTM 220
Query: 550 SKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--- 606
GS +E F E ++ LQH LVKL T+ + +I E++ SL F+
Sbjct: 221 KPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG 278
Query: 607 --TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664
KL+D+S A IA G+ ++ + IHRDL+A+N+L+ ++ KI+DFG
Sbjct: 279 SKQPLPKLIDFS------AQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFG 329
Query: 665 LAR 667
LAR
Sbjct: 330 LAR 332
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-31
Identities = 50/162 (30%), Positives = 71/162 (43%), Gaps = 21/162 (12%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRN 574
LG G FG VY+G + ++AVK L + S Q +F E L+I+K H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLL 630
+V+ +G Q R ++ E + L F+ ++ L H+ IA G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 631 YLHQDSRLRIIHRDLKASNVLL-----DNTMNPKISDFGLAR 667
YL IHRD+ A N LL KI DFG+AR
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVA--KIGDFGMAR 232
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-31
Identities = 49/190 (25%), Positives = 89/190 (46%), Gaps = 12/190 (6%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE---IAV 546
+ + EL L + + + +LG G FG V +G+ ++ +A+
Sbjct: 311 DTSVFESPFSDPEELKDKKLFLKRD--NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAI 368
Query: 547 KRLSKGSGQGM-EEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF 605
K L +G+ + EE E ++ +L + +V+L+G C + ML+ E L F+
Sbjct: 369 KVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFL- 426
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
+ + + S + ++ ++ G+ YL +HR+L A NVLL N KISDFGL
Sbjct: 427 -VGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGL 482
Query: 666 ARSFGLDQTE 675
+++ G D +
Sbjct: 483 SKALGADDSY 492
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 44/161 (27%), Positives = 68/161 (42%), Gaps = 18/161 (11%)
Query: 522 KNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNL 575
LG+G FG V + L ++AVK L + +EEF E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 576 VKLLGCCTQRDER------MLIYEYLPNKSLDYFIFD---TTRSKLLDWSKRSHIIAGIA 626
KL+G + + M+I ++ + L F+ L + IA
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
G+ YL S IHRDL A N +L M ++DFGL+R
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 48/174 (27%), Positives = 74/174 (42%), Gaps = 31/174 (17%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRN 574
+GEG FG V++ +AVK L + S +F+ E L+A+ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYF---------------------IFDTTRSKLL 613
+VKLLG C L++EY+ L+ F + L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+++ I +A G+ YL S + +HRDL N L+ M KI+DFGL+R
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 26/174 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKG-SGQGMEEFKNEVLLI 567
D + LGEG FG V + E +AVK L + + + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 568 AKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DY------------FIFDTTRSKLL 613
+ +H+N++ LLG CTQ +I EY +L +Y + + + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ +ARG+ YL + + IHRDL A NVL+ KI+DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 31/179 (17%)
Query: 517 DNFSEKNKLGEGGFGPVYKGML--IEGQE----IAVKRLSKG-SGQGMEEFKNEVLLIAK 569
N LGEG FG V K ++G+ +AVK L + S + + +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSL---------------------DYFIFDTT 608
+ H +++KL G C+Q +LI EY SL + D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 609 RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ L I++G+ YL + ++++HRDL A N+L+ KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 26/174 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKG-SGQGMEEFKNEVLLI 567
D + LGEG FG V + E +AVK L + + + + +E+ ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 568 AKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DY------------FIFDTTRSKLL 613
+ +H+N++ LLG CTQ +I EY +L +Y + + + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ +ARG+ YL + + IHRDL A NVL+ KI+DFGLAR
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 19/155 (12%)
Query: 523 NKLGEGGFGPVYKGMLIEG----QEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVK 577
+G G FG VY G L++ AVK L++ + G + +F E +++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 578 LLGCCTQRDE-RMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
LLG C + + +++ Y+ + L FI + T L+ + +A+G+ +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG------LQVAKGMKFL 208
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ + +HRDL A N +LD K++DFGLAR
Sbjct: 209 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 19/155 (12%)
Query: 522 KNKLGEGGFGPVYKGMLI--EGQEI--AVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLV 576
LGEG FG VY+G+ +G++I AVK K + E+F +E +++ L H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
KL+G + + +I E P L +++ L+ +S I + + YL
Sbjct: 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS------LQICKAMAYL 129
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ +HRD+ N+L+ + K+ DFGL+R
Sbjct: 130 ---ESINCVHRDIAVRNILVASPECVKLGDFGLSR 161
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-30
Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 16/186 (8%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS 553
QG K+ E+P L++ KLG+G FG V+ G +A+K L G+
Sbjct: 171 TQGLAKDAWEIPRESLRLE----------VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 220
Query: 554 GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLL 613
E F E ++ KL+H LV+L ++ + ++ EY+ SL F K L
Sbjct: 221 MS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF-LKGETGKYL 277
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
+ + A IA G+ Y+ R+ +HRDL+A+N+L+ + K++DFGLAR ++
Sbjct: 278 RLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
Query: 674 TEANTK 679
A
Sbjct: 335 YTARQG 340
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 46/168 (27%), Positives = 69/168 (41%), Gaps = 25/168 (14%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHR 573
LG G FG V + + +AVK L +G + +E+ ++ + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 574 NLVKLLGCCTQRDE-RMLIYEYLPNKSL-DY------------FIFDTTRSKLLDWSKRS 619
N+V LLG CT+ M+I E+ +L Y + L
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+A+G+ +L + + IHRDL A N+LL KI DFGLAR
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 49/170 (28%), Positives = 72/170 (42%), Gaps = 22/170 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGML--IEGQE----IAVKRLSKG-SGQGMEEFKNEVLLIAK 569
+N LG G FG V + + ++ +AVK L E +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 570 L-QHRNLVKLLGCCTQRDERMLIYEYLPNKSL-----------DYFIFDTTRSKLLDWSK 617
L QH N+V LLG CT ++I EY L + +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
H + +A+G+ +L + IHRD+ A NVLL N KI DFGLAR
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
+F E +G GGFG V+K I+G+ +KR+ + E+ + EV +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 576 VKLLGCCTQRDERM----------------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRS 619
V GC D + E+ +L+ +I + R + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
+ I +G+ Y+H ++I+RDLK SN+ L +T KI DFGL S + +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRT 179
Query: 680 RVVGT 684
R GT
Sbjct: 180 RSKGT 184
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 1e-29
Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 16/191 (8%)
Query: 489 RKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKR 548
K QG K+ E+P L++ KLG+G FG V+ G +A+K
Sbjct: 249 TSKPQTQGLAKDAWEIPRESLRLE----------VKLGQGCFGEVWMGTWNGTTRVAIKT 298
Query: 549 LSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTT 608
L G+ E F E ++ KL+H LV+L ++ + ++ EY+ SL F
Sbjct: 299 LKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF-LKGE 355
Query: 609 RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
K L + + A IA G+ Y+ R+ +HRDL+A+N+L+ + K++DFGLAR
Sbjct: 356 TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARL 412
Query: 669 FGLDQTEANTK 679
++ A
Sbjct: 413 IEDNEYTARQG 423
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 49/174 (28%), Positives = 67/174 (38%), Gaps = 26/174 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAK 569
+ S LG G FG V + +AVK L E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 570 L-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF---------------IFDTTRSKLL 613
L H N+V LLG CT ++I EY L F L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
D +A+G+ +L + IHRDL A N+LL + KI DFGLAR
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 16/169 (9%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
++G G F VYKG+ E+A + K + + FK E ++ LQH N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 581 CC--TQRDERML--IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
T + ++ + + E + + +L ++ R K++ I +GL +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 637 RLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFGLDQTEANTKRVVGT 684
IIHRDLK N+ + + KI D GLA + + K V+GT
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGT 193
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 42/176 (23%), Positives = 72/176 (40%), Gaps = 17/176 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS-KGSGQGMEEFKNEVLLIAKLQHRN 574
+F LG GGFG V++ ++ A+KR+ E+ EV +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 575 LVKLLGC---------CTQRDERMLIY---EYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
+V+ ++ +Y + ++L ++ + + S HI
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
IA + +LH ++HRDLK SN+ K+ DFGL + D+ E
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 14/196 (7%)
Query: 491 KHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRL 549
+ + +G+ + ++ ++ D ++ LG+G +G VY G + IA+K +
Sbjct: 3 RSTEEGDCESDLLEYDYEY-------DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI 55
Query: 550 SKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTR 609
+ + + E+ L L+H+N+V+ LG ++ + E +P SL +
Sbjct: 56 PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 115
Query: 610 SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARS 668
+ I GL YLH + +I+HRD+K NVL++ KISDFG ++
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172
Query: 669 FGLDQTEANTKRVVGT 684
L T+ GT
Sbjct: 173 --LAGINPCTETFTGT 186
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 17/201 (8%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATD---NFSEKNKLGEGGFGPVYKGMLIE-GQE 543
S ++ L+++ + D K+GEG G V G++
Sbjct: 17 NLYFQSGVVTHEQFKA----ALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQ 72
Query: 544 IAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF 603
+AVK + Q E NEV+++ QH N+V++ +E ++ E+L +L
Sbjct: 73 VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT-- 130
Query: 604 IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663
D L+ + + + + + L YLH +IHRD+K+ ++LL K+SDF
Sbjct: 131 --DIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDF 185
Query: 664 GLARSFGLDQTEANTKRVVGT 684
G D + + +VGT
Sbjct: 186 GFCAQISKDVPKRKS--LVGT 204
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 26/169 (15%)
Query: 522 KNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-Q 571
LGEG FG V I ++AVK L + + + + +E+ ++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSL-DY------------FIFDTTRSKLLDWSKR 618
H+N++ LLG CTQ +I EY +L +Y + + L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ARG+ YL + + IHRDL A NVL+ KI+DFGLAR
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 41/197 (20%), Positives = 84/197 (42%), Gaps = 12/197 (6%)
Query: 492 HSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSK 551
H + + ++ + ++ +S ++G GG V++ + + Q A+K ++
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNL 62
Query: 552 G--SGQGMEEFKNEVLLIAKLQHRNL--VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT 607
Q ++ ++NE+ + KLQ + ++L ++ E N L+ ++
Sbjct: 63 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--- 118
Query: 608 TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ K +D +R + + +HQ I+H DLK +N L+ + K+ DFG+A
Sbjct: 119 KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIAN 174
Query: 668 SFGLDQTEANTKRVVGT 684
D T VGT
Sbjct: 175 QMQPDTTSVVKDSQVGT 191
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-28
Identities = 53/251 (21%), Positives = 103/251 (41%), Gaps = 34/251 (13%)
Query: 428 DLIDI--KELPESGQDLFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGL 485
DLID + + + Q IR + + N ++ + ++S++ + +
Sbjct: 312 DLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEII 371
Query: 486 MYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI--EGQE 543
+ + + E+ +++ +GEG FG V++G+ + E
Sbjct: 372 DE---EDTYTMPSTRDYEIQRERIELG----------RCIGEGQFGDVHQGIYMSPENPA 418
Query: 544 I--AVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600
+ A+K S E+F E L + + H ++VKL+G T+ + +I E L
Sbjct: 419 MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGEL 477
Query: 601 DYFIFDT----TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656
F+ + L+ ++ ++ L YL R +HRD+ A NVL+ +
Sbjct: 478 RSFLQVRKFSLDLASLILYA------YQLSTALAYL---ESKRFVHRDIAARNVLVSSND 528
Query: 657 NPKISDFGLAR 667
K+ DFGL+R
Sbjct: 529 CVKLGDFGLSR 539
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 52/192 (27%), Positives = 98/192 (51%), Gaps = 17/192 (8%)
Query: 497 NEKEEMELPIFDLKIIANATD---NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG 552
+++E +E L+ I + D ++ K+G+G G VY M + GQE+A+++++
Sbjct: 1 SDEEILE----KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ 56
Query: 553 SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL 612
E NE+L++ + ++ N+V L DE ++ EYL SL D
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETC 112
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
+D + + + + L +LH + ++IHRD+K+ N+LL + K++DFG +
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 673 QTEANTKRVVGT 684
Q++ +T +VGT
Sbjct: 170 QSKRST--MVGT 179
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 41/156 (26%), Positives = 66/156 (42%), Gaps = 9/156 (5%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
++ KLGEGGF V L +G A+KR+ Q EE + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 577 KLLGCCTQRDERM----LIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
+L+ C + L+ + +L + + L + ++ GI RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+H HRDLK +N+LL + P + D G
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 45/168 (26%), Positives = 76/168 (45%), Gaps = 20/168 (11%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
+F E LG+G FG V K ++ + A+K++ + + +EV+L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 575 LVKLLGC----------CTQRDERMLIY---EYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
+V+ T ++ ++ EY N +L I + + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRL 121
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
I L Y+H IIHRDLK N+ +D + N KI DFGLA++
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 39/171 (22%), Positives = 74/171 (43%), Gaps = 9/171 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHR 573
+ + K+GEG FG +G++ +K ++ S + EE + EV ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+V+ + ++ +Y L I + + L + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+I+HRD+K+ N+ L ++ DFG+AR A +GT
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 48/174 (27%), Positives = 71/174 (40%), Gaps = 31/174 (17%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHR 573
LG G FG V ++AVK L + E +E+ ++ +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSL------------DYFIFDTTRSKLLDWSKRSHI 621
N+V LLG CT LI+EY L + I + +L + + +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 622 -------IAG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
A +A+G+ +L +HRDL A NVL+ + KI DFGLAR
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 46/170 (27%), Positives = 82/170 (48%), Gaps = 8/170 (4%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
+ + +LG+G FG VYK E G A K + S + +E++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VKLLG + ++ E+ P ++D + + L + + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
RIIHRDLKA NVL+ + +++DFG++ + ++ +GT
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGT 180
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
NF + K+G G F VY+ L++G +A+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGLLY 631
N++K + +E ++ E L I + +L+ + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+H R++HRD+K +NV + T K+ D GL R F T A++ +VGT
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 39/166 (23%), Positives = 74/166 (44%), Gaps = 12/166 (7%)
Query: 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNL--VKL 578
++G GG V++ + + Q A+K ++ Q ++ ++NE+ + KLQ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
++ E N L+ ++ + K +D +R + + +HQ
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 127
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
I+H DLK +N L+ + K+ DFG+A D T VGT
Sbjct: 128 GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 25/177 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
+NF + K+GEG +G VYK G+ +A+K++ ++ E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+L H N+VKLL ++ L++E+L K D + + + +
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKF----MDASALTGIPLPLIKSYLFQL 112
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
+GL + H R++HRDLK N+L++ K++DFGLAR+FG T VV
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV 165
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 39/171 (22%), Positives = 75/171 (43%), Gaps = 12/171 (7%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNL 575
+S ++G GG V++ + + Q A+K ++ Q ++ ++NE+ + KLQ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 576 --VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
++L ++ E N L+ ++ + K +D +R + + +H
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
Q I+H DLK +N L+ + K+ DFG+A D T VG
Sbjct: 173 Q---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 50/176 (28%), Positives = 88/176 (50%), Gaps = 25/176 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN--------EVLLIA 568
+ + + K+GEG +G VYK +G+ +A+KR+ ++ E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 569 KLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
+L H N+V L+ L++E++ K + D ++ L D + + +
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKV----LDENKTGLQDSQIKI-YLYQLL 129
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
RG+ + HQ RI+HRDLK N+L+++ K++DFGLAR+FG + T VV
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV 181
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 10/176 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHR 573
+++ +G G +G K +G+ + K L G + + +EV L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 574 NLVKLLGCCTQRDERML--IYEYLPNKSLDYFIFDTTRSK-LLDWSKRSHIIAGIARGLL 630
N+V+ R L + EY L I T+ + LD ++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 631 YLHQ--DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
H+ D ++HRDLK +NV LD N K+ DFGLAR D + A T VGT
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 50/209 (23%), Positives = 84/209 (40%), Gaps = 19/209 (9%)
Query: 483 GGLMYRRKKHSNQGNEKEEMELPIFDLKI-IANATDNFSEKNKLGEGGFGPVYKGMLIE- 540
G +R + NE + + + + + ++G G FG V++ +
Sbjct: 23 GSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQT 82
Query: 541 GQEIAVKRLSKGSGQGMEEFK-NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599
G + AVK++ +E F+ E++ A L +V L G + + E L S
Sbjct: 83 GFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP- 658
L I + L + + + GL YLH RI+H D+KA NVLL + +
Sbjct: 137 LGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRA 190
Query: 659 KISDFGLAR---SFGLDQTEANTKRVVGT 684
+ DFG A GL ++ + GT
Sbjct: 191 ALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 42/148 (28%), Positives = 65/148 (43%), Gaps = 14/148 (9%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEE-FKNEVLLIAKLQHRNLVKLLG 580
LG+GGF ++ + + A K + K E E+ + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
D ++ E +SL + R L + R + + I G YLH+
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHR---N 160
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLA 666
R+IHRDLK N+ L+ + KI DFGLA
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 43/148 (29%), Positives = 65/148 (43%), Gaps = 14/148 (9%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEE-FKNEVLLIAKLQHRNLVKLLG 580
LG+GGF ++ + + A K + K E E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
D ++ E +SL + R L + R + + I G YLH R
Sbjct: 83 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RN 134
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLA 666
R+IHRDLK N+ L+ + KI DFGLA
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 25/176 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN--------EVLLIA 568
+ + K+GEG +G VYK G+ A+K++ +E+ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 569 KLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
+L+H N+VKL + +L++E+L K L D L + +S + +
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKL----LDVCEGGLESVTAKS-FLLQLL 110
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
G+ Y H R++HRDLK N+L++ KI+DFGLAR+FG T +V
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV 162
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 53/170 (31%), Positives = 87/170 (51%), Gaps = 10/170 (5%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
+ F KLGEG +G VYK + E GQ +A+K++ ++E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPH 85
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VK G + + ++ EY S+ I R+K L + + I+ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
R IHRD+KA N+LL+ + K++DFG+A + NT V+GT
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGT 188
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 52/174 (29%), Positives = 90/174 (51%), Gaps = 11/174 (6%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG-MEEFKNEVLLIAKL 570
A+ + F++ K+G+G FG V+KG+ + +A+K + + +E+ + E+ ++++
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+ K G + + +I EYL S D LD ++ + I+ I +GL
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLD 133
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
YLH + + IHRD+KA+NVLL K++DFG+A Q + NT VGT
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 182
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 55/180 (30%), Positives = 85/180 (47%), Gaps = 29/180 (16%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
+ + + LGEG F VYK Q +A+K++ G E K+ E+ L+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHI---I 622
+L H N++ LL + L+++++ + + L SHI +
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVI----IKDNSLVLTP----SHIKAYM 118
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
+GL YLHQ I+HRDLK +N+LLD K++DFGLA+SFG A T +VV
Sbjct: 119 LMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV 174
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 107 bits (271), Expect = 4e-26
Identities = 45/177 (25%), Positives = 84/177 (47%), Gaps = 26/177 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
+ + K+GEG +G V+K E + +A+KR+ +++ E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+L+H+N+V+L + L++E+ K FD+ L +S + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY----FDSCNGDLDPEIVKS-FLFQL 110
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
+GL + H ++HRDLK N+L++ K+++FGLAR+FG + VV
Sbjct: 111 LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV 163
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 43/179 (24%), Positives = 80/179 (44%), Gaps = 14/179 (7%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQ 571
+ + + LG+G V++G + G A+K + S + E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 572 HRNLVKLLGCCTQRDERM--LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H+N+VKL + R LI E+ P SL + + + + L S+ ++ + G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 630 LYLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+L + I+HR++K N++ D K++DFG AR D + + + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGT 178
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 17/197 (8%)
Query: 497 NEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ 555
++ L DL + + F +G G +G VYKG ++ GQ A+K + +G
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGD 62
Query: 556 GMEEFKNEVLLIAKL-QHRNLVKLLGC------CTQRDERMLIYEYLPNKSL-DYFIFDT 607
EE K E+ ++ K HRN+ G D+ L+ E+ S+ D +
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKN 120
Query: 608 TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
T+ L ++I I RGL +LHQ ++IHRD+K NVLL K+ DFG++
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 668 SFGLDQTEANTKRVVGT 684
LD+T +GT
Sbjct: 178 Q--LDRTVGRRNTFIGT 192
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 50/148 (33%), Positives = 75/148 (50%), Gaps = 13/148 (8%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEE-FKNEVLLIAKLQHRNLVKLLG 580
LG+G F VY+ I G E+A+K + K + GM + +NEV + +L+H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
+ L+ E N + R K ++ H + I G+LYLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQIITGMLYLH---SH 131
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLA 666
I+HRDL SN+LL MN KI+DFGLA
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 48/177 (27%), Positives = 87/177 (49%), Gaps = 16/177 (9%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-----EVLLI 567
+++ F + KLG G + VYKG+ G +A+K + S +G E+ L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLM 57
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+L+H N+V+L ++ L++E++ N K + L+ + + +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
+GL + H++ +I+HRDLK N+L++ K+ DFGLAR+FG + VV
Sbjct: 118 LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVV 170
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 16/183 (8%)
Query: 506 IFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLS---KGSGQGMEEFK 561
+ +L + FS+ ++G G FG VY + + +A+K++S K S + ++
Sbjct: 43 VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 102
Query: 562 NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
EV + KL+H N ++ GC + L+ EY + D K L + + +
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAV 159
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
G +GL YLH +IHRD+KA N+LL K+ DFG A AN+
Sbjct: 160 THGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANS--F 210
Query: 682 VGT 684
VGT
Sbjct: 211 VGT 213
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 43/179 (24%), Positives = 80/179 (44%), Gaps = 14/179 (7%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQ 571
+ + + LG+G V++G + G A+K + S + E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 572 HRNLVKLLGCCTQRDERM--LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H+N+VKL + R LI E+ P SL + + + + L S+ ++ + G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 630 LYLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+L + I+HR++K N++ D K++DFG AR D + + + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGT 178
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 45/170 (26%), Positives = 67/170 (39%), Gaps = 10/170 (5%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGC 581
L EGGF VY+ + G+E A+KRL + EV + KL H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 582 CTQRDERM-------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+ E L+ L L F+ L I R + ++H+
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ IIHRDLK N+LL N K+ DFG A + + + +
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 7e-25
Identities = 40/175 (22%), Positives = 72/175 (41%), Gaps = 22/175 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
+ + + K+GEG +G V+K + GQ +A+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
+L+H NLV LL ++ L++EY + L + + I +
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQ 113
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
+ + H+ IHRD+K N+L+ K+ DFG AR ++ V
Sbjct: 114 AVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVA 164
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 23/175 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-----EVLLIAKL 570
+ + + +KLGEG + VYKG +A+K + +G EV L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDL 57
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPN---KSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
+H N+V L L++EYL + LD +++ + + R
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD------DCGNIINMHNVKLFLFQLLR 111
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
GL Y H+ +++HRDLK N+L++ K++DFGLAR+ T+ VV
Sbjct: 112 GLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV 162
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 41/174 (23%), Positives = 71/174 (40%), Gaps = 16/174 (9%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEV-LLIAKLQHRNLV 576
+F K+ LG G G + + + +++AVKR+ + EV LL +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ R + + E +Y + + ++ GL +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCAATLQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 637 RLRIIHRDLKASNVLLDNT-----MNPKISDFGLARSFGLDQTE-ANTKRVVGT 684
L I+HRDLK N+L+ + ISDFGL + + + + V GT
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 49/188 (26%), Positives = 87/188 (46%), Gaps = 36/188 (19%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN--------EVLLI 567
+ + K+G+G FG V+K + + A+K++ ME K E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 568 AKLQHRNLVKLLGCCTQRDERM--------LIYEYLPN--KSLDYFIFDTTRSKLLDWSK 617
L+H N+V L+ C + L++++ + L K S+
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL----LSNVLVKFTL-SE 125
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677
++ + GL Y+H++ +I+HRD+KA+NVL+ K++DFGLAR+F L +
Sbjct: 126 IKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 678 ---TKRVV 682
T RVV
Sbjct: 183 NRYTNRVV 190
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
+ + +GEG +G V K + G+ +A+K+ + E+ L+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLL 78
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
+L+H NLV LL C ++ L++E++ + LD LD+ + I
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQKYLFQIIN 135
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
G+ + H IIHRD+K N+L+ + K+ DFG AR+ E V
Sbjct: 136 GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVA 186
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 52/186 (27%), Positives = 80/186 (43%), Gaps = 40/186 (21%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
D + KLGEG +G VYK + + +A+KR+ +E + EV L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR---SHI--- 621
+LQHRN+++L LI+EY + K +D + I
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSF 137
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP-----KISDFGLARSFGLDQTEA 676
+ + G+ + H R +HRDLK N+LL + KI DFGLAR+FG
Sbjct: 138 LYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQ 193
Query: 677 NTKRVV 682
T ++
Sbjct: 194 FTHEII 199
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 44/185 (23%), Positives = 79/185 (42%), Gaps = 38/185 (20%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN-EVLLIAKLQHRN 574
++ +G G FG V++ L+E E+A+K++ + + FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 575 LVKLLGCCTQRDERM------LIYEYLPNKSLDYFIFDTTRSKLLD-WSKRSHIIAG--- 624
+V L ++ L+ EY+P T + ++K +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP----------ETVYRASRHYAKLKQTMPMLLI 143
Query: 625 ------IARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEAN 677
+ R L Y+H + I HRD+K N+LLD + K+ DFG A+ E N
Sbjct: 144 KLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPN 198
Query: 678 TKRVV 682
+
Sbjct: 199 VSYIC 203
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 13/181 (7%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLS-KGSGQGMEEFKNEVLLIAKLQ 571
D++ + +G G V +++A+KR++ + M+E E+ +++
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSL-----DYFIFDTTRSKLLDWSKRSHIIAGIA 626
H N+V +DE L+ + L S+ +S +LD S + I+ +
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEANTKR--VVG 683
GL YLH++ IHRD+KA N+LL + +I+DFG++ N R VG
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 684 T 684
T
Sbjct: 189 T 189
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 50/194 (25%), Positives = 73/194 (37%), Gaps = 35/194 (18%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKR--LSKGSGQGMEEFKNEVLLIAKL-Q 571
T F E K+G G FG V+K + ++G A+KR + EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 572 HRNLVKLLGCCTQRDERMLIY-EYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGL 629
H ++V+ + D MLI EY SL I + R ++ ++ + RGL
Sbjct: 70 HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNP-------------------KISDFGLARSFG 670
Y+H ++H D+K SN+ + T P KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 671 LDQTEANTKRVVGT 684
Q E G
Sbjct: 186 SPQVE------EGD 193
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 1e-23
Identities = 47/180 (26%), Positives = 75/180 (41%), Gaps = 17/180 (9%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHR 573
+ K +LG GGFG V + + + G+++A+K+ + E + E+ ++ KL H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 574 NLVKLL------GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
N+V D +L EY L ++ L +++ I+
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
L YLH+ RIIHRDLK N++L + KI D G A+ VGT
Sbjct: 133 ALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--FVGT 186
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 48/202 (23%), Positives = 75/202 (37%), Gaps = 31/202 (15%)
Query: 503 ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN 562
+P F+ + + + LG G G V +G+ +AVKR+ +
Sbjct: 5 NIPNFEQSL----KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALM 57
Query: 563 EV-LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI----FDTTRSKLLDWSK 617
E+ LL H N+++ T + E N +L + KL
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 116
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP-------------KISDFG 664
++ IA G+ +LH L+IIHRDLK N+L+ + ISDFG
Sbjct: 117 PISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 665 LARSFGLDQT--EANTKRVVGT 684
L + Q+ N GT
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGT 195
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 29/188 (15%), Positives = 53/188 (28%), Gaps = 22/188 (11%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM------LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK 569
+ + LGEG F VY+ Q+ +K + + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI--FDTTRSKLLDWSKRSHIIAGIAR 627
+K ++ +L+ E +L I + T K++ +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNP-----------KISDFGLARSFGLDQTEA 676
+ +H IIH D+K N +L N + D G + L
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 677 NTKRVVGT 684
T
Sbjct: 241 IFTAKCET 248
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 43/203 (21%), Positives = 74/203 (36%), Gaps = 16/203 (7%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANAT-DNFSEKNKLGEGGFGPVYKGM-LIEGQEIA 545
+ ++ S +G E ++ P +D + +F ++LG G +G V+K +G+ A
Sbjct: 27 QPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYA 86
Query: 546 VKRLSKG--SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY-EYLPNKSLD 601
VKR + EV K+ QH V+L + + + E SL
Sbjct: 87 VKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-WEEGGILYLQTELC-GPSLQ 144
Query: 602 YFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661
L ++ + L +LH ++H D+K +N+ L K+
Sbjct: 145 QHC--EAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLG 199
Query: 662 DFGLARSFGLDQTEANTKRVVGT 684
DFGL G G
Sbjct: 200 DFGLLVELG-TAGAGEV--QEGD 219
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 31/184 (16%)
Query: 517 DNFSEKNKLGEGGFGPVYKG--MLIEGQEIAVKRLSKGSGQGMEEFKN--------EVLL 566
+ ++GEG +G V+K + G+ +A+KR+ ++ + EV +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 567 IAKLQ---HRNLVKLLGCCTQRDER-----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKR 618
+ L+ H N+V+L CT L++E++ ++ L ++ D +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
++ + RGL +LH R++HRDLK N+L+ ++ K++DFGLAR + T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177
Query: 679 KRVV 682
VV
Sbjct: 178 SVVV 181
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 39/186 (20%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-EVLLIAKLQHR 573
++++ +G G FG VY+ L + G+ +A+K++ + + FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 574 NLVKLLGCCTQRDERM------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRS-------H 620
N+V+L E+ L+ +Y+P T ++ R+ +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP----------ETVYRVARHYSRAKQTLPVIY 157
Query: 621 I---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEA 676
+ + + R L Y+H I HRD+K N+LLD +T K+ DFG A+ L + E
Sbjct: 158 VKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEP 212
Query: 677 NTKRVV 682
N +
Sbjct: 213 NVSYIC 218
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 46/155 (29%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEE-FKNEVLLIAKLQH 572
++F LG+G FG VY + +A+K L K G+E + EV + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLY 631
N+++L G LI EY P ++ + + D + + I +A L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSY 124
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
H R+IHRD+K N+LL + KI+DFG +
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 6e-23
Identities = 50/182 (27%), Positives = 83/182 (45%), Gaps = 21/182 (11%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ-GMEEFKN----EVLLIA 568
AT + ++G G +G VYK G +A+K + +G G EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 569 KLQ---HRNLVKLLGCCTQRDER-----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH 620
+L+ H N+V+L+ C L++E++ ++ L ++ D L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
++ RGL +LH + I+HRDLK N+L+ + K++DFGLAR + T
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPV 179
Query: 681 VV 682
VV
Sbjct: 180 VV 181
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 489 RKKHSNQGNEKEEMELPIFDLKIIANATDNFSE------KNKLGEGGFGPVYKGMLIE-G 541
+ K ++ FD +I+ + LG G FG V+K G
Sbjct: 55 KSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATG 114
Query: 542 QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601
++A K + + EE KNE+ ++ +L H NL++L +++ +L+ EY+ L
Sbjct: 115 LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL- 173
Query: 602 YFIFD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP- 658
FD S L + I G+ ++HQ + I+H DLK N+L N
Sbjct: 174 ---FDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQ 227
Query: 659 -KISDFGLARSFGLDQTEANTKRVVGT 684
KI DFGLAR + + K GT
Sbjct: 228 IKIIDFGLARRYKPRE---KLKVNFGT 251
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 42/171 (24%), Positives = 74/171 (43%), Gaps = 23/171 (13%)
Query: 517 DNFSEKNKLGEGGFGPVY---------------KGMLIEGQEIAVKRLSKGSGQGMEE-F 560
+++ L +G F + K +L + ++ K S + + F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 561 KNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DY----FIFDTTRSKLLDW 615
KNE+ +I +++ + G T DE +IYEY+ N S+ + F+ D + +
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 616 SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
II + Y+H + I HRD+K SN+L+D K+SDFG +
Sbjct: 151 QVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 43/204 (21%), Positives = 79/204 (38%), Gaps = 19/204 (9%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEK----NKLGEGGFGPVYKGMLIE-GQEI 544
N ++ E + + + + + +LG G FG V++ + G+
Sbjct: 20 GPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVF 79
Query: 545 AVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI 604
K ++ KNE+ ++ +L H L+ L + E +LI E+L L
Sbjct: 80 VAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL---- 135
Query: 605 FD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP--KI 660
FD + ++ + + GL ++H+ I+H D+K N++ + KI
Sbjct: 136 FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKI 192
Query: 661 SDFGLARSFGLDQTEANTKRVVGT 684
DFGLA D+ K T
Sbjct: 193 IDFGLATKLNPDE---IVKVTTAT 213
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 5e-22
Identities = 31/180 (17%), Positives = 63/180 (35%), Gaps = 16/180 (8%)
Query: 516 TDNFSEKNKLGEG--GFGPVYKGMLIE-GQEIAVKR--LSKGSGQGMEEFKNEVLLIAKL 570
+ +G+G V G+ + V+R L S + + + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H N+V +E ++ ++ S D + T ++ ++I+ G+ + L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYILQGVLKAL 141
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT-----KRVVGT 684
Y+H +HR +KAS++L+ +S S K V
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 47/178 (26%), Positives = 73/178 (41%), Gaps = 12/178 (6%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKL 570
D F K KLG G FG V+ G E +K ++K Q E + E+ ++ L
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H N++K+ ++ E L + + R K L + ++ + L
Sbjct: 78 DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLARSFGLDQTEANTKRVVGT 684
Y H ++H+DLK N+L +T KI DFGLA F D+ + GT
Sbjct: 138 AYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGT 189
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-21
Identities = 42/206 (20%), Positives = 79/206 (38%), Gaps = 19/206 (9%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEK----NKLGEGGFGPVYKGMLIE-GQ 542
+ S+ + + + + D+ + +LG G FG V++ G
Sbjct: 124 GKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGN 183
Query: 543 EIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDY 602
A K + E + E+ ++ L+H LV L +E ++IYE++ L
Sbjct: 184 NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL-- 241
Query: 603 FIFDTTRSKLLDWSKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP-- 658
F+ + S+ + + +GL ++H+ +H DLK N++ +
Sbjct: 242 --FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNEL 296
Query: 659 KISDFGLARSFGLDQTEANTKRVVGT 684
K+ DFGL Q + K GT
Sbjct: 297 KLIDFGLTAHLDPKQ---SVKVTTGT 319
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 2e-21
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 20/179 (11%)
Query: 521 EKNKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
E K+G G +G VYK + ++ A+K++ +G+G M + E+ L+ +L+H N++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVIS 82
Query: 578 LLGCCTQRDER--MLIYEYLPN---KSLDYFIFDTTRSKL--LDWSKRSHIIAGIARGLL 630
L +R L+++Y + + + K L ++ I G+
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGL-DQTEANTKRVVGT 684
YLH + ++HRDLK +N+L+ KI+D G AR F + A+ VV T
Sbjct: 143 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 56/214 (26%), Positives = 86/214 (40%), Gaps = 27/214 (12%)
Query: 485 LMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEK----NKLGEGGFGPVYKGMLIE 540
+ + S + N + +L I + + SE KLG G +G V
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 541 -GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597
E A+K + K S + EV ++ L H N++KL + L+ E
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 598 KSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653
L FD R K ++ + II + G+ YLH+ I+HRDLK N+LL+
Sbjct: 121 GEL----FDEIIHRMKF---NEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLE 170
Query: 654 NTM---NPKISDFGLARSFGLDQTEANTKRVVGT 684
+ KI DFGL+ F + K +GT
Sbjct: 171 SKEKDALIKIVDFGLSAVFENQKK---MKERLGT 201
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 23/179 (12%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--GSGQGMEEFKNEVLLIAKLQH 572
+DN+ K +LG+G F V + + G E A K ++ S + ++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARG 628
N+V+L + L+++ + L F+ R S+ SH I I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFY---SEADASHCIQQILES 117
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTEANTKRVVGT 684
+ Y H I+HR+LK N+LL + K++DFGLA + GT
Sbjct: 118 IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 48/183 (26%), Positives = 75/183 (40%), Gaps = 23/183 (12%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVK-----RLSKGSGQGMEEFKNEVLLIAK 569
D + +G+G F V + + E GQ+ AVK + + G E+ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDW---SKRSHIIAG 624
L+H ++V+LL + +++E++ L R+ + SH +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTEANTKRV 681
I L Y H IIHRD+K VLL + N K+ FG+A G A
Sbjct: 139 ILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--R 193
Query: 682 VGT 684
VGT
Sbjct: 194 VGT 196
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 12/155 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEE-FKNEVLLIAKLQH 572
D+F LG+G FG VY + +A+K L K +G+E + E+ + + L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLY 631
N++++ R L+ E+ P L + + D + + + +A L Y
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHY 129
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
H ++IHRD+K N+L+ KI+DFG +
Sbjct: 130 CH---ERKVIHRDIKPENLLMGYKGELKIADFGWS 161
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 94.3 bits (234), Expect = 6e-21
Identities = 19/179 (10%), Positives = 38/179 (21%), Gaps = 36/179 (20%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSK---GSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
L G V+ +E ++ A+K + S +E A+L + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 581 CC--------------------------TQRDERMLIYEYLP---NKSLDYFIFDTTRSK 611
+L+ F
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
+ A + R L ++H N+ + + D G
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 23/179 (12%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQH 572
+ ++ LG+G FG V K QE AVK ++K + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARG 628
N++KL ++ E L FD R + S+ + II + G
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRF---SEHDAARIIKQVFSG 133
Query: 629 LLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ Y+H+ I+HRDLK N+LL + + KI DFGL+ F + K +GT
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGT 186
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 8e-21
Identities = 40/181 (22%), Positives = 71/181 (39%), Gaps = 25/181 (13%)
Query: 516 TDNFSEK----NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ ++ N +G G +G V + A K++ K + ++ FK E+ ++ L
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIA 626
H N+++L + L+ E L F+ + + + I+ +
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVF---RESDAARIMKDVL 116
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLARSFGLDQTEANTKRVVG 683
+ Y H+ L + HRDLK N L K+ DFGLA F + + VG
Sbjct: 117 SAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVG 170
Query: 684 T 684
T
Sbjct: 171 T 171
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 49/187 (26%), Positives = 79/187 (42%), Gaps = 28/187 (14%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK------GSGQGMEEFKNEVL 565
+ D++ +LG G F V K G+E A K + K G EE + EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHI 621
++ +++H N++ L + + +LI E + L FD + L ++ +
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESL---TEDEATQF 113
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGLDQTEAN 677
+ I G+ YLH RI H DLK N++L + P K+ DFG+A
Sbjct: 114 LKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--- 167
Query: 678 TKRVVGT 684
K + GT
Sbjct: 168 FKNIFGT 174
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 48/237 (20%), Positives = 70/237 (29%), Gaps = 72/237 (30%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS-KGSGQGMEEFKNEVLLIAKLQHRN 574
+F +G GGFG V++ ++ A+KR+ E+ EV +AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK----------------------- 611
+V+ + E D S
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 612 ----------------------LLDWSKRS------------HIIAGIARGLLYLHQDSR 637
L DW R HI IA + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK----------RVVGT 684
++HRDLK SN+ K+ DFGL + D+ E VGT
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 32/176 (18%), Positives = 68/176 (38%), Gaps = 16/176 (9%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
+ + LG G FG V++ + + K + G K E+ ++ +H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR--SHIIAGIARGLL 630
RN++ L +E ++I+E++ + F+ + + ++R + + L
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNP--KISDFGLARSFGLDQTEANTKRVVGT 684
+LH I H D++ N++ + KI +FG AR + +
Sbjct: 117 FLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTA 166
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 42/170 (24%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLS-KGSGQGMEEFKNEVLLIAKLQHRN 574
D+F + ++LG G G V+K G +A K + + + E+ ++ +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+V G E + E++ SLD + ++ + + + +GL YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLR- 148
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ +I+HRD+K SN+L+++ K+ DFG+ S L + AN+ VGT
Sbjct: 149 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANS--FVGT 193
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 50/166 (30%), Positives = 74/166 (44%), Gaps = 16/166 (9%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHRNLVKLLGCC 582
LGEG +G V + + + +AVK + E K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 583 TQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSH---IIAGIARGLLYLHQDSRL 638
+ + + L EY L D + + + ++AG+ YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV----YLH---GI 124
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
I HRD+K N+LLD N KISDFGLA F + E ++ GT
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 27/189 (14%)
Query: 510 KIIANATDNFSEK----NKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--GSGQGMEEFKN 562
+ + NA+ FS+ +LG+G F V + + G E A K ++ S + ++ +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 563 EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR-- 618
E + KLQH N+V+L + L+++ + L F+ R S+
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFY---SEADA 130
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTE 675
SH I I + Y H I+HR+LK N+LL + K++DFGLA +
Sbjct: 131 SHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA- 186
Query: 676 ANTKRVVGT 684
GT
Sbjct: 187 --WHGFAGT 193
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 51/184 (27%), Positives = 75/184 (40%), Gaps = 22/184 (11%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK------GSGQGMEEFKNEVL 565
D + +LG G F V K G E A K + K G EE + EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAG 624
++ ++ H N++ L R + +LI E + L FD + + L + + I
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQ 123
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGLDQTEANTKR 680
I G+ YLH +I H DLK N++L + P K+ DFGLA K
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKN 177
Query: 681 VVGT 684
+ GT
Sbjct: 178 IFGT 181
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 11/165 (6%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
KLG GG VY I ++A+K + + + ++ F+ EV ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
+ D L+ EY+ +L +I L + I G+ + H +R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
I+HRD+K N+L+D+ KI DFG+A++ + + T V+GT
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGT 175
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 52/187 (27%), Positives = 75/187 (40%), Gaps = 28/187 (14%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK------GSGQGMEEFKNEVL 565
D + +LG G F V K G E A K + K G EE + EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHI 621
++ ++ H N++ L R + +LI E + L FD + L S+ +
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESL---SEEEATSF 120
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGLDQTEAN 677
I I G+ YLH +I H DLK N++L + P K+ DFGLA
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--- 174
Query: 678 TKRVVGT 684
K + GT
Sbjct: 175 FKNIFGT 181
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 3e-20
Identities = 27/190 (14%), Positives = 59/190 (31%), Gaps = 41/190 (21%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQ--------- 571
LG+ + E G+ V +++ K EVL + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 572 ----------------HRNLVKLLGCCTQRDERMLIY---EYLPNKSL----DYFIFDTT 608
+ ++++ +RD +L +L + + ++
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRL--DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 609 RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
K L R + + R L LH ++H L+ +++LD ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 669 FGLDQTEANT 678
G + +
Sbjct: 256 DGARVVSSVS 265
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 3e-20
Identities = 28/194 (14%), Positives = 55/194 (28%), Gaps = 38/194 (19%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH-------- 572
LG+ + G+ V +++ K EVL + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 573 --------RNLVKLLGCCT-----QRDERMLIYEY-----LPNKSL----DYFIFDTTRS 610
+LVK + M + +L + + ++
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 611 KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
K L R + + R L LH ++H L+ +++LD ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 671 LDQTEANTKRVVGT 684
+ R
Sbjct: 263 -ASAVSPIGRGFAP 275
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 44/211 (20%), Positives = 84/211 (39%), Gaps = 27/211 (12%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAV 546
+ K N + E + D + K+ +G G V + + G E AV
Sbjct: 65 QPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAV 124
Query: 547 KRLSKGSGQG--------MEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597
K + + + E + E ++ ++ H +++ L+ L+++ +
Sbjct: 125 KIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK 184
Query: 598 KSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653
L FD T + L S++ I+ + + +LH I+HRDLK N+LLD
Sbjct: 185 GEL----FDYLTEKVAL---SEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLD 234
Query: 654 NTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ M ++SDFG + + + + GT
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEK---LRELCGT 262
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 50/166 (30%), Positives = 74/166 (44%), Gaps = 16/166 (9%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHRNLVKLLGCC 582
LGEG +G V + + + +AVK + E K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 583 TQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSH---IIAGIARGLLYLHQDSRL 638
+ + + L EY L D + + + ++AG+ YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV----YLH---GI 124
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
I HRD+K N+LLD N KISDFGLA F + E ++ GT
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 51/186 (27%), Positives = 78/186 (41%), Gaps = 28/186 (15%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK------GSGQGMEEFKNEVLL 566
N D + +LG G F V K G + A K + K G E+ + EV +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHII 622
+ ++QH N++ L + + +LI E + L FD + L ++ + +
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESL---TEEEATEFL 120
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGLDQTEANT 678
I G+ YLH L+I H DLK N++L + P KI DFGLA
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---F 174
Query: 679 KRVVGT 684
K + GT
Sbjct: 175 KNIFGT 180
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 17/176 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVL-----LIAKL 570
++ + ++G G +G V K + GQ +AVKR+ E+ + ++L ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSS 78
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLD--YFIFDTTRSKLLDWSKRSHIIAGIARG 628
+V+ G + + + E + + S D Y + ++ I +
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
L +L L+IIHRD+K SN+LLD + N K+ DFG+ S L + A T R G
Sbjct: 138 LNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGI--SGQLVDSIAKT-RDAGC 188
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 44/238 (18%), Positives = 74/238 (31%), Gaps = 50/238 (21%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVK----- 547
+ + E F + + K +G+G +G V + + A+K
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 548 RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT 607
++ + + + +E K EV L+ KL H N+ +L L+ E L +
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF 122
Query: 608 TRSKLLDWSKR-------------------------------------SHIIAGIARGLL 630
+ S+I+ I L
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182
Query: 631 YLHQDSRLRIIHRDLKASNVLL--DNTMNPKISDFGLARSFGLDQTEANT--KRVVGT 684
YLH I HRD+K N L + + K+ DFGL++ F GT
Sbjct: 183 YLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 32/190 (16%)
Query: 514 NATDNFSEK----NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGM---------EE 559
++T F E LG G V + + +E AVK + G E
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 560 FKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWS 616
EV ++ K+ H N+++L L+++ + L FD T + L S
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTL---S 122
Query: 617 KR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
++ I+ + + LH+ L I+HRDLK N+LLD+ MN K++DFG + +
Sbjct: 123 EKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179
Query: 675 EANTKRVVGT 684
+ V GT
Sbjct: 180 ---LREVCGT 186
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-19
Identities = 35/169 (20%), Positives = 65/169 (38%), Gaps = 23/169 (13%)
Query: 524 KLGEGGFGPVYKG--MLIEGQEIAVKRL-SKGSGQGMEEFKNEVLLIAKLQHRNLVKLL- 579
+ GG G +Y + G+ + +K L G + E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 580 -GCCTQRDERMLIY---EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
T R + Y EY+ +SL L ++ + I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ +++ DLK N++L K+ D G ++ + GT
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR--INSFGY----LYGT 240
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 46/192 (23%), Positives = 74/192 (38%), Gaps = 41/192 (21%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN----EVLLIA 568
D F + G+G FG V G G +A+K++ + F+N + +A
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLA 74
Query: 569 KLQHRNLVKLLGCCTQRDER-------MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS-- 619
L H N+V+L ER ++ EY+P T + R
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----------DTLHRCCRNYYRRQV 124
Query: 620 -----HI---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFG 670
I + + R + LH S + + HRD+K NVL++ K+ DFG A+
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK-- 181
Query: 671 LDQTEANTKRVV 682
L +E N +
Sbjct: 182 LSPSEPNVAYIC 193
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 53/187 (28%), Positives = 81/187 (43%), Gaps = 23/187 (12%)
Query: 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEV 564
+L + ++ LG+G FG V K QE AVK ++K + EV
Sbjct: 13 NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV 72
Query: 565 LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SH 620
L+ KL H N++KL ++ E L FD R + S+ +
Sbjct: 73 ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRF---SEHDAAR 125
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLARSFGLDQTEAN 677
II + G+ Y+H+ I+HRDLK N+LL++ + KI DFGL+ F +
Sbjct: 126 IIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--- 179
Query: 678 TKRVVGT 684
K +GT
Sbjct: 180 MKDRIGT 186
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 41/157 (26%), Positives = 66/157 (42%), Gaps = 28/157 (17%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGS----GQGMEEFKNEVLLIAKLQHRNLVKL- 578
LGEG +G V + + AVK L K G K E+ L+ +L+H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 579 --LGCCTQRDERMLIY---EYLPNKSLDYFIFD-TTRSKLLDWSKRSH---IIAGIARGL 629
L ++ +Y EY + + D + + +I G+
Sbjct: 73 DVLYNEEKQK----MYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE--- 123
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
YLH I+H+D+K N+LL KIS G+A
Sbjct: 124 -YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 55/180 (30%), Positives = 83/180 (46%), Gaps = 24/180 (13%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK---GSGQGMEEFKNEVLLIAKLQ 571
+D + + LG+G FG V GQE AVK +SK E EV L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIAR 627
H N++KL + L+ E L FD +R + S+ + II +
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRF---SEVDAARIIRQVLS 137
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTM---NPKISDFGLARSFGLDQTEANTKRVVGT 684
G+ Y+H+ +I+HRDLK N+LL++ N +I DFGL+ F + K +GT
Sbjct: 138 GITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGT 191
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 24/177 (13%)
Query: 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLL 579
++ LGEG V + + QE AVK + K G EV ++ + Q HRN+++L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQD 635
+ D L++E + S+ R ++ S ++ +A L +LH
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHF---NELEASVVVQDVASALDFLHN- 129
Query: 636 SRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTEANTKR-----VVGT 684
I HRDLK N+L ++ KI DF L L+ + G+
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 16/175 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-----EVLLIAKL 570
D+ +LG G +G V K + GQ +AVKR+ +E K ++ + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDISM-RTV 63
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGL 629
V G + + + E + + SLD F + + + I I + L
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+LH S+L +IHRD+K SNVL++ K+ DFG++ L A G
Sbjct: 123 EHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGY--LVDDVAKD-IDAGC 172
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 42/177 (23%), Positives = 69/177 (38%), Gaps = 22/177 (12%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
F LG G F V+ G+ A+K + K +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLL 630
+V L L+ + + L FD R +++ S +I + +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGVY---TEKDASLVIQQVLSAVK 120
Query: 631 YLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
YLH+ I+HRDLK N+L + I+DFGL++ GT
Sbjct: 121 YLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGT 170
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 43/178 (24%), Positives = 69/178 (38%), Gaps = 24/178 (13%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
TD + K +G G + + + E AVK + K EE +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLL 630
++ L ++ E + L D + S+R S ++ I + +
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFF---SEREASAVLFTITKTVE 130
Query: 631 YLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
YLH ++HRDLK SN+L N + +I DFG A+ + T T
Sbjct: 131 YLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 8e-19
Identities = 46/182 (25%), Positives = 82/182 (45%), Gaps = 22/182 (12%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--GSGQGMEEFKNEVLLIAK 569
T+ + +LG+G F V + + + GQE A ++ S + ++ + E +
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGI 625
L+H N+V+L ++ LI++ + L F+ R S+ SH I I
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYY---SEADASHCIQQI 119
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTEANTKRVV 682
+L+ HQ + ++HR+LK N+LL + + K++DFGLA +Q
Sbjct: 120 LEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FA 174
Query: 683 GT 684
GT
Sbjct: 175 GT 176
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 48/152 (31%), Positives = 76/152 (50%), Gaps = 17/152 (11%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+G+G F V ++ G+E+A+K + K + +++ EV ++ L H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 582 CTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSH---IIAGIARGLLYLHQDSR 637
LI EY + DY + ++ + RS I++ + Y H +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQ----YCH---Q 132
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
RI+HRDLKA N+LLD MN KI+DFG + F
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 44/171 (25%), Positives = 72/171 (42%), Gaps = 17/171 (9%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
LG GG V+ L + +++AVK L F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 580 --GCCTQRDERMLIY---EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
G + L Y EY+ +L + + + +IA + L + H
Sbjct: 79 DTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH- 133
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD-QTEANTKRVVGT 684
+ IIHRD+K +N+++ T K+ DFG+AR+ + T V+GT
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 34/216 (15%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKR 548
N + + ++ K +++ + KLG G +G V E A+K
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 549 LSK-------------GSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595
+ K + EE NE+ L+ L H N++KL + L+ E+
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 596 PNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651
L F+ R K + ++I+ I G+ YLH+ I+HRD+K N+L
Sbjct: 129 EGGEL----FEQIINRHKF---DECDAANIMKQILSGICYLHK---HNIVHRDIKPENIL 178
Query: 652 LDNT---MNPKISDFGLARSFGLDQTEANTKRVVGT 684
L+N +N KI DFGL+ F D + +GT
Sbjct: 179 LENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGT 211
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 43/195 (22%), Positives = 77/195 (39%), Gaps = 12/195 (6%)
Query: 493 SNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRL-S 550
S+ + K+ L I + A D ++G G G V+K + G IAVK++
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEIND-LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 551 KGSGQGMEEFKNEV-LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTR 609
G+ + + ++ +++ +V+ G + + E + +
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE--KLKKRM 117
Query: 610 SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
+ + I + L YL + +IHRD+K SN+LLD K+ DFG+ S
Sbjct: 118 QGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGI--SG 173
Query: 670 GLDQTEANTKRVVGT 684
L +A R G
Sbjct: 174 RLVDDKAKD-RSAGC 187
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 48/203 (23%), Positives = 81/203 (39%), Gaps = 25/203 (12%)
Query: 497 NEKEEMELPIFDLKIIANATDNFSEK-----NKLGEGGFGPVYKGMLIE-GQEIAVKRLS 550
+ + + + + +NF+ +LG G F V + + GQE A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 551 K--GSGQGMEEFKNEVLLIAKLQHR-NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT 607
K E +E+ ++ + ++ L E +LI EY + F
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSL 119
Query: 608 TRSKLLDW---SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKIS 661
+L + + +I I G+ YLHQ I+H DLK N+LL + + KI
Sbjct: 120 CLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIV 176
Query: 662 DFGLARSFGLDQTEANTKRVVGT 684
DFG++R G + ++GT
Sbjct: 177 DFGMSRKIGHACE---LREIMGT 196
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 44/152 (28%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK------GSGQGMEEFKNEVLLIAKLQHR--NL 575
LG GGFG VY G+ + + +A+K + K G EV+L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
++LL + D +LI E P D F F T R L + R + + + H
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 166
Query: 636 SRLRIIHRDLKASNVLLD-NTMNPKISDFGLA 666
++HRD+K N+L+D N K+ DFG
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSG 197
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 6e-18
Identities = 46/210 (21%), Positives = 78/210 (37%), Gaps = 51/210 (24%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-EVLLIAKLQ 571
++ +S LG G FG V + IE G+ A+K++ + +KN E+ ++ L
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLD 58
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLD-------------------------YFIF- 605
H N++KL+ + P+ I
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 606 --DTTRSKLLDWSKRS-------HI---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653
T K+L RS I I + R + ++H L I HRD+K N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVN 175
Query: 654 -NTMNPKISDFGLARSFGLDQTEANTKRVV 682
K+ DFG A+ L +E + +
Sbjct: 176 SKDNTLKLCDFGSAK--KLIPSEPSVAYIC 203
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 7e-18
Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 24/182 (13%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--------GSGQGMEEFKNEVLL 566
D + LG G G V + +++A++ +SK + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD-TTRSKLLDWSKRSHIIAGI 625
+ KL H ++K+ D ++ E + L FD +K L + +
Sbjct: 194 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQM 248
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTEANTKRVV 682
+ YLH+ IIHRDLK NVLL + KI+DFG ++ G + +
Sbjct: 249 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 302
Query: 683 GT 684
GT
Sbjct: 303 GT 304
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 44/188 (23%), Positives = 69/188 (36%), Gaps = 36/188 (19%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE--------FKNEVLL 566
D + LG G G V + +++A+K +SK + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIY---EYLPNKSLDYFIFD--TTRSKLLDWSKR--S 619
+ KL H ++K+ D Y E + L FD +L +
Sbjct: 69 LKKLNHPCIIKIKNFFDAED----YYIVLELMEGGEL----FDKVVGNKRL---KEATCK 117
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLARSFGLDQTEA 676
+ + YLH IIHRDLK NVLL + KI+DFG ++ G
Sbjct: 118 LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 172
Query: 677 NTKRVVGT 684
+ + GT
Sbjct: 173 -MRTLCGT 179
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 51/211 (24%), Positives = 84/211 (39%), Gaps = 27/211 (12%)
Query: 486 MYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEK----NKLGEGGFGPVYKGMLIE- 540
+Y + S + + D I + D S+ ++LG G VY+
Sbjct: 18 LYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGT 77
Query: 541 GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600
+ A+K L K + + + E+ ++ +L H N++KL E L+ E + L
Sbjct: 78 QKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135
Query: 601 DYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---D 653
FD + S+R + + I + YLH+ I+HRDLK N+L
Sbjct: 136 ----FDRIVEKGYY---SERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPA 185
Query: 654 NTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
KI+DFGL++ K V GT
Sbjct: 186 PDAPLKIADFGLSKIVEHQVL---MKTVCGT 213
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 18/150 (12%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK---GSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG G FG V G + G ++AVK L++ S + + K E+ + +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 581 CCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSH---IIAGIARGLLYLHQDS 636
+ + ++ EY+ L DY ++ + R I++ + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYIC---KHGRVEEMEARRLFQQILSAVD----YCH--- 128
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
R ++HRDLK NVLLD MN KI+DFGL+
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLS 158
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 35/165 (21%), Positives = 64/165 (38%), Gaps = 36/165 (21%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK--------GSGQGMEEFKNEVLLIAKLQHRNL 575
LG G FG V+ + + +E+ VK + K + + E+ ++++++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFI----------FD-TTRSKLLDWSKRSHIIAG 624
+K+ + N+ + F R LD S+I
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
+ + YL IIHRD+K N+++ K+ DFG A
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 35/168 (20%), Positives = 62/168 (36%), Gaps = 17/168 (10%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQHRNLVKL- 578
+G GG G VY+ + + +A+K +S + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 579 -LGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
G + D ++ + + L + L + I+ I L H
Sbjct: 101 DFG---EIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA- 153
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
HRD+K N+L+ + DFG+A + D+ VGT
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGT 198
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 38/154 (24%), Positives = 66/154 (42%), Gaps = 17/154 (11%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK------GSGQGMEEFKNEV----LLIAKLQHR 573
LG+GGFG V+ G L + ++A+K + + EV + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
+++LL ++ ML+ E P + D F + T + L + R + + + H
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156
Query: 634 QDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLA 666
++HRD+K N+L+D K+ DFG
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 7e-17
Identities = 47/150 (31%), Positives = 75/150 (50%), Gaps = 18/150 (12%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK---GSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG G FG V G + G ++AVK L++ S + + + E+ + +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 581 CCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSH---IIAGIARGLLYLHQDS 636
+ + ++ EY+ L DY +L + R I++G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVD----YCH--- 133
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
R ++HRDLK NVLLD MN KI+DFGL+
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLS 163
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 9e-17
Identities = 53/178 (29%), Positives = 75/178 (42%), Gaps = 22/178 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNEVLLIAKLQH 572
++F LGEG F V + A+K L K + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIA 626
VKL Q DE++ Y N L +I FD T ++ A I
Sbjct: 90 PFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 140
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
L YLH IIHRDLK N+LL+ M+ +I+DFG A+ + +A VGT
Sbjct: 141 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 37/159 (23%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKG--SGQGMEE-FKNEVLLIAKLQHRNLVKLLG 580
LGEG FG V Q++A+K +S+ M + E+ + L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 581 CCTQRDERMLIYEYLPNKSLDYFI--------FD--TTRSKLLDWSKRSH---IIAGIAR 627
Y+ + + + FD + ++ + R II I
Sbjct: 75 -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE- 122
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
Y H R +I+HRDLK N+LLD+ +N KI+DFGL+
Sbjct: 123 ---YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLS 155
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 41/208 (19%), Positives = 89/208 (42%), Gaps = 35/208 (16%)
Query: 487 YRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIA 545
R++ HS++ + + D + ++ +G G +G V + +E + +A
Sbjct: 29 QRKQHHSSKPTASMPRPHSDWQI------PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVA 82
Query: 546 VKRLSKGSGQGMEEFKN---------EVLLIAKLQHRNLVKLLGCCTQRDERM-----LI 591
+K++ + F++ E+ ++ +L H ++VK+L +D ++
Sbjct: 83 IKKILR-------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV 135
Query: 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651
E T L + ++ ++ + G+ Y+H S I+HRDLK +N L
Sbjct: 136 LEIAD-SDFKKLF--RTPVYLTELHIKT-LLYNLLVGVKYVH--SA-GILHRDLKPANCL 188
Query: 652 LDNTMNPKISDFGLARSFGLDQTEANTK 679
++ + K+ DFGLAR+ + +
Sbjct: 189 VNQDCSVKVCDFGLARTVDYPENGNSQL 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 44/172 (25%), Positives = 71/172 (41%), Gaps = 24/172 (13%)
Query: 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLL 579
LGEG F K + + Q AVK +SK + + E+ + + H N+VKL
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLH 72
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQD 635
+ L+ E L L F+ + S+ S+I+ + + ++H
Sbjct: 73 EVFHDQLHTFLVMELLNGGEL----FERIKKKKHF---SETEASYIMRKLVSAVSHMHD- 124
Query: 636 SRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ ++HRDLK N+L ++ + KI DFG AR D T T
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFT 172
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 46/179 (25%), Positives = 73/179 (40%), Gaps = 46/179 (25%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK-------------------------GSGQGME 558
+G+G +G V + A+K LSK +G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 559 EF-KNEVLLIAKLQHRNLVKL---LGCCTQRDERMLIYEYLPNKSLDYFIFDT-TRSKLL 613
E E+ ++ KL H N+VKL L D +++E + + + T L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPN-EDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 614 DWSKRSH---IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
+ R + +I GI YLH +IIHRD+K SN+L+ + KI+DFG++ F
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 41/179 (22%), Positives = 75/179 (41%), Gaps = 19/179 (10%)
Query: 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLI 567
+ D++ KLG G + V++ + I +++ VK L ++ K E+ ++
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKIL 84
Query: 568 AKLQ-HRNLVKLLGCCTQRDERM--LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAG 624
L+ N++ L R L++E++ N L D+ R +
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-YMYE 138
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVV 682
I + L Y H S I+HRD+K NV++D ++ D+GLA + + RV
Sbjct: 139 ILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVRVA 192
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 53/180 (29%), Positives = 78/180 (43%), Gaps = 27/180 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
+ F + LG+GGFG V + ++ A K+L K +G NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-------FDTTRSKLLDWSKRSHIIAG 624
R +V L + + + L+ + L + I F R+ A
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY--------AAE 294
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
I GL LH R RI++RDLK N+LLD+ + +ISD GLA QT K VGT
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 348
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 39/158 (24%), Positives = 67/158 (42%), Gaps = 22/158 (13%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHRNLVKLLGCC 582
+G G FG + + +AVK + +G ++E + E++ L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 583 TQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKRS---HIIAGIARGLLYLHQDSR 637
+I EY L ++ + + R +++G++ Y H
Sbjct: 86 LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH---S 134
Query: 638 LRIIHRDLKASNVLLD--NTMNPKISDFGLARSFGLDQ 673
++I HRDLK N LLD KI DFG ++S L
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 38/183 (20%), Positives = 69/183 (37%), Gaps = 34/183 (18%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ + LG GG G V+ + + +A+K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-YFIFD--------TTRSKLLDWS 616
+I +L H N+VK+ ++ + Y + + L
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN--PKISDFGLARSFGLDQT 674
+ + RGL Y+H + ++HRDLK +N+ + NT + KI DFGLAR +
Sbjct: 121 HARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFI-NTEDLVLKIGDFGLARIMDPHYS 176
Query: 675 EAN 677
Sbjct: 177 HKG 179
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 52/174 (29%), Positives = 79/174 (45%), Gaps = 12/174 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
D F + LG GGFG V+ + ++ A K+L+K +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLL 630
R +V L + + L+ + + Y I++ + + A I GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+LHQ II+RDLK NVLLD+ N +ISD GLA QT+ GT
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGT 352
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 38/181 (20%), Positives = 65/181 (35%), Gaps = 40/181 (22%)
Query: 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEV-LLIAKLQHRNLVKLL 579
K LG G G V + GQ+ A+K L + + EV ++V +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCIL 88
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFI----------FDTTRSKLLDW-SKR--SHIIAGIA 626
+YE + + I F + + ++R + I+ I
Sbjct: 89 D----------VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
+ +LH I HRD+K N+L + K++DFG A+ T+ +
Sbjct: 139 TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCY 191
Query: 684 T 684
T
Sbjct: 192 T 192
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 43/183 (23%), Positives = 75/183 (40%), Gaps = 46/183 (25%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ +G G +G V + G+++A+K+LS+ F++ E+L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAKRAYRELL 75
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-----YFIFD--------TTRSKL 612
L+ +QH N++ LL + P SL Y + K
Sbjct: 76 LLKHMQHENVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKF 123
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
+ K +++ + +GL Y+H ++HRDLK N+ ++ KI DFGLAR +
Sbjct: 124 SE-EKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
Query: 673 QTE 675
T
Sbjct: 180 MTG 182
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 39/174 (22%), Positives = 67/174 (38%), Gaps = 22/174 (12%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEE--FKN---------EV 564
++ + + G +G V G+ EG +A+KR+ G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 565 LLIAKLQHRNLVKLLGCCTQRDERM-----LIYEYLPNKSLDYFIFDTTRSKLLDWSKRS 619
L+ H N++ L +E L+ E + L I + ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQHIQ 137
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
+ + I GL LH+ ++HRDL N+LL + + I DF LAR D
Sbjct: 138 YFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 42/210 (20%), Positives = 71/210 (33%), Gaps = 29/210 (13%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAV 546
+ + +K A D LG G G V + ++ A+
Sbjct: 33 AQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFAL 92
Query: 547 KRLSKGSGQGMEEFKNEV-LLIAKLQHRNLVKLLGCC-TQRDERMLIY---EYLPNKSLD 601
K L + + EV L Q ++V+++ R + E L L
Sbjct: 93 KMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL- 146
Query: 602 YFIFDTTRSKLLDW-SKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658
F + + ++R S I+ I + YLH + I HRD+K N+L + P
Sbjct: 147 ---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RP 199
Query: 659 ----KISDFGLARSFGLDQTEANTKRVVGT 684
K++DFG A+ + T
Sbjct: 200 NAILKLTDFGFAKETTSHNS---LTTPCYT 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 41/183 (22%), Positives = 76/183 (41%), Gaps = 45/183 (24%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ + +G G +G V + G ++A+K+L + F++ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAKRAYRELR 76
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-----YFIFD--------TTRSKL 612
L+ ++H N++ LL + P+++LD Y + + +
Sbjct: 77 LLKHMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK 124
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
L + ++ + +GL Y+H IIHRDLK N+ ++ KI DFGLAR +
Sbjct: 125 LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
Query: 673 QTE 675
T
Sbjct: 182 MTG 184
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 40/180 (22%), Positives = 65/180 (36%), Gaps = 36/180 (20%)
Query: 505 PIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNE 563
+K A D LG G G V + ++ A+K L + + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARRE 60
Query: 564 V-LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI----------FDTTRSKL 612
V L Q ++V+++ +YE L I F + +
Sbjct: 61 VELHWRASQCPHIVRIVD----------VYENLYAGRKCLLIVMECLDGGELFSRIQDRG 110
Query: 613 LDW-SKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLA 666
++R S I+ I + YLH + I HRD+K N+L + K++DFG A
Sbjct: 111 DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 3e-14
Identities = 44/171 (25%), Positives = 73/171 (42%), Gaps = 25/171 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKG---SGQGMEEFKNE--VL-LIAK 569
++FS +G GGFG VY + ++ A+K L K QG NE +L L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 570 LQHRNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIA 623
+V + +++ I + + L Y + F + A
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY--------AA 299
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
I GL ++H +++RDLK +N+LLD + +ISD GLA F +
Sbjct: 300 EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 40/177 (22%), Positives = 76/177 (42%), Gaps = 31/177 (17%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVL 565
++ + +GEG +G V + +A+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 566 LIAKLQHRNLVKLLGCCTQRDERM-----LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH 620
++ + +H N++ + ++ + + L + +++ L +
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICY 132
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677
+ I RGL Y+H S ++HRDLK SN+LL+ T + KI DFGLAR D
Sbjct: 133 FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 47/183 (25%), Positives = 76/183 (41%), Gaps = 45/183 (24%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ + + +G G +G V + G +AVK+LS+ F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-------PFQSIIHAKRTYRELR 80
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-----YFIFD--------TTRSKL 612
L+ ++H N++ LL + P +SL+ Y + + +
Sbjct: 81 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
L +I I RGL Y+H IIHRDLK SN+ ++ KI DFGLAR +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 673 QTE 675
T
Sbjct: 186 MTG 188
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.8 bits (175), Expect = 1e-13
Identities = 35/200 (17%), Positives = 63/200 (31%), Gaps = 46/200 (23%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRL--------SKGSGQGMEEFKNEVLL 566
T+ K+GEG FG V++ + + +A+K + + + EE E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 567 IAKLQ---------HRNLVKLLGCC-------------------TQRDERMLIYEYLPNK 598
+L + L T+ + ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 599 SLDYFIF-------DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651
F + R+KL + I+ + L LR HRDL NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 652 LDNTMNPKISDFGLARSFGL 671
L T K+ +S +
Sbjct: 195 LKKTSLKKLHYTLNGKSSTI 214
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 39/224 (17%), Positives = 79/224 (35%), Gaps = 63/224 (28%)
Query: 486 MYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEI 544
M+ HS+ + + DN+ K+ +G G +G VY + +
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHV------PDNYIIKHLIGRGSYGYVYLAYDKNTEKNV 54
Query: 545 AVKRLSKGSGQGMEEFKN---------EVLLIAKLQHRNLVKLLGCCTQRDERM-----L 590
A+K++++ F++ E+ ++ +L+ +++L D +
Sbjct: 55 AIKKVNR-------MFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107
Query: 591 IYEYLP---------NKSLD-----YFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ E L +++ + G ++H
Sbjct: 108 VLEIADSDLKKLFKTPIFLTEEHIKTILYN------------------LLLGENFIH--E 147
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
IIHRDLK +N LL+ + K+ DFGLAR+ ++
Sbjct: 148 S-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 46/181 (25%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ +G G G V I + +A+K+LS+ F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-------PFQNQTHAKRAYRELV 76
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-----YFIFD--------TTRSKL 612
L+ + H+N++ LL + P KSL+ Y + + + +L
Sbjct: 77 LMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 124
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
+ S+++ + G+ +LH IIHRDLK SN+++ + KI DFGLAR+ G
Sbjct: 125 DH-ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
Query: 673 Q 673
Sbjct: 181 F 181
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 46/189 (24%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ +G G G V + + +A+K+LS+ F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYRELV 113
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-----YFIFDTTRSKL-------L 613
L+ + H+N++ LL + P K+L+ Y + + + L L
Sbjct: 114 LMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 161
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
D + S+++ + G+ +LH IIHRDLK SN+++ + KI DFGLAR+
Sbjct: 162 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGT 216
Query: 674 TEANTKRVV 682
+ T VV
Sbjct: 217 SFMMTPYVV 225
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 50/178 (28%), Positives = 79/178 (44%), Gaps = 25/178 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---EVLLIAKLQH 572
D+F +G+G FG V + +++ A+K ++K E +N E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIA 626
LV L Q +E M ++ + L L Y + F KL I +
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF--------ICELV 125
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
L YL RIIHRD+K N+LLD + I+DF +A +T+ T + GT
Sbjct: 126 MALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT--MAGT 177
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 36/162 (22%), Positives = 63/162 (38%), Gaps = 19/162 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQG-MEEFKNEVLLIAK 569
D LG G FG V + + +AVK L +G+ +E+ ++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 570 L-QHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
+ H N+V LLG CT+ M+I E+ +L ++ SKR+ + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
G + + I DLK + ++ + S F +S
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 20/43 (46%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+A+G+ +L + + IHRDL A N+LL KI DFGLAR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 14/148 (9%), Positives = 46/148 (31%), Gaps = 12/148 (8%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLL 579
G ++ + +++A+ + ++E + L ++++ + ++L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
R +++ E++ SL + + + +A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQ----EVADTSP-SPVGAIRAMQSLAAAADAAH---RAG 149
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ S V + + ++
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 38/179 (21%), Positives = 71/179 (39%), Gaps = 24/179 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
D+F +G G F V + + ++ A+K ++K + F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI------FDTTRSKLLDWSKRSHIIAGI 625
R + +L Q + + L+ EY L + ++ +A I
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY--------LAEI 171
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ +H+ L +HRD+K N+LLD + +++DFG D T + VGT
Sbjct: 172 VMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGT 226
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 42/184 (22%), Positives = 77/184 (41%), Gaps = 31/184 (16%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN------ 562
+I+ N + +F K+ LGEG +G V G+ +A+K++ F
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALR 55
Query: 563 ---EVLLIAKLQHRNLVKLLGCCTQRDERM-----LIYEYLPNKSLDYFIFDTTRSKLLD 614
E+ ++ +H N++ + +I E + L I +++L
Sbjct: 56 TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI----STQMLS 110
Query: 615 WSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
+ I R + LH + +IHRDLK SN+L+++ + K+ DFGLAR
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 675 EANT 678
+ +
Sbjct: 168 DNSE 171
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 39/179 (21%), Positives = 70/179 (39%), Gaps = 24/179 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEE---FKNEVLLIAKLQH 572
++F +G G FG V L ++ A+K L+K E F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI------FDTTRSKLLDWSKRSHIIAGI 625
+ + L Q D + L+ +Y L + ++ +A +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY--------LAEM 184
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ +HQ L +HRD+K N+L+D + +++DFG D T + VGT
Sbjct: 185 VIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGT 239
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 47/184 (25%), Positives = 91/184 (49%), Gaps = 28/184 (15%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN------ 562
++ + + KLG+G +G V+K + G+ +AVK++ F+N
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQR 54
Query: 563 ---EVLLIAKLQ-HRNLVKLLGCCT--QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS 616
E++++ +L H N+V LL + L+++Y+ L I R+ +L+
Sbjct: 55 TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVI----RANILEPV 109
Query: 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676
+ +++ + + + YLH S ++HRD+K SN+LL+ + K++DFGL+RSF +
Sbjct: 110 HKQYVVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 677 NTKR 680
N
Sbjct: 167 NNIP 170
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 43/204 (21%), Positives = 80/204 (39%), Gaps = 22/204 (10%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKR 548
+K+ N N + I ++ + +++ +G G FG V +++ A+K
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 101
Query: 549 LSKGSGQGMEE---FKNEVLLIAKLQHRNLVKLLGCCTQRDERM-LIYEYLPN----KSL 600
LSK + F E ++A +V+L Q D + ++ EY+P +
Sbjct: 102 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660
+ ++ A + L +H + IHRD+K N+LLD + + K+
Sbjct: 161 SNYDVPEKWARFY--------TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKL 209
Query: 661 SDFGLARSFGLDQTEANTKRVVGT 684
+DFG + VGT
Sbjct: 210 ADFGTCMKMNKEGMV-RCDTAVGT 232
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 2e-11
Identities = 22/128 (17%), Positives = 47/128 (36%), Gaps = 21/128 (16%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ ++ G+ + G++L E + N + Y T W +N
Sbjct: 2 NLLTNGEGLYAGQSLDV--EPYHFIMQEDCNL------VLYDH---STSVWASNTGIL-- 48
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
+ + +G V+ ++ ++W+S+S V L E GN+V+ +
Sbjct: 49 -GKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY-------GS 100
Query: 166 ILWQSFDY 173
+W + Y
Sbjct: 101 DIWSTGTY 108
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 44/164 (26%), Positives = 65/164 (39%), Gaps = 21/164 (12%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNEVLLIAKLQHRNLVKLLG 580
LG+G FG V A+K L K +E E ++ +H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 581 CCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
Q +R+ + EY L + + F R++ A I L YLH
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY--------GAEIVSALDYLH- 265
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
S +++RDLK N++LD + KI+DFGL + D T
Sbjct: 266 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 3e-11
Identities = 42/160 (26%), Positives = 70/160 (43%), Gaps = 22/160 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNEVLLIAKLQH 572
+F LG G FG V+ A+K L K +++ +E L+++ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIA 626
++++ G Q +++ +I +Y+ L + F +K A +
Sbjct: 66 PFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--------AAEVC 116
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
L YLH II+RDLK N+LLD + KI+DFG A
Sbjct: 117 LALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 5e-11
Identities = 24/126 (19%), Positives = 46/126 (36%), Gaps = 21/126 (16%)
Query: 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPL 104
++++S S+ G +L S+ L N + Y G W +N
Sbjct: 1 VNSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS---GKPVWASNTGGLG 50
Query: 105 SDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPD 164
S L NG LV+ + +N +W + ++ V L + N+V+
Sbjct: 51 SGCRLTLHNNGN----LVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIY-------G 99
Query: 165 NILWQS 170
++W +
Sbjct: 100 PVVWAT 105
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 40/160 (25%), Positives = 64/160 (40%), Gaps = 22/160 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNEVLLIAKLQH 572
D F LG G FG V E A+K L K +++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIA 626
LVKL + + + ++ EY+ + + F ++ A I
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF--------YAAQIV 151
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
YLH L +I+RDLK N+L+D +++DFG A
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 42/164 (25%), Positives = 64/164 (39%), Gaps = 22/164 (13%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNEVLLIAKLQHRNLVKLLG 580
LG+G FG V A+K L K +E E ++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 581 CCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
Q +R+ + EY L + + F R++ A I L YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--------GAEIVSALEYLHS 123
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
+++RD+K N++LD + KI+DFGL + D T
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 47/154 (30%), Positives = 69/154 (44%), Gaps = 25/154 (16%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFK-----NEVLLIAKLQHRNLVKL 578
LG+G FG V+ + + A+K L K ++ + VL +A +H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHM 83
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
C Q E + + EYL L Y I FD +R+ A I GL +L
Sbjct: 84 F-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--------YAAEIILGLQFL 134
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
H I++RDLK N+LLD + KI+DFG+
Sbjct: 135 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 25/166 (15%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFK-----NEVLLIAKLQHRNLVKL 578
LG+G FG V + E ++ AVK L K ++ + +L +A+ H L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 89
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
CC Q +R+ + E++ L + I FD R++ A I L++L
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF--------YAAEIISALMFL 140
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
H II+RDLK NVLLD+ + K++DFG+ + + T
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT 183
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 24/166 (14%)
Query: 525 LGEGGFGPVY---KGMLIEGQEI-AVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG V+ K + +++ A+K L K + + K E ++ ++ H +VKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
Q + ++ LI ++L L + F K +A +A L +L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--------LAELALALDHL 142
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
H L II+RDLK N+LLD + K++DFGL++ + +A +
Sbjct: 143 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 42/166 (25%), Positives = 69/166 (41%), Gaps = 25/166 (15%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNE--VLLIAKLQHRNLVKL 578
+G G + V L + I A++ + K E+ + E V A H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGL 118
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
C Q + R+ + EY+ L + + ++ A I+ L YL
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--------SAEISLALNYL 169
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
H+ II+RDLK NVLLD+ + K++D+G+ + +T
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 212
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 47/154 (30%), Positives = 66/154 (42%), Gaps = 25/154 (16%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNE--VLLIAKLQHRNLVKL 578
LG+G FG V E+ AVK L K ++ E VL + + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQL 86
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
C Q +R+ + EY+ L Y I F + A IA GL +L
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF--------YAAEIAIGLFFL 137
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
II+RDLK NV+LD+ + KI+DFG+
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 43/166 (25%), Positives = 69/166 (41%), Gaps = 25/166 (15%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNE--VLLIAKLQHRNLVKL 578
+G G + V L + I A+K + K E+ + E V A H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGL 75
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
C Q + R+ + EY+ L + + ++ A I+ L YL
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--------SAEISLALNYL 126
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
H+ II+RDLK NVLLD+ + K++D+G+ + +T
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 169
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 51/165 (30%), Positives = 71/165 (43%), Gaps = 31/165 (18%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKG---SGQGMEEFKNE--VLLI 567
+F+ LG+G FG V ML E + AVK L K +E E VL +
Sbjct: 341 TDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 568 AKLQHRNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHI 621
+ L +L C Q +R+ + EY+ L Y I F +
Sbjct: 398 P-GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY-------- 447
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
A IA GL +L II+RDLK NV+LD+ + KI+DFG+
Sbjct: 448 AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 489
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 46/154 (29%), Positives = 70/154 (45%), Gaps = 25/154 (16%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNE--VLLIAKLQHRNLVKL 578
+G+G FG V + AVK L K + +E +E VLL ++H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN-VKHPFLVGL 104
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
Q +++ + +Y+ L Y + F R++ A IA L YL
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY--------AAEIASALGYL 155
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
H L I++RDLK N+LLD+ + ++DFGL
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLC 186
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 26/168 (15%)
Query: 525 LGEGGFGPVY---KGMLIEGQEI-AVKRLSKGS----GQGMEEFKNEVLLIAKLQHRNLV 576
LG+GG+G V+ K +I A+K L K + K E ++ +++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 577 KLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLL 630
L+ Q ++ LI EYL L + F + +A I+ L
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY--------LAEISMALG 135
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
+LHQ II+RDLK N++L++ + K++DFGL + D T +T
Sbjct: 136 HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 3e-09
Identities = 20/130 (15%), Positives = 45/130 (34%), Gaps = 20/130 (15%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
D ++ G + G +L + + N L ++ W + + S
Sbjct: 2 DRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN----NRAVWASGTNGKAS 50
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
++ +G LV+ + + +W+SN++ L N+V+ D +N
Sbjct: 51 GCVLKMQNDGN----LVIYSGSR-AIWASNTNRQNGNYYLILQRDRNVVIYDNS----NN 101
Query: 166 ILWQSFDYPC 175
+W +
Sbjct: 102 AIWATHTNVG 111
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 6e-09
Identities = 25/125 (20%), Positives = 44/125 (35%), Gaps = 22/125 (17%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ + GQ++ +L + ++ L + N + Y+ G W +N D S
Sbjct: 3 NVLLSGQTLHADHSLQAG--AYTLTIQNKCNL------VKYQN---GRQIWASNTDRRGS 51
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
L +G LV+ + N+ VW S K L + G V+
Sbjct: 52 GCRLTLLSDGN----LVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIY-------GP 100
Query: 166 ILWQS 170
+LW
Sbjct: 101 VLWSL 105
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 29/158 (18%)
Query: 525 LGEGGFGPVY---KGMLIEGQEI-AVKRLSKGS----GQGMEEFKNE--VLLIAKLQHRN 574
LG G +G V+ K + ++ A+K L K + + E + E VL + Q
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPF 120
Query: 575 LVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARG 628
LV L Q + ++ LI +Y+ L + F ++ + I
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI--------YVGEIVLA 171
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
L +LH+ L II+RD+K N+LLD+ + ++DFGL+
Sbjct: 172 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 206
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 38/158 (24%), Positives = 65/158 (41%), Gaps = 27/158 (17%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH-RNLVKLLGC 581
K+G G FG +Y G I G+E+A+K + E + +Q + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS---HIIAGIARGLL----YLHQ 634
+ D +++ E L SL+ L ++ R + +A ++ Y+H
Sbjct: 74 GAEGDYNVMVMELL-GPSLED---------LFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPK---ISDFGLARSF 669
+ IHRD+K N L+ I DFGLA+ +
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 35/176 (19%), Positives = 65/176 (36%), Gaps = 43/176 (24%)
Query: 524 KLGEGGFGPVYKGMLIEGQEI------AVKRLSKGSGQGMEEFK-----NEVLLIAKLQH 572
+G+GGFG +Y + + + VK +G E K + I K
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 573 RNLVKLLG----------CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS--- 619
+K LG + R +I + L K+ + + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQ---------KIYEANAKRFSR 151
Query: 620 HIIAGIARGLL----YLHQDSRLRIIHRDLKASNVLLDNTMNPKI--SDFGLARSF 669
+ ++ +L Y+H+ +H D+KASN+LL+ ++ D+GLA +
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 33/174 (18%), Positives = 61/174 (35%), Gaps = 37/174 (21%)
Query: 523 NKLGEGGFGPVYKGM---------LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR 573
+ G +Y+ + Q+ ++K L G+ E LQ
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 574 NLVKLLGC------------CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
KL Q R L+ L +SL D + +L S+RS
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVL--SERS-- 160
Query: 622 IAGIARGLL----YLHQDSRLRIIHRDLKASNVLLDNTMNPKI--SDFGLARSF 669
+ +A LL +LH++ +H ++ A N+ +D ++ + +G A +
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-07
Identities = 20/125 (16%), Positives = 41/125 (32%), Gaps = 22/125 (17%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ + G+++ GE L + + N + Y W N
Sbjct: 2 NILYSGETLSPGEFLNN--GRYVFIMQEDCNL------VLYDV---DKPIWATNTGGLDR 50
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
++ +G LV+ + N+ +W+SN+ V L + N+V+
Sbjct: 51 RCHLSMQSDGN----LVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIY-------GT 99
Query: 166 ILWQS 170
W +
Sbjct: 100 ARWAT 104
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 40/178 (22%), Positives = 61/178 (34%), Gaps = 53/178 (29%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRL---SKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
KLG G F V+ ++ +A+K + + +E +KLL
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----------------IKLL 69
Query: 580 GCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSK------------LLDWSKRSH----- 620
D + K LD+F LL K+
Sbjct: 70 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 621 --IIAGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNTMNP------KISDFGLA 666
+ I++ GL Y+H R IIH D+K NVL++ +P KI+D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 36/172 (20%), Positives = 61/172 (35%), Gaps = 30/172 (17%)
Query: 511 IIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK 569
++ NF K+G G FG + G L + +A+K S +
Sbjct: 6 MVGP---NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG 62
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS---HIIAGIA 626
+ ++ ++ E L SL+ L D R+ + IA
Sbjct: 63 -SGDGIPQVYYFGPCGKYNAMVLELL-GPSLED---------LFDLCDRTFSLKTVLMIA 111
Query: 627 RGLL----YLHQDSRLRIIHRDLKASNVLLDNTMNPK-----ISDFGLARSF 669
L+ Y+H + +I+RD+K N L+ N I DF LA+ +
Sbjct: 112 IQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 32/173 (18%), Positives = 70/173 (40%), Gaps = 30/173 (17%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIA 568
++ ++ ++GEG FG +++G L+ Q++A+K + S + +
Sbjct: 6 NVVGV---HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLL 62
Query: 569 KLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS---HIIAGI 625
+ + + +L+ + L SL+ LLD R +A
Sbjct: 63 A-GCTGIPNVYYFGQEGLHNVLVIDLLG-PSLED---------LLDLCGRKFSVKTVAMA 111
Query: 626 ARGLL----YLHQDSRLRIIHRDLKASNVLLDNTMNPK-----ISDFGLARSF 669
A+ +L +H+ S +++RD+K N L+ + + DFG+ + +
Sbjct: 112 AKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 35/158 (22%), Positives = 64/158 (40%), Gaps = 27/158 (17%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV-KLLGC 581
K+G G FG +Y G + +E+A+K + + E + LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTGIPNVRWF 71
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS---HIIAGIARGLL----YLHQ 634
+ D +L+ + L SL+ L ++ R + +A ++ ++H
Sbjct: 72 GVEGDYNVLVMDLL-GPSLED---------LFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPK---ISDFGLARSF 669
S +HRD+K N L+ I DFGLA+ +
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 37/173 (21%), Positives = 66/173 (38%), Gaps = 40/173 (23%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIA---VKRLSKGSGQGMEEFK-----NEVLLIAKLQHRN 574
K+G GGFG +Y + ++ A VK + +G E K + I K R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 575 LVKLLG----------CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR--SHII 622
+ LG R R ++ E L L K+ + +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ---------KISGQNGTFKKSTV 153
Query: 623 AGIARGLL----YLHQDSRLRIIHRDLKASNVLLDNTMNPKI--SDFGLARSF 669
+ +L Y+H++ +H D+KA+N+LL ++ +D+GL+ +
Sbjct: 154 LQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 1e-06
Identities = 41/262 (15%), Positives = 83/262 (31%), Gaps = 48/262 (18%)
Query: 426 FHDLIDIKELPESGQDLFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAV-IFIGG 484
F D D K++ + + + + E+D++ + + + + V F+
Sbjct: 29 FVDNFDCKDVQDMPKSIL---SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEE 85
Query: 485 --------LMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKG 536
LM K Q + I + N F++ N V +
Sbjct: 86 VLRINYKFLMSPIKTEQRQ--PSMMTRMYIEQRDRLYNDNQVFAKYN---------VSRL 134
Query: 537 MLIEGQEIAVKRLSKGSG---QGMEEF-K----NEVLLIAKLQHRNLVKL----LGCCTQ 584
A+ L G+ K +V L K+Q + K+ L C
Sbjct: 135 QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS 194
Query: 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRD 644
+ + + + L + D +W+ RS + I + + + R + +
Sbjct: 195 PETVLEMLQKL------LYQIDP------NWTSRSDHSSNIKLRIHSIQAELRRLLKSKP 242
Query: 645 LKASNVLLDNTMNPKISD-FGL 665
+ ++L N N K + F L
Sbjct: 243 YENCLLVLLNVQNAKAWNAFNL 264
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 5e-04
Identities = 64/386 (16%), Positives = 115/386 (29%), Gaps = 116/386 (30%)
Query: 95 TWVAN---RDAPLSDR--SGVLRIN-GERNG------ILVLLNSTNDTVWSSNSSISAQK 142
TWVA + + + +N N +L L D W+S S S+
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223
Query: 143 PVAA---------LMESGN-----LVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINL 188
+ L++S LV+ + ++ W +F+ C LL
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK----AWNAFNLSCKILL------TTR 273
Query: 189 GTGLNRFLSSWKSTD---DPARGDFT-----------YGLDPRGIPQLVLRKN----SII 230
+ FLS+ +T D T P+ +P+ VL N SII
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII 333
Query: 231 --TFRAGSWNGLHWTGVPQLQLNPVYTFEYVS------NEKEAFYTYNLS--NSSVPSRM 280
+ R G W + + + T S E + LS S
Sbjct: 334 AESIRDGL---ATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF-DRLSVFPPSAH--- 386
Query: 281 VINPAGTVQRYTWMERTKT-----WTLFSRFSGVTLDQCDS-YALCGAY----ASCN--- 327
I P + W + K+ ++S V +S ++ Y
Sbjct: 387 -I-PTILLSLI-WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEY 443
Query: 328 ------INS-NSPECECLQGFVPNSQREWDMQYKSGGCVRRTPL-----DCKHGDGFLEH 375
++ N P+ +P ++ + + + +H +
Sbjct: 444 ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH----------IGHHLKNIEHPERMTLF 493
Query: 376 KAVKLPDTRFSWVDKNI----TLWEC 397
+ V L D F ++++ I T W
Sbjct: 494 RMVFL-D--FRFLEQKIRHDSTAWNA 516
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 6e-06
Identities = 28/136 (20%), Positives = 43/136 (31%), Gaps = 30/136 (22%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ + GQ++ L + F+L N Y G W + T RD
Sbjct: 4 NYLLSGQTLDTEGHLKN--GDFDLVMQDDCNL-VLYNGNWQ------SNTANNGRDC--- 51
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
L + G LV+ N TVW S + A + G LVV
Sbjct: 52 ----KLTLTD--YGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVF-------GP 98
Query: 166 ILWQSFDYPCDTLLPG 181
+++ D + G
Sbjct: 99 SVFKI-----DPWVRG 109
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-05
Identities = 24/116 (20%), Positives = 43/116 (37%), Gaps = 16/116 (13%)
Query: 40 SAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVAN 99
+ T + + GQ + L + ++ +L N L ++ K + T
Sbjct: 1 NIPFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVLYGGKYGWQSNTHGNG 53
Query: 100 RDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVV 155
LR+N G L++ + T+WSS SS + V L + G V+
Sbjct: 54 EHC-------FLRLNH--KGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 44/199 (22%), Positives = 73/199 (36%), Gaps = 38/199 (19%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAV 546
+ +K N G + + + + + + + + + +G+G FG V K +E + +A+
Sbjct: 28 KERKVYNDGYDDDNYDYIVKNGEKWMD---RYEIDSLIGKGSFGQVVKAYDRVEQEWVAI 84
Query: 547 K---RLSKGSGQGMEEFKNEVLLIAKLQHR------NLVKLLGCCTQRD------ERMLI 591
K Q EV L+ + +V L R+ E +
Sbjct: 85 KIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY 140
Query: 592 --YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASN 649
Y+ L N + + TR + LL+L L IIH DLK N
Sbjct: 141 NLYDLLRNTNFRGVSLNLTR----------KFAQQMCTALLFLA-TPELSIIHCDLKPEN 189
Query: 650 VLLDNTMNP--KISDFGLA 666
+LL N KI DFG +
Sbjct: 190 ILLCNPKRSAIKIVDFGSS 208
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 2e-05
Identities = 23/138 (16%), Positives = 44/138 (31%), Gaps = 24/138 (17%)
Query: 33 SFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEG 92
+ +F + +S+ ++ + + N + Y
Sbjct: 2 NIIFSKQPDDNHPQILHATESL----EILFGTHVYRFIMQTDCNL------VLYDN---N 48
Query: 93 TVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGN 152
W N + VL+ +G LV++ + N TVW S + A V L N
Sbjct: 49 NPIWATNTGGLGNGCRAVLQPDGV----LVVITNENVTVWQSPVAGKAGHYVLVLQPDRN 104
Query: 153 LVVKDGKDNNPDNILWQS 170
+V+ + LW +
Sbjct: 105 VVIY-------GDALWAT 115
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 40/162 (24%), Positives = 63/162 (38%), Gaps = 37/162 (22%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRL---SKGSGQGMEEFKNEVLLIAKLQHR------N 574
+G+G FG V K Q +A+K + + Q EE + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160
Query: 575 LVKLLGCCTQRD------ERMLI--YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
++ +L T R+ E + + YE + F R I
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVR----------KFAHSIL 210
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP--KISDFGLA 666
+ L LH + RIIH DLK N+LL K+ DFG +
Sbjct: 211 QCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.9 bits (102), Expect = 1e-04
Identities = 29/168 (17%), Positives = 53/168 (31%), Gaps = 14/168 (8%)
Query: 40 SAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVAN 99
+ Q++ G+ L+S + F+L GN L I
Sbjct: 9 FNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQDNGATVWVANEQQP 63
Query: 100 RDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSS-----NSSISAQKPVAALMESGNLV 154
+ + R+ + L + + VW + S+ + L + GN+V
Sbjct: 64 FSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIV 123
Query: 155 VKDGKD--NNPDNILWQSFDYPCDTLLPGMKL--GINLGTGLNRFLSS 198
+ D N I L PG +L G+ G G ++ +
Sbjct: 124 LVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQ 171
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 2e-04
Identities = 21/113 (18%), Positives = 38/113 (33%), Gaps = 13/113 (11%)
Query: 43 RTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDA 102
R + + Q + D L + + L N + K ++ + W +
Sbjct: 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCNL------VLTKG-SKTNIVWESGTSG 54
Query: 103 PLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVV 155
L +GE L + + +TV+ SN+ V L +G VV
Sbjct: 55 RGQHCFMRLGHSGE----LDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV 103
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 39/153 (25%), Positives = 60/153 (39%), Gaps = 40/153 (26%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
KLG G F V+ + + +A+K + K + E +E+ +LL
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEI------------RLLKSV 90
Query: 583 TQRDERMLIYEYLPNKSLDYF------------IFDTTRSKLLDWSKRS----------- 619
D E + + LD F +F+ LL W +S
Sbjct: 91 RNSDPNDPNREMVV-QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652
II + +GL YLH ++ RIIH D+K N+LL
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILL 180
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 684 | |||
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.98 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.98 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.97 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.97 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.97 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.97 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.97 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.96 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.95 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.95 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.95 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.94 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.93 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.93 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.93 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.93 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.93 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.93 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.93 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.93 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.93 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.93 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.93 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.93 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.93 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.93 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.93 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.92 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.92 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.92 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.92 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.92 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.92 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.92 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.92 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.92 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.92 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.92 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.92 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.92 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.92 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.92 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.92 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.92 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.92 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.92 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.92 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.92 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.92 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.92 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.92 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.92 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.92 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.92 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.92 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.91 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.91 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.91 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.91 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.91 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.91 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.91 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.91 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.91 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.91 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.91 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.91 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.91 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.91 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.91 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.91 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.91 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.91 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.91 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.91 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.91 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.91 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.91 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.91 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.91 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.91 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.91 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.91 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.91 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.91 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.91 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.91 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.91 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.91 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.91 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.91 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.91 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.91 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.91 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.91 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.91 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.91 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.91 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.91 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.91 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.91 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.91 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.9 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.9 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.9 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.9 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.9 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.9 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.9 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.9 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.9 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.9 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.9 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.9 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.9 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.9 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.9 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.9 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.9 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.9 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.9 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.9 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.9 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.9 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.9 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.9 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.9 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.9 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.9 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.9 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.9 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.9 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.9 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.9 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.9 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.9 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.9 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.9 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.9 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.9 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.9 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.9 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.9 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.9 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.9 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.9 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.9 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.9 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.9 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.9 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.9 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.9 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.9 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.89 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.89 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.89 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.89 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.89 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.89 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.89 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.89 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.89 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.89 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.89 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.89 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.89 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.89 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.89 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.89 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.89 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.89 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.89 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.89 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.89 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.89 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.89 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.89 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.89 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.89 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.89 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.89 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.89 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.89 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.89 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.89 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.89 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.89 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.89 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.89 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.89 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.89 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.89 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.89 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.89 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.89 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.89 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.89 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.89 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.89 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.88 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.88 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.88 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.88 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.88 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.88 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.88 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.88 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.88 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.88 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.88 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.88 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.88 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.88 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.88 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.88 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.88 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.88 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.88 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.87 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.87 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.87 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.87 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.87 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.87 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.87 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.87 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.87 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.87 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.87 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.87 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.86 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.86 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.86 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.86 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.86 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.85 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.85 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.85 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.85 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.85 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.85 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.84 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.83 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.83 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.81 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.8 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.75 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.7 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.68 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.66 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.66 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.6 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.59 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.51 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.37 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.29 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.2 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.19 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.99 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.92 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.64 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.49 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.47 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.4 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.32 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.28 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.99 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.91 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.76 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.74 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.6 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.39 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.22 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.19 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.19 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.15 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.12 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.08 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.71 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.57 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.03 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.71 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.42 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.24 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.44 |
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=364.16 Aligned_cols=230 Identities=17% Similarity=0.221 Sum_probs=178.7
Q ss_pred cccccccCCCCcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCC----CceEEEeecc
Q 005669 42 ARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDR----SGVLRINGER 117 (684)
Q Consensus 42 ~~~~~~l~~g~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~----~~~l~~~~~~ 117 (684)
+++.|+|.+|++|++|++|+|++|.|+||||+++ ++|| |+ +.+ +||+||||.|+.++ +++|+|+.
T Consensus 11 ~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~-- 79 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAF-- 79 (276)
T ss_dssp CTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEE--
T ss_pred cccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeC--
Confidence 4567999999999999999999999999999443 5676 66 667 99999999999874 78999998
Q ss_pred CceEEE--ecCCCCeEEEecccCC-----CCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCCCeecccccC
Q 005669 118 NGILVL--LNSTNDTVWSSNSSIS-----AQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGT 190 (684)
Q Consensus 118 ~g~l~l--~~~~~~~~w~s~~~~~-----~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~~~~t 190 (684)
||+||| .|++|.+||+|++... ..++.|+|+|+|||||++ +.+|||| |||||||||||++.+.++
T Consensus 80 ~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~------~~~lWqS--~ptdtlLpg~~~~~~l~~ 151 (276)
T 3m7h_A 80 YVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD------SLALWNG--TPAIPLVPGAIDSLLLAP 151 (276)
T ss_dssp EESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE------EEEEEES--CTTSCCCCSCTTCEEECS
T ss_pred CCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC------CceeeCc--cccccccccccccccccc
Confidence 999999 7888899999997642 235789999999999997 3689999 999999999999998888
Q ss_pred ccceeEEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCCCCCcccccccccccCCeeEEEEEecCC-eeEEEE
Q 005669 191 GLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEK-EAFYTY 269 (684)
Q Consensus 191 g~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 269 (684)
|.+ | ++.+||++|.|+++|+++|...++ +++..+||++|+|++... .-.++... .+.+.++++ ..++++
T Consensus 152 g~~--L---~S~~dps~G~fsl~l~~dGnlvLy-~~~~~~yW~Sgt~~~~~~--~l~l~~dG--nLvl~d~~~~~vWsS~ 221 (276)
T 3m7h_A 152 GSE--L---VQGVVYGAGASKLVFQGDGNLVAY-GPNGAATWNAGTQGKGAV--RAVFQGDG--NLVVYGAGNAVLWHSH 221 (276)
T ss_dssp SEE--E---CTTCEEEETTEEEEECTTSCEEEE-CTTSSEEEECCCTTTTCC--EEEECTTS--CEEEECTTSCEEEECS
T ss_pred Ccc--c---ccCCCCCCceEEEeecCCceEEEE-eCCCeEEEECCCCCCccE--EEEEcCCC--eEEEEeCCCcEEEEec
Confidence 865 5 578999999999999999964442 345689999999976321 11122111 122333333 333333
Q ss_pred ecCCCCcceeEEECcCCcEEEEEEecCCceEEEeee
Q 005669 270 NLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSR 305 (684)
Q Consensus 270 ~~~~~~~~~r~~l~~~G~l~~~~w~~~~~~W~~~~~ 305 (684)
......+|++|+.||+|++|.| ...|..++.
T Consensus 222 --t~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~ 252 (276)
T 3m7h_A 222 --TGGHASAVLRLQANGSIAILDE---KPVWARFGF 252 (276)
T ss_dssp --CTTCTTCEEEECTTSCEEEEEE---EEEEESSSC
T ss_pred --CCCCCCEEEEEcCCccEEEEcC---CCeEEccCc
Confidence 2233458999999999999998 345766655
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=312.10 Aligned_cols=217 Identities=17% Similarity=0.167 Sum_probs=167.7
Q ss_pred ccccccCCCCcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEE
Q 005669 43 RTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILV 122 (684)
Q Consensus 43 ~~~~~l~~g~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~ 122 (684)
++.|+|.+|++|++|++| ++|.|+|||+.+++. . +|.. +|+||+|||+.| .++.|+|+. |||||
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gnl-----~-ly~~---~~~vW~an~~~~---~~~~l~l~~--dGnLv 69 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCNL-----V-LFDS---DVRVWASNTAGA---TGCRAVLQS--DGLLV 69 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSCE-----E-EEES---SSEEECCCCCSC---SCCBCCBCS--SSCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCcE-----E-EEEC---CEEEEECCCCCC---CCeEEEEcC--CCcEE
Confidence 456999999999999999 599999999876642 2 3443 799999999998 468899988 99999
Q ss_pred EecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCc-CCCCeecccc-cCcc-----cee
Q 005669 123 LLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTL-LPGMKLGINL-GTGL-----NRF 195 (684)
Q Consensus 123 l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTl-Lpgq~l~~~~-~tg~-----~~~ 195 (684)
|+|++|.+||+|++......+.|+|+|+|||||++. ++||||||||||+ |||| +.+. .+|+ ++.
T Consensus 70 l~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~-------~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~ 140 (236)
T 1dlp_A 70 ILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP-------GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQT 140 (236)
T ss_dssp CBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS-------EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCE
T ss_pred EEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC-------CEEECCCCCCcccccCCc--cceEEecCCcCCCccce
Confidence 999999999999976533456899999999999942 7999999999877 5554 4443 4444 567
Q ss_pred EEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCCCCCcccccccccccCCeeEEEEEecCCeeEEEEecCCCC
Q 005669 196 LSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSS 275 (684)
Q Consensus 196 L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (684)
|+ +.+||++|.|+|+++++| +++++++..+||++++|++. +...+.+.....+ +.+..+.++.+.+|.....
T Consensus 141 L~---s~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl-~ly~~~~~~vw~s~~~~~~- 212 (236)
T 1dlp_A 141 LH---ATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRM-DVLTNQNIAVWTSGNSRSA- 212 (236)
T ss_dssp EC---SSCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEE-EEEETTTEEEEECCCCCSS-
T ss_pred EE---cCcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcE-EEEeCCCcEEEEeCCCCCC-
Confidence 87 578999999999999999 57777877899999999753 5566666544422 2233344455555544333
Q ss_pred cceeEEECcCCcEEEEE
Q 005669 276 VPSRMVINPAGTVQRYT 292 (684)
Q Consensus 276 ~~~r~~l~~~G~l~~~~ 292 (684)
..+|++||+||++++|.
T Consensus 213 ~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 213 GRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp SCCEEEECSSSCEEEEC
T ss_pred CCEEEEEcCCCcEEEeC
Confidence 46899999999999994
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=293.00 Aligned_cols=162 Identities=30% Similarity=0.415 Sum_probs=145.4
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|++.+.||+|+||+||+|+... ++.||||++.+. .....+.+.+|+++|++++|||||++++++++++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999999999999754 899999999753 2344678999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
||+++|+|.+++.+ ...+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999954 346999999999999999999999998 999999999999999999999999999998766
Q ss_pred CCccCCcccccC
Q 005669 673 QTEANTKRVVGT 684 (684)
Q Consensus 673 ~~~~~~~~~~GT 684 (684)
.....+..++||
T Consensus 186 ~~~~~~~~~~GT 197 (311)
T 4aw0_A 186 SKQARANSFVGT 197 (311)
T ss_dssp TTCCCBCCCCSC
T ss_pred CCcccccCcccC
Confidence 555556677887
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=293.08 Aligned_cols=165 Identities=30% Similarity=0.503 Sum_probs=140.9
Q ss_pred CCCCccceecccCcEeEEEEEee------CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56788899999999999999864 367899999987766677889999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEE
Q 005669 591 IYEYLPNKSLDYFIFDTT----------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI 660 (684)
|||||++|+|.++|.... ....+++.++..|+.||++||+|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996532 2357999999999999999999999998 999999999999999999999
Q ss_pred EeeccccccCCCCCccCCcccccC
Q 005669 661 SDFGLARSFGLDQTEANTKRVVGT 684 (684)
Q Consensus 661 ~DFGla~~~~~~~~~~~~~~~~GT 684 (684)
+|||+|+..........+....||
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt 193 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLP 193 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEEC
T ss_pred CCcccceecCCCCceeecCceecC
Confidence 999999987554433333334444
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=293.59 Aligned_cols=165 Identities=27% Similarity=0.467 Sum_probs=133.7
Q ss_pred CCCCccceecccCcEeEEEEEee------CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
++|...++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677789999999999999864 367899999987766677889999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcE
Q 005669 591 IYEYLPNKSLDYFIFDTTR------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~v 658 (684)
|||||++|+|.+++..... ...+++.+++.|+.||++||+|||+++ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999965321 246899999999999999999999988 9999999999999999999
Q ss_pred EEEeeccccccCCCCCccCCcccccC
Q 005669 659 KISDFGLARSFGLDQTEANTKRVVGT 684 (684)
Q Consensus 659 kI~DFGla~~~~~~~~~~~~~~~~GT 684 (684)
||+|||+|+.+.............||
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt 223 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLP 223 (329)
T ss_dssp EECCCC----------------CCCC
T ss_pred EEcccccceeccCCCcceecCccccc
Confidence 99999999987554433333344554
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-33 Score=292.74 Aligned_cols=159 Identities=27% Similarity=0.424 Sum_probs=142.5
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
+.|+..++||+|+||+||+|.... |+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 568999999999999999999864 8999999997665556677899999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCCCc
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~~~ 675 (684)
++|+|.+++.+ ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..+..
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999998853 35899999999999999999999998 99999999999999999999999999998865433
Q ss_pred cCCcccccC
Q 005669 676 ANTKRVVGT 684 (684)
Q Consensus 676 ~~~~~~~GT 684 (684)
....++||
T Consensus 226 -~~~~~~GT 233 (346)
T 4fih_A 226 -RRKSLVGT 233 (346)
T ss_dssp -CBCCCCSC
T ss_pred -cccccccC
Confidence 23456776
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.8e-33 Score=293.28 Aligned_cols=163 Identities=24% Similarity=0.398 Sum_probs=135.9
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
.++|++.++||+|+||+||+|+... ++.||||++... .....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 3689999999999999999999754 899999999754 2334567999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
||+++|+|.++|... +...+++.++..++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+...
T Consensus 103 Ey~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999999543 3456799999999999999999999998 999999999999999999999999999987532
Q ss_pred CCccCCcccccC
Q 005669 673 QTEANTKRVVGT 684 (684)
Q Consensus 673 ~~~~~~~~~~GT 684 (684)
.. .+..++||
T Consensus 179 ~~--~~~~~~GT 188 (350)
T 4b9d_A 179 VE--LARACIGT 188 (350)
T ss_dssp HH--HHHHHHSC
T ss_pred cc--cccccCCC
Confidence 21 22345666
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=287.41 Aligned_cols=164 Identities=34% Similarity=0.503 Sum_probs=138.6
Q ss_pred CCCccceecccCcEeEEEEEee------CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
.++..++||+|+||+||+|.+. +++.||||+++... ....++|++|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4566789999999999999863 36789999997543 3446789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 005669 591 IYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN 657 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~ 657 (684)
|||||++|+|.++|..... ...+++.++..|+.||++||+|||+++ ||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 9999999999999964321 246899999999999999999999998 999999999999999999
Q ss_pred EEEEeeccccccCCCCCccCCcccccC
Q 005669 658 PKISDFGLARSFGLDQTEANTKRVVGT 684 (684)
Q Consensus 658 vkI~DFGla~~~~~~~~~~~~~~~~GT 684 (684)
+||+|||+|+.+........+...+||
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt 210 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLP 210 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred EEECCcccceeccCCCceeEecccccC
Confidence 999999999987554433334445554
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=283.97 Aligned_cols=161 Identities=29% Similarity=0.468 Sum_probs=131.8
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.+++.+.++||+|+||+||+|++. ..||||+++.. .....++|.+|+.++++++|||||+++|++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 456788899999999999999864 36999998753 33446789999999999999999999998864 56899999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
||++|+|.++|... ...+++.++..|+.||++||+|||+++ ||||||||+||||++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999999542 356999999999999999999999988 9999999999999999999999999999876544
Q ss_pred CccCCcccccC
Q 005669 674 TEANTKRVVGT 684 (684)
Q Consensus 674 ~~~~~~~~~GT 684 (684)
....+...+||
T Consensus 187 ~~~~~~~~~GT 197 (307)
T 3omv_A 187 GSQQVEQPTGS 197 (307)
T ss_dssp -------CCCC
T ss_pred cceeecccccC
Confidence 33344456676
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=294.11 Aligned_cols=160 Identities=27% Similarity=0.421 Sum_probs=143.6
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.+.|+..++||+|+||.||+|.... |+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 3579999999999999999999864 899999999876666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~~ 674 (684)
|++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999843 35899999999999999999999998 99999999999999999999999999998865433
Q ss_pred ccCCcccccC
Q 005669 675 EANTKRVVGT 684 (684)
Q Consensus 675 ~~~~~~~~GT 684 (684)
....++||
T Consensus 303 --~~~~~~GT 310 (423)
T 4fie_A 303 --RRKSLVGT 310 (423)
T ss_dssp --CBCCCEEC
T ss_pred --cccccccC
Confidence 23456776
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=273.47 Aligned_cols=158 Identities=29% Similarity=0.480 Sum_probs=125.8
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|++.+.||+|+||+||+|... +++.||||++++. .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999975 4899999999754 2334567999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
||+ +|+|.+++.+ ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 5788888844 356999999999999999999999998 999999999999999999999999999987543
Q ss_pred CCccCCcccccC
Q 005669 673 QTEANTKRVVGT 684 (684)
Q Consensus 673 ~~~~~~~~~~GT 684 (684)
. .....+||
T Consensus 166 ~---~~~~~~GT 174 (275)
T 3hyh_A 166 N---FLKTSCGS 174 (275)
T ss_dssp ------------
T ss_pred C---ccCCeeEC
Confidence 2 22345665
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=277.83 Aligned_cols=154 Identities=26% Similarity=0.415 Sum_probs=126.9
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC--------
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-------- 586 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-------- 586 (684)
++|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46889999999999999999975 48999999997543 334567899999999999999999999987644
Q ss_pred ----eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEe
Q 005669 587 ----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISD 662 (684)
Q Consensus 587 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~D 662 (684)
..|+||||+++|+|.+++.........++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999965443344667788999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCC
Q 005669 663 FGLARSFGLDQ 673 (684)
Q Consensus 663 FGla~~~~~~~ 673 (684)
||+|+.+..+.
T Consensus 162 FGla~~~~~~~ 172 (299)
T 4g31_A 162 FGLVTAMDQDE 172 (299)
T ss_dssp CCCC-------
T ss_pred CccceecCCCc
Confidence 99999886543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=281.42 Aligned_cols=158 Identities=27% Similarity=0.322 Sum_probs=133.2
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.+.|+..++||+|+||+||+|++.. |+.||||+++.... ..+|+.++++++|||||++++++.+++..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 4567888899999999999999754 89999999976422 24699999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-cEEEEeeccccccCCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFGLDQ 673 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~-~vkI~DFGla~~~~~~~ 673 (684)
+++|+|.+++.+ ...+++.++..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.+..+.
T Consensus 132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999954 346999999999999999999999998 99999999999999887 69999999999886543
Q ss_pred Ccc---CCcccccC
Q 005669 674 TEA---NTKRVVGT 684 (684)
Q Consensus 674 ~~~---~~~~~~GT 684 (684)
... ....++||
T Consensus 206 ~~~~~~~~~~~~GT 219 (336)
T 4g3f_A 206 LGKSLLTGDYIPGT 219 (336)
T ss_dssp --------CCCCCC
T ss_pred cccceecCCccccC
Confidence 221 22345676
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=274.72 Aligned_cols=157 Identities=30% Similarity=0.439 Sum_probs=132.8
Q ss_pred CccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEe----CCeeEEEE
Q 005669 520 SEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDERMLIY 592 (684)
Q Consensus 520 ~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~ 592 (684)
+..++||+|+||+||+|.+.. ++.||+|++... .....+.+.+|++++++++|||||++++++.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 566789999999999999765 889999998643 23345679999999999999999999999875 34579999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~-~~~~vkI~DFGla~~~~~ 671 (684)
||+++|+|.+++.+ ...+++..+..++.||+.||+|||+++ ++||||||||+||||+ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999954 346899999999999999999999875 4599999999999998 478999999999986533
Q ss_pred CCCccCCcccccC
Q 005669 672 DQTEANTKRVVGT 684 (684)
Q Consensus 672 ~~~~~~~~~~~GT 684 (684)
. .+..++||
T Consensus 185 ~----~~~~~~GT 193 (290)
T 3fpq_A 185 S----FAKAVIGT 193 (290)
T ss_dssp T----SBEESCSS
T ss_pred C----ccCCcccC
Confidence 2 23456776
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-32 Score=280.41 Aligned_cols=160 Identities=28% Similarity=0.324 Sum_probs=131.5
Q ss_pred CCCCccceecccCcEeEEEEEee----CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
++|++.+.||+|+||+||+|+.. .++.||||++++.. .....++.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 36789999997542 2334578899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++|+|.+++.+ ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999954 346999999999999999999999998 9999999999999999999999999999764
Q ss_pred CCCCccCCcccccC
Q 005669 671 LDQTEANTKRVVGT 684 (684)
Q Consensus 671 ~~~~~~~~~~~~GT 684 (684)
.... ....++||
T Consensus 178 ~~~~--~~~~~~GT 189 (304)
T 3ubd_A 178 DHEK--KAYSFCGT 189 (304)
T ss_dssp ---C--CCCSCCCC
T ss_pred CCCc--cccccccC
Confidence 4332 23346676
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=278.59 Aligned_cols=175 Identities=27% Similarity=0.401 Sum_probs=144.9
Q ss_pred ccHHHHHhhcCCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCCc-ccHHHHHHHHHHHhccCC-CceeeE
Q 005669 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQH-RNLVKL 578 (684)
Q Consensus 507 ~~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H-~nIv~l 578 (684)
++....+...++|++.++||+|+||+||+|.+.. ++.||||++..... ...+++.+|+.+|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3444555667889999999999999999998653 35899999976533 345679999999999965 899999
Q ss_pred EEEEEeC-CeeEEEEEccCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecC
Q 005669 579 LGCCTQR-DERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRD 644 (684)
Q Consensus 579 ~g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrD 644 (684)
+|+|.+. +..+||||||++|+|.++|..... ...+++.++..++.||++||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999765 568999999999999999965321 345899999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCcEEEEeeccccccCCCCCccCCcccccC
Q 005669 645 LKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684 (684)
Q Consensus 645 Lkp~NILl~~~~~vkI~DFGla~~~~~~~~~~~~~~~~GT 684 (684)
|||+|||+++++.+||+|||+|+.+..+.....+...+||
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt 250 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeecccccc
Confidence 9999999999999999999999988655544334445554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=272.89 Aligned_cols=162 Identities=25% Similarity=0.367 Sum_probs=128.6
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC----eeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD----ERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV~ 592 (684)
++|.+.++||+|+||+||+|++ +|+.||||+++... ........|+..+.+++|||||+++++|.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3577789999999999999987 68999999997532 11122334566667889999999999998754 579999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS-----RLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
||+++|+|.+++.. ..++++++.+++.|+++||+|||++. .++||||||||+||||++++.+||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999953 35899999999999999999999871 2359999999999999999999999999999
Q ss_pred ccCCCCCcc--CCcccccC
Q 005669 668 SFGLDQTEA--NTKRVVGT 684 (684)
Q Consensus 668 ~~~~~~~~~--~~~~~~GT 684 (684)
......... .....+||
T Consensus 157 ~~~~~~~~~~~~~~~~~GT 175 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp EEETTTTEESCC-----CC
T ss_pred cccCCCCceeeeccccccc
Confidence 875543321 22345665
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-29 Score=269.81 Aligned_cols=162 Identities=24% Similarity=0.421 Sum_probs=135.2
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe------CC
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ------RD 586 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~------~~ 586 (684)
.++|++.++||+|+||+||+|.+. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999975 48999999997542 2334678899999999999999999999764 35
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
..||||||++ |+|.+++. ....+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 6899999996 67888883 3457999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCC--ccCCcccccC
Q 005669 667 RSFGLDQT--EANTKRVVGT 684 (684)
Q Consensus 667 ~~~~~~~~--~~~~~~~~GT 684 (684)
+.+..... ......++||
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT 225 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVAT 225 (398)
T ss_dssp BCC-------CCCCCSSCCC
T ss_pred eecccCccccccccccceeC
Confidence 98754321 2233456776
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=261.43 Aligned_cols=150 Identities=24% Similarity=0.376 Sum_probs=133.2
Q ss_pred HHHhhcCCCCccceecccCcEeEEEEEee----CCcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 005669 511 IIANATDNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR 585 (684)
Q Consensus 511 ~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 585 (684)
.+....+.|++.++||+|+||+||+|+.. .++.||+|++... ....++.+|+++|+.+ +||||+++++++.+.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 34456688999999999999999999864 3678999998754 3356788999999998 699999999999999
Q ss_pred CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CcEEEEeec
Q 005669 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFG 664 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~-~~vkI~DFG 664 (684)
++.++||||+++++|.+++ +.+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CEEEEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 9999999999999999988 23899999999999999999999998 9999999999999876 799999999
Q ss_pred cccccCC
Q 005669 665 LARSFGL 671 (684)
Q Consensus 665 la~~~~~ 671 (684)
+|+....
T Consensus 164 la~~~~~ 170 (361)
T 4f9c_A 164 LAQGTHD 170 (361)
T ss_dssp TCEECTT
T ss_pred CCcccCC
Confidence 9987653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=275.68 Aligned_cols=159 Identities=28% Similarity=0.383 Sum_probs=135.7
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHH---HHHHHHhccCCCceeeEEEEEEeCCee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFK---NEVLLIAKLQHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~---~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 588 (684)
.++|++.+.||+|+||+||+|+... |+.||||++++.. ........ +++.+++.++|||||++++++++.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 4679999999999999999999865 8999999986431 12223333 346677788999999999999999999
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
|+||||++||+|..+|.+ ...+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999954 356999999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCccCCcccccC
Q 005669 669 FGLDQTEANTKRVVGT 684 (684)
Q Consensus 669 ~~~~~~~~~~~~~~GT 684 (684)
+.... +..++||
T Consensus 342 ~~~~~----~~t~~GT 353 (689)
T 3v5w_A 342 FSKKK----PHASVGT 353 (689)
T ss_dssp CSSCC----CCSCCSC
T ss_pred cCCCC----CCCccCC
Confidence 75432 3346776
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7.9e-28 Score=273.09 Aligned_cols=161 Identities=25% Similarity=0.419 Sum_probs=141.3
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.++|++.+.||+|+||.||+|.... |+.||+|++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 3679999999999999999999864 899999999876555667889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC--CcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT--MNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~--~~vkI~DFGla~~~~~~ 672 (684)
|++|+|.+++.+ ....+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999998843 2356899999999999999999999998 9999999999999854 89999999999998644
Q ss_pred CCccCCcccccC
Q 005669 673 QTEANTKRVVGT 684 (684)
Q Consensus 673 ~~~~~~~~~~GT 684 (684)
.. ....+||
T Consensus 311 ~~---~~~~~GT 319 (573)
T 3uto_A 311 QS---VKVTTGT 319 (573)
T ss_dssp SE---EEEECSS
T ss_pred Cc---eeeeEEC
Confidence 32 2334565
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=244.78 Aligned_cols=161 Identities=42% Similarity=0.745 Sum_probs=144.6
Q ss_pred cHHHHHhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 005669 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 508 ~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 587 (684)
.+.++...+++|+..+.||+|+||.||+|...+++.||||++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 34445667899999999999999999999987899999999987666677889999999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
.++||||+++++|.+++..... ...+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999998854322 235899999999999999999999998 999999999999999999999999999
Q ss_pred cccCC
Q 005669 667 RSFGL 671 (684)
Q Consensus 667 ~~~~~ 671 (684)
+....
T Consensus 187 ~~~~~ 191 (321)
T 2qkw_B 187 KKGTE 191 (321)
T ss_dssp EECSS
T ss_pred ccccc
Confidence 87643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=235.65 Aligned_cols=167 Identities=41% Similarity=0.679 Sum_probs=148.6
Q ss_pred CCcCcccHHHHHhhcCCCCcc------ceecccCcEeEEEEEeeCCcEEEEEEccCC----CcccHHHHHHHHHHHhccC
Q 005669 502 MELPIFDLKIIANATDNFSEK------NKLGEGGFGPVYKGMLIEGQEIAVKRLSKG----SGQGMEEFKNEVLLIAKLQ 571 (684)
Q Consensus 502 ~~~~~~~~~~l~~~t~~y~~~------~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~ 571 (684)
.....|++.++..++++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 345678899999999999877 8999999999999987 6789999998753 2334567899999999999
Q ss_pred CCceeeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 005669 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (684)
Q Consensus 572 H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NIL 651 (684)
||||+++++++...+..++||||+++++|.+++........+++..+..++.||+.||.|||+++ |+||||||+||+
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 99999999999999999999999999999999865545567999999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCC
Q 005669 652 LDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 652 l~~~~~vkI~DFGla~~~~~~ 672 (684)
+++++.+||+|||+++.....
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSC
T ss_pred EcCCCcEEEeecccccccccc
Confidence 999999999999999887543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.9e-26 Score=235.36 Aligned_cols=152 Identities=28% Similarity=0.484 Sum_probs=138.2
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
..++|+..++||+|+||.||++... +++.||||++........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 4568999999999999999999964 489999999876555567789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
|+++++|.+++.. ..+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999853 25899999999999999999999998 9999999999999999999999999999876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=252.16 Aligned_cols=161 Identities=20% Similarity=0.259 Sum_probs=141.5
Q ss_pred cHHHHHhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEE
Q 005669 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583 (684)
Q Consensus 508 ~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~ 583 (684)
.++++....++|+..++||+|+||+||+++... ++.||+|++.+. .......+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 455666778899999999999999999999865 789999998642 1222344889999999999999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEee
Q 005669 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (684)
Q Consensus 584 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DF 663 (684)
+.+..++||||+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999542 356999999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCC
Q 005669 664 GLARSFGLDQ 673 (684)
Q Consensus 664 Gla~~~~~~~ 673 (684)
|+|+.+..+.
T Consensus 220 Gla~~~~~~~ 229 (437)
T 4aw2_A 220 GSCLKLMEDG 229 (437)
T ss_dssp TTCEECCTTS
T ss_pred hhhhhcccCC
Confidence 9998875543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=236.13 Aligned_cols=152 Identities=31% Similarity=0.480 Sum_probs=137.9
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.++|...++||+|+||.||++.... ++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 3678889999999999999999854 889999998776666778899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+++++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999543 346899999999999999999999998 999999999999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=236.24 Aligned_cols=161 Identities=26% Similarity=0.379 Sum_probs=142.4
Q ss_pred CcccHHHHHhhcCC----------CCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCC
Q 005669 505 PIFDLKIIANATDN----------FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR 573 (684)
Q Consensus 505 ~~~~~~~l~~~t~~----------y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ 573 (684)
+.++++++..+++. |+..++||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 44666666665543 666789999999999999986 5899999999876666778899999999999999
Q ss_pred ceeeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 005669 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (684)
Q Consensus 574 nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~ 653 (684)
||+++++++...+..++||||+++++|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 99999999999999999999999999999883 245899999999999999999999998 99999999999999
Q ss_pred CCCcEEEEeeccccccCCC
Q 005669 654 NTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 654 ~~~~vkI~DFGla~~~~~~ 672 (684)
.++.+||+|||+++.+...
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKD 194 (321)
T ss_dssp TTCCEEECCCTTCEECCSS
T ss_pred CCCcEEEeeeeeeeecccC
Confidence 9999999999999987543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.3e-26 Score=239.62 Aligned_cols=170 Identities=45% Similarity=0.760 Sum_probs=148.2
Q ss_pred CcCcccHHHHHhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEE
Q 005669 503 ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGC 581 (684)
Q Consensus 503 ~~~~~~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~ 581 (684)
....+++.++....++|+..+.||+|+||.||++...+++.||||++.... ......+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 355688899999999999999999999999999998789999999997643 2233478999999999999999999999
Q ss_pred EEeCCeeEEEEEccCCCChhHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEE
Q 005669 582 CTQRDERMLIYEYLPNKSLDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (684)
Q Consensus 582 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI 660 (684)
+...+..++||||+++++|.+++..... ...+++..+..++.|++.||.|||++...+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 9999999999999999999999965432 345899999999999999999999992222999999999999999999999
Q ss_pred EeeccccccCCC
Q 005669 661 SDFGLARSFGLD 672 (684)
Q Consensus 661 ~DFGla~~~~~~ 672 (684)
+|||+++.+...
T Consensus 176 ~Dfg~~~~~~~~ 187 (326)
T 3uim_A 176 GDFGLAKLMDYK 187 (326)
T ss_dssp CCCSSCEECCSS
T ss_pred ccCccccccCcc
Confidence 999999987543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=237.04 Aligned_cols=154 Identities=25% Similarity=0.388 Sum_probs=134.7
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-------
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------- 586 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------- 586 (684)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467889999999999999999986 58999999997543 334578999999999999999999999986654
Q ss_pred --------------------------------------------------eeEEEEEccCCCChhHHHhccCCCCCCCHH
Q 005669 587 --------------------------------------------------ERMLIYEYLPNKSLDYFIFDTTRSKLLDWS 616 (684)
Q Consensus 587 --------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 616 (684)
..++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 279999999999999999765544556778
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 617 ~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
.+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 89999999999999999998 999999999999999999999999999988654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-26 Score=239.87 Aligned_cols=153 Identities=29% Similarity=0.473 Sum_probs=137.3
Q ss_pred hhcCCCCccceecccCcEeEEEEEe-eCCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
...++|++.+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|++++++++||||+++++++...+..++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3457899999999999999999997 45899999998753 23345678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 92 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999998543 45899999999999999999999998 9999999999999999999999999998875
Q ss_pred CC
Q 005669 671 LD 672 (684)
Q Consensus 671 ~~ 672 (684)
..
T Consensus 166 ~~ 167 (328)
T 3fe3_A 166 VG 167 (328)
T ss_dssp SS
T ss_pred CC
Confidence 43
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-26 Score=248.15 Aligned_cols=157 Identities=22% Similarity=0.268 Sum_probs=138.9
Q ss_pred HHHHHhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 005669 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ 584 (684)
Q Consensus 509 ~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 584 (684)
+..+....++|+..++||+|+||.||++.... ++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 44556677899999999999999999999865 889999998642 12233458899999999999999999999999
Q ss_pred CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
.+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999998843 34899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCC
Q 005669 665 LARSFGLD 672 (684)
Q Consensus 665 la~~~~~~ 672 (684)
+|+.+...
T Consensus 214 ~a~~~~~~ 221 (410)
T 3v8s_A 214 TCMKMNKE 221 (410)
T ss_dssp TCEECCTT
T ss_pred eeEeeccC
Confidence 99987544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=238.23 Aligned_cols=151 Identities=30% Similarity=0.420 Sum_probs=133.0
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 58899999986542 2234668899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|+++++|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999998883 3446899999999999999999999998 999999999999999999999999999877533
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=239.72 Aligned_cols=149 Identities=26% Similarity=0.339 Sum_probs=134.4
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.++|+..+.||+|+||.||++.... ++.||+|++++. .......+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 3678999999999999999999764 899999998753 233456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|||+++++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999998854 346899999999999999999999998 9999999999999999999999999998753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=240.66 Aligned_cols=154 Identities=31% Similarity=0.509 Sum_probs=135.5
Q ss_pred cCCCCccceecccCcEeEEEEEee--------CCcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR 585 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 585 (684)
.++|++.+.||+|+||.||+|... ++..||||+++... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467889999999999999999863 24579999997653 33456789999999999 899999999999999
Q ss_pred CeeEEEEEccCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 005669 586 DERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl 652 (684)
+..++||||+++++|.+++..... ...+++.++..++.||+.||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999965431 245899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCC
Q 005669 653 DNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 653 ~~~~~vkI~DFGla~~~~~~ 672 (684)
+.++.+||+|||+|+.+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~ 256 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNI 256 (370)
T ss_dssp CTTCCEEECCCSSCEETTCC
T ss_pred CCCCCEEEccccCCcccCcc
Confidence 99999999999999977543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.5e-26 Score=247.48 Aligned_cols=161 Identities=22% Similarity=0.283 Sum_probs=141.3
Q ss_pred cHHHHHhhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEE
Q 005669 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583 (684)
Q Consensus 508 ~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~ 583 (684)
.+++.....++|+..+.||+|+||.||+++.. +++.||+|++++. .....+.+.+|..++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34555667789999999999999999999985 4899999998742 1223445889999999999999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEee
Q 005669 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (684)
Q Consensus 584 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DF 663 (684)
+.+..++||||+++|+|.+++.+. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999999543 246899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCC
Q 005669 664 GLARSFGLDQ 673 (684)
Q Consensus 664 Gla~~~~~~~ 673 (684)
|+|+.+....
T Consensus 207 Gla~~~~~~~ 216 (412)
T 2vd5_A 207 GSCLKLRADG 216 (412)
T ss_dssp TTCEECCTTS
T ss_pred hhheeccCCC
Confidence 9999876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=240.65 Aligned_cols=150 Identities=31% Similarity=0.462 Sum_probs=133.3
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 589 (684)
..++|++.+.||+|+||.||+++... ++.||||++++. .....+.+.+|..+++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 34789999999999999999999764 889999998753 233456688899999988 7999999999999999999
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+||||+++++|..++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999998543 45899999999999999999999998 999999999999999999999999999865
Q ss_pred C
Q 005669 670 G 670 (684)
Q Consensus 670 ~ 670 (684)
.
T Consensus 175 ~ 175 (353)
T 3txo_A 175 I 175 (353)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=243.44 Aligned_cols=149 Identities=25% Similarity=0.383 Sum_probs=131.9
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 589 (684)
..++|++.++||+|+||.||+++... ++.||+|++++. .....+.+.+|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 34679999999999999999999865 789999998754 223345688899999887 8999999999999999999
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 130 lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999998854 345899999999999999999999998 999999999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.8e-25 Score=235.47 Aligned_cols=152 Identities=30% Similarity=0.401 Sum_probs=135.9
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc------ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG------QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 587 (684)
..+.|++.+.||+|+||.||++.... ++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 45679999999999999999999864 89999999876432 135789999999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----cEEEEee
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM----NPKISDF 663 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~----~vkI~DF 663 (684)
.++||||+++++|.+++. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999983 3456999999999999999999999998 99999999999998776 7999999
Q ss_pred ccccccCCC
Q 005669 664 GLARSFGLD 672 (684)
Q Consensus 664 Gla~~~~~~ 672 (684)
|+++.+...
T Consensus 164 G~a~~~~~~ 172 (361)
T 2yab_A 164 GLAHEIEDG 172 (361)
T ss_dssp SSCEECCTT
T ss_pred CCceEcCCC
Confidence 999987543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=231.72 Aligned_cols=150 Identities=27% Similarity=0.438 Sum_probs=134.1
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.++|++.+.||+|+||.||++... .++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999975 48899999986432 23356788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++++|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999998542 46899999999999999999999998 99999999999999999999999999988754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=239.86 Aligned_cols=151 Identities=25% Similarity=0.379 Sum_probs=135.8
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.++|++.+.||+|+||.||++.... ++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3679999999999999999999765 789999998643 233456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999843 456999999999999999999999998 99999999999999999999999999998754
Q ss_pred C
Q 005669 672 D 672 (684)
Q Consensus 672 ~ 672 (684)
.
T Consensus 168 ~ 168 (384)
T 4fr4_A 168 E 168 (384)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=233.70 Aligned_cols=150 Identities=28% Similarity=0.398 Sum_probs=134.9
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.++|++.+.||+|+||.||++... +++.||+|++++. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367899999999999999999986 4899999998753 123456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999854 345899999999999999999999998 99999999999999999999999999997643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=234.92 Aligned_cols=161 Identities=32% Similarity=0.521 Sum_probs=135.2
Q ss_pred hcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC----eeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD----ERML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~l 590 (684)
..++|++.++||+|+||.||+|... ++.||||++... ........+|+.++++++||||+++++++.... ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3468999999999999999999874 789999999753 233445667899999999999999999998754 3699
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCceEecCCCCCcEEEcCCCcEEE
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD----------SRLRIIHRDLKASNVLLDNTMNPKI 660 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~----------~~~~IvHrDLkp~NILl~~~~~vkI 660 (684)
||||+++++|.+++.. ..+++..+..++.||+.||+|||+. + |+||||||+|||++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 9999999999999954 3489999999999999999999998 6 999999999999999999999
Q ss_pred EeeccccccCCCCCccCCcccccC
Q 005669 661 SDFGLARSFGLDQTEANTKRVVGT 684 (684)
Q Consensus 661 ~DFGla~~~~~~~~~~~~~~~~GT 684 (684)
+|||+|+.+.............||
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt 196 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGT 196 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCC
T ss_pred ccCCcccccccccCccccccCccC
Confidence 999999887654433333333443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=236.70 Aligned_cols=151 Identities=29% Similarity=0.442 Sum_probs=133.8
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCee
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 588 (684)
...++|...+.||+|+||.||+++... ++.||||++++.. ....+.+..|..++.++ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 456789999999999999999999864 8899999997531 23456788899999887 899999999999999999
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999854 245899999999999999999999998 99999999999999999999999999987
Q ss_pred cC
Q 005669 669 FG 670 (684)
Q Consensus 669 ~~ 670 (684)
..
T Consensus 168 ~~ 169 (345)
T 1xjd_A 168 NM 169 (345)
T ss_dssp CC
T ss_pred cc
Confidence 53
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-25 Score=236.12 Aligned_cols=149 Identities=26% Similarity=0.367 Sum_probs=133.0
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 590 (684)
.++|+..+.||+|+||.||+++... ++.||+|++.+.. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 3578899999999999999999864 8899999997542 23345688899999988 89999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 88 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999998542 45899999999999999999999998 9999999999999999999999999998743
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=238.44 Aligned_cols=164 Identities=29% Similarity=0.448 Sum_probs=140.3
Q ss_pred cccHHHHHhhcCCCCccceecccCcEeEEEEEee------CCcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceee
Q 005669 506 IFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVK 577 (684)
Q Consensus 506 ~~~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~ 577 (684)
.++....+...++|++.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 4556666777899999999999999999999843 25789999997643 23356789999999999 7999999
Q ss_pred EEEEEEeCCe-eEEEEEccCCCChhHHHhccCC-----------------------------------------------
Q 005669 578 LLGCCTQRDE-RMLIYEYLPNKSLDYFIFDTTR----------------------------------------------- 609 (684)
Q Consensus 578 l~g~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------- 609 (684)
+++++.+.+. .++||||+++++|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 8999999999999999965432
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 610 ----------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 610 ----------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122899999999999999999999998 999999999999999999999999999977544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.92 E-value=8.7e-25 Score=227.23 Aligned_cols=150 Identities=27% Similarity=0.469 Sum_probs=131.2
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
++|+..++||+|+||+||++.... ++.||+|++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 578999999999999999999864 8899999987542 2334678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|++++.+ ..+.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.++..
T Consensus 82 ~~~~~l~-~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQDLK-KYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHH-HHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCCCHH-HHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986544 44432 2356899999999999999999999998 999999999999999999999999999987543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-25 Score=232.23 Aligned_cols=152 Identities=30% Similarity=0.511 Sum_probs=134.5
Q ss_pred cCCCCccceecccCcEeEEEEEee----CCcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
.++|++.+.||+|+||.||+|... .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 457888999999999999999975 2456999999764 33445678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++++|.+++... ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999998532 346899999999999999999999998 9999999999999999999999999999875
Q ss_pred CC
Q 005669 671 LD 672 (684)
Q Consensus 671 ~~ 672 (684)
..
T Consensus 203 ~~ 204 (325)
T 3kul_A 203 DD 204 (325)
T ss_dssp --
T ss_pred cC
Confidence 44
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.6e-25 Score=225.20 Aligned_cols=150 Identities=27% Similarity=0.503 Sum_probs=136.3
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
.++|+..+.||+|+||.||++...+++.||+|++... ....+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 3578889999999999999999988899999999864 344578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
++++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 99999999854 2346899999999999999999999998 99999999999999999999999999987643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=229.62 Aligned_cols=152 Identities=21% Similarity=0.327 Sum_probs=135.8
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
..++|++.+.||+|+||.||++.... ++.+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 35789999999999999999999764 789999998754 3445678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--CCcEEEEeeccccccCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--TMNPKISDFGLARSFGL 671 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~--~~~vkI~DFGla~~~~~ 671 (684)
|+++++|.+++.. ....+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.+..
T Consensus 82 ~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred eCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999843 2346899999999999999999999998 999999999999987 78999999999998754
Q ss_pred C
Q 005669 672 D 672 (684)
Q Consensus 672 ~ 672 (684)
.
T Consensus 157 ~ 157 (321)
T 1tki_A 157 G 157 (321)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-25 Score=238.62 Aligned_cols=153 Identities=20% Similarity=0.222 Sum_probs=133.3
Q ss_pred HHhhcCCCCccceecccCcEeEEEEE------eeCCcEEEEEEccCCCcccHHHHHHHHHHHhccC---CCceeeEEEEE
Q 005669 512 IANATDNFSEKNKLGEGGFGPVYKGM------LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ---HRNLVKLLGCC 582 (684)
Q Consensus 512 l~~~t~~y~~~~~LG~G~fG~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~ 582 (684)
+....++|.+.++||+|+||.||+|. ...++.||||++... ...++.+|++++++++ |+||+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 34456789999999999999999994 345889999999754 3467788888888887 99999999999
Q ss_pred EeCCeeEEEEEccCCCChhHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC------
Q 005669 583 TQRDERMLIYEYLPNKSLDYFIFDTT--RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN------ 654 (684)
Q Consensus 583 ~~~~~~~lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~------ 654 (684)
...+..++||||+++|+|.+++.... ....+++.++..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence 99999999999999999999996422 3456999999999999999999999988 999999999999998
Q ss_pred -----CCcEEEEeeccccccC
Q 005669 655 -----TMNPKISDFGLARSFG 670 (684)
Q Consensus 655 -----~~~vkI~DFGla~~~~ 670 (684)
++.+||+|||+|+.+.
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~ 234 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMK 234 (365)
T ss_dssp -----CTTEEECCCTTCEEGG
T ss_pred ccccccCCEEEeeCchhhhhh
Confidence 8999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=233.37 Aligned_cols=158 Identities=32% Similarity=0.530 Sum_probs=132.5
Q ss_pred HHhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 512 IANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 512 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
+....++|++.+.||+|+||.||++.. .++.||||++.... ....+++.+|+.++++++||||+++++++...+..+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 344557899999999999999999986 68899999987543 233467899999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+||||+++++|.+++........+++..+..++.||+.||+|||+++ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999999954332334899999999999999999999875 34999999999999999999999999999865
Q ss_pred CC
Q 005669 670 GL 671 (684)
Q Consensus 670 ~~ 671 (684)
..
T Consensus 190 ~~ 191 (309)
T 3p86_A 190 AS 191 (309)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=5.2e-25 Score=235.48 Aligned_cols=150 Identities=26% Similarity=0.323 Sum_probs=135.2
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.++|+..+.||+|+||.||++... +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367899999999999999999986 4899999998643 223456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998542 45899999999999999999999998 99999999999999999999999999998753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.5e-25 Score=228.39 Aligned_cols=150 Identities=28% Similarity=0.439 Sum_probs=128.6
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc--------------------------ccHHHHHHHHHHHh
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--------------------------QGMEEFKNEVLLIA 568 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~--------------------------~~~~~~~~Ei~~l~ 568 (684)
.++|++.+.||+|+||.||+|.... ++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999999754 88999999875421 12356889999999
Q ss_pred ccCCCceeeEEEEEEe--CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 005669 569 KLQHRNLVKLLGCCTQ--RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646 (684)
Q Consensus 569 ~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLk 646 (684)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++.++..++.||+.||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999997754 3356899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCcEEEEeeccccccCCC
Q 005669 647 ASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 647 p~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|+|||++.++.+||+|||+++.+...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~ 190 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGS 190 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSS
T ss_pred HHHEEECCCCCEEEecCCCccccccc
Confidence 99999999999999999999987543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=229.22 Aligned_cols=151 Identities=28% Similarity=0.424 Sum_probs=135.0
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc------ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG------QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 588 (684)
.+.|...+.||+|+||.||++.... ++.||+|.+..... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3568899999999999999999864 88999999875422 2357899999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----cEEEEeec
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM----NPKISDFG 664 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~----~vkI~DFG 664 (684)
++||||+++++|.+++. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999983 3456899999999999999999999998 99999999999998877 79999999
Q ss_pred cccccCCC
Q 005669 665 LARSFGLD 672 (684)
Q Consensus 665 la~~~~~~ 672 (684)
+++.+...
T Consensus 164 ~a~~~~~~ 171 (326)
T 2y0a_A 164 LAHKIDFG 171 (326)
T ss_dssp TCEECCTT
T ss_pred CCeECCCC
Confidence 99987543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.3e-25 Score=229.89 Aligned_cols=152 Identities=30% Similarity=0.491 Sum_probs=133.3
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
...++|++.++||+|+||.||++...+++.||+|++.... ......+.+|+.++++++||||+++++++.+++..++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 4557899999999999999999999889999999987542 22346788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++ +|.+.+.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.++.
T Consensus 98 ~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 999985 77777643 2345899999999999999999999998 99999999999999999999999999998753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=5.6e-25 Score=233.80 Aligned_cols=158 Identities=30% Similarity=0.506 Sum_probs=138.9
Q ss_pred HHHhhcCCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEE
Q 005669 511 IIANATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583 (684)
Q Consensus 511 ~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~ 583 (684)
.+....++|++.+.||+|+||.||++.... ++.||||.++... ....+.+.+|+.++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 344567889999999999999999999853 4789999998643 334567899999999999999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 005669 584 QRDERMLIYEYLPNKSLDYFIFDTTR---------------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642 (684)
Q Consensus 584 ~~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvH 642 (684)
+.+..++||||+++++|.+++..... ...+++.+++.++.||++||.|||+++ |+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 99999999999999999999865321 256899999999999999999999998 999
Q ss_pred cCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 643 RDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 643 rDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||||+|||++.++.+||+|||+++.+..
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 226 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYS 226 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred CCCCcceEEECCCCeEEEeecCCCccccc
Confidence 99999999999999999999999987643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-25 Score=233.64 Aligned_cols=149 Identities=28% Similarity=0.399 Sum_probs=125.6
Q ss_pred cCCCCccceecccCcEeEEEEEee----CCcEEEEEEccCCC----cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGS----GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 587 (684)
.++|++.+.||+|+||.||++... +++.||+|++++.. ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 467999999999999999999973 58899999997642 2334567889999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999854 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ccC
Q 005669 668 SFG 670 (684)
Q Consensus 668 ~~~ 670 (684)
...
T Consensus 170 ~~~ 172 (327)
T 3a62_A 170 ESI 172 (327)
T ss_dssp ---
T ss_pred ccc
Confidence 754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=228.70 Aligned_cols=155 Identities=26% Similarity=0.391 Sum_probs=136.8
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC--eeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD--ERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV 591 (684)
.++|.+.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4678999999999999999999865 8999999987542 334677889999999999999999999998765 67999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCcEEEEeecccc
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLAR 667 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl----~~~~~vkI~DFGla~ 667 (684)
|||+++++|.+++........+++.++..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555555999999999999999999999998 9999999999999 788889999999999
Q ss_pred ccCCCC
Q 005669 668 SFGLDQ 673 (684)
Q Consensus 668 ~~~~~~ 673 (684)
.+....
T Consensus 165 ~~~~~~ 170 (319)
T 4euu_A 165 ELEDDE 170 (319)
T ss_dssp ECCTTC
T ss_pred ecCCCC
Confidence 875443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.4e-25 Score=235.56 Aligned_cols=150 Identities=30% Similarity=0.368 Sum_probs=133.9
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 589 (684)
..++|+..+.||+|+||.||++.... ++.||+|++++. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 35789999999999999999999865 789999998753 223456788999999988 7999999999999999999
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999998542 45899999999999999999999998 999999999999999999999999999875
Q ss_pred C
Q 005669 670 G 670 (684)
Q Consensus 670 ~ 670 (684)
.
T Consensus 172 ~ 172 (353)
T 2i0e_A 172 I 172 (353)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.2e-25 Score=230.88 Aligned_cols=155 Identities=30% Similarity=0.491 Sum_probs=136.2
Q ss_pred hcCCCCccceecccCcEeEEEEEee------CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 587 (684)
..++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 4578999999999999999999863 24789999997542 3445678999999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTR---------------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLk 646 (684)
.++||||+++++|.+++..... ...+++.++..++.||+.||+|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999965432 234899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCcEEEEeeccccccCCC
Q 005669 647 ASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 647 p~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|+||++++++.+||+|||+++.+...
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~ 203 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEE 203 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTT
T ss_pred hheEEEcCCCCEEEcccccccccccc
Confidence 99999999999999999999987544
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=5e-25 Score=237.74 Aligned_cols=152 Identities=32% Similarity=0.553 Sum_probs=128.3
Q ss_pred cCCCCccceecccCcEeEEEEEee----CCcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
.++|++.+.||+|+||.||+|... .+..||||+++.. .....+++.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999875 4678999999764 23345679999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++++|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999953 2346899999999999999999999998 9999999999999999999999999999875
Q ss_pred CC
Q 005669 671 LD 672 (684)
Q Consensus 671 ~~ 672 (684)
..
T Consensus 199 ~~ 200 (373)
T 2qol_A 199 DD 200 (373)
T ss_dssp --
T ss_pred cC
Confidence 43
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=231.79 Aligned_cols=154 Identities=28% Similarity=0.438 Sum_probs=134.2
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC-----CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-----SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
.+.|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357899999999999999999975 4899999998632 1224678999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---EEEEeecc
Q 005669 590 LIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN---PKISDFGL 665 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~---vkI~DFGl 665 (684)
+||||+++++|.+.+.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775432 2345899999999999999999999998 999999999999986554 99999999
Q ss_pred ccccCCC
Q 005669 666 ARSFGLD 672 (684)
Q Consensus 666 a~~~~~~ 672 (684)
++.+...
T Consensus 180 a~~~~~~ 186 (351)
T 3c0i_A 180 AIQLGES 186 (351)
T ss_dssp CEECCTT
T ss_pred eeEecCC
Confidence 9987643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=235.34 Aligned_cols=155 Identities=32% Similarity=0.479 Sum_probs=136.1
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC--------CcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEe
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ 584 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~ 584 (684)
..++|.+.++||+|+||.||+|.... +..||||++.... .....++.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 34688999999999999999998632 3579999997642 33456789999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 005669 585 RDERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (684)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NIL 651 (684)
.+..++||||+++++|.+++..... ...+++.++..++.||+.||.|||+++ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999965431 245899999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCC
Q 005669 652 LDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 652 l~~~~~vkI~DFGla~~~~~~ 672 (684)
+++++.+||+|||+|+.+...
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~ 244 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHI 244 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCC
T ss_pred EcCCCcEEEcccCcccccccc
Confidence 999999999999999987543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=222.93 Aligned_cols=152 Identities=31% Similarity=0.488 Sum_probs=137.3
Q ss_pred hcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
..++|+..+.||+|+||.||++...++..||+|++... ....+++.+|+.++.+++||||+++++++...+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 34678999999999999999999888889999999764 33457799999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+++++|.+++... ...+++.++..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999998543 335899999999999999999999998 999999999999999999999999999877544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=232.82 Aligned_cols=152 Identities=28% Similarity=0.452 Sum_probs=134.5
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
..++|++.+.||+|+||.||++.... ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45679999999999999999999754 8899999997542 23456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CcEEEEeeccccc
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLARS 668 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~---~~vkI~DFGla~~ 668 (684)
|||+++++|.+.+. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999998884 3456899999999999999999999998 9999999999999764 4599999999988
Q ss_pred cCCC
Q 005669 669 FGLD 672 (684)
Q Consensus 669 ~~~~ 672 (684)
+...
T Consensus 181 ~~~~ 184 (362)
T 2bdw_A 181 VNDS 184 (362)
T ss_dssp CTTC
T ss_pred ecCC
Confidence 7543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-25 Score=238.96 Aligned_cols=152 Identities=28% Similarity=0.456 Sum_probs=135.0
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
..++|...+.||+|+||.||+|... +++.||||.++... ....+++.+|++++++++||||+++++++...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467888999999999999999986 58899999987542 233456889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
||+++++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 192 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp ECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999998542 235899999999999999999999998 99999999999999999999999999987643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=226.32 Aligned_cols=149 Identities=29% Similarity=0.497 Sum_probs=133.1
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
++|+..+.||+|+||.||++....++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788999999999999999998779999999987542 22346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++ +|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 986 88888743 2356899999999999999999999998 99999999999999999999999999987753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=223.93 Aligned_cols=151 Identities=28% Similarity=0.471 Sum_probs=133.9
Q ss_pred hcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
..++|+..+.||+|+||.||++...+++.||+|++... ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 45678999999999999999999888889999999864 33457899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++++|.+++... ...+++.++..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 9999999998542 345899999999999999999999998 99999999999999999999999999987643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.91 E-value=7e-25 Score=231.25 Aligned_cols=158 Identities=28% Similarity=0.468 Sum_probs=124.2
Q ss_pred HHhhcCCCCccceecccCcEeEEEEEeeCC----cEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 005669 512 IANATDNFSEKNKLGEGGFGPVYKGMLIEG----QEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR 585 (684)
Q Consensus 512 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g----~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~ 585 (684)
+....++|++.+.||+|+||.||+|..... ..||||++... .....+++.+|+.++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 344567899999999999999999997553 27999999754 344567899999999999999999999999877
Q ss_pred Cee------EEEEEccCCCChhHHHhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 005669 586 DER------MLIYEYLPNKSLDYFIFDTTR---SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (684)
Q Consensus 586 ~~~------~lV~Ey~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~ 656 (684)
+.. ++||||+++++|.+++..... ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCC
Confidence 665 999999999999999854322 225899999999999999999999998 99999999999999999
Q ss_pred cEEEEeeccccccCCC
Q 005669 657 NPKISDFGLARSFGLD 672 (684)
Q Consensus 657 ~vkI~DFGla~~~~~~ 672 (684)
.+||+|||+|+.+...
T Consensus 175 ~~kl~Dfg~a~~~~~~ 190 (323)
T 3qup_A 175 TVCVADFGLSRKIYSG 190 (323)
T ss_dssp CEEECCCCC-------
T ss_pred CEEEeecccccccccc
Confidence 9999999999877543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=5.5e-25 Score=228.97 Aligned_cols=152 Identities=33% Similarity=0.549 Sum_probs=132.1
Q ss_pred cCCCCccceecccCcEeEEEEEe-----eCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeC--Cee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGML-----IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 588 (684)
.++|++.++||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46789999999999999999984 24789999999876666677899999999999999999999998653 558
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++||||+++++|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999998543 235899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCC
Q 005669 669 FGLD 672 (684)
Q Consensus 669 ~~~~ 672 (684)
+...
T Consensus 164 ~~~~ 167 (295)
T 3ugc_A 164 LPQD 167 (295)
T ss_dssp ----
T ss_pred ccCC
Confidence 7543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=222.29 Aligned_cols=152 Identities=24% Similarity=0.388 Sum_probs=137.4
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
..++|++.+.||+|+||.||++.... +..+|+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 44679999999999999999999865 67999999987655667889999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCcEEEEeeccccccC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFG 670 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl---~~~~~vkI~DFGla~~~~ 670 (684)
|+++++|.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||+++.+.
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999988854 345899999999999999999999998 9999999999999 788999999999998875
Q ss_pred CC
Q 005669 671 LD 672 (684)
Q Consensus 671 ~~ 672 (684)
..
T Consensus 161 ~~ 162 (277)
T 3f3z_A 161 PG 162 (277)
T ss_dssp TT
T ss_pred Cc
Confidence 44
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=231.10 Aligned_cols=156 Identities=31% Similarity=0.477 Sum_probs=133.8
Q ss_pred hhcCCCCccceecccCcEeEEEEEee------CCcEEEEEEccCC-CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR 585 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 585 (684)
...++|...+.||+|+||.||+|... .++.||||.+... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 34578999999999999999999962 2568999999754 233457899999999999 899999999999999
Q ss_pred CeeEEEEEccCCCChhHHHhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC
Q 005669 586 DERMLIYEYLPNKSLDYFIFDTTRS--------------------KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDL 645 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDL 645 (684)
+..++||||+++++|.+++...... ..+++.++..++.||+.||+|||+++ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 9999999999999999999653321 34799999999999999999999998 999999
Q ss_pred CCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 646 KASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 646 kp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
||+|||++.++.+||+|||+++.+...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~ 225 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSD 225 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccC
Confidence 999999999999999999999877544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=7.9e-25 Score=235.63 Aligned_cols=152 Identities=34% Similarity=0.522 Sum_probs=132.4
Q ss_pred cCCCCccceecccCcEeEEEEEee------CCcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 588 (684)
.++|++.+.||+|+||.||+|... .++.||||+++.. ......++.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467889999999999999999853 3668999999754 334456788999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---cEEEE
Q 005669 589 MLIYEYLPNKSLDYFIFDTT----RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM---NPKIS 661 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~---~vkI~ 661 (684)
++||||+++++|.+++.... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996543 2245899999999999999999999998 99999999999999554 59999
Q ss_pred eeccccccC
Q 005669 662 DFGLARSFG 670 (684)
Q Consensus 662 DFGla~~~~ 670 (684)
|||+|+.+.
T Consensus 227 DFG~a~~~~ 235 (367)
T 3l9p_A 227 DFGMARDIY 235 (367)
T ss_dssp CCHHHHHHH
T ss_pred CCccccccc
Confidence 999998663
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=232.11 Aligned_cols=152 Identities=26% Similarity=0.382 Sum_probs=136.0
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.++|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999986 4889999999876555566889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--CCcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--TMNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~--~~~vkI~DFGla~~~~~~ 672 (684)
+++++|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999998843 2346899999999999999999999998 999999999999974 577999999999987544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.8e-25 Score=235.60 Aligned_cols=149 Identities=27% Similarity=0.341 Sum_probs=124.0
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHHHHHH-HhccCCCceeeEEEEEEeCCeeEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLL-IAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
.++|+..+.||+|+||.||+++... ++.||+|++.+.. ......+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4679999999999999999999865 7899999997542 2233456667766 567899999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999854 345889999999999999999999998 9999999999999999999999999998753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=238.80 Aligned_cols=153 Identities=26% Similarity=0.399 Sum_probs=133.6
Q ss_pred hhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
...++|++.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34578999999999999999999875 48899999987643 2335678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc---CCCcEEEEeecccc
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFGLAR 667 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~---~~~~vkI~DFGla~ 667 (684)
||||+++++|.+.+.. ...+++.++..++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||+|+
T Consensus 88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999988854 345899999999999999999999998 99999999999998 46789999999998
Q ss_pred ccCCC
Q 005669 668 SFGLD 672 (684)
Q Consensus 668 ~~~~~ 672 (684)
.+...
T Consensus 162 ~~~~~ 166 (444)
T 3soa_A 162 EVEGE 166 (444)
T ss_dssp CCCTT
T ss_pred EecCC
Confidence 87544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-25 Score=231.48 Aligned_cols=152 Identities=25% Similarity=0.381 Sum_probs=129.5
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe---
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE--- 587 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~--- 587 (684)
..++|++.+.||+|+||.||++... +++.||||++.... ......+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4578999999999999999999974 58899999997642 2334578899999999999999999999876543
Q ss_pred -eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 588 -RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 588 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
.++||||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999854 245899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCC
Q 005669 667 RSFGLD 672 (684)
Q Consensus 667 ~~~~~~ 672 (684)
+.+...
T Consensus 164 ~~~~~~ 169 (311)
T 3ork_A 164 RAIADS 169 (311)
T ss_dssp ------
T ss_pred cccccc
Confidence 887543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-24 Score=227.16 Aligned_cols=155 Identities=31% Similarity=0.512 Sum_probs=135.0
Q ss_pred hcCCCCccceecccCcEeEEEEEee--------CCcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEe
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ 584 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~ 584 (684)
..++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578999999999999999999863 36789999997643 33456789999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 005669 585 RDERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (684)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NIL 651 (684)
.+..++||||+++++|.+++..... ...+++.++..++.||+.||.|||+++ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999965332 234899999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCC
Q 005669 652 LDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 652 l~~~~~vkI~DFGla~~~~~~ 672 (684)
++.++.+||+|||+++.+...
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~ 210 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNI 210 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTT
T ss_pred EcCCCCEEEcccccccccccc
Confidence 999999999999999987543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-24 Score=224.80 Aligned_cols=152 Identities=30% Similarity=0.542 Sum_probs=120.5
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.++|+..++||+|+||.||+|.... ++.||+|+++... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4679999999999999999999754 8899999987543 3345678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 594 YLPNKSLDYFIFDTT---RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 594 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|++ ++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58888875432 2245899999999999999999999998 9999999999999999999999999999875
Q ss_pred C
Q 005669 671 L 671 (684)
Q Consensus 671 ~ 671 (684)
.
T Consensus 160 ~ 160 (317)
T 2pmi_A 160 I 160 (317)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-24 Score=242.20 Aligned_cols=154 Identities=29% Similarity=0.417 Sum_probs=136.9
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
..++|+..+.||+|+||.||++... +++.||+|++.+. .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999986 4899999998643 22345678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 262 VmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999988543 2345899999999999999999999998 9999999999999999999999999999875
Q ss_pred CC
Q 005669 671 LD 672 (684)
Q Consensus 671 ~~ 672 (684)
..
T Consensus 338 ~~ 339 (576)
T 2acx_A 338 EG 339 (576)
T ss_dssp TT
T ss_pred cC
Confidence 43
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-25 Score=242.76 Aligned_cols=149 Identities=26% Similarity=0.335 Sum_probs=124.7
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.++|++.++||+|+||.||++.... ++.||||++... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 4679999999999999999999754 889999998743 233456678899999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|||+++++|..++.. ...+++..+..++.||+.||+|||+ ++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999998854 3468999999999999999999998 77 9999999999999999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=241.65 Aligned_cols=153 Identities=30% Similarity=0.504 Sum_probs=137.8
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
..++|+..++||+|+||.||+|.+.. +..||||.++.. ....+++.+|+.++++++||||+++++++...+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34668888999999999999999875 889999999764 3456789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|+++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999999653 2356899999999999999999999998 999999999999999999999999999987543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.91 E-value=3.4e-24 Score=240.97 Aligned_cols=155 Identities=32% Similarity=0.456 Sum_probs=137.5
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.++|...+.||+|+||.||++... +++.||+|++.+. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999986 4899999998653 123456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 592 YEYLPNKSLDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|||+++++|..++..... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999865432 346999999999999999999999998 9999999999999999999999999999875
Q ss_pred CCC
Q 005669 671 LDQ 673 (684)
Q Consensus 671 ~~~ 673 (684)
...
T Consensus 341 ~~~ 343 (543)
T 3c4z_A 341 AGQ 343 (543)
T ss_dssp TTC
T ss_pred CCC
Confidence 443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=230.67 Aligned_cols=151 Identities=28% Similarity=0.447 Sum_probs=133.1
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
..++|.+.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3478999999999999999999974 5889999998643 12234578999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+ +|+|.+++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 87 v~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 99999 6788887744 345899999999999999999999998 9999999999999999999999999998775
Q ss_pred CC
Q 005669 671 LD 672 (684)
Q Consensus 671 ~~ 672 (684)
..
T Consensus 160 ~~ 161 (336)
T 3h4j_B 160 DG 161 (336)
T ss_dssp TS
T ss_pred CC
Confidence 43
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-24 Score=227.07 Aligned_cols=150 Identities=21% Similarity=0.276 Sum_probs=132.7
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.++|++.+.||+|+||.||+|... +++.||||.+.... ..+.+.+|+.+++++ +|+||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 467999999999999999999974 58899999987542 234688999999999 99999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc-----EEEEeeccccc
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN-----PKISDFGLARS 668 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~-----vkI~DFGla~~ 668 (684)
|+ +++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+|+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 89999998543 356999999999999999999999998 999999999999998887 99999999998
Q ss_pred cCCCC
Q 005669 669 FGLDQ 673 (684)
Q Consensus 669 ~~~~~ 673 (684)
+....
T Consensus 160 ~~~~~ 164 (330)
T 2izr_A 160 YIDPE 164 (330)
T ss_dssp SBCTT
T ss_pred eecCC
Confidence 75443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=225.82 Aligned_cols=156 Identities=32% Similarity=0.463 Sum_probs=136.7
Q ss_pred hcCCCCccceecccCcEeEEEEEee------CCcEEEEEEccCCCc-ccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCC
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD 586 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 586 (684)
..++|+..+.||+|+||.||++... .++.||||++..... ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 4467899999999999999999852 367899999976432 3457789999999999 8999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTR---------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NIL 651 (684)
..++||||+++++|.+++..... ...+++.++..++.||+.||.|||+++ |+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999865432 125899999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCC
Q 005669 652 LDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 652 l~~~~~vkI~DFGla~~~~~~~ 673 (684)
++.++.+||+|||+++.+....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~ 199 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDS 199 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCT
T ss_pred EcCCCCEEEccccccccccccc
Confidence 9999999999999999876543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=238.59 Aligned_cols=151 Identities=29% Similarity=0.483 Sum_probs=135.9
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999986 58999999986431 23356789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++++|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999984 3456999999999999999999999998 99999999999999999999999999998754
Q ss_pred C
Q 005669 672 D 672 (684)
Q Consensus 672 ~ 672 (684)
.
T Consensus 169 ~ 169 (476)
T 2y94_A 169 G 169 (476)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-24 Score=220.74 Aligned_cols=150 Identities=31% Similarity=0.418 Sum_probs=134.5
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999986 48899999986432 3345778999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|+++++|.+++. ....+++.++..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++.+..
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 999999998883 3456899999999999999999999998 99999999999999999999999999987643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-24 Score=231.13 Aligned_cols=148 Identities=26% Similarity=0.363 Sum_probs=131.1
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
..++|+..+.||+|+||.||++... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 4578999999999999999999986 58899999997643 334678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc--EEEEeecccccc
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN--PKISDFGLARSF 669 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~--vkI~DFGla~~~ 669 (684)
|+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+|+..
T Consensus 97 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 97 YASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 9999999998854 345899999999999999999999998 999999999999987665 999999999854
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=9.7e-25 Score=229.95 Aligned_cols=159 Identities=26% Similarity=0.452 Sum_probs=137.9
Q ss_pred HHHHhhcCCCCccceecccCcEeEEEEEee------CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEE
Q 005669 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582 (684)
Q Consensus 510 ~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~ 582 (684)
.+.+...++|++.+.||+|+||.||+|... .++.||+|.+.... ......+.+|+.++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344556688999999999999999999865 26789999997543 23445788999999999999999999999
Q ss_pred EeCCeeEEEEEccCCCChhHHHhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC
Q 005669 583 TQRDERMLIYEYLPNKSLDYFIFDTT-------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT 655 (684)
Q Consensus 583 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~ 655 (684)
.+.+..++||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence 99999999999999999999985422 1245789999999999999999999998 9999999999999999
Q ss_pred CcEEEEeeccccccCC
Q 005669 656 MNPKISDFGLARSFGL 671 (684)
Q Consensus 656 ~~vkI~DFGla~~~~~ 671 (684)
+.+||+|||+++.+..
T Consensus 175 ~~~kl~Dfg~~~~~~~ 190 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYE 190 (322)
T ss_dssp CCEEECCTTCCCGGGG
T ss_pred CeEEECcCcccccccc
Confidence 9999999999987643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-24 Score=223.76 Aligned_cols=149 Identities=26% Similarity=0.390 Sum_probs=133.6
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
++|+..++||+|+||.||++.... ++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 678999999999999999999865 89999999865432 234668899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|+++++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+|+.+..
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9999999888743 345899999999999999999999998 99999999999999999999999999988753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=236.41 Aligned_cols=151 Identities=25% Similarity=0.440 Sum_probs=131.8
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC-----C
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-----D 586 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~ 586 (684)
..++|++.+.||+|+||.||+|.... ++.||||++... .....+++.+|+.++++++|+||+++++++... +
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 35789999999999999999999755 789999999753 233456789999999999999999999999776 5
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
..++||||++ ++|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 6899999987 599888843 456899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCC
Q 005669 667 RSFGLD 672 (684)
Q Consensus 667 ~~~~~~ 672 (684)
+.+...
T Consensus 177 ~~~~~~ 182 (432)
T 3n9x_A 177 RTINSE 182 (432)
T ss_dssp EEC---
T ss_pred cccccc
Confidence 987543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=239.29 Aligned_cols=150 Identities=24% Similarity=0.438 Sum_probs=122.8
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC-----Ce
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-----DE 587 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 587 (684)
.++|++.+.||+|+||.||+|... +++.||||++... .....+++.+|+.++++++|+||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999875 4889999998753 233456788999999999999999999999543 56
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.|+||||++ ++|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 688888843 456999999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCC
Q 005669 668 SFGLD 672 (684)
Q Consensus 668 ~~~~~ 672 (684)
.+...
T Consensus 205 ~~~~~ 209 (458)
T 3rp9_A 205 TVDYP 209 (458)
T ss_dssp CTTSC
T ss_pred hccCc
Confidence 87543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=239.38 Aligned_cols=153 Identities=32% Similarity=0.490 Sum_probs=136.2
Q ss_pred HhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 513 ANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 513 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
+...++|+..++||+|+||.||+|...++..||||+++.. ....+.+.+|+.++++++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 3455778889999999999999999988889999999864 345788999999999999999999999986 66789999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
||+++|+|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 262 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred eecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 999999999999532 1235789999999999999999999998 99999999999999999999999999998743
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=229.74 Aligned_cols=152 Identities=24% Similarity=0.364 Sum_probs=131.3
Q ss_pred hcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCC--CcccHHHHHHHHHHHhccCC--CceeeEEEEEEeCCeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQH--RNLVKLLGCCTQRDERML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~l 590 (684)
..++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| +||+++++++..++..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 45679999999999999999999888999999998754 23345778999999999976 999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||| +.+++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+|+.+.
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 567899999854 346899999999999999999999998 99999999999997 5789999999999876
Q ss_pred CCCC
Q 005669 671 LDQT 674 (684)
Q Consensus 671 ~~~~ 674 (684)
....
T Consensus 159 ~~~~ 162 (343)
T 3dbq_A 159 PDTT 162 (343)
T ss_dssp ----
T ss_pred cccc
Confidence 5443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-24 Score=231.01 Aligned_cols=147 Identities=32% Similarity=0.442 Sum_probs=126.7
Q ss_pred ccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005669 521 EKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (684)
Q Consensus 521 ~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 599 (684)
..+.||+|+||.||+|... +++.||+|+++.......+++.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3568999999999999975 489999999987655667789999999999999999999999999999999999999999
Q ss_pred hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE--cCCCcEEEEeeccccccCCC
Q 005669 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 600 L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl--~~~~~vkI~DFGla~~~~~~ 672 (684)
|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 173 L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 173 LFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp EHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 98888542 245899999999999999999999998 9999999999999 56789999999999987544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-25 Score=237.93 Aligned_cols=148 Identities=23% Similarity=0.314 Sum_probs=125.9
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCC--------cccHHHHHHHHHHHhccC---------CCceeeE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS--------GQGMEEFKNEVLLIAKLQ---------HRNLVKL 578 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~---------H~nIv~l 578 (684)
.++|++.++||+|+||+||+|+. +++.||||++.... ....+.+.+|+.++++++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999997 78999999997542 223478899999998885 8888888
Q ss_pred EEEEE------------------------------eCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 005669 579 LGCCT------------------------------QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARG 628 (684)
Q Consensus 579 ~g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~g 628 (684)
.+.+. ..+..++||||+++|++.+.+. ...+++.++..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 87753 2678999999999997655552 2468999999999999999
Q ss_pred HHHHH-hCCCCceEecCCCCCcEEEcCCC--------------------cEEEEeeccccccCC
Q 005669 629 LLYLH-QDSRLRIIHRDLKASNVLLDNTM--------------------NPKISDFGLARSFGL 671 (684)
Q Consensus 629 L~yLH-~~~~~~IvHrDLkp~NILl~~~~--------------------~vkI~DFGla~~~~~ 671 (684)
|+||| +++ |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 99999 888 99999999999999887 899999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.9e-24 Score=223.29 Aligned_cols=149 Identities=28% Similarity=0.420 Sum_probs=131.4
Q ss_pred cCCCCcc-ceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEE
Q 005669 516 TDNFSEK-NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 516 t~~y~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
.+.|++. +.||+|+||.||++... +++.||||++........+.+.+|+.++.++ +||||+++++++.+++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4567774 78999999999999965 5899999999876666678899999999985 7999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---EEEEeecccccc
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN---PKISDFGLARSF 669 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~---vkI~DFGla~~~ 669 (684)
||+++++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.+
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999998543 45899999999999999999999998 999999999999988766 999999999876
Q ss_pred C
Q 005669 670 G 670 (684)
Q Consensus 670 ~ 670 (684)
.
T Consensus 165 ~ 165 (316)
T 2ac3_A 165 K 165 (316)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=228.26 Aligned_cols=153 Identities=31% Similarity=0.559 Sum_probs=129.1
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-Cc----EEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
.++|+..++||+|+||.||+|.+.. ++ +||+|.+... .....+++.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 3578899999999999999999643 33 4688888643 3345678999999999999999999999998754 78
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+|+||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999998653 346899999999999999999999998 999999999999999999999999999988
Q ss_pred CCCCC
Q 005669 670 GLDQT 674 (684)
Q Consensus 670 ~~~~~ 674 (684)
.....
T Consensus 168 ~~~~~ 172 (327)
T 3poz_A 168 GAEEK 172 (327)
T ss_dssp TTTCC
T ss_pred cCCcc
Confidence 65443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-24 Score=222.08 Aligned_cols=151 Identities=32% Similarity=0.553 Sum_probs=131.4
Q ss_pred CCCCccceecccCcEeEEEEEe-----eCCcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC--Cee
Q 005669 517 DNFSEKNKLGEGGFGPVYKGML-----IEGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DER 588 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 588 (684)
+.|+..++||+|+||.||++.. ..++.||+|++... .....+.+.+|+.++++++||||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588899999999999999983 34789999999754 334567899999999999999999999999876 668
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++||||+++++|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999998543 345899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCC
Q 005669 669 FGLD 672 (684)
Q Consensus 669 ~~~~ 672 (684)
+...
T Consensus 176 ~~~~ 179 (302)
T 4e5w_A 176 IETD 179 (302)
T ss_dssp CCTT
T ss_pred ccCC
Confidence 7544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=222.64 Aligned_cols=150 Identities=27% Similarity=0.457 Sum_probs=134.5
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-C-------cEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-G-------QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g-------~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 587 (684)
.++|...+.||+|+||.||++.... + ..||+|.+........+.+.+|+.++++++||||+++++++..++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4678889999999999999998754 3 4799999977666667889999999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc--------EE
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN--------PK 659 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~--------vk 659 (684)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999543 234899999999999999999999998 999999999999998877 99
Q ss_pred EEeeccccccC
Q 005669 660 ISDFGLARSFG 670 (684)
Q Consensus 660 I~DFGla~~~~ 670 (684)
|+|||+++...
T Consensus 162 l~Dfg~~~~~~ 172 (289)
T 4fvq_A 162 LSDPGISITVL 172 (289)
T ss_dssp ECCCCSCTTTS
T ss_pred eccCccccccc
Confidence 99999997664
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.3e-24 Score=230.81 Aligned_cols=151 Identities=17% Similarity=0.247 Sum_probs=135.6
Q ss_pred hcCCCCccceeccc--CcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 515 ATDNFSEKNKLGEG--GFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 515 ~t~~y~~~~~LG~G--~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
..++|++.++||+| +||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45689999999999 99999999986 48999999987542 334567888999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+||||+++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+..+
T Consensus 103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999998653 2355899999999999999999999998 999999999999999999999999998765
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-24 Score=228.39 Aligned_cols=149 Identities=27% Similarity=0.380 Sum_probs=122.4
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
..++|++.+.||+|+||.||+|.... ++.||||++.... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 45779999999999999999999865 7899999997542 34678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCcEEEEeeccccccC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGLARSFG 670 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~---~~~vkI~DFGla~~~~ 670 (684)
|+++++|.+++. ....+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999884 3456899999999999999999999998 999999999999975 8899999999998765
Q ss_pred C
Q 005669 671 L 671 (684)
Q Consensus 671 ~ 671 (684)
.
T Consensus 203 ~ 203 (349)
T 2w4o_A 203 H 203 (349)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.6e-24 Score=220.19 Aligned_cols=147 Identities=29% Similarity=0.417 Sum_probs=127.0
Q ss_pred hcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhc--cCCCceeeEEEEEEeC----Cee
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK--LQHRNLVKLLGCCTQR----DER 588 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~~----~~~ 588 (684)
..++|++.+.||+|+||.||+|.. +++.||||++... ....+.+|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 457899999999999999999987 6899999998642 34556667777666 7999999999997643 457
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecCCCCCcEEEcCCCcEEE
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH--------QDSRLRIIHRDLKASNVLLDNTMNPKI 660 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~~~~IvHrDLkp~NILl~~~~~vkI 660 (684)
++||||+++++|.+++. ...+++..+..++.||+.||+||| +++ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 99999999999999993 346899999999999999999999 766 999999999999999999999
Q ss_pred EeeccccccCCC
Q 005669 661 SDFGLARSFGLD 672 (684)
Q Consensus 661 ~DFGla~~~~~~ 672 (684)
+|||+|+.....
T Consensus 155 ~Dfg~a~~~~~~ 166 (301)
T 3q4u_A 155 ADLGLAVMHSQS 166 (301)
T ss_dssp CCCTTCEEEETT
T ss_pred eeCCCeeecccc
Confidence 999999877543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-24 Score=225.88 Aligned_cols=151 Identities=25% Similarity=0.264 Sum_probs=128.0
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 591 (684)
.++|+..++||+|+||+||+|... +++.||||++.... .....+...|+..+.++ +|+||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999986 58999999986532 22334455566666555 899999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 56888887543 346999999999999999999999998 99999999999999999999999999988754
Q ss_pred C
Q 005669 672 D 672 (684)
Q Consensus 672 ~ 672 (684)
.
T Consensus 210 ~ 210 (311)
T 3p1a_A 210 A 210 (311)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.1e-24 Score=218.83 Aligned_cols=156 Identities=29% Similarity=0.432 Sum_probs=135.0
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 590 (684)
..++|++.+.||+|+||.||++... +++.||+|++... ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467999999999999999999986 5899999998754 233456788999999999 99999999999999999999
Q ss_pred EEEccCCCChhHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC--------------
Q 005669 591 IYEYLPNKSLDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-------------- 655 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~-------------- 655 (684)
||||+++++|.+++..... ...+++.++..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999864322 256899999999999999999999998 9999999999999844
Q ss_pred -----CcEEEEeeccccccCCCC
Q 005669 656 -----MNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 656 -----~~vkI~DFGla~~~~~~~ 673 (684)
..+||+|||+++......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~ 188 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ 188 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC
T ss_pred ccCCceEEEEcccccccccCCcc
Confidence 479999999999876443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-23 Score=217.84 Aligned_cols=152 Identities=28% Similarity=0.448 Sum_probs=133.8
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
+.|.....||+|+||.||+|... +++.||||.+........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 44556679999999999999975 47899999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCcEEEEeeccccccCC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSFGL 671 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~-~~~vkI~DFGla~~~~~ 671 (684)
++++|.+++........+++..+..++.||+.||.|||+++ |+|+||||+||+++. ++.+||+|||+++.+..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 99999999966544456789999999999999999999998 999999999999987 89999999999988753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=228.00 Aligned_cols=152 Identities=31% Similarity=0.507 Sum_probs=130.5
Q ss_pred CCCCccceecccCcEeEEEEEeeC-Cc----EEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
++|+..+.||+|+||.||+|.... ++ +||+|.+.... ......+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 578889999999999999999754 43 48888876432 334466788999999999999999999986 466889
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999998542 346889999999999999999999998 9999999999999999999999999999886
Q ss_pred CCCC
Q 005669 671 LDQT 674 (684)
Q Consensus 671 ~~~~ 674 (684)
....
T Consensus 167 ~~~~ 170 (325)
T 3kex_A 167 PDDK 170 (325)
T ss_dssp CCTT
T ss_pred cccc
Confidence 5443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6.4e-24 Score=234.86 Aligned_cols=149 Identities=28% Similarity=0.462 Sum_probs=133.3
Q ss_pred hcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-eeEEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-ERMLIYE 593 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E 593 (684)
..++|+..++||+|+||.||+|... ++.||||+++... ..+.+.+|+.++++++||||+++++++.+.+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 4567888999999999999999874 7899999998643 4578999999999999999999999987765 7899999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|+++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999653 2345799999999999999999999998 9999999999999999999999999998654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-24 Score=231.88 Aligned_cols=154 Identities=26% Similarity=0.390 Sum_probs=135.6
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC--eeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD--ERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV 591 (684)
.++|.+.++||+|+||.||+|.... ++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4678999999999999999999865 8999999987532 334577889999999999999999999998765 67999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCcEEEEeecccc
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLAR 667 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl----~~~~~vkI~DFGla~ 667 (684)
|||+++++|.+++........+++.++..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999965444445999999999999999999999998 9999999999999 778889999999999
Q ss_pred ccCCC
Q 005669 668 SFGLD 672 (684)
Q Consensus 668 ~~~~~ 672 (684)
.+...
T Consensus 165 ~~~~~ 169 (396)
T 4eut_A 165 ELEDD 169 (396)
T ss_dssp ECCCG
T ss_pred EccCC
Confidence 87543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=228.36 Aligned_cols=153 Identities=25% Similarity=0.377 Sum_probs=134.7
Q ss_pred hhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc--------ccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--------QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ 584 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 584 (684)
...++|+..+.||+|+||.||++... +++.||||++..... .....+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 34578999999999999999999965 488999999876421 133467789999999999999999999999
Q ss_pred CCeeEEEEEccCCC-ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEee
Q 005669 585 RDERMLIYEYLPNK-SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (684)
Q Consensus 585 ~~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DF 663 (684)
.+..++||||+.+| +|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 99999999999777 99988843 346899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCC
Q 005669 664 GLARSFGLD 672 (684)
Q Consensus 664 Gla~~~~~~ 672 (684)
|+++.+...
T Consensus 175 g~a~~~~~~ 183 (335)
T 3dls_A 175 GSAAYLERG 183 (335)
T ss_dssp TTCEECCTT
T ss_pred ccceECCCC
Confidence 999987544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-24 Score=232.23 Aligned_cols=151 Identities=28% Similarity=0.376 Sum_probs=133.8
Q ss_pred cCCCCccceecccCcEeEEEEEee----CCcEEEEEEccCCC----cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCC
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGS----GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD 586 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 586 (684)
.++|++.+.||+|+||.||++... +++.||||+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 367999999999999999999973 58899999987532 23345678899999999 6999999999999999
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
..++||||+++++|.+++... ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999998543 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCC
Q 005669 667 RSFGLD 672 (684)
Q Consensus 667 ~~~~~~ 672 (684)
+.+...
T Consensus 207 ~~~~~~ 212 (355)
T 1vzo_A 207 KEFVAD 212 (355)
T ss_dssp EECCGG
T ss_pred eecccC
Confidence 877543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.3e-24 Score=226.61 Aligned_cols=166 Identities=29% Similarity=0.296 Sum_probs=143.0
Q ss_pred ccCCcCcccHHHHHhhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccC-----CC
Q 005669 500 EEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-----HR 573 (684)
Q Consensus 500 ~~~~~~~~~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----H~ 573 (684)
.+.+...+++++.....++|++.++||+|+||.||++... +++.||||++... ......+..|+.++++++ ||
T Consensus 18 ~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 18 GDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp --CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred cCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCC
Confidence 3444556777777778899999999999999999999985 4889999999753 344566788999999986 99
Q ss_pred ceeeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 005669 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (684)
Q Consensus 574 nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~ 653 (684)
||+++++++...+..++||||+ +++|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 171 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLD 171 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEc
Confidence 9999999999999999999999 89999998643 2345899999999999999999999998 99999999999997
Q ss_pred C-------------------------CCcEEEEeeccccccCC
Q 005669 654 N-------------------------TMNPKISDFGLARSFGL 671 (684)
Q Consensus 654 ~-------------------------~~~vkI~DFGla~~~~~ 671 (684)
. ++.+||+|||+|+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~ 214 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence 5 78899999999987643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-24 Score=224.50 Aligned_cols=163 Identities=29% Similarity=0.457 Sum_probs=138.7
Q ss_pred ccHHHHHhhcCCCCccceecccCcEeEEEEEee------CCcEEEEEEccCCCc-ccHHHHHHHHHHHhcc-CCCceeeE
Q 005669 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKL-QHRNLVKL 578 (684)
Q Consensus 507 ~~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l 578 (684)
+.........++|++.+.||+|+||.||++... +++.||||++..... ...+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 445556667789999999999999999999852 357899999976432 3346788999999999 79999999
Q ss_pred EEEEEeCC-eeEEEEEccCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecC
Q 005669 579 LGCCTQRD-ERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRD 644 (684)
Q Consensus 579 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrD 644 (684)
++++...+ ..++||||+++++|.+++..... ...+++..+..++.||+.||.|||+++ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99998755 48999999999999999965332 123889999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 645 LKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 645 Lkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|||+||+++.++.+||+|||+++.+...
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 201 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKD 201 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTC
T ss_pred CccceEEECCCCCEEECCCccccccccC
Confidence 9999999999999999999999887544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.6e-24 Score=219.80 Aligned_cols=151 Identities=26% Similarity=0.388 Sum_probs=135.0
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
..++|...+.||+|+||.||++...+ ++.+|+|.+... .....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34678899999999999999999865 789999998653 22345678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++++|.+++.. ...+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 93 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999998843 346899999999999999999999998 9999999999999999999999999998875
Q ss_pred C
Q 005669 671 L 671 (684)
Q Consensus 671 ~ 671 (684)
.
T Consensus 167 ~ 167 (294)
T 2rku_A 167 Y 167 (294)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=222.44 Aligned_cols=151 Identities=30% Similarity=0.409 Sum_probs=135.2
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc------ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG------QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 588 (684)
.++|++.+.||+|+||.||++.... ++.||+|.+..... ...+++.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4678999999999999999999864 88999999875422 1367899999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----cEEEEeec
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM----NPKISDFG 664 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~----~vkI~DFG 664 (684)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999843 346899999999999999999999998 99999999999999887 79999999
Q ss_pred cccccCCC
Q 005669 665 LARSFGLD 672 (684)
Q Consensus 665 la~~~~~~ 672 (684)
+++.+...
T Consensus 165 ~~~~~~~~ 172 (321)
T 2a2a_A 165 LAHEIEDG 172 (321)
T ss_dssp TCEECCTT
T ss_pred cceecCcc
Confidence 99987543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.6e-24 Score=217.63 Aligned_cols=149 Identities=28% Similarity=0.498 Sum_probs=135.7
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
.++|+..+.||+|+||.||++...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 35788899999999999999998888899999998643 34578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++...
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccc
Confidence 999999998543 346899999999999999999999998 9999999999999999999999999998764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.7e-24 Score=228.86 Aligned_cols=157 Identities=26% Similarity=0.355 Sum_probs=133.1
Q ss_pred HHhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC-----CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 005669 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-----SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR 585 (684)
Q Consensus 512 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~ 585 (684)
+....++|++.+.||+|+||.||++.... ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 34556789999999999999999999754 789999998643 234567899999999999999999999999999
Q ss_pred CeeEEEEEccCCCChhHHHhccCC-------------------------------------CCCCCHHHHHHHHHHHHHH
Q 005669 586 DERMLIYEYLPNKSLDYFIFDTTR-------------------------------------SKLLDWSKRSHIIAGIARG 628 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~qi~~g 628 (684)
+..++||||+++++|.+++..... ...+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999998842100 1123677788999999999
Q ss_pred HHHHHhCCCCceEecCCCCCcEEEcCCC--cEEEEeeccccccCC
Q 005669 629 LLYLHQDSRLRIIHRDLKASNVLLDNTM--NPKISDFGLARSFGL 671 (684)
Q Consensus 629 L~yLH~~~~~~IvHrDLkp~NILl~~~~--~vkI~DFGla~~~~~ 671 (684)
|+|||+++ |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~ 222 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence 99999998 99999999999998766 899999999987643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.8e-24 Score=218.18 Aligned_cols=152 Identities=32% Similarity=0.552 Sum_probs=135.2
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
..++|++.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 4467999999999999999999974 58999999986431 2234678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++++|.+++... ...+++.++..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999998532 356899999999999999999999998 9999999999999999999999999998875
Q ss_pred C
Q 005669 671 L 671 (684)
Q Consensus 671 ~ 671 (684)
.
T Consensus 164 ~ 164 (278)
T 3cok_A 164 M 164 (278)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=2.7e-24 Score=222.63 Aligned_cols=154 Identities=31% Similarity=0.501 Sum_probs=138.5
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
...++|+..+.||+|+||.||++.... ++.||+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 355778999999999999999999865 789999999764 345678999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999998553 3456899999999999999999999998 999999999999999999999999999987544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.1e-24 Score=224.68 Aligned_cols=151 Identities=26% Similarity=0.388 Sum_probs=135.2
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
..++|.+.+.||+|+||.||++...+ ++.+|+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34678999999999999999999865 789999998653 22345678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++++|.+++.. ...+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999998854 246899999999999999999999998 9999999999999999999999999999875
Q ss_pred C
Q 005669 671 L 671 (684)
Q Consensus 671 ~ 671 (684)
.
T Consensus 193 ~ 193 (335)
T 2owb_A 193 Y 193 (335)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.3e-24 Score=231.08 Aligned_cols=149 Identities=24% Similarity=0.366 Sum_probs=129.6
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCC--CcccHHHHHHHHHHHhccC--CCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQ--HRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~ 592 (684)
+.|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++++++ |+||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999878999999998754 2344577899999999996 599999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
| +.+++|.+++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+|+.+...
T Consensus 136 E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 567899999854 346899999999999999999999998 99999999999996 579999999999987654
Q ss_pred C
Q 005669 673 Q 673 (684)
Q Consensus 673 ~ 673 (684)
.
T Consensus 208 ~ 208 (390)
T 2zmd_A 208 T 208 (390)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3e-24 Score=227.37 Aligned_cols=158 Identities=32% Similarity=0.468 Sum_probs=136.9
Q ss_pred HHhhcCCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEE
Q 005669 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCT 583 (684)
Q Consensus 512 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~ 583 (684)
.+...++|+..+.||+|+||.||++.... .+.||+|.+.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 44556789999999999999999999743 2479999997643 23456789999999999 8999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHHhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 005669 584 QRDERMLIYEYLPNKSLDYFIFDTT-----------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (684)
Q Consensus 584 ~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl 652 (684)
..+..++||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 9999999999999999999986432 1345899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCC
Q 005669 653 DNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 653 ~~~~~vkI~DFGla~~~~~~ 672 (684)
+.++.+||+|||+++.+...
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~ 217 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMND 217 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGC
T ss_pred CCCCeEEECccccccccccc
Confidence 99999999999999877543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.2e-24 Score=223.51 Aligned_cols=160 Identities=28% Similarity=0.490 Sum_probs=129.2
Q ss_pred HHHHHhhcCCCCccceecccCcEeEEEEEeeC----CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEE
Q 005669 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582 (684)
Q Consensus 509 ~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~ 582 (684)
+..+....++|.+.+.||+|+||.||+|.... ++.||+|.+... .....+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 34445566789999999999999999998653 458999998754 233456789999999999999999999999
Q ss_pred EeCCe-----eEEEEEccCCCChhHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC
Q 005669 583 TQRDE-----RMLIYEYLPNKSLDYFIFDTT---RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 654 (684)
Q Consensus 583 ~~~~~-----~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~ 654 (684)
.+.+. .++||||+++++|.+++.... ....+++.++..++.||++||.|||+++ |+||||||+||+++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcC
Confidence 87653 499999999999999985432 3456999999999999999999999998 999999999999999
Q ss_pred CCcEEEEeeccccccCC
Q 005669 655 TMNPKISDFGLARSFGL 671 (684)
Q Consensus 655 ~~~vkI~DFGla~~~~~ 671 (684)
++.+||+|||+++.+..
T Consensus 183 ~~~~kl~Dfg~~~~~~~ 199 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYS 199 (313)
T ss_dssp TSCEEECSCSCC-----
T ss_pred CCcEEEeecCcceeccc
Confidence 99999999999987754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.90 E-value=7.6e-24 Score=224.05 Aligned_cols=142 Identities=30% Similarity=0.362 Sum_probs=125.7
Q ss_pred cceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005669 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 599 (684)
.+.||+|+||.||++.... ++.||||++.. .....+.+|+.+++++. ||||+++++++.+.+..++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 3789999999999999864 88999999964 34567889999999997 9999999999999999999999999999
Q ss_pred hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---cEEEEeeccccccCCC
Q 005669 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM---NPKISDFGLARSFGLD 672 (684)
Q Consensus 600 L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~---~vkI~DFGla~~~~~~ 672 (684)
|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999854 356899999999999999999999998 99999999999997665 8999999999876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.90 E-value=8e-24 Score=219.32 Aligned_cols=154 Identities=29% Similarity=0.424 Sum_probs=133.4
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.++|...++||+|+||.||++.... ++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 3678899999999999999999754 8899999987542 3456789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCcEEEEeecccccc
Q 005669 594 YLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSF 669 (684)
Q Consensus 594 y~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl---~~~~~vkI~DFGla~~~ 669 (684)
|+++++|.+.+.... ....+++..+..++.||+.||+|||+++ |+||||||+||++ +.++.+||+|||+++.+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999998885432 2456899999999999999999999998 9999999999999 45678999999999877
Q ss_pred CCC
Q 005669 670 GLD 672 (684)
Q Consensus 670 ~~~ 672 (684)
...
T Consensus 178 ~~~ 180 (285)
T 3is5_A 178 KSD 180 (285)
T ss_dssp ---
T ss_pred CCc
Confidence 543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=8e-24 Score=218.20 Aligned_cols=152 Identities=34% Similarity=0.547 Sum_probs=134.1
Q ss_pred hcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
..++|++.+.||+|+||.||+|...+++.||+|.+... ....+.+.+|++++++++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 34678899999999999999999887889999999764 345678999999999999999999999986 4568999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+++++|.+++... ....+++.++..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.+...
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999998432 1235899999999999999999999998 999999999999999999999999999987543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-24 Score=237.21 Aligned_cols=151 Identities=31% Similarity=0.523 Sum_probs=132.3
Q ss_pred hcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
..++|+..++||+|+||.||+|...++..||||+++... ...+++.+|+.++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 456788899999999999999999888889999998643 346789999999999999999999999876 678999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++++|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999432 2345899999999999999999999998 99999999999999999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.90 E-value=8.3e-24 Score=216.99 Aligned_cols=152 Identities=34% Similarity=0.546 Sum_probs=125.3
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCC----cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS----GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.++|+..+.||+|+||.||++.. .++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46789999999999999999997 48899999987542 23357789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--------CCcEEEEee
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--------TMNPKISDF 663 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~--------~~~vkI~DF 663 (684)
|||+++++|.+++. ...+++..+..++.|++.||.|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999883 346899999999999999999999987556899999999999986 778999999
Q ss_pred ccccccCCC
Q 005669 664 GLARSFGLD 672 (684)
Q Consensus 664 Gla~~~~~~ 672 (684)
|+++.+...
T Consensus 161 g~~~~~~~~ 169 (271)
T 3dtc_A 161 GLAREWHRT 169 (271)
T ss_dssp CC-------
T ss_pred Ccccccccc
Confidence 999876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.8e-24 Score=229.49 Aligned_cols=149 Identities=28% Similarity=0.562 Sum_probs=123.3
Q ss_pred hhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCC--e
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRD--E 587 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~--~ 587 (684)
...++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999975 4899999998643 2334567889999999997 999999999998654 6
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.++||||++ ++|..++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999998 588888843 36899999999999999999999998 9999999999999999999999999999
Q ss_pred ccC
Q 005669 668 SFG 670 (684)
Q Consensus 668 ~~~ 670 (684)
.+.
T Consensus 158 ~~~ 160 (388)
T 3oz6_A 158 SFV 160 (388)
T ss_dssp ESS
T ss_pred ccc
Confidence 764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=222.68 Aligned_cols=152 Identities=32% Similarity=0.488 Sum_probs=135.1
Q ss_pred cCCCCccceecccCcEeEEEEEe-----eCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEE--eCCee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGML-----IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT--QRDER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~ 588 (684)
.++|+..+.||+|+||.||++.. ..++.||||++........+.+.+|++++++++|+||+++++++. ..+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36788999999999999999984 347899999998766666678999999999999999999999987 45668
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++||||+++++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999998543 235899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCC
Q 005669 669 FGLD 672 (684)
Q Consensus 669 ~~~~ 672 (684)
+...
T Consensus 177 ~~~~ 180 (327)
T 3lxl_A 177 LPLD 180 (327)
T ss_dssp CCTT
T ss_pred cccC
Confidence 7543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6.8e-24 Score=245.72 Aligned_cols=162 Identities=31% Similarity=0.378 Sum_probs=138.3
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 589 (684)
..++|++.+.||+|+||.||++.... ++.||||++++. .....+.+..|..++..+ +|++|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 35679999999999999999999765 789999998743 233456788899999988 7999999999999999999
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+||||+++|+|..++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999998543 45899999999999999999999998 999999999999999999999999999975
Q ss_pred CCCCCccCCcccccC
Q 005669 670 GLDQTEANTKRVVGT 684 (684)
Q Consensus 670 ~~~~~~~~~~~~~GT 684 (684)
..... .+..++||
T Consensus 493 ~~~~~--~~~~~~GT 505 (674)
T 3pfq_A 493 IWDGV--TTKTFCGT 505 (674)
T ss_dssp CCTTC--CBCCCCSC
T ss_pred ccCCc--ccccccCC
Confidence 43322 23345555
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-23 Score=216.24 Aligned_cols=150 Identities=29% Similarity=0.478 Sum_probs=135.5
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.+.|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 456889999999999999999875 48899999987543 3456789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|+++++|.+++. ...+++.++..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||+++.+...
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999983 346899999999999999999999998 999999999999999999999999999887543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=216.11 Aligned_cols=152 Identities=29% Similarity=0.460 Sum_probs=134.1
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
..++|++.+.||+|+||.||++.... ++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 45789999999999999999999754 889999998653 233456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---EEEEeeccccc
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN---PKISDFGLARS 668 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~---vkI~DFGla~~ 668 (684)
|||+++++|.+.+... ..+++.++..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999998888543 45899999999999999999999998 999999999999976655 99999999987
Q ss_pred cCCC
Q 005669 669 FGLD 672 (684)
Q Consensus 669 ~~~~ 672 (684)
....
T Consensus 158 ~~~~ 161 (284)
T 3kk8_A 158 VNDS 161 (284)
T ss_dssp CCSS
T ss_pred cccC
Confidence 7543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=8.5e-24 Score=219.48 Aligned_cols=150 Identities=33% Similarity=0.508 Sum_probs=124.0
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
...++|++.++||+|+||.||++... ..||+|+++... ....+.+.+|+.++++++|+||+++++++ ..+..++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 34578999999999999999999863 469999987542 33456789999999999999999999965 55678999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++++|.+++.. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999998843 2456899999999999999999999998 99999999999999999999999999987653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=6.9e-24 Score=218.79 Aligned_cols=150 Identities=29% Similarity=0.427 Sum_probs=133.0
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
..++|++.+.||+|+||.||++.... ++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 45679999999999999999998765 679999998643 12235678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999988543 45899999999999999999999988 9999999999999999999999999997654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-23 Score=216.89 Aligned_cols=152 Identities=30% Similarity=0.503 Sum_probs=127.0
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-----cccHHHHHHHHHHHhcc---CCCceeeEEEEEEeC
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-----GQGMEEFKNEVLLIAKL---QHRNLVKLLGCCTQR 585 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~~ 585 (684)
..++|++.++||+|+||.||++... +++.||||++.... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999974 48899999986421 12234667788777766 499999999999876
Q ss_pred C-----eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEE
Q 005669 586 D-----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (684)
Q Consensus 586 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI 660 (684)
. ..++||||++ ++|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4799999998 5999888543 2344899999999999999999999998 999999999999999999999
Q ss_pred EeeccccccCC
Q 005669 661 SDFGLARSFGL 671 (684)
Q Consensus 661 ~DFGla~~~~~ 671 (684)
+|||+|+.+..
T Consensus 162 ~Dfg~a~~~~~ 172 (308)
T 3g33_A 162 ADFGLARIYSY 172 (308)
T ss_dssp CSCSCTTTSTT
T ss_pred eeCccccccCC
Confidence 99999987753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.90 E-value=7.5e-24 Score=232.14 Aligned_cols=151 Identities=25% Similarity=0.384 Sum_probs=128.3
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--------cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--------GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ 584 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 584 (684)
...++|.+.+.||+|+||.||+|.... ++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 345789999999999999999999755 7899999986431 112235789999999999999999999975
Q ss_pred CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CcEEEE
Q 005669 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKIS 661 (684)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~---~~vkI~ 661 (684)
.+..++||||+++++|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 556899999999999988873 3456899999999999999999999998 9999999999999654 459999
Q ss_pred eeccccccCC
Q 005669 662 DFGLARSFGL 671 (684)
Q Consensus 662 DFGla~~~~~ 671 (684)
|||+|+.+..
T Consensus 285 DFG~a~~~~~ 294 (419)
T 3i6u_A 285 DFGHSKILGE 294 (419)
T ss_dssp CSSTTTSCC-
T ss_pred ecccceecCC
Confidence 9999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=224.55 Aligned_cols=153 Identities=33% Similarity=0.516 Sum_probs=127.1
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc-----ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-----QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~-----~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 587 (684)
...++|+..+.||+|+||.||++.... ++.||||++..... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 445789999999999999999999864 89999999875321 113468899999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.++||||+++ +|..++.. ....+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 78887743 2346889999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCC
Q 005669 668 SFGLD 672 (684)
Q Consensus 668 ~~~~~ 672 (684)
.+...
T Consensus 161 ~~~~~ 165 (346)
T 1ua2_A 161 SFGSP 165 (346)
T ss_dssp TTTSC
T ss_pred eccCC
Confidence 87543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.5e-24 Score=219.86 Aligned_cols=151 Identities=27% Similarity=0.415 Sum_probs=124.7
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC----CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
..++|++.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 45688999999999999999998743 4579999987542 334567899999999999999999999984 56789
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999998542 346899999999999999999999998 999999999999999999999999999887
Q ss_pred CC
Q 005669 670 GL 671 (684)
Q Consensus 670 ~~ 671 (684)
..
T Consensus 167 ~~ 168 (281)
T 1mp8_A 167 ED 168 (281)
T ss_dssp --
T ss_pred Cc
Confidence 54
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=218.32 Aligned_cols=152 Identities=26% Similarity=0.400 Sum_probs=129.2
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC----cccHHHHHHHHHHHhccCCCceeeEEEEEE--eCCe
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS----GQGMEEFKNEVLLIAKLQHRNLVKLLGCCT--QRDE 587 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~--~~~~ 587 (684)
..++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++. +.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999975 47899999987531 234577899999999999999999999984 4557
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.++||||++++ |.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999977 66666442 3456899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCC
Q 005669 668 SFGL 671 (684)
Q Consensus 668 ~~~~ 671 (684)
.+..
T Consensus 158 ~~~~ 161 (305)
T 2wtk_C 158 ALHP 161 (305)
T ss_dssp ECCT
T ss_pred ccCc
Confidence 8753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=224.89 Aligned_cols=158 Identities=22% Similarity=0.390 Sum_probs=138.5
Q ss_pred HHHHHhhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcc--------cHHHHHHHHHHHhcc-CCCceeeE
Q 005669 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ--------GMEEFKNEVLLIAKL-QHRNLVKL 578 (684)
Q Consensus 509 ~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--------~~~~~~~Ei~~l~~l-~H~nIv~l 578 (684)
........++|++.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3344556678999999999999999999986 5899999998754311 135678899999999 79999999
Q ss_pred EEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcE
Q 005669 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (684)
Q Consensus 579 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~v 658 (684)
++++...+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999854 245899999999999999999999998 9999999999999999999
Q ss_pred EEEeeccccccCCC
Q 005669 659 KISDFGLARSFGLD 672 (684)
Q Consensus 659 kI~DFGla~~~~~~ 672 (684)
||+|||+++.+...
T Consensus 240 kl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 240 RLSDFGFSCHLEPG 253 (365)
T ss_dssp EECCCTTCEECCTT
T ss_pred EEEecCcccccCCC
Confidence 99999999987543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=221.41 Aligned_cols=152 Identities=33% Similarity=0.550 Sum_probs=134.5
Q ss_pred cCCCCccceecccCcEeEEEEEe-----eCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC--ee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGML-----IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD--ER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~ 588 (684)
.++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45688899999999999999984 348899999998766666778999999999999999999999987654 67
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++||||+++++|.+++... ...+++.++..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999999543 345899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCC
Q 005669 669 FGLD 672 (684)
Q Consensus 669 ~~~~ 672 (684)
+...
T Consensus 195 ~~~~ 198 (326)
T 2w1i_A 195 LPQD 198 (326)
T ss_dssp CCSS
T ss_pred cccc
Confidence 7544
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=222.50 Aligned_cols=150 Identities=28% Similarity=0.506 Sum_probs=130.6
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
.++|+..+.||+|+||.||++.... ++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 4679999999999999999999865 88999999865432 23456789999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
||+++++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999887632 345899999999999999999999998 99999999999999999999999999987654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=5.5e-24 Score=240.46 Aligned_cols=152 Identities=31% Similarity=0.514 Sum_probs=135.0
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
...++|++.++||+|+||.||+|.+.++..||||+++... ...+++.+|+++|++++|+||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3456788899999999999999999888889999998643 346789999999999999999999999876 67899999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|+++++|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 99999999999432 2345899999999999999999999998 99999999999999999999999999987753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=218.16 Aligned_cols=152 Identities=28% Similarity=0.472 Sum_probs=131.2
Q ss_pred hhcCCCCccc-eecccCcEeEEEEEee---CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 005669 514 NATDNFSEKN-KLGEGGFGPVYKGMLI---EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 514 ~~t~~y~~~~-~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 587 (684)
...++|.+.+ .||+|+||.||++... .++.||||++.... ....+++.+|+.++++++||||+++++++ ..+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3456788777 9999999999999653 26789999997542 23357799999999999999999999999 5677
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.++||||+++++|.+++.. ...+++.++..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 92 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred cEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 8999999999999999954 345899999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCC
Q 005669 668 SFGLD 672 (684)
Q Consensus 668 ~~~~~ 672 (684)
.+...
T Consensus 166 ~~~~~ 170 (291)
T 1xbb_A 166 ALRAD 170 (291)
T ss_dssp ECCTT
T ss_pred eeccC
Confidence 87544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.7e-24 Score=234.55 Aligned_cols=147 Identities=29% Similarity=0.452 Sum_probs=124.5
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC------C
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------D 586 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~ 586 (684)
.++|++.++||+|+||.||++.... ++.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 5789999999999999999998754 889999999753 233456788999999999999999999999654 3
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
..++||||++++ |...+. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999865 555552 24899999999999999999999998 999999999999999999999999999
Q ss_pred cccCC
Q 005669 667 RSFGL 671 (684)
Q Consensus 667 ~~~~~ 671 (684)
+....
T Consensus 212 ~~~~~ 216 (464)
T 3ttj_A 212 RTAGT 216 (464)
T ss_dssp -----
T ss_pred eecCC
Confidence 98754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-23 Score=215.16 Aligned_cols=149 Identities=29% Similarity=0.453 Sum_probs=133.2
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC------cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS------GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999986 48999999987542 123678999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----cEEEEeecc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM----NPKISDFGL 665 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~----~vkI~DFGl 665 (684)
+||||+++++|.+++.. ...+++.++..++.||+.||.|||+++ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999854 345899999999999999999999998 99999999999998877 799999999
Q ss_pred ccccCC
Q 005669 666 ARSFGL 671 (684)
Q Consensus 666 a~~~~~ 671 (684)
++.+..
T Consensus 159 ~~~~~~ 164 (283)
T 3bhy_A 159 AHKIEA 164 (283)
T ss_dssp CEECC-
T ss_pred ceeccC
Confidence 988754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.3e-23 Score=221.24 Aligned_cols=149 Identities=28% Similarity=0.522 Sum_probs=129.2
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe--------
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-------- 584 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-------- 584 (684)
.++|++.++||+|+||.||++... +++.||||++.... ......+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999984 58999999986542 2335678899999999999999999999987
Q ss_pred CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
.+..++||||+++ +|...+.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 4468999999986 66666633 2345899999999999999999999998 9999999999999999999999999
Q ss_pred cccccC
Q 005669 665 LARSFG 670 (684)
Q Consensus 665 la~~~~ 670 (684)
+|+.+.
T Consensus 170 ~a~~~~ 175 (351)
T 3mi9_A 170 LARAFS 175 (351)
T ss_dssp TCEECC
T ss_pred hccccc
Confidence 998875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-23 Score=221.61 Aligned_cols=148 Identities=25% Similarity=0.414 Sum_probs=128.9
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
..++|++.+.||+|+||.||++.... ++.||||++..... ...+|++++.++ +||||+++++++.+++..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 45679999999999999999999864 88999999976532 235688888887 7999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC----CcEEEEeeccccc
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT----MNPKISDFGLARS 668 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~----~~vkI~DFGla~~ 668 (684)
||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999998843 356899999999999999999999998 9999999999998533 3599999999998
Q ss_pred cCCC
Q 005669 669 FGLD 672 (684)
Q Consensus 669 ~~~~ 672 (684)
+...
T Consensus 170 ~~~~ 173 (342)
T 2qr7_A 170 LRAE 173 (342)
T ss_dssp CBCT
T ss_pred CcCC
Confidence 7543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=223.41 Aligned_cols=149 Identities=30% Similarity=0.490 Sum_probs=130.9
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
+.|+..+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45888899999999999999974 588999999875432 23457889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
||++ |+|.+++... ...+++.++..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9998 5777776432 346899999999999999999999998 99999999999999999999999999987753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.1e-23 Score=232.78 Aligned_cols=153 Identities=32% Similarity=0.482 Sum_probs=132.7
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc-------------ccHHHHHHHHHHHhccCCCceeeEE
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-------------QGMEEFKNEVLLIAKLQHRNLVKLL 579 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~-------------~~~~~~~~Ei~~l~~l~H~nIv~l~ 579 (684)
...++|.+.++||+|+||.||+|.... ++.||+|++..... ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 345789999999999999999999865 78999999875421 3356789999999999999999999
Q ss_pred EEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---
Q 005669 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM--- 656 (684)
Q Consensus 580 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~--- 656 (684)
+++.+.+..++||||+++++|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 999999999999999999999988854 345899999999999999999999998 99999999999998765
Q ss_pred cEEEEeeccccccCCC
Q 005669 657 NPKISDFGLARSFGLD 672 (684)
Q Consensus 657 ~vkI~DFGla~~~~~~ 672 (684)
.+||+|||+|+.+...
T Consensus 187 ~~kl~Dfg~a~~~~~~ 202 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKD 202 (504)
T ss_dssp SEEECCCTTCEECCTT
T ss_pred cEEEEECCCCEEcCCC
Confidence 6999999999987544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-23 Score=217.74 Aligned_cols=149 Identities=34% Similarity=0.536 Sum_probs=131.3
Q ss_pred CCC-CccceecccCcEeEEEEEee-----CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeC--Ce
Q 005669 517 DNF-SEKNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DE 587 (684)
Q Consensus 517 ~~y-~~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~ 587 (684)
++| +..++||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 444 88999999999999998642 47899999998643 23456789999999999999999999999884 67
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.++||||+++++|.+++.. ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 8999999999999999843 24899999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCC
Q 005669 668 SFGLD 672 (684)
Q Consensus 668 ~~~~~ 672 (684)
.+...
T Consensus 183 ~~~~~ 187 (318)
T 3lxp_A 183 AVPEG 187 (318)
T ss_dssp ECCTT
T ss_pred ccccc
Confidence 87543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=219.67 Aligned_cols=153 Identities=27% Similarity=0.385 Sum_probs=133.2
Q ss_pred hcCCCCccceecccCcEeEEEEEe-eCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe----CCeeE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDERM 589 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~ 589 (684)
..++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346799999999999999999997 4589999999876656667789999999999999999999999873 34679
Q ss_pred EEEEccCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
+||||+++++|.+++.... ....+++.++..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999886432 2456899999999999999999999998 99999999999999999999999999876
Q ss_pred cC
Q 005669 669 FG 670 (684)
Q Consensus 669 ~~ 670 (684)
..
T Consensus 184 ~~ 185 (317)
T 2buj_A 184 AC 185 (317)
T ss_dssp SC
T ss_pred cc
Confidence 53
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.7e-24 Score=223.86 Aligned_cols=152 Identities=33% Similarity=0.524 Sum_probs=127.6
Q ss_pred HhhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 513 ANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 513 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
....++|++.++||+|+||.||++... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345578999999999999999999875 488999999975432 23456789999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE-----cCCCcEEEEeec
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL-----DNTMNPKISDFG 664 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl-----~~~~~vkI~DFG 664 (684)
+||||+++ +|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+ ++++.+||+|||
T Consensus 110 lv~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999985 89888844 345899999999999999999999998 9999999999999 455569999999
Q ss_pred cccccCC
Q 005669 665 LARSFGL 671 (684)
Q Consensus 665 la~~~~~ 671 (684)
+|+.+..
T Consensus 183 ~a~~~~~ 189 (329)
T 3gbz_A 183 LARAFGI 189 (329)
T ss_dssp HHHHHC-
T ss_pred CccccCC
Confidence 9988753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-23 Score=214.60 Aligned_cols=151 Identities=33% Similarity=0.592 Sum_probs=131.6
Q ss_pred cCCCCccc-eecccCcEeEEEEEee---CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 516 TDNFSEKN-KLGEGGFGPVYKGMLI---EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 516 t~~y~~~~-~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
.++|.+.+ .||+|+||.||+|... .++.||||+++... ....+.+.+|++++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34566665 9999999999999864 47789999998643 34467789999999999999999999999 5667899
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++++|.+++.. ....+++.++..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999843 3456899999999999999999999998 9999999999999999999999999999875
Q ss_pred CC
Q 005669 671 LD 672 (684)
Q Consensus 671 ~~ 672 (684)
..
T Consensus 162 ~~ 163 (287)
T 1u59_A 162 AD 163 (287)
T ss_dssp TC
T ss_pred cC
Confidence 43
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-23 Score=215.32 Aligned_cols=150 Identities=17% Similarity=0.303 Sum_probs=132.6
Q ss_pred hcCCCCccceecccCcEeEEEEEe-eCCcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++......++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 346799999999999999999997 458999999987532 335688999999999 7999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc-----EEEEeecccc
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN-----PKISDFGLAR 667 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~-----vkI~DFGla~ 667 (684)
||+ +++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+|+
T Consensus 86 e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 99999999543 345899999999999999999999998 999999999999987766 9999999999
Q ss_pred ccCCC
Q 005669 668 SFGLD 672 (684)
Q Consensus 668 ~~~~~ 672 (684)
.+...
T Consensus 160 ~~~~~ 164 (298)
T 1csn_A 160 FYRDP 164 (298)
T ss_dssp ESBCT
T ss_pred ccccc
Confidence 87654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-23 Score=219.86 Aligned_cols=152 Identities=26% Similarity=0.387 Sum_probs=129.4
Q ss_pred HHHHhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhcc--CCCceeeEEEEEEeC--
Q 005669 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL--QHRNLVKLLGCCTQR-- 585 (684)
Q Consensus 510 ~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l--~H~nIv~l~g~~~~~-- 585 (684)
.......++|++.++||+|+||.||+|... ++.||||++... ....+.+|.+++..+ +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 334455678999999999999999999874 899999998642 234455566666554 899999999999887
Q ss_pred --CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCceEecCCCCCcEEEcCC
Q 005669 586 --DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD--------SRLRIIHRDLKASNVLLDNT 655 (684)
Q Consensus 586 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--------~~~~IvHrDLkp~NILl~~~ 655 (684)
...++||||+++++|.+++.. ..+++..+..++.|++.||.|||++ + |+||||||+|||++.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKN 178 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTT
T ss_pred CCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCC
Confidence 788999999999999999943 3589999999999999999999988 6 9999999999999999
Q ss_pred CcEEEEeeccccccCCC
Q 005669 656 MNPKISDFGLARSFGLD 672 (684)
Q Consensus 656 ~~vkI~DFGla~~~~~~ 672 (684)
+.+||+|||+|+.+...
T Consensus 179 ~~~kl~Dfg~a~~~~~~ 195 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISD 195 (337)
T ss_dssp SCEEECCCTTCEECC--
T ss_pred CCEEEEeCCCceeeccc
Confidence 99999999999877543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=218.02 Aligned_cols=150 Identities=29% Similarity=0.480 Sum_probs=132.9
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
..++|++.+.||+|+||.||++.... ++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 44689999999999999999999864 88999999987666677889999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
|+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 99999999988542 345899999999999999999999998 999999999999999999999999998643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=233.74 Aligned_cols=151 Identities=29% Similarity=0.412 Sum_probs=129.6
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
.+.|+..++||+|+||.||++... .++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999986 48899999987542 334577899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCcEEEEeecccccc
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGLARSF 669 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~---~~~vkI~DFGla~~~ 669 (684)
||+++++|.+.+... ..+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+|+.+
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999998888543 45899999999999999999999998 999999999999975 455999999999987
Q ss_pred CCC
Q 005669 670 GLD 672 (684)
Q Consensus 670 ~~~ 672 (684)
...
T Consensus 190 ~~~ 192 (494)
T 3lij_A 190 ENQ 192 (494)
T ss_dssp BTT
T ss_pred CCC
Confidence 543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=221.41 Aligned_cols=160 Identities=33% Similarity=0.510 Sum_probs=136.8
Q ss_pred ccHHHHHhhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEe
Q 005669 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ 584 (684)
Q Consensus 507 ~~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~ 584 (684)
+++.++....++|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 444555667789999999999999999999975 5889999998754 33457889999999999 79999999999987
Q ss_pred ------CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcE
Q 005669 585 ------RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (684)
Q Consensus 585 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~v 658 (684)
.+..++||||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 46789999999999999998643 2356899999999999999999999998 9999999999999999999
Q ss_pred EEEeeccccccCC
Q 005669 659 KISDFGLARSFGL 671 (684)
Q Consensus 659 kI~DFGla~~~~~ 671 (684)
||+|||+++.+..
T Consensus 169 kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 169 KLVDFGVSAQLDR 181 (326)
T ss_dssp EECCCTTTC----
T ss_pred EEeeCcCceecCc
Confidence 9999999987653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.9e-23 Score=215.05 Aligned_cols=153 Identities=25% Similarity=0.366 Sum_probs=135.2
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---------cccHHHHHHHHHHHhccC-CCceeeEEEEE
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---------GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCC 582 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---------~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~ 582 (684)
...++|++.+.||+|+||.||++.... ++.||||++.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 445789999999999999999999864 8899999987542 122456789999999995 99999999999
Q ss_pred EeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEe
Q 005669 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISD 662 (684)
Q Consensus 583 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~D 662 (684)
...+..++||||+++++|.+++.. ...+++.++..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999854 345899999999999999999999998 99999999999999999999999
Q ss_pred eccccccCCC
Q 005669 663 FGLARSFGLD 672 (684)
Q Consensus 663 FGla~~~~~~ 672 (684)
||+++.+...
T Consensus 168 fg~~~~~~~~ 177 (298)
T 1phk_A 168 FGFSCQLDPG 177 (298)
T ss_dssp CTTCEECCTT
T ss_pred ccchhhcCCC
Confidence 9999887543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=219.13 Aligned_cols=151 Identities=19% Similarity=0.233 Sum_probs=130.5
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
..++|++.+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.++++++||||+++++++..++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999975 488999999875422 234678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++++|.+++... ..+++.++..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999998542 45899999999999999999999998 9999999999999999999999999998765
Q ss_pred C
Q 005669 671 L 671 (684)
Q Consensus 671 ~ 671 (684)
.
T Consensus 186 ~ 186 (309)
T 2h34_A 186 D 186 (309)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=214.84 Aligned_cols=151 Identities=28% Similarity=0.452 Sum_probs=135.5
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
..++|.+.+.||+|+||.||++... +++.||||.+... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999986 5899999998643 22345678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++++|.+++... ..+++.++..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||+++...
T Consensus 89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999998543 35899999999999999999999998 9999999999999999999999999998875
Q ss_pred C
Q 005669 671 L 671 (684)
Q Consensus 671 ~ 671 (684)
.
T Consensus 163 ~ 163 (276)
T 2h6d_A 163 D 163 (276)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-23 Score=221.43 Aligned_cols=152 Identities=32% Similarity=0.560 Sum_probs=128.9
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-----CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
.++|...+.||+|+||.||+|.... +..||||.+.... ......+.+|+.++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567788999999999999998753 2369999997542 334567889999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+||||+++++|.+++... ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999998542 356899999999999999999999998 999999999999999999999999999987
Q ss_pred CCC
Q 005669 670 GLD 672 (684)
Q Consensus 670 ~~~ 672 (684)
...
T Consensus 198 ~~~ 200 (333)
T 1mqb_A 198 EDD 200 (333)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=217.00 Aligned_cols=152 Identities=28% Similarity=0.482 Sum_probs=130.7
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC----CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEe-CCee
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDER 588 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~ 588 (684)
....|+..+.||+|+||.||+|...+ ...+|+|.+.... ....+.+.+|+.++++++||||+++++++.. ++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34568888999999999999998643 2368999987543 3345678999999999999999999999654 5578
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++||||+++++|.+++.. ....+++.++..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+|+.
T Consensus 103 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999999954 3456899999999999999999999998 99999999999999999999999999987
Q ss_pred cCC
Q 005669 669 FGL 671 (684)
Q Consensus 669 ~~~ 671 (684)
+..
T Consensus 178 ~~~ 180 (298)
T 3f66_A 178 MYD 180 (298)
T ss_dssp CSC
T ss_pred ccc
Confidence 753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=214.65 Aligned_cols=150 Identities=33% Similarity=0.536 Sum_probs=132.1
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe---------
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--------- 584 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--------- 584 (684)
..++|+..+.||+|+||.||++... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3457889999999999999999986 58999999997543 456789999999999999999998864
Q ss_pred -------CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 005669 585 -------RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN 657 (684)
Q Consensus 585 -------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~ 657 (684)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+|+||||+||++++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34579999999999999999543 2356899999999999999999999998 999999999999999999
Q ss_pred EEEEeeccccccCCC
Q 005669 658 PKISDFGLARSFGLD 672 (684)
Q Consensus 658 vkI~DFGla~~~~~~ 672 (684)
+||+|||+++.+...
T Consensus 161 ~kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 161 VKIGDFGLVTSLKND 175 (284)
T ss_dssp EEECCCTTCEESSCC
T ss_pred EEECcchhheecccc
Confidence 999999999987544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=224.61 Aligned_cols=152 Identities=24% Similarity=0.320 Sum_probs=126.6
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCCccc-----------HHHHHHHHHHHhccCCCceee
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQG-----------MEEFKNEVLLIAKLQHRNLVK 577 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~~-----------~~~~~~Ei~~l~~l~H~nIv~ 577 (684)
..++|++.++||+|+||.||+|.+.. ++.||||++....... ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998754 4789999987643211 112344566777888999999
Q ss_pred EEEEEEeC----CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 005669 578 LLGCCTQR----DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (684)
Q Consensus 578 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~ 653 (684)
+++++... ...++||||+ +++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998764 4579999999 99999998542 356999999999999999999999998 99999999999998
Q ss_pred --CCCcEEEEeeccccccCCC
Q 005669 654 --NTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 654 --~~~~vkI~DFGla~~~~~~ 672 (684)
.++.+||+|||+|+.+...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGG
T ss_pred cCCCCeEEEEECCcceecccC
Confidence 8899999999999887543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-23 Score=214.99 Aligned_cols=150 Identities=26% Similarity=0.405 Sum_probs=133.7
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.++|++.+.||+|+||.||++.... ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 4679999999999999999999864 788999998643 123356789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999998543 35899999999999999999999998 99999999999999999999999999987643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=224.36 Aligned_cols=149 Identities=26% Similarity=0.454 Sum_probs=125.1
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-----
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD----- 586 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----- 586 (684)
..++|+..+.||+|+||.||+|... +++.||||++... .....+++.+|+.++++++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3478999999999999999999975 4899999999653 2233567889999999999999999999997653
Q ss_pred -eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecc
Q 005669 587 -ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (684)
Q Consensus 587 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGl 665 (684)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 7899998853 35899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCC
Q 005669 666 ARSFGL 671 (684)
Q Consensus 666 a~~~~~ 671 (684)
|+....
T Consensus 175 a~~~~~ 180 (367)
T 1cm8_A 175 ARQADS 180 (367)
T ss_dssp CEECCS
T ss_pred cccccc
Confidence 998654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=221.80 Aligned_cols=151 Identities=32% Similarity=0.563 Sum_probs=126.8
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-Cc----EEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
.++|++.++||+|+||.||+|.... ++ +||+|.+... .....+++.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 4679999999999999999999653 43 4688887643 3445678999999999999999999999998754 78
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+++||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998543 346899999999999999999999998 999999999999999999999999999987
Q ss_pred CCC
Q 005669 670 GLD 672 (684)
Q Consensus 670 ~~~ 672 (684)
...
T Consensus 168 ~~~ 170 (327)
T 3lzb_A 168 GAE 170 (327)
T ss_dssp ---
T ss_pred cCc
Confidence 544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=219.29 Aligned_cols=155 Identities=27% Similarity=0.430 Sum_probs=121.2
Q ss_pred hhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
...++|++.+.||+|+||.||++... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999865 58899999987542 33456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 592 YEYLPNKSLDYFIFDT-----TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
|||+++++|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999988531 12456899999999999999999999998 999999999999999999999999999
Q ss_pred cccCC
Q 005669 667 RSFGL 671 (684)
Q Consensus 667 ~~~~~ 671 (684)
+.+..
T Consensus 169 ~~~~~ 173 (303)
T 2vwi_A 169 AFLAT 173 (303)
T ss_dssp HHCC-
T ss_pred heecc
Confidence 87653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.8e-23 Score=216.97 Aligned_cols=148 Identities=26% Similarity=0.462 Sum_probs=125.7
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEE-----------
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT----------- 583 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~----------- 583 (684)
.++|+..+.||+|+||.||++.... ++.||+|++........+++.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999865 8999999998766666788999999999999999999999873
Q ss_pred ---eCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCcEE
Q 005669 584 ---QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPK 659 (684)
Q Consensus 584 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~-~~~~vk 659 (684)
+.+..++||||++ ++|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 59998883 346899999999999999999999998 99999999999997 567999
Q ss_pred EEeeccccccCC
Q 005669 660 ISDFGLARSFGL 671 (684)
Q Consensus 660 I~DFGla~~~~~ 671 (684)
|+|||+++.+..
T Consensus 162 l~Dfg~~~~~~~ 173 (320)
T 2i6l_A 162 IGDFGLARIMDP 173 (320)
T ss_dssp ECCCTTCBCC--
T ss_pred EccCccccccCC
Confidence 999999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.1e-23 Score=215.94 Aligned_cols=152 Identities=31% Similarity=0.496 Sum_probs=130.7
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
...++|++.+.||+|+||.||++.... ++.||+|.+... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 345789999999999999999999864 899999999754 34577899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
||+++++|.+++.. ....+++.++..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999853 2356899999999999999999999998 999999999999999999999999999877543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.89 E-value=3.5e-23 Score=225.37 Aligned_cols=146 Identities=26% Similarity=0.346 Sum_probs=124.0
Q ss_pred CCCCcc-ceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhc-cCCCceeeEEEEEEe----CCeeE
Q 005669 517 DNFSEK-NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAK-LQHRNLVKLLGCCTQ----RDERM 589 (684)
Q Consensus 517 ~~y~~~-~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~-l~H~nIv~l~g~~~~----~~~~~ 589 (684)
++|... +.||+|+||+||++.... ++.||||++... ..+.+|+.++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456655 689999999999999764 889999998642 467788888754 589999999999876 56689
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCcEEEEeeccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGLA 666 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~---~~~vkI~DFGla 666 (684)
+||||+++++|.+++... ....+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+|
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999542 2346899999999999999999999998 999999999999987 788999999999
Q ss_pred cccCC
Q 005669 667 RSFGL 671 (684)
Q Consensus 667 ~~~~~ 671 (684)
+....
T Consensus 212 ~~~~~ 216 (400)
T 1nxk_A 212 KETTS 216 (400)
T ss_dssp EECC-
T ss_pred cccCC
Confidence 97653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-23 Score=222.50 Aligned_cols=148 Identities=30% Similarity=0.527 Sum_probs=127.8
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
++|...++||+|+||.||++... +++.||+|++...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999986 5889999998754221 122455799999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++ ++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 98 4888877542 346899999999999999999999998 9999999999999999999999999998764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=216.38 Aligned_cols=149 Identities=32% Similarity=0.467 Sum_probs=129.5
Q ss_pred CCCccceecccCcEeEEEEEeeC-C---cEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCee-EEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-G---QEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER-MLI 591 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~-~lV 591 (684)
.|...++||+|+||.||+|...+ + ..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45566899999999999998644 2 379999987543 33457789999999999999999999999876665 999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+.+++|.+++.. ....+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999854 3456899999999999999999999998 99999999999999999999999999987643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=217.40 Aligned_cols=149 Identities=30% Similarity=0.493 Sum_probs=131.7
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe----------
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ---------- 584 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~---------- 584 (684)
.++|+..+.||+|+||.||++... +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467899999999999999999975 5899999999652 3445778999999999999999999999865
Q ss_pred ---CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEE
Q 005669 585 ---RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (684)
Q Consensus 585 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~ 661 (684)
.+..++||||+++++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 34679999999999999999542 345788999999999999999999998 9999999999999999999999
Q ss_pred eeccccccC
Q 005669 662 DFGLARSFG 670 (684)
Q Consensus 662 DFGla~~~~ 670 (684)
|||+++.+.
T Consensus 159 dfg~~~~~~ 167 (303)
T 1zy4_A 159 DFGLAKNVH 167 (303)
T ss_dssp CCCCCSCTT
T ss_pred eCcchhhcc
Confidence 999998764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-23 Score=220.25 Aligned_cols=154 Identities=34% Similarity=0.507 Sum_probs=130.8
Q ss_pred hcCCCCccceecccCcEeEEEEEee------CCcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 587 (684)
..++|++.+.||+|+||.||+|... +++.||||.+... ......++.+|+.++++++||||+++++++...+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 3468999999999999999999842 3678999999754 33445678999999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCcEEE
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTR----SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKI 660 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~---~~~vkI 660 (684)
.++||||+++++|.+++..... ...+++.++..++.||+.||.|||+++ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999965432 245899999999999999999999998 999999999999984 456999
Q ss_pred EeeccccccCC
Q 005669 661 SDFGLARSFGL 671 (684)
Q Consensus 661 ~DFGla~~~~~ 671 (684)
+|||+++.+..
T Consensus 185 ~Dfg~~~~~~~ 195 (327)
T 2yfx_A 185 GDFGMARDIYR 195 (327)
T ss_dssp CCCHHHHHHHC
T ss_pred Ccccccccccc
Confidence 99999986643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.9e-23 Score=215.79 Aligned_cols=154 Identities=24% Similarity=0.410 Sum_probs=128.5
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
..++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 4467999999999999999999974 5899999998753 23345678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 591 IYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||+++.+
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999885422 2456899999999999999999999998 999999999999999999999999999876
Q ss_pred CC
Q 005669 670 GL 671 (684)
Q Consensus 670 ~~ 671 (684)
..
T Consensus 187 ~~ 188 (310)
T 2wqm_A 187 SS 188 (310)
T ss_dssp --
T ss_pred cC
Confidence 54
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.7e-23 Score=218.09 Aligned_cols=150 Identities=27% Similarity=0.395 Sum_probs=127.6
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--------cccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--------GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR 585 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~ 585 (684)
..++|.+.+.||+|+||.||++.... ++.||||.+.... ......+.+|+.++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 34679999999999999999999754 7899999986532 12234578999999999999999999998765
Q ss_pred CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---EEEEe
Q 005669 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN---PKISD 662 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~---vkI~D 662 (684)
+ .++||||+++++|.+++. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999999883 3456899999999999999999999998 999999999999987654 99999
Q ss_pred eccccccCC
Q 005669 663 FGLARSFGL 671 (684)
Q Consensus 663 FGla~~~~~ 671 (684)
||+++.+..
T Consensus 161 fg~~~~~~~ 169 (322)
T 2ycf_A 161 FGHSKILGE 169 (322)
T ss_dssp CTTCEECCC
T ss_pred Cccceeccc
Confidence 999998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.3e-23 Score=218.13 Aligned_cols=150 Identities=35% Similarity=0.599 Sum_probs=130.3
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcE--EEEEEccCC-CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQE--IAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~--vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 591 (684)
++|+..+.||+|+||.||++.... +.. +|+|.+... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 578899999999999999999754 554 499988753 334456789999999999 899999999999999999999
Q ss_pred EEccCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcE
Q 005669 592 YEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~v 658 (684)
|||+++++|.+++.... ....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986432 2346899999999999999999999998 9999999999999999999
Q ss_pred EEEeecccccc
Q 005669 659 KISDFGLARSF 669 (684)
Q Consensus 659 kI~DFGla~~~ 669 (684)
||+|||+++..
T Consensus 182 kL~Dfg~~~~~ 192 (327)
T 1fvr_A 182 KIADFGLSRGQ 192 (327)
T ss_dssp EECCTTCEESS
T ss_pred EEcccCcCccc
Confidence 99999999854
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-23 Score=231.82 Aligned_cols=152 Identities=33% Similarity=0.466 Sum_probs=135.7
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
..++|+..+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999986 58999999986542 3456789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCcEEEEeecccc
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLAR 667 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl---~~~~~vkI~DFGla~ 667 (684)
||||+++++|.+.+.. ...+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999988843 356899999999999999999999998 9999999999999 567899999999999
Q ss_pred ccCCC
Q 005669 668 SFGLD 672 (684)
Q Consensus 668 ~~~~~ 672 (684)
.+...
T Consensus 178 ~~~~~ 182 (484)
T 3nyv_A 178 HFEAS 182 (484)
T ss_dssp HBCCC
T ss_pred Ecccc
Confidence 87544
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.3e-23 Score=237.59 Aligned_cols=149 Identities=32% Similarity=0.579 Sum_probs=129.0
Q ss_pred CCCccc-eecccCcEeEEEEEee---CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 518 NFSEKN-KLGEGGFGPVYKGMLI---EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 518 ~y~~~~-~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++.+.+ +||+|+||.||+|... ++..||||+++... ....+++.+|++++++++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333344 7999999999999875 35679999998653 3456789999999999999999999999976 5689999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
||+++++|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+..+
T Consensus 415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999843 2456899999999999999999999998 999999999999999999999999999987543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=217.90 Aligned_cols=150 Identities=25% Similarity=0.393 Sum_probs=131.6
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
..++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467889999999999999999975 589999999986554455678999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCcEEEEeeccccccC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFG 670 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl---~~~~~vkI~DFGla~~~~ 670 (684)
|+++++|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+||++ ++++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999988542 45899999999999999999999998 9999999999999 788899999999998654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.89 E-value=5.7e-23 Score=213.34 Aligned_cols=144 Identities=9% Similarity=0.045 Sum_probs=127.9
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.++|++.+.||+|+||.||+|.... ++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3679999999999999999999865 89999999986532 2346789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
|||+++++|.+++.. . ....++..++.||+.||+|||+++ |+||||||+|||++.++.+||+++|...
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC
Confidence 999999999999832 2 356678899999999999999998 9999999999999999999999887654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=223.00 Aligned_cols=151 Identities=26% Similarity=0.418 Sum_probs=134.3
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcc---c--------------HHHHHHHHHHHhccCCCceeeE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ---G--------------MEEFKNEVLLIAKLQHRNLVKL 578 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~---~--------------~~~~~~Ei~~l~~l~H~nIv~l 578 (684)
.++|.+.+.||+|+||.||++.. +++.||||.+...... . .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999999 8999999998743111 1 1789999999999999999999
Q ss_pred EEEEEeCCeeEEEEEccCCCChhHH------HhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEE
Q 005669 579 LGCCTQRDERMLIYEYLPNKSLDYF------IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVL 651 (684)
Q Consensus 579 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~IvHrDLkp~NIL 651 (684)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ ++ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999988 422 224679999999999999999999999 87 999999999999
Q ss_pred EcCCCcEEEEeeccccccCC
Q 005669 652 LDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 652 l~~~~~vkI~DFGla~~~~~ 671 (684)
++.++.+||+|||+++.+..
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~ 204 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVD 204 (348)
T ss_dssp ECTTSCEEECCCTTCEECBT
T ss_pred EcCCCcEEEecccccccccc
Confidence 99999999999999988643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.1e-23 Score=212.47 Aligned_cols=152 Identities=32% Similarity=0.631 Sum_probs=129.9
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCccc-------HHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQG-------MEEFKNEVLLIAKLQHRNLVKLLGCCTQRD 586 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~-------~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 586 (684)
..++|+..+.||+|+||.||++... +++.||+|++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3478999999999999999999985 58899999986543221 267899999999999999999999986554
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc-----EEEE
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN-----PKIS 661 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~-----vkI~ 661 (684)
++||||+++++|.+.+.. ....+++..+..++.|++.||+|||+++ .+|+||||||+|||++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 799999999999888854 3456899999999999999999999875 34999999999999987776 9999
Q ss_pred eeccccccCC
Q 005669 662 DFGLARSFGL 671 (684)
Q Consensus 662 DFGla~~~~~ 671 (684)
|||+++....
T Consensus 172 Dfg~~~~~~~ 181 (287)
T 4f0f_A 172 DFGLSQQSVH 181 (287)
T ss_dssp CCTTCBCCSS
T ss_pred CCCccccccc
Confidence 9999986543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=233.26 Aligned_cols=152 Identities=31% Similarity=0.450 Sum_probs=134.3
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
..++|++.++||+|+||.||++... +++.||||++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999975 4889999998643 233467889999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc---CCCcEEEEeeccccc
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFGLARS 668 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~---~~~~vkI~DFGla~~ 668 (684)
|||+++++|.+.+... ..+++.++..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999998888543 45899999999999999999999998 99999999999995 456799999999988
Q ss_pred cCCC
Q 005669 669 FGLD 672 (684)
Q Consensus 669 ~~~~ 672 (684)
+...
T Consensus 174 ~~~~ 177 (486)
T 3mwu_A 174 FQQN 177 (486)
T ss_dssp BCCC
T ss_pred CCCC
Confidence 7543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=223.10 Aligned_cols=158 Identities=23% Similarity=0.351 Sum_probs=132.2
Q ss_pred cHHHHHhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCc-----------ccHHHHHHHHHHHhccCCCcee
Q 005669 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG-----------QGMEEFKNEVLLIAKLQHRNLV 576 (684)
Q Consensus 508 ~~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~-----------~~~~~~~~Ei~~l~~l~H~nIv 576 (684)
...++....++|.+.+.||+|+||.||++...+++.||||++..... ...+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35667788899999999999999999999988899999999864321 1136789999999999999999
Q ss_pred eEEEEEEeC-----CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 005669 577 KLLGCCTQR-----DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (684)
Q Consensus 577 ~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NIL 651 (684)
++++++... ...++||||++ ++|.+.+.. ....+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998543 35799999998 577777743 3446899999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEeeccccccCC
Q 005669 652 LDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 652 l~~~~~vkI~DFGla~~~~~ 671 (684)
++.++.+||+|||+++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~ 186 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTA 186 (362)
T ss_dssp ECTTCCEEECCTTC------
T ss_pred EcCCCCEEEEecCccccccc
Confidence 99999999999999986543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=224.31 Aligned_cols=148 Identities=24% Similarity=0.355 Sum_probs=133.7
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999986 4889999998765 23345678999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
|+++++|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 99999999998543 3589999999999999999999985 7 999999999999999999999999999765
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=5.5e-23 Score=214.00 Aligned_cols=150 Identities=31% Similarity=0.542 Sum_probs=130.9
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
++|+..+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 67899999999999999999986 48999999987542 2334678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|++ ++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.++.
T Consensus 83 ~~~-~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 155 (299)
T 2r3i_A 83 FLH-QDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155 (299)
T ss_dssp CCS-EEHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ccc-CCHHHHHHhh-hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence 998 5898888543 2345899999999999999999999998 99999999999999999999999999988754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.2e-23 Score=218.38 Aligned_cols=161 Identities=27% Similarity=0.405 Sum_probs=136.8
Q ss_pred cHHHHHhhcCCCCcc-ceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccC-CCceeeEEEEE
Q 005669 508 DLKIIANATDNFSEK-NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCC 582 (684)
Q Consensus 508 ~~~~l~~~t~~y~~~-~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~ 582 (684)
.++..+...+.|.+. +.||+|+||.||++.... ++.||+|++... .......+.+|+.++++++ ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344455566777776 889999999999999764 899999998753 2334678899999999994 69999999999
Q ss_pred EeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCcEE
Q 005669 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPK 659 (684)
Q Consensus 583 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~---~~~vk 659 (684)
...+..++||||+++++|.+++.. .....+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+|
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence 999999999999999999988843 22456899999999999999999999998 999999999999987 78999
Q ss_pred EEeeccccccCCC
Q 005669 660 ISDFGLARSFGLD 672 (684)
Q Consensus 660 I~DFGla~~~~~~ 672 (684)
|+|||+++.+...
T Consensus 175 L~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 175 IVDFGMSRKIGHA 187 (327)
T ss_dssp ECCGGGCEEC---
T ss_pred EeeCccccccCCc
Confidence 9999999987543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-22 Score=214.75 Aligned_cols=145 Identities=24% Similarity=0.416 Sum_probs=129.7
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEe--CCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQ--RDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~--~~~~~lV 591 (684)
.++|++.++||+|+||.||++... +++.||||+++.. ..+.+.+|+.++++++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 467999999999999999999874 5889999999743 3577899999999997 9999999999987 6678999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-cEEEEeeccccccC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFG 670 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~-~vkI~DFGla~~~~ 670 (684)
|||+++++|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998872 3889999999999999999999998 99999999999999766 89999999999775
Q ss_pred CC
Q 005669 671 LD 672 (684)
Q Consensus 671 ~~ 672 (684)
..
T Consensus 183 ~~ 184 (330)
T 3nsz_A 183 PG 184 (330)
T ss_dssp TT
T ss_pred CC
Confidence 43
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=218.12 Aligned_cols=150 Identities=27% Similarity=0.425 Sum_probs=125.6
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
.++|++.+.||+|+||.||++.. .++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 35788889999999999999987 4789999999743 34578999999999999999999999876 4589999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc-EEEEeeccccccC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN-PKISDFGLARSFG 670 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~-vkI~DFGla~~~~ 670 (684)
++++|.+++........+++..+..++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.+.
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 99999999965443345789999999999999999999932223999999999999988876 7999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.6e-23 Score=217.63 Aligned_cols=153 Identities=25% Similarity=0.401 Sum_probs=133.6
Q ss_pred HHHHHhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhc--cCCCceeeEEEEEEeCC
Q 005669 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK--LQHRNLVKLLGCCTQRD 586 (684)
Q Consensus 509 ~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~~~ 586 (684)
+.......++|.+.+.||+|+||.||++.. +++.||||++.. .....+.+|++++.. ++||||+++++++...+
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 333445567899999999999999999987 589999999864 334677888888887 78999999999998876
Q ss_pred ----eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecCCCCCcEEEcC
Q 005669 587 ----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH--------QDSRLRIIHRDLKASNVLLDN 654 (684)
Q Consensus 587 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~~~~IvHrDLkp~NILl~~ 654 (684)
..++||||+++++|.+++.. ..+++.++..++.|++.||.||| +++ |+||||||+|||++.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK 182 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred CccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence 78999999999999999953 35899999999999999999999 666 999999999999999
Q ss_pred CCcEEEEeeccccccCCC
Q 005669 655 TMNPKISDFGLARSFGLD 672 (684)
Q Consensus 655 ~~~vkI~DFGla~~~~~~ 672 (684)
++.+||+|||+++.+...
T Consensus 183 ~~~~kL~Dfg~~~~~~~~ 200 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSA 200 (342)
T ss_dssp TSCEEECCCTTCEEEETT
T ss_pred CCCEEEEECCCceecccc
Confidence 999999999999887544
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-23 Score=224.61 Aligned_cols=149 Identities=28% Similarity=0.487 Sum_probs=122.9
Q ss_pred CCCccceecccCcEeEEEEEeeC----CcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEe-CCeeEEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDERMLI 591 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV 591 (684)
.|+..+.||+|+||.||+|...+ ...||+|.++.. .....+++.+|+.++++++||||+++++++.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46677899999999999998753 236899998754 23446789999999999999999999999765 4578999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++++|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999953 2345889999999999999999999998 99999999999999999999999999987643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-23 Score=219.54 Aligned_cols=156 Identities=29% Similarity=0.391 Sum_probs=134.6
Q ss_pred hhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEe-------
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQ------- 584 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~------- 584 (684)
....+|++.++||+|+||.||++... +++.||||++........+.+.+|+.+++++. ||||+++++++..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34467999999999999999999975 48899999987665566678899999999996 9999999999953
Q ss_pred -CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEee
Q 005669 585 -RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (684)
Q Consensus 585 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DF 663 (684)
....+++|||++ |+|.+++........+++.++..++.||+.||.|||+++ .+|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 344799999996 688888865444567999999999999999999999875 35999999999999999999999999
Q ss_pred ccccccCC
Q 005669 664 GLARSFGL 671 (684)
Q Consensus 664 Gla~~~~~ 671 (684)
|+++.+..
T Consensus 183 g~~~~~~~ 190 (337)
T 3ll6_A 183 GSATTISH 190 (337)
T ss_dssp TTCBCCSS
T ss_pred ccceeccc
Confidence 99988754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.8e-23 Score=210.85 Aligned_cols=152 Identities=26% Similarity=0.403 Sum_probs=133.0
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC--CeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV 591 (684)
.++|+..+.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 46788999999999999999997 48899999987642 33456789999999999999999999999877 778999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|||+++++|.+++... ....+++.++..++.||+.||.|||+++ .+|+||||||+||+++.++.+||.|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999999542 2346899999999999999999999875 459999999999999999999999999886643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.8e-23 Score=221.72 Aligned_cols=153 Identities=25% Similarity=0.389 Sum_probs=126.1
Q ss_pred HhhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeC------
Q 005669 513 ANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------ 585 (684)
Q Consensus 513 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------ 585 (684)
+...++|+..+.||+|+||.||+|... +++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 445678999999999999999999974 589999999875422 234799999999999999999998543
Q ss_pred --------------------------------CeeEEEEEccCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 005669 586 --------------------------------DERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYL 632 (684)
Q Consensus 586 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yL 632 (684)
...++||||++ ++|.+.+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999998 4777766432 2345799999999999999999999
Q ss_pred HhCCCCceEecCCCCCcEEEc-CCCcEEEEeeccccccCCCC
Q 005669 633 HQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 633 H~~~~~~IvHrDLkp~NILl~-~~~~vkI~DFGla~~~~~~~ 673 (684)
|+++ |+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 196 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE 196 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence 9998 99999999999997 68899999999999875443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.89 E-value=5e-23 Score=223.69 Aligned_cols=150 Identities=25% Similarity=0.380 Sum_probs=126.0
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe------eE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE------RM 589 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~------~~ 589 (684)
..+|...+.||+|+||.||++....+..+|+|++..... ...+|+++++.++||||+++++++...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 456899999999999999999988777899998865422 22369999999999999999999965433 78
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCcEEEEeeccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARS 668 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~-~~~~vkI~DFGla~~ 668 (684)
+||||++++.+............+++..+..++.||++||+|||+++ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999997655544332233567899999999999999999999998 99999999999999 799999999999998
Q ss_pred cCCC
Q 005669 669 FGLD 672 (684)
Q Consensus 669 ~~~~ 672 (684)
+...
T Consensus 192 ~~~~ 195 (394)
T 4e7w_A 192 LIAG 195 (394)
T ss_dssp CCTT
T ss_pred ccCC
Confidence 7543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=6.4e-23 Score=220.34 Aligned_cols=150 Identities=25% Similarity=0.417 Sum_probs=131.1
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeC-----Ce
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-----DE 587 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 587 (684)
..++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3468999999999999999999975 47899999997543 23346788999999999999999999999765 36
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.++||||++ ++|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 899999998 488888843 35899999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCC
Q 005669 668 SFGLD 672 (684)
Q Consensus 668 ~~~~~ 672 (684)
.....
T Consensus 177 ~~~~~ 181 (364)
T 3qyz_A 177 VADPD 181 (364)
T ss_dssp ECCGG
T ss_pred ecCCC
Confidence 87543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.89 E-value=8.4e-24 Score=228.37 Aligned_cols=152 Identities=17% Similarity=0.215 Sum_probs=124.6
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHH---HHHhccCCCceeeEE-------E
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEV---LLIAKLQHRNLVKLL-------G 580 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei---~~l~~l~H~nIv~l~-------g 580 (684)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+ +++++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3467888999999999999999974 5899999998743 334467889999 555566899999998 6
Q ss_pred EEEeCCe-----------------eEEEEEccCCCChhHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 005669 581 CCTQRDE-----------------RMLIYEYLPNKSLDYFIFDTTR----SKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639 (684)
Q Consensus 581 ~~~~~~~-----------------~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ 639 (684)
++...+. .++||||+ +|+|.+++..... ...+++..+..++.||+.||+|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 6665532 78999999 5799999864321 122446888899999999999999998
Q ss_pred eEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 640 IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|+||||||+|||++.++.+||+|||+|+..+
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence 9999999999999999999999999998754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-23 Score=236.73 Aligned_cols=150 Identities=18% Similarity=0.232 Sum_probs=114.4
Q ss_pred eecccCcEeEEEEEe-eCCcEEEEEEccCCC----------cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEE
Q 005669 524 KLGEGGFGPVYKGML-IEGQEIAVKRLSKGS----------GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 524 ~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~----------~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 591 (684)
..+.|++|.+..++. .-|+.+++|.+.+.. ....++|.+|+++|+++ +|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456666666665543 238899999987531 22346799999999999 799999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||++|++|.++|.+ ...++.. +|+.||+.||+|+|+++ ||||||||+||||++++.+||+|||+|+.+..
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999943 3456654 48899999999999999 99999999999999999999999999998754
Q ss_pred CCCccCCcccccC
Q 005669 672 DQTEANTKRVVGT 684 (684)
Q Consensus 672 ~~~~~~~~~~~GT 684 (684)
+.. .....+||
T Consensus 392 ~~~--~~~t~vGT 402 (569)
T 4azs_A 392 DCS--WPTNLVQS 402 (569)
T ss_dssp --C--CSHHHHHH
T ss_pred CCc--cccCceec
Confidence 432 23334554
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.9e-23 Score=220.37 Aligned_cols=149 Identities=21% Similarity=0.314 Sum_probs=123.1
Q ss_pred cCCCCccceecccCcEeEEEEEee----CCcEEEEEEccCCCcc-----------cHHHHHHHHHHHhccCCCceeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGSGQ-----------GMEEFKNEVLLIAKLQHRNLVKLLG 580 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~-----------~~~~~~~Ei~~l~~l~H~nIv~l~g 580 (684)
.++|.+.+.||+|+||.||+|... .+..+|+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999985 4678999998764321 1234667888999999999999999
Q ss_pred EEEe----CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 005669 581 CCTQ----RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (684)
Q Consensus 581 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~ 656 (684)
++.. ....++||||+ +++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67899999999 99999998432 36899999999999999999999998 99999999999998877
Q ss_pred --cEEEEeeccccccCC
Q 005669 657 --NPKISDFGLARSFGL 671 (684)
Q Consensus 657 --~vkI~DFGla~~~~~ 671 (684)
.+||+|||+|+.+..
T Consensus 189 ~~~~kL~Dfg~a~~~~~ 205 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCP 205 (345)
T ss_dssp TTSEEECCCTTCEESSG
T ss_pred CCcEEEEeCCCceeccc
Confidence 999999999988754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=7.2e-23 Score=216.92 Aligned_cols=146 Identities=35% Similarity=0.578 Sum_probs=122.6
Q ss_pred hcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHH--HhccCCCceeeEEEEEEe-----CCe
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLL--IAKLQHRNLVKLLGCCTQ-----RDE 587 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~--l~~l~H~nIv~l~g~~~~-----~~~ 587 (684)
..++|++.+.||+|+||.||+|.. +++.||||++... ....+..|.++ +..++|+||+++++.+.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 457899999999999999999976 6899999998743 23444445544 445899999999986643 235
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCceEecCCCCCcEEEcCCCcE
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD---------SRLRIIHRDLKASNVLLDNTMNP 658 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---------~~~~IvHrDLkp~NILl~~~~~v 658 (684)
.++||||+++++|.+++.. ...++..+..++.||++||.|||++ + |+||||||+|||++.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 6899999999999999843 2358899999999999999999998 6 9999999999999999999
Q ss_pred EEEeeccccccCC
Q 005669 659 KISDFGLARSFGL 671 (684)
Q Consensus 659 kI~DFGla~~~~~ 671 (684)
||+|||+|+.+..
T Consensus 160 kL~DFG~a~~~~~ 172 (336)
T 3g2f_A 160 VISDFGLSMRLTG 172 (336)
T ss_dssp EECCCTTCEECSS
T ss_pred EEeeccceeeccc
Confidence 9999999988754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.88 E-value=8.7e-23 Score=211.77 Aligned_cols=152 Identities=28% Similarity=0.413 Sum_probs=130.7
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEe----CCee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~ 588 (684)
.+.|...+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 3457888899999999999999754 789999998743 23345678999999999999999999999875 3558
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCcEEEEeecccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLAR 667 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~-~~~~vkI~DFGla~ 667 (684)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ .+|+||||||+|||++ +++.+||+|||+++
T Consensus 105 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999999542 45899999999999999999999875 3599999999999997 78999999999998
Q ss_pred ccCC
Q 005669 668 SFGL 671 (684)
Q Consensus 668 ~~~~ 671 (684)
....
T Consensus 181 ~~~~ 184 (290)
T 1t4h_A 181 LKRA 184 (290)
T ss_dssp GCCT
T ss_pred cccc
Confidence 6643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.6e-23 Score=212.17 Aligned_cols=151 Identities=28% Similarity=0.450 Sum_probs=130.8
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC----CcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
..++|...+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45678999999999999999998654 246999999765 23346778999999999999999999999864 4578
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.+
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999998543 345899999999999999999999998 999999999999999999999999999877
Q ss_pred CC
Q 005669 670 GL 671 (684)
Q Consensus 670 ~~ 671 (684)
..
T Consensus 164 ~~ 165 (281)
T 3cc6_A 164 ED 165 (281)
T ss_dssp --
T ss_pred cc
Confidence 54
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.8e-23 Score=237.01 Aligned_cols=143 Identities=29% Similarity=0.503 Sum_probs=126.0
Q ss_pred ceecccCcEeEEEEEee---CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLI---EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
++||+|+||.||+|.+. .++.||||+++... ....+++.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999764 35789999997542 334678999999999999999999999996 4568899999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..+
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 999999953 346899999999999999999999998 999999999999999999999999999987544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-22 Score=211.00 Aligned_cols=147 Identities=26% Similarity=0.336 Sum_probs=127.7
Q ss_pred cCCCCcc-ceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHH-hccCCCceeeEEEEEEe----CCee
Q 005669 516 TDNFSEK-NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLI-AKLQHRNLVKLLGCCTQ----RDER 588 (684)
Q Consensus 516 t~~y~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l-~~l~H~nIv~l~g~~~~----~~~~ 588 (684)
.++|.+. +.||+|+||.||++... +++.||+|+++.. ..+.+|+.++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567766 77999999999999975 4889999998642 4677888887 55689999999999987 6678
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCcEEEEeecc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGL 665 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~---~~~vkI~DFGl 665 (684)
++||||+++++|.+++... ....+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999998653 3346899999999999999999999998 999999999999997 78899999999
Q ss_pred ccccCC
Q 005669 666 ARSFGL 671 (684)
Q Consensus 666 a~~~~~ 671 (684)
|+....
T Consensus 167 a~~~~~ 172 (299)
T 3m2w_A 167 AKETTG 172 (299)
T ss_dssp CEECTT
T ss_pred cccccc
Confidence 987753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.3e-23 Score=211.88 Aligned_cols=156 Identities=28% Similarity=0.405 Sum_probs=132.0
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe--CCeeEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDERML 590 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~l 590 (684)
.++|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999986 48999999997542 3345678999999999999999999998854 567899
Q ss_pred EEEccCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 591 IYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~--~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
||||+++++|.+++.... ....+++..+..++.|++.||+|||+++ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986532 2345899999999999999999999875 1249999999999999999999999999998
Q ss_pred ccCC
Q 005669 668 SFGL 671 (684)
Q Consensus 668 ~~~~ 671 (684)
.+..
T Consensus 165 ~~~~ 168 (279)
T 2w5a_A 165 ILNH 168 (279)
T ss_dssp HC--
T ss_pred eecc
Confidence 8754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.5e-23 Score=214.38 Aligned_cols=154 Identities=26% Similarity=0.362 Sum_probs=121.6
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
..++|+..+.||+|+||.||++... +++.||+|++..... ...+.+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3578999999999999999999975 588999999975422 2223344555568888999999999999999999999
Q ss_pred EEccCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 592 YEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
|||+++ +|.+++... .....+++..+..++.||+.||.|||++ + |+||||||+||+++.++.+||+|||+|+.+
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999985 787776432 2345799999999999999999999997 7 999999999999999999999999999877
Q ss_pred CCC
Q 005669 670 GLD 672 (684)
Q Consensus 670 ~~~ 672 (684)
...
T Consensus 161 ~~~ 163 (290)
T 3fme_A 161 VDD 163 (290)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=4.4e-23 Score=221.94 Aligned_cols=149 Identities=30% Similarity=0.467 Sum_probs=116.2
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC------
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------ 585 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------ 585 (684)
..++|+..+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3478999999999999999999875 4889999999753 223456788999999999999999999998754
Q ss_pred CeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecc
Q 005669 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGl 665 (684)
...++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5579999999 6889888732 46899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCC
Q 005669 666 ARSFGL 671 (684)
Q Consensus 666 a~~~~~ 671 (684)
|+....
T Consensus 179 a~~~~~ 184 (367)
T 2fst_X 179 ARHTAD 184 (367)
T ss_dssp ------
T ss_pred cccccc
Confidence 987643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.8e-23 Score=217.44 Aligned_cols=149 Identities=27% Similarity=0.419 Sum_probs=130.8
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeC-----Ce
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-----DE 587 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 587 (684)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999976 48899999997542 23356788999999999999999999998764 67
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999998 589888743 35899999999999999999999998 9999999999999999999999999999
Q ss_pred ccCC
Q 005669 668 SFGL 671 (684)
Q Consensus 668 ~~~~ 671 (684)
.+..
T Consensus 161 ~~~~ 164 (353)
T 2b9h_A 161 IIDE 164 (353)
T ss_dssp ECC-
T ss_pred cccc
Confidence 8753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=217.05 Aligned_cols=159 Identities=23% Similarity=0.281 Sum_probs=121.0
Q ss_pred HHHhhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe--
Q 005669 511 IIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE-- 587 (684)
Q Consensus 511 ~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~-- 587 (684)
......++|++.+.||+|+||.||++... +++.||||++... ......+.+|++.++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34556789999999999999999999985 4889999998654 3334567788889999999999999999976443
Q ss_pred -----eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceEecCCCCCcEEEcC-CCcEE
Q 005669 588 -----RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH--QDSRLRIIHRDLKASNVLLDN-TMNPK 659 (684)
Q Consensus 588 -----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--~~~~~~IvHrDLkp~NILl~~-~~~vk 659 (684)
.++||||++++.+..+.........+++..+..++.|++.||.||| +++ |+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999997543333222234567899999999999999999999 777 999999999999996 89999
Q ss_pred EEeeccccccCCCC
Q 005669 660 ISDFGLARSFGLDQ 673 (684)
Q Consensus 660 I~DFGla~~~~~~~ 673 (684)
|+|||+|+.+....
T Consensus 173 l~Dfg~a~~~~~~~ 186 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE 186 (360)
T ss_dssp ECCCTTCBCCCTTS
T ss_pred EeeCCCceecCCCC
Confidence 99999999875443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=9.9e-23 Score=223.26 Aligned_cols=148 Identities=27% Similarity=0.433 Sum_probs=122.1
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeC----C--eeE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR----D--ERM 589 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~----~--~~~ 589 (684)
.+|+..+.||+|+||.||+|.+.. ++.||||++.... ....+|++++++++|+||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 468888999999999999999864 8999999987542 2234799999999999999999998542 2 257
Q ss_pred EEEEccCCCChhHHHhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CcEEEEeecccc
Q 005669 590 LIYEYLPNKSLDYFIFD-TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGLAR 667 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~-~~vkI~DFGla~ 667 (684)
+||||+++ +|...+.. ......+++..+..++.||++||+|||+++ |+||||||+||||+.+ +.+||+|||+|+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 55554432 123457999999999999999999999998 9999999999999955 678999999999
Q ss_pred ccCCC
Q 005669 668 SFGLD 672 (684)
Q Consensus 668 ~~~~~ 672 (684)
.+...
T Consensus 206 ~~~~~ 210 (420)
T 1j1b_A 206 QLVRG 210 (420)
T ss_dssp ECCTT
T ss_pred hcccC
Confidence 87543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=219.06 Aligned_cols=147 Identities=29% Similarity=0.441 Sum_probs=124.7
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC------
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ 586 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 586 (684)
.++|+..+.||+|+||.||++... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999875 4889999998753 2334567889999999999999999999997665
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 68999999985 6777773 24899999999999999999999998 999999999999999999999999999
Q ss_pred cccCC
Q 005669 667 RSFGL 671 (684)
Q Consensus 667 ~~~~~ 671 (684)
+....
T Consensus 175 ~~~~~ 179 (371)
T 2xrw_A 175 RTAGT 179 (371)
T ss_dssp -----
T ss_pred ccccc
Confidence 87753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.2e-23 Score=216.70 Aligned_cols=156 Identities=23% Similarity=0.358 Sum_probs=133.6
Q ss_pred HHHHHhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCC--CcccHHHHHHHHHHHhccC--CCceeeEEEEEEe
Q 005669 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQ--HRNLVKLLGCCTQ 584 (684)
Q Consensus 509 ~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~ 584 (684)
++.+....++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++++++ |+||+++++++..
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 34445556789999999999999999999888999999998753 2344577899999999997 5999999999999
Q ss_pred CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
.+..++||| +.+++|.+++.. ...+++.++..++.||++||.|||+++ |+||||||+|||+++ +.+||+|||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 999999999 567899999854 346899999999999999999999998 999999999999975 799999999
Q ss_pred cccccCCC
Q 005669 665 LARSFGLD 672 (684)
Q Consensus 665 la~~~~~~ 672 (684)
+++.+...
T Consensus 172 ~~~~~~~~ 179 (313)
T 3cek_A 172 IANQMQPD 179 (313)
T ss_dssp SSCC----
T ss_pred ccccccCc
Confidence 99987544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.9e-23 Score=213.01 Aligned_cols=149 Identities=28% Similarity=0.460 Sum_probs=125.7
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeC-CeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-DERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey 594 (684)
.++|+..+.||+|+||.||++.. .++.||||.++.. ...+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46789999999999999999987 5889999999753 3457899999999999999999999997654 468999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
+++++|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999985421 223789999999999999999999998 99999999999999999999999999987643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=236.86 Aligned_cols=148 Identities=21% Similarity=0.343 Sum_probs=128.3
Q ss_pred cCCCCccceecccCcEeEEEEEee--CCcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe-----
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI--EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE----- 587 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~----- 587 (684)
.++|++.+.||+|+||.||++.+. +++.||||++... .......+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999985 4889999998653 23445678899999999999999999999987665
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.++||||+++++|.+++. ..+++.++..++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 699999999999988762 26899999999999999999999998 9999999999999986 89999999999
Q ss_pred ccCCC
Q 005669 668 SFGLD 672 (684)
Q Consensus 668 ~~~~~ 672 (684)
.+...
T Consensus 230 ~~~~~ 234 (681)
T 2pzi_A 230 RINSF 234 (681)
T ss_dssp ETTCC
T ss_pred hcccC
Confidence 87543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-22 Score=209.01 Aligned_cols=154 Identities=31% Similarity=0.447 Sum_probs=135.4
Q ss_pred HhhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 513 ANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 513 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
....++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345578999999999999999999986 5889999998653 2345678999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CcEEEEeeccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLA 666 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~---~~vkI~DFGla 666 (684)
+|+||+++++|.+.+... ..+++.++..++.||+.||.|||+++ |+|+||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999998888543 35899999999999999999999998 9999999999999754 46999999999
Q ss_pred cccCCC
Q 005669 667 RSFGLD 672 (684)
Q Consensus 667 ~~~~~~ 672 (684)
+.+...
T Consensus 172 ~~~~~~ 177 (287)
T 2wei_A 172 TCFQQN 177 (287)
T ss_dssp GTBCCC
T ss_pred eeecCC
Confidence 887543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.6e-23 Score=211.19 Aligned_cols=151 Identities=32% Similarity=0.457 Sum_probs=124.3
Q ss_pred cCCCCccceecccCcEeEEEEEeeC--Cc--EEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE--GQ--EIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~--g~--~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 588 (684)
.++|++.+.||+|+||.||+|.+.. ++ .||||+++.. .....+.+.+|++++++++||||+++++++...+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4679999999999999999998643 33 6899998754 2344678899999999999999999999998655 8
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
++|+||+++++|.+++... ...+++.++..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999998543 245899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCC
Q 005669 669 FGLD 672 (684)
Q Consensus 669 ~~~~ 672 (684)
+...
T Consensus 171 ~~~~ 174 (291)
T 1u46_A 171 LPQN 174 (291)
T ss_dssp CCC-
T ss_pred cccc
Confidence 7543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.2e-23 Score=219.92 Aligned_cols=147 Identities=17% Similarity=0.247 Sum_probs=128.4
Q ss_pred cCCCCccceecccCcEeEEEEEeeC---------CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceee---------
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE---------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK--------- 577 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~--------- 577 (684)
.++|++.+.||+|+||.||+|.... ++.||+|.+... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999764 789999998753 46889999999999999887
Q ss_pred ------EEEEEEe-CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcE
Q 005669 578 ------LLGCCTQ-RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNV 650 (684)
Q Consensus 578 ------l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NI 650 (684)
+++++.. ++..++||||+ +++|.+++... ....+++.++..++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6778776 67889999999 99999999643 2356999999999999999999999998 99999999999
Q ss_pred EEcCCC--cEEEEeeccccccCCC
Q 005669 651 LLDNTM--NPKISDFGLARSFGLD 672 (684)
Q Consensus 651 Ll~~~~--~vkI~DFGla~~~~~~ 672 (684)
|++.++ .+||+|||+|+.+...
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~ 214 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPS 214 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGG
T ss_pred EEcCCCCceEEEecCcceeeccCC
Confidence 999988 8999999999887543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-22 Score=208.15 Aligned_cols=150 Identities=24% Similarity=0.384 Sum_probs=125.0
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEE-EeCCeeEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC-TQRDERMLIY 592 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~lV~ 592 (684)
..++|++.+.||+|+||.||++... +++.||||++.... ...++.+|+.++++++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4578999999999999999999974 58899999876432 234588899999999988766666655 6677889999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCcEEEEeecccccc
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSF 669 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl---~~~~~vkI~DFGla~~~ 669 (684)
||+ +++|.+++... ...+++.++..++.||+.||.|||+++ |+||||||+|||+ ++++.+||+|||+|+.+
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 89999998532 345899999999999999999999998 9999999999999 78899999999999987
Q ss_pred CCC
Q 005669 670 GLD 672 (684)
Q Consensus 670 ~~~ 672 (684)
...
T Consensus 159 ~~~ 161 (296)
T 4hgt_A 159 RDA 161 (296)
T ss_dssp BCT
T ss_pred cCc
Confidence 554
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-22 Score=213.72 Aligned_cols=153 Identities=27% Similarity=0.499 Sum_probs=128.9
Q ss_pred hhcCCCCccceecccCcEeEEEEEee--CCcEEEEEEccCCC--cccHHHHHHHHHHHhcc---CCCceeeEEEEEE---
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLI--EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKL---QHRNLVKLLGCCT--- 583 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~--- 583 (684)
...++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45578999999999999999999983 57899999986432 22234566777777766 8999999999987
Q ss_pred --eCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEE
Q 005669 584 --QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (684)
Q Consensus 584 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~ 661 (684)
.....++||||++ ++|.+++... ....+++.++..++.||+.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4566899999998 5999888543 2345899999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCC
Q 005669 662 DFGLARSFGL 671 (684)
Q Consensus 662 DFGla~~~~~ 671 (684)
|||+++.+..
T Consensus 163 Dfg~~~~~~~ 172 (326)
T 1blx_A 163 DFGLARIYSF 172 (326)
T ss_dssp SCCSCCCCCG
T ss_pred cCcccccccC
Confidence 9999987653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=8.6e-23 Score=222.61 Aligned_cols=149 Identities=28% Similarity=0.418 Sum_probs=116.2
Q ss_pred CCCCc-cceecccCcEeEEEEEee---CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe--CCeeEE
Q 005669 517 DNFSE-KNKLGEGGFGPVYKGMLI---EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDERML 590 (684)
Q Consensus 517 ~~y~~-~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~l 590 (684)
+.|++ .++||+|+||.||+|... +++.||||++... .....+.+|+.++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44554 458999999999999975 3788999999753 234578899999999999999999999965 678999
Q ss_pred EEEccCCCChhHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCcEEE
Q 005669 591 IYEYLPNKSLDYFIFDTT------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNTMNPKI 660 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl----~~~~~vkI 660 (684)
||||+++ +|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999985 6766664211 1235899999999999999999999998 9999999999999 67889999
Q ss_pred EeeccccccCC
Q 005669 661 SDFGLARSFGL 671 (684)
Q Consensus 661 ~DFGla~~~~~ 671 (684)
+|||+|+.+..
T Consensus 174 ~Dfg~a~~~~~ 184 (405)
T 3rgf_A 174 ADMGFARLFNS 184 (405)
T ss_dssp CCTTCCC----
T ss_pred EECCCceecCC
Confidence 99999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.9e-22 Score=217.26 Aligned_cols=148 Identities=26% Similarity=0.468 Sum_probs=126.8
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCee---
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER--- 588 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~--- 588 (684)
..++|...+.||+|+||.||+|.... ++.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 34789999999999999999999754 8899999997642 23356788999999999999999999999877654
Q ss_pred ---EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecc
Q 005669 589 ---MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (684)
Q Consensus 589 ---~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGl 665 (684)
++||||++ ++|.+.+ ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 5787776 234899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCC
Q 005669 666 ARSFGL 671 (684)
Q Consensus 666 a~~~~~ 671 (684)
|+..+.
T Consensus 191 a~~~~~ 196 (371)
T 4exu_A 191 ARHADA 196 (371)
T ss_dssp C-----
T ss_pred cccccc
Confidence 987654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=9.3e-23 Score=213.85 Aligned_cols=155 Identities=24% Similarity=0.384 Sum_probs=125.0
Q ss_pred HHhhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcc------cHHHHHHHHHHHhcc----CCCceeeEEE
Q 005669 512 IANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ------GMEEFKNEVLLIAKL----QHRNLVKLLG 580 (684)
Q Consensus 512 l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l----~H~nIv~l~g 580 (684)
.+...++|++.+.||+|+||.||++... +++.||||++...... ....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 4455688999999999999999999874 4889999999754321 223456789999888 8999999999
Q ss_pred EEEeCCeeEEEEEc-cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCcE
Q 005669 581 CCTQRDERMLIYEY-LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNP 658 (684)
Q Consensus 581 ~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~-~~~~v 658 (684)
++...+..++|+|| +.+++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++ +++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 789999999854 345899999999999999999999998 99999999999999 88999
Q ss_pred EEEeeccccccCCC
Q 005669 659 KISDFGLARSFGLD 672 (684)
Q Consensus 659 kI~DFGla~~~~~~ 672 (684)
||+|||+++.+...
T Consensus 180 kl~dfg~~~~~~~~ 193 (312)
T 2iwi_A 180 KLIDFGSGALLHDE 193 (312)
T ss_dssp EECCCSSCEECCSS
T ss_pred EEEEcchhhhcccC
Confidence 99999999987543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.87 E-value=6e-22 Score=205.70 Aligned_cols=151 Identities=23% Similarity=0.374 Sum_probs=129.2
Q ss_pred hcCCCCccceecccCcEeEEEEEe-eCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEE-EeCCeeEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC-TQRDERMLIY 592 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~lV~ 592 (684)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ..+++.+|+.++++++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999997 458999999987543 235689999999999988766655555 6677889999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCcEEEEeecccccc
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSF 669 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl---~~~~~vkI~DFGla~~~ 669 (684)
||+ +++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 89999998532 346899999999999999999999998 9999999999999 48889999999999987
Q ss_pred CCCC
Q 005669 670 GLDQ 673 (684)
Q Consensus 670 ~~~~ 673 (684)
....
T Consensus 159 ~~~~ 162 (296)
T 3uzp_A 159 RDAR 162 (296)
T ss_dssp BCTT
T ss_pred cccc
Confidence 6543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-22 Score=218.92 Aligned_cols=150 Identities=12% Similarity=0.156 Sum_probs=112.7
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhcc--CCCceeeEE-------EEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKL--QHRNLVKLL-------GCC 582 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l--~H~nIv~l~-------g~~ 582 (684)
..+|...+.||+|+||.||+|.+. +++.||||++..... ...+.+++|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 445888999999999999999975 588999999987532 3345677885544444 699988755 455
Q ss_pred EeC-----------------CeeEEEEEccCCCChhHHHhccCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCc
Q 005669 583 TQR-----------------DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR------SHIIAGIARGLLYLHQDSRLR 639 (684)
Q Consensus 583 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qi~~gL~yLH~~~~~~ 639 (684)
... ...++||||++ ++|.+++.... ..+++..+ ..++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 433 33799999999 89999996532 22345555 678899999999999998
Q ss_pred eEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 640 IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|+||||||+|||++.++.+||+|||+|+..+.
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~ 246 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC
Confidence 99999999999999999999999999998753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.5e-22 Score=216.86 Aligned_cols=150 Identities=24% Similarity=0.311 Sum_probs=130.1
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhcc------CCCceeeEEEEEEeCCe
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL------QHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l------~H~nIv~l~g~~~~~~~ 587 (684)
...+|++.++||+|+||.||+|.... ++.||||++... ......+.+|+.+++.+ +|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 45679999999999999999998765 789999999753 33446677888888877 57799999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc--EEEEeecc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN--PKISDFGL 665 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~--vkI~DFGl 665 (684)
.++||||++ ++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999997 5888887543 2345899999999999999999999998 999999999999999887 99999999
Q ss_pred ccccC
Q 005669 666 ARSFG 670 (684)
Q Consensus 666 a~~~~ 670 (684)
|+...
T Consensus 249 a~~~~ 253 (429)
T 3kvw_A 249 SCYEH 253 (429)
T ss_dssp CEETT
T ss_pred ceecC
Confidence 98754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.9e-22 Score=217.01 Aligned_cols=135 Identities=26% Similarity=0.365 Sum_probs=113.6
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccC--------CCceeeEEEEEE---
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ--------HRNLVKLLGCCT--- 583 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--------H~nIv~l~g~~~--- 583 (684)
.++|++.++||+|+||.||++.... ++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 4789999999999999999998754 789999999753 344567889999999985 788999999987
Q ss_pred -eCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCC
Q 005669 584 -QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTM 656 (684)
Q Consensus 584 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~IvHrDLkp~NILl~~~~ 656 (684)
.....++||||+.+ +|.+.+... ....+++..+..++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEeccCc-cHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 45578999999954 555555332 235689999999999999999999998 7 99999999999998775
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.5e-22 Score=220.06 Aligned_cols=150 Identities=24% Similarity=0.361 Sum_probs=129.6
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCC-CceeeEEEEEEeCCeeEEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH-RNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E 593 (684)
.++|++.++||+|+||.||++... +++.||||++..... ..++.+|+++++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 478999999999999999999974 489999998875432 3458899999999976 667777777788889999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCcEEEEeeccccccC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFG 670 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl---~~~~~vkI~DFGla~~~~ 670 (684)
|+ +++|.+++... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+|+.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 89999998532 346899999999999999999999998 9999999999999 688999999999999876
Q ss_pred CCC
Q 005669 671 LDQ 673 (684)
Q Consensus 671 ~~~ 673 (684)
...
T Consensus 158 ~~~ 160 (483)
T 3sv0_A 158 DTS 160 (483)
T ss_dssp CTT
T ss_pred CCc
Confidence 543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=8.4e-22 Score=208.26 Aligned_cols=151 Identities=23% Similarity=0.346 Sum_probs=130.8
Q ss_pred hcCCCCccceecccCcEeEEEEEe-e-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCC------ceeeEEEEEEeCC
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGML-I-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR------NLVKLLGCCTQRD 586 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~-~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~------nIv~l~g~~~~~~ 586 (684)
..++|++.+.||+|+||.||++.. . +++.||||+++.. ....+.+.+|+.+++.++|+ +++++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 346899999999999999999987 2 4789999999753 34456788999999988765 4999999999999
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC------------
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN------------ 654 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~------------ 654 (684)
..++||||+ +++|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 999999999 78998888543 2346899999999999999999999998 999999999999987
Q ss_pred -------CCcEEEEeeccccccCC
Q 005669 655 -------TMNPKISDFGLARSFGL 671 (684)
Q Consensus 655 -------~~~vkI~DFGla~~~~~ 671 (684)
++.+||+|||+++....
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~ 189 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE 189 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS
T ss_pred cccccccCCCceEeeCcccccCcc
Confidence 66899999999987643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-22 Score=214.48 Aligned_cols=147 Identities=27% Similarity=0.471 Sum_probs=126.9
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe-----
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE----- 587 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~----- 587 (684)
.++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999975 48999999997542 2335678899999999999999999999987654
Q ss_pred -eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 588 -RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 588 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
.++||||++ ++|.+++ ...+++.++..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIM-----GLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 5787766 234899999999999999999999998 999999999999999999999999999
Q ss_pred cccCC
Q 005669 667 RSFGL 671 (684)
Q Consensus 667 ~~~~~ 671 (684)
+....
T Consensus 174 ~~~~~ 178 (353)
T 3coi_A 174 RHADA 178 (353)
T ss_dssp TC---
T ss_pred cCCCC
Confidence 87643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.2e-22 Score=230.02 Aligned_cols=154 Identities=27% Similarity=0.401 Sum_probs=132.9
Q ss_pred HhhcCCCCccceecccCcEeEEEEEeeC----CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 005669 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 513 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 587 (684)
....++|++.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3345778999999999999999998743 4579999987543 334567899999999999999999999985 566
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 89999999999999998542 345899999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCC
Q 005669 668 SFGLD 672 (684)
Q Consensus 668 ~~~~~ 672 (684)
.+...
T Consensus 540 ~~~~~ 544 (656)
T 2j0j_A 540 YMEDS 544 (656)
T ss_dssp SCCC-
T ss_pred ecCCC
Confidence 87543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=3.2e-22 Score=210.99 Aligned_cols=155 Identities=25% Similarity=0.368 Sum_probs=132.8
Q ss_pred HHHhhcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcc------cHHHHHHHHHHHhccC--CCceeeEEEE
Q 005669 511 IIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ------GMEEFKNEVLLIAKLQ--HRNLVKLLGC 581 (684)
Q Consensus 511 ~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~--H~nIv~l~g~ 581 (684)
+.....++|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33445678999999999999999999864 4889999998754211 2245678999999996 5999999999
Q ss_pred EEeCCeeEEEEEccCC-CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCcEE
Q 005669 582 CTQRDERMLIYEYLPN-KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPK 659 (684)
Q Consensus 582 ~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~-~~~~vk 659 (684)
+...+..++|+|++.+ ++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+|
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence 9999999999999986 899999854 346899999999999999999999998 99999999999999 788999
Q ss_pred EEeeccccccCC
Q 005669 660 ISDFGLARSFGL 671 (684)
Q Consensus 660 I~DFGla~~~~~ 671 (684)
|+|||+++.+..
T Consensus 191 L~Dfg~~~~~~~ 202 (320)
T 3a99_A 191 LIDFGSGALLKD 202 (320)
T ss_dssp ECCCTTCEECCS
T ss_pred EeeCcccccccc
Confidence 999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8.1e-22 Score=208.19 Aligned_cols=152 Identities=24% Similarity=0.379 Sum_probs=126.6
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHH-HHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVL-LIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
.++|+..+.||+|+||.||++... +++.||||++.... .....++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467889999999999999999985 48899999997642 233345556665 677789999999999999999999999
Q ss_pred EccCCCChhHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 593 EYLPNKSLDYFIFDT--TRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
||+++ +|.+++... .....+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+++.+
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 777766421 2245689999999999999999999998 7 999999999999999999999999999877
Q ss_pred CC
Q 005669 670 GL 671 (684)
Q Consensus 670 ~~ 671 (684)
..
T Consensus 177 ~~ 178 (327)
T 3aln_A 177 VD 178 (327)
T ss_dssp --
T ss_pred cc
Confidence 53
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-22 Score=213.11 Aligned_cols=153 Identities=29% Similarity=0.485 Sum_probs=129.3
Q ss_pred HHHHhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 005669 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 510 ~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 587 (684)
++.....++|++.+.||+|+||.||+|...+ .+|+|.+... .....+.+.+|+.++++++|+||+++++++...+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3334456789999999999999999998743 5999998754 23334567889999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.++||||+++++|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+||+++ ++.+||+|||+++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp EEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred eEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 9999999999999999843 2346899999999999999999999998 99999999999998 6799999999988
Q ss_pred ccC
Q 005669 668 SFG 670 (684)
Q Consensus 668 ~~~ 670 (684)
...
T Consensus 178 ~~~ 180 (319)
T 2y4i_B 178 ISG 180 (319)
T ss_dssp ---
T ss_pred ccc
Confidence 653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.5e-22 Score=217.20 Aligned_cols=150 Identities=27% Similarity=0.322 Sum_probs=120.6
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 344556889999999998776667999999998642 345678999999886 8999999999999999999999999
Q ss_pred CCCChhHHHhccCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-------------CcE
Q 005669 596 PNKSLDYFIFDTTRSK----LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-------------MNP 658 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~-------------~~v 658 (684)
+ ++|.+++....... ..++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999985432211 1133346789999999999999998 9999999999999754 489
Q ss_pred EEEeeccccccCCCC
Q 005669 659 KISDFGLARSFGLDQ 673 (684)
Q Consensus 659 kI~DFGla~~~~~~~ 673 (684)
||+|||+|+.+....
T Consensus 168 kL~DFG~a~~~~~~~ 182 (434)
T 2rio_A 168 LISDFGLCKKLDSGQ 182 (434)
T ss_dssp EECCCTTCEECCC--
T ss_pred EEcccccceecCCCC
Confidence 999999999886543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.9e-21 Score=205.18 Aligned_cols=149 Identities=23% Similarity=0.295 Sum_probs=121.6
Q ss_pred hcCCCCccc-eecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe----CCee
Q 005669 515 ATDNFSEKN-KLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDER 588 (684)
Q Consensus 515 ~t~~y~~~~-~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~ 588 (684)
..++|.+.+ .||+|+||.||++... +++.||||++... .....+....++.++|+||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 346788854 6999999999999986 4899999998653 1222233334667799999999999976 4458
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCcEEEEeecc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGL 665 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~---~~~vkI~DFGl 665 (684)
++||||+++++|.+++... ....+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999999543 2356999999999999999999999998 999999999999975 45599999999
Q ss_pred ccccCC
Q 005669 666 ARSFGL 671 (684)
Q Consensus 666 a~~~~~ 671 (684)
++....
T Consensus 178 ~~~~~~ 183 (336)
T 3fhr_A 178 AKETTQ 183 (336)
T ss_dssp CEEC--
T ss_pred ceeccc
Confidence 987653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.9e-21 Score=208.88 Aligned_cols=158 Identities=26% Similarity=0.337 Sum_probs=131.6
Q ss_pred HHHHhhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccC-CC-----ceeeEEEEE
Q 005669 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HR-----NLVKLLGCC 582 (684)
Q Consensus 510 ~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~-----nIv~l~g~~ 582 (684)
+......++|++.+.||+|+||.||+|.... ++.||||+++.. .....++.+|+.+++.++ |+ +|+++++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 3445567899999999999999999999764 789999999753 334567788999888885 54 499999999
Q ss_pred EeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc--CCCcEEE
Q 005669 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NTMNPKI 660 (684)
Q Consensus 583 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~--~~~~vkI 660 (684)
...+..++||||+++ +|.+++.... ...+++..+..++.||+.||.|||.+. .+|+||||||+|||++ .++.+||
T Consensus 126 ~~~~~~~lv~e~~~~-~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 126 MFRNHLCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EETTEEEEEEECCCC-BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEE
T ss_pred ccCCceEEEEecCCC-CHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEE
Confidence 999999999999974 8988885432 345899999999999999999999531 2399999999999994 5778999
Q ss_pred EeeccccccCC
Q 005669 661 SDFGLARSFGL 671 (684)
Q Consensus 661 ~DFGla~~~~~ 671 (684)
+|||+|+.++.
T Consensus 203 ~DFG~a~~~~~ 213 (382)
T 2vx3_A 203 VDFGSSCQLGQ 213 (382)
T ss_dssp CCCTTCEETTC
T ss_pred EeccCceeccc
Confidence 99999998754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-21 Score=215.71 Aligned_cols=150 Identities=24% Similarity=0.359 Sum_probs=122.5
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEEE
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
....+|...+.||+|+||+|+.....+++.||||++..... ..+.+|+.+++++ +||||+++++++.+.+..++||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 34456888899999999997665556789999999975432 3356899999999 7999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-----CCcEEEEeecccc
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----TMNPKISDFGLAR 667 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~-----~~~vkI~DFGla~ 667 (684)
||++ ++|.+++.... ..+.+.++..++.||+.||+|||+++ |+||||||+|||++. ...+||+|||+|+
T Consensus 98 E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9997 58988885432 23445566789999999999999998 999999999999943 3358899999999
Q ss_pred ccCCC
Q 005669 668 SFGLD 672 (684)
Q Consensus 668 ~~~~~ 672 (684)
.+...
T Consensus 172 ~~~~~ 176 (432)
T 3p23_A 172 KLAVG 176 (432)
T ss_dssp CC---
T ss_pred eccCC
Confidence 87543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.1e-22 Score=227.24 Aligned_cols=154 Identities=29% Similarity=0.439 Sum_probs=132.0
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEe------CCe
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ------RDE 587 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~------~~~ 587 (684)
.++|++.++||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999975 4889999998754 33445678999999999999999999999765 667
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---EEEEeec
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN---PKISDFG 664 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~---vkI~DFG 664 (684)
.++||||+++++|.+++........+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976554456899999999999999999999998 999999999999986664 9999999
Q ss_pred cccccCCC
Q 005669 665 LARSFGLD 672 (684)
Q Consensus 665 la~~~~~~ 672 (684)
+++.+...
T Consensus 170 ~a~~~~~~ 177 (676)
T 3qa8_A 170 YAKELDQG 177 (676)
T ss_dssp CCCBTTSC
T ss_pred cccccccc
Confidence 99987543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.1e-21 Score=204.47 Aligned_cols=151 Identities=22% Similarity=0.346 Sum_probs=128.1
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-C-cEEEEEEccCCCcccHHHHHHHHHHHhccCCCc------eeeEEEEEEeCC
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-G-QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN------LVKLLGCCTQRD 586 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------Iv~l~g~~~~~~ 586 (684)
..++|++.+.||+|+||.||++.... + +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 35789999999999999999999753 4 68999999753 344567888999999987665 999999999999
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE--------------
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL-------------- 652 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl-------------- 652 (684)
..++||||+. ++|.+.+... ....+++.++..++.||+.||+|||+++ |+||||||+|||+
T Consensus 96 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELLG-KNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEeccC-CChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 9999999995 5565665432 2346899999999999999999999998 9999999999999
Q ss_pred -----cCCCcEEEEeeccccccCC
Q 005669 653 -----DNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 653 -----~~~~~vkI~DFGla~~~~~ 671 (684)
+.++.+||+|||+++....
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~ 194 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHE 194 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTS
T ss_pred ccccccCCCcEEEeecCccccccc
Confidence 5678999999999987643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.4e-21 Score=204.99 Aligned_cols=151 Identities=21% Similarity=0.353 Sum_probs=116.9
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcc-c-HHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ-G-MEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
..++|+..+.||+|+||.||++... +++.||||++...... . .+.+.++..+++.++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3467888999999999999999986 4899999999764322 2 23344555678888999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
|||+ ++.+..+... ....+++..+..++.||++||.|||++ + |+|+||||+||+++.++.+||+|||+++.+.
T Consensus 103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 4555555432 235689999999999999999999985 7 9999999999999999999999999998764
Q ss_pred C
Q 005669 671 L 671 (684)
Q Consensus 671 ~ 671 (684)
.
T Consensus 177 ~ 177 (318)
T 2dyl_A 177 D 177 (318)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.3e-21 Score=208.25 Aligned_cols=150 Identities=25% Similarity=0.378 Sum_probs=128.5
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccC-----------CCceeeEEEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-----------HRNLVKLLGCCT 583 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~g~~~ 583 (684)
.++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 367999999999999999999974 4889999999753 334567889999999886 899999999998
Q ss_pred eCC----eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEc-----
Q 005669 584 QRD----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLD----- 653 (684)
Q Consensus 584 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~IvHrDLkp~NILl~----- 653 (684)
..+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 689999999 88999988543 234589999999999999999999998 8 99999999999994
Q ss_pred -CCCcEEEEeeccccccCC
Q 005669 654 -NTMNPKISDFGLARSFGL 671 (684)
Q Consensus 654 -~~~~vkI~DFGla~~~~~ 671 (684)
..+.+||+|||+|+.+..
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~ 190 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE 190 (373)
T ss_dssp TTEEEEEECCCTTCEETTB
T ss_pred cCcceEEEcccccccccCC
Confidence 445799999999988754
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.9e-21 Score=165.79 Aligned_cols=104 Identities=18% Similarity=0.400 Sum_probs=89.2
Q ss_pred cccCCCCcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEEec
Q 005669 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLN 125 (684)
Q Consensus 46 ~~l~~g~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l~~ 125 (684)
++|.+||.|.+|++|.| |.|.|.|...++ |.++. ..++||+|||+.|.. ..+.|+|+. ||||||+|
T Consensus 2 n~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~----~~~~vW~ant~~~~~-~~~~L~l~~--dGnLvL~d 67 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD----HSTSTWASNTEIGGK-SGCSAVLQS--DGNFVVYD 67 (105)
T ss_dssp CEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTC-CSCEEEECT--TSCEEEEC
T ss_pred CCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE----CCEEEEEecCCCCCC-ccEEEEEeC--CccEEEEC
Confidence 78999999999999988 779999987765 44542 468999999999976 457899988 99999999
Q ss_pred CCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEee
Q 005669 126 STNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQS 170 (684)
Q Consensus 126 ~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQS 170 (684)
+++.+||+|++......+.|+|+|+|||||++. +||||
T Consensus 68 ~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~-------~~W~S 105 (105)
T 4h3o_A 68 SSGRSLWASHSTRGSGNYILILQDDGNVIIYGS-------DIWST 105 (105)
T ss_dssp TTCCEEEECCCCCCSSCEEEEECTTSCEEEEES-------EEEEC
T ss_pred CCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC-------cEecC
Confidence 999999999987644567899999999999954 59998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.8e-21 Score=199.10 Aligned_cols=145 Identities=19% Similarity=0.195 Sum_probs=116.3
Q ss_pred HHHHhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCc------------------ccHHHHHHHHHHHhccC
Q 005669 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG------------------QGMEEFKNEVLLIAKLQ 571 (684)
Q Consensus 510 ~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l~ 571 (684)
..+......|+..+.||+|+||.||+|...+++.||||.++.... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344455667778899999999999999996689999999964321 12456889999999999
Q ss_pred CCceeeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 005669 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (684)
Q Consensus 572 H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NIL 651 (684)
| +++.+++.. +..++||||+++++|.+ +. ..+...++.||+.||.|||+++ |+||||||+|||
T Consensus 163 ~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 G---LAVPKVYAW-EGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp T---SSSCCEEEE-ETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred C---CCcCeEEec-cceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 4 555554433 55699999999999977 41 1234579999999999999998 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCC
Q 005669 652 LDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 652 l~~~~~vkI~DFGla~~~~~~ 672 (684)
++ ++.+||+|||+|+.....
T Consensus 226 l~-~~~vkl~DFG~a~~~~~~ 245 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVEVGEE 245 (282)
T ss_dssp EE-TTEEEECCCTTCEETTST
T ss_pred EE-CCcEEEEECCCCeECCCC
Confidence 99 999999999999977543
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-20 Score=168.17 Aligned_cols=108 Identities=21% Similarity=0.332 Sum_probs=93.7
Q ss_pred ccccccCCCCcccCCCEEE--ecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCce
Q 005669 43 RTLDTISLGQSIKDGETLV--SAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGI 120 (684)
Q Consensus 43 ~~~~~l~~g~~l~~~~~l~--S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~ 120 (684)
++.++|.+|++|.+|++|+ |++|.|+|+|+.+|+ | +||.. +++||+|||+.| +.++.|.|+. |||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~---~~~vW~sn~~~~--~~~~~l~l~~--dGN 72 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN---NNPIWATNTGGL--GNGCRAVLQP--DGV 72 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--CSSCEEEECT--TSC
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC---CEEEEeCCCccC--CCceEEEEcc--CCE
Confidence 4568999999999999999 999999999998775 1 57865 799999999977 3457899988 999
Q ss_pred EEEecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEee
Q 005669 121 LVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQS 170 (684)
Q Consensus 121 l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQS 170 (684)
|||+|.++.++|+|.+....+...++|+|+|||||++ .++|||
T Consensus 73 LVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~-------~~~W~S 115 (119)
T 1b2p_A 73 LVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG-------DALWAT 115 (119)
T ss_dssp EEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE-------SEEEEC
T ss_pred EEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC-------ccEeCC
Confidence 9999999999999997654456789999999999996 279998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.5e-20 Score=164.00 Aligned_cols=110 Identities=22% Similarity=0.417 Sum_probs=94.3
Q ss_pred ccccCCCCcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEEe
Q 005669 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLL 124 (684)
Q Consensus 45 ~~~l~~g~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l~ 124 (684)
.|+|.+||.|.+|++|+ ++|.|+|+|+..|+ | |+|. .+++||+||++.|. .++.+.|+. ||||||+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~---~~~~vW~sn~~~~~--~~~~l~l~~--dGNLVl~ 66 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD---SGKPVWASNTGGLG--SGCRLTLHN--NGNLVIY 66 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE---TTEEEEECCCTTSC--SSCEEEECT--TSCEEEE
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE---CCEEEEECCCCCCC--CcEEEEEeC--CCCEEEE
Confidence 37899999999999999 99999999988775 2 6676 37999999998773 357899988 9999999
Q ss_pred cCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCC
Q 005669 125 NSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPC 175 (684)
Q Consensus 125 ~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PT 175 (684)
|.++.++|+|.+....+...++|+|+|||||++. ++||||+||.
T Consensus 67 ~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~-------~~W~S~~~~~ 110 (110)
T 3a0c_A 67 DQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP-------VVWATGSGPA 110 (110)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS-------EEEECSCCC-
T ss_pred CCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC-------CEecCCCcCC
Confidence 9999999999987544567899999999999952 7999999983
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2e-21 Score=219.21 Aligned_cols=136 Identities=21% Similarity=0.269 Sum_probs=108.3
Q ss_pred CccceecccCcEeEEEEEeeCCcEEEEEEccCCCcc--------cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ--------GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 520 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
...+.||+|+||.||++.. .++.+++|+....... ..+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4457899999999999944 5788999886543211 134578999999999999999766666678888999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||+++ .+||+|||+|+.+..
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999832 5689999999999999998 999999999999998 999999999998865
Q ss_pred C
Q 005669 672 D 672 (684)
Q Consensus 672 ~ 672 (684)
.
T Consensus 482 ~ 482 (540)
T 3en9_A 482 D 482 (540)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.5e-19 Score=160.44 Aligned_cols=110 Identities=23% Similarity=0.386 Sum_probs=92.5
Q ss_pred ccccCCCCcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEEe
Q 005669 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLL 124 (684)
Q Consensus 45 ~~~l~~g~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l~ 124 (684)
.|+|.+||+|.+|++|+ +|.|+|+|+.+++ . ++|. .+++||+||++.|. .++.|.|+. ||||||+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn---l---vly~---~~~~vW~sn~~~~~--~~~~l~l~~--~GnLvl~ 66 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN---L---VKYQ---NGRQIWASNTDRRG--SGCRLTLLS--DGNLVIY 66 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC---E---EEEE---TTEEEEECSCTTSC--SSCEEEECT--TSCEEEE
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc---E---EEEe---CCEEEEeCCCCCCC--CceEEEECC--CCcEEEE
Confidence 48999999999999998 7999999987764 1 3354 47899999999884 457899988 9999999
Q ss_pred cCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCC
Q 005669 125 NSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCD 176 (684)
Q Consensus 125 ~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTD 176 (684)
|.++.++|+|++........++|+|+|||||++. ++||||.+++.
T Consensus 67 d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~-------~~W~S~~~~~~ 111 (115)
T 2dpf_A 67 DHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP-------VLWSLGPNGCR 111 (115)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS-------EEECSSTTCBC
T ss_pred CCCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC-------CEEECCCCCCc
Confidence 9989999999876444567899999999999942 79999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.9e-19 Score=159.15 Aligned_cols=110 Identities=20% Similarity=0.434 Sum_probs=92.2
Q ss_pred ccccCCCCcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEEe
Q 005669 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLL 124 (684)
Q Consensus 45 ~~~l~~g~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l~ 124 (684)
.|+|.+||+|.+|++| ++|.|+|+|+.+++- ++|.. +++||+||++.+ +.++.+.|+. ||||||+
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgnl------vl~~~---~~~vW~sn~~~~--~~~~~l~l~~--~GNLvl~ 65 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCNL------VLYDN---NRAVWASGTNGK--ASGCVLKMQN--DGNLVIY 65 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSCE------EEEET---TEEEEECCCTTS--CSSEEEEECT--TSCEEEE
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCcE------EEEEC---CEEEEeCCCcCC--CCCEEEEEeC--CCCEEEE
Confidence 3899999999999999 578999999988752 45654 689999999864 3457899988 9999999
Q ss_pred cCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCC
Q 005669 125 NSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYP 174 (684)
Q Consensus 125 ~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~P 174 (684)
| ++.++|+|.+....+...++|+++|||||++. .+.++||||++.
T Consensus 66 d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~----~~~~~W~S~~~~ 110 (112)
T 1xd5_A 66 S-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDN----SNNAIWATHTNV 110 (112)
T ss_dssp E-TTEEEEECCCCCSCCCCEEEECTTSCEEEECT----TSCEEEECCCCC
T ss_pred c-CCEEEEECCccCCCCCEEEEEeCCCcEEEECC----CCceEEECCCcc
Confidence 9 78899999876544567899999999999975 357999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-19 Score=197.66 Aligned_cols=153 Identities=18% Similarity=0.209 Sum_probs=114.7
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC---cccHHHHHHHHHHHhccCC-Cce---------ee---
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQH-RNL---------VK--- 577 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H-~nI---------v~--- 577 (684)
....|...+.||+|+||.||+|.+. +++.||||++.... ....+.+++|+.+++.++| +|. +.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3455777889999999999999965 48999999987432 2336789999999999987 211 11
Q ss_pred ---------EEEEEEe-----CCeeEEEEEccCCCChhHHHhc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 005669 578 ---------LLGCCTQ-----RDERMLIYEYLPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639 (684)
Q Consensus 578 ---------l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ 639 (684)
+..+... ....+++|+++ +++|.+++.. ......+++..+..++.||++||+|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1111111 12346666665 5889888741 122345788899999999999999999998
Q ss_pred eEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 640 IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|+||||||+||||+.++.+||+|||+|+..+.
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~ 263 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCC
Confidence 99999999999999999999999999987643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=5.3e-19 Score=180.54 Aligned_cols=140 Identities=14% Similarity=0.156 Sum_probs=108.6
Q ss_pred CCCccceecccCcEeEEEEEe-eCCcE--EEEEEccCCCcc------------------------cHHHHHHHHHHHhcc
Q 005669 518 NFSEKNKLGEGGFGPVYKGML-IEGQE--IAVKRLSKGSGQ------------------------GMEEFKNEVLLIAKL 570 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~Ei~~l~~l 570 (684)
-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 366778999999999999998 67888 999987543111 013578899999999
Q ss_pred CCCce--eeEEEEEEeCCeeEEEEEccCC-C----ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEe
Q 005669 571 QHRNL--VKLLGCCTQRDERMLIYEYLPN-K----SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH-QDSRLRIIH 642 (684)
Q Consensus 571 ~H~nI--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~~~~IvH 642 (684)
+|+++ +.++.. +..++||||+.+ | +|.+.... .++.++..++.|++.||.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88753 444442 356899999942 3 66665421 234567789999999999999 887 999
Q ss_pred cCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 643 RDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 643 rDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|||||+|||+++ .++|+|||+|.....+
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 999999999998 9999999999887543
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.9e-18 Score=150.60 Aligned_cols=103 Identities=23% Similarity=0.432 Sum_probs=86.3
Q ss_pred cccCCCCcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEEec
Q 005669 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLN 125 (684)
Q Consensus 46 ~~l~~g~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l~~ 125 (684)
++|.+||.|.+|++|+ +|.|.|+|+.+|+ | +.|.. .++||++|++.+ +.++.|.|+. ||||||+|
T Consensus 2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----L-vly~~---~~~vW~snt~~~--~~~~~l~l~~--dGNLvl~~ 66 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN--NGRYVFIMQEDCN-----L-VLYDV---DKPIWATNTGGL--DRRCHLSMQS--DGNLVVYS 66 (109)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--SSSCEEEECT--TSCEEEEC
T ss_pred CCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----E-EEEeC---CEEEEECCcccC--CCCEEEEEeC--CCCEEEEC
Confidence 6899999999999996 7899999988775 2 22543 689999999876 3457899988 99999999
Q ss_pred CCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEee
Q 005669 126 STNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQS 170 (684)
Q Consensus 126 ~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQS 170 (684)
.++.++|+|++.......+|+|+|+|||||++. ++|||
T Consensus 67 ~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~-------~~W~s 104 (109)
T 3dzw_A 67 PRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT-------ARWAT 104 (109)
T ss_dssp TTSCEEEECCCCCSSSCEEEEECTTSCEEEEES-------CCCCC
T ss_pred CCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC-------CEEeC
Confidence 989999999986543456899999999999963 69998
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.70 E-value=6e-17 Score=142.16 Aligned_cols=105 Identities=24% Similarity=0.332 Sum_probs=84.4
Q ss_pred ccccccCCCCcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEE
Q 005669 43 RTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILV 122 (684)
Q Consensus 43 ~~~~~l~~g~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~ 122 (684)
.+.|+|.+||.|..|+.|+|. .|.|-|...|+ |.+ |.. .+||++|++.. +.++.|.|+. |||||
T Consensus 4 ~~~dtL~~gq~L~~g~~L~sg--~~~L~~q~dGn-----Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~--dGNLv 67 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTAK--NHQLVMQGDCN-----LVL-YGG----KYGWQSNTHGN--GEHCFLRLNH--KGELI 67 (110)
T ss_dssp CBTTEEETTCEEETTEEEECS--SCEEEECTTSC-----EEE-ECS----SSCEECCCTTS--SSSCEEEECT--TSCEE
T ss_pred cccCEECCCCEecCCCEEEeC--CEEEEEcCCCe-----EEE-ECC----eEEEECCCcCC--CcCEEEEEeC--CCcEE
Confidence 357999999999999999984 58887755553 334 543 47999999863 3457899988 99999
Q ss_pred EecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEee
Q 005669 123 LLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQS 170 (684)
Q Consensus 123 l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQS 170 (684)
|+|.++.++|+|++......++|+|+|+||||||+ .++|+|
T Consensus 68 l~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~-------~~~W~t 108 (110)
T 3r0e_B 68 IKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG-------PAIFET 108 (110)
T ss_dssp EECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC-------SEEEES
T ss_pred EEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec-------CCEecC
Confidence 99999999999998643345789999999999995 379997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.68 E-value=2.8e-16 Score=138.66 Aligned_cols=107 Identities=20% Similarity=0.283 Sum_probs=87.1
Q ss_pred cccccCCCCcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEE
Q 005669 44 TLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVL 123 (684)
Q Consensus 44 ~~~~l~~g~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l 123 (684)
+.|+|.+||.|.+|+.|.+ |.|.|-|...|+ |.+ |.. ...++||.+|++.+. .++.|.|+. ||||||
T Consensus 5 ~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL-~~~-~~~~~vWssnt~~~~--~~~~l~l~~--dGNLVl 71 (113)
T 3mez_B 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVL-TKG-SKTNIVWESGTSGRG--QHCFMRLGH--SGELDI 71 (113)
T ss_dssp CSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEE-EET-TTTEEEEECCCTTSC--SSCEEEECT--TSCEEE
T ss_pred cCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEE-EEC-CCCEEEEECCcccCC--cCEEEEEeC--CCcEEE
Confidence 5689999999999999975 789998876664 444 322 136899999998763 457899988 999999
Q ss_pred ecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEee
Q 005669 124 LNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQS 170 (684)
Q Consensus 124 ~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQS 170 (684)
+|.++.++|+|++......++|+|+|+||||||+ .++|+|
T Consensus 72 ~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~-------~~~W~s 111 (113)
T 3mez_B 72 TDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG-------PAVWST 111 (113)
T ss_dssp ECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC-------SEEEES
T ss_pred ECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec-------CCEecC
Confidence 9999999999998653345789999999999995 479997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=2.8e-16 Score=138.00 Aligned_cols=89 Identities=24% Similarity=0.384 Sum_probs=72.8
Q ss_pred CCceEEEeeccCceEEEecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCCCeecc
Q 005669 107 RSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGI 186 (684)
Q Consensus 107 ~~~~l~~~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~ 186 (684)
...+|.|+. ||||||++ .+.+||++++........++|+|+|||||++. ++.++||||
T Consensus 20 ~~~~l~~~~--dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~----~~~~~W~S~--------------- 77 (110)
T 3a0c_A 20 PSYRLIMQG--DCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQ----SNRVIWQTK--------------- 77 (110)
T ss_dssp TTEEEEECT--TSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECT----TCCEEEECC---------------
T ss_pred CCEEEEEcC--CCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECC----CCcEEEecC---------------
Confidence 457899987 99999999 47899999986543456899999999999987 467999999
Q ss_pred cccCccceeEEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCCC
Q 005669 187 NLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSW 237 (684)
Q Consensus 187 ~~~tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~~ 237 (684)
+++++|.|+++|+++|+ ++++++ .||+++++
T Consensus 78 ----------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 ----------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp ----------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred ----------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 24567899999999998 444554 89999875
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.66 E-value=3.2e-16 Score=138.27 Aligned_cols=94 Identities=20% Similarity=0.311 Sum_probs=76.1
Q ss_pred CCCceEEEeeccCceEEEecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCCCeec
Q 005669 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLG 185 (684)
Q Consensus 106 ~~~~~l~~~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~ 185 (684)
+...+|.|+. ||+|+|++. +.++|++++........|+|+|+|||||++ . +.++||||+
T Consensus 18 ~~~~~L~~~~--dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~----~~~~W~S~~------------- 76 (112)
T 1xd5_A 18 EGGYLFIIQN--DCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-G----SRAIWASNT------------- 76 (112)
T ss_dssp ETTEEEEECT--TSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-T----TEEEEECCC-------------
T ss_pred CCCEEEEEcC--CCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-C----CEEEEECCc-------------
Confidence 4457899987 999999988 789999998653345789999999999998 2 469999993
Q ss_pred ccccCccceeEEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCCCCC
Q 005669 186 INLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNG 239 (684)
Q Consensus 186 ~~~~tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~~~~ 239 (684)
+|++|.|+++|+++|+..++ .....+||++++|+|
T Consensus 77 ------------------~~~~g~~~l~l~~dGnlvl~-~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ------------------NRQNGNYYLILQRDRNVVIY-DNSNNAIWATHTNVG 111 (112)
T ss_dssp ------------------CCSCCCCEEEECTTSCEEEE-CTTSCEEEECCCCCC
T ss_pred ------------------cCCCCCEEEEEeCCCcEEEE-CCCCceEEECCCccC
Confidence 34568999999999994433 235789999999986
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.64 E-value=8.2e-16 Score=134.68 Aligned_cols=108 Identities=25% Similarity=0.396 Sum_probs=87.1
Q ss_pred cccccCCCCcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEE
Q 005669 44 TLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVL 123 (684)
Q Consensus 44 ~~~~l~~g~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l 123 (684)
+.|||.+||.|..|+.| .+|.|.|.|...|+ | +.|.. +|.+|+..+ +.++.|+|+. ||||||
T Consensus 2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----L-vl~~~------~Wssnt~~~--~~~~~l~l~~--dGnLvl 63 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----L-VLYNG------NWQSNTANN--GRDCKLTLTD--YGELVI 63 (109)
T ss_dssp CCSEEETTCEECTTCEE--EETTEEEEECTTSC-----E-EEETT------TEECCCTTS--CSSCEEEECT--TSCEEE
T ss_pred ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----E-EEEeC------eEEcCCCCC--CCcEEEEEcC--CCeEEE
Confidence 57999999999999999 56899999977665 2 22431 699998865 3468899988 999999
Q ss_pred ecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCC
Q 005669 124 LNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPG 181 (684)
Q Consensus 124 ~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpg 181 (684)
+|.++.++|++++......+.|+|+|+|||||++ .++|+| .|.+||
T Consensus 64 ~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~-------~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 64 KNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG-------PSVFKI-----DPWVRG 109 (109)
T ss_dssp ECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC-------SEEEEE-----CTTSCC
T ss_pred EeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe-------cCEECC-----CCccCC
Confidence 9999999999997653345689999999999995 479998 555554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=9.6e-17 Score=171.12 Aligned_cols=144 Identities=15% Similarity=0.194 Sum_probs=103.5
Q ss_pred HHHhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCc--------------ccHHH--------HHHHHHHHh
Q 005669 511 IIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG--------------QGMEE--------FKNEVLLIA 568 (684)
Q Consensus 511 ~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~--------------~~~~~--------~~~Ei~~l~ 568 (684)
.+.....-|++.+.||+|++|.||+|...+|++||||+++.... ..... ..+|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33344445899999999999999999998899999998763210 00111 234666777
Q ss_pred ccCCCce--eeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 005669 569 KLQHRNL--VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646 (684)
Q Consensus 569 ~l~H~nI--v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLk 646 (684)
++.+.++ ...++. ...+|||||+++.+|..+. .......++.||+.+|.|||+.+ |||||||
T Consensus 169 rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLK 232 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHG---LIHGDFN 232 (397)
T ss_dssp HHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred HHHhcCCCCCeeeec----cCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCC
Confidence 7755443 223322 1237999999998886543 11234568899999999999998 9999999
Q ss_pred CCcEEEcCCC----------cEEEEeeccccccC
Q 005669 647 ASNVLLDNTM----------NPKISDFGLARSFG 670 (684)
Q Consensus 647 p~NILl~~~~----------~vkI~DFGla~~~~ 670 (684)
|.|||+++++ .+.|+||+=+-...
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9999998776 38999999765543
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.60 E-value=4.3e-15 Score=132.18 Aligned_cols=86 Identities=22% Similarity=0.302 Sum_probs=70.8
Q ss_pred ceEEEeeccCceEEEecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCCCeecccc
Q 005669 109 GVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINL 188 (684)
Q Consensus 109 ~~l~~~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~~~ 188 (684)
.+|.|+. ||+|+|++. +.+||++++........|+|+|+|||||++. .+.++||||
T Consensus 32 ~~L~~~~--dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~----~~~~lW~S~----------------- 87 (119)
T 1b2p_A 32 YRFIMQT--DCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN----ENVTVWQSP----------------- 87 (119)
T ss_dssp EEEEECT--TSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT----TCCEEEECS-----------------
T ss_pred EEEEEec--CCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeC----CCcEEEcCC-----------------
Confidence 5688877 999999998 7899999986543457899999999999986 467999999
Q ss_pred cCccceeEEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCC
Q 005669 189 GTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGS 236 (684)
Q Consensus 189 ~tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~ 236 (684)
++|++|.|+++++++|+ +++++ .+||++|+
T Consensus 88 --------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp --------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred --------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 34567999999999999 44444 38999986
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=6.3e-15 Score=130.56 Aligned_cols=91 Identities=23% Similarity=0.357 Sum_probs=74.1
Q ss_pred CceEEEeeccCceEEEecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCCCeeccc
Q 005669 108 SGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGIN 187 (684)
Q Consensus 108 ~~~l~~~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~~ 187 (684)
...|.|+. ||+|+|++ .+.++|++++........++|+++|||||++. ++.++|||||+
T Consensus 21 ~~~L~~~~--dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~----~~~~vW~S~~~-------------- 79 (115)
T 2dpf_A 21 AYTLTIQN--KCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDH----NNNDVWGSACW-------------- 79 (115)
T ss_dssp TEEEEECT--TSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECT----TCCEEEECCCC--------------
T ss_pred CEEEEEcC--CCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECC----CceEEEEcCCC--------------
Confidence 46788877 99999998 47899999976533456899999999999986 35799999997
Q ss_pred ccCccceeEEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCCCCCc
Q 005669 188 LGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGL 240 (684)
Q Consensus 188 ~~tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~~~~~ 240 (684)
+++|.|++.++++|+ +++++. .||++++|...
T Consensus 80 -----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 -----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp -----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred -----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 345789999999998 444554 89999999653
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.51 E-value=6.5e-14 Score=122.97 Aligned_cols=103 Identities=19% Similarity=0.320 Sum_probs=81.4
Q ss_pred ccccCCCCcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEEe
Q 005669 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLL 124 (684)
Q Consensus 45 ~~~l~~g~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l~ 124 (684)
.++|.+||.|.+|+.| .+|.|.|.|...|+ |.+ |.. .. ||.+|+..+ +..+.|.|+. ||||||+
T Consensus 2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn-----Lvl-~~~---~~-vW~snt~~~--~~~~~l~l~~--dGNLVl~ 65 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN-----LVL-YNE---AG-GFQSNTHGR--GVDCTLRLNN--RGQLEIH 65 (111)
T ss_dssp TTEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ECS---SC-CEECCCTTS--CSSCEEEECT--TSCEEEE
T ss_pred cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe-----EEE-ECC---CC-EEECCcccC--CcCEEEEEcC--CCcEEEE
Confidence 4789999999999999 46889999976664 223 432 34 999999876 2357899988 9999999
Q ss_pred cCCCC-eEEEecccC--CCCCceEEEecCccEEEecCCCCCCCCeeEee
Q 005669 125 NSTND-TVWSSNSSI--SAQKPVAALMESGNLVVKDGKDNNPDNILWQS 170 (684)
Q Consensus 125 ~~~~~-~~w~s~~~~--~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQS 170 (684)
|.++. ++|+|++.. .....++.|+|+||||||+ .++|+|
T Consensus 66 ~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~-------~~~W~s 107 (111)
T 3mez_A 66 SANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG-------PAIWST 107 (111)
T ss_dssp CSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC-------SEEEEC
T ss_pred eCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec-------cCEEcc
Confidence 99876 599999632 2245789999999999995 479997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.37 E-value=1.8e-12 Score=114.15 Aligned_cols=95 Identities=24% Similarity=0.292 Sum_probs=72.5
Q ss_pred CCCCCCCCceEEEeeccCceEEEecC-CCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcC
Q 005669 101 DAPLSDRSGVLRINGERNGILVLLNS-TNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLL 179 (684)
Q Consensus 101 ~~pv~~~~~~l~~~~~~~g~l~l~~~-~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlL 179 (684)
+.|+.+...+|.|+. ||||||++. .+.++|++++........++|+|+|||||++. .+.++|||=.+
T Consensus 18 g~~L~~g~~~L~~q~--dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~----~~~~iW~S~t~------ 85 (113)
T 3mez_B 18 NAQLATRDYSLVMRD--DCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDD----RLNTVFVSNTV------ 85 (113)
T ss_dssp TCEEEETTEEEEECT--TSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECT----TSCEEEECSCC------
T ss_pred CCEeEcCCEEEEEcC--CCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECC----CCCEEEECCCc------
Confidence 344444557899987 999999998 48899999986533456899999999999987 35789998210
Q ss_pred CCCeecccccCccceeEEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCC
Q 005669 180 PGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGS 236 (684)
Q Consensus 180 pgq~l~~~~~tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~ 236 (684)
...|.|.+.++++|++.++ + .+.|.+|+
T Consensus 86 -------------------------~~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 86 -------------------------GQEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp -------------------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred -------------------------CCCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 0125689999999997776 3 58898875
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=3.4e-12 Score=129.82 Aligned_cols=147 Identities=15% Similarity=0.069 Sum_probs=115.4
Q ss_pred HhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEE
Q 005669 513 ANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 513 ~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV 591 (684)
......|.....++.|+.+.||+.... ++.+++|............+.+|+.+++.+. |..+.++++++...+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344567887788888899999999753 6899999987532223356889999999984 67888999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD------------------------------------ 635 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~------------------------------------ 635 (684)
|||++|.+|.+.+. +......++.+++++|..||+.
T Consensus 89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999976531 1122347888999999999981
Q ss_pred --------------------CCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 636 --------------------SRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 636 --------------------~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
.+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 113589999999999998766678999998854
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.29 E-value=1e-11 Score=108.84 Aligned_cols=90 Identities=18% Similarity=0.265 Sum_probs=69.1
Q ss_pred CCceEEEeeccCceEEEecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCCCeecc
Q 005669 107 RSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGI 186 (684)
Q Consensus 107 ~~~~l~~~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~ 186 (684)
....|.|+. ||||||++.++ +|++++........++|+|+|||||++..+ ..++|||.-+
T Consensus 20 g~~~L~~q~--dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~---~~~vW~S~t~------------- 79 (111)
T 3mez_A 20 ESAAFVMQG--DCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANS---NTPVWVYPRS------------- 79 (111)
T ss_dssp TTEEEEECT--TSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSC---SSCSEEESSS-------------
T ss_pred CCEEEEEcc--CCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCC---CEEEEEeccc-------------
Confidence 456899987 99999999876 999998653334689999999999998731 2369999621
Q ss_pred cccCccceeEEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCC
Q 005669 187 NLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGS 236 (684)
Q Consensus 187 ~~~tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~ 236 (684)
.....|.|.+.++++|+..++ . .++|.+++
T Consensus 80 ----------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~t 109 (111)
T 3mez_A 80 ----------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTPA 109 (111)
T ss_dssp ----------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred ----------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence 011347899999999997776 3 68898875
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=2.7e-11 Score=123.82 Aligned_cols=113 Identities=20% Similarity=0.349 Sum_probs=86.8
Q ss_pred ccccccCCCCc----ccCCCEEEecCCeEEEeeeCCC--CCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeec
Q 005669 43 RTLDTISLGQS----IKDGETLVSAKESFELGFFSPG--NSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGE 116 (684)
Q Consensus 43 ~~~~~l~~g~~----l~~~~~l~S~~g~f~lGF~~~~--~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~ 116 (684)
...||+.||+. |..|+.|.|+ ..++.|+|+.. .....+ + |.+ ..+++|.+++..+- . +.|.++.
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnlv--L-y~~--~~~~yW~Sgt~~~~--~-~~l~l~~- 203 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNLV--A-YGP--NGAATWNAGTQGKG--A-VRAVFQG- 203 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCEE--E-ECT--TSSEEEECCCTTTT--C-CEEEECT-
T ss_pred ccccccccccccccccccCcccccC-CCCCCceEEEeecCCceEE--E-EeC--CCeEEEECCCCCCc--c-EEEEEcC-
Confidence 45799999999 8889998654 56777776532 122333 3 322 35899999998772 2 7899988
Q ss_pred cCceEEEecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccC
Q 005669 117 RNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDY 173 (684)
Q Consensus 117 ~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~ 173 (684)
||+|+++|.++.++|++++... ...+|+|+++|||||++. .++||||||
T Consensus 204 -dGnLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~------~~~Wqsf~~ 252 (276)
T 3m7h_A 204 -DGNLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE------KPVWARFGF 252 (276)
T ss_dssp -TSCEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE------EEEEESSSC
T ss_pred -CCeEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC------CCeEEccCc
Confidence 9999999998899999997643 357899999999999963 479999997
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.19 E-value=6.1e-11 Score=103.73 Aligned_cols=86 Identities=23% Similarity=0.372 Sum_probs=66.3
Q ss_pred CceEEEeeccCceEEEecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCCCeeccc
Q 005669 108 SGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGIN 187 (684)
Q Consensus 108 ~~~l~~~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~~ 187 (684)
...|.|+. ||||||++. .++|++++........++|+|+|||||++. .+.++|||-.+
T Consensus 25 ~~~L~~q~--dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~----~~~~iW~S~t~-------------- 82 (110)
T 3r0e_B 25 NHQLVMQG--DCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDD----DFKTIWSSRSS-------------- 82 (110)
T ss_dssp SCEEEECT--TSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECT----TCCEEEECCCC--------------
T ss_pred CEEEEEcC--CCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeC----CCCEEEEcCCc--------------
Confidence 36788877 999999987 589999986533346899999999999987 45789998421
Q ss_pred ccCccceeEEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCC
Q 005669 188 LGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGS 236 (684)
Q Consensus 188 ~~tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~ 236 (684)
...|.|.+.++++|+..++ + .+.|.+|+
T Consensus 83 -----------------~~~~~~~~~L~~dGNlvly--~--~~~W~t~~ 110 (110)
T 3r0e_B 83 -----------------SKQGEYVLILQDDGFGVIY--G--PAIFETSS 110 (110)
T ss_dssp -----------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred -----------------CCCCCEEEEEcCCccEEEe--c--CCEecCCC
Confidence 0124689999999997776 3 37888764
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=9.8e-11 Score=102.36 Aligned_cols=87 Identities=20% Similarity=0.324 Sum_probs=67.1
Q ss_pred CceEEEeeccCceEEEecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCCCeeccc
Q 005669 108 SGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGIN 187 (684)
Q Consensus 108 ~~~l~~~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~~ 187 (684)
...|.|+. ||||||++. +.++|++++........++|+|+|||||++. .+.++|||....
T Consensus 20 ~~~L~~q~--dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~----~~~~~W~S~t~~------------- 79 (109)
T 3dzw_A 20 RYVFIMQE--DCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSP----RNNPIWASNTGG------------- 79 (109)
T ss_dssp TEEEEECT--TSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECT----TSCEEEECCCCC-------------
T ss_pred CEEEEEcC--CCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECC----CCCEEEECCCCC-------------
Confidence 46788877 999999998 6899999986533456899999999999986 357899984210
Q ss_pred ccCccceeEEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCC
Q 005669 188 LGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGS 236 (684)
Q Consensus 188 ~~tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~ 236 (684)
..+.|.+.++++|++.++ +. +.|.+|.
T Consensus 80 ------------------~~~~~~~~L~ddGNlvly--~~--~~W~s~t 106 (109)
T 3dzw_A 80 ------------------ENGNYVCVLQKDRNVVIY--GT--ARWATGT 106 (109)
T ss_dssp ------------------SSSCEEEEECTTSCEEEE--ES--CCCCCCC
T ss_pred ------------------CCCCEEEEEeCCCEEEEE--CC--CEEeCCC
Confidence 125688999999997776 32 6777765
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=3.7e-11 Score=121.49 Aligned_cols=141 Identities=16% Similarity=0.156 Sum_probs=104.0
Q ss_pred hcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCc--eeeEEEEEEeCCeeEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN--LVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~ 592 (684)
....+......+.|..+.||+....+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 34455543333456669999998766788999997653 2356788999999886444 567899888878899999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS------------------------------------ 636 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~------------------------------------ 636 (684)
||++|.+|. . . . .+ ...++.++++.|..||+..
T Consensus 95 e~i~G~~l~--~-~--~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 95 GEVPGQDLL--S-S--H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp ECCSSEETT--T-S--C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EecCCcccC--c-C--c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999998884 2 1 1 12 2356778888888888643
Q ss_pred -------------------CCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 637 -------------------RLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 637 -------------------~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+..++|+|++|.|||++++..++|+||+.|..-
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999988766789999998653
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.1e-10 Score=101.81 Aligned_cols=91 Identities=24% Similarity=0.443 Sum_probs=68.9
Q ss_pred CCCCCCceEEEeeccCceEEEecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCCC
Q 005669 103 PLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGM 182 (684)
Q Consensus 103 pv~~~~~~l~~~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpgq 182 (684)
|+.+....|.|+. ||||||+++ +|++++........++|+++|||||++. ++.++|+|- |
T Consensus 17 ~L~~g~~~L~~q~--dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~----~~~~vWss~-----t----- 76 (109)
T 3r0e_A 17 HLKNGDFDLVMQD--DCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNG----DGSTVWKSG-----A----- 76 (109)
T ss_dssp EEEETTEEEEECT--TSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECT----TSCEEEECC-----C-----
T ss_pred EeECCCEEEEEec--CCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeC----CCCEEEcCC-----C-----
Confidence 3333457899977 999999985 7999987543456899999999999987 357899762 1
Q ss_pred eecccccCccceeEEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCCCC
Q 005669 183 KLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWN 238 (684)
Q Consensus 183 ~l~~~~~tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~~~ 238 (684)
....+.|.+.++++|++.++ . .+.|.+++|-
T Consensus 77 ---------------------~~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~~ 107 (109)
T 3r0e_A 77 ---------------------QSVKGNYAAVVHPDGRLVVF--G--PSVFKIDPWV 107 (109)
T ss_dssp ---------------------CCSSSCCEEEEETTTEEEEE--C--SEEEEECTTS
T ss_pred ---------------------cCCCcCEEEEEcCCCeEEEE--e--cCEECCCCcc
Confidence 00235789999999987776 3 5889999873
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=7.9e-10 Score=117.82 Aligned_cols=142 Identities=17% Similarity=0.246 Sum_probs=107.6
Q ss_pred ccceecccCcEeEEEEEeeCCcEEEEEEcc--CCC-cccHHHHHHHHHHHhccC--CCceeeEEEEEEeC---CeeEEEE
Q 005669 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLS--KGS-GQGMEEFKNEVLLIAKLQ--HRNLVKLLGCCTQR---DERMLIY 592 (684)
Q Consensus 521 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~--~~~-~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~---~~~~lV~ 592 (684)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4578999999999998865 4678888876 322 122456788999999987 45688999998776 3479999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS------------------------------------ 636 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~------------------------------------ 636 (684)
||++|..+.+.. ...++..++..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998774321 234678888999999999999999731
Q ss_pred -------------------CCceEecCCCCCcEEEcCCCc--EEEEeeccccc
Q 005669 637 -------------------RLRIIHRDLKASNVLLDNTMN--PKISDFGLARS 668 (684)
Q Consensus 637 -------------------~~~IvHrDLkp~NILl~~~~~--vkI~DFGla~~ 668 (684)
+..++|+|++|.|||++.++. +.|+||+.|..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999987653 69999998864
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.99 E-value=2.5e-09 Score=92.59 Aligned_cols=77 Identities=26% Similarity=0.408 Sum_probs=60.1
Q ss_pred ceEEEeeccCceEEEecCCCCeEEEecccCC-CCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCCCeeccc
Q 005669 109 GVLRINGERNGILVLLNSTNDTVWSSNSSIS-AQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGIN 187 (684)
Q Consensus 109 ~~l~~~~~~~g~l~l~~~~~~~~w~s~~~~~-~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~~ 187 (684)
-+|.|+. ||||||++. +.+||++++... .....+.|+++|||||+|. ++.++|+|=
T Consensus 21 y~l~~q~--DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~----~~~~vWss~---------------- 77 (105)
T 4h3o_A 21 YHFIMQD--DCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDS----SGRSLWASH---------------- 77 (105)
T ss_dssp EEEEECT--TSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECT----TCCEEEECC----------------
T ss_pred EEEEECC--CCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECC----CcEEEEEec----------------
Confidence 5688877 999999986 579999998642 2346799999999999987 467899871
Q ss_pred ccCccceeEEEccCCCCCCCCceEEeeCCCCCcEEE
Q 005669 188 LGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLV 223 (684)
Q Consensus 188 ~~tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~ 223 (684)
+....+.|.+.++++|++.++
T Consensus 78 ---------------t~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 78 ---------------STRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp ---------------CCCCSSCEEEEECTTSCEEEE
T ss_pred ---------------CCCCCCCEEEEEeCCCeEEEE
Confidence 011346789999999997765
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.92 E-value=3.6e-09 Score=105.87 Aligned_cols=87 Identities=24% Similarity=0.331 Sum_probs=68.8
Q ss_pred ceEEEeeccCceEEEecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCCCeecccc
Q 005669 109 GVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINL 188 (684)
Q Consensus 109 ~~l~~~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~~~ 188 (684)
-+|.++. ||+|+|++. +.+||.+++... ....++|+++|||||+|. .+.++|+|+++
T Consensus 28 f~l~f~~--~gnl~ly~~-~~~vW~an~~~~-~~~~l~l~~dGnLvl~d~----~~~~vW~s~~~--------------- 84 (236)
T 1dlp_A 28 FRFTMQS--DCNLVLFDS-DVRVWASNTAGA-TGCRAVLQSDGLLVILTA----QNTIRWSSGTK--------------- 84 (236)
T ss_dssp EEEEECT--TSCEEEEES-SSEEECCCCCSC-SCCBCCBCSSSCBCCBCT----TTCCSCCCCCC---------------
T ss_pred EEEEECC--CCcEEEEEC-CEEEEECCCCCC-CCeEEEEcCCCcEEEEcC----CCcEEEeCCcc---------------
Confidence 5677766 999999997 689999997654 556789999999999987 46789999864
Q ss_pred cCccceeEEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCCCC
Q 005669 189 GTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWN 238 (684)
Q Consensus 189 ~tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~~~ 238 (684)
.+.|.|.+.|+++|++.++ .. .+|.+..+.
T Consensus 85 ----------------~~~~~~~~~l~d~Gnlvl~--~~--~~W~S~~~p 114 (236)
T 1dlp_A 85 ----------------GSIGNYVLVLQPDRTVTIY--GP--GLWDSGTSN 114 (236)
T ss_dssp ----------------CCSSCCEEEECSSSCEEEE--CS--EEEECSCCC
T ss_pred ----------------ccCCcEEEEEeCCCCEEEe--cC--CEEECCCCC
Confidence 1235788999999997765 22 789988764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.54 E-value=1.1e-07 Score=98.67 Aligned_cols=137 Identities=19% Similarity=0.203 Sum_probs=101.7
Q ss_pred cceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccC-CCc--eeeEEEEEEeCC---eeEEEEEcc
Q 005669 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRN--LVKLLGCCTQRD---ERMLIYEYL 595 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~n--Iv~l~g~~~~~~---~~~lV~Ey~ 595 (684)
.+.++.|....||+.. ..+++|+... ......+.+|+.+++.+. +.. +.+++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4578999999999863 5688888653 234567889999998883 332 455555544333 248899999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD---------------------------------------- 635 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---------------------------------------- 635 (684)
+|.+|..... ..++.+++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998865432 2367788888999999999999862
Q ss_pred ---------------CCCceEecCCCCCcEEEcC--CCcEEEEeecccccc
Q 005669 636 ---------------SRLRIIHRDLKASNVLLDN--TMNPKISDFGLARSF 669 (684)
Q Consensus 636 ---------------~~~~IvHrDLkp~NILl~~--~~~vkI~DFGla~~~ 669 (684)
.+..++|+|++|.||++++ ...+.|+||+.+..-
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1235899999999999988 556899999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=9.8e-07 Score=91.68 Aligned_cols=137 Identities=20% Similarity=0.165 Sum_probs=98.2
Q ss_pred cceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCC---ceeeEEEEEE-eCCeeEEEEEccCC
Q 005669 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR---NLVKLLGCCT-QRDERMLIYEYLPN 597 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~g~~~-~~~~~~lV~Ey~~~ 597 (684)
.+.++.|....||+. +..+++|+.. .......+.+|..+|+.+.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 457888998999987 5678888853 233456789999999999642 3667777774 34557899999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD------------------------------------------ 635 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~------------------------------------------ 635 (684)
..+..... ..++..+...++.++++.|..||+.
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88866321 1235555566666666666666643
Q ss_pred ---------------CCCceEecCCCCCcEEEcC---CCc-EEEEeecccccc
Q 005669 636 ---------------SRLRIIHRDLKASNVLLDN---TMN-PKISDFGLARSF 669 (684)
Q Consensus 636 ---------------~~~~IvHrDLkp~NILl~~---~~~-vkI~DFGla~~~ 669 (684)
.+..++|+|++|.|||++. ++. +.|+||+.+..-
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2235799999999999987 355 589999988753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.3e-06 Score=88.56 Aligned_cols=136 Identities=17% Similarity=0.156 Sum_probs=99.3
Q ss_pred ceecccCcE-eEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005669 523 NKLGEGGFG-PVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (684)
Q Consensus 523 ~~LG~G~fG-~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 599 (684)
+.+..|..+ .||+..... +..+++|+-.. .....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556555 689877654 56789998653 23467888999998884 4457889999999999999999999988
Q ss_pred hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 005669 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS------------------------------------------- 636 (684)
Q Consensus 600 L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~------------------------------------------- 636 (684)
+.+..... ......+..++++.|..||...
T Consensus 107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 87655221 1223356666677777776431
Q ss_pred ------------CCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 637 ------------RLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 637 ------------~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
+..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999887778999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=1.1e-06 Score=93.05 Aligned_cols=80 Identities=6% Similarity=-0.022 Sum_probs=57.2
Q ss_pred ccee-cccCcEeEEEEEee-------CCcEEEEEEccCCC---cccHHHHHHHHHHHhccC-C--CceeeEEEEEEeC--
Q 005669 522 KNKL-GEGGFGPVYKGMLI-------EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQ-H--RNLVKLLGCCTQR-- 585 (684)
Q Consensus 522 ~~~L-G~G~fG~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~-H--~nIv~l~g~~~~~-- 585 (684)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88999999998764 26788898865432 111256788988888884 2 4577888887655
Q ss_pred -CeeEEEEEccCCCChh
Q 005669 586 -DERMLIYEYLPNKSLD 601 (684)
Q Consensus 586 -~~~~lV~Ey~~~gsL~ 601 (684)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3468999999987664
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=2.6e-05 Score=83.88 Aligned_cols=75 Identities=9% Similarity=0.137 Sum_probs=51.1
Q ss_pred cceecccCcEeEEEEEee-CCcEEEEEEccCCCc-------ccHHHHHHHHHHHhccCC--C-ceeeEEEEEEeCCeeEE
Q 005669 522 KNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-------QGMEEFKNEVLLIAKLQH--R-NLVKLLGCCTQRDERML 590 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~Ei~~l~~l~H--~-nIv~l~g~~~~~~~~~l 590 (684)
.+.||.|..+.||++... +++.++||....... ...+++..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999764 468899998653211 234567889998887742 3 34566654 3455789
Q ss_pred EEEccCCC
Q 005669 591 IYEYLPNK 598 (684)
Q Consensus 591 V~Ey~~~g 598 (684)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999863
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.91 E-value=2.4e-05 Score=81.91 Aligned_cols=141 Identities=16% Similarity=0.199 Sum_probs=80.5
Q ss_pred ceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccC--CCceeeEEE------EEEeCCeeEEEEEc
Q 005669 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ--HRNLVKLLG------CCTQRDERMLIYEY 594 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--H~nIv~l~g------~~~~~~~~~lV~Ey 594 (684)
+.|+.|..+.||+....++ .+++|+.... ..++..|..+++.+. .-.+++++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999886544 5899988752 234445555555543 112333332 12346678999999
Q ss_pred cCCCChh--------------HHHhccCC----C-------CCCCHHHH-------------------------------
Q 005669 595 LPNKSLD--------------YFIFDTTR----S-------KLLDWSKR------------------------------- 618 (684)
Q Consensus 595 ~~~gsL~--------------~~l~~~~~----~-------~~l~~~~~------------------------------- 618 (684)
++|..+. ..++.... . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 01111100 0 01122211
Q ss_pred HHHHHHHHHHHHHHHh----------CCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 619 SHIIAGIARGLLYLHQ----------DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 619 ~~i~~qi~~gL~yLH~----------~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
..+..++.+++.+|++ ..+..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111224446666763 1234699999999999998788999999998853
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00014 Score=75.48 Aligned_cols=140 Identities=19% Similarity=0.148 Sum_probs=94.2
Q ss_pred CccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccC---CCceeeEEEEEEeCCeeEEEEEccC
Q 005669 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 520 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
...+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+++++.++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3456899999999999876 5678889987532 3567888999888874 3678899999888888999999999
Q ss_pred CCChhH-----------HHhccCC-C------------------CCCCHHHHH---HHH----------------HHHHH
Q 005669 597 NKSLDY-----------FIFDTTR-S------------------KLLDWSKRS---HII----------------AGIAR 627 (684)
Q Consensus 597 ~gsL~~-----------~l~~~~~-~------------------~~l~~~~~~---~i~----------------~qi~~ 627 (684)
+..+.. .|+.... . -.-+|.+.. ++. ..++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 876521 1222111 0 012454322 111 11222
Q ss_pred HH-HHHHh-CCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 628 GL-LYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 628 gL-~yLH~-~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
.+ ..|.. ..++.++|+|+.+.|++++.++ +.|+||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 22 23422 2346799999999999999887 8999984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00011 Score=75.31 Aligned_cols=79 Identities=19% Similarity=0.232 Sum_probs=59.4
Q ss_pred CCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCC---CceeeEEEEEEeCCeeEEEEEc
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH---RNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H---~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.....+.+|.|..+.||+....+|+.+.+|+...........+..|+..|+.+.. .-++++++.. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 3455678999999999999999999999998765544445678899999888742 2355666542 24789999
Q ss_pred cCCCCh
Q 005669 595 LPNKSL 600 (684)
Q Consensus 595 ~~~gsL 600 (684)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00028 Score=76.45 Aligned_cols=74 Identities=15% Similarity=0.187 Sum_probs=46.1
Q ss_pred ccceecccCcEeEEEEEeeCCcEEEEEEccCC-----C--cc--cHHHHHHHHHHHh-ccCCCceeeEEEEEEeCCeeEE
Q 005669 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG-----S--GQ--GMEEFKNEVLLIA-KLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 521 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~-----~--~~--~~~~~~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~l 590 (684)
..+.||.|....||++.. +++.++||..... . .. ....+..|+..+. ...+..+++++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 346899999999999964 4678999943211 0 11 2223333433222 22334667777765 566799
Q ss_pred EEEcc-CC
Q 005669 591 IYEYL-PN 597 (684)
Q Consensus 591 V~Ey~-~~ 597 (684)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00066 Score=70.33 Aligned_cols=144 Identities=15% Similarity=0.123 Sum_probs=80.7
Q ss_pred cceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCc--eeeEEEE------EEeCCeeEEEEE
Q 005669 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN--LVKLLGC------CTQRDERMLIYE 593 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~------~~~~~~~~lV~E 593 (684)
.+.|+.|....+|+....++ .+++|..... ...+.+..|+.+++.+.... +.+++.. ....+..++++|
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 35677788899999887555 6888988652 12345667777777664212 3333321 123456789999
Q ss_pred ccCCCChhH----H----------HhccCCC------CCC---CHHHHHH------------HHHHHHHHHHHHHhC---
Q 005669 594 YLPNKSLDY----F----------IFDTTRS------KLL---DWSKRSH------------IIAGIARGLLYLHQD--- 635 (684)
Q Consensus 594 y~~~gsL~~----~----------l~~~~~~------~~l---~~~~~~~------------i~~qi~~gL~yLH~~--- 635 (684)
|++|..+.. . ++..... ... .|..... +...+.+.+.++++.
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 999865421 0 1111000 001 1221100 011234455555532
Q ss_pred -CCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 636 -SRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 636 -~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
.+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 234699999999999999876668999987753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00068 Score=69.69 Aligned_cols=74 Identities=11% Similarity=0.205 Sum_probs=46.7
Q ss_pred CCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCce-eeEEEEEEeCCeeEEEEEcc-C
Q 005669 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL-VKLLGCCTQRDERMLIYEYL-P 596 (684)
Q Consensus 519 y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~-~ 596 (684)
+...+.|+.|....+|+. +.+++|+....... .....+|+.+++.+....+ .++++.. .+.-++++||+ +
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 333678999999999998 56888887653221 1223568777777642222 4666543 44457899999 6
Q ss_pred CCCh
Q 005669 597 NKSL 600 (684)
Q Consensus 597 ~gsL 600 (684)
+.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 6555
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.003 Score=68.95 Aligned_cols=74 Identities=14% Similarity=0.071 Sum_probs=48.5
Q ss_pred cceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCce-eeEEEEEEeCCeeEEEEEccCCCC
Q 005669 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL-VKLLGCCTQRDERMLIYEYLPNKS 599 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gs 599 (684)
.+.|+.|-...+|+....+ ++.+++|+........ ..-.+|..+++.+...++ .++++.+. + .+||||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3578889899999998765 4788898875432211 122578888888864444 57777662 2 25999998755
Q ss_pred h
Q 005669 600 L 600 (684)
Q Consensus 600 L 600 (684)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0019 Score=67.32 Aligned_cols=141 Identities=17% Similarity=0.127 Sum_probs=73.5
Q ss_pred ceecccCcEe-EEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccC--CCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005669 523 NKLGEGGFGP-VYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ--HRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (684)
Q Consensus 523 ~~LG~G~fG~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 599 (684)
+.|+.|.... +|+....+++.+++|....... +.+..|+.+++.+. .-.+.+++.+....+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4565554444 6676653467788876554321 33455667666663 234567777643333 78999998766
Q ss_pred hhHHHhcc---------------------CCC--CCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 005669 600 LDYFIFDT---------------------TRS--KLLDWSKRS-------H-------------IIAGIARGLLYLH--- 633 (684)
Q Consensus 600 L~~~l~~~---------------------~~~--~~l~~~~~~-------~-------------i~~qi~~gL~yLH--- 633 (684)
+...+... ... ..++..... . ....+...+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 64433110 000 111211100 0 0001112222221
Q ss_pred hCCCCceEecCCCCCcEEEcCC----CcEEEEeeccccc
Q 005669 634 QDSRLRIIHRDLKASNVLLDNT----MNPKISDFGLARS 668 (684)
Q Consensus 634 ~~~~~~IvHrDLkp~NILl~~~----~~vkI~DFGla~~ 668 (684)
...+..++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1223569999999999999874 6799999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00069 Score=73.55 Aligned_cols=73 Identities=18% Similarity=0.260 Sum_probs=50.5
Q ss_pred cceecccCcEeEEEEEeeC--------CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCc-eeeEEEEEEeCCeeEEEE
Q 005669 522 KNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN-LVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~ 592 (684)
.+.|+.|-...+|+....+ ++.+++|+.... ...+.+.+|..+++.+...+ .+++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 3578888899999998753 478999987431 12256668999888885333 366777653 2 3899
Q ss_pred EccCCCCh
Q 005669 593 EYLPNKSL 600 (684)
Q Consensus 593 Ey~~~gsL 600 (684)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0031 Score=65.35 Aligned_cols=142 Identities=13% Similarity=0.136 Sum_probs=82.7
Q ss_pred ceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCC--CceeeEEEE-----EEeCCeeEEEEEcc
Q 005669 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH--RNLVKLLGC-----CTQRDERMLIYEYL 595 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~-----~~~~~~~~lV~Ey~ 595 (684)
..++ |....||+....+|+.+++|..... ....+.+..|..+++.+.. -.+++++.. ....+..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4576 7788999987766778999998643 1234567778888877742 224444432 22345668899999
Q ss_pred CCCChh-----HH---------Hhcc-C-----CCCCCCHHHH----------------------HHHHHHHHHHHHHHH
Q 005669 596 PNKSLD-----YF---------IFDT-T-----RSKLLDWSKR----------------------SHIIAGIARGLLYLH 633 (684)
Q Consensus 596 ~~gsL~-----~~---------l~~~-~-----~~~~l~~~~~----------------------~~i~~qi~~gL~yLH 633 (684)
+|..+. .. ++.. . .....++... ...+..++..+.-+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 985432 10 1110 0 0111222211 011112222222221
Q ss_pred h-CCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 634 Q-DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 634 ~-~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
. ..+..++|+|++|.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1234589999999999999 4 899999988764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0014 Score=69.64 Aligned_cols=141 Identities=17% Similarity=0.218 Sum_probs=83.6
Q ss_pred ceecccCcEeEEEEEeeC--------CcEEEEEEccCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEEEE
Q 005669 523 NKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E 593 (684)
+.|..|-...+|+....+ ++.+++|+.... ........+|.++++.+. +.-..++++.+.. .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 567778888999988742 478999986432 234566778999988874 3334667776643 28999
Q ss_pred ccCCCChhHH-----------------HhccC--CCCCCC--HHHHHHHHHHHHH-------------------HHHH--
Q 005669 594 YLPNKSLDYF-----------------IFDTT--RSKLLD--WSKRSHIIAGIAR-------------------GLLY-- 631 (684)
Q Consensus 594 y~~~gsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~qi~~-------------------gL~y-- 631 (684)
|++|..|..- |+... -.+... +.++.++..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998655311 11110 011122 3444445443321 2222
Q ss_pred --HHhC-CCCceEecCCCCCcEEEcCC----CcEEEEeeccccc
Q 005669 632 --LHQD-SRLRIIHRDLKASNVLLDNT----MNPKISDFGLARS 668 (684)
Q Consensus 632 --LH~~-~~~~IvHrDLkp~NILl~~~----~~vkI~DFGla~~ 668 (684)
|... .+..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2222 23468999999999999876 7899999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0026 Score=67.38 Aligned_cols=73 Identities=15% Similarity=0.123 Sum_probs=44.8
Q ss_pred ceecccCcEeEEEEEeeC---------CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCc-eeeEEEEEEeCCeeEEEE
Q 005669 523 NKLGEGGFGPVYKGMLIE---------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN-LVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~ 592 (684)
+.|+.|....+|+....+ ++.+++|+...... .......|..+++.+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 567888888999988654 26888888754322 1223467888888774333 44666544 2 36899
Q ss_pred EccCCCCh
Q 005669 593 EYLPNKSL 600 (684)
Q Consensus 593 Ey~~~gsL 600 (684)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.01 Score=61.97 Aligned_cols=33 Identities=27% Similarity=0.326 Sum_probs=28.4
Q ss_pred CCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 637 ~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+..++|+|+.|.||++++++.+.|+||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 346999999999999998888999999877643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.71 E-value=0.13 Score=55.22 Aligned_cols=74 Identities=14% Similarity=0.136 Sum_probs=48.9
Q ss_pred cceecccCcEeEEEEEeeC--------CcEEEEEEccCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEEE
Q 005669 522 KNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~ 592 (684)
.+.+..|-...+|+....+ ++.+++|+....... ...-.+|.++++.+. +.-..++++.+ . -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3567778888999998753 578999986543222 223357888888774 32345666533 2 37899
Q ss_pred EccCCCCh
Q 005669 593 EYLPNKSL 600 (684)
Q Consensus 593 Ey~~~gsL 600 (684)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.42 E-value=0.41 Score=50.97 Aligned_cols=30 Identities=23% Similarity=0.365 Sum_probs=25.1
Q ss_pred ceEecCCCCCcEEE------cCCCcEEEEeeccccc
Q 005669 639 RIIHRDLKASNVLL------DNTMNPKISDFGLARS 668 (684)
Q Consensus 639 ~IvHrDLkp~NILl------~~~~~vkI~DFGla~~ 668 (684)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.24 E-value=1.8 Score=41.71 Aligned_cols=88 Identities=9% Similarity=0.017 Sum_probs=64.7
Q ss_pred CCCceeeEEEEEEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCceEecCCCCCc
Q 005669 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL-YLHQDSRLRIIHRDLKASN 649 (684)
Q Consensus 571 ~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~-yLH~~~~~~IvHrDLkp~N 649 (684)
.||++ -..+-.+.+...+.++.-+++.=...+ ..++..++++++.+|+.... +++. -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 67887 334446677777777765433222223 23788999999999988777 5554 5788999999
Q ss_pred EEEcCCCcEEEEeeccccccCC
Q 005669 650 VLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 650 ILl~~~~~vkI~DFGla~~~~~ 671 (684)
|+++.++.++|.-.|+-..+.+
T Consensus 115 L~f~~~~~p~i~hRGi~~~lpP 136 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESLPP 136 (219)
T ss_dssp EEECTTCCEEESCCEETTTBSS
T ss_pred EEEeCCCcEEEEEcCCcccCCC
Confidence 9999999999999998776643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.44 E-value=1.4 Score=42.34 Aligned_cols=89 Identities=13% Similarity=0.075 Sum_probs=66.3
Q ss_pred CCCceeeEEEEEEeCCeeEEEEEccCC-CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 005669 571 QHRNLVKLLGCCTQRDERMLIYEYLPN-KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASN 649 (684)
Q Consensus 571 ~H~nIv~l~g~~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~N 649 (684)
.||+++.. .+-.+.+.+.+.++.-+. -++.. + ..++...+++++.+|+....+++. -+|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 68888876 456666766666665442 22222 2 347889999999999998866654 4788999999
Q ss_pred EEEcCCCcEEEEeeccccccCCC
Q 005669 650 VLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 650 ILl~~~~~vkI~DFGla~~~~~~ 672 (684)
|+++.++.++|.-.|+-..+.+.
T Consensus 110 L~f~~~~~p~i~~RGik~~l~P~ 132 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVDPL 132 (215)
T ss_dssp EEECTTSCEEESCCEETTTBSCC
T ss_pred EEEcCCCCEEEEEccCccCCCCC
Confidence 99999999999999987666443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 684 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-48 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-27 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-23 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-17 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 4e-14 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 9e-14 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 3e-13 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 3e-10 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 5e-48
Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 6/168 (3%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+ ++G G FG VYKG + + ++ + Q ++ FKNEV ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+G T + ++ ++ SL + + + K I A+G+ YLH S
Sbjct: 68 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
IIHRDLK++N+ L + KI DFGLA +++ G+
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 3e-46
Identities = 38/172 (22%), Positives = 75/172 (43%), Gaps = 11/172 (6%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQH 572
D+F + ++LG G G V+K G +A K + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
+V G E + E++ SLD + ++ + + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ +I+HRD+K SN+L+++ K+ DFG++ ++ VGT
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGT 166
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 6e-46
Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 6/166 (3%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
N D + +LG+G FG VYK E A K + S + +E++ E+ ++A H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
N+VKLL + ++ E+ ++D + + + L S+ + L YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYL 126
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
H +IIHRDLKA N+L + K++DFG++ ++
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 2e-45
Identities = 61/186 (32%), Positives = 98/186 (52%), Gaps = 17/186 (9%)
Query: 499 KEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGME 558
++E E+P LK++ +LG G FG V+ G ++AVK L +GS +
Sbjct: 5 EDEWEVPRETLKLV----------ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPD 53
Query: 559 EFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR 618
F E L+ +LQH+ LV+L TQ + +I EY+ N SL F+ + K L +K
Sbjct: 54 AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKL 111
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
+ A IA G+ ++ + + IHRDL+A+N+L+ +T++ KI+DFGLAR ++ A
Sbjct: 112 LDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168
Query: 679 KRVVGT 684
Sbjct: 169 -GAKFP 173
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 2e-44
Identities = 50/173 (28%), Positives = 76/173 (43%), Gaps = 16/173 (9%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG---MEEFKNEVLLIAKLQ 571
FS+ ++G G FG VY + + +A+K++S Q ++ EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H N ++ GC + L+ EY + D K L + + + G +GL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
LH +IHRD+KA N+LL K+ DFG A A VGT
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGT 174
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (394), Expect = 3e-43
Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 19/191 (9%)
Query: 507 FDLKIIANATDNFSEK---------NKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG- 552
F + A F+++ +G G FG V G L +A+K L G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 553 SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL 612
+ + +F +E ++ + H N++ L G T+ M+I E++ N SLD F+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQ 124
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
+ ++ GIA G+ YL + +HRDL A N+L+++ + K+SDFGL+R D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 673 QTEANTKRVVG 683
++ +G
Sbjct: 182 TSDPTYTSALG 192
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-43
Identities = 49/170 (28%), Positives = 73/170 (42%), Gaps = 8/170 (4%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQHRN 574
+++ LGEG +G V + + +AVK + E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VK G + + + L EY L I + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ I HRD+K N+LLD N KISDFGLA F + E ++ GT
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 5e-43
Identities = 44/168 (26%), Positives = 76/168 (45%), Gaps = 7/168 (4%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+ + +LG G FG V G ++A+K + +GS +EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+L G CT++ +I EY+ N L ++ + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ +HRDL A N L+++ K+SDFGL+R D ++
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFP 164
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 9e-43
Identities = 47/170 (27%), Positives = 73/170 (42%), Gaps = 8/170 (4%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHR 573
+++ +G G +G K G+ + K L GS + +EV L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 574 NLVKLLGCCTQRDERML--IYEYLPNKSLDYFIFDTTRSK-LLDWSKRSHIIAGIARGLL 630
N+V+ R L + EY L I T+ + LD ++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 631 YLHQ--DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
H+ D ++HRDLK +NV LD N K+ DFGLAR D + A
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (388), Expect = 1e-42
Identities = 49/166 (29%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
+ + K+KLG G +G VY+G+ + +AVK L + + + +EEF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
V+LLG CT+ +I E++ +L ++ + R + + ++ I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
+ IHRDL A N L+ K++DFGL+R D A+
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 50/176 (28%), Positives = 86/176 (48%), Gaps = 12/176 (6%)
Query: 515 ATDNFS-EKNKLGEGGFGPVYKGMLI---EGQEIAVKRLSKGSGQG-MEEFKNEVLLIAK 569
DN +LG G FG V +G+ + ++A+K L +G+ + EE E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
L + +V+L+G C Q + ML+ E L F+ + + + S + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR-VVGT 684
YL + +HRDL A NVLL N KISDFGL+++ G D + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 4e-42
Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 16/192 (8%)
Query: 491 KHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLS 550
K QG K+ E+P L++ KLG+G FG V+ G +A+K L
Sbjct: 1 KPQTQGLAKDAWEIPRESLRLE----------VKLGQGCFGEVWMGTWNGTTRVAIKTLK 50
Query: 551 KGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS 610
G+ E F E ++ KL+H LV+L ++ + ++ EY+ SL F+
Sbjct: 51 PGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TG 107
Query: 611 KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
K L + + A IA G+ Y+ + + +HRDL+A+N+L+ + K++DFGLAR
Sbjct: 108 KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE 164
Query: 671 LDQTEANTKRVV 682
++ A
Sbjct: 165 DNEYTARQGAKF 176
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 5e-42
Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 7/168 (4%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+ ++G G FG V+ G + ++A+K + +G+ E+F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+L G C ++ L++E++ + L ++ + L + + G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+IHRDL A N L+ K+SDFG+ R F LD ++
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFP 165
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-41
Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 17/174 (9%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+ +G+G FG V++G G+E+AVK S + + E+ L+H N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 582 CTQRD----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-- 635
+ + + L+ +Y + SL ++ + + A GL +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 636 ---SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF--GLDQTEANTKRVVGT 684
+ I HRDLK+ N+L+ I+D GLA D + VGT
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-40
Identities = 47/174 (27%), Positives = 89/174 (51%), Gaps = 10/174 (5%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ + ++ K+G+G G VY M + GQE+A+++++ E NE+L++ +
Sbjct: 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN 74
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
++ N+V L DE ++ EYL SL + +T D + + + + L
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALE 130
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+LH ++IHRD+K+ N+LL + K++DFG +Q++ +T +VGT
Sbjct: 131 FLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (374), Expect = 1e-40
Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 41/213 (19%)
Query: 500 EEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS 553
+E P +N +GEG FG V++ +AVK L + +
Sbjct: 6 LSLEYP----------RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA 55
Query: 554 GQGME-EFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL 612
M+ +F+ E L+A+ + N+VKLLG C L++EY+ L+ F+ + +
Sbjct: 56 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTV 115
Query: 613 ---------------------LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651
L +++ I +A G+ YL + + +HRDL N L
Sbjct: 116 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL 172
Query: 652 LDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ M KI+DFGL+R+
Sbjct: 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIP 205
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-40
Identities = 43/159 (27%), Positives = 69/159 (43%), Gaps = 8/159 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+G+G FG V G G ++AVK + + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 577 KLLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
+LLG + + ++ EY+ SL ++ R +L + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
+HRDL A NVL+ K+SDFGL + Q
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 5e-40
Identities = 51/191 (26%), Positives = 71/191 (37%), Gaps = 26/191 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQG-MEEFKNEVLLIAK 569
+ S LG G FG V + +AVK L + E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 570 L-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL---------------L 613
L H N+V LLG CT ++I EY L F+ S + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
D +A+G+ +L IHRDL A N+LL + KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 674 TEANTKRVVGT 684
Sbjct: 200 NYVVKGNARLP 210
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-39
Identities = 46/172 (26%), Positives = 76/172 (44%), Gaps = 14/172 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
++F LG+G FG VY + +A+K L K + + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
N+++L G LI EY P ++ + ++ D + + I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
H R+IHRD+K N+LL + KI+DFG + + + GT
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGT 167
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 48/196 (24%), Positives = 71/196 (36%), Gaps = 31/196 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQG-MEEFKNEVLLIAK 569
+N LG G FG V ++AVK L + + E +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 570 L-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--------------------TT 608
L H N+V LLG CT LI+EY L ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 609 RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
+L + +A+G+ +L +HRDL A NVL+ + KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 669 FGLDQTEANTKRVVGT 684
D
Sbjct: 214 IMSDSNYVVRGNARLP 229
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-39
Identities = 43/170 (25%), Positives = 75/170 (44%), Gaps = 13/170 (7%)
Query: 521 EKNKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSGQG--MEEFKNEVLLIAKLQHRNL 575
E +LG G FG V KG + +AVK L + +E E ++ +L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
V+++G C + + ML+ E L+ ++ + ++ ++ G+ YL +
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 126
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK-RVVGT 684
+HRDL A NVLL KISDFGL+++ D+ +
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-39
Identities = 52/186 (27%), Positives = 83/186 (44%), Gaps = 24/186 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEG---QEIAVKRLSK-GSGQGMEEFKNEVLLIAKL-Q 571
++ ++ +GEG FG V K + + + A+KR+ + S +F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI-------------FDTTRSKLLDWSKR 618
H N++ LLG C R L EY P+ +L F+ + + L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
H A +ARG+ YL Q + IHRDL A N+L+ KI+DFGL+R +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 679 KRVVGT 684
Sbjct: 184 TMGRLP 189
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-38
Identities = 50/175 (28%), Positives = 70/175 (40%), Gaps = 13/175 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSK---GSGQGMEEFKNEVLLIAK 569
+ KLG+G FG V +G + +AVK L + M++F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
L HRNL++L G +M + E P SL + S +A G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
YL R IHRDL A N+LL KI DFGL R+ + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 3e-38
Identities = 48/171 (28%), Positives = 75/171 (43%), Gaps = 16/171 (9%)
Query: 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKL 578
++G G F VYKG+ E E+A L + + FK E ++ LQH N+V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 579 LGCC----TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+ +L+ E + + +L ++ R K++ I +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 635 DSRLRIIHRDLKASNVLL-DNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ IIHRDLK N+ + T + KI D GLA K V+GT
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGT 176
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-38
Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 14/182 (7%)
Query: 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE-----IAVKRLSKG-SGQGMEEFKN 562
L+I+ T+ F + LG G FG VYKG+ I E +A+K L + S + +E +
Sbjct: 3 LRIL-KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 563 EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
E ++A + + ++ +LLG C LI + +P L ++ + + +
Sbjct: 61 EAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWC 117
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
IA+G+ YL R++HRDL A NVL+ + KI+DFGLA+ G ++ E + +
Sbjct: 118 VQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 683 GT 684
Sbjct: 175 VP 176
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 141 bits (357), Expect = 1e-37
Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 13/165 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQ- 571
++FS +G GGFG VY + G+ A+K L K QG NE ++++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 572 --HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
+V + D+ I + + L Y + + + + A I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
++H +++RDLK +N+LLD + +ISD GLA F +
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-37
Identities = 48/171 (28%), Positives = 71/171 (41%), Gaps = 10/171 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
++F LGEG F V + +E A+K L K + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
VKL ++ Y N L +I + D + A I L YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYL 124
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
H IIHRDLK N+LL+ M+ +I+DFG A+ + +A VG
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 140 bits (354), Expect = 2e-37
Identities = 38/170 (22%), Positives = 68/170 (40%), Gaps = 8/170 (4%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
D++ +LG G FG V++ G A K + E + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
V L +E ++IYE++ L + D + + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 636 SRLRIIHRDLKASNVLLDNTMNP--KISDFGLARSFGLDQTEANTKRVVG 683
+H DLK N++ + K+ DFGL Q+ T
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 190
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-37
Identities = 40/167 (23%), Positives = 74/167 (44%), Gaps = 5/167 (2%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQ 571
+ ++ + +GEG +G V +A+K++S Q + E+ ++ + +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H N++ + + YL + ++ +++ L + + I RGL Y
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
+H ++HRDLK SN+LL+ T + KI DFGLAR D
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 139 bits (352), Expect = 4e-37
Identities = 39/161 (24%), Positives = 68/161 (42%), Gaps = 8/161 (4%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
D + +LG G FG V++ + G+ K ++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
+ L + E +LI E+L L I + ++ + + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 636 SRLRIIHRDLKASNVLLDNTMNP--KISDFGLARSFGLDQT 674
I+H D+K N++ + KI DFGLA D+
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 7e-37
Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 12/173 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQ 571
+ +GEG FG V++G+ + +A+K + + E+F E L + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H ++VKL+G T+ + +I E L F+ S LD + ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
L R +HRD+ A NVL+ + K+ DFGL+R D T +
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 172
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-36
Identities = 42/182 (23%), Positives = 78/182 (42%), Gaps = 17/182 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGML------IEGQEIAVKRLSKG-SGQGMEEFKNEVLLIAK 569
+ + +LG+G FG VY+G+ +A+K +++ S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF-------DTTRSKLLDWSKRSHII 622
++V+LLG +Q ++I E + L ++ + SK +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
IA G+ YL+ + + +HRDL A N ++ KI DFG+ R + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 683 GT 684
Sbjct: 197 LP 198
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 4e-36
Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQE-----IAVKRLSKGSGQGM-EEFKNEVLLIAKL 570
+ + +G G FG VYKGML +A+K L G + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
H N+++L G ++ M+I EY+ N +LD F+ + + + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
YL + +HRDL A N+L+++ + K+SDFGL+R D T
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 45/195 (23%), Positives = 86/195 (44%), Gaps = 21/195 (10%)
Query: 498 EKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS 553
+ + + L + +F+E +G G FG VY G L++ AVK L++ +
Sbjct: 16 AVQHVVIGPSSLIV------HFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 67
Query: 554 GQG-MEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIFDTTRSK 611
G + +F E +++ H N++ LLG C + + +++ Y+ + L FI + +
Sbjct: 68 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETH 125
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
+A+G+ + + +HRDL A N +LD K++DFGLAR
Sbjct: 126 NPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182
Query: 672 DQTEANTKR--VVGT 684
+ ++ +
Sbjct: 183 KEFDSVHNKTGAKLP 197
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-34
Identities = 48/190 (25%), Positives = 68/190 (35%), Gaps = 25/190 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQG--MEEFKNEVLLIA 568
D LG G FG V + + +AVK L +G+ +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 569 KLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIF-------------DTTRSKLLD 614
H N+V LLG CT+ M+I E+ +L ++ + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 615 WSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
+A+G+ +L + IHRDL A N+LL KI DFGLAR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 675 EANTKRVVGT 684
Sbjct: 190 YVRKGDARLP 199
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 128 bits (322), Expect = 1e-33
Identities = 45/179 (25%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGM---------EEFKNEVLL 566
+N+ K LG G V + + +E AVK + G E EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 567 IAKLQ-HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+ K+ H N+++L L+++ + L ++ T L + I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ LH +L I+HRDLK N+LLD+ MN K++DFG + + + V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGT 172
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 128 bits (321), Expect = 1e-33
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRN 574
+ + K+GEG +G VYK G+ A+K RL K E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VKL + +L++E+L L+ + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
R++HRDLK N+L++ KI+DFGLAR+FG+ +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 2e-33
Identities = 41/170 (24%), Positives = 75/170 (44%), Gaps = 15/170 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
++++ +G G FG VY+ L + G+ +A+K++ + E+ ++ KL H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75
Query: 576 VKLLGCCTQRDERM------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
V+L E+ L+ +Y+P + + L + + R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 630 LYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANT 678
Y+H I HRD+K N+LLD +T K+ DFG A+ + +
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 127 bits (321), Expect = 3e-33
Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 10/158 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
+F LG G FG V+ G+ A+K L K + +E +E L+++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
++++ G + +I +Y+ L + + R A + L YL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVCLALEYL 120
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
H II+RDLK N+LLD + KI+DFG A+
Sbjct: 121 H---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 5e-33
Identities = 33/161 (20%), Positives = 65/161 (40%), Gaps = 9/161 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
+ + LG G FG V++ + + K + G K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNI 63
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
+ L +E ++I+E++ + I T + L+ + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 636 SRLRIIHRDLKASNVLLDNTMNP--KISDFGLARSFGLDQT 674
I H D++ N++ + KI +FG AR
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 1e-32
Identities = 50/173 (28%), Positives = 75/173 (43%), Gaps = 13/173 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEV-LLIAKLQ 571
++F LG+G FG V+ + Q A+K L K +E E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H L + ++ + EYL L Y I + D S+ + A I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
LH I++RDLK N+LLD + KI+DFG+ + L + NT GT
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (314), Expect = 2e-32
Identities = 37/173 (21%), Positives = 64/173 (36%), Gaps = 8/173 (4%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQ 571
+ D + ++ LG G F V + +A+K ++K + +G E +NE+ ++ K++
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H N+V L LI + + L I S +I + + Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKY 122
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
LH + + LD ISDFGL++ GT
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGT 172
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 8e-32
Identities = 51/191 (26%), Positives = 75/191 (39%), Gaps = 26/191 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKG-SGQGMEEFKNEVLLI 567
D LGEG FG V I ++AVK L + + + + +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 568 AKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-------------L 613
+ +H+N++ LLG CTQ +I EY +L ++ L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
+ARG+ YL + IHRDL A NVL+ KI+DFGLAR
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 674 TEANTKRVVGT 684
T
Sbjct: 190 YYKKTTNGRLP 200
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-31
Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 8/165 (4%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHR 573
+NF + K+GEG +G VYK G+ +A+K++ + E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+VKLL ++ L++E+L + D + + + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
R++HRDLK N+L++ K++DFGLAR+FG+
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 121 bits (303), Expect = 4e-31
Identities = 41/178 (23%), Positives = 72/178 (40%), Gaps = 15/178 (8%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG---MEEFKNEVLLIAKLQ 571
+D + LG GG V+ + +++AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 572 HRNLVKLLGCCTQRDER----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
H +V + ++ EY+ +L + + + +IA +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE-ANTKRVVGT 684
L + H + IIHRD+K +N+++ T K+ DFG+AR+ T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 9e-31
Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 13/161 (8%)
Query: 521 EK-NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-----FKNEVLLIAKLQHR 573
EK + LGEG F VYK Q +A+K++ G ++ E+ L+ +L H
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N++ LL + L+++++ S +L S + +GL YLH
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
Q I+HRDLK +N+LLD K++DFGLA+SFG
Sbjct: 118 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-29
Identities = 44/181 (24%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG--MEEFKNEVLLIAKLQHR 573
+ + K+G+G FG V+K + GQ++A+K++ + + E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 574 NLVKLLGCCTQRDERM--------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
N+V L+ C + L++++ + + S+ ++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR--VVG 683
GL Y+H++ +I+HRD+KA+NVL+ K++DFGLAR+F L + + V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 684 T 684
T
Sbjct: 184 T 184
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-29
Identities = 43/172 (25%), Positives = 69/172 (40%), Gaps = 12/172 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
++F LG+G FG V G+ A+K L K + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
L L D + EY L + + +R ++ + A I L YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
H +++RD+K N++LD + KI+DFGL + A K GT
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGT 168
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 4e-28
Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 16/180 (8%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRLSKGSGQGM--EEFKNEVLLIAKL 570
A + ++GEG +G V+K ++ G+ +A+KR+ +G+ EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 571 ---QHRNLVKLLGCCTQRDERMLIYEYLPNKSLD---YFIFDTTRSKLLDWSKRSHIIAG 624
+H N+V+L CT L + +D D + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ RGL +LH R++HRDLK N+L+ ++ K++DFGLAR + VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVT 178
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 6e-28
Identities = 42/164 (25%), Positives = 78/164 (47%), Gaps = 9/164 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHR 573
+ + K+GEG +G V+K E + +A+KR+ E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+V+L + L++E+ YF + LD + + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677
++HRDLK N+L++ K+++FGLAR+FG+ +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (281), Expect = 1e-27
Identities = 42/157 (26%), Positives = 61/157 (38%), Gaps = 10/157 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
D F LG G FG V E G A+K L K + +E NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
LVKL ++ EY+ + + R A I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
H L +I+RDLK N+L+D +++DFG A+
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-27
Identities = 40/171 (23%), Positives = 64/171 (37%), Gaps = 19/171 (11%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE------FKNEVLLIAKLQ--HRN 574
LG GGFG VY G+ + +A+K + K E EV+L+ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+++LL + D +LI E + T L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 635 DSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
++HRD+K N+L+D N K+ DFG + GT
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGT 172
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 3e-27
Identities = 41/169 (24%), Positives = 74/169 (43%), Gaps = 7/169 (4%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLL 566
K + + +G G +G V + G ++A+K+L + S + E+ L
Sbjct: 11 KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYE-YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+ ++H N++ LL T + + YL + + + + L + ++ +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
+GL Y+H IIHRDLK N+ ++ KI DFGLAR + T
Sbjct: 131 LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 5e-27
Identities = 50/182 (27%), Positives = 77/182 (42%), Gaps = 20/182 (10%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS------GQGMEEFKNEVLL 566
N D + +LG G F V K G + A K + K G E+ + EV +
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
+ ++QH N++ L + + +LI E + L F+ + L + + + I
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQIL 123
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGLDQTEANTKRVV 682
G+ YLH L+I H DLK N++L + P KI DFGLA K +
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177
Query: 683 GT 684
GT
Sbjct: 178 GT 179
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 6e-27
Identities = 42/177 (23%), Positives = 74/177 (41%), Gaps = 20/177 (11%)
Query: 509 LKIIANA-TDNFSEKNK-LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVL 565
L+I NA D++ ++ LG G G V + ++ A+K L + + EV
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVE 56
Query: 566 LIAKL-QHRNLVKLLGCC----TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH 620
L + Q ++V+++ R +++ E L L I D + + S
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASE 115
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQT 674
I+ I + YLH + I HRD+K N+L + K++DFG A+ +
Sbjct: 116 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (270), Expect = 1e-26
Identities = 39/186 (20%), Positives = 70/186 (37%), Gaps = 20/186 (10%)
Query: 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLL 566
+L++ + + K+G G FG +Y G I G+E+A+K + + E +
Sbjct: 2 ELRV----GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKI 55
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
+Q + + C + ++ L SL+ S+ + +
Sbjct: 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMI 113
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVL---LDNTMNPKISDFGLARSFGLDQTEAN-----T 678
+ Y+H IHRD+K N L I DFGLA+ + +T +
Sbjct: 114 SRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 679 KRVVGT 684
K + GT
Sbjct: 171 KNLTGT 176
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 107 bits (267), Expect = 2e-26
Identities = 29/185 (15%), Positives = 71/185 (38%), Gaps = 21/185 (11%)
Query: 511 IIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAK 569
++ ++ ++GEG FG +++G + Q++A+K + S + ++E
Sbjct: 2 VVGV---HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKL 56
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
L + + Q ++ L SL+ + + + + +
Sbjct: 57 LAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARV 114
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNP-----KISDFGLARSFGLDQTEAN-----TK 679
+H+ +++RD+K N L+ + + DFG+ + + T+ + K
Sbjct: 115 QSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171
Query: 680 RVVGT 684
+ GT
Sbjct: 172 NLSGT 176
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 8e-26
Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 15/168 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS----GQGMEEFKNEVLLIA 568
+NF LG G +G V+ I G+ A+K L K + + E + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 569 KLQHR-NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
++ LV L + LI +Y+ L + R + + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVL 140
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
L +LH +L II+RD+K N+LLD+ + ++DFGL++ F D+TE
Sbjct: 141 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 105 bits (263), Expect = 2e-25
Identities = 40/207 (19%), Positives = 82/207 (39%), Gaps = 20/207 (9%)
Query: 483 GGLMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-G 541
G + R + +++ + + D++ KLG G + V++ + I
Sbjct: 1 GPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNN 60
Query: 542 QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERM--LIYEYLPNK 598
+++ VK L ++ K E+ ++ L+ N++ L R L++E++ N
Sbjct: 61 EKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117
Query: 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMN 657
+ L + I + L Y H + I+HRD+K NV++D+
Sbjct: 118 DFKQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRK 168
Query: 658 PKISDFGLARSFGLDQTEANTKRVVGT 684
++ D+GLA + Q V +
Sbjct: 169 LRLIDWGLAEFYHPGQE---YNVRVAS 192
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 3e-25
Identities = 49/176 (27%), Positives = 76/176 (43%), Gaps = 7/176 (3%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLL 566
K I + + + +G G +G V + G +AVK+LS+ S + E+ L
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLI-YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+ ++H N++ LL T YL + + + + + L +I I
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
RGL Y+H IIHRDLK SN+ ++ KI DFGLAR + T R
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW 183
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-23
Identities = 42/177 (23%), Positives = 75/177 (42%), Gaps = 21/177 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHR 573
+ +G G G V + +A+K+LS+ + + E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 574 NLVKLLGCCTQRD------ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
N++ LL T + + L+ E + + D + S+++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
G+ +LH IIHRDLK SN+++ + KI DFGLAR+ G V T
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVT 181
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 96.4 bits (239), Expect = 2e-23
Identities = 34/170 (20%), Positives = 54/170 (31%), Gaps = 20/170 (11%)
Query: 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS----------GQGMEEFKNEVLLIAKLQH 572
+GEG V+ + E VK G G F + A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
R L KL G + Y + N L I ++ + ++ I +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
+ I+H DL NVL+ I DF + G + +R V
Sbjct: 120 YHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDV 165
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 79.6 bits (196), Expect = 1e-18
Identities = 20/128 (15%), Positives = 47/128 (36%), Gaps = 21/128 (16%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ ++ G+ + G++L + + L ++ T W +N
Sbjct: 2 NLLTNGEGLYAGQSLDV-------EPYHFIMQEDCNLVLYDH----STSVWASNTGILGK 50
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
+ + +G V+ ++ ++W+S+S V L E GN+V+ +
Sbjct: 51 KGCKAVLQS---DGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY-------GS 100
Query: 166 ILWQSFDY 173
+W + Y
Sbjct: 101 DIWSTGTY 108
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.2 bits (204), Expect = 1e-17
Identities = 33/166 (19%), Positives = 63/166 (37%), Gaps = 23/166 (13%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
KLG G F V+ ++ +A+K + E ++E+ L+ ++ + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 583 TQRDERMLIYEYLPNKSLDYF-------------IFDTTRSKLLDWSKRSHIIAGIARGL 629
++L + + + + + + I + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 630 LYLHQDSRLRIIHRDLKASNVLLD------NTMNPKISDFGLARSF 669
Y+H+ R IIH D+K NVL++ N + KI+D G A +
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 66.6 bits (162), Expect = 4e-14
Identities = 26/128 (20%), Positives = 45/128 (35%), Gaps = 22/128 (17%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ + G+++ GE L SF N L ++ W N
Sbjct: 2 NILYSGETLSTGEFLNYG--SFVFIMQEDCN-----LVLYD----VDKPIWATNTGGL-- 48
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
RS L + + N LV+ N +N +W+SN+ V L + N+V+
Sbjct: 49 SRSCFLSMQTDGN--LVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIY-------GT 99
Query: 166 ILWQSFDY 173
W + +
Sbjct: 100 DRWATGTH 107
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 66.1 bits (161), Expect = 9e-14
Identities = 18/89 (20%), Positives = 32/89 (35%), Gaps = 7/89 (7%)
Query: 84 IWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKP 143
I Y + L L + + LVL + +D VWS+N++
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMET--DCNLVLFDR-DDRVWSTNTAGKGTGC 68
Query: 144 VAALMESGNLVVKDGKDNNPDNILWQSFD 172
A L +G + V + + +W S +
Sbjct: 69 RAVLQPNGRMDVLTNQ----NIAVWTSGN 93
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 64.0 bits (155), Expect = 3e-13
Identities = 20/131 (15%), Positives = 44/131 (33%), Gaps = 20/131 (15%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
D ++ G + G +L + + N + Y W + + S
Sbjct: 2 DRLNSGHQLDTGGSLAEGG--YLFIIQNDCNL------VLYDN---NRAVWASGTNGKAS 50
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
++ +G + S + +W+SN++ L N+V+ D N +N
Sbjct: 51 GCVLKMQNDGNLV-----IYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYD----NSNN 101
Query: 166 ILWQSFDYPCD 176
+W + +
Sbjct: 102 AIWATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 55.8 bits (134), Expect = 3e-10
Identities = 22/139 (15%), Positives = 44/139 (31%), Gaps = 24/139 (17%)
Query: 35 LFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTV 94
+F + +S+ ++ + + N L ++
Sbjct: 4 IFSKQPDDNHPQILHATESL----EILFGTHVYRFIMQTDCN-----LVLY----DNNNP 50
Query: 95 TWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLV 154
W N + R + +G+LV++ + N TVW S + A V L N+V
Sbjct: 51 IWATNTGGLGNG----CRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVV 106
Query: 155 VKDGKDNNPDNILWQSFDY 173
+ + LW +
Sbjct: 107 IY-------GDALWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 50.3 bits (120), Expect = 2e-08
Identities = 20/115 (17%), Positives = 31/115 (26%), Gaps = 35/115 (30%)
Query: 84 IWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERN------------------------- 118
I + EG+ + L S + + N
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVL 62
Query: 119 ---GILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQS 170
G+LV+L + N WSS + S V L + + LW S
Sbjct: 63 QSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIY-------GPGLWDS 110
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 684 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.97 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.97 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.97 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.97 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.97 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.97 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.96 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.96 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.96 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.96 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.96 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.96 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.96 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.96 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.96 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.96 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.96 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.96 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.96 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.96 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.96 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.95 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.95 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.95 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.95 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.95 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.95 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.95 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.95 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.95 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.95 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.95 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.95 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.95 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.95 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.94 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.94 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.94 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.94 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.94 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.94 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.94 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.94 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.94 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.93 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.93 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.93 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.93 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.93 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.92 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.92 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.92 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.92 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.91 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.84 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.82 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.82 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.82 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.7 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.6 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.58 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.37 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.14 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.14 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.05 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.0 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.81 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.56 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.93 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.64 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.91 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.39 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.17 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.5 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 88.28 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 86.6 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 81.65 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 81.1 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 80.67 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 80.4 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-32 Score=279.42 Aligned_cols=163 Identities=30% Similarity=0.416 Sum_probs=140.5
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.++|++.+.||+|+||+||+|+.. +++.||||+++... ....+++.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 467999999999999999999985 48999999987543 2334678999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
|+++|+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..+.
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999883 3456999999999999999999999998 9999999999999999999999999999886554
Q ss_pred CccCCcccccC
Q 005669 674 TEANTKRVVGT 684 (684)
Q Consensus 674 ~~~~~~~~~GT 684 (684)
........+||
T Consensus 158 ~~~~~~~~~GT 168 (271)
T d1nvra_ 158 RERLLNKMCGT 168 (271)
T ss_dssp EECCBCCCCSC
T ss_pred ccccccceeeC
Confidence 44344456676
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.6e-31 Score=274.10 Aligned_cols=151 Identities=28% Similarity=0.486 Sum_probs=137.9
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.++|+..++||+|+||+||+|... +|+.||||+++.......+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 357999999999999999999975 4899999999866555677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
+++|+|.+++.+ ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..+.
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999988743 35899999999999999999999998 9999999999999999999999999999886443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=1.1e-31 Score=276.65 Aligned_cols=155 Identities=30% Similarity=0.498 Sum_probs=139.3
Q ss_pred hhcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 514 ~~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
...++|+..++||+|+||+||+|.+.. ++.||||+++.. ....+++.+|+.+|++++|||||++++++.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 345678889999999999999999865 889999999764 445678999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
||+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+..+
T Consensus 93 E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 93 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred ecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999998653 3457899999999999999999999998 999999999999999999999999999987654
Q ss_pred C
Q 005669 673 Q 673 (684)
Q Consensus 673 ~ 673 (684)
.
T Consensus 169 ~ 169 (287)
T d1opja_ 169 T 169 (287)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.6e-31 Score=267.93 Aligned_cols=150 Identities=28% Similarity=0.514 Sum_probs=131.3
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
++|+..++||+|+||+||+|.+.+++.||||+++.. ....+++.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 568888999999999999999988889999999864 4456789999999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCC
Confidence 9999998854 3456899999999999999999999998 999999999999999999999999999987544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.1e-31 Score=273.08 Aligned_cols=149 Identities=30% Similarity=0.453 Sum_probs=137.1
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
+.|++.+.||+|+||+||+|.... ++.||||+++.......+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 568889999999999999999754 8899999998766677788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++|+|.+++.+. ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 161 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccC
Confidence 999999987543 346999999999999999999999998 9999999999999999999999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.3e-31 Score=271.98 Aligned_cols=162 Identities=30% Similarity=0.415 Sum_probs=137.5
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|++.+.||+|+||+||+|... +++.||||++.+. .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999985 4899999998643 2344577999999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999998843 346899999999999999999999998 999999999999999999999999999988655
Q ss_pred CCccCCcccccC
Q 005669 673 QTEANTKRVVGT 684 (684)
Q Consensus 673 ~~~~~~~~~~GT 684 (684)
.........+||
T Consensus 162 ~~~~~~~~~~GT 173 (288)
T d1uu3a_ 162 SKQARANSFVGT 173 (288)
T ss_dssp --------CCCC
T ss_pred CcccccccccCC
Confidence 444444455666
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.2e-31 Score=268.36 Aligned_cols=161 Identities=31% Similarity=0.481 Sum_probs=131.8
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
.++|++.++||+|+||+||+|+.. ..||||+++.. .....++|++|+.++++++|||||++++++. .+..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 467899999999999999999863 46999998754 3455678999999999999999999999875 456899999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
|+++|+|.+++... ...+++.++..++.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999998542 346999999999999999999999998 9999999999999999999999999999876544
Q ss_pred CccCCcccccC
Q 005669 674 TEANTKRVVGT 684 (684)
Q Consensus 674 ~~~~~~~~~GT 684 (684)
.......+.||
T Consensus 159 ~~~~~~~~~gt 169 (276)
T d1uwha_ 159 GSHQFEQLSGS 169 (276)
T ss_dssp -------CCCC
T ss_pred CcccccccccC
Confidence 33333445554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.3e-31 Score=267.56 Aligned_cols=152 Identities=35% Similarity=0.553 Sum_probs=134.5
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEcc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (684)
.++|++.++||+|+||.||+|.+.+++.||||+++.. ....+++.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 3578888999999999999999988889999999764 3456789999999999999999999998754 5679999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
++|+|.+++... ....+++.+++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999877432 2335899999999999999999999998 9999999999999999999999999999886443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1e-30 Score=265.69 Aligned_cols=149 Identities=29% Similarity=0.421 Sum_probs=134.8
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|++.+.||+|+||+||+|+... ++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 578999999999999999999864 889999998642 2334577899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999854 345899999999999999999999998 99999999999999999999999999987654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.3e-31 Score=277.66 Aligned_cols=150 Identities=23% Similarity=0.341 Sum_probs=135.6
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
..++|++.++||+|+||+||+|... +++.||+|+++.. .....+++.+|+.+|++++|||||++++++.++++.++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4578999999999999999999975 4889999999764 2334567899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||+++|+|.+++.+ ...+++..+..++.||+.||.|||++ + |+||||||+||||++++.+||+|||+|+.+.
T Consensus 84 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999999954 34589999999999999999999974 6 9999999999999999999999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7e-30 Score=258.73 Aligned_cols=151 Identities=28% Similarity=0.486 Sum_probs=137.6
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
++|+..++||+|+||+||+|+.+++++||||+++.. ....+++.+|+.++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 678999999999999999999988889999999864 3456789999999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
+|+|..++... ...+++..+.+++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 99999987543 346899999999999999999999998 9999999999999999999999999999875443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.4e-30 Score=265.58 Aligned_cols=156 Identities=28% Similarity=0.413 Sum_probs=126.7
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe--CCeeEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDERMLI 591 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV 591 (684)
++|++.+.||+|+||+||+|+.. +|+.||||.+.... ....+.+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999975 48999999987643 3345678899999999999999999999865 4558999
Q ss_pred EEccCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 592 YEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~--~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
|||+++|+|.+++.+.. ....+++.++..++.||+.||+|||+++ ..+|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999985432 2457999999999999999999999864 13499999999999999999999999999998
Q ss_pred cCCC
Q 005669 669 FGLD 672 (684)
Q Consensus 669 ~~~~ 672 (684)
+..+
T Consensus 164 ~~~~ 167 (269)
T d2java1 164 LNHD 167 (269)
T ss_dssp C---
T ss_pred cccC
Confidence 8644
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=2.4e-30 Score=268.06 Aligned_cols=152 Identities=32% Similarity=0.523 Sum_probs=126.2
Q ss_pred CCCCccceecccCcEeEEEEEeeC-C---cEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-G---QEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
+.|++.++||+|+||+||+|.+.. + ..||||.+... .....++|.+|+++|++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 457778899999999999999753 2 35899998754 334456899999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++|+|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998853 2446899999999999999999999998 99999999999999999999999999998765
Q ss_pred CC
Q 005669 672 DQ 673 (684)
Q Consensus 672 ~~ 673 (684)
..
T Consensus 181 ~~ 182 (299)
T d1jpaa_ 181 DT 182 (299)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.96 E-value=1.1e-29 Score=268.45 Aligned_cols=153 Identities=24% Similarity=0.418 Sum_probs=137.7
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999975 4899999999876666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc--CCCcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~--~~~~vkI~DFGla~~~~~~ 672 (684)
+++|+|.+++.+ ....+++.++..++.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999998843 2346999999999999999999999998 99999999999995 4678999999999988644
Q ss_pred C
Q 005669 673 Q 673 (684)
Q Consensus 673 ~ 673 (684)
.
T Consensus 180 ~ 180 (350)
T d1koaa2 180 Q 180 (350)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.96 E-value=1.2e-29 Score=268.31 Aligned_cols=153 Identities=26% Similarity=0.383 Sum_probs=137.3
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.++|++.++||+|+||.||+|... +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999975 4899999999876555567788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc--CCCcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~--~~~~vkI~DFGla~~~~~~ 672 (684)
+++|+|.+.+.. ....+++.++..++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.+..+
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999887632 3446999999999999999999999998 99999999999997 6789999999999988654
Q ss_pred C
Q 005669 673 Q 673 (684)
Q Consensus 673 ~ 673 (684)
.
T Consensus 183 ~ 183 (352)
T d1koba_ 183 E 183 (352)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=6.5e-30 Score=265.77 Aligned_cols=149 Identities=30% Similarity=0.510 Sum_probs=133.0
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
+.|+..++||+|+||+||+|... +++.||||++..... ...+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35888999999999999999975 488999999876432 23456889999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
||+++|+|..++.. ...+++.++..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999776633 356899999999999999999999998 99999999999999999999999999987653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.4e-30 Score=268.78 Aligned_cols=161 Identities=26% Similarity=0.343 Sum_probs=140.8
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
.++|++.+.||+|+||.||+|+.. +++.||||++++. .....+.+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367999999999999999999975 4899999998753 233467789999999999999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999854 346899999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCccCCcccccC
Q 005669 672 DQTEANTKRVVGT 684 (684)
Q Consensus 672 ~~~~~~~~~~~GT 684 (684)
... ....++||
T Consensus 158 ~~~--~~~~~~GT 168 (337)
T d1o6la_ 158 DGA--TMKTFCGT 168 (337)
T ss_dssp TTC--CBCCCEEC
T ss_pred CCc--ccccceeC
Confidence 332 23345665
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.4e-29 Score=265.56 Aligned_cols=156 Identities=31% Similarity=0.482 Sum_probs=132.7
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-C-----cEEEEEEccCC-CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCe
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-G-----QEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g-----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 587 (684)
.++|++.++||+|+||+||+|+... + ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4678899999999999999999754 2 36999998654 334456789999999998 89999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCC
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTR--------------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKA 647 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp 647 (684)
.++||||+++|+|.++|..... ...+++.+++.++.||++||+|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999965321 235899999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEeeccccccCCCCC
Q 005669 648 SNVLLDNTMNPKISDFGLARSFGLDQT 674 (684)
Q Consensus 648 ~NILl~~~~~vkI~DFGla~~~~~~~~ 674 (684)
+|||++.++.+||+|||+|+.......
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~ 219 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSN 219 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTT
T ss_pred hccccccCCeEEEeeccccccccCCCc
Confidence 999999999999999999998765443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=4.1e-30 Score=267.10 Aligned_cols=152 Identities=26% Similarity=0.342 Sum_probs=124.1
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
..+.|++.+.||+|+||+||+|... +++.||||++.... ......+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4567999999999999999999976 48899999997543 233456789999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc---CCCcEEEEeecccccc
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFGLARSF 669 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~---~~~~vkI~DFGla~~~ 669 (684)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999843 456999999999999999999999998 99999999999994 5789999999999987
Q ss_pred CCC
Q 005669 670 GLD 672 (684)
Q Consensus 670 ~~~ 672 (684)
...
T Consensus 161 ~~~ 163 (307)
T d1a06a_ 161 DPG 163 (307)
T ss_dssp ---
T ss_pred cCC
Confidence 543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.5e-29 Score=258.33 Aligned_cols=151 Identities=32% Similarity=0.582 Sum_probs=130.3
Q ss_pred CCCCccc-eecccCcEeEEEEEeeC---CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEE
Q 005669 517 DNFSEKN-KLGEGGFGPVYKGMLIE---GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 517 ~~y~~~~-~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
++|...+ +||+|+||+||+|.+.. +..||||+++... ....++|.+|+++|++++|||||+++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 49999999999998643 4579999997643 3446789999999999999999999999864 568999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++|+|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998743 2356899999999999999999999998 99999999999999999999999999998865
Q ss_pred CC
Q 005669 672 DQ 673 (684)
Q Consensus 672 ~~ 673 (684)
..
T Consensus 162 ~~ 163 (285)
T d1u59a_ 162 DD 163 (285)
T ss_dssp CS
T ss_pred cc
Confidence 43
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.96 E-value=2.3e-29 Score=257.60 Aligned_cols=151 Identities=26% Similarity=0.387 Sum_probs=135.3
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcc---------cHHHHHHHHHHHhccC-CCceeeEEEEEEe
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ---------GMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQ 584 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---------~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~ 584 (684)
.++|++.+.||+|+||+||+|+.. +++.||||++++.... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999975 5889999998764211 2245789999999997 9999999999999
Q ss_pred CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
++..|+||||+++|+|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999954 346899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCC
Q 005669 665 LARSFGLD 672 (684)
Q Consensus 665 la~~~~~~ 672 (684)
+|+.+...
T Consensus 156 ~a~~~~~~ 163 (277)
T d1phka_ 156 FSCQLDPG 163 (277)
T ss_dssp TCEECCTT
T ss_pred heeEccCC
Confidence 99988654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-29 Score=257.88 Aligned_cols=148 Identities=29% Similarity=0.429 Sum_probs=127.7
Q ss_pred CccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEe----CCeeEEEE
Q 005669 520 SEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDERMLIY 592 (684)
Q Consensus 520 ~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~ 592 (684)
+..++||+|+||+||+|.+.. ++.||+|++... .....+.+.+|+++|++++|||||++++++.. +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 556789999999999999864 789999998653 23345678999999999999999999999875 34579999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~-~~~~vkI~DFGla~~~~~ 671 (684)
||+++|+|.+++.+ ...+++.++..++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999854 346899999999999999999999875 4599999999999996 578999999999987543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.7e-30 Score=261.36 Aligned_cols=151 Identities=31% Similarity=0.523 Sum_probs=131.6
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccC
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (684)
++|++.+.||+|+||+||+|.+.++++||||+++.. ....+.|.+|+.++++++|||||++++++. .+..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 578999999999999999999988889999999754 445678999999999999999999999985 456899999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
+|+|..++... ....+++.+++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999888543 2346899999999999999999999998 9999999999999999999999999999875443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=2e-29 Score=263.02 Aligned_cols=149 Identities=28% Similarity=0.404 Sum_probs=134.7
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|++.+.||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56899999999999999999975 4899999998643 2344678899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
||+++++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999988843 445789999999999999999999998 99999999999999999999999999998753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.5e-29 Score=257.42 Aligned_cols=144 Identities=29% Similarity=0.503 Sum_probs=125.5
Q ss_pred ceecccCcEeEEEEEeeC---CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005669 523 NKLGEGGFGPVYKGMLIE---GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (684)
++||+|+||+||+|.+.+ ++.||||+++.. .....+++.+|+++|++++|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998654 468999998753 23345679999999999999999999999964 567899999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
|+|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 999999853 356899999999999999999999998 9999999999999999999999999999876543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=1.7e-29 Score=262.02 Aligned_cols=164 Identities=29% Similarity=0.483 Sum_probs=141.1
Q ss_pred HHHHHhhcCCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEE
Q 005669 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGC 581 (684)
Q Consensus 509 ~~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~ 581 (684)
+.+++...++|++.+.||+|+||+||+|+... ++.||||+++... ....+++.+|+.++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 34455567889999999999999999998642 4689999997643 3345679999999999999999999999
Q ss_pred EEeCCeeEEEEEccCCCChhHHHhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 005669 582 CTQRDERMLIYEYLPNKSLDYFIFDTT---------------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640 (684)
Q Consensus 582 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~I 640 (684)
+...+..+++|||+++|+|.+++.... ....+++.+++.|+.||+.||+|||+++ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 999999999999999999999986422 1234899999999999999999999998 9
Q ss_pred EecCCCCCcEEEcCCCcEEEEeeccccccCCCCCc
Q 005669 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (684)
Q Consensus 641 vHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~~~ 675 (684)
|||||||+||||+.++.+||+|||+|+.+......
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~ 196 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccc
Confidence 99999999999999999999999999987554433
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.6e-29 Score=257.15 Aligned_cols=151 Identities=29% Similarity=0.445 Sum_probs=134.9
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC------cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS------GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 588 (684)
.+.|++.+.||+|+||+||+|... +|+.||||++++.. ....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999985 48999999986431 22357899999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----cEEEEeec
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM----NPKISDFG 664 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~----~vkI~DFG 664 (684)
++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999854 346999999999999999999999998 99999999999998776 49999999
Q ss_pred cccccCCC
Q 005669 665 LARSFGLD 672 (684)
Q Consensus 665 la~~~~~~ 672 (684)
+|+.+...
T Consensus 163 ~a~~~~~~ 170 (293)
T d1jksa_ 163 LAHKIDFG 170 (293)
T ss_dssp TCEECTTS
T ss_pred hhhhcCCC
Confidence 99987544
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.4e-29 Score=258.59 Aligned_cols=151 Identities=32% Similarity=0.566 Sum_probs=128.3
Q ss_pred CCCCccceecccCcEeEEEEEeeCC-----cEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEG-----QEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g-----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
+.|+..+.||+|+||.||+|.+... ..||||++.... .....+|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677889999999999999997642 379999987543 3345678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+.++++.+++... ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999998887543 356899999999999999999999998 9999999999999999999999999999875
Q ss_pred CC
Q 005669 671 LD 672 (684)
Q Consensus 671 ~~ 672 (684)
..
T Consensus 162 ~~ 163 (283)
T d1mqba_ 162 DD 163 (283)
T ss_dssp --
T ss_pred CC
Confidence 44
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.8e-28 Score=256.26 Aligned_cols=152 Identities=20% Similarity=0.314 Sum_probs=134.8
Q ss_pred hcCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
..++|++.+.||+|+||+||+|... +++.||||.++... .....+.+|+++|++++||||+++++++.+++..|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3578999999999999999999986 48899999997643 334568899999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--CCcEEEEeeccccccCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--TMNPKISDFGLARSFGL 671 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~--~~~vkI~DFGla~~~~~ 671 (684)
|+++++|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++. ...+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 9999999999843 2346899999999999999999999998 999999999999984 45799999999998754
Q ss_pred C
Q 005669 672 D 672 (684)
Q Consensus 672 ~ 672 (684)
.
T Consensus 157 ~ 157 (321)
T d1tkia_ 157 G 157 (321)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.95 E-value=8.7e-29 Score=261.70 Aligned_cols=149 Identities=26% Similarity=0.325 Sum_probs=135.3
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (684)
++|++++.||+|+||.||+|++. +|+.||||++.+. .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 4899999998642 2344567899999999999999999999999999999999
Q ss_pred EccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
||+.+|+|..++.. ...+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999998854 346899999999999999999999998 99999999999999999999999999998753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.4e-28 Score=254.80 Aligned_cols=152 Identities=29% Similarity=0.511 Sum_probs=131.1
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
++|++.++||+|+||+||+|.+. +++.||||+++... ....+++.+|++++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999975 48999999996542 2346788999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
|+.++.+.... . .....+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....+.
T Consensus 82 ~~~~~~~~~~~-~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMD-A-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHH-H-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhh-h-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99865554333 2 23456999999999999999999999998 9999999999999999999999999999875443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.8e-28 Score=256.24 Aligned_cols=162 Identities=30% Similarity=0.519 Sum_probs=131.7
Q ss_pred CCCCccceecccCcEeEEEEEeeC-Cc----EEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
.+|++.++||+|+||+||+|.+.. |+ +||+|+++.. .....+++.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 468999999999999999998753 43 6899998753 345577899999999999999999999999864 5678
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
++||+.+++|.+.+... ...+++..++.++.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999998887543 456899999999999999999999998 9999999999999999999999999999986
Q ss_pred CCCCccCCcccccC
Q 005669 671 LDQTEANTKRVVGT 684 (684)
Q Consensus 671 ~~~~~~~~~~~~GT 684 (684)
.......+....||
T Consensus 163 ~~~~~~~~~~~~gt 176 (317)
T d1xkka_ 163 AEEKEYHAEGGKVP 176 (317)
T ss_dssp TTCC--------CC
T ss_pred cccccccccccccC
Confidence 65544433334444
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.4e-28 Score=254.83 Aligned_cols=172 Identities=27% Similarity=0.395 Sum_probs=131.7
Q ss_pred HHHHhhcCCCCccceecccCcEeEEEEEeeC------CcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEE
Q 005669 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGC 581 (684)
Q Consensus 510 ~~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~ 581 (684)
...+...++|++.++||+|+||.||+|.... ++.||||+++... ....+++.+|...+.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 3333445789999999999999999998643 4689999997542 33456678888888777 68999999999
Q ss_pred EEeCC-eeEEEEEccCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCC
Q 005669 582 CTQRD-ERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKA 647 (684)
Q Consensus 582 ~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp 647 (684)
+.+.+ ..++||||+++|+|.+++..... ...+++.++..++.||++||+|||+++ ||||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 87654 58999999999999999864321 245899999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEeeccccccCCCCCccCCcccccC
Q 005669 648 SNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684 (684)
Q Consensus 648 ~NILl~~~~~vkI~DFGla~~~~~~~~~~~~~~~~GT 684 (684)
+||||++++.+||+|||+|+...............||
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 199 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 199 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeC
Confidence 9999999999999999999987655544444445555
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=1.7e-28 Score=260.80 Aligned_cols=151 Identities=28% Similarity=0.388 Sum_probs=130.6
Q ss_pred cCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCC---cccHHHHHH---HHHHHhccCCCceeeEEEEEEeCCee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKN---EVLLIAKLQHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~---Ei~~l~~l~H~nIv~l~g~~~~~~~~ 588 (684)
.++|++.+.||+|+||.||+|+... |+.||||++.+.. ......+.+ |+.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 3679999999999999999999764 8999999986421 122233444 46677788899999999999999999
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
|+||||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999854 345899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCC
Q 005669 669 FGLD 672 (684)
Q Consensus 669 ~~~~ 672 (684)
+...
T Consensus 157 ~~~~ 160 (364)
T d1omwa3 157 FSKK 160 (364)
T ss_dssp CSSS
T ss_pred cCCC
Confidence 7644
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.2e-28 Score=253.41 Aligned_cols=147 Identities=33% Similarity=0.477 Sum_probs=126.3
Q ss_pred ccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcc-----cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 521 EKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ-----GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 521 ~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
.+++||+|+||+||+|.+.. ++.||||+++..... ..+.+.+|+.++++++|||||++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 35789999999999999754 899999998754221 235688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
++++++..+. .....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9988776655 33456899999999999999999999998 9999999999999999999999999999876543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.95 E-value=2.2e-28 Score=251.78 Aligned_cols=150 Identities=28% Similarity=0.480 Sum_probs=135.4
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (684)
++|+..++||+|+||+||+|++.+++.||||+++... ....+.+.+|+.+|++++||||+++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999889999999997542 33357899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+.++.+..+. .....+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9988777666 33567999999999999999999999998 999999999999999999999999999987543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3e-28 Score=254.45 Aligned_cols=150 Identities=30% Similarity=0.467 Sum_probs=132.2
Q ss_pred CCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC---CcccHHHHHHHHHHHh-ccCCCceeeEEEEEEeCCeeEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIA-KLQHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~lV 591 (684)
++|++.+.||+|+||+||+|+... ++.||||++++. .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 578999999999999999999864 899999999743 2334456677777665 68999999999999999999999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~ 671 (684)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999854 345899999999999999999999998 99999999999999999999999999997754
Q ss_pred C
Q 005669 672 D 672 (684)
Q Consensus 672 ~ 672 (684)
.
T Consensus 156 ~ 156 (320)
T d1xjda_ 156 G 156 (320)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.7e-28 Score=252.69 Aligned_cols=156 Identities=27% Similarity=0.470 Sum_probs=135.7
Q ss_pred cCCCCccceecccCcEeEEEEEee------CCcEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCee
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 588 (684)
.++|+..++||+|+||.||+|.+. +++.||||+++.. .......+.+|+.++++++||||+++++++..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467888899999999999999864 2578999999754 233445689999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHHhcc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEE
Q 005669 589 MLIYEYLPNKSLDYFIFDT-------TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~ 661 (684)
++||||+++|+|.+++... .....+++..+..++.|+++||.|||+++ |+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999987532 12245799999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCCC
Q 005669 662 DFGLARSFGLDQT 674 (684)
Q Consensus 662 DFGla~~~~~~~~ 674 (684)
|||+|+.+.....
T Consensus 176 DFGla~~~~~~~~ 188 (308)
T d1p4oa_ 176 DFGMTRDIYETDY 188 (308)
T ss_dssp CTTCCCGGGGGGC
T ss_pred ecccceeccCCcc
Confidence 9999998755443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.3e-28 Score=248.73 Aligned_cols=151 Identities=28% Similarity=0.428 Sum_probs=124.2
Q ss_pred cCCCCccceecccCcEeEEEEEeeC----CcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (684)
.++|++.+.||+|+||.||+|.+.. +..||||.++... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4678899999999999999998753 3578999987543 334567999999999999999999999985 567899
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccC
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~ 670 (684)
||||+++|+|.+++.. ....+++.+++.++.||++||.|||+++ |+||||||+||++++++.+||+|||+|+.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999988743 2456899999999999999999999998 9999999999999999999999999999875
Q ss_pred CC
Q 005669 671 LD 672 (684)
Q Consensus 671 ~~ 672 (684)
..
T Consensus 160 ~~ 161 (273)
T d1mp8a_ 160 DS 161 (273)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.3e-28 Score=251.29 Aligned_cols=166 Identities=30% Similarity=0.406 Sum_probs=140.1
Q ss_pred cCCCCccceecccCcEeEEEEEee------CCcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCe
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDE 587 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 587 (684)
.++|++.++||+|+||.||+|++. .++.||||+++... .....++.+|+.+++++ +|||||+++++|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 467888999999999999999863 25689999997643 33455789999999999 69999999999999999
Q ss_pred eEEEEEccCCCChhHHHhccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 005669 588 RMLIYEYLPNKSLDYFIFDTT---------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl 652 (684)
.++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ ||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999986532 1235899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCccCCcccccC
Q 005669 653 DNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684 (684)
Q Consensus 653 ~~~~~vkI~DFGla~~~~~~~~~~~~~~~~GT 684 (684)
+.++.+||+|||+++.+.............||
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt 210 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLP 210 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred cccCcccccccchheeccCCCcceEeeecccC
Confidence 99999999999999988655443333334443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.3e-28 Score=248.44 Aligned_cols=152 Identities=32% Similarity=0.451 Sum_probs=124.7
Q ss_pred CCCCccceecccCcEeEEEEEeeC--C--cEEEEEEccCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE--G--QEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~--g--~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (684)
++|++.+.||+|+||.||+|+... + .+||||++++. .....++|.+|+.++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568899999999999999998643 2 37899998754 23445789999999999999999999999965 5678
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+||||++++++.+.+... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999887543 345899999999999999999999998 999999999999999999999999999988
Q ss_pred CCCCC
Q 005669 670 GLDQT 674 (684)
Q Consensus 670 ~~~~~ 674 (684)
.....
T Consensus 162 ~~~~~ 166 (273)
T d1u46a_ 162 PQNDD 166 (273)
T ss_dssp CC-CC
T ss_pred ccCCC
Confidence 65543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.95 E-value=6.4e-28 Score=247.05 Aligned_cols=151 Identities=25% Similarity=0.374 Sum_probs=132.3
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe----
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE---- 587 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~---- 587 (684)
.++|++.+.||+|+||+||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999975 58999999997543 2334578999999999999999999999986543
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.|+||||+++++|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999988844 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCC
Q 005669 668 SFGLD 672 (684)
Q Consensus 668 ~~~~~ 672 (684)
.....
T Consensus 160 ~~~~~ 164 (277)
T d1o6ya_ 160 AIADS 164 (277)
T ss_dssp ECC--
T ss_pred hhccc
Confidence 76443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.3e-27 Score=248.64 Aligned_cols=152 Identities=35% Similarity=0.602 Sum_probs=131.9
Q ss_pred CCCCccceecccCcEeEEEEEeeC-Cc--EEEEEEccCC-CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeeEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ--EIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 591 (684)
++|++.++||+|+||+||+|.+.+ +. .||||+++.. .....+++.+|+++|.++ +|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578888999999999999999865 33 5788887643 344566899999999999 799999999999999999999
Q ss_pred EEccCCCChhHHHhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcE
Q 005669 592 YEYLPNKSLDYFIFDT-------------TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~v 658 (684)
|||+++|+|.+++... .....+++.++..++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 23467999999999999999999999998 9999999999999999999
Q ss_pred EEEeeccccccCC
Q 005669 659 KISDFGLARSFGL 671 (684)
Q Consensus 659 kI~DFGla~~~~~ 671 (684)
||+|||+|+....
T Consensus 167 kl~DfG~a~~~~~ 179 (309)
T d1fvra_ 167 KIADFGLSRGQEV 179 (309)
T ss_dssp EECCTTCEESSCE
T ss_pred EEccccccccccc
Confidence 9999999987643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.5e-27 Score=246.94 Aligned_cols=165 Identities=30% Similarity=0.430 Sum_probs=134.6
Q ss_pred cCCCCccceecccCcEeEEEEEeeC--------CcEEEEEEccCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR 585 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 585 (684)
.++|++.+.||+|+||.||+|+... +..||||+++... .....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4678889999999999999998643 2479999997653 33457788899999888 799999999999999
Q ss_pred CeeEEEEEccCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 005669 586 DERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (684)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl 652 (684)
+..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+++ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999964421 246899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCccCCccccc
Q 005669 653 DNTMNPKISDFGLARSFGLDQTEANTKRVVG 683 (684)
Q Consensus 653 ~~~~~vkI~DFGla~~~~~~~~~~~~~~~~G 683 (684)
+.++.+||+|||+++..........+....|
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 199 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRL 199 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCC
T ss_pred cCCCCeEeccchhhccccccccccccccCCC
Confidence 9999999999999998865544433333333
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.8e-27 Score=248.62 Aligned_cols=149 Identities=26% Similarity=0.341 Sum_probs=127.5
Q ss_pred cCCCCccc-eecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEe----CCee
Q 005669 516 TDNFSEKN-KLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ----RDER 588 (684)
Q Consensus 516 t~~y~~~~-~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~ 588 (684)
.++|++.. .||+|+||+||+|.+. +++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788765 5999999999999974 4899999998642 5678899987655 89999999999875 3568
Q ss_pred EEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCcEEEEeecc
Q 005669 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGL 665 (684)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~---~~~vkI~DFGl 665 (684)
|+||||+++|+|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||+++ .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999542 2356999999999999999999999998 999999999999975 56799999999
Q ss_pred ccccCCCC
Q 005669 666 ARSFGLDQ 673 (684)
Q Consensus 666 a~~~~~~~ 673 (684)
|+......
T Consensus 161 a~~~~~~~ 168 (335)
T d2ozaa1 161 AKETTSHN 168 (335)
T ss_dssp CEECCCCC
T ss_pred eeeccCCC
Confidence 99875443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.4e-27 Score=243.94 Aligned_cols=147 Identities=29% Similarity=0.516 Sum_probs=128.0
Q ss_pred cceecccCcEeEEEEEeeCC----cEEEEEEccCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC-CeeEEEEEcc
Q 005669 522 KNKLGEGGFGPVYKGMLIEG----QEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-DERMLIYEYL 595 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~g----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey~ 595 (684)
.++||+|+||+||+|.+.++ ..||||+++.. .....++|.+|++++++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997542 36899999753 444567899999999999999999999998764 5789999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
++++|.+++.. ....+++..++.++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++.+....
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999998853 3445788999999999999999999998 9999999999999999999999999999875443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=7.3e-28 Score=244.23 Aligned_cols=150 Identities=27% Similarity=0.463 Sum_probs=125.7
Q ss_pred cCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe-CCeeEEEEEc
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDERMLIYEY 594 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey 594 (684)
.++|+..++||+|+||.||+|.. .|++||||+++.. ...+++.+|++++++++||||++++|+|.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 35678889999999999999998 5789999999753 345789999999999999999999999965 4568999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~ 672 (684)
+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence 9999999998543 2235899999999999999999999988 999999999999999999999999999986543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.1e-27 Score=244.98 Aligned_cols=149 Identities=26% Similarity=0.396 Sum_probs=124.7
Q ss_pred CCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHH--HHHHHhccCCCceeeEEEEEEeCC----eeEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN--EVLLIAKLQHRNLVKLLGCCTQRD----ERML 590 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~--Ei~~l~~l~H~nIv~l~g~~~~~~----~~~l 590 (684)
+.|...++||+|+||.||+|++ +|+.||||+++.. ..+++.+ |+..+.+++||||+++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4567778999999999999986 6899999998643 2234444 455556789999999999998654 5799
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecCCCCCcEEEcCCCcEEEEeecc
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS-----RLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----~~~IvHrDLkp~NILl~~~~~vkI~DFGl 665 (684)
||||+++|+|.+++.+ ..+++.++..++.|++.||+|||+.. ..+|+||||||+||||++++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999954 35899999999999999999999741 23599999999999999999999999999
Q ss_pred ccccCCCC
Q 005669 666 ARSFGLDQ 673 (684)
Q Consensus 666 a~~~~~~~ 673 (684)
++.+....
T Consensus 155 ~~~~~~~~ 162 (303)
T d1vjya_ 155 AVRHDSAT 162 (303)
T ss_dssp CEEEETTT
T ss_pred cccccCCC
Confidence 99885543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.1e-26 Score=239.48 Aligned_cols=151 Identities=27% Similarity=0.474 Sum_probs=135.5
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeeEEEEE
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (684)
++|++.++||+|+||+||+|++. +++.||||+++... ....+++.+|+.++++++||||+++++++.+.+..++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999975 48899999986542 3346788999999999999999999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccccccCCCC
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~~~~~ 673 (684)
++.+++|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.|+.+....
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988773 3456899999999999999999999998 9999999999999999999999999999875443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.3e-27 Score=242.25 Aligned_cols=150 Identities=25% Similarity=0.380 Sum_probs=128.6
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCc------ccHHHHHHHHHHHhccC--CCceeeEEEEEEeCC
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG------QGMEEFKNEVLLIAKLQ--HRNLVKLLGCCTQRD 586 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~ 586 (684)
.++|++.+.||+|+||+||+|+.. +++.||||++++... ....++.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 367999999999999999999975 489999999875311 11234678999999996 899999999999999
Q ss_pred eeEEEEEccCC-CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCcEEEEeec
Q 005669 587 ERMLIYEYLPN-KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFG 664 (684)
Q Consensus 587 ~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~-~~~vkI~DFG 664 (684)
..++||||+.+ +++.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 577777643 346899999999999999999999998 999999999999985 5799999999
Q ss_pred cccccCC
Q 005669 665 LARSFGL 671 (684)
Q Consensus 665 la~~~~~ 671 (684)
+|+....
T Consensus 157 ~a~~~~~ 163 (273)
T d1xwsa_ 157 SGALLKD 163 (273)
T ss_dssp TCEECCS
T ss_pred cceeccc
Confidence 9987643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=9.3e-27 Score=246.49 Aligned_cols=149 Identities=26% Similarity=0.409 Sum_probs=125.1
Q ss_pred CCCccceecccCcEeEEEEEeeC-CcEEEEEEccCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeC------CeeEE
Q 005669 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------DERML 590 (684)
Q Consensus 518 ~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~l 590 (684)
.|+..++||+|+||+||+|++.. ++.||||++..... ...+|+++|++++|+||+++++++... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 57888999999999999999864 89999999976432 234799999999999999999998643 34789
Q ss_pred EEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-cEEEEeecccccc
Q 005669 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSF 669 (684)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~-~vkI~DFGla~~~ 669 (684)
||||++++.+..+.........+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755544433334567999999999999999999999998 99999999999999765 8999999999987
Q ss_pred CCCC
Q 005669 670 GLDQ 673 (684)
Q Consensus 670 ~~~~ 673 (684)
....
T Consensus 174 ~~~~ 177 (350)
T d1q5ka_ 174 VRGE 177 (350)
T ss_dssp CTTS
T ss_pred cCCc
Confidence 5443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=9.7e-27 Score=245.83 Aligned_cols=150 Identities=26% Similarity=0.402 Sum_probs=126.9
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC----eeE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD----ERM 589 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~ 589 (684)
..+|++.++||+|+||+||+|... +++.||||+++... ....+++.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467999999999999999999874 58999999997543 334567889999999999999999999997643 235
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccccc
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~~ 669 (684)
+++||+.+++|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55667789999999843 35899999999999999999999998 999999999999999999999999999887
Q ss_pred CCC
Q 005669 670 GLD 672 (684)
Q Consensus 670 ~~~ 672 (684)
...
T Consensus 160 ~~~ 162 (345)
T d1pmea_ 160 DPD 162 (345)
T ss_dssp CGG
T ss_pred cCC
Confidence 544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.93 E-value=2.7e-26 Score=240.73 Aligned_cols=146 Identities=25% Similarity=0.427 Sum_probs=127.8
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeC--CeeEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQR--DERMLI 591 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV 591 (684)
.++|++.++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+.+|++++ ||||+++++++... ...++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 367999999999999999999975 4899999999753 3567899999999995 99999999999754 468999
Q ss_pred EEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-cEEEEeeccccccC
Q 005669 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFG 670 (684)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~-~vkI~DFGla~~~~ 670 (684)
|||+++++|..+. +.+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999997653 35899999999999999999999998 99999999999998654 69999999999876
Q ss_pred CCC
Q 005669 671 LDQ 673 (684)
Q Consensus 671 ~~~ 673 (684)
...
T Consensus 182 ~~~ 184 (328)
T d3bqca1 182 PGQ 184 (328)
T ss_dssp TTC
T ss_pred CCC
Confidence 443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=4.8e-26 Score=237.69 Aligned_cols=151 Identities=28% Similarity=0.507 Sum_probs=128.4
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEe--------
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-------- 584 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-------- 584 (684)
.++|++.++||+|+||+||+|++. +|+.||||++... .....+++.+|+.+|++++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999975 5899999998643 33445778999999999999999999999865
Q ss_pred CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeec
Q 005669 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (684)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFG 664 (684)
....++||||++++.+.... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34579999999988776544 33456899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCC
Q 005669 665 LARSFGLD 672 (684)
Q Consensus 665 la~~~~~~ 672 (684)
+|+.+...
T Consensus 163 ~~~~~~~~ 170 (318)
T d3blha1 163 LARAFSLA 170 (318)
T ss_dssp TCEECCC-
T ss_pred eeeecccc
Confidence 99887543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.1e-26 Score=242.04 Aligned_cols=150 Identities=26% Similarity=0.457 Sum_probs=124.7
Q ss_pred hcCCCCccceecccCcEeEEEEEeeC-CcEEEEEEccCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-----
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD----- 586 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----- 586 (684)
..++|++.++||+|+||+||+|.+.. |+.||||+++.. .....+.+.+|+++|++++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 35789999999999999999999754 899999999754 2233567889999999999999999999997655
Q ss_pred -eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecc
Q 005669 587 -ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (684)
Q Consensus 587 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGl 665 (684)
+.++||||+ +.+|..++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 469999999 567777663 245999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCC
Q 005669 666 ARSFGLD 672 (684)
Q Consensus 666 a~~~~~~ 672 (684)
|+.....
T Consensus 168 a~~~~~~ 174 (346)
T d1cm8a_ 168 ARQADSE 174 (346)
T ss_dssp CEECCSS
T ss_pred eeccCCc
Confidence 9987543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.9e-26 Score=241.01 Aligned_cols=150 Identities=27% Similarity=0.377 Sum_probs=132.6
Q ss_pred CCCCccceecccCcEeEEEEEee----CCcEEEEEEccCC----CcccHHHHHHHHHHHhccCC-CceeeEEEEEEeCCe
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG----SGQGMEEFKNEVLLIAKLQH-RNLVKLLGCCTQRDE 587 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~ 587 (684)
++|++.++||+|+||+||+|... +|+.||||++++. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999863 3789999998643 12345678899999999966 899999999999999
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.+++|||+.+++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999998543 35788999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCC
Q 005669 668 SFGLD 672 (684)
Q Consensus 668 ~~~~~ 672 (684)
.+...
T Consensus 178 ~~~~~ 182 (322)
T d1vzoa_ 178 EFVAD 182 (322)
T ss_dssp ECCGG
T ss_pred hhccc
Confidence 87543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.92 E-value=1.9e-25 Score=230.38 Aligned_cols=149 Identities=17% Similarity=0.297 Sum_probs=129.2
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCC-CceeeEEEEEEeCCeeEEEEE
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH-RNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E 593 (684)
.++|++.++||+|+||+||+|++. +++.||||++.... ....+++|++.++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 367999999999999999999975 48899999986532 23457889999999965 899999999999999999999
Q ss_pred ccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-----CCcEEEEeeccccc
Q 005669 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----TMNPKISDFGLARS 668 (684)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~-----~~~vkI~DFGla~~ 668 (684)
|+ +++|.+++.. ....+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 6888888743 2346899999999999999999999998 999999999999964 57899999999998
Q ss_pred cCCC
Q 005669 669 FGLD 672 (684)
Q Consensus 669 ~~~~ 672 (684)
+...
T Consensus 156 ~~~~ 159 (293)
T d1csna_ 156 YRDP 159 (293)
T ss_dssp SBCT
T ss_pred cccC
Confidence 7543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=7e-26 Score=234.98 Aligned_cols=152 Identities=28% Similarity=0.479 Sum_probs=125.4
Q ss_pred hcCCCCccceecccCcEeEEEEEee-C-CcEEEEEEccCC--CcccHHHHHHHHHHHhcc---CCCceeeEEEEEEe---
Q 005669 515 ATDNFSEKNKLGEGGFGPVYKGMLI-E-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKL---QHRNLVKLLGCCTQ--- 584 (684)
Q Consensus 515 ~t~~y~~~~~LG~G~fG~Vy~~~~~-~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~--- 584 (684)
..++|++.++||+|+||+||+|.+. + ++.||||+++.. .......+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3478999999999999999999974 3 567999998643 222234566777777665 79999999999863
Q ss_pred --CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEe
Q 005669 585 --RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISD 662 (684)
Q Consensus 585 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~D 662 (684)
....+++|||++++.+..... .....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 245799999999887765442 34556899999999999999999999998 99999999999999999999999
Q ss_pred eccccccCC
Q 005669 663 FGLARSFGL 671 (684)
Q Consensus 663 FGla~~~~~ 671 (684)
||+++....
T Consensus 160 fg~~~~~~~ 168 (305)
T d1blxa_ 160 FGLARIYSF 168 (305)
T ss_dssp CCSCCCCCG
T ss_pred hhhhhhhcc
Confidence 999987643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.7e-25 Score=236.42 Aligned_cols=148 Identities=30% Similarity=0.446 Sum_probs=125.8
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC-----Ce
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-----DE 587 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 587 (684)
.++|++.++||+|+||+||+|... +++.||||+++... ....+++.+|+++|++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 578999999999999999999975 58999999997643 23345788999999999999999999998643 33
Q ss_pred eEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.++++||+.+++|.+++. .+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 467778889999999883 346999999999999999999999998 9999999999999999999999999998
Q ss_pred ccC
Q 005669 668 SFG 670 (684)
Q Consensus 668 ~~~ 670 (684)
...
T Consensus 170 ~~~ 172 (348)
T d2gfsa1 170 HTD 172 (348)
T ss_dssp CCT
T ss_pred ccC
Confidence 764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.92 E-value=6.9e-25 Score=226.78 Aligned_cols=149 Identities=24% Similarity=0.379 Sum_probs=122.8
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCc-eeeEEEEEEeCCeeEEEEEc
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN-LVKLLGCCTQRDERMLIYEY 594 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey 594 (684)
++|++.+.||+|+||.||+|.+. +++.||||++..... .+++.+|++++++++|+| |+.+..+..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999975 488999999876432 346788999999998766 55556666788889999999
Q ss_pred cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc---CCCcEEEEeeccccccCC
Q 005669 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFGLARSFGL 671 (684)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~---~~~~vkI~DFGla~~~~~ 671 (684)
+. ++|...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 455555432 3456899999999999999999999998 99999999999986 355799999999998865
Q ss_pred CC
Q 005669 672 DQ 673 (684)
Q Consensus 672 ~~ 673 (684)
..
T Consensus 159 ~~ 160 (299)
T d1ckia_ 159 AR 160 (299)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=9.5e-25 Score=231.32 Aligned_cols=148 Identities=28% Similarity=0.428 Sum_probs=121.7
Q ss_pred cCCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe------CC
Q 005669 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ------RD 586 (684)
Q Consensus 516 t~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~------~~ 586 (684)
.++|++.++||+|+||+||+|.+. +|+.||||++.... .....++.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999976 48999999997542 3344578899999999999999999999964 36
Q ss_pred eeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEEeeccc
Q 005669 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (684)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla 666 (684)
+.|+||||+.++.+.. + ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~~~-~-----~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQV-I-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHHH-H-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHHh-h-----hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 7899999998765543 3 235899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCC
Q 005669 667 RSFGLD 672 (684)
Q Consensus 667 ~~~~~~ 672 (684)
+.....
T Consensus 167 ~~~~~~ 172 (355)
T d2b1pa1 167 RTAGTS 172 (355)
T ss_dssp ------
T ss_pred hccccc
Confidence 877543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=2e-21 Score=186.91 Aligned_cols=135 Identities=21% Similarity=0.230 Sum_probs=107.1
Q ss_pred CccceecccCcEeEEEEEeeCCcEEEEEEccCCCc------------------ccHHHHHHHHHHHhccCCCceeeEEEE
Q 005669 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG------------------QGMEEFKNEVLLIAKLQHRNLVKLLGC 581 (684)
Q Consensus 520 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l~H~nIv~l~g~ 581 (684)
.+.++||+|+||.||+|...+|++||||+++.... .......+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999988899999998753210 001234568889999999999998865
Q ss_pred EEeCCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCcEEEE
Q 005669 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (684)
Q Consensus 582 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~IvHrDLkp~NILl~~~~~vkI~ 661 (684)
. ..+++|||+++..+.. ++......++.|++++|+|||+++ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 2379999999865532 334445689999999999999998 9999999999999965 58999
Q ss_pred eeccccccCCC
Q 005669 662 DFGLARSFGLD 672 (684)
Q Consensus 662 DFGla~~~~~~ 672 (684)
|||+|+....+
T Consensus 145 DFG~a~~~~~~ 155 (191)
T d1zara2 145 DFPQSVEVGEE 155 (191)
T ss_dssp CCTTCEETTST
T ss_pred ECCCcccCCCC
Confidence 99999887543
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.84 E-value=6e-21 Score=166.50 Aligned_cols=112 Identities=20% Similarity=0.415 Sum_probs=94.2
Q ss_pred ccccCCCCcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEEe
Q 005669 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLL 124 (684)
Q Consensus 45 ~~~l~~g~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l~ 124 (684)
.|+|.+||.|.+|++|+| |.|.|.|..+|+ |.++. ..++||.||++.|.. ++.|.|+. ||+|+|+
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~--~~~l~l~~--dGnLvl~ 65 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKAS--GCVLKMQN--DGNLVIY 65 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCS--SEEEEECT--TSCEEEE
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc----CCcEEEEccCccCCC--CcEEEEec--cccEEEE
Confidence 489999999999999975 889999998875 44543 468999999998854 46899988 9999999
Q ss_pred cCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCC
Q 005669 125 NSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCD 176 (684)
Q Consensus 125 ~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTD 176 (684)
++ +.++|++++....+...|+|+|+|||||++. ++.++|||+.+|++
T Consensus 66 ~~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~----~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 66 SG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDN----SNNAIWATHTNVGN 112 (112)
T ss_dssp ET-TEEEEECCCCCSCCCCEEEECTTSCEEEECT----TSCEEEECCCCCCC
T ss_pred ec-CCeEEEEeeccCCCceEEEEcCCCCEEEECC----CCcEEecCCCccCC
Confidence 97 4678888876545567899999999999987 46799999999986
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.82 E-value=1.4e-20 Score=162.57 Aligned_cols=107 Identities=24% Similarity=0.341 Sum_probs=91.2
Q ss_pred ccccCCCCcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEEe
Q 005669 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLL 124 (684)
Q Consensus 45 ~~~l~~g~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l~ 124 (684)
.|+|.+||.|.+|++|. +|.|.|.|+.+|+ |.|+. ..++||.||++.|. .++.|.++. ||+|+|+
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~--~~~~l~l~~--~Gnlvl~ 65 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLS--RSCFLSMQT--DGNLVVY 65 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSC--SSCEEEECT--TSCEEEE
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe----CCceeeEeCCCCCC--CccEEEEec--cceEEEE
Confidence 37899999999999995 6899999998885 55653 36889999999884 356899987 9999999
Q ss_pred cCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccC
Q 005669 125 NSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDY 173 (684)
Q Consensus 125 ~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~ 173 (684)
+++|.++|+|++.......+|+|+|+|||||++. ++||||+|
T Consensus 66 ~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~-------~~W~S~t~ 107 (108)
T d1jpca_ 66 NPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT-------DRWATGTH 107 (108)
T ss_dssp CTTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC-------CCCCCCCC
T ss_pred CCCccceEEccccCCCCcEEEEEcCCCCEEEeCC-------CcccCCCC
Confidence 9999999999977655566799999999999964 49999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.82 E-value=3.4e-20 Score=160.25 Aligned_cols=107 Identities=21% Similarity=0.402 Sum_probs=90.2
Q ss_pred cccCCCCcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEEec
Q 005669 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLN 125 (684)
Q Consensus 46 ~~l~~g~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l~~ 125 (684)
|+|.+||.|.+|++|.+ |.|.|+|...++ |.++ . ..++||+||++.|+. ..+.|.|+. ||+|||+|
T Consensus 2 ~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~-~---~~~~vW~ant~~~~~-~~~~l~l~~--dGnLvl~~ 67 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLY-D---HSTSVWASNTGILGK-KGCKAVLQS--DGNFVVYD 67 (109)
T ss_dssp CEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEE-E---TTEEEEECCCCCTTC-CCCEEEECT--TSCEEEEC
T ss_pred CCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEE-e---CCEEEEEeCCCCCCc-eeEEEEEcC--CceEEEEe
Confidence 78999999999999964 789999987765 3343 2 368899999999986 457899988 99999999
Q ss_pred CCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccC
Q 005669 126 STNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDY 173 (684)
Q Consensus 126 ~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~ 173 (684)
++|.++|+|++....+.+.|+|+|+|||||+++ ++|||+-|
T Consensus 68 ~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~-------~~W~S~t~ 108 (109)
T d1kj1a_ 68 AEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS-------DIWSTGTY 108 (109)
T ss_dssp SSSCEEEECCCCCCSSCCEEEECTTSCEEEECC-------EEEECCCC
T ss_pred CCCcEEEEEeeECCCCCEEEEEeCCCcEEEECC-------CEecCCCc
Confidence 999999999987545667899999999999953 59999865
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.82 E-value=1.6e-20 Score=198.91 Aligned_cols=151 Identities=21% Similarity=0.275 Sum_probs=121.2
Q ss_pred CCCCccceecccCcEeEEEEEee-CCcEEEEEEccCCCcccHHHHHHHHHHHhccC-----------CCceeeEEEEEEe
Q 005669 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-----------HRNLVKLLGCCTQ 584 (684)
Q Consensus 517 ~~y~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~g~~~~ 584 (684)
++|++.++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999975 5899999999764 233467788999888875 5789999988764
Q ss_pred --CCeeEEEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCC-----
Q 005669 585 --RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTM----- 656 (684)
Q Consensus 585 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~IvHrDLkp~NILl~~~~----- 656 (684)
....+++++++.................+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 34566777776655544333334456678999999999999999999998 66 99999999999998654
Q ss_pred -cEEEEeeccccccCC
Q 005669 657 -NPKISDFGLARSFGL 671 (684)
Q Consensus 657 -~vkI~DFGla~~~~~ 671 (684)
.+|++|||.|+....
T Consensus 169 ~~~kl~dfg~s~~~~~ 184 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE 184 (362)
T ss_dssp EEEEECCCTTCEETTB
T ss_pred ceeeEeeccccccccc
Confidence 399999999987653
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.70 E-value=1.2e-17 Score=146.48 Aligned_cols=103 Identities=20% Similarity=0.303 Sum_probs=86.8
Q ss_pred EEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEEecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCC
Q 005669 83 GIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNN 162 (684)
Q Consensus 83 giw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~ 162 (684)
.|||..+++++.+|++|++.|+.....+|.|+. ||||||++. +.++|++++........|.|+|+|||||++.
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~--DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~---- 83 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMET--DCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTN---- 83 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEET--TTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEET----
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcC--CCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcC----
Confidence 389999999999999999999987667899988 999999987 5789999987654567899999999999987
Q ss_pred CCCeeEeeccCCCCCcCCCCeecccccCccceeEEEccCCCCCCCCceEEeeCCCCCcEEE
Q 005669 163 PDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLV 223 (684)
Q Consensus 163 ~~~~~WQSFd~PTDTlLpgq~l~~~~~tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~ 223 (684)
++.++|||+. +.++|.|.+.|++||++.++
T Consensus 84 ~~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 84 QNIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp TTEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred CCCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 4689999973 23568899999999997765
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.60 E-value=2.4e-16 Score=136.65 Aligned_cols=111 Identities=23% Similarity=0.293 Sum_probs=91.3
Q ss_pred EEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEEecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCC
Q 005669 84 IWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNP 163 (684)
Q Consensus 84 iw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~ 163 (684)
|||.--++.+..|..+++.++.+...+|.|+. ||||||+++ +.++|++++.+ ..+..+.|+|+|||||++. +
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~--DGNLvL~~~-~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~----~ 74 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQS--DCNLVLFDS-DVRVWASNTAG-ATGCRAVLQSDGLLVILTA----Q 74 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECT--TSCEEEEES-SSEEECCCCCS-CSCCBCCBCSSSCBCCBCT----T
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECC--CCeEEEEcC-CeeEEEcccCC-CCceEEEEeccCCEEEEcc----C
Confidence 67766667788899999999987777899988 999999985 67999999865 3567899999999999987 4
Q ss_pred CCeeEeeccCCCCCcCCCCeecccccCccceeEEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCCC
Q 005669 164 DNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSW 237 (684)
Q Consensus 164 ~~~~WQSFd~PTDTlLpgq~l~~~~~tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~~ 237 (684)
+.+||||+. +.+.|.|.+.|++||++.++ +.++|.+|.-
T Consensus 75 ~~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvlY----~~~~Wssgt~ 113 (115)
T d1dlpa1 75 NTIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTIY----GPGLWDSGTS 113 (115)
T ss_dssp TCCSCCCCC-------------------------------CCCSSCCEEEECSSSCEEEE----CSEEEECSCC
T ss_pred CCEEEEcCC-------------------------------CCCCCCEEEEECCCCcEEEe----CCCeecCCCC
Confidence 678999862 34679999999999997655 3479998863
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.58 E-value=4.2e-15 Score=129.56 Aligned_cols=103 Identities=20% Similarity=0.352 Sum_probs=81.8
Q ss_pred cccCCCCcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEEec
Q 005669 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLN 125 (684)
Q Consensus 46 ~~l~~g~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l~~ 125 (684)
++|.+||+| ...+..|.|.|.|...|+ |.+ |. ..++||.+|+..|.. .+.|.|+. ||+|+|+|
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVL-y~---~~~~vWssnt~~~~~--~~~l~l~~--dGnLvL~d 77 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVL-YD---NNNPIWATNTGGLGN--GCRAVLQP--DGVLVVIT 77 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----EEE-EE---TTEEEEECCCTTSCS--SCEEEECT--TSCEEEEC
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc-----EEE-EE---CCeEEEEecCCCCCc--ceEEEEEe--CCCEEEEC
Confidence 455555555 346779999999998886 333 43 468899999987743 47899988 99999999
Q ss_pred CCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeecc
Q 005669 126 STNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFD 172 (684)
Q Consensus 126 ~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd 172 (684)
++|.++|++++.......+|+|+|+|||||++ .++|||-.
T Consensus 78 ~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg-------~~~W~S~T 117 (119)
T d1b2pa_ 78 NENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG-------DALWATQT 117 (119)
T ss_dssp TTCCEEEECSCCCCSSCEEEEECTTSCEEEEE-------SEEEECCC
T ss_pred CCCcEEEECCCcCCCCceEEEEcCCCCEEEEC-------CCEeccCC
Confidence 99999999998765556779999999999995 36999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.37 E-value=4.1e-13 Score=115.94 Aligned_cols=98 Identities=23% Similarity=0.357 Sum_probs=76.7
Q ss_pred CCcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEEecCCCCe
Q 005669 51 GQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDT 130 (684)
Q Consensus 51 g~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l~~~~~~~ 130 (684)
.|+|.+++.| .+|.|.|.|...|+ |.++. ...+||.+|...+ ..+.+.|+. ||||||+|.++.+
T Consensus 14 ~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~----~~~~vW~s~t~~~---~~~~l~l~~--dGNLvl~d~~~~~ 77 (115)
T d1dlpa1 14 PQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD----SDVRVWASNTAGA---TGCRAVLQS--DGLLVILTAQNTI 77 (115)
T ss_dssp CSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE----SSSEEECCCCCSC---SCCBCCBCS--SSCBCCBCTTTCC
T ss_pred cceecCCCcE--EcCCEEEEECCCCe-----EEEEc----CCeeEEEcccCCC---CceEEEEec--cCCEEEEccCCCE
Confidence 4555566666 46779999988876 45543 3578999997643 346788887 9999999999999
Q ss_pred EEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeec
Q 005669 131 VWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSF 171 (684)
Q Consensus 131 ~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSF 171 (684)
||++.+....+..+++|+++||||||+ .++|+|-
T Consensus 78 vWsS~t~~~~g~y~l~Lq~DGNlvlY~-------~~~Wssg 111 (115)
T d1dlpa1 78 RWSSGTKGSIGNYVLVLQPDRTVTIYG-------PGLWDSG 111 (115)
T ss_dssp SCCCCCCCCSSCCEEEECSSSCEEEEC-------SEEEECS
T ss_pred EEEcCCCCCCCCEEEEECCCCcEEEeC-------CCeecCC
Confidence 999998765567789999999999994 3699985
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.14 E-value=4.5e-11 Score=103.93 Aligned_cols=97 Identities=26% Similarity=0.403 Sum_probs=70.3
Q ss_pred cccCCCCcccCCCEEEecCCeEEEeeeCCCCCCceEEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeccCceEEEec
Q 005669 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLN 125 (684)
Q Consensus 46 ~~l~~g~~l~~~~~l~S~~g~f~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~anr~~pv~~~~~~l~~~~~~~g~l~l~~ 125 (684)
++|.++|+|+. |.|.|.|-..|+ |.|+ . ...+||.++.... +..+.+.|+. +|||||+|
T Consensus 24 ~~l~~~q~l~~--------g~y~L~~q~DGN-----LvL~-~---~~~~vW~s~t~~~--~~~~~~~l~~--~GnLvl~d 82 (120)
T d1dlpa2 24 QTLHATQSLQL--------SPYRLSMETDCN-----LVLF-D---RDDRVWSTNTAGK--GTGCRAVLQP--NGRMDVLT 82 (120)
T ss_dssp CEECSSCCCBC--------SSCEEEEETTTE-----EEEE-B---TTBCCSCCCCCSS--CSSCEEEEET--TTEEEEEE
T ss_pred cEEcCCCeeEc--------CCEEEEEcCCCc-----EEEe-c---CCcEEEEEccccC--CCcEEEEEeC--CeeEEEEc
Confidence 45555555544 446666655553 3343 2 3567899885433 3457899988 99999999
Q ss_pred CCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEee
Q 005669 126 STNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQS 170 (684)
Q Consensus 126 ~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQS 170 (684)
.++.++|+|++........+.|+++||||||+. ++|.|
T Consensus 83 ~~~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~~-------~~W~t 120 (120)
T d1dlpa2 83 NQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGG-------ALWTT 120 (120)
T ss_dssp TTTEEEEECCCCCSSSCCEEEECSSSCEEEECC-------CCCBC
T ss_pred CCCCEEEEeCCCCCCCcEEEEECCCCcEEEeCC-------CcccC
Confidence 999999999987655667899999999999943 58875
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.14 E-value=1.1e-10 Score=101.02 Aligned_cols=85 Identities=21% Similarity=0.296 Sum_probs=66.9
Q ss_pred eEEEeeccCceEEEecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCCCeeccccc
Q 005669 110 VLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLG 189 (684)
Q Consensus 110 ~l~~~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~~~~ 189 (684)
.|.|+. ||||||+++ +.++|++++........+.|+++|||||++. .+.++|+|.-
T Consensus 33 ~l~mQ~--DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~----~g~~vWsS~t----------------- 88 (119)
T d1b2pa_ 33 RFIMQT--DCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN----ENVTVWQSPV----------------- 88 (119)
T ss_dssp EEEECT--TSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT----TCCEEEECSC-----------------
T ss_pred EEEECC--CCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECC----CCcEEEECCC-----------------
Confidence 577766 999999987 4689999987644567899999999999987 4678998621
Q ss_pred CccceeEEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCC
Q 005669 190 TGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGS 236 (684)
Q Consensus 190 tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~ 236 (684)
.-+.|.|.+.|+++|++.++ +.+.|.++.
T Consensus 89 --------------~~~~~~~~l~Lq~DGNlvlY----g~~~W~S~T 117 (119)
T d1b2pa_ 89 --------------AGKAGHYVLVLQPDRNVVIY----GDALWATQT 117 (119)
T ss_dssp --------------CCCSSCEEEEECTTSCEEEE----ESEEEECCC
T ss_pred --------------cCCCCceEEEEcCCCCEEEE----CCCEeccCC
Confidence 11457899999999998775 247898875
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.05 E-value=3.7e-10 Score=96.27 Aligned_cols=86 Identities=19% Similarity=0.334 Sum_probs=65.8
Q ss_pred ceEEEeeccCceEEEecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCCCeecccc
Q 005669 109 GVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINL 188 (684)
Q Consensus 109 ~~l~~~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~~~ 188 (684)
-+|.|+. ||||||++. +.+||++++........+.|+++|||||++. .+.++|+|
T Consensus 21 ~~l~~q~--DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~----~g~~vWsS------------------ 75 (108)
T d1jpca_ 21 FVFIMQE--DCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNP----SNKPIWAS------------------ 75 (108)
T ss_dssp EEEEECT--TSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT----TCCEEEEC------------------
T ss_pred EEEEECC--CCeEEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEECC----CccceEEc------------------
Confidence 4678877 999999986 4799999987644456899999999999987 56899986
Q ss_pred cCccceeEEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCC
Q 005669 189 GTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGS 236 (684)
Q Consensus 189 ~tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~ 236 (684)
.+....+.|.+.|+++|++.++ . .+.|.++.
T Consensus 76 -------------~t~~~~~~~~l~L~ddGNlVly--~--~~~W~S~t 106 (108)
T d1jpca_ 76 -------------NTGGQNGNYVCILQKDRNVVIY--G--TDRWATGT 106 (108)
T ss_dssp -------------CCCCSCSCEEEEECTTSCEEEE--E--CCCCCCCC
T ss_pred -------------cccCCCCcEEEEEcCCCCEEEe--C--CCcccCCC
Confidence 1112456889999999997776 2 24676653
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.00 E-value=1.2e-09 Score=93.01 Aligned_cols=87 Identities=25% Similarity=0.395 Sum_probs=66.2
Q ss_pred ceEEEeeccCceEEEecCCCCeEEEecccCC-CCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCCCeeccc
Q 005669 109 GVLRINGERNGILVLLNSTNDTVWSSNSSIS-AQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGIN 187 (684)
Q Consensus 109 ~~l~~~~~~~g~l~l~~~~~~~~w~s~~~~~-~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~~ 187 (684)
-.|.|+. ||||||+.. +.+||++++... .....+.|+++|||||++. ++.++|+|=
T Consensus 21 ~~l~~q~--dgnLvl~~~-~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~----~g~~vW~s~---------------- 77 (109)
T d1kj1a_ 21 YHFIMQE--DCNLVLYDH-STSVWASNTGILGKKGCKAVLQSDGNFVVYDA----EGRSLWASH---------------- 77 (109)
T ss_dssp EEEEECT--TSCEEEEET-TEEEEECCCCCTTCCCCEEEECTTSCEEEECS----SSCEEEECC----------------
T ss_pred EEEEecC--CCeEEEEeC-CEEEEEeCCCCCCceeEEEEEcCCceEEEEeC----CCcEEEEEe----------------
Confidence 5677776 999999975 579999998642 2356799999999999987 568899871
Q ss_pred ccCccceeEEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCCC
Q 005669 188 LGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSW 237 (684)
Q Consensus 188 ~~tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~~ 237 (684)
+..+.|.|.+.|+++|++.++ + .+.|.|+.+
T Consensus 78 ---------------t~~~~~~~~l~L~ddGNlvly--~--~~~W~S~t~ 108 (109)
T d1kj1a_ 78 ---------------SVRGNGNYVLVLQEDGNVVIY--G--SDIWSTGTY 108 (109)
T ss_dssp ---------------CCCCSSCCEEEECTTSCEEEE--C--CEEEECCCC
T ss_pred ---------------eECCCCCEEEEEeCCCcEEEE--C--CCEecCCCc
Confidence 111357789999999997765 3 368887764
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.81 E-value=1.3e-08 Score=87.03 Aligned_cols=89 Identities=21% Similarity=0.346 Sum_probs=66.9
Q ss_pred ceEEEeeccCceEEEecCCCCeEEEecccCCCCCceEEEecCccEEEecCCCCCCCCeeEeeccCCCCCcCCCCeecccc
Q 005669 109 GVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINL 188 (684)
Q Consensus 109 ~~l~~~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WQSFd~PTDTlLpgq~l~~~~ 188 (684)
-.|.|+. ||||||++. +.+||++++........+.|+.+|||||++. +.++|.|
T Consensus 21 ~~l~~q~--DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-----~~~~w~s------------------ 74 (112)
T d1xd5a_ 21 YLFIIQN--DCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYSG-----SRAIWAS------------------ 74 (112)
T ss_dssp EEEEECT--TSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEET-----TEEEEEC------------------
T ss_pred EEEEEcC--CCCEEEEcC-CcEEEEccCccCCCCcEEEEeccccEEEEec-----CCeEEEE------------------
Confidence 5688877 999999985 5799999976544567899999999999985 3456654
Q ss_pred cCccceeEEEccCCCCCCCCceEEeeCCCCCcEEEEecCCeeEEecCCC
Q 005669 189 GTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSW 237 (684)
Q Consensus 189 ~tg~~~~L~Sw~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~yw~~g~~ 237 (684)
...-..|.|.+.|+++|++.++ .....+.|.|+.-
T Consensus 75 -------------~t~~~~~~~~l~L~ddGNlvly-~~~~~~~W~S~t~ 109 (112)
T d1xd5a_ 75 -------------NTNRQNGNYYLILQRDRNVVIY-DNSNNAIWATHTN 109 (112)
T ss_dssp -------------CCCCSCCCCEEEECTTSCEEEE-CTTSCEEEECCCC
T ss_pred -------------eeccCCCceEEEEcCCCCEEEE-CCCCcEEecCCCc
Confidence 1222446789999999997766 2345688988763
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.56 E-value=1.3e-07 Score=93.15 Aligned_cols=149 Identities=15% Similarity=0.083 Sum_probs=103.4
Q ss_pred HHHhhcCCCCccceecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeE
Q 005669 511 IIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERM 589 (684)
Q Consensus 511 ~l~~~t~~y~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~ 589 (684)
++....+.|+..+..+-++...||+... +++.+++|+...........+.+|...+..+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444456676655544444578998864 56778888876554444556788888888774 545788888888899999
Q ss_pred EEEEccCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 005669 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS--------------------------------- 636 (684)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--------------------------------- 636 (684)
+|||+++|.++...... ......++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 99999999888654411 1112334555666666666421
Q ss_pred -----------------------CCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 637 -----------------------RLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 637 -----------------------~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999876677999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.93 E-value=1.6e-05 Score=77.25 Aligned_cols=131 Identities=18% Similarity=0.181 Sum_probs=87.4
Q ss_pred eecccCc-EeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccC--CCceeeEEEEEEeCCeeEEEEEccCCCCh
Q 005669 524 KLGEGGF-GPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ--HRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (684)
Q Consensus 524 ~LG~G~f-G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (684)
.+..|.. +.||+....++..+++|...... ...+..|...++.+. ...+.+++.+..+++..++|||+++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555553 67899988778888999876543 234677888777663 34467888888888889999999998765
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 005669 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ---------------------------------------------- 634 (684)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~---------------------------------------------- 634 (684)
.... .... .++.++++.|.-||+
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3210 1111 112223333333332
Q ss_pred -----C----CCCceEecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 635 -----D----SRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 635 -----~----~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
. .+..++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 112479999999999999877778999998865
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.64 E-value=7.5e-05 Score=77.62 Aligned_cols=76 Identities=12% Similarity=0.159 Sum_probs=50.9
Q ss_pred cceecccCcEeEEEEEeeC-CcEEEEEEccCC-------CcccHHHHHHHHHHHhccC-C--CceeeEEEEEEeCCeeEE
Q 005669 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-------SGQGMEEFKNEVLLIAKLQ-H--RNLVKLLGCCTQRDERML 590 (684)
Q Consensus 522 ~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~-------~~~~~~~~~~Ei~~l~~l~-H--~nIv~l~g~~~~~~~~~l 590 (684)
.+.||.|....||+....+ ++.++||.-... .+...++...|.+.|+.+. + ..+++++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3579999999999998755 678999975321 1223456667888887663 3 346666654 4556789
Q ss_pred EEEccCCCC
Q 005669 591 IYEYLPNKS 599 (684)
Q Consensus 591 V~Ey~~~gs 599 (684)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.91 E-value=0.0015 Score=65.48 Aligned_cols=135 Identities=12% Similarity=0.134 Sum_probs=78.7
Q ss_pred EeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCce--eeEE-----EEEEeCCeeEEEEEccCCCChh--
Q 005669 531 GPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL--VKLL-----GCCTQRDERMLIYEYLPNKSLD-- 601 (684)
Q Consensus 531 G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI--v~l~-----g~~~~~~~~~lV~Ey~~~gsL~-- 601 (684)
-.||++...+|+.+++|..+.. ....+++..|...+..|....+ +..+ ......+..+.++++++|..++
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999988999999998754 3345778889888887743222 1111 1224466778999999874432
Q ss_pred ---HH------H---hc------cCCCCCCCH-------------------HH---HHHHHHHHHHHHHHH-HhCCCCce
Q 005669 602 ---YF------I---FD------TTRSKLLDW-------------------SK---RSHIIAGIARGLLYL-HQDSRLRI 640 (684)
Q Consensus 602 ---~~------l---~~------~~~~~~l~~-------------------~~---~~~i~~qi~~gL~yL-H~~~~~~I 640 (684)
.+ + +. ......++. .. ....+.++...+.-. .+..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 11 0 00 000111111 11 112222233222222 12234568
Q ss_pred EecCCCCCcEEEcCCCcEEEEeeccccc
Q 005669 641 IHRDLKASNVLLDNTMNPKISDFGLARS 668 (684)
Q Consensus 641 vHrDLkp~NILl~~~~~vkI~DFGla~~ 668 (684)
||+|+.|.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.39 E-value=0.0039 Score=64.13 Aligned_cols=72 Identities=17% Similarity=0.231 Sum_probs=49.7
Q ss_pred ceecccCcEeEEEEEeeC--------CcEEEEEEccCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeeEEEEE
Q 005669 523 NKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYE 593 (684)
Q Consensus 523 ~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E 593 (684)
+.|+.|-.-.+|+....+ .+.|.+++.-. ........+|..+++.+. +.-..++++++.. .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 578888889999998654 24566666542 223445668888888885 4334577877642 68899
Q ss_pred ccCCCCh
Q 005669 594 YLPNKSL 600 (684)
Q Consensus 594 y~~~gsL 600 (684)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.17 E-value=0.07 Score=52.24 Aligned_cols=157 Identities=15% Similarity=0.065 Sum_probs=80.9
Q ss_pred cHHHHHhhcCCCCccc-----eecccCcEeEEEEEeeCCcEEEEEEccCCCcccHHHHHHHHHHHhccCCCce--eeEEE
Q 005669 508 DLKIIANATDNFSEKN-----KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL--VKLLG 580 (684)
Q Consensus 508 ~~~~l~~~t~~y~~~~-----~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI--v~l~g 580 (684)
+.++++....+|.+.+ .|..|---+.|+....+| .+++|+.... ...+++..|+.++..+.+.++ ...+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccce
Confidence 3456666667776533 345666678899887555 5889988643 223455566777766642222 11110
Q ss_pred ------EEEeCCeeEEEEEccCCCChhHH--------------Hhcc------CCCCCCCH------------------H
Q 005669 581 ------CCTQRDERMLIYEYLPNKSLDYF--------------IFDT------TRSKLLDW------------------S 616 (684)
Q Consensus 581 ------~~~~~~~~~lV~Ey~~~gsL~~~--------------l~~~------~~~~~l~~------------------~ 616 (684)
+.........++.+..+...... ++.. ........ .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 12234556667777665433110 0000 00000000 0
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCcEEEEeecccc
Q 005669 617 KRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (684)
Q Consensus 617 ~~~~i~~qi~~gL~yLH~-~~~~~IvHrDLkp~NILl~~~~~vkI~DFGla~ 667 (684)
.....+..+...+.-.+. .-+.++||+|+.+.||+++.+...-|+||+.|.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111122222222222222 123469999999999999988777899999875
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.50 E-value=0.014 Score=36.42 Aligned_cols=33 Identities=33% Similarity=0.794 Sum_probs=26.0
Q ss_pred cCCCccCCCCCCcccccCCCCCcccccCCCccCC
Q 005669 312 DQCDSYALCGAYASCNINSNSPECECLQGFVPNS 345 (684)
Q Consensus 312 ~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~~ 345 (684)
|+|.+-+.||. |.|+.--..-.|.|-.||+|..
T Consensus 2 dECsignpCGn-GTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCGN-GTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSSS-SCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccCC-ceeeecccceEEeecCCcCCCc
Confidence 78999999995 8897643333799999999853
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.28 E-value=0.08 Score=35.10 Aligned_cols=32 Identities=34% Similarity=0.708 Sum_probs=24.5
Q ss_pred cCCCc-cCCCCCCcccccCCCCCcccccCCCcc
Q 005669 312 DQCDS-YALCGAYASCNINSNSPECECLQGFVP 343 (684)
Q Consensus 312 ~~C~~-~~~CG~~g~C~~~~~~~~C~C~~gf~~ 343 (684)
|+|.. ...|..+|.|......-.|.|++||.-
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G 36 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYTG 36 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEES
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCcC
Confidence 56875 468999999986543337999999963
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.60 E-value=0.16 Score=32.95 Aligned_cols=31 Identities=32% Similarity=0.758 Sum_probs=22.8
Q ss_pred cCCCccCCCCCCcccccCCCCCcccccCCCcc
Q 005669 312 DQCDSYALCGAYASCNINSNSPECECLQGFVP 343 (684)
Q Consensus 312 ~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~ 343 (684)
|+|. ...|-..|.|......-.|.|++||.-
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G 31 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEG 31 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEET
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCc
Confidence 4566 367999999976543338999999864
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.65 E-value=0.4 Score=31.68 Aligned_cols=32 Identities=25% Similarity=0.574 Sum_probs=24.0
Q ss_pred ccCCCccCCCCCCcccccCCCCCcccccCCCcc
Q 005669 311 LDQCDSYALCGAYASCNINSNSPECECLQGFVP 343 (684)
Q Consensus 311 ~~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~ 343 (684)
-|+|.... |+.++.|.....+-.|.|++||..
T Consensus 5 idEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEPD-VCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCcC-CCCCCEeECCCCCeEeECCCCccc
Confidence 47898655 557899987654437999999975
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.10 E-value=0.26 Score=31.91 Aligned_cols=31 Identities=26% Similarity=0.609 Sum_probs=22.5
Q ss_pred cCCCccCCCCCCcccccCCCCCcccccCCCcc
Q 005669 312 DQCDSYALCGAYASCNINSNSPECECLQGFVP 343 (684)
Q Consensus 312 ~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~ 343 (684)
|+|.. ..|...|.|......-.|.|++||.-
T Consensus 2 d~C~~-~PC~n~g~C~~~~~~y~C~C~~G~~G 32 (39)
T d2vj3a2 2 NECVS-NPCQNDATCLDQIGEFQCICMPGYEG 32 (39)
T ss_dssp CTTTT-CCCCSSCEEEECSSCEEEECCTTEES
T ss_pred cCCcC-CCCCCCCEEECCCCCEEEeCCCCCcc
Confidence 45643 56999999976544337999999864
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.67 E-value=0.23 Score=32.15 Aligned_cols=32 Identities=41% Similarity=0.600 Sum_probs=24.0
Q ss_pred ccCCCccCCCCCCcccccCCCCCcccccCCCcc
Q 005669 311 LDQCDSYALCGAYASCNINSNSPECECLQGFVP 343 (684)
Q Consensus 311 ~~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~ 343 (684)
.|+|. ...|-..|.|......-.|.|++||.-
T Consensus 3 ~d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G 34 (39)
T d1edmb_ 3 GDQCE-SNPCLNGGSCKDDINSYECWCPFGFEG 34 (39)
T ss_dssp CCTTT-TCCCCTTCEEEEETTEEEEECCTTCCS
T ss_pred cccCC-CCCCCCCcEEEcCCCCEEEECCCCCCC
Confidence 36787 477999999976544337999999963
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.40 E-value=0.39 Score=31.37 Aligned_cols=31 Identities=26% Similarity=0.647 Sum_probs=23.0
Q ss_pred cCCCccCCCCCCcccccCCCCCcccccCCCccC
Q 005669 312 DQCDSYALCGAYASCNINSNSPECECLQGFVPN 344 (684)
Q Consensus 312 ~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~ 344 (684)
|+|...+.| ..+|.....+-.|.|++||...
T Consensus 2 dEC~~~~~C--~~~C~n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 2 DECQDPDTC--SQLCVNLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp CTTTTTTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred ccCCCCCCC--CCEeECCCCCEEeECCCCCeEC
Confidence 678877777 4589765444379999999864
|